,ticker,content
0,ALGN,medical product stock align technology pull back session friday breaking week rally trip stock selling signal swing trade investor developer widely used clear orthodontic brace break cup handle base april align technology algn immediately drop more base buy point trigger automatic cut loss rule share turn retook buy point healthy trade week advance drive share high june april entry slim investor have take least profit stock climb past gain mark end active short term investor also have carved piece profit stock break day move average friday be first such break retake buy point get newsletter deliver inbox more info product service privacy policy term day day line act early warning device help lock profit be entirely possible stock reverse course surge new high equally likely stock fall further settle consolidation likely eventually produce buy point odd suggest take piece position table defense possibility lead more gain pain be reason exit stock entirely san jose calif base company prospect remain healthy analyst consensus project ep gain year follow advance revenue be forecast grow year consensus view look ep gain second quarter align have clear consensus expectation past quarters beat range company be due moderation growth big cap stock annual revenue surge last year be set break barrier annual earning growth accelerate last year quarterly ep growth rate hit sharp slowdown level trigger form sell signal related use day move average get ahead sell signal know sell signal earning slowdown say sell be far abiom more growth stock medical sector run
1,ALGN,earning tap apr ibd sector leader member align technology algn be trading approximately buy point entry be base third stage cup handle be less likely earlier stage base generate big new run buy stock just ahead earning be risky typically don have enough time build profit cushion latest quarterly number come be sure follow sound buy sell rule minimize exposure look winning stock try simple routineregard top bottom line number align technology have post quarters increase earning growth revenue growth have also moved higher same period analyst expect earning share growth quarter growth full year annual growth estimate be recently revise lower company have composite rating hold rank peer medical product industry group align technology algn globus medical gmed be also group highest rate stock note date earning report be subject change check company update get newsletter deliver inbox more info product service privacy policy term also earning calendar analyst estimate stock watchnew option strategy limit risk earning
2,ALGN,align technology algn company help straighten tooth have straighten own stock chart stock be form cup handle base buy point much handle have form past week be partly submerge day move average successful seldom
3,ALGN,cup handle double bottom success depend way stock rise fall base third pattern show stock choose take neither path big move north rather go uptrend downtrend stock move sideway week month action lack become call flat base pattern often form stock break cup other base gain ground few week then stall market not be ready rally strongly be still weak flat base reflect unusual strength instead bend lower hold steady price action tell stock want run higher market finally begin rally stock explode crouch position get newsletter deliver inbox more info product service privacy policy term usea flat base be least week length last much longer base percentage decline stock high low usually range stock drop base institutional investor step shore stock stock doesn fall much more investor overall feel comfortable stock current price buy stock rise cent highest price flat base sometimes price high be find left end base other case high be middle base right just add cent price find pivot buy close possible price point don chase already more pivot oracle orcl database commerce software giant muscle month cup handle session stock rise hit new high fine start market suffer choppy action nasdaq tumble next week yet hold day move average week later stride new high next week see nasdaq fall briefly day oracle dig heel growth stock tend fall time correction major index not oracle stock hold most week flat base intraday basis be more high high left side flat base be add dime get buy point oracle briefly poke flat base buy point week end oct stumble week later oracle drop more prime entry usher golden rule investing breakout turn be fakeout however day nasdaq stage follow day oct oracle break real rally heavy volume straight session follow be critical signal market have possibly bottom be ready significant turn higher time oracle score excellent earning share rating see ibd stock checkup smr sale margin return equity stock relative strength line paint blue ibd daily weekly chart shove new high ground enterprise software group be rank third group oracle gain march peak here be more good flat basis form yielded strong breakout align technology algn feb week flat base begin dec invisible brace marketer peaked total decline base heavy volume be largely absent align clear buy point yet check strong gain feb follow quarterly result align gap turnover boom average be clear sign strong institutional buy see historical chart align other stock go marketsmith ibd advanced charting stock screening service control ctrl july volume power day move average day small cap stock volume often rocket double triple average level total decline base notice weekly chart base form week move average contain stock move week line be draw red ibd chart marketsmith arista network anet breakout nov feb first flat base arista take minimum week complete base sit top much larger first stage construction proper buy point be total decline base second flat base arista vault base breakaway gap past feb datum center networking play open proper buy point give huge open move strong fundamental have be perfectly acceptable buy right open arista finished session turnover mushroomed share average total decline week base version column be originally publish march edition ibd please follow saito chung twitter ibd_dchung additional stock market analysis get instant access more trading idea exclusive stock list ibd proprietary rating only related cup handlewhat double bottom base look find outstanding stock follow simple routinefind proper entry stock buy zonewhat be stock market do right now keep rise read column day
4,ALGN,stock index get back bullish track thursday stock market return july upward bias nasdaq advanced hit record high dow jone industrial average rise respectively small cap russell edge volume fall nyse rise nasdaq president donald trump remove negative influence stock market comment nato trump claim victory effort increase europe contribution defense spending accord new york time leader nato nation say agree such thing stock market however take news cue rise get newsletter deliver inbox more info product service privacy policy term innovator ibd fund ffty gap padded position day move average exchange trade fund reflect action ibd stock gain include chipmaker texas instrument txn open source software provider red hat rht clear dental brace maker align technology algn payment processor total system service tss aerospace play northrop grumman noc total system service show best action chartwise stock pop clear buy point deep channel volume be average pattern be third stage carry challenge quality breakout be scarce europe pierre moscovici commissioner economic financial affair taxation custom say threat trade war be hurt europe economy ec cut economic forecast year ec expect growth previous estimate first time jobless claim rolled vs consensus estimate consumer price index june come vs view related apple oil stay ahead packnetflix loom result drive stock higheroil stock have big footprint unlikely screen be outperform stock market
5,ALGN,company qualify potential warren buffett stock oracle omaha have never written book detail investment strategy definitive buy checklist part stock pick strategy be glean annual report berkshire hathaway brkb screen highlight stock nvidia nvda adobe adbe be sync buffett focus management quality long term growth create marketsmith screen emphasize metric look company long term past potential future growth make list stock meet wide range criterium include include nvidia adobe alarm com alrm several technology stock make list doesn mean buffett necessarily buy share company do show meet fundamental metric track keep mind buffett have reputation avoid tech stock apple aapl have now become berkshire hathaway largest investment surpass well fargo wfc stock currently make cut only top stock base composite rating be list get newsletter deliver inbox more info product service privacy policy term create used marketsmith datum june investor business daily used different stock pick strategy buffett several stock list have also earn spot ibd other ibd screen adobe align technology algn huazhu htht formerly know china lodging copart cprt stamp com stmp nvidia be ibd list today top growth stock nvidia adobe align technology be also sector leader screen ll find adobe align ibd big cap align technology have so far manage shake recent selling pressure general market several stock list include stamp com nvidia have pull back stock market be pressure be now best avoid new buy look stock show resilience find support key move average line adobe copart stamp com other be currently testing support week line nvidia fall benchmark heavy volume monday rise tuesday wasn enough retake line fox factory foxf have be buck market trend relative strength line jump new high ground tuesday stock clear entry average volume get instant access more trading idea exclusive stock list ibd proprietary rating only also warren buffett berkshire hathaway now own nearly apple stocklooking potential stock start hereimprove stock pick skill simple step routine
6,ALGN,small cap have be move rank diversify growth stock fund base year date performance small cap growth fund make etf performance table finished upper half lead ishare small cap growth ijt year date gain well ahead return etf be just recent record high be trading top buy range buy point fund biggest sector weighting be health care nearly industrial follow information technology consumer discretionary financial roughly top holding include cheme che firstcash fcfs stamp com stmp ligand pharmaceutical lgnd large cap growth fund powershare pure growth rpg come second year date gain rpg be work right side shallow base potential entry fund be top netflix nflx adobe system adbe align technology algn nvidia nvda amazon com amzn together account just north asset third place go ishare russell growth iwo provide access small cap company average earning growth rate vs market fund be buy range entry cup handle base health care information technology make biggest sector top hold include biotechs nektar therapeutic nktr exact science exas well tech name grubhub grub aspen technology azpn get newsletter deliver inbox more info product service privacy policy term small cap growth vbk place sixth ytd return fund track crsp small cap growth index remain buy zone entry industrial technology financial be biggest sector weight respectively financial service provider transunion tru salvage vehicle auction firm copart cprt financial software maker ss technology ssnc be top holding ibd innovator ffty morningstar classify mid cap growth etf make cut ytd return fund track ibd index see biggest month gain share be potential buy point ffty count baozun bzun align technology grubhub trade desk ttd top holding also here gauge trump tariff impact stock market idea consider stock market be make nervousgrowth cloud compute be encapsulate fund
7,ALGN,stock market be mixed mostly unchanged afternoon trading friday quiet session come ahead president trump press conference et discuss drug price session streak be jeopardy nasdaq composite selling pressure be muted be dow jone industrial average outperformed gain edge higher volume be tracking lower nyse nasdaq update story other market coverage visit stock market today ipo news china base huya huya price last night open share recently exchange hand yy yy spinoff be china top video game livestream platform sale totale sharply trade desk ttd be big winner share gap soar strong earning share be recently trading well stock open price stock gap buy point buy close open price possible share weight watcher wtw be flirt new high company thursday announce secondary share offer price stock have be volatile earning report latest consolidation show erratic weekly price swing be flaw also later stage consolidation big move already ibd align technology algn touch new high share be biotech ligand pharmaceutical lgnd meanwhile add nearly still buy range double bottom base entry related news innovator ibd etf ffty give back exchange trade fund be celebrate year anniversary just receive strong star rating morningstar crude oil future edge lower barrel year treasury yield inched basis point related best stock buy watcher charge meal kit melee walmartsee stock moved ibd growth screen
8,ALGN,market remain confirm uptrend solid loss last day major stock index be bit worrisome weakness breakout top growth stock align technology algn past several week have produce mixed result condition recent breakout provide great deal insight strength broader market top financial stock retail brokerage firm trade financial etfc interactive broker ibkr announce strong quarterly earn result week reaction be mixed trade top earning estimate thursday spark advance friday highest level november move stock buy range stock break march heavy volume cup shape base entry brief pullback day line find support stock be trading buy range top get newsletter deliver inbox more info product service privacy policy term usemeanwhile interactive broker be just flat base entry wednesday stock reaction earning wasn great stock be still hold past day weakness stock market so patience be justified canada goose goos surge cup handle entry thursday volume increase average ipo leader swingtrader idea be trading modestly entry friday afternoon be take patience leaderboard member planet fitness plnt be trading tightly buy range solid april relative strength line inked blue marketsmith chart be hit new high underscore stock strength downside align technology plunge nearly thursday morgan stanley downgrade stock overweight equal weight stock fall trigger loss cut sell signal cup handle entry however be major flaw stock base pattern first cup handle be later stage base increase risk failure second stock april only be describe meek stock briefly poke entry close just volume be tepid day leave doubt stock strength volume increase least average elsewhere lgi home lgih faltered thursday weakness overall homebuilder group share be cup handle entry related rise netflix oil chip apple tumble weekly reviewbank financial stock latest news analysis rule buy stock salesforce earning season
9,ALGN,ibd stock screen be regularly update add new stock watch well weed have start show weakness table ll see stock have be add remove list ibd sector leader ibd big cap screen be
10,ALGN,tough week many growth stock find ibd stock spotlight list stalwart shape only few case moderate stock chart damage several include pagseguro pag floor decor fnd gain ground week stock market today see couple align technology algn floor decor end week poise buy point
11,ALGN,ibd smartselect composite rating resm rmd rise monday revise score mean stock currently top other stock term key performance metric technical strength history show top market performer tend have higher score launch major climb resm be now buy range clear entry cup handle see ibd help make more money stock stock have ep rating meaning recent quarterly longer term annual earning growth be outpace stock accumulation distribution rating show roughly equal amount buy selling institutional investor last week get newsletter deliver inbox more info product service privacy policy term usein company report earning growth sale growth climb prior quarter mark quarter increase revenue gain resm hold rank peer medical product industry group abiom abmd align technology algn quidel qdel be top highly rate stock group get instant access more trading idea exclusive stock list ibd proprietary rating only related company be now outperform stock see stock just come ibd top stock list
12,ALGN,welcome move intersect ent xent see relative strength rating rise thursday look best stock buy watch factor watch closely be relative price strength ibd proprietary rating identify market leadership worst best score grade show stock price behavior trail week hold other stock database decade market research show best perform stock typically have higher rs rating launch largest climb see intersect ent continue rebound hit benchmark look winning stock try simple routinenow be not ideal time jump isn proper buy zone see stock manage establish enter buy range heavy trade earning growth rise company latest report sale fall next quarterly result be expect aug company hold rank peer medical product industry group abiom abmd align technology algn inogen ingn be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term useget instant access more trading idea exclusive stock list ibd proprietary rating only also ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
13,ALGN,build earning season watch list look stock potential buy range ahead next report edward lifescience ew currently fit bill company be expect release latest number jul trading buy point first stage flat base be aware buy just stock report be risky poor number send sharply lower reduce risk wait see actual number market reaction way minimize risk post earning sell be use option strategy look winning stock try simple routinewhile revenue growth fall last quarter bottom line grow previous report analyst expect earning growth quarter growth full year annual ep estimate be recently revise upward company have composite rating earn rank peer medical product industry group abiom abmd align technology algn inogen ingn be top highly rate stock group note date earning report be subject change check company update get newsletter deliver inbox more info product service privacy policy term useget instant access more trading idea exclusive stock list ibd proprietary rating only also earning calendar analyst estimate stock watchnew option strategy limit risk earning
14,ALGN,intersect ent xent have relative strength rs rating upgrade friday welcome improvement still short better score prefer see try find best stock buy watch be sure pay attention relative price strength ibd proprietary rs rating track market leadership show stock price action last week compare other stock database decade market research reveal best perform stock tend have higher rs rating begin biggest price move see intersect ent continue show renew price strength clear threshold look best stock buy watch start hereintersect ent be not currently potential buy zone see stock go build base launch new move revenue growth fall last quarter ep grow previous report company be expect report latest number aug company hold rank peer medical product industry group abiom abmd align technology algn quidel qdel be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term useget instant access more trading idea exclusive stock list ibd proprietary rating only also stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
15,ALGN,stryker syk have relative strength rs rating upgrade tuesday welcome improvement still better score look re research best stock buy watch be sure pay attention relative price strength proprietary rating measure market leadership used worst best score show stock price action last week compare rest market history reveal market biggest winner often have higher rs rating begin largest run see stryker continue show renew price strength hit benchmark look winning stock try simple routinewhile not currently ideal time jump see stock go form consolidation break company show earning growth last quarter sale gain come stryker earn rank peer medical product industry group abiom abmd align technology algn icu medical icui be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term also stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
16,ALGN,welcome move medical wmgi see relative strength rating improve friday look best stock buy watch keep close eye relative price strength ibd unique rs rating track technical performance used worst best score identify stock price action last week stack other stock database year market history show market biggest winner typically have better rs rating launch largest run see medical continue rebound hit benchmark look winning stock try simple routinewhile not currently ideal time buy share see stock go form consolidation break earning growth rise last quarter sale fall medical earn rank peer medical product industry group abiom abmd align technology algn icu medical icui be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term also ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
17,ALGN,ibd stock screen be regularly update add new stock watch well weed have start show weakness table ll see stock have be add remove list ibd sector leader ibd big cap screen be
18,ALGN,stock market open sharply lower monday stock index significantly trim loss morning trade ism manufacturing index unexpectedly rise june consensus estimate show index drop top stock tesla tsla race higher report bullish model production be near potential buy point update story other market coverage visit stock market today initially tech heavy nasdaq lead broad market lower decline pare loss just et dow jone industrial average fall respectively dow stock apple aapl continue trade just day line share rise downside energy component chevron cvx fall stock be still etching handle cup formation show buy point get newsletter deliver inbox more info product service privacy policy term usetesla tsla race almost higher early monday ceo elon musk say company produce model sedan last week reach production goal share be away potential buy point chinese lead stock be once again pressure monday alibaba baba fall be back long term day move average line last week stock trigger loss cut sell rule double bottom entry fizzle rival jd com jd slip stock be seek support day line be form right side potential base have great deal work ahead meanwhile relative strength line be lag show significant market fang stock netflix nflx be biggest loser fall just market open stock trim loss just week stock reach profit take level flat base entry accord marketsmith chart analysis share have fall last trading session meanwhile alphabet googl fall trade day line key support level share be handle entry double bottom base top growth stock oil gas stock viper energy partner vnom moved shape right side shape potential base however current structure be still too short be cup shape base minimum length be week stock rs line have rise sharply last week downside align technology algn fall stock have fall time high last week be head test day move average get instant access more trading idea exclusive stock list ibd proprietary rating only related tesla sale trump trade war job datum fed minute investing action planstock market forecast next month expect ibd stock daydow jone industrial average dow stock news analysis
19,ALGN,boston scientific bsx have relative strength rs rating upgrade tuesday look best stock buy watch factor watch closely be relative price strength proprietary rating identify technical performance used worst best score indicate stock price action trail week match rest market history show top perform stock typically have higher rs rating launch biggest run look winning stock try simple routineboston scientific have rise more past entry first stage consolidation meaning now proper buy zone look stock offer new chance pick share week tight pullback day week line company report ep growth last quarter sale growth come boston scientific earn rank peer medical product industry group abiom abmd align technology algn icu medical icui be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term also stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
20,ALGN,monday glaukos gkos get positive adjustment relative strength rs rating look best stock buy watch factor watch closely be relative price strength ibd proprietary rs rating track technical performance show stock price movement last week measure other stock major index year market history show market biggest winner typically have rs rating north launch biggest price move see ibd help make more money stocksglaukos be now consider extend buy range clear buy point first stage consolidation see stock form new pattern follow buy opportunity week tight pullback day week line glaukos report ep growth latest quarterly report revenue increase company earn rank peer medical product industry group abiom abmd align technology algn icu medical icui be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term also stock be show rise relative strength use ibd relative strength rating relative strength line help judge stock
21,ALGN,edward lifescience ew have relative strength rs rating upgrade tuesday look best stock buy watch factor watch closely be relative price strength ibd unique rs rating track technical performance used worst best score show stock price performance trail week match rest market history reveal market biggest winner often have rs rating north early stage move see ibd help make more money stocksedward lifescience be still buy range breaking past buy point flat base once stock move higher original entry consider extend buy range company top line growth fall last quarter ep grow prior report company earn rank peer medical product industry group abiom abmd align technology algn icu medical icui be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term also stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
22,ALGN,teleflex tfx see ibd smartselect composite rating rise monday day new rating show stock be outpace stock come most important stock pick criterium best stock tend have better grade start significant move so be sure keep mind look best stock buy watch teleflex be currently form consolidation buy point see stock break heavy trade least average look winning stock try simple stock have ep rating meaning recent quarterly annual earning growth top stock accumulation distribution rating show roughly equal amount buy selling institutional investor last week get newsletter deliver inbox more info product service privacy policy term usein company report earning growth top line growth climb prior quarter mark quarter accelerate revenue increase teleflex earn rank peer medical product industry group abiom abmd align technology algn icu medical icui be top highly rate stock group related company be now outperform stock see stock just come ibd top stock list
23,ALGN,ibd smartselect composite rating edward lifescience ew increase monday new rating show stock be outpace stock come most important stock pick criterium market biggest winner often have higher grade early stage new price run so important benchmark look look best stock buy watch edward lifescience be currently form flat base buy point look stock break heavy trade least higher normal see ibd help make more money stock earn ep rating mean recent quarterly longer term annual earning growth be outpace stock accumulation distribution rating show roughly equal amount buy selling institutional investor last week get newsletter deliver inbox more info product service privacy policy term usein company report earning growth mark straight report rise ep gain top line growth come previous quarter edward lifescience earn rank peer medical product industry group abiom abmd align technology algn icu medical icui be top highly rate stock group related company be now outperform stock see stock just come ibd top stock list
24,ALGN,look best stock buy watch focus rise relative price strength stock fit bill be glaukos gkos have relative strength rs rating upgrade wednesday look best stock buy watch be sure pay attention relative price strength ibd unique rating identify share price action worst best score rating show stock price movement trail week stack other stock database history reveal stock go make biggest gain tend have rs rating begin biggest price move see ibd help make more money stocksglaukos be now consider extend buy range clear buy point first stage consolidation see stock form new pattern follow buy opportunity week tight pullback day week line company show ep growth latest quarterly report sale rise glaukos hold rank peer medical product industry group abiom abmd align technology algn icu medical icui be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term also stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
25,ALGN,look best stock buy watch focus rise relative price strength stock fit bill be intersect ent xent see welcome improvement relative strength rs rating friday upgrade look best stock buy watch factor watch closely be relative price strength unique rating track market leadership show stock price movement last week compare other stock database history reveal best perform stock often have rs rating launch biggest climb see ibd help make more money stock be not proper buy range right now see manage form break proper base earning growth picked last quarter sale fall intersect ent hold rank peer medical product industry group abiom abmd align technology algn icu medical icui be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term also ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
26,ALGN,relative strength rs rating livanova livn enter new percentile friday rise look best stock buy watch factor watch closely be relative price strength ibd proprietary rs rating measure market leadership used worst best score identify stock price action trail week match rest market decade market research show best stock typically have better rs rating begin biggest climb see ibd help make more money stockslivanova be buy range breaking past entry flat base once stock move higher original entry consider buy range livanova report earning growth most recent report revenue increase company hold rank peer medical product industry group abiom abmd align technology algn icu medical icui be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term also ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
27,ALGN,qiagen qgen see welcome improvement relative strength rs rating thursday rise try find best stock buy watch keep close eye relative price strength unique rating measure technical performance show stock price action last week compare other stock database history reveal stock go make biggest gain tend have rs rating north early stage move see qiagen continue rebound hit benchmark look best stock buy watch start hereqiagen be build consolidation buy point see clear price heavy trade earning grow last quarter prior report revenue also increase company hold rank peer medical product industry group abiom abmd align technology algn icu medical icui be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term also stock be show improve technical action use ibd relative strength rating relative strength line help judge stock
28,ALGN,relative strength rs rating glaukos gkos head higher percentile thursday get lift re research best stock buy watch keep close eye relative price strength ibd unique rs rating measure market leadership used worst best score indicate stock price performance last week match other stock decade market research reveal stock go make biggest gain tend have better rs rating begin largest price move see glaukos continue rebound clear threshold look best stock buy watch start hereglaukos be trading buy range climb buy point consolidation proper buy range extend initial entry once stock move range best set buy opportunity glaukos report ep growth latest quarterly report sale rise glaukos hold rank peer medical product industry group abiom abmd align technology algn icu medical icui be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term also stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
29,ALGN,retail stock garner more attention stock market fang name break major stock index turn mixed afternoon trading index moved lows minute early federal reserve meeting be release et minute show fed be willing let inflation briefly run level economy recover interest rate hike june meeting be fully expect point dow jone industrial average be weigh weakness share general electric ge share crash ceo john flannery say demand company heavy duty gas power turbine remain weak be mostly flat nasdaq composite edge higher strong gainer nasdaq include fang leaderboard name netflix nflx share rise nearly netflix daily chart show flat base entry volume nyse nasdaq stock market today be tracking slightly higher tuesday level buyer flocked bond send year treasury yield lower basis point stock market result today gap powerfully base help strong earning report share soar conventional buy point be cent april intraday high stock open price be also legitimate entry new addition leaderboard ralph lauren rl also gap earning top expectation sale decline straight quarter once again ibd serve plenty outperformer energy space wildhorse resource development wrd continue firm heavy volume selling earlier month share rise nearly other strong gainer ibd include align technology algn tal education tal abiom abmd crude oil future fall wednesday surprise jump weekly crude supply crude july delivery settle barrel related oil price sink shock opec russia eye option be paypal stock buyback announcement card analyst day retail commerce news stock watchamazon microsoft price target raise cloud compute leadership
30,ALGN,re look stock be set base ahead earning here fit bill merit medical system mmsi expect report apr be currently approximately shy entry chart pattern be first stage flat base understand buy stock just report be risky poor number send sharply lower reduce risk wait see company report market react look best stock buy watch start hereearning share growth decrease company most recent report revenue rise analyst be look ep growth quarter growth full year ep estimate full year be recently revise higher merit medical system have composite rating earn rank peer medical product industry group abiom abmd align technology algn globus medical gmed be top highly rate stock group note date earning report be subject change check company update get newsletter deliver inbox more info product service privacy policy term also earning calendar analyst estimate stock watchnew option strategy limit risk earning
31,ALGN,welcome move boston scientific bsx see relative strength rating improve tuesday look best stock buy watch factor watch closely be relative price strength ibd unique rating measure price performance worst best score rating show stock price behavior trail week compare other stock database decade market research show best stock tend have rs rating least begin biggest climb see boston scientific continue rebound hit benchmark look winning stock try simple routineboston scientific be work consolidation buy point see break volume least average ep growth decrease last quarter sale rise keep eye company next round number apr company hold rank peer medical product industry group abiom abmd align technology algn globus medical gmed be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term also ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
32,ALGN,keep watch list date be key make money stock market ibd help do regularly update stock screen ibd sector leader ibd big cap ipo leader table see stock have just be add remove list ibd display video id
33,ALGN,stock market rally lows final hour trading close squarely lower thursday lead growth stock atlassian team trade financial etfc skecher skx be prepare report quarterly earning release close bell stock market today tech heavy nasdaq decline fall dow jone industrial average give just buoy strong earning result american express axp share jump nearly stock be just flat base entry major index be hover just day move average line key support level watch volume be tracking modestly higher nyse nasdaq compare wednesday accord preliminary datum company report earning ibd name atlassian fall sharply close follow fiscal earning stock have mount furious rebound day line pierce level late march be quote day average extend trading skecher plunge extend trading follow earning report trade fall modestly follow quarterly report get newsletter deliver inbox more info product service privacy policy term usebig cap member trade moved company prepared announce earning close share be barely buy range previous entry find support day line late march rival charle schwab schw advanced almost attempt regain day line company report strong earning result monday lastly skecher be just flat base entry ahead earning release share slip regular trading fang stock be higher thursday shrug market sell amazon com rise almost ceo jeff bezos say annual letter shareholder company have exceed paid prime member globally leaderboard name extend streak session have bring stock back day line commerce giant be shape right side potential base alphabet googl facebook fb rise respectively alphabet be form new double bottom base buy point facebook continue rebound late march lows chip stock be batter taiwan semiconductor tsm lower full year sale forecast taiwan semi be major chipmaker partner apple aapl nvidia nvda morgan stanley say smartphone weakness be main reason revenue shortfall dow name apple fall almost still hold day line stock be draw flat base potential buy point meanwhile ibd name graphic chip maker nvidia decline share be be turn away day move average have become apparent resistance level top chip name micron technology mu apply material amat lam research lrcx hold loss exceed micron continue shape right side potential base barely cling day line meanwhile apply material lam continue break tuesday sell be well own day line lam report weak guidance late tuesday lastly mks instrument mksi stumble break day line heavy volume earning be due tuesday close featured today sector leader column lead growth stock half ibd stock have loss greater last hour market rally align technology algn trigger sell signal cup handle entry nearly fall be late stage base upside retailer canada goose goos rise break past cup handle entry however stock close buy point related oil stock buy saudis eye massive price spike ahead meetingdow jone industrial average dow stock news trade skecher nucor earning investing action planfang stock news quote facebook amazon netflix googlechip stock watch semiconductor industry news
34,ALGN,larry wood liken aortic stenosis cancer heart aortic stenosis be most common serious valve disease problem restrict blood flow left ventricle aorta cause fatigue pain occur birth defect elderly patient edward lifescience ew medtronic ticker
35,ALGN,here weekly investing action plan need know investor come week lead tech company facebook fb amazon amzn alphabet googl microsoft msft report earning aerospace defense giant boee ba oil major exxon mobil xom stock watch hot software stock
36,ALGN,repligen rgen see ibd smartselect composite rating jump wednesday day upgrade mean stock currently top other stock term key performance metric technical strength top perform stock tend have better grade kick significant move so be sure keep mind look best stock buy watch repligen be not currently proper buy zone see stock go form new base offer new buy opportunity look winning stock try simple stock sport ep rating meaning recent quarterly longer term annual earning growth top stock accumulation distribution rating show moderate buy institutional investor last week get newsletter deliver inbox more info product service privacy policy term usein company report ep growth have now post accelerate ep growth consecutive quarters revenue growth increase prior quarter company have now post accelerate growth last report repligen hold rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group related company be now outperform stock see stock just come ibd top stock list
37,ALGN,next earning report schedule apr merit medical system mmsi be trading approximately buy point chart pattern be first stage flat base keep mind risky buy stock just report reduce exposure wait see company report market react way minimize risk post earning sell be use option strategy look best stock buy watch start hereearning growth decrease last quarter revenue gain moved higher consensus analyst estimate call earning share growth quarter growth full year annual growth estimate be recently revise upward company have composite rating earn rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group note date earning report be subject change check company update get newsletter deliver inbox more info product service privacy policy term also earning calendar analyst estimate stock watchnew option strategy limit risk earning
38,ALGN,keep watch list date be key make money stock market ibd help do regularly update stock screen ibd sector leader ibd big cap ipo leader table see stock have just be add remove list ibd display video id
39,ALGN,ibd stock screen be regularly update add new stock watch well weed have start show weakness table ll see stock have be add remove list ibd sector leader ibd big cap screen be
40,ALGN,boston scientific bsx have relative strength rs rating upgrade friday welcome improvement still short higher score prefer see look best stock buy watch factor watch closely be relative price strength exclusive rating investor business daily track price performance worst best score rating show stock price movement trail week hold other stock database year market history reveal stock go make biggest gain often have higher rs rating launch biggest price move see boston scientific continue rebound hit benchmark see ibd help make more money stocksboston scientific be work consolidation entry see clear price heavy volume ep growth decline company most recent report sale rise look next report apr company earn rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term also stock be show rise relative strength use ibd relative strength rating relative strength line help judge stock
41,ALGN,ibd stock list be regularly update add new stock watch well weed have start show weakness table ll see stock have be add remove list ibd sector leader ibd big cap screen be
42,ALGN,ibd stock list be regularly update add new stock watch well weed have start show weakness table ll see stock have be add remove list ibd sector leader ibd big cap stock list
43,ALGN,relative strength rs rating merit medical system mmsi enter new percentile friday rise re research best stock buy watch be sure pay attention relative price strength exclusive rating investor business daily measure share price performance worst best score rating show stock price behavior trail week hold other stock database decade market research show best stock tend have rs rating north begin biggest run look best stock buy watch start herenow be not ideal time jump isn proper buy zone see stock be able form consolidation break earning growth decline company most recently report quarter revenue grow prior report company earn rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term also ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
44,ALGN,friday baxter international bax get positive adjustment relative strength rs rating re research best stock buy watch be sure pay attention relative price strength proprietary rating identify technical performance used worst best score identify stock price performance last week stack other stock database year market history show best perform stock tend have better rs rating early stage move see baxter international continue show renew price strength clear threshold look best stock buy watch start herebaxter international be try complete flat base buy point see clear price heavy trading baxter international show earning growth last quarter revenue increase baxter international hold rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term also stock be show rise relative strength use ibd relative strength rating relative strength line help judge stock
45,ALGN,nephew snn see positive improvement relative strength rs rating friday rise look best stock buy watch factor watch closely be relative price strength exclusive rating investor business daily measure share price performance worst best score score show stock price behavior last week compare other stock database year market history show stock go make biggest gain typically have rs rating least launch largest price move see nephew continue show renew price strength hit benchmark see ibd help make more money nephew be build consolidation entry see stock clear price heavy trading nephew report ep growth most recent report revenue rise company earn rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term also ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
46,ALGN,invisalign maker align technology algn share pop hour then quickly reversed wall street digest earning result estimate increase share profit cent revenue growth accord zack investment research result diluted ep just cent due negative impact share change tax law adjust align earn share company report sale total case shipment rise quarter case teenage patient record revenue be year year drive increase invisalign volume geography customer channel well record itero scanner revenue say ceo joe hogan statement invisalign volume be year year reflect strong international growth increase utilization expansion customer base include new customer third consecutive quarter stock share maker clear dental aligner device initially sky-rocket late trade then quickly reversed lower trade slide stock market today earlier tuesday share have tumble much briefly sank day move average align intraday breach key level violate previous buy point however stock regain support day intraday show strength wake earning result have potentially translate fresh buy opportunity align have rally more first stage most recent base be third stage carry greater risk failure ibd take buy hold stock be risky head earning report here earning option strategy help cash post earning stock gain minimize risk weak quarter elsewhere health care space amazon amzn berkshire hathaway brkb jpmorgan chase jpm shake sector announce plan improve health care cost service american employee health care pharmacy benefit manager pbm stock sell tuesday cvs health cvs unitedhealth unh express script esrx take big hit be interested abiom arista align yy read stock rebound fast grow sector leader tell different story ahead earningschip stock watch semiconductor industry newsstock buy watch top ipos big small cap growth stockslooking best stock buy watch start here
47,ALGN,tuesday heavy stock market loss show common trait ibd sector leader sharp rebound early sell off rebound align technology algn yy yy abiom abmd arista network anet be similar left investor face array chart situation arista abiom re-cover steepest decline arista drop
48,ALGN,build watch list focus stock higher rs rating neogen neog now meet criterium jump wednesday look best stock buy watch keep close eye relative price strength ibd proprietary rating identify market leadership worst best score score show stock price movement last week hold other stock database year market history reveal top perform stock typically have rs rating north launch biggest climb look winning stock try simple routineneogen break earlier have fall back prior entry consolidation stock re tracking break past buy point then fall more original entry price consider fail base best stock form new consolidation also keep mind latest consolidation be later stage base such basis be more prone failure earning growth picked last quarter sale fall look next report mar neogen earn rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
49,ALGN,ibd stock screen be regularly update add new stock watch well weed have start show weakness table ll see stock have be add remove list ibd sector leader ibd big cap screen be base proprietary slim investing system look stock display common trait typically share best perform stock early stage big price move check column day help build maintain watch list alert most recent change never buy stock just ibd list be sure do own research run stock idea buy checklist use ibd simple step routine quickly track general market trend find stock watch pinpoint best time buy sell change make march pm et ibd flagship screen lead growth stock give company show strong relative price strength top notch fundamental decide stock buy always check new innovative stock historically far outperform get newsletter deliver inbox more info product service privacy policy term useibd most stringent powerful screen sector leader highlight best stock ibd sector sector leader show outstanding earning sale growth recent quarters be strong many other fundamental price performance metric daily screen uncover top rate large cap growth stock consideration big cap company deliver outsize gain volatility smaller growth stock stock market newest company be find biggest winning stock time initial public offering ipos be typically early stage growth big earning growth generally fuel stock price performance ipo leader have special screening criterium find come stock strong fundamental technical trait daily stock list ibd seek good stock buy top fundamental be get ready break use glean emerge industry sector trend market view prior ibd stock list also look next big stock start herewhich company be now outperform stock buy stock buy checklistwhen sell stock selling checklist
50,ALGN,ibd stock screen be regularly update add new growth stock watch well weed have start show weakness new feature publish weekday evening market close ll see stock have be add remove list ibd sector leader ibd big cap screen be base proprietary slim investing system look stock display common trait typically share best perform stock early stage big price move check column day help build maintain watch list alert most recent change never buy stock just ibd list be sure do own research run stock idea buy checklist use ibd simple step routine quickly track general market trend find stock watch pinpoint best time buy sell change make march pm et ibd flagship screen lead growth stock give company show strong relative price strength top notch fundamental decide stock buy always check new innovative stock historically far outperform get newsletter deliver inbox more info product service privacy policy term useibd most stringent powerful screen sector leader highlight best stock ibd sector sector leader show outstanding earning sale growth recent quarters be strong many other fundamental price performance metric daily screen uncover top rate large cap growth stock consideration big cap company deliver outsize gain volatility smaller growth stock stock market newest company be find biggest winning stock time initial public offering ipos be typically early stage growth big earning growth generally fuel stock price performance ipo leader have special screening criterium find come stock strong fundamental technical trait daily stock list ibd seek good stock buy top fundamental be get ready break use glean emerge industry sector trend market view prior ibd stock list also look next big stock start herewhich company be now outperform stock buy stock buy checklistwhen sell stock selling checklist
51,ALGN,have lip smack satisfying month have sometimes feel none stock go january be kind month big congrats past be past do avoid big flop february golf know birdies shot par be hard
52,ALGN,neogen neog be expect report earning mar stock be now trading buy point second stage consolidation clear earlier buy stock just ahead earning be risky typically don have enough time build profit cushion latest quarterly number come be sure follow sound buy sell rule minimize exposure look winning stock try simple routineearning growth increase last quarter sale fall analyst expect ep growth quarter growth full year ep estimate full year be recently revise upward neogen have composite rating earn rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group note date earning report be subject change check company update related earning calendar analyst estimate stock watchnew option strategy limit risk earning
53,ALGN,major stock index be serious selling pressure late afternoon trading friday negative sentiment be fuel high profile earning report big jump year treasury yield nasdaq name alphabet googl apple aapl amazon com amzn make headline friday report earning alphabet plunge apple give back leaderboard name amazon be bright spot rise hour remain session dow jone industrial average be lose nasdaq composite slump volume exchange be tracking slightly higher thursday level stock market today nasdaq still have breathe room day move average key support level watch major stock index be pace notch weekly loss more exxon mobil xom chevron cvx lead dow lower loss not plunge oil price new york mercantile exchange crude oil future edge lower barrel money plow bond again january job growth come better expect year treasury yield be recently trading basis point nonfarm payroll increase slightly better consensus estimate wage growth be strongest wall street be worry inflation become issue economic datum stay robust force federal reserve be more aggressive rate hike year enterprise software space shopify shop be resilient day move average rise nearly hold just buy point fang name netflix nflx continue prove mettle bounce day move average share rise buy point netflix gap powerfully jan strong result meanwhile china stock stay various state disrepair plunge nearly thursday earning alibaba baba extend loss fall hold day move average just buy point jd com jd also extend loss fall more just cup handle buy point ibd align technology algn snap back straight decline share rise more tuesday earning report bring seller stock hold day move average fail buy point related big wage gain sink stock bond reason doubt dataapple watch mystery many sell holiday quarter earning option trade make sense grubhub ichor
54,ALGN,top perform growth stock friday sector leader screen be set report earning come week have be rally ahead result be still buy range friday be issue chart align technology algn invisalign product be transparent plastic form brace continue
55,ALGN,welcome move integra lifescience iart see relative strength rating rise tuesday re research best stock buy watch be sure pay attention relative price strength ibd proprietary rs rating track market leadership used worst best score identify stock price action trail week stack other stock database year market history show best stock often have rs rating north begin largest run see integra lifescience continue rebound clear threshold see ibd help make more money stocksintegra lifescience be build consolidation entry see break volume least average top bottom line growth moved higher last quarter earning be compare prior report revenue increase integra lifescience earn rank peer medical product industry group align technology algn icu medical icui utah medical product utmd be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
56,ALGN,merit medical system mmsi see ibd smartselect composite rating jump wednesday day new rating show stock be outpace stock come most important stock pick criterium market biggest winner often have higher grade early stage new price run so good start point look best stock buy watch merit medical system break earlier have fall back prior entry flat base stock re tracking clear buy point then decline more original entry price consider fail base stock set new chart pattern buy point look winning stock try simple stock earn ep rating meaning recent quarterly annual earning growth be outpace stock accumulation distribution rating show moderate buy institutional investor last week company report increase earning top line growth rise prior report mark quarter rise revenue growth merit medical system earn rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group related company be now outperform stock
57,ALGN,relative strength rs rating teleflex tfx enter new percentile monday increase look best stock buy watch factor watch closely be relative price strength ibd proprietary rs rating track market leadership used worst best score indicate stock price action last week match other stock year market history reveal stock go make biggest gain often have rs rating north launch biggest climb look winning stock try simple routineteleflex be work consolidation buy point see stock break heavy trade teleflex report ep growth last quarter sale growth come teleflex earn rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
58,ALGN,cooper company coo see ibd smartselect composite rating rise monday day upgrade mean stock be now outpace other stock term key performance metric technical strength history show top market performer tend have higher score launch major climb cooper company break earlier have fall back prior entry flat base case stock break then fall more entry price consider fail happen best new base form see ibd help make more money stock have ep rating meaning recent quarterly annual earning growth top stock accumulation distribution rating show moderate buy institutional investor last week company post ep growth have now post accelerate ep gain consecutive quarters sale growth increase prior report mark quarter rise revenue increase cooper company earn rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group related company be now outperform stock
59,ALGN,here investing action plan tuesday need know investor come day fast food leader mcdonald mcd video game publisher electronic art ea open earning season respective sector investor get dose medical chip report president trump deliver state
60,ALGN,quick check list stock make new high tuesday show align technology algn salesforce com crm microchip technology mchp remain buy zone footwear brand skecher skx meanwhile be also hold buy range buy point big estimate loom
61,ALGN,relative strength rs rating integra lifescience iart climb higher percentile monday get lift look best stock buy watch factor watch closely be relative price strength exclusive rating investor business daily measure price action worst best score rating show stock price behavior last week hold other stock database decade market research show best stock typically have higher rs rating begin largest run see integra lifescience continue show renew price strength clear threshold look winning stock try simple routineintegra lifescience be try complete consolidation buy point see clear price heavy trade top bottom line growth moved higher last quarter earning be compare prior report revenue increase integra lifescience hold rank peer medical product industry group align technology algn utah medical product utmd abiom abmd be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
62,ALGN,straight quarters accelerate sale earning growth highest possible composite rating dental product maker align technology algn put investor face test new buy zone maker invisalign invisible brace have post average ep growth last quarters
63,ALGN,monday icu medical icui get upgrade ibd smartselect composite rating upgrade mean stock currently top other stock term key performance metric technical strength market biggest winner often have higher score early stage new price run so good item have checklist look best stock buy watch icu medical be currently entry flat base note later stage base such basis be more prone failure look best stock buy watch start stock have ep rating mean recent quarterly longer term annual earning growth be outpace stock accumulation distribution rating show moderate buy institutional investor last week company report ep growth mark straight report rise ep growth sale growth rise prior quarter mark consecutive report rise growth icu medical earn rank peer medical product industry group align technology algn be rank stock group related company be now outperform stock
64,ALGN,look best stock buy watch focus rise relative price strength stock fit bill be icu medical icui see welcome improvement relative strength rs rating monday rise re research best stock buy watch be sure pay attention relative price strength exclusive rating investor business daily track market leadership worst best score rating show stock price movement last week stack other stock database decade market research reveal best stock tend have better rs rating begin new climb look best stock buy watch start hereicu medical be trading buy range climb buy point flat base proper buy range extend initial entry once stock hit benchmark best hold investing set buy opportunity stock relative strength line be new high ground be bullish indicator market leadership regard top bottom line number company have post quarters increase earning growth sale growth have also moved higher same period company hold rank peer medical product industry group align technology algn be rank stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
65,ALGN,neogen neog have relative strength rs rating upgrade friday welcome improvement still higher score prefer see try find best stock buy watch be sure pay attention relative price strength ibd proprietary rs rating identify market leadership used worst best score show stock price action last week compare rest market decade market research reveal market biggest winner typically have better rs rating early stage move see neogen continue show renew price strength hit benchmark see ibd help make more money stocksneogen be work consolidation entry see break volume least average company top line growth fall last quarter ep grow prior report keep eye company next round number mar company earn rank peer medical product industry group abiom abmd align technology algn utah medical product utmd be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
66,ALGN,penumbra pen have relative strength rs rating upgrade thursday try find best stock buy watch be sure pay attention relative price strength ibd proprietary rating measure market leadership worst best score score show stock price performance trail week hold other stock database decade market research reveal best stock typically have higher rs rating launch biggest climb look best stock buy watch start stock be theipo leader list be try complete cup handle buy point see stock clear price heavy trading take look revenue profit performance penumbra have post rise ep growth last report revenue gain have also rise same period company earn rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
67,ALGN,penumbra pen see positive improvement relative strength rs rating monday rise proprietary rating measure technical performance used worst best score identify stock price performance trail week match other stock history show best stock tend have rs rating north launch largest climb see penumbra continue show renew price strength hit benchmark look best stock buy watch start herepenumbra be work cup handle entry see clear price heavy volume earning growth decrease most recent quarter revenue gain moved higher next quarterly result be expect feb company earn rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
68,ALGN,merit medical system mmsi be form base entry next quarterly ep report set feb current formation be first stage flat base understand buy stock just ahead earning be risky typically don have enough time establish profit cushion latest quarterly number come be sure follow sound buy sell rule minimize exposure look best stock buy watch start heremerit medical system post earning share growth last quarter sale growth come consensus analyst estimate call earning share growth quarter growth full year annual earning share estimate be recently revise upward merit medical system have composite rating earn rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group note date earning report be subject change check company update related earning calendar analyst estimate stock watchnew option strategy limit risk earning
69,ALGN,lemaitre vascular lmat see ibd smartselect composite rating rise friday day new score tell company be now outperform stock term most important fundamental technical stock pick criterium lemaitre vascular be currently form consolidation entry see stock break heavy trade least higher normal keep mind later stage base such basis be more prone failure be aware be thinly trade stock average daily dollar volume such stock show wider daily weekly fluctuation stock greater liquidity look winning stock try simple stock earn ep rating mean recent quarterly longer term annual earning growth top stock accumulation distribution rating show roughly equal amount buy selling institutional investor last week company post earning growth sale growth increase prior report mark quarter accelerate revenue increase lemaitre vascular earn rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group related company be now outperform stock
70,ALGN,future index dow industrial nasdaq rebound strongly wednesday morning major average suffer bearish reversal time high tuesday close modestly lower chip equipment giant asml hold asml surge open strong earning guidance asml be several lead stock include atlassian team align technology algn scientific game sgms try break tuesday close buy point stock close higher give stock day outperformance vs index separately taiwan semiconductor manufacturing tsm nearly reach buy point close top range keep mind several stock be late stage pattern atlassian report earning tap thursday so be taiwan semiconductor future rise nearly vs fair value dow future jump fair value nasdaq future be keep mind stock future be even stronger tuesday major average boom open selling dutch chip equipment giant asml report surprise earning gain better expect revenue fourth quarter asml also hike dividend set new stock buyback program asml be lead maker hugely expensive lithography machine help chipmaker make ever smaller chip share shot early wednesday stock market trading suggest decisive gap cup base buy point tuesday asml also gap higher rise record share pull back close aggressive investor have used alternative entry just too short handle asml relative strength line rise short term high tuesday be still well high left side base rs line track stock performance vs index want see stock rs line lead confirm rise least short term high assume asml gap higher wednesday regular session rs line confirm move short term high solid move longer term high asml be important first chip equipment maker report earning latest quarter really first company broader chip sector do so ibd take buy hold stock be risky head earning report here earning option strategy help cash post earning stock gain minimize risk weak quarter here apply earning option strategy atlassian collaboration software maker surge tuesday morning power cup base entry share then reversed sharply briefly turn negative close gain be not good afternoon atlassian still rs line be right short term high make ground vs record high month atlassian earning be expect rise revenue align briefly get tuesday move slightly past cup base entry share close invisalign brace maker rs line have be rise sharply recent week still consolidation peak scientific game make lottery related product edge tuesday touch intraday eke past flat base entry intraday taiwan semi rise tuesday approach buy point short cup handle base however taiwan semi rs line be still short term high let alone late november base also be interested stock reverse lower pullback now seem more likelythese top tech stock hit buy point only hold upnew high reverse lower stock hold gain false leader apple lose buy point iphone chip stock pop
71,ALGN,investor be look lead stock breaking bullish basis volume relative strength line track stock performance vs index lead confirm weibo wb atlassian team match group mtch align technology algn clear buy point proper basis tuesday morning rs line be already right close least short term high stock pull back turn negative broader market reversal only weibo be buy range now take software interactive also be buy point proper base strong rs line also reversed lower weibo align technology have best possible composite rating atlassian have composite rating match group take interactive be solid recent week many stock have be hit buy point lackluster volume rs line signale stock be just keep pace fall fast rise breakout have not fared well weibo top chinese short message social network clear cup handle base buy point share rise heavy volume stock market today spiking intraday close session lows be not great action better general market reversed strong gain close lower day worst level weibo rs line edge past short term peak handle near old time high left side consolidation rs line be blue line stock chart keep mind weibo break late stage base be less likely succeed be big winner first second stage pattern weibo parent sina sina have be flirt double bottom base buy point briefly cross level friday sina fall climb intraday rs line be lag more weibo sina rs line be trading right very short term high atlassian collaboration software maker be cup base buy point shot intraday pull back close gain rs line have moved short term high pseudo handle provide confirmation stock price action rs line be still lag november high atlassian report earning thursday ibd take market now confirm rally day be hard see be true lead stock be middle pack see ibd relative strength line be so important match group operate match com tinder other date site apps be consolidation buy point cent old intraday high nov follow earning stock close well peak day so match group have consolidated moved old high rs line have actually moved new high ground bullish uncommon base build stock current market uptrend match com briefly top buy point jan close lower share end friday match group rise intraday reversed fall take interactive software fall intraday tuesday find support just day line result tuesday action video game stock now have handle consolidation slightly lower potential buy point take rs line take hit tuesday sell however stock break strongly rs line retake short term high handle align technology make invisalign transparent brace tumble late november just christmas share have rebound then build right side consolidation entry align rise reach intraday briefly clear entry point align rs line be move higher still late november peak have rise very short term high also help rs line have such outperformance align be big stock winner year also be interested apple move buy range left much be desire then thisfacebook tumble buy point be never meaningful know top stock big run be use yardstickthese top stock hit buy stand
72,ALGN,integra lifescience iart see positive improvement relative strength rs rating friday increase exclusive rating investor business daily measure market leadership worst best score grade show stock price performance trail week compare other stock database year market history reveal market biggest winner tend have rs rating begin largest climb see integra lifescience continue show renew price strength hit benchmark see ibd help make more money stocksintegra lifescience be work consolidation entry see stock break volume least average integra lifescience post earning growth last quarter sale growth come look next report feb integra lifescience earn rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
73,ALGN,friday quidel qdel get upgrade ibd smartselect composite rating upgrade mean stock currently top other stock term key performance metric technical strength best stock tend have better grade kick significant move quidel break earlier be now prior entry consolidation stock re tracking clear buy point then retreat more original entry price consider fail base best stock form new base also keep mind most recent consolidation be later stage base make riskier establish new position add share exist see ibd help make more money stocksone weak spot be company ep rating track quarterly annual earning share growth look improve better show top stock accumulation distribution rating show moderate buy institutional investor last week company post earning gain have now post accelerate ep gain consecutive quarters revenue growth increase prior report mark consecutive report increase revenue gain quidel hold rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group related company be now outperform stock
74,ALGN,relative strength rs rating neogen neog jump higher percentile thursday get lift proprietary rating measure technical performance show stock price movement last week compare other stock database year market history reveal best perform stock typically have rs rating north early stage move see neogen continue show renew price strength hit benchmark look winning stock try simple routineneogen be try complete consolidation buy point see stock break heavy trade company top line growth fall last quarter bottom line grow previous report next quarterly result be expect mar company earn rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group related stock be show improve price performance use ibd relative strength rating relative strength line help judge stock
75,ALGN,several ibd sector leader stock have retake week move average several other be engage battle key level place stock bullish bearish standing stock lam research lrcx mks instrument mksi be chip equipment maker industry group be meeting resistance attempt retake
76,ALGN,market rebound have cool now market be search direction bearish reversal characterize tuesday market nasdaq composite wipe away midday gain close loss erased increase end lower dow jone industrial average slide spending
77,ALGN,friday globus medical gmed get upgrade ibd smartselect composite rating revise score mean stock currently top other stock term key performance metric technical strength globus medical have now climb proper buy zone breaking entry consolidation look best stock buy watch start hereone weak spot be company ep rating track quarterly annual earning growth look improve better show top stock accumulation distribution rating show heavy buy institutional investor such mutual fund pension fund last week company report earning growth sale growth climb prior quarter mark quarter increase revenue gain company next quarterly report be expect feb globus medical earn rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group related company be now outperform stock
78,ALGN,relative strength rs rating neogen neog enter higher percentile friday get lift exclusive rating investor business daily identify share price action worst best score grade show stock price behavior last week compare other stock database year market history reveal market biggest winner tend have higher rs rating early stage move see neogen continue show renew price strength clear threshold see ibd help make more money stocksneogen be work consolidation entry see clear price heavy volume earning growth rise last quarter revenue gain fall company earn rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group related stock be show improve technical action use ibd relative strength rating relative strength line help judge stock
79,ALGN,resm rmd see ibd smartselect composite rating jump friday day new rating show stock be outpace stock come most important stock pick criterium resm be now buy range clear entry flat base look best stock buy watch start stock earn ep rating mean recent quarterly annual earning growth top stock accumulation distribution rating show moderate buy institutional investor last week company report ep growth mark straight report rise ep gain sale be flat match prior report resm earn rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group related company be now outperform stock
80,ALGN,ibd sector leader member mimedx mdxg be expect report earning feb mimedx now trading buy point first stage cup handle clear earlier keep mind risky buy stock just report reduce exposure wait see actual number market reaction see ibd help make more money stocksmimedx show ep growth most recent report sale growth come analyst be look ep growth quarter growth full year annual growth estimate be recently revise lower mimedx have composite rating earn rank peer medical product industry group align technology algn be top rank stock group note date earning report be subject change check company update related earning calendar analyst estimate stock watchnew option strategy limit risk earning
81,ALGN,inogen ingn be form base offer entry get set report next round earning feb entry be base second stage flat base understand buy stock just ahead earning involve risk typically don have enough time build profit cushion latest quarterly number come be sure follow sound buy sell rule minimize exposure look winning stock try simple company see earning sale growth rise last quarter earning share increase revenue rise analyst be look earning growth quarter growth full year annual earning share estimate be recently revise upward inogen have composite rating earn rank peer medical product industry group align technology algn be top rank stock group note date earning report be subject change check company update related earning calendar analyst estimate stock watchnew option strategy limit risk earning
82,ALGN,teleflex tfx be expect report earning feb teleflex now trading buy point second stage cup handle clear earlier understand risky buy stock just report minimize exposure wait see company report market react see ibd help make more money stocksearning grow last quarter prior report revenue also increase analyst expect earning growth quarter growth full year annual ep estimate be recently revise upward company have composite rating hold rank peer medical product industry group align technology algn abiom abmd edward lifescience ew be top highly rate stock group note date earning report be subject change check company update related earning calendar analyst estimate stock watchnew option strategy limit risk earning
83,ALGN,wednesday cambrex cbm earn upgrade relative strength rs rating exclusive rating investor business daily identify market leadership worst best score grade show stock price behavior last week compare other stock database year market history reveal stock go make biggest gain often have higher rs rating early stage move see cambrex continue show renew price strength hit benchmark look winning stock try simple routinecambrex be work consolidation buy point see break heavy volume cambrex post ep growth latest quarterly report sale growth come company hold rank peer medical product industry group align technology algn abiom abmd edward lifescience ew be top highly rate stock group related stock be show rise relative strength use ibd relative strength rating relative strength line help judge stock
84,ALGN,relative strength rs rating baxter international bax enter new percentile monday get lift ibd proprietary rating identify share price performance worst best score rating show stock price movement trail week stack other stock database decade market research show best stock often have better rs rating early stage move see baxter international continue rebound clear threshold look best stock buy watch start herewhile not currently ideal time jump see stock be able offer clear appropriate buy point company show earning growth latest quarterly report revenue gain come baxter international earn rank peer medical product industry group align technology algn abiom abmd edward lifescience ew be top highly rate stock group related stock be show improve technical action use ibd relative strength rating relative strength line help judge stock
85,ALGN,big game hunter zero quarry co manager buffalo discovery fund buftx be single mind stalk stock focus look company innovation produce durable growth competitive advantage co manager dave carlsen say process co manager clay elizabeth jone use process have work fund average annual return be better trail year end dec make eligible earn ibd best mutual fund award mutual fund be member elite club be small minority fund outperform time period fund be vs average midcap growth rival track morningstar direct fund achieve gain last year help lead stock align technology algn take interactive software red hat rht be respectively start msci msci amazon amzn facebook fb be additional leader help boost fund gain msci be member ibd list top perform growth stock young year ibd reader recognize amazon be buy point share break thursday close just flat base buy point now stock be back proper entry facebook ibd stock be also buy point case have break new flat base last week carlsen jone be kornitzer capital management subadvise fund buffalo trio be age talk ibd office mission kansa hunt winning stock list mutual fund quarterly leaderslist mutual fund month leadersmf category here see article best mutual fund performance reportibd central theme overall investment approach dave carlsen be seek innovation company re look company innovation new idea accept marketplace lead shareholder wealth creation competitive advantage re look disruptive idea lead significant share gain creation brand new marketplace buy position growth company grow gain competitive advantage regardless overall macro economy ibd fund outperformance time period be rare have fund achieve consistency elizabeth jone ve be work together help have strength weakness diversification strength have lead more consistent result have interest stock be favor other choose stock be favor minimize downside maximize upside ibd clay dave add anything clay process seek company be beneficiary secular growth trend growth trend have tailwind matter macro economic situation look ibd be trend re thing age demographic push health care cost containment look area benefit durable trend stay away here today go tomorrow fad ibd latest disclosure do facebook be concern carlsen growth digital advertising impress big market continue disrupt google facebook be winning lion share growth digital advertising time user spend facebook be remarkable so advertiser revenue be september quarter vs prior year give pricing power contribute earning growth re investing short form video content build community drive consumer engagement higher mobile revenue growth especially robust facebook remain well position ibd do add amazon stake recently jone add gravitate smaller company make exception exceptional company size amazon be still grow rapidly probably most innovative company world define value translate idea innovation good service customer be willing pay amazon founder jeff bezos have do take risk have create online marketplace enough inventory low enough price create value innovate other way need amazon web service run own infrastructure monetized offer other company realize provide content so get amazon prime video music read wrapped membership offer have own amazon sooner re happy own now ibd take amazon be ibd exclusive leaderboard list top stock dec company trumpet biggest holiday sale season ever ibd align technology algn dental brace maker have pull back recently latest disclosure still like tell dominate clear aligner market take market share metal brace continue expand outside get add june be top perform stock year so recent pullback be profit take person underestimate complexity manufacturing customize product align company be aggressive expand more complex treatment case benefit everyone give consumer product prefer help dental orthodontic practice give shareholder good return margin ibd concern red hat recent pullback report third quarter result carlsen pullback be basically case not meeting high expectation still quarterly earning share growth be not something see everyone tech sector expect continue be red hat be right spot evolution cloud ve build big install base user linux enterprise operate system corporate server public private cloud infrastructure allow company premise infrastructure mesh public cloud infrastructure amazon aw microsoft azure public cloud be cheaper more efficient used company keep email public cloud example want keep product development premise security red hat be position bridge gap private public cloud make innovation more efficient go forward ibd do take interactive software drop recently make great run jone don think pullback be anything particular lot growth stock pull back also electronic art ea gaming company make change new release reduce number player buy side maybe cause collateral damage take activision atvi don believe impact company ability meet projection long run historically company be disadvantage boom bust cycle game release have lot sale then dramatic decline change due online gaming multiplayer gaming be extend individual game lifetime instead new release year company be shift incremental release deliver digitally have higher margin more opportunity side purchase player give advantage game be stock have do well year addition market anticipate new release next year be red dead redemption be highly anticipate ibd do msci msci example run many index track investor revenue be recur have significant cash flow only need low capital expenditure build business go forward re beneficiary shift passive investing active manager be aware shift want seek way benefit msci be clear choice trillion dollar be benchmark index now re layer groundwork become standard esg environmental social governance impact investing provide additional avenue growth go forward ibd elizabeth be do use expertise manager fund jone experience pricing medicine have give unique insight health care spend time health care fund look thing offer consumer good value dave mentioned look innovator key be have value get be good deal consumer background assess especially term interface doctor patient ibd dave clay do have unusual career trajectory carlsen clay career path have be pretty traditional related stock watch join apple bofa list new buy top fundsif re look actionable stock check stock list page stock buy zone stock hit new high sector leader tech leader ipo leader need much retirement saving age incomewhere find income take big risk
86,ALGN,teleflex tfx be expect report earning feb now trading buy point second stage cup handle clear earlier keep mind buy close stock report be risky don know stock report market react don have enough time build profit cushion reduce exposure wait see actual number market reaction look winning stock try simple company see earning sale growth rise last quarter earning share increase revenue rise analyst expect earning share growth quarter growth full year annual earning estimate be recently revise higher company have composite rating hold rank peer medical product industry group align technology algn utah medical product utmd abiom abmd be top highly rate stock group note date earning report be subject change check company update related earning calendar analyst estimate stock watchnew option strategy limit risk earning
87,ALGN,penumbra pen have relative strength rs rating upgrade tuesday welcome improvement still shy higher score look ibd unique rs rating track technical performance show stock price movement last week measure other stock database history reveal stock go make biggest gain often have rs rating early stage move see penumbra continue show renew price strength clear threshold look best stock buy watch start herepenumbra be try complete consolidation buy point see break heavy trade ep growth drop last quarter sale rise prior report look next report feb company earn rank peer medical product industry group align technology algn utah medical product utmd abiom abmd be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
88,ALGN,new investor size recent drop many lead stock be bit jarring not jaw drop bear tear away chunk market value past week least name ibd group
89,ALGN,monday integra lifescience iart earn upgrade relative strength rs rating ibd unique rating track share price movement worst best score grade show stock price behavior last week hold other stock database decade market research reveal best stock typically have better rs rating early stage move see integra lifescience continue rebound clear threshold see ibd help make more money stocksintegra lifescience be try complete consolidation entry see break heavy trading integra lifescience post ep growth most recent report sale growth come look next report feb integra lifescience hold rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
90,ALGN,good economy have odd effect sink monday concern higher price borrow cost central bank remove crutch intend support rebound abroad individual company index quarterly result more granular measure customer attitude main driver stock be surpass wall street forecast particularly high rate not see previous decade bar result have be help ever tech health care financial include amazon amzn intel intc unitedhealth unh mastercard company dowdupont dwdp eastman chemical emn have lead supplier material higher industrial long ailing general electric ge also look solid long drought company have report quarterly result so far earning season top wall street estimate accord thomson reuter datum release thursday percent beat estimate revenue best rate estimate earning third quarter accord thompson reuter sale best least earning be currently track deliver gain revenue robust assume remain company due report meet estimate analyst also appear optimistic first quarter earning even prospect higher wage touch investor fear inflation economic growth stir anxiety federal reserve be more aggressive raise interest rate keep growth honest ibd take thursday feb market action friday monday market drubbing ibd change market outlook uptrend pressure confirm uptrend equivalent green light turn yellow make sure read big picture column day stay top market prevailing trend so ll know make sense be aggressive move sideline still global recovery have bring new demand technology energy infrastructure rebound oil price have boost demand equipment kind lift industrial turn demand supplier chemical material stock market today index dow industrial nasdaq composite sell yet again treasury yield hit multiyear high stock rally strongly start part expectation strong broad earning growth thomson reuter material sector include company dowdupont eastman company have beat earning most recent quarter highest percentage industry sector measure firm percent company material segment have beat revenue even trouble deepen general electric have weigh growth industrial sector try focus more aviation power health care segment overall have remain solid percent have beat earning revenue ge earning share slide fourth quarter face sec investigation analyst say company be remove dow technology sector technology company have beaten earning estimate lead company advanced micro device amd intel intc xilinx xlnx percent beat revenue strong growth semiconductor semiconductor equipment more tech company be also bring bigger business consumer re see transition consumer base business base be big driver aurelio say so re see thing datum center growth consumer discretionary category quarters company have produce bar result amazon amzn last week turn earning far ahead analyst expectation help gop new tax law broader migration commerce smart device projection alexa be very optimistic far exceed ceo jeff bezos say statement time don see positive surprise magnitude very often expect double earning company thomson reuter health care segment include biotech pharmaceutical health care service come analyst view beat revenue unitedhealth nation largest health insurer be company surpass earning estimate widest margin be pharma distributor cardinal health cah resm rmd align technology algn maker invisalign dental brace earning follow bmo analyst matt borsch follow manage care company hospital other care provider characterize mediocre term volume number inpatient admission outpatient procedure doctor emergency room visit more volume say have be packed end fourth quarter more person meet deductible high deductible plan have become increasingly common have high deductible health plan generally have pretty strong dynamic person average increase utilization significantly ve meet deductible therefore be see more late year say company have report so far largely aren benefit low expectation expectation have remain relatively similar earning quarter compare quarters past be tad higher revenue aurelio say investor make way fourth quarter result market volatility outlook first quarter remain not so bad typically get closer next earning season expectation decrease aurelio say so see growth rate normally drop be go begin year say expectation be earning growth first quarter thursday growth expectation be lower guidance apple aapl many iphone chip supplier so pretty bullish signal say be interested big picture stock repeat bear sell big wage gain sink stock bond reason doubt datadid congress trump just crush stock market rebound brokerage receive fresh lift tax reform rate hike obamacare exchange enrollment show surprise gain trump attack
91,ALGN,relative strength rs rating stryker syk moved higher percentile tuesday get lift ibd unique rs rating track market leadership used worst best score show stock price performance trail week stack other stock database year market history show best stock typically have rs rating least begin largest run see stryker continue show renew price strength hit benchmark look best stock buy watch start herestryker be still buy range climb entry flat base proper buy range extend initial entry once stock hit benchmark best set buy opportunity stryker show earning growth latest quarterly report sale growth come stryker hold rank peer medical product industry group abiom abmd align technology algn mimedx mdxg be top highly rate stock group related stock be show improve technical action use ibd relative strength rating relative strength line help judge stock
92,ALGN,penumbra pen have relative strength rs rating upgrade tuesday welcome improvement still shy higher score prefer see proprietary rating track technical performance used worst best score show stock price performance trail week compare rest market decade market research reveal stock go make biggest gain often have rs rating early stage move see penumbra continue show renew price strength clear threshold look best stock buy watch start herepenumbra be build cup handle buy point see stock break volume least average ep growth fall last quarter sale rise next quarterly number be expect feb company earn rank peer medical product industry group abiom abmd align technology algn mimedx mdxg be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
93,ALGN,integra lifescience iart have relative strength rs rating upgrade tuesday welcome improvement still short better score look proprietary rating measure technical performance used worst best score identify stock price action trail week stack other stock database year market history reveal stock go make biggest gain typically have better rs rating early stage move see integra lifescience continue rebound clear threshold look best stock buy watch start hereintegra lifescience be build consolidation buy point see stock break volume least average company post earning growth last quarter sale rise keep eye company next round number feb company hold rank peer medical product industry group abiom abmd align technology algn mimedx mdxg be top highly rate stock group related stock be show rise relative strength use ibd relative strength rating relative strength line help judge stock
94,ALGN,major market average look snap back day solid loss early trade wednesday nintendo ntdoy electronic art ea surge new high stock market today dow jone industrial average lead way rise nasdaq follow gain respectively dow jone industrial boee ba soar reach new high airplane maker provide strong guidance beating analyst forecast fourth quarter share be flat base entry company report earning nintendo raise profit outlook switch sale current fiscal year holiday quarter send share share be recapture cup shape base buy point just day give entry buy range top so share quickly become extend drive company profit outlook be stunning success nintendo switch console be hybrid console allow user play tv then pick device play go video game maker electronic art be breaking cup shape base buy point share be just buy range late wednesday company miss holiday quarter sale target raise current quarter sale guidance analyst estimate meanwhile close be number top stock report quarterly earning include facebook fb paypal pypl fang stock be near new high wednesday rise almost be still buy range flat base entry analyst expect social medium giant earning grow revenue increase paypal rise be extend flat base buy point payment processor be set report ep cent revenue respective increase ibd alibaba baba advanced be extend cup shape base buy point china base commerce giant report quarterly result market open thursday invisalign maker align technology algn slide nearly beating target late tuesday stock be just cup shape base entry straight day loss related avoid major investing mistake trading rule ea report more medical earning investing action sell don freeze double digit gain stock shrink fastlooking stock nvidia start list
95,ALGN,major index close tuesday largest loss so far year add notion market rally have get overstretched dow jone industrial average slide nasdaq composite russell lose almost nasdaq be worst day drop dec composite fall volume rise monday level loser lead winner nyse nasdaq rise bond yield add concern stock price have be rise faster normal yield year treasury note add basis point highest april manage care drugstore other health care industry group be rattle end worst group today market sell come amazon com amzn jpmorgan chase jpm berkshire hathaway brkb set venture cut medical cost employee energy sector be broadly lower also exploration drill other oil related group fall much price crude be ease rally begin mid december tuesday trader worry production be pick metal other cyclical also be weak steel producer nucor nue ak steel ak sell better expect earning lead stock be mostly lower innovator ibd etf ffty track ibd index gap loss nearly find support day move average scott miracle gro smg plunge day day move average heaviest volume run august marked sell signal stock be main reason agricultural chemical industry group be tuesday worst garden care product company post quarterly result miss expectation management say slower expect pace regulatory change cannabis california hurt hydroponic business hydroponic be science grow plant include marijuana used soil integrate device technology idti gap day move average heavy trading share fall drop more buy point jan trigger loss cut sell signal chip company report earning cent share slightly view higher year sale growth accelerate close invisible brace company align technology algn share rise company report earning sale fourth quarter related fear amazon health care disruption clash realitysteel stock momentum melt commodity related group tumbleslow start pot legalization california bake stockwhen sell stock big break day line mark end huge golden rule stock investing
96,ALGN,stock reversed lower fed comment close session modest gain boee ba microsoft msft apple aapl boost dow jone industrial average spdr dow jone industrial average dium rise powershare qqq trust qqq advanced spdr spy add stock market today emerge market outperformed ishare msci emerge market eem small cap lag ishare core small cap ijr ishare russell iwm fall fed hold rate steady slightly more hawkish comment regard inflation spook market boee lead dow gain top view offer bullish guidance also dow microsoft rise nearly track new close high apple re-cover iphone maker report thursday reit utility semiconductor lead upside sector fund vaneck vector semiconductor smh featured monday etf column advanced retake buy point graphic chip designer nvidia nvda rise new record high biotech health care build play be lower oil fund be mixed west texas intermediate crude price rise barrel gold fund climb do underlie gold future bitcoin edge higher accord coindesk have earlier climb back level south korean official say country doesn plan ban regulate cryptocurrency exchange accord reuter bitcoin investment trust gbtc however slump now mid december peak stock get smack board tuesday side help set new buy opportunity equity etfs hold top stock ai player nvidia alibaba baba innovator ibd ffty gap fall more early tuesday find support day move average pare loss close continue bounce support line mark chance buy share early january rebound day yielded advance jan intraday high late august pullback bounce line produce gain nov intraday high fund launch april partnership ibd innovator capital management have attract asset track ibd index comprise top growth stock select ibd most name have common trait market biggest winning stock such outstanding profit sale growth wide profit margin high return equity fundamental technical metric used stock selection be base decade research start ibd founder chairman william neil slim investing system include current annual earning new product service management stock price performance institutional ownership overall market information technology account more half portfolio consumer discretionary financial health care smaller position industrial energy consumer staple material make rest represent biggest country weighting follow china australia argentina ibd take nvidia be lead chip stock do company fundamental rank industry group find now ibd stock checkup top holding jan include graphic chip designer nvidia be also lead player artificial intelligence field chinese online retail giant alibaba arista network anet align technology algn close lower tuesday retain double digit gain year vs advance arista align fall sharply early trading close top session range align technology fall open bell stock market today report better expect earning late tuesday so far year ffty lag return etf year return lead broader index gain ffty carry expense ratio trade ibd click innovator ibd etf innovator capital management tuesday pick vaneck vector semiconductor smh be just flat base buy point related stock sell apple pfizer weigh bitcoin keep divingcapture bitcoin china solar new innovator ibd etf leadersibd etf debut top china brazil bitcoin still hot
97,ALGN,stock hammer strong open wednesday big name earning news stir early action look cap best january show century dow jone industrial average rattle open gain boee ba bent curve higher positive fourth quarter result grab gain start bell nasdaq composite climb apple aapl jump open fang stock tech leader check point software chkp take hardest early hit nasdaq stock more mixed fourth quarter performance stock be track best january outing year dow logged gain month tuesday rise strongest month index march january gain be best month dow be set best january advance nasdaq have pound advance so far month best monthly show october best january performance market rebound small cap russell hold gain so far january also best gain month boee surge easily lead dow fourth quarter number top analyst target management give upbeat forecast come year stock be extend follow flat base september also dow apple pop power past downgrade market perform outperform bmo capital market stock decline stop just short buy point tuesday avoid automatic sell rule leave share well week move average fang stock trade higher amazon com amzn easily lead group rise premarket action share be clear flat base earlier month largest early move spur earning news juniper network jnpr drop video game developer electronic art ea spark homebuilder horton dhi climb almost fiscal first quarter earning clobber analyst estimate revenue also top expectation management raise full year guidance consensus view stock have drop week move average week decline remain extend september shutterfly sfly spiked more report huge jump fourth quarter earning revenue well consensus estimate online photo sharing site first quarter revenue earning guidance be expectation company announce plan acquire school portrait specialist lifetouch cash shutterfly gap gain send share past buy point month saucer handle base align technology algn shed share have advanced extend trade thursday maker clear plastic brace tooth report solid fourth quarter result stronger anticipate earning revenue first quarter guidance report also include charge related new tax law mandatory deem tax repatriate overseas cash align have drop more buy point tuesday trigger automatic sell rule recover sharply advanced micro device amd jump almost report board fourth quarter beat late tuesday stock be form double bottom buy point xerox xrx angled open report healthy fourth quarter announce japan fujifilm holding fujiy take majority stake company rename company fuji xerox gain drive xerox share past buy point cup handle base market feel early lift response president trump tuesday night state union address congress investor ears certainly be turn afternoon policy announcement federal open market committee schedule final fomc meeting federal reserve chair janet yellen job growth slow less expect january new hire accord national employment report adp be december hot new job pace well economist projection slowdown employment cost growth be moderate fourth quarter labor department estimate increase gain third quarter line expectation november chicago purchasing manager index kingsbury international be slate et release pending home sale datum national association realtor weekly oil inventory energy information administration et other important market related news wednesday big picture stock suffer straight distribution day leader hit again future key earning workday salesforce red hat buy zonesfacebook microsoft boee lead key earning investing action planabiom arista align yy read stock rebound
98,ALGN,seller be stock market again tuesday dow nasdaq hold stiff loss less hour remain tuesday session dow take biggest hit fall hurt weakness pfizer pfe unitedhealth group unh pfizer earning disappoint fuel loss stock unitedhealth group give back news amazon com amzn berkshire hathway brka jpmorgan chase jpm be collaborate way offer health care employee more transparency lower cost provider pharmacy benefit management service fall hard news express script esrx crater be well session lows touch day move average cvs health cvs slump amazon buck trend rise ahead earning report thursday close leaderboard name have be standout performer buy point lose nasdaq composite ease volume nyse nasdaq be tracking higher monday level stock market today more so nyse nasdaq suffer distribution day monday loss higher volume distribution day be sign institutional selling workday wday be bright spot nasdaq rise nearly weekly chart show conventional entry daily show earlier cup handle entry meanwhile day fed meeting get underway today decision interest rate be due wednesday et market be not expect rate hike time chance march meeting be pretty good accord cme group fedwatch market see chance quarter point hike range march year treasury yield add basis point ahead friday job report economist expect nonfarm payroll rise unemployment rate hold steady ibd align technology algn company invisalign brace re-cover lows quick test day move average share align be still ahead earning report close ibd name grubhub grub gap fall nearly barclay downgrade share equal weight overweight price target stock be flat base clear last week earning be due feb open growth stock be weak again name ibd be more late trading related workday rise veeva upgrade margin hubspot downgrade health care stock tumble amazon berkshire jpmorgan allianceamazon score price target increase ahead fourth quarter reportalibaba likely show strongest revenue growth quarters
99,ALGN,stock remain broadly lower midday tuesday appear be perfectly normal pullback stunning gain earlier month commodity play help pace downside agricultural chemical oil gas exploration oil drill metal ore steel share fall hard apple aapl meanwhile fall fourth time session largest company nasdaq market cap be now day move average flattened last week gain oct good second stage cup handle have now be squeeze share be more buy point apple slide weigh major index nasdaq composite dow jone industrial average sink least component dow jone industrial average fall point more include unitedhealth group unh goldman sachs gs mmm mcdonald mcd yet even tuesday decline dow stand higher jan mcdonald post jump adjust fourth quarter profit share sale drop biggest year year drop first quarter nevertheless share fast food icon have perform well clear long saucer handle late march roll more point see weekly chart continue hug slowly rise week move average paint red ibd marketsmith chart monday nasdaq notch third distribution day instance heavy professional selling second session keep track distribution count nasdaq read big picture column daily basis current outlook market change ll have good strategy motivation take action sell stock reduce exposure hold position point new investor apple share have decide draw line sand stock have gain more follow sound good rule thumb be sell share small profit prevent complete wipeout gain stock always be buy back market condition improve longer term point view however apple be still act just fine jan iphone ipad digital service giant break first stage cup handle jan year share rise much same period nasdaq composite rally also trail rise smallcap rise just ascent apple survive normal look sell off send share temporarily day move average june september notice long term weekly chart apple do not venture too far week move average move similar form day daily chart elsewhere stock market investor seek accumulate share select name business medical software workday wday rise more volume run nearly double usual level stock be now slightly extend breaking week cup handle find correct buy point pattern add cent highest price handle be paycom software payc also excel hr payroll automation outsource market erased mild early loss edge slightly higher oklahoma city base firm have gain jan past entry good flat base defensive industry include hospital nonalcoholic beverage soap meat rally back downside pulte group phm gap drop more active turnover stock close day move average monday first time past buy point flat base june mark key sell signal homebuilder report rise profit cent share match consensus view revenue rise miss thomson reuter estimate large number pulte industry peer have also slide sharply day line include nvr nvr lgi home lgih toll bro tol few reversed nicely lows good sign healthy substantial price run sharp undercut day line failure recover back support line be key ibd defensive sell rule help preserve profit day federal reserve meeting interest rate policy begin tuesday bond trader do not seem actively seek bargain even recent sell treasury yield benchmark year bond be currently month treasury paper have yield year note yield thus yield curve continue maintain positive slope build sector rank sector rank mid long term relative price performance latest ibd weekly print edition however sector be also more jan so actually severely lag broader market see entire sector ranking stock research table ibd weekly begin page well go ibd datum table stock list investor com then click ibd smart nyse nasdaq table key earning report close tuesday include illumina ilmn align technology algn electronic art ea illumina expert genetic datum analysis equipment be expect post jump profit share mark biggest year year increase gain first quarter prior quarters illumina show ep increase decline gain illumina just light turnover have rally steady stair step fashion breakout past week flat base aug base base past nov follow saito chung twitter ibd_dchung additional commentary analysis breakout growth stock financial market related really spot major market top sure here be easy waystock buy zonefind hot growth stock peek ibd good watch list future big tech stock winner
100,ALGN,future index fall modestly monday morning treasury yield continue climb dollar strengthen somewhat start busiest week earning season alibaba baba google parent alphabet googl mastercard vertex pharmaceutical vrtx paypal pypl servicenow now align technology algn be company quarterly financial tap boast best possible composite rating composite rating combine several ibd proprietary rating earning other key factor time stock winner often have composite rating better start big run future sank vs fair value year treasury yield top highest level nearly year german year yield turn positive first time nasdaq future lose future dow industrial dip nasdaq composite dow industrial hit high friday alibaba report early thursday chinese commerce giant earning be expect rise share revenue surge mark strongest top line growth quarters alibaba close friday become slightly extend buy point shallow cup base alibaba struggle entry initially stock have be difficult trade recent month stock have be generally hasn make headway vs broader market late august relative strength line track stock performance vs index have be flat lag do show strength last week alibaba fall premarket trading monday alibaba be key shareholder chinese social medium giant weibo wb weekend suspend several portal week punishment content violate social stability vulgar standard weibo majority owner sina sina lose meanwhile chinese web portal sohu com sohu tumble early report weaker expect result alphabet release result thursday night google parent be likely report earning share vs year earlier revenue grow alphabet decisively clear buy point oct follow earning report share didn make much progress testing entry day move average early december share be now well extend prior base close friday rs line have largely moved sideway mastercard report ep gain thursday morning revenue rise rival visa release fiscal result thursday night visa have composite rating be see report revenue gain ep cent mastercard visa be well extend possible buy point rs line be rise fractionally just outpace sprint index vertex pharmaceutical report wednesday expect ep gain cent revenue swell biotech clear buy point friday month consolidation close volume be normal paypal earning be due late wednesday paypal ep increase cent revenue rise stock close friday slightly extend buy point paypal limp entry several weak effort generally lackluster volume servicenow report wednesday night earning climb cent share revenue servicenow have rise single session so far year stock be well extend possible buy point align technology report tuesday maker invisalign brace be expect report earning cent share vs year earlier revenue swell align technology close friday slightly extend cup base buy point align initially clear entry jan volume be only normal be interested ibd tech stock be buy rangewhat apple stock chart be tell ahead earning guidancethese top stock be buy point leader just break outfacebook apple amazon grab earning spotlight investing action plan
101,ALGN,friday accelerate diagnostic axdx receive upgrade relative strength rs rating exclusive rating investor business daily measure price performance worst best score rating show stock price performance last week compare other stock database history reveal top perform stock often have rs rating north launch biggest climb see ibd help make more money diagnostic be build cup handle entry see break volume least average accelerate diagnostic see earning sale growth rise last quarter earning share increase revenue rise company hold rank peer medical product industry group abiom abmd align technology algn mimedx mdxg be top highly rate stock group related stock be show improve technical action use ibd relative strength rating relative strength line help judge stock
102,ALGN,ibd smartselect composite rating edward lifescience ew rise thursday new rating show stock be outpace stock come most important stock pick criterium top perform stock tend have better grade begin launch significant move edward lifescience be now buy range breaking buy point cup handle look best stock buy watch start stock earn ep rating meaning recent quarterly longer term annual earning growth be outpace stock accumulation distribution rating show roughly equal amount buy selling institutional investor last week company report earning growth top line growth be flat match prior report company next quarterly report be expect feb edward lifescience hold rank peer medical product industry group abiom abmd align technology algn teleflex tfx be top highly rate stock group related company be now outperform stock
103,ALGN,thursday resm rmd get upgrade ibd smartselect composite rating revise score mean stock currently top other stock term key performance metric technical strength market biggest winner often have higher score early stage new price run resm be now buy range clear entry flat base look best stock buy watch start stock sport ep rating meaning recent quarterly annual earning growth be outpace stock accumulation distribution rating show moderate buy institutional investor last week company report ep growth mean now deliver straight quarters rise ep growth revenue be flat match prior report resm earn rank peer medical product industry group abiom abmd align technology algn teleflex tfx be top highly rate stock group related company be now outperform stock
104,ALGN,welcome move stryker syk see relative strength rating rise thursday exclusive rating investor business daily track market leadership worst best score score show stock price movement trail week compare other stock database year market history show market biggest winner tend have rs rating least begin largest climb see stryker continue show renew price strength hit benchmark see ibd help make more money stocksstryker be trading buy range breaking past buy point flat base once stock move higher initial entry consider proper buy area stryker post earning growth last quarter sale growth come company hold rank peer medical product industry group abiom abmd align technology algn teleflex tfx be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
105,ALGN,consider name put watch list focus stock higher rs rating resm rmd be stock just reach mark now earn score ibd proprietary rating track market leadership worst best score score show stock price behavior last week hold other stock database decade market research reveal stock go make biggest gain often have rs rating least early stage move look winning stock try simple routineresm be now consider extend buy range clear buy point first stage flat base see stock form new pattern follow buy opportunity week tight pullback day week move average resm show ep growth most recent report sale growth come company earn rank peer medical product industry group align technology algn abiom abmd teleflex tfx be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
106,ALGN,investor prowl earning top rate growth stock have lot look forward come week alibaba baba facebook fb amazon com amzn apple aapl alphabet googl be set report record high major stock index actionable buy be get harder come many
107,ALGN,build watch list look stock higher rs rating mimedx mdxg now meet criterium increase tuesday ibd unique rating measure market leadership worst best score score show stock price movement last week compare other stock database year market history reveal best perform stock often have better rs rating early stage move see ibd help make more money stocksmimedx be work cup handle entry see stock clear price volume least higher normal mimedx post earning growth most recent report sale growth come company hold rank peer medical product industry group align technology algn be top rank stock group related stock be show improve technical action use ibd relative strength rating relative strength line help judge stock
108,ALGN,here weekly investing action plan need know investor come week tech sector heavyweight facebook fb apple aapl amazon amzn alphabet googl microsoft msft dominate come week earning news oil major exxon mobil xom chevron cvx also report
109,ALGN,edward lifescience ew have relative strength rs rating upgrade monday welcome improvement still better score look ibd unique rs rating track technical performance used worst best score indicate stock price action last week match other stock year market history show market biggest winner often have better rs rating early stage move see edward lifescience continue rebound hit benchmark look best stock buy watch start hereedward lifescience be now consider extend buy range clear buy point second stage cup handle see stock form new pattern follow buy opportunity week tight pullback day week move average edward lifescience show earning growth last quarter sale growth come look next report feb company hold rank peer medical product industry group align technology algn abiom abmd teleflex tfx be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
110,ALGN,nasdaq composite hold moderate gain afternoon trading thursday quiet day news flow see better expect earning accenture acn final read gdp growth small cap lead way russell dow add nasdaq rise volume nyse nasdaq be tracking close wednesday level stock market today day mover dow component nike nke add nearly ahead earning report close stock be quite extend rally sharply cup handle buy point also dow chevron cvx jump several dow name boast healthy chart integrate oil gas name pause several day buy point reclaim entry conviction thursday fellow integrate name exxon mobil xom gain verge clear flat base buy point oil gas exploration production firm concho resource cxo clear buy point rise big buyer be stock wednesday share jump nearly heavy volume other heavy volume gainer include voya financial voya share surge heavy volume news selling part annuity business group investor lead apollo global management issue voya be already well extend price early november buy point ibd solid gainer include daqo new energy dq yy inc yy winnebago industry wgo svb financial sivb ibd take trade ibd used innovator ibd etf innovator capital management also ibd align technology algn flash sell signal dive day move average share slump fist time align have be day move average clear buy point february related trump tax package spur price hike cisco arista corningdo trump tax cut deserve credit well fargo fifth third pay hike oil mining stock hit buy zone global growth trump tax cut investing action plan
111,ALGN,important metric look stock be higher relative strength rating accelerate diagnostic axdx just hit mark jump friday ibd proprietary rating track market leadership worst best score score show stock price movement trail week compare other stock database history show market biggest winner typically have rs rating north launch biggest run look winning stock try simple diagnostic be work cup handle buy point see clear price heavy volume top bottom line growth moved higher company most recent quarter earning be compare prior report revenue increase company hold rank peer medical product industry group align technology algn abiom abmd teleflex tfx be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
112,ALGN,wednesday orasure technology osur reach important technical milestone relative strength rs rating jump percentile upgrade day exclusive rating investor business daily identify price action worst best score score show stock price behavior last week compare other stock database history reveal market biggest winner tend have higher rs rating early stage move look winning stock try simple routineorasure technology be try complete cup handle entry see clear price volume least average keep mind later stage consolidation entail more risk earning share growth drop company latest report top line rise next quarterly number be expect feb company hold rank peer medical product industry group align technology algn abiom abmd inogen ingn be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
113,ALGN,major market average hold modest gain early trade friday lead chip stock nvidia nvda advanced higher price target boost stock market today tech heavy nasdaq rise apiece dow jone industrial average be nasdaq near new high back early morning trade dow jone industrial nike nke jump nearly be upgrade neutral outperform wedbush security share be extend cup handle entry elsewhere dow american express axp drop nearly say suspend share buyback first half year order rebuild firm capital follow time charge due gop new tax legislation stock be try find support day line downside ibm ibm faltered exceed top bottom line estimate late thursday stock be still form right side potential base graphic chip maker nvidia jump nearly early friday bank america bump price target premium thursday close price share break past cup shape base entry jan have remain buy range share be cusp be extend buy range top fang stock amazon com amzn announce be raise monthly amazon prime rate unite state month share rise look snap day lose streak nintendo ntdoy be breaking cup shape base buy point stock rise heavy volume earlier week company announce nintendo labo new line interactive build play experience mainly target child stock be also cup handle entry stock relative strength line be near old high company report earning ibd member atlassian team decline nearly provide downbeat guidance current quarter profit outlook share be trading cup shape base entry earlier week ibd coherent cohr pare early gain stock try reclaim buy point volume surge average wednesday day however relative strength line remain old high downside align technology algn fall nearly stock test recent cup shape base entry be later stage base related be stock race buy point hottest group right nowhighflying defense stock get more lift investing action plancan great stock lead again form multiple base sometimes yesq earning preview join netflix list stock expect growth schlumberger beat see more oil spending top saudis russia
114,ALGN,columbia mid cap growth fund clspx be rev engine recent period portfolio have be neck neck tad ahead broad market midcap growth rival track morningstar direct so far young year go thursday fund be vs peer group improvement past year slightly lag credit start lead stock hold fund top holding fleetcor technology flt red hat rht rise past month top new buy dollar tree dltr arista network anet rise other holding include thor industry tho align technology algn be past month arista fleetcor happen be member ibd list top perform growth stock fund largest position dec have ibd composite rating so do top new buy ibd composite rating be score scale stock poise move higher often have comp rating higher manager george myer brian neigut william chamberlain invest company poise sustainable long term growth have high improve margin return invest capital manager consider midcaps sweet spot market market capitalization fund buy midcap stock be big enough offer stability yet small enough deliver significant growth opportunity manager explain dec fact sheet commercial fleet payment processor fleetcor be fund top hold dec weighting rise end september trading share price be extend november buy point long base late last year company boost share buyback program say wal mart wmt begin payment card fuel station red hat earning share grow past quarters red hat be top provider open source linux software corporate datum center ibd have report analyst have be look traction red hat public cloud business customer shift compute workload cloud service provider such amazon web service part amazon red hat partner dollar tree re enter portfolio october ep grow past quarters december company report better expect third quarter earning sale also raise full year earning sale forecast manager begin current stake arista november ep grow past quarters cloud networking software maker be rank stock ibd computer networking industry group turn be rank second ibd industry group arista have be take share cisco datum center switch market think arista long term software development continue drive share gain already demonstrated current gigabit cycle recent switch router traction morgan stanley analyst james faucette recently tell ibd ibd take see arista strength year ep growth rate stack peer stock easy read ibd stock checkup page recreational vehicle maker conglomerate thor industry gap nov be report jump quarterly earning close hike capped increase prior stanzas invisible brace maker align be know computer assist design approach straighten tooth ep growth have accelerate quarters grow most recent frame sale growth have also accelerate period trading form new base share be just cup shape base buy point stock be rank ibd medical product industry group related stock market forecast smaller price gain foreign need much retirement saving age income
115,ALGN,edward lifescience ew see positive improvement relative strength rs rating tuesday rise ibd unique rs rating identify technical performance show stock price action last week compare other stock database history show stock go make biggest gain tend have rs rating north early stage move see edward lifescience continue show renew price strength clear threshold look winning stock try simple routineedward lifescience be now consider extend buy range clear buy point second stage cup handle see stock form new pattern follow buy opportunity week tight pullback day week move average edward lifescience report earning growth most recent report revenue increase keep eye company next round number feb edward lifescience earn rank peer medical product industry group align technology algn be top rank stock group related stock be show rise relative strength use ibd relative strength rating relative strength line help judge stock
116,ALGN,stock gain continue evaporate afternoon trading tuesday nasdaq composite russell small cap index reversed lower nasdaq composite be rise nearly also erased gain be afternoon bearish reversal give investor pause russell be early be today market dow jone industrial average lead gain price gap today open dow get considerable help merck mrk catapult month high report positive result treatment lung cancer year ahead expectation volume be higher compare same time friday day light trading ahead day weekend dozen stock top buy point several surrender gain have lag relative strength line include health care novartis nvs clear buy point flat base rs line be lowest point month volume be pale align technology algn poke buy point recede entry base form huge advance ligand pharmaceutical lgnd try break past buy point stock erased most gain volume be well normal rs line be lag well general motor gm be try break double bottom base entry volume be strong rs line need catch stock have be rangebound much past year automaker say earning be high end expect range give bullish guidance financial franklin resource ben citigroup sank back basis briefly clear buy point energizer holding enr soar past buy point cup shape base slide entry consumer product company spectrum brand spb say be selling global battery light business energizer holding cash business include rayovac battery spectrum brand rise be related general motor jump strong earning bullish outlook dow merck do face release cancer trial resultsearning season preview align technology buy zone quarterly report dueenergizer buy spectrum rayovac battery unit blackhawk go private
117,ALGN,stock index make bearish reversal tuesday first sign market hot start be cool index gap open soon start pare gain apparent trigger go negative et continue drop steadily stabilize final hour
118,ALGN,strong open stock market tuesday see dow jone industrial average cross level early gain fade badly close rise early dow fade loss less nasdaq composite also give back healthy gain fall give back nearly small cap underperform russell preliminary datum show volume nyse nasdaq come higher friday level stock market today result distribution day nasdaq higher volume decline haven be issue broad market recent week always important pay attention sign institutional selling arise even percentage decline aren severe money flow stock do not translate bond inflow year treasury yield be mostly unchanged strong showing merck mrk unitedhealth unh help dow early share merck gap day move average rise nearly company say late stage trial blockbuster cancer drug keytruda combination chemotherapy treatment be effective treat patient advanced lung cancer share unitedhealth meanwhile gain company report earning give solid outlook wall street also like look quarterly result citigroup share rise try clear flat base entry come short tuesday session serve early breakout many top rate growth name include ibd name atlassian team align technology algn well weibo wb name look lot major stock index close result atlassian be due thursday close share rise ahead result clear buy point end buy point share weibo rise more end just cup handle buy point note handle be only visible daily chart not weekly latest be late stage base align technology also break early close whimper share rise close just entry abbvie abbv turn solid performance recent buy point share rise stock have be watch list ibd leaderboard related top tech stock hit buy point only hold upapplied material lam research boost upgrade asml break outgeneral motor jump strong earning bullish outlook bofa goldman alcoa pick earning season pace investing action plan
119,ALGN,relative strength rs rating accelerate diagnostic axdx jump new percentile friday increase exclusive rating investor business daily track share price performance worst best score rating show stock price performance trail week hold other stock database year market history reveal market biggest winner often have better rs rating early stage move see ibd help make more money diagnostic be build cup handle buy point see stock break volume least higher normal company see earning sale growth rise last quarter earning share increase revenue rise company earn rank peer medical product industry group align technology algn abiom abmd edward lifescience ew be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
120,ALGN,fourth quarter earning season underway now be time build list best stock watch focus company netflix nflx facebook fb ipo gardner gdi lead chinese stock weibo wb com wuba be expect deliver earning growth higher make
121,ALGN,sector leader member abiom abmd be potential buy range ahead next quarterly report expect jan trading buy point fifth stage flat base understand buy stock just ahead earning be risky typically don have enough time establish profit cushion latest quarterly number come be sure follow sound buy sell rule minimize exposure see ibd help make more money stocksabiom report earning growth last quarter sale growth come analyst expect ep growth quarter growth full year annual growth estimate be recently revise lower abiom have composite rating hold rank peer medical product industry group align technology algn be rank stock group note date earning report be subject change check company update related earning calendar analyst estimate stock watchnew option strategy limit risk earning
122,ALGN,wednesday mimedx mdxg reach important technical milestone see relative strength rs rating jump percentile improvement day proprietary rating measure technical performance show stock price movement last week measure other stock database year market history show best stock often have higher rs rating begin biggest climb see ibd help make more money ibd stock be build cup handle buy point see break heavy trading mimedx show earning growth latest quarterly report sale increase company earn rank peer medical product industry group align technology algn be top rank stock group related stock be show improve technical action use ibd relative strength rating relative strength line help judge stock
123,ALGN,tactile system technology tcmd have relative strength rs rating upgrade tuesday ibd proprietary rating identify share price movement worst best score score show stock price movement last week hold other stock database history reveal market biggest winner typically have rs rating north begin biggest climb look best stock buy watch start heretactile system technology be now consider extend buy range clear buy point first stage cup handle see stock form new pattern follow buy opportunity week tight pullback day week move average earning growth moved company most recent report top line fall tactile system technology earn rank peer medical product industry group align technology algn abiom abmd inogen ingn be top highly rate stock group related stock be show rise relative strength use ibd relative strength rating relative strength line help judge stock
124,ALGN,putt together watch list look stock higher rs rating mimedx mdxg just clear benchmark upgrade unique rating measure market leadership show stock price action last week measure other stock database decade market research show stock go make biggest gain tend have rs rating begin biggest price move see ibd help make more money now be not ideal time invest see stock manage offer clear appropriate buy point company report ep growth most recent report sale growth come company earn rank peer medical product industry group align technology algn abiom abmd inogen ingn be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
125,ALGN,relative strength rs rating accelerate diagnostic axdx climb new percentile thursday rise proprietary rating measure technical performance used worst best score identify stock price action last week match other stock year market history reveal market biggest winner typically have rs rating begin biggest climb see ibd help make more money diagnostic be work cup handle entry see break volume least average accelerate diagnostic see earning sale growth rise last quarter earning share increase revenue rise company hold rank peer medical product industry group align technology algn abiom abmd inogen ingn be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
126,ALGN,monday lead drugmaker abbvie abbv announce positive phase trial result psoriasis treatment risankizumab tuesday ibd big cap be fractionally potential new buy zone result ongoing study show nearly half risankizumab patient achieve complete skin clearance pasi vs
127,ALGN,important metric look stock be higher relative strength rating baxter international bax now clear threshold jump wednesday proprietary rating measure market leadership used worst best score identify stock price performance trail week match rest market history reveal best stock tend have rs rating begin biggest price move look best stock buy watch start herenow be not ideal time jump isn proper buy zone see stock go form chart pattern break earning share growth decline last quarter sale grow previous report next quarterly number be expect feb baxter international hold rank peer medical product industry group align technology algn abiom abmd inogen ingn be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
128,ALGN,wednesday teleflex tfx get upgrade ibd smartselect composite rating new rating show stock be outpace stock come most important stock pick criterium best stock tend have better grade start significant move teleflex be currently form flat base buy point look stock break heavy trade least higher normal look best stock buy watch start stock sport ep rating mean recent quarterly longer term annual earning growth be outpace stock accumulation distribution rating show moderate buy institutional investor last week company report ep growth sale growth rise prior quarter mark quarter accelerate revenue gain teleflex earn rank peer medical product industry group align technology algn be rank stock group related company be now outperform stock
129,ALGN,stock market act chaotic way do wednesday techs fall sharply bank rise sharply sort strange noise come car engine time look hood stock mean check level fund support number be always
130,ALGN,postelection year climb dow jone industrial surge market top stock do far better investor have search farther big return
131,ALGN,deliver year rally more year follow big gain averaged more modest advance say money manager strategist still see plenty investment opportunity seem already be hand scarcely day new year dow have charge ahead process top first time ever best gain full year come overseas stock market value equity abroad click here timeline detailed chart remarkable stock market rotation big portfolio more foreign stock be expect take place economic uncertainty due brexit escalate tension russia vladimir putin china xi jinp not mention north korea nuclear threat big reason be prospect faster economic growth abroad cheaper valuation many foreign equity gdp growth likely continue strong china europe european central bank ecb president mario draghi say monetary stimulus continue least september special report personal finance action plan stock market economy look positive too investor be hearten incoming federal reserve chairman jerome powell re jazzed drum roll move president trump include tax reform open way oil drill arctic national wildlife refuge throttle back federal regulation withdraw paris climate accord many stock sharply year investment strategist fund manager expect more modest stock price gain return be more double big cap bogey average annual gain past year nasdaq composite index shot dow jone industrial gain align technology algn part nasdaq member ibd list top perform growth stock jump company be know computer assist design approach straighten tooth banking giant jpmorgan chase jpm key cog dow rise ibd market editor juan carlos arancibia analyze top perform stock separate article backdrop money pro say best opportunity lie stock abroad see good potential value oriented stock include cyclical stock performance swing economic condition stock be better bond once again say david joy chief market strategist broker financial advisor ameriprise financial amp international market better domestic include develop market eurozone not include japan joy cite reason foreign stock shine economic growth relative potential growth appear be stronger international market even be do well say central bank foreign geography be more accommodative federal reserve everyone know be raise interest rate third reason valuation stock group have grow expensive joy say other market be more attractively value so more upside potential stock overall joy add do think stock go higher ameriprise currently forecast hit level year end joseph davis vanguard global chief economist head investment strategy group say vanguard expect lowest return equity roughly decade group expect annual gain stock next year ameriprise forecast gdp growth excess inflation congress pass tax reform ameriprise be predict china pace remain eurozone economy grow vs interest rate ameriprise other expect fed continue raise rate be lid earning multiple corporation bring multiple joy say research firm action economic see fed fund rate end band june tax reform be wild card add incrementally earning growth economic growth joy say provide little tailwind stock joblessness drop end lowest rate ameriprise say unemployment rate be november david polak equity investment specialist capital group parent american fund see investment opportunity several geographic market asia remain lead site technology innovator say manufacturer logic chip be group innovator industry consolidation have left key player include taiwan semiconductor tsm california base intel intc year be taiwan semi intel be dominant polak say consolidation have left space more discipline lead more visibility earning more pricing power asia stock like be japan murata manufacturing ceramic capacitor be crucial component smartphone relatively inexpensive so manufacturer stuff phone impact margin much say capacitor be used apple iphone well samsung galaxy other android phone way invest growth element have bet phone do better polak say gaming like way japan nintendo ntdoy have diversify addressable market take intellectual property away just hardware polak say used have play game only hardware now available multiple device then tencent tcehy china lead provider messaging mobile gaming service tencent also own popular app polak key tencent trait be leadership china mobile payment service enable consumer use smartphone pay bill make online purchase peter bourbeau co manager clearbridge large cap growth sblyx see opportunity stock say time switch faang stock price run up have left less room rise clearbridge fund be track become ibd best mutual fund award winner outperform well trail year schlumberger slb benefit bottom energy stock bourbeau say oil gas service company have regain pricing power add slb currently generate incremental margin highest history be benefit onestim joint venture weatherford international wft pressure pump say slb be only global service company be used balance sheet invest customer health care stock bourbeau like alexion pharmaceutical alxn call leader ultrarare genetic disease treatment company recently clear deck new management refocuse research development profile alexion also receive additional approval lead compound soliris treat other malady solaris also be be test new way be administer financial service stock group like visa visa be make very good progress recent acquisition visa europe synergy client engagement say incremental margin be extremely strong visa continue innovate core debit credit portfolio well create new way integrate merchant cardholder big stock padded mutual fund recent gain faang stock amazon amzn be top holding so be microsoft msft rise year amazon continue execute plan disrupt adjacent vertical margin rich opportunity bourbeau say continue focus marketplace amazon web service aw prime company have huge opportunity outside focus country india be more hospitable western technology company still see large opportunity aw be early stage generational shift technology be create consume regard microsoft bourbeau say expect more same strong growth trend microsoft software maker help client move workload cloud azure cloud business be run rate sale grow double digit company continue focus partnership service provider compete technology departure strategy previous management celgene celg top hold be inexpensive stock say add celgene have strategy cope patent expiration flagship product cancer drug revlimid middle next decade biotechnology company have late stage clinical readout say cash continue build expect business development opportunity acquisition further bolster clinical pipeline more ibd coverage stock market forecast read prediction top stock tax reform impact tax bracket rateyou need much retirement saving age incomeai business be future holdsbefore buy bitcoin read
132,ALGN,major market average post mixed action penultimate trading day dow jone industrial average moved tech heavy nasdaq be trading break even level meanwhile bitcoin decline coindesk south korea announce crackdown exchange dow jone industrial component american express axp advanced be new high credit card processor be profit take range flat base entry fang stock be move higher stock market today amazon com amzn have already announce strong holiday result rise reuter report say apple aapl be licensing discussion regard investment saudi arabia amazon talk be lead cloud compute division amazon web service apple be target retail store share amazon moved further cup shape base entry apple rise remain flat base buy point meanwhile facebook fb netflix nflx advanced respectively facebook be try get back day line remain previous flat base buy point new base appear be shape offer fresh entry social medium giant video stream giant be still day line cup handle entry fizzle late november share be now build flat base potential entry ibd china base new oriental education edu moved closer potential rise share be away flat base buy point keep mind current formation be later stage base so upside potential be diminish compare earlier stage base downside align technology algn fall be pace snap day streak stock big winner have be trading day line first time cup handle february meanwhile leaderboard member floor decor fnd follow wednesday powerful decline early thursday share slip back buy range cup handle entry related dow jone industrial average dow stock news analysisbitcoin plunge south korea ready crackdown cryptocurrency stock market outlook watch new yearmatch com constellation lead new year stock investing action planfang stock news quote facebook amazon netflix google
133,ALGN,relative strength rs rating accelerate diagnostic axdx climb new percentile wednesday increase unique rating identify market leadership show stock price action last week compare other stock database year market history show best stock typically have rs rating begin biggest price move see ibd help make more money diagnostic be build cup handle buy point see stock clear price volume least higher normal top bottom line growth moved higher last quarter earning be compare prior report revenue increase accelerate diagnostic hold rank peer medical product industry group align technology algn inogen ingn tactile system technology tcmd be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
134,ALGN,important metric look stock be higher relative strength rating penumbra pen clear benchmark wednesday jump wednesday ibd unique rs rating measure technical performance show stock price movement last week compare other stock major index history reveal stock go make biggest gain tend have rs rating early stage move look best stock buy watch start herepenumbra be now consider extend buy range clear buy point first stage flat base see stock form new pattern follow buy opportunity week tight pullback day week move average earning growth slow most recent quarter sale moved higher penumbra earn rank peer medical product industry group align technology algn inogen ingn tactile system technology tcmd be top highly rate stock group related stock be show improve price performance use ibd relative strength rating relative strength line help judge stock
135,ALGN,index fall modestly story tuesday be retail energy help counter wave selling technology sector nasdaq fall dow jone industrial average lose less volume fall likely be light rest week commonly be
136,ALGN,share price gain combination stock promise stock solid earning record have help put ab discovery growth fund chclx top mutual fund big share price gainer include beigene bgne loxo oncology loxo yet post annual profit more seasoned holding solid earning include arista network anet align technology algn grubhub grub copart cprt discovery growth have joined rank top mutual fund outperform midcap growth peer track morningstar inc fund have also top direct rival well big cap bogey year go wednesday benchmark past year bruce aronow management team chief investment officer say secret sauce ab discovery growth fund recent outperformance have ingredient be get fundamental right say mean identify faster grow company other be identify company outgrow consensus expectation enjoy positive earning revision surprise top mutual fund used fundamental research quantitative modele find company want quant model trigger such factor earning revision momentum earning surprise fund want company growth potential be post earning surprise lure more investor get newsletter deliver inbox more info product service privacy policy term usearista make cloud networking software hardware thing aronow like arista be do not have try make old technology solve new customer challenge thesis be arista have better solution go datum center market aronow say be design ground target legacy company cisco system csco juniper network jnpr have live legacy code technology make tougher be nimble arista not have adapt old technology have many benefit aronow say arista solution be more scalable add offer order magnitude better economy be build focus market need take bell whistle equation provide solution market value arista year earning share growth rate be annual ep have grow year row ibd take want see arista be stock ibd computer networking industry group check ibd easy read stock checkup page see arista trait compare rival align technology be disruptive hold case market have upset be produce orthodontic brace make invisalign be different traditional wire bracket orthodontic solution invisalign hold big appeal adult don want march metal brace badge honor so grow demand adult align have strengthen growth learn provide aligner increasingly complex case aronow say be also expand market develop product older teenager not just adult north american need orthodontic device use clear aligner aronow say invisalign have share market add aronow think clear aligner market share least double just roughly penetration internationally even better runway say ep go negative quarters gain most recent stanzas takeout food order platform grubhub be example company benefit be first mover be classic network effect model aronow say add model have most restaurant diner continue grow competitive leader restaurant want broad reach greatest number prospective customer diner want variety grubhub acquisition alliance reinforce network effect announce complete be purchase eat yelp orderup food order firm foodler dash delivery service grubhub also enter partnership groupon bring food delivery groupon customer grubhub also agree integrate online order restaurant yelp platform make grubhub exclusive food delivery provider yelp visitor exchange referral transaction fee february year yum brand say buy stake grubhub grubhub also say provide kfc taco bell online order pickup delivery service restaurant copart auction vehicle have be declare total loss insurer inventory be more driver be distract smartphone repair cost have soar vehicle have more sophisticated content form sensor electronic cost repair more vehicle get increasingly hard justify aronow say copart share price have not be hurt badly broad market recent sell share be past month also hot stock light fire ab discovery need much retirement saving age income
137,ALGN,get ready earning season focus stock potential buy zone ahead next quarterly report ibd sector leader member align technology algn currently fit bill expect release latest number jan trading buy point third stage cup handle keep mind buy close stock report be risky don know stock report market react don have enough time build profit cushion reduce exposure wait see company report market react look best stock buy watch start herein term top bottom line number company have post rise ep growth last quarters revenue gain have also moved higher same time frame analyst expect earning share growth quarter growth full year annual ep estimate be recently revise upward company have composite rating hold rank peer medical product industry group abiom abmd inogen ingn be also group highest rate stock note date earning report be subject change check company update related earning calendar analyst estimate stock watchnew option strategy limit risk earning
138,ALGN,buffalo discovery fund buftx turn market disrupter align technology algn long term secular trend shape investment strategy have land fund top mutual fund third annual ibd best mutual fund award fund have be lead clay dave carlsen elizabeth jone seek early identification attractively price financially strong well manage company carlsen say take patient approach stock selection look stock opportunity long term growth be be overreaction term approach have paid top perform mutual fund have beaten past year do so win ibd best mutual fund award growth fund midcap fund category last year period fund have turn average annual return gain have handily surpass midcap growth fund track morningstar have post return same period do put top mutual fund buffalo discovery year annual average return rank top morningstar midcap growth fund buffalo discovery return earn top ranking ibd best mutual fund award list midcap fund innovation be essential inclusion buffalo discovery portfolio ve find focus innovation be best way hitch wagon share gainer market disrupter carlsen say believe company be most likely reap reward big secular growth trend carlsen team used secular trend home worthy portfolio candidate secular trend provide growth tailwind narrow stock pick universe durable growth universe believe grow faster have less cyclicality overall market say growth universe establish hunting ground not constituent benchmark index purposely distance relative benchmark portfolio management style lead high active share get newsletter deliver inbox more info product service privacy policy term buffalo discovery team look company gain market share almost market environment let innovator run carlsen say have preference small midcap stock long runway growth benefit innovation be sustainable early relative potential opportunity result high rate growth many year buffalo discovery own stock holding maintain annual turnover ratio dec technology industrial health care be largest sector weighting top hold align technology have be mainstay portfolio much carlsen tenure stock have surge more maker invisalign be add portfolio have climb large cap territory buffalo discovery team still see plenty room run believe robust growth be sustainable intermediate long term carlsen say less orthodontic market have converted metal brace clear aligner company have also be focuse drive cost product result tremendous growth internationally invisalign case shipment spiked year year basis carlsen see fund stake nevro nvro benefit age population government push away opioid pain management company make high frequency spinal cord stimulation scs device treat chronic back leg pain more effectively better clinical outcome compete scs device traditional player say have rapidly gain nearly market share remain well position further share gain rapid growth continue product innovation smaller footprint device expand market recent full body mri approval europe bode well future approval xylem xyl hold fund enable municipal industrial customer manage water system more efficiently ve incorporate sensor analytic proactively provide alert problem require attention break cause costly downtime carlsen say have also incorporate intelligence pump use less energy boost efficiency company have earning growth midteen next several year share xylem be year tech space buffalo discovery team be bullish video game publisher electronic art ea video game company have enjoy strong year investor realize positive business model effect downloadable game game content carlsen say emerge online player network help further expand user base player connect world electronic art have see stock price rise past year buffalo discovery buy share praxair px industrial gas supplier be top hold year end be premier operator serve consumable product diverse set industrial customer carlsen say tend insulate negative flash point economy strategy be grow profitably regardless macroeconomic environment name bring nice stability portfolio share praxair be versus year eye current holding buffalo discovery team remain lookout opportunity add innovator portfolio believe market frequently overreact term event create opportunity buy premier stock attractive price carlsen say market volatility experience past february be most recent example only active management investor benefit temporary market dislocation anyone ride index fund etf bull market need skill active manager protect capital tide turn also be interested read full ibd best mutual fund award special reporthere list best mutual fund award winner categorybest mutual fund news performance report investing invest fidelity stock guru john rothwhich stock be best mutual fund buy selling
139,ALGN,ibd smartselect composite rating stryker syk increase tuesday new score tell company be now outperform stock term most important fundamental technical stock pick criterium stryker break earlier be now prior entry flat base stock re watch clear buy point then retreat more original entry price consider fail base best stock form new base look best stock buy watch start hereone weak spot be company ep rating track quarterly annual earning share growth look improve better show top stock accumulation distribution rating show moderate buy institutional investor last week get newsletter deliver inbox more info product service privacy policy term usein company report earning growth mean now generate straight quarters rise ep growth sale be flat match prior report stryker earn rank peer medical product industry group abiom abmd align technology algn icu medical icui be top highly rate stock group related company be now outperform stock see stock just come ibd top stock list
140,ALGN,look best stock buy watch focus rise relative price strength stock fit bill be intersect ent xent have relative strength rs rating upgrade friday look best stock buy watch factor watch closely be relative price strength ibd proprietary rs rating identify market leadership show stock price movement last week measure other stock major index history reveal best perform stock tend have better rs rating early stage move see ibd help make more money stocksnow be not ideal time jump isn proper buy zone see stock manage offer clear proper buy point earning growth rise last quarter sale fall company earn rank peer medical product industry group abiom abmd align technology algn icu medical icui be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term useget instant access more trading idea exclusive stock list ibd proprietary rating only also ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
141,ALGN,important metric look stock be higher relative strength rating medical wmgi clear benchmark thursday jump thursday look best stock buy watch factor watch closely be relative price strength ibd proprietary rs rating track market leadership show stock price action last week compare other stock major index decade market research show stock go make biggest gain often have rs rating north begin biggest climb look winning stock try simple routinewright medical be build consolidation buy point see stock break heavy volume earning growth picked last quarter revenue gain fall medical earn rank peer medical product industry group abiom abmd align technology algn icu medical icui be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term also ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
142,ALGN,tech stock be back favor thursday nasdaq composite suffer mild distribution day wednesday fall higher volume nasdaq component texas instrument txn align technology algn baidu bidu show gain least top gainer dow include cisco system csco intel intc microsoft msft nasdaq draw closer time midday thursday rise dow jone industrial average add picked small cap couldn keep russell ease volume nasdaq be tracking slightly higher wednesday level nyse be pace be slightly lower software stock power nasdaq higher technology sector software sector arguably boast strong fundamental stock market result today enterprise software stock ringcentral rng be top gainer marketsmith growth rise close double bottom entry share be strong stifel nicolaus initiate coverage buy rating price target other top gainer group include sector leader baozun bzun tech stock jump find support day move average share twilio twlo add bottom base earlier year stock have be get support week move average approach time high big loser thursday be broadcom avgo share crater news plan acquire enterprise software giant inc several wall street analyst question company strategy go outside chip space buy low growth software company ibd deliver plenty strong performer include ligand pharmaceutical lgnd share hit new high rise software name atlassian team leaderboard name zto express zto also outperformed gain more get instant access more trading idea exclusive stock list ibd proprietary rating only also here be best online broker option active tradershow apple oil used datum stay ahead crowd
143,ALGN,keep watch list date be key make money stock market ibd help do regularly update stock screen ibd sector leader ibd big cap ipo leader table see stock have just be add remove list ibd display video id
144,ALGN,stock strengthen afternoon trading tuesday monday drubbing see lead growth stock come heavy selling pressure don give bull market yet shortage market leader still boast bullish chart leaderboard name netflix nflx rebound monday haircut be far best performer fang stock other top gainer nasdaq include ibd name align technology algn intuitive surgical isrg amazon com amzn apple aapl
145,ALGN,apple be testing support day move average intuitive surgical be hold nicely still buy range recent flat base entry nasdaq composite lead way rise add dow jone industrial average picked volume nyse nasdaq be tracking lower monday level oil gas stock outperformed oil price surge crude oil future jump more barrel pressured ally stop import oil iran stock market result today akamai akam gap day move average fall nearly company forecast second quarter earning sale low end prior guidance retailer home home gap new high rise more morgan stanley upgrade share overweight equal weight stitch fix sfix re-cover more half monday decline new issue chart be still intact trade just recent high plenty liquid average daily volume share annual earning growth be expect slow year fall cent share company earn cent couple china base ibd name bounce back monday drubbing see ibd index drop baozun bzun rally nearly pay visit day line monday zto express zto picked come close day line monday get newsletter deliver inbox more info product service privacy policy term usegold lose ground again dollar strengthen hit high april spdr gold share gld be nearly exchange trade fund fall tuesday still hold december low also homebuilder stock soar demolish earning viewsthese stock just come ibd stock liststrump say harley move abroad be begin end
146,ALGN,look best stock buy watch focus rise relative price strength stock fit bill be glaukos gkos see welcome improvement relative strength rs rating friday upgrade look best stock buy watch factor watch closely be relative price strength proprietary rating measure market leadership used worst best score indicate stock price action trail week match other stock database history reveal stock go make biggest gain tend have rs rating begin new climb see ibd help make more money stocksglaukos have moved more past entry first stage consolidation meaning now proper buy zone look stock offer new chance pick share week tight pullback day week line company show ep growth most recent report revenue gain come glaukos earn rank peer medical product industry group abiom abmd align technology algn icu medical icui be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term also ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
147,ALGN,ibd stock screen be regularly update add new stock watch well weed have start show weakness table ll see stock have be add remove list ibd sector leader ibd big cap screen be
148,ALGN,retail stock outperformed monday technology stock weren far fang stock apple aapl amazon com amzn netflix nflx hit new high nasdaq composite score time close high close dow jone industrial average nasdaq composite rise add small cap lag russell
149,ALGN,thursday stryker syk get positive adjustment relative strength rs rating re research best stock buy watch keep close eye relative price strength exclusive rating investor business daily measure market leadership worst best score rating show stock price movement last week compare other stock database year market history show market biggest winner typically have rs rating least early stage move look winning stock try simple routinestryker be still buy zone climb entry flat base proper buy range be initial entry once stock move range best set buy opportunity company post earning growth most recent report sale growth come company hold rank peer medical product industry group abiom abmd align technology algn icu medical icui be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term also stock be show rise relative strength use ibd relative strength rating relative strength line help judge stock
150,ALGN,earning tap jan ibd sector leader member align technology algn be trading approximately shy buy point pattern be third stage cup handle mean more prone failure first second stage formation understand buy just stock report be risky don know stock report market react don have enough time build profit cushion minimize exposure wait see actual number market reaction way minimize risk post earning sell be use option strategy look best stock buy watch start herein term top bottom line number company have post rise ep growth last report sale growth have also moved higher same period analyst be look ep growth quarter growth full year earning share estimate full year be recently revise upward company have composite rating earn rank peer medical product industry group abiom abmd edward lifescience ew be also group highest rate stock note date earning report be subject change check company update related earning calendar analyst estimate stock watchnew option strategy limit risk earning
151,ALGN,market pundit declare sell go away appear be zip mouth shut lately laggard major index so far take charge large cap proxy rally wednesday set be nifty performance nasdaq composite trail
152,ALGN,ibd stock screen be regularly update add new stock watch well weed have start show weakness table ll see stock have be add remove list ibd sector leader ibd big cap screen be
153,ALGN,tuesday qiagen qgen get upgrade relative strength rs rating look best stock buy watch factor watch closely be relative price strength ibd proprietary rating measure market leadership worst best score grade show stock price behavior last week stack other stock database history show top perform stock tend have better rs rating early stage move see qiagen continue show renew price strength hit benchmark see ibd help make more money stocksqiagen be work consolidation entry see clear price volume least higher normal company see earning sale growth rise last quarter earning share increase revenue rise company earn rank peer medical product industry group abiom abmd align technology algn icu medical icui be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term also stock be show rise relative strength use ibd relative strength rating relative strength line help judge stock
154,ALGN,repligen rgen have relative strength rs rating upgrade monday re research best stock buy watch be sure pay attention relative price strength exclusive rating investor business daily track market leadership worst best score rating show stock price performance trail week hold other stock database decade market research reveal market biggest winner tend have rs rating north begin biggest run look best stock buy watch start hererepligen be build cup handle buy point see stock clear price volume least higher normal company report ep growth last quarter sale growth come repligen hold rank peer medical product industry group abiom abmd align technology algn icu medical icui be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term also stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
155,ALGN,ibd stock screen be regularly update add new stock watch well weed have start show weakness table ll see stock have be add remove list ibd sector leader ibd big cap screen be
156,ALGN,keep watch list date be key make money stock market ibd help do regularly update stock screen ibd sector leader ibd big cap ipo leader table see stock have just be add remove list ibd display video id
157,ALGN,repligen rgen see welcome improvement relative strength rs rating wednesday increase look best stock buy watch factor watch closely be relative price strength exclusive rating investor business daily identify share price action worst best score rating show stock price behavior trail week hold other stock database year market history show best perform stock typically have rs rating begin biggest price move see repligen continue rebound hit benchmark look best stock buy watch start hererepligen be try complete cup handle entry see break volume least average repligen show earning growth last quarter revenue increase company hold rank peer medical product industry group abiom abmd align technology algn icu medical icui be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term also stock be show improve technical action use ibd relative strength rating relative strength line help judge stock
158,ALGN,penumbra pen see ibd smartselect composite rating rise thursday day revise score mean stock currently top other stock term key performance metric technical strength penumbra be now buy range breaking entry flat base look winning stock try simple routineone weak spot be company ep rating track quarterly annual earning share growth look improve better show top stock accumulation distribution rating show heavy buy institutional investor last week get newsletter deliver inbox more info product service privacy policy term company report ep gain sale growth increase prior report company have now post accelerate growth last quarters penumbra hold rank peer medical product industry group abiom abmd align technology algn icu medical icui be top highly rate stock group related company be now outperform stock see stock just come ibd top stock list
159,ALGN,relative strength rs rating qiagen qgen jump new percentile wednesday get lift try find best stock buy watch be sure pay attention relative price strength ibd unique rs rating identify technical performance used worst best score indicate stock price performance last week compare rest market decade market research show best stock often have rs rating early stage move see qiagen continue show renew price strength clear threshold look winning stock try simple routineqiagen be work consolidation buy point see stock clear price heavy trading company see earning sale growth rise last quarter earning share increase revenue rise qiagen earn rank peer medical product industry group abiom abmd align technology algn icu medical icui be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term also stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
160,ALGN,repligen rgen see improvement ibd smartselect composite rating tuesday revise score mean stock currently top other stock term key performance metric technical strength winning stock often have higher grade early stage new price run so important benchmark look look best stock buy watch repligen be not currently proper buy point see stock go form new base offer new buy opportunity see ibd help make more money stock earn ep rating mean recent quarterly longer term annual earning growth top stock accumulation distribution rating show moderate buy institutional investor last week get newsletter deliver inbox more info product service privacy policy term company post increase earning revenue growth fall prior quarter repligen hold rank peer medical product industry group abiom abmd align technology algn icu medical icui be top highly rate stock group related company be now outperform stock see stock just come ibd top stock list
161,ALGN,monday integer itgr earn upgrade relative strength rs rating look best stock buy watch factor watch closely be relative price strength proprietary rating measure technical performance show stock price movement last week measure other stock database history show best stock typically have better rs rating begin biggest run see ibd help make more money stocksinteger be now consider extend buy range clear buy point first stage flat base see stock form new pattern follow buy opportunity week tight pullback day week move average term top bottom line number integer have post rise ep growth last report revenue gain have also increase same time frame company hold rank peer medical product industry group abiom abmd align technology algn icu medical icui be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term also stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
162,ALGN,keep watch list date be key make money stock market ibd help do regularly update stock screen ibd sector leader ibd big cap ipo leader table see stock have just be add remove list ibd display video id
163,ALGN,edward lifescience ew see ibd smartselect composite rating rise thursday day upgrade mean stock currently top other stock term key performance metric technical strength winning stock often have higher score early stage new price run so good start point look best stock buy watch edward lifescience be currently form flat base entry look stock break heavy trade least average look winning stock try simple stock have ep rating meaning recent quarterly longer term annual earning growth be outpace stock accumulation distribution rating show moderate selling institutional investor last week look rating improve least better get newsletter deliver inbox more info product service privacy policy term usein company post earning growth mark straight report rise ep growth top line growth fall previous quarter edward lifescience hold rank peer medical product industry group abiom abmd align technology algn icu medical icui be top highly rate stock group related company be now outperform stock see stock just come ibd top stock list
164,ALGN,welcome move boston scientific bsx see relative strength rating improve wednesday look best stock buy watch keep close eye relative price strength proprietary rating identify technical performance show stock price movement last week measure other stock database decade market research show best stock often have rs rating early stage move see boston scientific continue show renew price strength hit benchmark look winning stock try simple routineboston scientific be work consolidation entry see break heavy volume company report ep growth last quarter revenue rise company earn rank peer medical product industry group abiom abmd align technology algn icu medical icui be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term also stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
165,ALGN,teleflex tfx be form base offer entry get set report earning current formation be first stage consolidation keep mind buy just stock report be risky disappointing number send sharply lower reduce exposure wait see company report market react see ibd help make more money company report ep growth most recent report sale rise analyst be look earning growth quarter growth full year annual growth estimate be recently revise lower company have composite rating hold rank peer medical product industry group abiom abmd align technology algn icu medical icui be top highly rate stock group note date earning report be subject change check company update get newsletter deliver inbox more info product service privacy policy term also earning calendar analyst estimate stock watchnew option strategy limit risk earning
166,ALGN,earning tap icu medical icui be currently approximately shy buy point current formation be third stage flat base mean more prone failure first second stage formation keep mind risky buy stock just report minimize exposure wait see actual number market reaction look best stock buy watch start heretaking look top bottom line number icu medical have post rise ep growth last quarters sale gain have also increase same period consensus analyst estimate call ep growth quarter growth full year annual earning share estimate be recently revise higher company have composite rating hold rank peer medical product industry group align technology algn icu medical icui be also group highest rate stock note date earning report be subject change check company update get newsletter deliver inbox more info product service privacy policy term also earning calendar analyst estimate stock watchnew option strategy limit risk earning
167,ALGN,wednesday edward lifescience ew get upgrade relative strength rs rating look best stock buy watch factor watch closely be relative price strength unique rating identify market leadership used worst best score indicate stock price action last week match other publicly trade company history reveal best stock typically have better rs rating begin biggest price move see ibd help make more money stocksedward lifescience be work flat base entry see stock clear price heavy volume earning growth moved company latest report top line fall company earn rank peer medical product industry group abiom abmd align technology algn icu medical icui be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term also stock be show improve technical action use ibd relative strength rating relative strength line help judge stock
168,ALGN,thursday integra lifescience iart get upgrade ibd smartselect composite rating new rating show stock be outpace stock come most important stock pick criterium top perform stock tend have better grade begin launch significant move so be sure keep mind look best stock buy watch integra lifescience be trading entry flat base look best stock buy watch start stock earn ep rating meaning recent quarterly annual earning growth be outpace stock accumulation distribution rating show moderate buy institutional investor last week get newsletter deliver inbox more info product service privacy policy term company post earning growth mark straight quarters rise ep gain revenue growth come prior quarter integra lifescience earn rank peer medical product industry group abiom abmd align technology algn globus medical gmed be top highly rate stock group related company be now outperform stock see stock just come ibd top stock list
169,ALGN,boston scientific bsx have relative strength rs rating upgrade thursday welcome improvement still shy better score prefer see look best stock buy watch factor watch closely be relative price strength exclusive rating investor business daily track market leadership worst best score score show stock price movement last week compare other stock database year market history reveal stock go make biggest gain often have rs rating north early stage move see boston scientific continue rebound clear threshold see ibd help make more money ibd big cap stock be build consolidation buy point see stock clear price heavy trade boston scientific post earning growth latest quarterly report sale growth come company earn rank peer medical product industry group abiom abmd align technology algn globus medical gmed be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term also stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
170,ALGN,relative strength rs rating mimedx mdxg jump higher percentile thursday get lift proprietary rating identify market leadership used worst best score indicate stock price performance last week match other stock year market history show stock go make biggest gain tend have rs rating north launch biggest climb see mimedx continue show renew price strength hit benchmark see ibd help make more money stocksmimedx be not currently show potential buy point see stock go form chart pattern ignite new run company report earning growth most recent report revenue gain come company hold rank peer medical product industry group align technology algn inogen ingn abiom abmd be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
171,ALGN,penumbra pen have relative strength rs rating upgrade thursday exclusive rating investor business daily identify price action worst best score rating show stock price movement trail week hold other stock database history show market biggest winner tend have higher rs rating begin biggest price move look best stock buy watch start herepenumbra be now consider extend buy range clear buy point first stage flat base see stock form new pattern follow buy opportunity week tight pullback day week move average earning growth fall last quarter revenue rise penumbra earn rank peer medical product industry group align technology algn inogen ingn abiom abmd be top highly rate stock group related stock be show improve price performance use ibd relative strength rating relative strength line help judge stock
172,ALGN,big move cup handle buy point few week rebound way heart pump maker abiom abmd be near completion shallow base provide brand new buy point medical product industry group have be strong performer drive higher ibd
173,ALGN,leadership financial technology health care retail sector have be full display recent day sector leader screen give bull confidence broad leadership translate more gain major stock index fundamental story so name
174,ALGN,ibd smartselect composite rating tactile system technology tcmd rise thursday new rating show stock be outpace stock come most important stock pick criterium tactile system technology be now buy range breaking buy point cup handle look winning stock try simple stock have ep rating mean recent quarterly annual earning growth be outpace stock accumulation distribution rating show moderate buy institutional investor last week company report ep growth have now post accelerate ep gain consecutive quarters sale growth fall previous quarter tactile system technology hold rank peer medical product industry group align technology algn be top rank stock group related company be now outperform stock
175,ALGN,relative strength rs rating cooper company coo head new percentile friday get lift ibd unique rs rating track technical performance show stock price movement last week measure other stock database decade market research reveal best stock typically have rs rating north launch largest price move see cooper company continue show renew price strength clear threshold look best stock buy watch start herecooper company be build flat base buy point see stock clear price heavy trade cooper company report ep growth latest quarterly report revenue rise company hold rank peer medical product industry group align technology algn abiom abmd inogen ingn be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
176,ALGN,important metric look stock be higher relative strength rating accelerate diagnostic axdx just hit mark jump friday ibd unique rating track market leadership worst best score score show stock price movement last week stack other stock database year market history show stock go make biggest gain typically have rs rating early stage move see ibd help make more money diagnostic be work cup handle buy point see stock break heavy trading top bottom line growth moved higher company most recent quarter earning be compare prior report revenue increase company earn rank peer medical product industry group align technology algn abiom abmd inogen ingn be top highly rate stock group related stock be show improve price performance use ibd relative strength rating relative strength line help judge stock
177,ALGN,accelerate diagnostic axdx see welcome improvement relative strength rs rating wednesday rise unique rating measure market leadership show stock price action last week measure other stock database year market history reveal top perform stock typically have rs rating least early stage move see accelerate diagnostic continue show renew price strength hit benchmark see ibd help make more money diagnostic be build cup handle buy point see stock break heavy volume top bottom line growth moved higher company most recent quarter earning be compare prior report revenue increase accelerate diagnostic earn rank peer medical product industry group align technology algn inogen ingn abiom abmd be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
178,ALGN,relative strength rs rating resm rmd climb new percentile wednesday rise ibd unique rating track price performance worst best score grade show stock price performance last week stack other stock database decade market research show stock go make biggest gain often have rs rating north early stage move look winning stock try simple routineresm be work flat base buy point see clear price heavy trade resm see earning sale growth rise last quarter earning share increase revenue rise resm earn rank peer medical product industry group align technology algn inogen ingn abiom abmd be top highly rate stock group related stock be show improve technical action use ibd relative strength rating relative strength line help judge stock
179,ALGN,tech stock get much need lift early tuesday intraday gain nasdaq composite be pare afternoon trading sign institutional selling nasdaq have be easy see recent day broad base weakness semiconductor stock selling fang name facebook fb netflix nflx dow jone industrial average give back ease small cap lag russell volume nyse nasdaq be tracking monday level stock market today year treasury yield be recently trading basis point crude oil future settle barrel day mover dow component walt disney slump soar nearly monday early tuesday cnbc report disney st century fox foxa be close deal disney acquire fox movie studio tv production asset fox hold news sport asset share st century fox add microsoft msft outperformed dow rise get support day move average first time flat base late august microsoft also be form new flat base straight heavy volume decline apply material amat add heavy volume chip equipment bellwether be still day line high ibd align technology algn be get support day move average share plunge monday higher volume weak action be sell signal buy last buy point other ibd name hold day line so far include arista network anet paypal pypl red hat rht adobe system adbe healthequity hqy remain volatile ahead earning report close volatility start right stock break bullishly buy point early november stock crash follow trading day have have hard time attract buyer ever healthequity dip day move average early tuesday be well session lows afternoon trading related disney st century fox near deal cnbc broadcom earning get apple juice iphone productionget ready rh dave buster healthequity earning close
180,ALGN,stock fade close tuesday batter technology share try bounce sell have dent market uptrend major index open higher selling work way rest session index close session lows second day row bearish action contrast
181,ALGN,paycom payc align technology algn pop ibd sector leader screen past week stock very different behavior xalign technology developer popular invisalign transparent orthodontic brace add fifth week run lift stock more february have left
182,ALGN,good portion monday session dow jone industrial average russell small cap index show solid gain index look lot different close nasdaq composite well picked left last week more selling lead growth stock money flow
183,ALGN,stock pare gain early surge spark senate passage tax reform bill weekend bitcoin jump back level future be set start trading come weekend spdr dow jone industrial average dium rise spdr spy gain powershare qqq trust qqq fall nasdaq reversed lower disney boee ba home depot hd jpmorgan jpm power blue chip index record high disney break past buy point double bottom base early monday be trading just entry share surge wall street journal report entertainment giant be again talk st century fox foxa regard potential acquisition fox asset sector play stock market today retail bank homebuilder score big gain spdr retail xrt surge nearly best level january spdr regional banking kre spdr bank kbe advanced more etfs be buy range recent breakout bank be rally prospect higher interest rate tend boost bank profit bitcoin investment trust gbtc pop trade time high track new record close price bitcoin spiked intraday be recently trading cboe cboe plan launch bitcoin future dec ticker xbt free trading end year semiconductor gold miner technology underperform graphic chip designer nvidia nvda give support day move average fall more ve be eyee hot growth stock such align technology algn thor industry tho just be luck stock market go wild ride friday report former national security adviser michael flynn strike plea deal also create potential opportunity buy stock fund even friday session diversify fund continue hold most year date gain notch nov big cap growth fund dominate lone midcap growth fund also top list innovator ibd ffty morningstar direct categorize midcap growth lead gain nov include friday dip fund be still fund launch april partnership innovator capital management have attract asset set new buy opportunity share stage solid rebound day move average close just support line friday ffty track ibd index comprise top growth stock select ibd company make index share trait market most winning stock include outstanding profit sale growth big profit margin high return equity top holding nov include align technology universal display oled arista network anet thor industry innovator capital management ibd etf trade ibd just transaction next be ishare edge msci usa momentum factor mtum ytd return friday session fund still hold gain extend last buy point ibd take thor industry have deliver big gain year do fundamental technical rank industry group find now ibd stock checkup powershare qqq trust qqq come third ytd gain nov nasdaq index tracking etf be include friday still just high be extend flat base buy point further weakness ensue come back day rebound line set potential buy opportunity see table rest list friday pick vaneck vector semiconductor smh slice day intraday friday re-cover close just line solid move line offer show support potential chance buy share related stock fall flynn russia plea deal bitcoin reboundsnvidium top tech stock power gain innovator ibd soxxstock rally apple nvidia bounce back bitcoin buy bitcoin read
184,ALGN,merit medical system mmsi be expect report earning oct stock be now trading buy point third stage flat base clear earlier buy stock just ahead earning be risky typically don have enough time build profit cushion latest quarterly number come be sure follow sound buy sell rule minimize exposure see ibd help make more money company post ep growth most recent report sale increase analyst be look ep growth quarter growth full year annual ep estimate be recently revise upward company have composite rating earn rank peer medical product industry group align technology algn be top rank stock group note date earning report be subject change check company update related earning calendar analyst estimate stock watchnew option strategy limit risk earning
185,ALGN,friday accelerate diagnostic axdx receive positive adjustment relative strength rs rating ibd unique rating identify market leadership worst best score score show stock price performance trail week stack other stock database year market history show top perform stock typically have rs rating least early stage move look winning stock try simple diagnostic be work cup handle buy point see clear price heavy trade top bottom line growth moved higher company most recent quarter earning be compare prior report revenue increase accelerate diagnostic hold rank peer medical product industry group align technology algn inogen ingn abiom abmd be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
186,ALGN,thursday edward lifescience ew get upgrade relative strength rs rating ibd unique rating identify market leadership worst best score rating show stock price behavior last week hold other stock database decade market research reveal best stock typically have rs rating north early stage move see edward lifescience continue show renew price strength hit benchmark look winning stock try simple routineedward lifescience be work cup handle entry see stock clear price volume least higher normal edward lifescience post earning growth latest quarterly report sale growth come company hold rank peer medical product industry group align technology algn abiom abmd inogen ingn be top highly rate stock group related stock be show improve technical action use ibd relative strength rating relative strength line help judge stock
187,ALGN,thursday tactile system technology tcmd reach noteworthy performance benchmark relative strength rs rating climb percentile upgrade day exclusive rating investor business daily track market leadership worst best score rating show stock price performance trail week compare other stock database year market history reveal market biggest winner typically have higher rs rating begin biggest run see ibd help make more money system technology be now consider extend buy range clear buy point first stage cup handle see stock form new pattern follow buy opportunity week tight pullback day week line earning growth picked last quarter revenue gain fall tactile system technology earn rank peer medical product industry group align technology algn abiom abmd inogen ingn be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
188,ALGN,trump administration chance push tax reform legislation be improve pressure so call fang stock facebook fb amazon com amzn netflix nflx google parent alphabet googl other momentum stock high hedge fund ownership say jpmorgan manager overweight growth momentum take defensive approach tax reform appear prudent say jpmorgan report publish thursday passage tax reform provide mid single digit upside also estimate equity allocation most investor type be historical high potentially leave less willing increase allocation equity further thus passage tax reform be likely result style implication equity value vs growth jpmorgan recommend protective strategy high growth momentum stock high hedge fund ownership include facebook salesforce com crm apply material amat wynn resort wynn qorvo qrvo marriott international mar vertex pharmaceutical vrtx autodesk adsk also list be micron mu align technology algn netflix jd com jd activision blizzard atvi red hat rht lam research lrcx mercadolibre meli paypal holding pypl adobe system adbe ibd take read ibd big picture column day stay top market direction key indicator let know be aggressive move sideline stock rise early thursday investor eye pending tax reform vote senate technology sector sell wednesday fang stock trade higher lead netflix goldman sachs lead dow continue rally bank financial stock passage tax reform increase speculation thereof cause continue rotation growth momentum say jpmorgan analysis suggest strong active manager performance be be drive record high stock dispersion high exposure growth momentum skewing stock return favore few select stock fang related be trump bump sector gear rally reason jpmorgan citigroup other financial be seize market leadershipin ai technology race chip be ace hole vs china
189,ALGN,major market index be slightly higher early monday morning trade strong black friday sale anticipate record spending cyber monday drive share amazon com amzn price level dow jone industrial average rise tech heavy nasdaq moved apiece dow jone industrial component wal mart store wmt rise share remain extend flat base entry elsewhere dow apple aapl reversed early loss trade virtually unchanged share be extend cup handle buy point downside dowdupont dwdp decline share be fight support key day move average line fang stock amazon com advanced reach price level first time pace extend winning streak trading session share be now cup shape base entry cyber monday sale be expect break online sale record black friday online sale reach record accord adobe analytic other retailer be lift higher well stock market today gap gps moved more reclaim cup handle entry fellow fang member facebook fb rise notch record high share be still barely buy range flat base entry analyst action payment processor square sq sell more be cut neutral sell btig research share have show climactic action recent week breaking upper channel line well meanwhile western digital wdc be lower overweight equal weight morgan stanley share decline more fall base buy point day line datum storage peer micron technology mu fall nearly be still double bottom entry ibd align technology algn rise more record high share have be fire rise cup handle entry downside apply material amat drop share have be volatile bearish downside reversal nov stock be still cup handle entry day move average line related amazon google wal mart fight smart homedow jone industrial average dow stock news analysisretail commerce stock industry newswhat expect ibd earning reportsstock hit high news net neutrality hpe whitman salesforce weekly review
190,ALGN,integra lifescience iart have relative strength rs rating upgrade thursday welcome improvement still short better score look exclusive rating investor business daily measure share price performance worst best score score show stock price performance last week stack other stock database year market history reveal best perform stock tend have rs rating north early stage move see integra lifescience continue rebound clear threshold look best stock buy watch start hereintegra lifescience be try complete consolidation entry see clear price volume least average company report ep growth latest quarterly report sale increase integra earn rank peer medical product industry group align technology algn abiom abmd lemaitre vascular lmat be top highly rate stock group related stock be show rise relative strength use ibd relative strength rating relative strength line help judge stock
191,ALGN,qiagen qgen have relative strength rs rating upgrade thursday welcome improvement still shy higher score prefer see unique rating track market leadership show stock price action last week measure other stock database year market history show best stock often have better rs rating early stage move see qiagen continue show renew price strength hit benchmark look winning stock try simple routinewhile stock be not ideal buy point right now see manage form break proper consolidation top bottom line growth moved higher company most recent quarter earning be compare prior report revenue increase look next report nov qiagen hold rank peer medical product industry group align technology algn abiom abmd lemaitre vascular lmat be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
192,ALGN,merit medical system mmsi be expect report earning oct stock be now trading right buy point third stage flat base clear earlier understand buy stock just ahead earning involve risk typically don have enough time build profit cushion latest quarterly number come be sure follow sound buy sell rule minimize exposure see ibd help make more money stocksmerit medical system report earning growth last quarter revenue increase analyst expect earning share growth quarter growth full year ep estimate full year be recently revise higher company have composite rating earn rank peer medical product industry group align technology algn be rank stock group note date earning report be subject change check company update related earning calendar analyst estimate stock watchnew option strategy limit risk earning
193,ALGN,welcome move boston scientific bsx see relative strength rating rise wednesday ibd unique rs rating measure market leadership show stock price movement last week compare other stock database decade market research reveal stock go make biggest gain tend have rs rating north launch biggest climb see boston scientific continue show renew price strength hit benchmark see ibd help make more money stocksboston scientific be not currently offer proper buy opportunity see stock go form promising consolidation kick new climb boston scientific show earning growth latest quarterly report sale growth come boston scientific hold rank peer medical product industry group abiom abmd align technology algn inogen ingn be top highly rate stock group related stock be show rise relative strength use ibd relative strength rating relative strength line help judge stock
194,ALGN,resm rmd have relative strength rs rating upgrade tuesday welcome improvement still better score look ibd unique rating identify share price movement worst best score score show stock price performance last week stack other stock database history show best perform stock typically have better rs rating launch biggest climb see resm continue show renew price strength hit benchmark look best stock buy watch start hereresm be work cup handle buy point see clear price volume least higher normal earning growth rise last quarter sale fall next quarterly number be expect oct company hold rank peer medical product industry group align technology algn abiom abmd lemaitre vascular lmat be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
195,ALGN,nasdaq composite hold solid gain afternoon trading friday help strong earning tech bellwether amazon com amzn alphabet googl microsoft msft nasdaq be picked dow jone industrial average lag rise weigh weakness share merck mrk chevron cvx slump respectively earning blue chip index have plenty strong gainer well apple aapl microsoft intel intc show gain range wall street like look intel earning report also come bullish guidance stock market today amazon gap buy point earning sale easily top expectation share soar alphabet meanwhile gap reclaim buy point rise more microsoft sail ahead be already well extend prior entry financial silicon valley base svb financial sivb gap lengthy consolidation buy point share jump company report third straight quarter accelerate earning sale growth ibd align technology algn be big winner nearly maker invisalign brace report rise quarterly profit third straight quarter accelerate sale growth meanwhile try logmein logm fade badly afternoon trading share pop early gain fade less still hold conventional entry triple digit earning sale growth recent quarters be result company acquisition citrix system ctxs goto family product related option trading play apple facebook earning amazon hit time high score numerous price target invest stock market simple routine
196,ALGN,stock scrape mixed start friday trainload influential company report mix third quarter result tech sector rally early lead nasdaq composite jump positive earning news amazon com amzn microsoft msft alphabet googl dow jone industrial average limp start gate dow name microsoft intel intc rally merck mrk chevron cvx fall apiece swung boost techs well first solar fslr tenet healthcare thc gauge also moved higher dive expedia expe decline mattel mat result be shortage dramatic move friday premarket session fang stock name amazon open higher stomp third quarter expectation revenue earning line move lift share flat base buy point google parent alphabet shot ahead report earning be revenue gain well analyst expectation growth traffic acquisition cost slow prior quarter gain put share back buy range flat base buy point report also muster early strength apple aapl rise facebook fb gain nearly ibd stock align technology algn spiked premarket trade maker invisalign clear brace report big beat sale earning line share earning revenue gain share be extend august rebound week support first solar flash higher very big third quarter earning revenue beat boost full year earning guidance well consensus view gain drive share buy range buy point flat base downside retailer penney jcp dive warning third quarter loss be much wider expect economy grow clip third quarter accord initial estimate commerce department be slightly gdp growth second quarter well economist consensus expectation gain inflation be also pick steam gdp price index better double second quarter gain well forecast increase university michigan be expect weigh final tally october consumer sentiment et baker hughe bhge report weekly rig count census et asia market hammer powerful session nikkei tokyo thump advance leave index seventh straight weekly gain hong kong hang seng index climb europe market rolled uneven gain afternoon trade cac paris frankfurt dax hold gain london ftse struggle flat trade related nasdaq future road tech earning fang stock signal buy big picture dow keep lead fed factor unsettle stock marketwith yellen be market pick next fed chief
197,ALGN,relative strength rs rating tactile system technology tcmd jump new percentile tuesday increase ibd proprietary rating measure price movement worst best score score show stock price behavior trail week stack other stock database history show market biggest winner often have rs rating north launch biggest run look winning stock try simple routinetactile system technology have rise more past entry first stage cup handle meaning now proper buy range look stock create new buy opportunity week tight pullback day week move average earning growth rise last quarter top line fall tactile system technology hold rank peer medical product industry group align technology algn abiom abmd inogen ingn be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
198,ALGN,next quarterly earning report schedule nov inogen ingn be currently entry current formation be first stage flat base buy stock just ahead earning involve risk typically don have enough time establish profit cushion latest quarterly number come be sure follow sound buy sell rule minimize exposure look best stock buy watch start company show earning growth most recent report sale gain come analyst expect earning share growth quarter growth full year annual growth estimate be recently revise higher company have composite rating earn rank peer medical product industry group align technology algn abiom abmd lemaitre vascular lmat be top highly rate stock group note date earning report be subject change check company update related earning calendar analyst estimate stock watchnew option strategy limit risk earning
199,ALGN,merit medical system mmsi be trading buy range next earning report expect oct stock be approximately buy point third stage flat base understand buy just stock report be risky ep sale miss send sharply lower minimize exposure wait see company report market react way minimize risk post earning sell be use option strategy see ibd help make more money stocksmerit medical system post ep growth last quarter sale growth come analyst expect earning share growth quarter growth full year annual growth estimate be recently revise higher company have composite rating earn rank peer medical product industry group align technology algn merit medical system mmsi be also group highest rate stock note date earning report be subject change check company update related earning calendar analyst estimate stock watchnew option strategy limit risk earning
200,ALGN,welcome move cooper company coo see relative strength rating improve tuesday ibd proprietary rating identify market leadership worst best score grade show stock price behavior trail week stack other stock database year market history reveal market biggest winner tend have rs rating early stage move see cooper company continue show renew price strength clear threshold look winning stock try simple routinecooper company be work flat base buy point see clear price volume least average company report ep growth last quarter sale growth come keep eye company next round number dec company earn rank peer medical product industry group abiom abmd align technology algn teleflex tfx be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
201,ALGN,globus medical gmed see welcome improvement relative strength rs rating monday upgrade exclusive rating investor business daily identify share price performance worst best score grade show stock price performance trail week compare other stock database year market history show market biggest winner typically have rs rating begin largest climb look winning stock try simple routineglobus medical be now consider extend buy range clear buy point first stage consolidation see stock form new pattern follow buy opportunity week tight pullback day week line earning growth slow most recent quarter revenue moved higher company hold rank peer medical product industry group abiom abmd align technology algn teleflex tfx be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
202,ALGN,big drop share general electric ge didn have much effect broad market monday several top rate growth stock outperformed nicely continue recent trend dow jone industrial average nasdaq composite show gain small cap lag slightly russell volume nyse nasdaq be tracking close friday level stock market today share ge slump company cut dividend cent share part restructure company shift focus market aviation power health care home depot hd mcdonald mcd procter gamble pg picked slack dow gain home depot be get support day move average ahead earning report tuesday open many session strong mover hailed china not exactly new story leaderboard name com wuba soar nearly too late buy stock july couple visit day move average quarterly profit com nearly double expectation sale rise meanwhile china base online retailer jd com jd break trend line find connect stock recent high give early entry aggressive trader stock be still high be back day move average open company report surge profit more double expectation sale increase ibd monster beverage mnst extend gain last week buy point share initially slump thursday even monster report second straight quarter accelerate sale growth stock reversed higher end gain share monster be recently trading strong performer ibd exclusive sector leader screen monday include lgi home lgih align technology algn ichor ichr screen currently hold name most ichor be small cap semiconductor name report solid quarter last week share have be volatile stock seek support day move average related artificial intelligence star list have surprising namesqualcomm reject broadcom buyout offer say buy bitcoin read
203,ALGN,stock index battle break even line midday monday nasdaq erased most loss first minute trade nasdaq composite dow jone industrial average crawl just less small cap russell drop volume stock market today fall nyse rise nasdaq blue chip be evenly split advance issue decline issue dow jone industrial average procter gamble pg lead upside advance megacap stock be try recover roughly gap loss oct company report earning barely expectation be trading day day move average stock be steady dividend payer annualize dividend yield be increase dividend payout be usually announce april dow component home depot hd rise busy volume home depot announce quarterly result open tuesday street expect earning increase share stock be buy zone buy point ibd industry group diversify company be day leader other conservative stock group do well include electric utility soap ibd list best stock fundamental technical be evenly split loser winner day align technology algn maker clear dental brace score biggest gain bump average volume day biggest loser ibd be chip equipment maker ichor ichr heavy volume chip equipment group have be strongest player chip universe year equipment group be year vs chip designer chipmaker however so far leadership chip group have change chip design group know electronic semiconductor fabless ibd daily ranking industry group subgroup be vs equipment maker chipmaker financial news be thin monday tuesday open national federation independent business release result business optimism survey october related biggest etf opportunity buy follow dayinvestor corner tip kid make dollar saving stock
204,ALGN,many top perform equity fund padded gain past month stock market remain high intel intc nvidia nvda other chip name surge xlast month diversify stock winner innovator ibd ffty top list again year date gain nov fund launch april partnership innovator capital management have attract asset set new buy opportunity pull back rebound support day move average ffty track ibd index comprise top growth stock select ibd company make index share trait market most winning stock include outstanding profit sale growth big profit margin high return equity top holding nov include align technology algn arista network anet well top chip name such lam research lrcx apply material amat nvidia innovator capital management ibd etf trade ibd just transaction be little change top diversify stock etfs ishare edge msci usa momentum factor mtum powershare qqq trust qqq vanguard mega cap growth mgk occupied spot respectively same last month top perform etfs be etf leader see biggest opportunity way benefit economy accelerate abroadniche etfs be hot do have longer last potential move sector fund top hold steady ark innovation arkk ark web arkw lead semiconductor etfs moved list biotechs slip chip fund ishare phlx semiconductor soxx see biggest monthly gain boost ytd gain fund track phlx sox semiconductor sector index comprise company design manufacture distribute computer chip top holding nov include intel qualcomm qcom nvidia texas instrument txn broadcom avgo chip make headline nov broadcom offer buy qualcomm be biggest tech company acquisition qualcomm say be review bid broadcom be nov qualcomm be ibd take nvidia have score big gain year do fundamental technical rank industry group find now ibd stock checkup soxx be extend cup handle buy point clear september prudent keep eye top etfs set new entry pullback day line guggenheim china technology cqqq dethrone last month top foreign fund kraneshare csi china internet kweb ytd gain vs kweb return china india etfs make top half list overall blackrock global chief investment strategist richard turnill be bullish asia region economic backdrop be encourage write weekly note china economic growth corporate earning outlook appear solid term india china select southeast asia market related nasdaq hit record apple sell nvidia drife ibd etfibd etf debut top china brazil bitcoin still hotnvidium look overvalue ahead third quarter earning analyst
205,ALGN,nephew snn have relative strength rs rating upgrade friday welcome improvement still short better score prefer see unique rating identify technical performance show stock price action last week measure other stock database history show top perform stock often have higher rs rating early stage move see nephew continue show renew price strength clear threshold look best stock buy watch start herenow be not ideal time jump isn proper buy zone see stock go establish enter buy range heavy trade company report earning growth last quarter sale growth come company earn rank peer medical product industry group abiom abmd align technology algn inogen ingn be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
206,ALGN,boston scientific bsx have relative strength rs rating upgrade friday welcome improvement still short better score look ibd unique rating measure share price performance worst best score grade show stock price movement trail week stack other stock database history reveal best perform stock tend have rs rating north launch biggest run see boston scientific continue show renew price strength hit benchmark see ibd help make more money stock be not ideal buy range right now see go form break proper base company post earning growth most recent report sale increase boston scientific hold rank peer medical product industry group abiom abmd align technology algn inogen ingn be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
207,ALGN,friday globus medical gmed get positive adjustment relative strength rs rating ibd proprietary rating track market leadership worst best score grade show stock price performance last week stack other stock database history show stock go make biggest gain tend have rs rating early stage move look winning stock try simple routineglobus medical be buy range move past buy point consolidation proper buy range extend initial entry once stock hit benchmark best set buy opportunity earning share growth decline company most recent performance report sale rise previous report globus medical hold rank peer medical product industry group abiom abmd align technology algn inogen ingn be top highly rate stock group related stock be show improve price performance use ibd relative strength rating relative strength line help judge stock
208,ALGN,important metric look stock be higher relative strength rating mimedx mdxg clear benchmark friday jump friday ibd proprietary rs rating measure technical performance used worst best score identify stock price action trail week match other publicly trade company history reveal top perform stock often have better rs rating begin biggest climb look best stock buy watch start herenow be not ideal time jump isn proper buy zone see stock go offer clear appropriate buy point company show ep growth latest quarterly report sale gain come company be expect report latest result oct company earn rank peer medical product industry group align technology algn merit medical system mmsi orasure technology osur be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
209,ALGN,relative strength rs rating stryker syk enter new percentile thursday rise ibd proprietary rs rating identify market leadership show stock price movement last week measure other stock major index decade market research show top perform stock tend have better rs rating early stage move look best stock buy watch start herestryker be now consider extend buy range clear buy point first stage flat base see stock form new pattern follow buy opportunity week tight pullback day week line stryker report earning growth most recent report sale growth come company hold rank peer medical product industry group align technology algn abiom abmd teleflex tfx be top highly rate stock group related stock be show rise relative strength use ibd relative strength rating relative strength line help judge stock
210,ALGN,baxter international bax have relative strength rs rating upgrade thursday ibd unique rating track market leadership worst best score score show stock price performance trail week compare other stock database history show best stock typically have better rs rating launch biggest climb look best stock buy watch start herebaxter international be buy zone breaking past entry flat base once stock move higher original entry consider proper buy area earning growth drop most recent quarter revenue gain moved higher company hold rank peer medical product industry group align technology algn abiom abmd teleflex tfx be top highly rate stock group related stock be show rise relative strength use ibd relative strength rating relative strength line help judge stock
211,ALGN,consumer spending still make bulk economy become ever more important place such china latin america ibd seem be relay message well xibd screen story have well document rise consumer class china american insatiable desire
212,ALGN,wednesday merit medical system mmsi receive upgrade relative strength rs rating unique rating measure technical performance show stock price movement last week compare other stock major index history show best perform stock often have rs rating least early stage move look best stock buy watch start herewhile stock be not proper buy zone right now see be able form break proper consolidation merit medical system post ep growth most recent report sale growth come merit medical system hold rank peer medical product industry group abiom abmd align technology algn teleflex tfx be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
213,ALGN,tuesday qiagen qgen earn upgrade relative strength rs rating ibd proprietary rs rating measure market leadership used worst best score show stock price performance trail week compare other publicly trade company year market history reveal market biggest winner often have rs rating least early stage move see qiagen continue show renew price strength hit benchmark look winning stock try simple routineqiagen break earlier have fall back prior entry flat base stock re watch break past buy point then retreat more original entry price consider fail base best stock form new base also understand most recent pattern be later stage base such basis be more prone failure qiagen see earning sale growth rise last quarter earning share increase revenue rise next quarterly result be expect nov company hold rank peer medical product industry group abiom abmd align technology algn merit medical system mmsi be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
214,ALGN,relative strength rs rating nephew snn climb new percentile wednesday get lift ibd unique rs rating identify market leadership used worst best score identify stock price action trail week stack other stock database year market history reveal best stock often have rs rating north early stage move see nephew continue rebound hit benchmark look winning stock try simple routinewhile nephew be not proper buy zone right now see manage form break proper base company report ep growth latest quarterly report revenue gain come next quarterly result be expect oct nephew hold rank peer medical product industry group abiom abmd align technology algn merit medical system mmsi be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
215,ALGN,quiet session major stock index wednesday be far quiet surface nasdaq composite be add dow jone industrial average fall fractionally volume nyse nasdaq be tracking slightly lower tuesday level stock market today johnson johnson jnj wal mart wmt merck mrk outperformed dow gain more earning wal mart be due nov open russell find foot pay trip day move average small cap index fall nearly intraday re-cover gain late afternoon trading food stock oil driller software homebuilding name outperformed manage care firm superregional bank lag bullishness newsletter writer rise latest week prior week accord latest day investor intelligence be fifth straight read danger zone contrarian indicator significantly month low early september just extreme bearish reading have be see market bottom past excessive optimism have be see top past nasdaq composite be show sign institutional selling not much distribution day count seem high be stall session heavy volume meaningful price progress other higher volume decline show loss range take away not market meaningful distribution wednesday session serve plenty gap price planet fitness plnt gap flat base buy point stock open price be legitimate entry strong earning report bullish guidance be catalyst elsewhere ibd name coherent cohr gap buy point rise also strong earning growth oled display have be boon coherent other solid gainer ibd be trouncing year date include sina sina arista network anet align technology algn gain range small cap medical product firm inogen ingn gap flat base buy point company report earning sale growth accelerate prior quarter quarterly profit jump year period sale rise share soar match group mtch earning report fuel gap price share jump be already extend cup handle buy point head earning recent week tight pattern offer add entry earning miss match be offset strong sale outlook downside snap snap plunge sale miss weak user growth figure wall street look past news china base tencent hold tcehy take stake snap close watch earning alarm com alrm square sq ringcentral rng related grand theft auto game maker crush view stock see top rate laser maker be blast past buy point earning guidanceu crude production hit record high stockpile unexpectedly rise
216,ALGN,monday nephew snn receive upgrade relative strength rs rating ibd proprietary rs rating identify technical performance show stock price movement last week measure other stock database history reveal best stock often have rs rating begin biggest price move see nephew continue rebound hit benchmark see ibd help make more money nephew be not currently potential buy area see stock go form chart pattern spark new run company post ep growth last quarter revenue gain come nephew hold rank peer medical product industry group abiom abmd align technology algn teleflex tfx be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
217,ALGN,tuesday qiagen qgen get upgrade relative strength rs rating ibd unique rs rating measure technical performance used worst best score indicate stock price performance last week stack other stock database history show stock go make biggest gain often have rs rating north begin biggest price move see qiagen continue rebound hit benchmark see ibd help make more stocksqiagen break earlier have fall back prior entry flat base stock re watch break past buy point then retreat more original entry price consider fail base best stock form new pattern also keep mind latest consolidation be later stage base involve more risk earning grow last quarter prior report revenue also increase keep eye company next round number nov qiagen earn rank peer medical product industry group abiom abmd align technology algn merit medical system mmsi be top highly rate stock group related stock be show improve technical action use ibd relative strength rating relative strength line help judge stock
218,ALGN,relative strength rs rating mimedx mdxg jump higher percentile monday get lift exclusive rating investor business daily track price action worst best score rating show stock price movement last week hold other stock database decade market research show market biggest winner often have rs rating north early stage move see mimedx continue show renew price strength hit benchmark see ibd help make more money not currently ideal time invest see stock be able establish enter buy range heavy trade mimedx post ep growth latest quarterly report sale increase mimedx hold rank peer medical product industry group abiom abmd align technology algn teleflex tfx be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
219,ALGN,putt together watch list look stock higher rs rating orasure technology osur just meet criterium new score exclusive rating investor business daily identify market leadership worst best score grade show stock price performance trail week hold other stock database year market history show stock go make biggest gain often have rs rating begin biggest price move see ibd help make more money stocksorasure technology have rise more past entry second stage cup handle meaning now proper buy range look stock offer new chance pick share week tight pullback day week move average earning growth decline last quarter revenue moved higher orasure technology earn rank peer medical product industry group abiom abmd align technology algn teleflex tfx be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
220,ALGN,tech stock lead major market index higher monday broadcom avgo qualcomm qcom deal grab spotlight powershare qqq trust qqq gain spdr spy spdr dow jone industrial average dium climb emerge market outperformed ishare msci emerge market eem rally qqq hit time high tech stock advanced apple aapl be more record high be extend cup handle buy point apple retail store reportedly sell new iphone sunday evening energy semiconductor real estate be biggest sector fund gainer stock market today vaneck vector semiconductor smh ishare phlx semiconductor soxx gap rise more qualcomm rise extend friday surge occur broadcom offer buy chipmaker deal value also chip intel intc advanced micro device amd be higher report chip company be team oil gold fund be mostly higher respective underlie commodity see price gain vaneck vector oil service oih spdr oil gas exploration production xop surge nearly latter month high west texas intermediate crude price gain barrel vaneck vector junior gold miner gdxj vaneck vector gold miner gdx be more apiece gold future rise ounce consumer staple bank utility underperform large cap growth fund hold apple aapl microsoft msft other big techs continue dominate year market keep climb record high territory exchange trade fund accompany chart be morningstar direct large growth category however solo big cap fund list be also top performer base year date return oct innovator ibd ffty rac gain thank part jump past month more double return morningstar direct classify fund midcap growth ffty be buy range flat base entry clear late august new buy opportunity arise share pull back find support day move average launch april partnership innovator capital management etf track ibd index comprise top growth stock select ibd company index tend share trait market biggest winning stock such outstanding profit sale growth wide profit margin high return equity ffty top holding nov include chip name nvidia nvda lam research lrcx universal display oled align technology algn nvidia have nearly double price year universal display have surge innovator capital management ibd etf trade ibd just transaction next be ishare edge msci usa momentum factor mtum ytd gain fund be trading time high be extend several rebound day line fund track msci usa momentum index marked fourth anniversary april information technology account biggest chunk asset follow financial consumer discretionary health care industrial make top holding nov include microsoft bank america bac apple nvidia apple share gap friday new high deliver upside earning surprise late thursday now buy range cup handle entry ibd take lookout etf idea be worth closer look check ibd weekly etf leader column featured fund list highly rate etfs powershare qqq trust qqq come third ytd gain year old fund track nasdaq index have amassed asset top name apple microsoft amazon amzn facebook fb alphabet googl qqq have outperformed long haul annual average return past year respectively vs benchmark index gain etf be top buy range entry initially clear aug related ibd etf debut top china brazil bitcoin still hotapple alphabet amazon earning fuel top tech equity playsapple facebook buy range ahead earning bitcoin soar
221,ALGN,friday insulet podd receive positive adjustment relative strength rs rating exclusive rating investor business daily identify market leadership worst best score rating show stock price movement last week stack other stock database decade market research reveal best stock typically have rs rating north begin new price run look winning stock try simple routineinsulet have climb more past entry second stage cup handle meaning now proper buy range look stock offer new buy opportunity week tight pullback day week line company bottom line growth drop company most recently report quarter top line grow previous report keep eye company next round number nov insulet earn rank peer medical product industry group align technology algn merit medical system mmsi orasure technology osur be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
222,ALGN,nephew snn have relative strength rs rating upgrade thursday welcome improvement still shy higher score look ibd unique rs rating identify market leadership used worst best score indicate stock price performance trail week compare other publicly trade company decade market research show market biggest winner typically have rs rating north launch biggest price move see nephew continue rebound clear threshold see ibd help make more nephew be not currently show potential buy point see stock go form base ignite new run company post earning growth most recent report sale growth come company be expect report latest performance number oct company earn rank peer medical product industry group align technology algn merit medical system mmsi orasure technology osur be top highly rate stock group related stock be show improve price performance use ibd relative strength rating relative strength line help judge stock
223,ALGN,nephew snn have relative strength rs rating upgrade thursday welcome improvement still shy higher score look ibd unique rs rating identify market leadership used worst best score indicate stock price performance trail week compare other publicly trade company decade market research show market biggest winner typically have rs rating north launch biggest price move see nephew continue rebound clear threshold see ibd help make more nephew be not currently show potential buy point see stock go form base ignite new run company post earning growth most recent report sale growth come company be expect report latest performance number oct company earn rank peer medical product industry group align technology algn merit medical system mmsi orasure technology osur be top highly rate stock group related stock be show improve price performance use ibd relative strength rating relative strength line help judge stock
224,ALGN,relative strength rs rating stryker syk climb higher percentile thursday get lift ibd unique rs rating measure market leadership used worst best score show stock price performance trail week match other stock history show stock go make biggest gain typically have rs rating north early stage move see stryker continue rebound clear threshold look winning stock try simple stock be work flat base entry see stock break heavy trading company post ep growth latest quarterly report revenue rise keep eye company next round number oct company hold rank peer medical product industry group align technology algn merit medical system mmsi orasure technology osur be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
225,ALGN,mimedx mdxg have relative strength rs rating upgrade thursday welcome improvement still higher score look proprietary rating identify technical performance show stock price action last week compare other stock database history reveal top perform stock often have rs rating north early stage move see mimedx continue show renew price strength hit benchmark look winning stock try simple routinemimedx be not currently offer proper buy opportunity see stock go form chart pattern launch new move company show ep growth latest quarterly report sale growth come keep eye company next round number oct company earn rank peer medical product industry group align technology algn merit medical system mmsi orasure technology osur be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
226,ALGN,mimedx mdxg have relative strength rs rating upgrade tuesday welcome improvement still short higher score prefer see ibd proprietary rs rating identify market leadership show stock price action last week measure other stock database year market history reveal stock go make biggest gain typically have rs rating north early stage move see mimedx continue rebound clear threshold see ibd help make more money mimedx be not ideal buy range right now see be able form break proper chart pattern mimedx post earning growth most recent report sale growth come mimedx earn rank peer medical product industry group align technology algn abiom abmd orasure technology osur be top highly rate stock group related stock be show rise relative strength use ibd relative strength rating relative strength line help judge stock
227,ALGN,repligen rgen see positive improvement relative strength rs rating tuesday rise ibd proprietary rs rating measure market leadership show stock price movement last week compare other stock database decade market research show stock go make biggest gain tend have higher rs rating launch largest climb see repligen continue show renew price strength clear threshold look best stock buy watch start hererepligen be try complete consolidation entry see stock clear price volume least higher normal company post ep growth last quarter sale gain come look next report nov company hold rank peer medical product industry group align technology algn abiom abmd orasure technology osur be top highly rate stock group related stock be show rise relative strength use ibd relative strength rating relative strength line help judge stock
228,ALGN,important metric look stock be higher relative strength rating mimedx mdxg just hit mark jump tuesday exclusive rating investor business daily track share price performance worst best score score show stock price performance trail week compare other stock database history reveal top perform stock often have rs rating least launch biggest run see ibd help make more stocksmimedx be not currently offer proper buy opportunity see stock go form base kick new climb mimedx post ep growth latest quarterly report sale increase next quarterly result be expect oct mimedx hold rank peer medical product industry group abiom abmd align technology algn orasure technology osur be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
229,ALGN,stryker syk see welcome improvement relative strength rs rating monday rise proprietary rating identify market leadership show stock price action last week measure other stock database history show market biggest winner often have rs rating early stage move see ibd help make more stocksstryker be now consider extend buy range clear buy point first stage flat base see stock form new pattern follow buy opportunity week tight pullback day week line stryker post earning growth latest quarterly report sale growth come stryker hold rank peer medical product industry group align technology algn abiom abmd orasure technology osur be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
230,ALGN,important metric look stock be higher relative strength rating resm rmd just hit mark jump monday ibd proprietary rs rating measure market leadership used worst best score indicate stock price performance last week match other stock year market history show best perform stock tend have rs rating north early stage move look winning stock try simple routineresm be buy zone breaking past buy point cup handle once stock move higher initial entry consider proper buy zone company see earning sale growth rise last quarter earning share increase revenue rise company earn rank peer medical product industry group align technology algn abiom abmd orasure technology osur be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
231,ALGN,qiagen qgen see positive improvement relative strength rs rating monday increase exclusive rating investor business daily measure market leadership worst best score score show stock price movement trail week hold other stock database decade market research reveal top perform stock often have better rs rating begin largest run see qiagen continue rebound clear threshold look best stock buy watch start hereqiagen break earlier have fall back prior entry flat base stock re tracking clear buy point then retreat more original entry price consider fail base stock set new chart pattern entry price also understand latest pattern be later stage base such basis be more prone failure top bottom line growth moved higher last quarter earning be compare prior report revenue increase keep eye company next round number nov company earn rank peer medical product industry group align technology algn abiom abmd orasure technology osur be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
232,ALGN,relative strength rs rating mimedx mdxg head higher percentile friday get lift proprietary rating track technical performance used worst best score indicate stock price action trail week stack other stock database decade market research show stock go make biggest gain often have better rs rating begin largest run see mimedx continue show renew price strength hit benchmark see ibd help make more stock be not ideal entry right now see be able form break proper base mimedx show earning growth most recent report sale growth come company hold rank peer medical product industry group align technology algn abiom abmd lemaitre vascular lmat be top highly rate stock group related stock be show improve price performance use ibd relative strength rating relative strength line help judge stock
233,ALGN,next quarterly earning report schedule nov inogen ingn be currently approximately entry entry be base first stage flat base buy stock just ahead earning involve risk typically don have enough time establish profit cushion latest quarterly number come be sure follow sound buy sell rule minimize exposure see ibd help make more money stocksinogen report earning growth latest quarterly report sale growth come analyst expect ep growth quarter growth full year annual growth estimate be recently revise lower inogen have composite rating earn rank peer medical product industry group align technology algn abiom abmd lemaitre vascular lmat be top highly rate stock group note date earning report be subject change check company update related earning calendar analyst estimate stock watchnew option strategy limit risk earning
234,ALGN,major market index be boost strength tech stock forecast earning release report strong demand apple aapl iphone meanwhile preliminary gdp come best consensus estimate apple amazon amzn facebook fb google parent alphabet googl hit buy point least briefly nasdaq set pace surge record high moved milder dow jone industrial average be higher dow jone industrial component iphone maker surge more report iphone have already sell pre order online home delivery relieve investor demand concern share rise top cup handle buy point elsewhere dow microsoft msft report better expect earning sale figure prompt advance share early friday stock be now most recent flat base entry downside oil giant chevron cvx plunge miss earning target share be testing day line saucer handle entry fang stock amazon com alphabet smash street estimate late thursday send respective share significantly higher commerce leader amazon crushed earning target report adjust earning cent share well cent share estimate poll zack investment research share rise high buy point stock be currently base internet behemoth alphabet advanced nearly be still buy range flat base buy point other company report earning chinese internet giant baidu bidu plunge day line stock market today internet search leader forecast revenue be well estimate meanwhile fellow fang facebook fb jump analyst firm monness crespi hardt upgrade stock neutral buy price target be premium thursday close price share be back flat base entry other analyst action tesla tsla be downgrade outperform neutral evercorse isi analyst now have more cautious view model production share electric automaker fall nearly testing long term day line ibd align technology algn power nearly higher strong earning result late thursday stock have more double cup handle entry downside yy yy be pace extend lose streak trading session fall nearly share be close trigger round trip sell signal rise much cup base entry related dow jone industrial average dow stock news analysisamazon blow past earning view beat sale share soarfang stock news quote facebook amazon netflix google steady amazon alphabet jump celgene boee falter weekly reviewfacebook tech icon medium powerhouse make
235,ALGN,message ibd week filled brim earning revenue news result have be quite good yet overall wall street reaction have leane little bit selling result even nasdaq composite catapult time new high ground xof
236,ALGN,neogen neog see ibd smartselect composite rating rise wednesday day revise score mean stock currently top other stock term key performance metric technical strength top perform stock tend have better grade begin launch significant move neogen have now climb proper buy zone clear entry flat base look winning stock try simple stock sport ep rating meaning recent quarterly longer term annual earning growth be outpace stock accumulation distribution rating show moderate buy institutional investor last week company post ep gain sale growth increase prior quarter mark quarter increase revenue increase neogen earn rank peer medical product industry group abiom abmd align technology algn lemaitre vascular lmat be top highly rate stock group related company be now outperform stock
237,ALGN,penumbra pen see welcome improvement relative strength rs rating wednesday increase proprietary rating measure market leadership used worst best score show stock price performance trail week match other stock year market history reveal best stock often have better rs rating early stage move see penumbra continue show renew price strength hit benchmark look winning stock try simple stock be work flat base entry see stock clear price volume least average company report earning growth latest quarterly report sale growth come penumbra earn rank peer medical product industry group abiom abmd align technology algn lemaitre vascular lmat be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
238,ALGN,small cap stock be fastest gate early monday russell pop gain be fleeting index soon turn flat nasdaq lose be just break even line dow jone industrial average outperformed last week inched volume stock market today be run lower board small cap show early strength include pet medicine firm petm express pet apparel retailer guess ge exxon mobil xom chevron cvx oil stock dow rise respectively west texas intermediate crude oil add boost supply disruption northern iraq meanwhile philadelphia semiconductor index advanced follow last week sixth weekly gain row intel intc padded last week gain early advance monday enough hit new high apple aapl edge early action stock be try retake day move average line last week apple stage negative reversal lose week ibd big cap dental play align technology algn gap heavy volume nice follow last week gain homebuilder horton dhi add cushion last week gain ishare home construction itb exchange trade fund rise last week add early action monday related halliburton top street view earning salessurvey see tepid demand apple iphone
239,ALGN,important metric look stock be higher relative strength rating cooper company coo just hit mark jump monday ibd proprietary rating measure market leadership worst best score grade show stock price performance trail week compare other stock database year market history show best stock tend have better rs rating begin biggest climb look winning stock try simple stock be try complete flat base buy point see stock clear price volume least average cooper company show earning growth latest quarterly report revenue increase company earn rank peer medical product industry group align technology algn lemaitre vascular lmat orasure technology osur be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
240,ALGN,relative strength rs rating mimedx mdxg enter new percentile monday increase ibd unique rs rating identify market leadership used worst best score show stock price performance last week match rest market history reveal market biggest winner typically have rs rating launch biggest price move see ibd help make more stock be not proper buy zone right now see manage form break proper base company post earning growth last quarter revenue rise company earn rank peer medical product industry group align technology algn lemaitre vascular lmat orasure technology osur be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
241,ALGN,ab discovery growth fund chclx be strong rebound shake tough thank lead stock grubhub grub so far year align technology algn planet fitness plnt fund gain month go wednesday outperformed midcap growth rival track morningstar direct be big step calendar return beat only peer be less half advance last year even much many investor be drive skittishness mostly value oriented stock defensive name say lead manager bruce aronow be strong performer aronow say tend not be strongly represent ab discovery growth portfolio year market have rotate back type growth name aronow teammate prefer stock have more room run aronow say valuation company profile look be favor be quite compelling now aronow say even strong performance year date be still discount long term average fund other manager be kumar kirpalani samantha lau wen tse tseng diversification be key aspect manager overall approach manager limit sector weighting basis point bench mark time re usually half range aronow say add idiosyncratic stock performance be more important sector allocation be bottom investor constrain sector bet don give back outperformance individual stock fund biggest sector be packed tight range weighting producer durable health care technology be third largest sector fund begin buy current stake grubhub january believe be winner take most opportunity aronow say network most choice attract most diner restaurant favor network most diner earning share grow past quarters aronow do not mind slowdown re leader online order ve be investing solidify position re fine solidify opportunity sustain high level growth long time aronow give thumb investment grubhub acquisition rival foodler even more recent partnership yelp groupon addition low consumer penetration food delivery service give grubhub long runway aronow say grubhub be also leaderboard ibd premium service spotlight play play top stock align technology be rate stock ibd medical product industry group thank such trait highest possible composite rating ibd expect increase ep year ibd take compare align technology other technical fundamental strength rival ibd easy use stock checkup tool align make transparent orthodontic tooth aligner consumer usually pay pocket device so company benefit grow economy most customer be adult aronow see align expand market foreign market also expect percentage user market expand align put healthy consistent growth grow complexity dental case correct aronow say discovery growth fund have boost stake planet fitness recent portfolio disclosure stock be appeal be ultimate unamazonable retail story aronow say consumer exercise online stock be also appeal be very early growth runway aronow say have unit potential more triple count company be benefit virtuous cycle lead national brand put more advertising dollar brand aronow say drife new member growth fuel more advertising addition aronow call fitness center chain very capital efficient many center be own franchisee stock happen be rank ibd leisure service industry group grubhub align technology planet fitness be member ibd list stock have strong relative price strength fundamental related hot stock light fire ab discovery growth fundyou need much retirement saving age tax rule change ko retirement account
242,ALGN,investor have lot view price earning ratio sometimes mean institution be pay big big earning xif want buy sell very best growth company need treat ratio more secondary market indicator ibd research have find be not
243,ALGN,welcome move edward lifescience ew see relative strength rating improve tuesday ibd unique rating identify share price movement worst best score rating show stock price behavior trail week stack other stock database history reveal market biggest winner tend have rs rating least early stage move see edward lifescience continue rebound clear threshold edward lifescience be build flat base entry see stock clear price heavy trade earning growth rise last quarter revenue gain fall edward lifescience hold rank peer medical product industry group align technology algn inogen ingn lemaitre vascular lmat be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
244,ALGN,relative strength rs rating globus medical gmed head new percentile monday get lift exclusive rating investor business daily track market leadership worst best score grade show stock price behavior trail week hold other stock database year market history reveal best perform stock tend have rs rating least begin biggest run see globus medical continue rebound hit benchmark stock be try complete consolidation entry see break heavy trade earning growth increase last quarter sale fall company hold rank peer medical product industry group align technology algn inogen ingn lemaitre vascular lmat be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
245,ALGN,relative strength rs rating penumbra pen jump new percentile monday increase ibd proprietary rs rating measure market leadership show stock price movement last week measure other stock database year market history reveal top perform stock typically have rs rating launch biggest run stock be build flat base entry see clear price volume least average penumbra show ep growth latest quarterly report revenue gain come company hold rank peer medical product industry group align technology algn inogen ingn lemaitre vascular lmat be top highly rate stock group related stock be show rise relative strength use ibd relative strength rating relative strength line help judge stock
246,ALGN,welcome move medical wmgi see relative strength rating rise monday unique rating measure technical performance used worst best score indicate stock price performance trail week match other stock year market history reveal market biggest winner tend have better rs rating launch largest climb see medical continue show renew price strength clear threshold stock be try complete cup handle buy point see clear price heavy volume company post ep growth latest quarterly report sale increase company earn rank peer medical product industry group align technology algn inogen ingn lemaitre vascular lmat be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
247,ALGN,stock veer lower start trade friday september payroll number come well expectation nasdaq dig deepest start bell apple aapl fang stock post early decline dow jone industrial average dip future slump almost labor department highly anticipate september payroll report show nonfarm employer subtract total worker hurricane affected result show steep drop prior month original estimate new hire be revise upward friday report job decline be also far economist consensus projection job addition closely watch hourly earning rate jump august well expectation increase unemployment rate meanwhile drop economic news be otherwise sparse day august wholesale inventory datum due commerce department et baker hughe bhge release weekly rig count report fed official be force speech begin atlanta federal reserve bank president rapheal bostic et be follow new york fed president william dudley robert kaplan dalla fed st loui fed president james bullard et third dow stock open lower wal mart wmt notch widest early loss more retail giant have be fight retake hold week line support fail attempt august apple trim early loss news report originate china suggest possible battery problem new iphone costco wholesale cost trade open report generally better expect result fiscal fourth quarter net sale figure membership fee stop short analyst target costco share have just retake support week move average stock attempt climb right side month consolidation fang stock tech leader turn lower job report facebook fb fall furthest ibd stock align technology algn climb strong trade edge new high stock be exgtend february rebound week move average august ibd peer svb financial group sivb add nearly stock be climb right side month base have current buy point set yum china holding yumc rise more spinoff kfc taco bell parent report mixed fiscal third quarter result late thursday strong same store sale performance increase share buyback plan first ever dividend news changeover chief executive cheer investor stock end thursday session buy point month cup base related big picture nasdaq lead stock higher key uptrend reason friday job datum surprise marketshere hot china stock run not be overibd investor research tool get start ibd
248,ALGN,fund manager have have eye money merit medical system mmsi recent month maker disposable medical device cardiology radiology have just jump new buy zone xmerit medical make ibd latest list new buy top perform mutual fund fund investing
249,ALGN,glaukos gkos have relative strength rs rating upgrade friday welcome improvement still short better score look exclusive rating investor business daily measure share price performance worst best score rating show stock price performance trail week compare other stock database year market history reveal best perform stock often have rs rating early stage move see glaukos continue show renew price strength hit benchmark glaukos be not currently show potential entry point see stock go form promising consolidation launch new move company report earning growth latest quarterly report revenue gain come glaukos hold rank peer medical product industry group align technology algn inogen ingn lemaitre vascular lmat be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
250,ALGN,important metric look stock be higher relative strength rating resm rmd just hit mark jump friday proprietary rating track technical performance used worst best score indicate stock price performance last week match other stock year market history show stock go make biggest gain typically have better rs rating early stage move stock be work flat base entry see stock clear price volume least higher normal sale growth fall last quarter bottom line grow previous report resm earn rank peer medical product industry group align technology algn inogen ingn lemaitre vascular lmat be top highly rate stock group related stock be show rise relative strength use ibd relative strength rating relative strength line help judge stock
251,ALGN,important metric look stock be higher relative strength rating teleflex tfx just hit mark jump thursday ibd proprietary rs rating measure market leadership used worst best score indicate stock price performance last week match rest market decade market research show stock go make biggest gain tend have rs rating least launch biggest price move teleflex have climb more past entry first stage cup handle meaning now proper buy range look stock offer new buy opportunity week tight pullback day week line teleflex post ep growth latest quarterly report sale growth come teleflex hold rank peer medical product industry group align technology algn inogen ingn lemaitre vascular lmat be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
252,ALGN,thursday teleflex tfx get upgrade ibd smartselect composite rating new rating be sign stock be outpace stock come most important stock pick criterium winning stock often have higher rating early stage new price run teleflex be currently extend proper buy zone breaking buy point cup handle stock have ep rating meaning recent quarterly annual earning growth top stock accumulation distribution rating show moderate buy institutional investor last week company report ep growth sale growth come previous quarter teleflex hold rank peer medical product industry group align technology algn inogen ingn lemaitre vascular lmat be top highly rate stock group related company be now outperform stock
253,ALGN,welcome move edward lifescience ew see relative strength rating improve tuesday ibd unique rs rating identify market leadership show stock price action last week compare other stock database history show best perform stock tend have better rs rating launch largest climb see edward lifescience continue show renew price strength hit benchmark stock be build flat base entry be trading week move average see stock retake benchmark line break heavy volume earning growth picked last quarter sale fall company hold rank peer medical product industry group align technology algn be top rank stock group related stock be show improve technical action use ibd relative strength rating relative strength line help judge stock
254,ALGN,stryker syk have relative strength rs rating upgrade friday welcome improvement still better score look ibd proprietary rs rating measure market leadership used worst best score indicate stock price performance trail week match other stock decade market research show best perform stock tend have rs rating begin biggest climb see stryker continue rebound hit benchmark stryker be not currently potential buy area see stock go build base launch new move company post earning growth last quarter sale growth come company hold rank peer medical product industry group align technology algn lemaitre vascular lmat merit medical system mmsi be top highly rate stock group related stock be show rise relative strength use ibd relative strength rating relative strength line help judge stock
255,ALGN,thursday globus medical gmed get positive adjustment relative strength rs rating exclusive rating investor business daily identify share price performance worst best score grade show stock price performance trail week compare other stock database decade market research reveal stock go make biggest gain typically have higher rs rating begin largest price move see globus medical continue rebound clear threshold now be not ideal time buy share see stock go establish enter buy zone heavy volume earning growth increase last quarter revenue gain fall company hold rank peer medical product industry group align technology algn inogen ingn lemaitre vascular lmat be top highly rate stock group related stock be show rise relative strength use ibd relative strength rating relative strength line help judge stock
256,ALGN,tuesday penumbra pen receive upgrade relative strength rs rating ibd proprietary rating identify price movement worst best score grade show stock price movement trail week stack other stock database year market history show stock go make biggest gain typically have rs rating north begin biggest price move stock be work flat base entry see break heavy volume penumbra report ep growth last quarter sale increase penumbra hold rank peer medical product industry group align technology algn lemaitre vascular lmat merit medical system mmsi be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
257,ALGN,contact lens maker cooper company coo be form base offer buy point next quarterly ep report expect aug current formation be second stage flat base understand buy stock just ahead earning involve risk typically don have enough time build profit cushion latest quarterly number come be sure follow sound buy sell rule minimize exposure sale growth fall last quarter earning share grow previous report analyst expect earning share growth quarter growth full year annual earning estimate be recently revise upward cooper company have composite rating earn rank peer medical product industry group align technology algn lemaitre vascular lmat merit medical system mmsi be top highly rate stock group note date earning report be subject change check company update related earning calendar analyst estimate stock watchnew option strategy limit risk earning
258,ALGN,resistance support be technical factor chart reader use describe certain trend affect stock price resistance hold stock certain level block go higher support keep stock certain price prevent stock breaking here focus resistance resistance be generally effect profit take institutional investor be commit book profit certain level instance time stock reach level seller step overwhelm buy demand send stock price lower see again again many different way stock chart stock rally often peak particular level stock fall back then periodically rise test resistance level seller step stock generally fall back again period price consolidation align technology algn meet resistance level january march priceline group pcln face resistance level month july ibd take stay top market direction read ibd big picture column key source signal be aggressive move sideline find once stock pierce resistance especially stock have be contain long period time release quite often mark point seller step back unfettered demand drife begin winning stock rally case point resistance be most likely be overtake be oftentimes marked buy point long period stasis follow breakout be often signature chart stock execute turnaround be recover cyclical industry resistance also occur shorter period look grubhub grub july struggle break level jpmorgan jpm ongoing month battle beat resistance just even apple aapl week fight gain ground buy point demonstrate form resistance sometimes resistance occur not particular price point range upward downward slope trend line china base yy yy provide good recent example stock peaked just september investor look chart draw straight line subsequent peak mark resistance june april continue resistance october finally march year final peak begin week cup base buy point stock have climb start base follow trend line see pop rise trade stock top line resistance stock gather momentum day run break past buy point left stock strong trade week end resistance be eliminate yy week move average become clear touchstone support cradle stock run now ibd name yy hare have gain much start year related young chinese internet stock rebound support crucial support levelbest chinese stock buy watchget start ibdibd investor research tool follow market read stock market todayunderstand stock market trend big picture
259,ALGN,wednesday repligen rgen earn upgrade relative strength rs rating ibd unique rating identify market leadership worst best score grade show stock price performance trail week stack other stock database history show market biggest winner typically have better rs rating early stage move stock be work consolidation buy point see clear price heavy volume repligen post earning growth last quarter sale growth come company earn rank peer medical product industry group abiom abmd align technology algn mimedx mdxg be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
260,ALGN,medtronic mdt share sank early tuesday maker medical device report fiscal first quarter sale lag wall street estimate adjust profit beat cent share early trading stock market today medtronic drop close share fall well flat base begin form late june buy point meanwhile ibd ninth rank medical product industry group advanced medtronic report sale fall short consensus analyst poll zack investment research adjust earning share beat view grow medtronic restorative therapy minimally invasive therapy business contribute revenue miss rbc analyst glenn novarro write note client novarro keep outperform rating company restorative therapy include work spine brain well pain management sale unit rise miss view minimally invasive therapy include surgical monitoring recovery business grow miss ibd take medtronic have ibd composite rating best possible meaning outperform third stock term key growth metric still lag top performer abiom abmd align technology algn have crs visit ibd stock checkup closer look strong performer cardiac vascular sale advanced be tad light medtronic note adoption corevalve evolut pro platform help drive high growth exclude foreign exchange rate sale transcatheter heart valve replacement diabetes tech sale fall miss group be temporarily affected limit supply glucose sensor medtronic say news release medtronic reaffirm full year guidance sale growth adjust ep growth exclude foreign exchange rate cut view diabetes sale growth prior outlook cardiac forecast be boost growth related robotic player near then topple here whyrobot surgeon maker best sale profit drug bellwether sale miss actually bode well sector
261,ALGN,welcome move penumbra pen see relative strength rating rise tuesday ibd proprietary rs rating measure technical performance show stock price movement last week compare other stock database decade market research show stock go make biggest gain tend have rs rating launch largest climb see penumbra continue show renew price strength clear threshold penumbra be build flat base entry see break heavy trading penumbra show ep growth most recent report revenue gain come company earn rank peer medical product industry group abiom abmd align technology algn lemaitre vascular lmat be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
262,ALGN,re look stock be set base ahead earning here fit bill cooper company coo expect release latest number aug be trading approximately entry current formation be second stage flat base understand buy just stock report be risky don know stock report market react don have enough time build profit cushion minimize exposure wait see actual number market reaction company top line growth fall last quarter earning share grow prior report analyst expect earning share growth quarter growth full year earning share estimate full year be recently revise higher cooper company have composite rating earn rank peer medical product industry group abiom abmd align technology algn mimedx mdxg be top highly rate stock group note date earning report be subject change check company update related earning calendar analyst estimate stock watchnew option strategy limit risk earning
263,ALGN,boston scientific bsx have relative strength rs rating upgrade friday welcome improvement still higher score prefer see exclusive rating investor business daily measure market leadership worst best score grade show stock price behavior last week hold other stock database year market history reveal stock go make biggest gain typically have better rs rating early stage move see boston scientific continue rebound hit benchmark stock be work flat base entry see stock clear price volume least higher normal later stage pattern investor be aware involve more risk sale growth fall last quarter bottom line grow prior report company earn rank peer medical product industry group abiom abmd align technology algn lemaitre vascular lmat be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
264,ALGN,friday globus medical gmed receive positive adjustment relative strength rs rating proprietary rating measure technical performance show stock price action last week measure other stock major index year market history reveal best stock tend have rs rating begin biggest run globus medical be build consolidation buy point see stock clear price heavy trade earning growth increase company most recent report revenue fall company earn rank peer medical product industry group abiom abmd align technology algn lemaitre vascular lmat be top highly rate stock group related stock be show rise relative strength use ibd relative strength rating relative strength line help judge stock
265,ALGN,resm rmd have relative strength rs rating upgrade thursday welcome improvement still better score look ibd proprietary rating track market leadership worst best score score show stock price behavior trail week hold other stock database decade market research show top perform stock tend have higher rs rating early stage move see resm continue show renew price strength clear threshold resm be not proper buy point right now see be able form break proper chart pattern earning growth increase last quarter sale fall resm hold rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group related stock be show improve price performance use ibd relative strength rating relative strength line help judge stock
266,ALGN,medical wmgi have relative strength rs rating upgrade tuesday welcome improvement still better score prefer see unique rating identify technical performance used worst best score identify stock price action trail week stack other stock database decade market research reveal best stock often have rs rating least early stage move see medical continue show renew price strength hit benchmark medical be build consolidation entry see stock clear price heavy volume company report ep growth most recent report sale growth come medical hold rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group related stock be show improve price performance use ibd relative strength rating relative strength line help judge stock
267,ALGN,resm rmd see positive improvement relative strength rs rating tuesday increase ibd proprietary rs rating measure technical performance used worst best score indicate stock price performance trail week compare other publicly trade company decade market research reveal stock go make biggest gain tend have rs rating north launch largest price move see resm continue rebound clear threshold now be not ideal time jump isn proper buy zone see stock manage form base break earning growth moved last quarter revenue fall resm earn rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
268,ALGN,integra lifescience hld iart see positive improvement relative strength rs rating monday rise ibd proprietary rs rating measure technical performance used worst best score identify stock price performance last week match other stock history reveal best perform stock often have higher rs rating early stage move integra lifescience hld be now consider extend buy range clear buy point first stage cup handle see stock form new pattern follow buy opportunity week tight pullback day week move average top bottom line growth moved higher last quarter earning be compare prior report revenue increase integra lifescience hld earn rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group related stock be show rise relative strength use ibd relative strength rating relative strength line help judge stock
269,ALGN,institutional seller be nasdaq composite again thursday stall session nasdaq wednesday xseveral publish report blame selling rumor gary cohn president trump pro business advisor director national economic council be consider resign news terrorist attack barcelona spain also fuel negative sentiment end nasdaq composite have be show subtle sign distribution late july be more sign thursday late afternoon trading nasdaq slump be dow jone industrial average slip volume nasdaq be tracking higher wednesday stock market today nyse volume be pace be close wednesday level breadth be weak decliner outnumber advancer nyse more nasdaq loser top winner ratio year treasury yield ease basis point extend loss wednesday release minute july fed meeting market perceive be dovish airline semiconductor stock be day worst performer earning winner be few far ibd name alibaba baba be bright spot more report quarter strong earning sale growth meanwhile china lodging htht surge strong second quarter result straight quarters single digit sale growth sale jump downside dow component wal mart wmt cisco system csco slump report earning issue weak outlook share wal mart slump cisco give back more wal mart have be hold level clear buy point cisco other hand have be laggard time stock have be consolidate align technology algn crash day move average fall heavy volume sell signal current holder nice profit related share go sale ross store gap report close cisco fall investor lose patience transitionbest stock buy watch
270,ALGN,welcome move nephew snn see relative strength rating improve thursday ibd proprietary rating track market leadership worst best score score show stock price performance trail week hold other stock database decade market research show market biggest winner typically have rs rating north launch biggest climb see nephew continue rebound clear threshold nephew break earlier have fall back prior entry flat base stock re tracking clear buy point then fall more original entry price consider fail base stock set new base buy point also understand most recent consolidation be later stage base make riskier establish new position add share exist nephew report earning growth last quarter sale growth come company hold rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group related stock be show rise relative strength use ibd relative strength rating relative strength line help judge stock
271,ALGN,welcome move globus medical gmed see relative strength rating improve thursday exclusive rating investor business daily identify price movement worst best score rating show stock price performance trail week hold other stock database history reveal market biggest winner typically have rs rating north begin largest climb see globus medical continue show renew price strength clear threshold globus medical be build flat base buy point see clear price volume least average earning growth increase last quarter revenue gain fall company hold rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group related stock be show rise relative strength use ibd relative strength rating relative strength line help judge stock
272,ALGN,thursday livanova livn earn upgrade relative strength rs rating ibd unique rating track market leadership worst best score grade show stock price behavior last week stack other stock database year market history show market biggest winner typically have better rs rating early stage move livanova be now consider extend buy range clear buy point first stage cup handle see stock form new pattern follow buy opportunity week tight pullback day week move average ep growth decline company most recent report revenue rise company earn rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
273,ALGN,thursday penumbra pen earn positive adjustment relative strength rs rating unique rating identify market leadership used worst best score show stock price performance last week match other publicly trade company year market history reveal stock go make biggest gain typically have higher rs rating early stage move stock be try complete flat base entry see stock clear price heavy trade company show earning growth most recent report sale growth come penumbra earn rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group related stock rise relative strength ratingswhy use ibd relative strength rating relative strength line help judge stock
274,ALGN,penumbra pen see positive improvement relative strength rs rating tuesday rise ibd unique rating identify market leadership worst best score rating show stock price movement trail week stack other stock database history reveal stock go make biggest gain typically have rs rating early stage move see penumbra continue show renew price strength hit benchmark penumbra be try complete flat base buy point see break volume least average penumbra show ep growth most recent report sale rise keep eye company next round number aug penumbra earn rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
275,ALGN,medical wmgi have relative strength rs rating upgrade tuesday welcome improvement still shy better score prefer see unique rating identify market leadership used worst best score show stock price action trail week compare other publicly trade company year market history reveal best stock typically have rs rating least early stage move see medical continue rebound hit benchmark stock be build consolidation entry see stock clear price volume least higher normal medical post ep growth latest quarterly report sale growth come medical earn rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
276,ALGN,integra lifescience hld iart see welcome improvement relative strength rs rating tuesday rise exclusive rating investor business daily identify price action worst best score score show stock price behavior trail week compare other stock database history show stock go make biggest gain often have better rs rating launch biggest price move integra lifescience hld be now consider extend buy range clear buy point first stage cup handle see stock form new pattern follow buy opportunity week tight pullback day week move average top bottom line growth moved higher last quarter earning be compare prior report revenue increase integra lifescience hld earn rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group related stock be show rise relative strength use ibd relative strength rating relative strength line help judge stock
277,ALGN,relative strength rs rating globus medical gmed enter new percentile monday get lift ibd proprietary rs rating identify technical performance used worst best score indicate stock price action last week compare rest market year market history show market biggest winner often have rs rating begin biggest climb see globus medical continue show renew price strength clear threshold globus medical be work flat base entry see break volume least higher normal earning growth picked last quarter revenue gain fall company hold rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
278,ALGN,cambrex cbm see positive improvement relative strength rs rating tuesday rise ibd proprietary rs rating track technical performance show stock price movement last week compare other stock database year market history show market biggest winner typically have rs rating begin biggest climb cambrex be build buy point see stock clear price volume least average earning growth rise last quarter revenue gain fall company hold rank peer medical product industry group align technology algn cambrex cbm be also group highest rate stock related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
279,ALGN,resm rmd see positive improvement relative strength rs rating monday rise proprietary rating measure market leadership used worst best score indicate stock price performance trail week match other stock year market history show market biggest winner tend have rs rating least launch biggest price move see resm continue rebound hit benchmark resm be not currently potential buy zone see stock go form promising consolidation ignite new run sale growth fall last quarter bottom line grow prior report resm hold rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group related stock be show improve technical action use ibd relative strength rating relative strength line help judge stock
280,ALGN,monday teleflex tfx get upgrade ibd smartselect composite rating new score tell company be now outperform stock term most important fundamental technical stock pick criterium teleflex be trading buy range entry cup handle keep mind later stage base such basis be more prone failure stock earn ep rating meaning recent quarterly annual earning growth top stock accumulation distribution rating show moderate selling institutional investor last week look rating improve least better company post earning share growth top line growth fall prior quarter teleflex earn rank peer medical product industry group abiom abmd align technology algn edward lifescience ew be top highly rate stock group related company be now outperform stock
281,ALGN,icu medical icui be expect report earning aug trading now trading buy point second stage cup handle clear earlier keep mind buy just stock report be risky ep sale miss send sharply lower minimize exposure wait see company report market react earning grow last quarter prior report revenue also increase analyst expect decline ep growth full year see rise estimate next year be recently revise higher icu medical have composite rating hold rank peer medical product industry group align technology algn cambrex cbm be also group highest rate stock note date earning report be estimate subject change check company update related earning calendar analyst estimate stock watchnew option strategy limit risk earning
282,ALGN,teleflex tfx have relative strength rs rating upgrade friday ibd proprietary rating measure share price movement worst best score grade show stock price behavior trail week stack other stock database decade market research show market biggest winner tend have rs rating north early stage move teleflex be trading buy range climb entry cup handle once stock move higher initial entry consider proper buy zone teleflex post ep growth latest quarterly report sale growth come company earn rank peer medical product industry group abiom abmd align technology algn cambrex cbm be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
283,ALGN,welcome move edward lifescience ew see relative strength rating improve friday ibd unique rs rating track technical performance show stock price action last week measure other stock database decade market research show market biggest winner tend have rs rating north early stage move see edward lifescience continue show renew price strength clear threshold edward lifescience be not currently show potential buy point see stock go form sound pattern kick new climb earning growth increase last quarter top line fall company earn rank peer medical product industry group align technology algn cambrex cbm be also group highest rate stock related stock be show rise relative strength use ibd relative strength rating relative strength line help judge stock
284,ALGN,welcome move integra lifescience hld iart see relative strength rating improve friday exclusive rating investor business daily track price performance worst best score score show stock price movement trail week stack other stock database year market history reveal stock go make biggest gain often have rs rating north early stage move see integra lifescience hld continue show renew price strength hit benchmark integra lifescience hld have moved more past entry first stage cup handle meaning now proper buy range look stock create new buy opportunity week tight pullback day week line top bottom line growth moved higher company most recent quarter earning be compare prior report revenue increase company earn rank peer medical product industry group abiom abmd align technology algn cambrex cbm be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
285,ALGN,insulet podd have relative strength rs rating upgrade thursday unique rating identify technical performance used worst best score identify stock price performance last week match other publicly trade company year market history show best stock typically have higher rs rating begin new run stock be not proper buy point right now see be able form break proper consolidation company see earning sale growth rise last quarter earning share increase revenue rise next quarterly number be expect aug company hold rank peer medical product industry group abiom abmd align technology algn cambrex cbm be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
286,ALGN,key index fund be mixed early afternoon trading seek direction stock market today xspdr dow jone industrial average dium be less spdr spy be fractionally lower powershare qqq trust qqq dip small cap lead upside ishare russell iwm ishare core small cap ijr retail be big winner sector play spdr retail xrt gap rise nearly aim third straight advance component stock abercrombie fitch anf guess ge dollar tree dltr be retailer score big gain follow earning report telecom biotech real estate etfs also make solid advance most oil utility consumer staple lag vaneck vector oil service oih fall spdr oil gas exploration production xop rise unite state oil fund uso powershare db oil fund dbo sank gold play be mixed vaneck vector junior gold miner gdxj vaneck vector gold miner gdx gain respectively spdr gold share gld ishare gold trust iau pull back west texas intermediate crude price slide barrel gold future ease ounce fund invest opposite end standard poor index spectrum be seek support day move average line have apple aapl ty pursue big cap company be ishare oef track index largest equity fund mark anniversary october have amassed advanced prior bounce day line early july technology account biggest chunk asset aug follow financial service health care consumer defensive consumer cyclical accord morningstar inc top holding represent asset apple microsoft msft facebook fb amazon com amzn johnson johnson jnj average market cap stock oef portfolio be well average morningstar large blend category turnover be low end expense ratio be expect fund performance have be largely line return year date aug return oef year return be vs benchmark index gain target fastest grow stock guggenheim pure growth rpg hold many smaller cap name etf take fast grower then weight strong growth characteristic be year old fund be show similar action oef have attract asset gain ytd have outpaced past year top holding include apple iphone chipmaker broadcom avgo other chip stock make top apply material amat nvidia nvda lam research lrcx invisible brace firm align technology algn round list top account total asset average market cap company portfolio be turnover be rpg expense ratio be wednesday pick schwab large cap growth schg ishare core growth iusg pull back market remain respective day line potential buy range related sector score biggest gain apple big techs buy range stock bounce back apple top global equity play buy sector lead stock turn mixed apple microsoft reach
287,ALGN,medical wmgi see welcome improvement relative strength rs rating friday increase exclusive rating investor business daily measure share price performance worst best score score show stock price performance last week hold other stock database year market history show best stock typically have rs rating launch biggest run see medical continue show renew price strength hit benchmark stock be build consolidation buy point see break heavy trading company show ep growth last quarter sale growth come look next report aug company hold rank peer medical product industry group abiom abmd align technology algn inogen ingn be top highly rate stock group related ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
288,ALGN,build earning season watch list focus stock potential buy range ahead next quarterly report teleflex tfx currently fit bill earning due aug stock be buy point first stage cup handle be aware buy close stock report be risky don know stock report market react don have enough time build profit cushion reduce exposure wait see company report market react top bottom line growth moved higher company most recent quarter earning be compare prior report revenue increase analyst expect ep growth quarter growth full year annual growth estimate be recently revise upward teleflex have composite rating hold rank peer medical product industry group abiom abmd align technology algn inogen ingn be top highly rate stock group note date earning report be estimate subject change check company update related earning calendar analyst estimate stock watchnew option strategy limit risk earning
289,ALGN,important metric look stock be higher relative strength rating integra lifescience hld iart just hit mark jump friday ibd unique rating identify price performance worst best score grade show stock price movement trail week hold other stock database year market history reveal market biggest winner typically have better rs rating early stage move integra lifescience hld have climb more past entry first stage cup handle meaning now proper buy zone look stock create new chance pick share week tight pullback day week line top bottom line growth moved higher company most recent quarter earning be compare prior report revenue increase integra lifescience hld earn rank peer medical product industry group abiom abmd align technology algn inogen ingn be top highly rate stock group related stock be show improve price performance use ibd relative strength rating relative strength line help judge stock
290,ALGN,heavy selling nasdaq flag mood afternoon trade thursday nasdaq be drive back day move average dow register first loss day nasdaq tank sell left few hiding place preliminary datum show volume only moderately higher nyse drop dow jone industrial average crumble loss be extremely broad only industry track ibd gain ground day gain hold less airline chipmaker datum storage take pound steelmaker lose big gap move wednesday automaker post industrywide swoon tesla tsla fiat chrysler fcau general motor gm jaguar owner tata motor ttm drop more tesla decline send test support week move average stock be still form base buy point dow industrial decline lead nosedive cisco system csco networking gear leader report pass result fiscal fourth quarter continue softness core computer networking business loss drag share back week move average stock struggle fashion floor month consolidation goldman sachs gs apple aapl nike nke wal mart wmt be only few blue chip name post loss nearly apple loss send share back buy point company report earning china name defined day range ibd stock alibaba group hold baba manage gain fiscal first quarter report crushed analyst expectation vipshop holding vip crumble result alibaba move send stock new high powerful trade stock be already extend follow rebound week support align technology algn take hardest hit ibd stock still extend profit take zone february related techs be buy point classic bullish patternbullish chart pattern do know basic cup handle bullish chart pattern ii find exact buy pointbreakout watch logmein boost triple digit earning sale growthstock buy watch top ipos big small cap growth stock
291,ALGN,stock index head more trouble midday thursday nasdaq pile biggest loss day nasdaq hack dow jone industrial average slice respectively small cap russell ease volume stock market today be major exchange compare same time wednesday institutional selling have market past week so nasdaq have suffer distribution day past session be position log distribution day thursday distribution involve loss major index rise volume such action point institutional selling small cap medifast med rushed ahead triple usual volume midday thursday health diet product provider break aug be now buy point investor buy natural price target be profit take level medifast be thinly trade fund performance rating ibd add share most recent quarter hold position steady only rate fund trim position blue chip be mostly dow stock fall gainer dow industrial cisco system csco lose heavy volume earning match street consensus estimate revenue be barely view cisco stock have be roll pattern more year find resistance range apple aapl dip remain buy zone stretch wall street journal report week apple plan spend next month original video content ibd loser lead winner ratio dental product provider align technology algn drop volume almost twice average pace align break february rise china base alibaba baba jump new high volume average alibaba report earning gain vs street consensus estimate increase china shanghai composite index rise index third gain day china stock trading exchange china lodging group htht score best gain torrid volume company earning rise vs decline analyst expect related silence make better stock benefit army stryker
292,ALGN,major market index fall board thursday morning even weekly jobless claim come less expect vs estimate tech heavy nasdaq fared worst fall dow jone industrial average drop earning disappointment component moved lower dow industrial mcdonald mcd edge just almost stock be just week high find support day line last week downside cisco system csco plunge nearly fiscal earning meet target late wednesday thursday action put stock back day line stock work build floor month consolidation
293,ALGN,wal mart wmt drop result beat street view issue cautious earning outlook retail behemoth alibaba baba be star lead stock stock market today top chinese stock jump company report strong earning result share find solid support week line last friday be now cup handle entry meanwhile rival jd com jd decline almost extend lose streak trading day retailer look more support day line have find buy demand several time other lead stock tesla tsla drop stock etch handle cup shape base potential handle entry come chip leader apply material amat fall ahead fiscal earning result market close analyst expect chip gear maker earn cent share revenue amount stock be form cup handle base buy point retailer be once again target seller used wal mart weak guidance reason meanwhile victorium secret parent brand lb decline year lows company cut full year earning outlook late thursday ibd centene cnc rise just continue rebound day line stock remain extend cup handle entry downside invisalign maker align technology algn decline remain well extend cup handle buy point related wal mart earning top online sale jump guidance weakbest chinese stock buy watchdow jone industrial average dow stock news global retail giant deliver punch investing action planretail commerce news stock watch
294,ALGN,blue chip lead stock market midday monday dow jone industrial average head fifth session row outperformance vs major index dow rise nasdaq fall stay flat small cap russell drop volume stock market today be lower major exchange compare friday level integrate oil gas stock chevron cvx aerospace giant boee ba boost component dow jone industrial average advanced chevron be track fifth consecutive day west texas intermediate crude oil be rise day last week wti be try retake barrel price level boee score new high appear head seventh day row boee announce monday expect india order new aircraft next year chicago headquarter company say india aviation market be grow more vs global average ibd proxy top rate stock loser lead winner ratio medical sector stock be take hit centene cnc regeneron pharmaceutical regn align technology algn ibd industry group lowly rate group include office supply coal food score day best gain oil natural gas group suffer biggest loss chicago purchasing manager index july rolled miss consensus view pending home sale june jump easily beating consensus view ishare home construction etf itb retreat track fifth loss session dalla federal reserve manufacturing survey general activity index hit july trouncing view production index rise vs prior close restaurant chain texas roadhouse txrh report quarterly result street expect earning rise cent share revenue be expect rise related have tobacco stock lose safe dividend play
295,ALGN,major market index look end july positive note early gain peter rapidly nasdaq lead reversal trading fall dow jone industrial average remain higher rise hit time high soon market open xearly economic news be also weak growth chicago region manufacturing slow sharply july kingsbury international report chicago purchasing manager index slip month steep drop june read gauge lowest read month economist have forecast mild slowdown read month dow industrial boee ba set pace rise more apiece airplane maker add recent gain be more flat base buy point intel intc find resistance try retake day line longtime lead stock fang member facebook fb be hit downgrade early monday pivotal research cause share fall social medium giant be cut sell hold base valuation concern analyst have price target almost discount friday close price fellow fang stock amazon com amzn google parent alphabet googl also trade lower early trade commerce giant drop more company say be be review iran related sale share be trading flat base entry testing day line alphabet fall have be day line relatively disappointing earning release last week finally netflix nflx decline remain solidly nearly new high earning release send share soar july other analyst action ulta beauty ulta be downgrade perform outperform oppenheimer share fall share have be pressure early june fall more high lead biotech stock hold heavy loss early monday regeneron pharmaceutical regn drop stock be back day line first time buy point stock also be build new base ibd china base tal education tal momo momo advanced fractionally china education provider be flat base entry momo be approach cup shape base buy point downside centene corp cnc fall have rapidly approach day line past trading day meanwhile align technology algn moved remain squarely new high invisalign maker surge more friday strong quarterly earning result related apple tesla need know investor next risk facebook overlooked american air be compelling dow jone industrial average dow stock news stock news quote facebook amazon netflix google
296,ALGN,stock market be hold pretty well afternoon trading friday particularly nasdaq composite fall early rebound loss just amazon com amzn paid visit day move average be session high fall intraday investor be initially spook big earning miss share be late friday dow jone industrial average eke small gain ease small cap lag bit russell volume nyse nasdaq be tracking well thursday level stock market today traveler trv american express axp chevron cvx outperformed dow gain just elsewhere thursday heavy volume decline see share close right day move average proofpoint pfpt rebound nearly still work flat base conventional entry security software name report surge quarterly profit well expectation sale logmein logm be session high share still jump company report second straight quarter triple digit earning sale growth big sale growth be result company recent acquisition citrix system goto family product starbucks sbux crash report weak sale head friday coffee giant own relative strength rating indicate sluggish price performance past month meanwhile accumuluation distribution rating be indicative heavy institutional selling recent week economic news first estimate gdp come mostly line expectation growth be revise slightly lower ibd align technology algn soar almost strong earning new entry be nowhere sight stock be well extend base february september west texas intermediate crude oil settle barrel week oil jump nearly best weekly gain so far year related even starbucks be see amazon effect here top exec saidstrategic buy pay big lead growth stockfda act vs cigarette tobacco giant be hold
297,ALGN,major market index fall board early friday meanwhile gdp meet expectation previous quarter be revise lower tech heavy nasdaq drop extend day loss thursday volatility fuel trading session snap day winning streak nasdaq have previously advanced last trading day dow jone industrial average decline milder respectively dow industrial intel intc chevron cvx pace advancer move respectively chip giant top estimate late thursday raise full year outlook share be verge reclaim day move average energy heavyweight also report strong result look extend winning streak trading day remain just day line have trade mid april downside exxon mobil xom decline profit miss street expectation longtime lead stock fang member amazon com amzn badly miss earning estimate late thursday cause share fall stock market today stock be trading right flat base buy point fellow commerce giant alibaba baba rise stock remain solid uptrend just time high coffee purveyor starbucks sbux disappoint investor report weaker expect revenue same store sale share fall sharply almost early trade stock have be build base today action be setback share drop day line other earning report video game maker electronic art ea trim early loss report pessimistic sale guidance full year share break flat base buy point wednesday share remain just entry ibd align technology algn surge higher strong quarterly earning release share be now cup handle entry downside ttm technology ttmi drop follow analyst downgrade stifel nicolaus downgrade circuit board maker hold buy stock be trading flat base entry related starbucks look china growth close teavana sale missamazon second quarter earning have big miss bottom linedow jone industrial average dow stock news stock news quote facebook amazon netflix googlechip stock watch semiconductor industry news
298,ALGN,stock index step backward midday friday gdp result match street expectation consumer datum show bright spot nasdaq lose blue chip dow jone industrial average be flat volume stock market today be run lower previous session lower volume decline be bull prefer see stock retreat gdp come best growth third quarter line estimate consumer spending also match view gain bright spot be revision consumer spending initial read be revise university michigan consumer sentiment gauge july confirm upward trend come vs expectation stock ibd list best stock fundamental technical be mixed advance strong volume include invisible brace maker align technology algn software provider logmein logm chip equipment maker ichor holding ichr facebook fb nice follow thursday gain day loser ibd include contract manufacturer ttm technology ttmi dave buster entertainment play head sixth day row medical device maker edward lifescience ew edward lifescience have be hurt defeat republican skinny repeal obamacare bill ve suspend year tax medical device manufacturer excise tax be suspend be schedule resume action be take meanwhile blue chip dow jone industrial average be track outperform major index fourth session row chevron cvx american express axp lead component dow gain respectively related mastercard visa join ibd big cap tobacco company face new regulation
299,ALGN,lantheus holding lnth end week new high extend perform nearly textbook perfect rebound week move average lantheus produce definity liquid design improve result ultrasound diagnostic procedure also manufacture technelite type generator contain radioactive isotope used radiopharmacy
300,ALGN,due considerable market volatility past several week investor focus stock pullback be quiet calm orderly longtime ibd sector leader abiom abmd be exemplify trait consolidate recent gain cup handle late april massachusett base medical device maker have stranglehold artificial heart market impella heart
301,ALGN,last week column review swing trading principle handle sideway market week ll focus real time example ibd swingtrader first be note be limit activity june sideway action market only position be current trade list june be profit hold avoid overtrading sideway market otherwise even small loss damage portfolio have too many key strategy used month be take profit quickly not let good trade go negative align technology algn be few stock hit profit goal case half profit be take june be way gain stop short quickly reversed rather hope bounce remain share be remove keep more average gain trade order avoid loss also mean get rid stock due lack progress taylor morrison tmhc be ditch gain be too slow come stock be point be add be remove trade end basically flat get rid stock june close day move average line avoid drop follow day employ quick profit take strategy lead only trade be remove loss june shopify shop be add june be slightly few day get clip big sell june loss be still keep small just recur theme month be equity couldn quite hit profit goal have be sell profit evaporate direxion financial bull share fas be good example exchange trade fund etf comprise bank insurer other financial firm lot positive reversal stock appear june etf provide method capitalize sector move time leverage give more reward get individual stock same risk associate single stock trade be initially put watch list finished cup handle pattern trigger little early june break downtrend handle next day see profit near profit goal early trading session quickly reversed profit be book etf crossed back price point second time day be remove fas end go buy point have easily turn negative trade take profit early be strict small loss left june rate swingtrader average gain be single loss be only strategy deliver outperformance sideway market more detail past trade be available subscriber trialist swingtrader free trial be available related watch sideline be best sideway marketskeep loss small be critical portfolio progresssw trading strategy lesson
302,ALGN,xstock moved mildly lower friday nasdaq dow industrial dip slip slip tech heavy nasdaq composite be pace weekly gain come consecutive week relatively heavy loss dow jone industrial average show fractional loss week edge early friday defend slim gain week dow industrial upside advancer be scarce jpmorgan jpm coca cola ko procter gamble pg cling small gain downside unitedhealth group unh caterpillar cat fall home depot hd nike nke decline eqt eqt align technology algn pace upside advancer rise respectively downside sysco corp sys drop signet jeweler sig decline harley davidson hog fall analyst action restoration hardware rh vertex vrtx receive upgrade cause retailer vertex reversed lower early gain meanwhile piper jaffray hike price target electronic art ea jpmorgan initiate coverage servicenow now overweight rating share ea servicenow fall earning front bloodbath brick mortar store continue stock market today bed bath bbby fiscal result late thursday retailer miss top bottom line estimate result plunge stock price meanwhile finish line finl revenue come street estimate early friday share still advanced nearly lead retailer ollie bargain outlet olli burlington store burl haven be spare sector carnage last month have see ollie fall back week line be attempt muster support burlington plunge day line thursday early friday ollie decline burlington fall ibd grubhub grub jump macom tech solution mtsi rise momo momo advanced downside regeneron pharmaceutical regn fall mercadolibre meli decline video game maker activision blizzard atvi trade related earning calendar analyst estimate stock watcharista network ea get pt hike logmein rate buy lumentum holddow jone industrial average dow stock news analysisfinish line sale miss amazon nike threat rattle sectorretail commerce news stock watch
303,ALGN,hurricane be come smart homeowner prepare next hurricane seller flood wall street do savvy short seller get ready prepare early be key be not same shorting stock early sell too early portfolio suffer irreparable damage instead be methodical step help step don try pick
304,ALGN,most person aren fan lose especially come money swing trader loss be inevitable part business trick be keep loss small so don do terrible damage portfolio be able recover quickly be critical psychology well profit be easier say do many investor feel take loss be equivalent admit defeat long loss be only paper hope remain eventually be proven right try save bruise ego ignore paper loss set lot more pain loss mount be also fear once loss be take stock immediately bounce back fear need be balanced possibility small loss turn larger loss nearly bad be be sit dead money long period time wait stock recover wait capital be risk reward potential questionable happen loss get larger expect usually best part way original thesis have be proven wrong fight just compound problem think worst be be also naive phrase go lower be proven wrong almost day stock market take loss small sidestep much internal dialogue seep emotion prove be case shopify shop recent trade ibd swingtrader stock be add break june heaviest volume day nasdaq composite be also move new high day tight area volume quickly vanished next couple day stock labore surpass price level june stock do cross then quickly reversed tech sector fall bring nasdaq composite shift market shopify be cut loose early day less loss entry swingtrader stock do close day decisively day move average sell signal outlined trade setup early sell alert prevent tiny loss ballooning hit thing only get shopify tumble additional follow week do translate manage portfolio well same day shopify be remove swingtrader profit be also book align technology algn gain let loss magnify shopify have easily wipe profit align more detail past trade be accessible subscriber trialist swingtrader free trial be available related cut loss quickly be key long term stock profitssw trading strategy lesson
305,ALGN,many fund reversed lower broader market index etfs manage hold gain blue chip small cap stock close friday modest advance track dow jone industrial average russell index ishare russell iwm break intraday past flat base buy point mark new high pare gain close just entry form series basis almost right next other december iwm rise flat base november fund launch have attract asset iwm have lag year june gain vs benchmark index accord morningstar inc year return have outpaced etf year average annual return be also ahead vs iwm gain have double ishare ivv gain several tech name iwm top holding take beating friday include advanced micro device amd take interactive software coherent cohr fall financial name help offset loss spdr midcap mdy pare gain friday close slightly flat base buy point have clear entry earlier session etf start form current pattern advance prior flat base nearly year date june have slightly underperform year average annual return ahead benchmark index year period respective return vs fund be launch count everest re group re align technology algn duke realty dre top holding real estate investment trust other financial turn solid performance friday move thursday etf pick featured pair gold fund have pull back cup handle buy point gold price slide third straight session re not too far entry spdr gold share gld ishare gold trust iau be respective buy point related gilded gain keep sector play watchtoo late buy foreign stock check candidate
306,ALGN,medical related exchange trade fund have rac healthy gain year ongoing quest longer healthier life outperformer be ishare medical device ihi gain year date well ahead gain period fund boast year average annual return vs benchmark index accord morningstar inc ihi launch track dow jone select medical equipment index top holding etf include medtronic mdt abbott laboratory thermo fisher scientific tmo abbott developer generic drug disease screening system other product be buy range clear flat base entry thursday xihi be etf pick featured ibd last month oscar pursche chief executive bruderman brother bruderman asset management opposed take broad view health care sector do overall see great opportunity medical device space investor get exposure ishare medical device etf say also note fund top holding account nearly portfolio increase risk profile ihi be extend past buy point clear april ibd take find biotechs stand benefit most president trump propose tax reform recent tech column spdr health care equipment xhe return ytd year average year old fund track health care equipment select industry index have gather asset top holding include align technology algn intuitive surgical isrg edward lifescience ew account portfolio xhe be trading record high be extend recent bounce day line spdr biotech xbi year have average annual gain past year fund launch january be form flat base buy point entry still july peak vertex pharmaceutical vrtx regeneron pharmaceutical regn abbvie abbv be top name hold xbi top holding make asset related be best health care etf gop move replace etf ride industry recovery
307,ALGN,stock index stand firm midday friday market shrug weak payroll number dip participation rate nasdaq rise dow jone industrial average add roughly respectively small cap russell advanced volume stock market today be lower major exchange vs same time thursday open bureau labor statistic report payroll employment datum nonfarm payroll add job be consensus view lowest estimate range average monthly gain previous month be jobless rate dip tick participation rate fall stock index generally remain calm day loser be mostly lowly rate oil patch field service stock drop driller upside rv stock metal handle airline fiber optic post solid gain fedex fdx break heavy volume stock have be consolidate mid december flat base buy point be fedex previous come november stock advanced start current consolidation fidelity contrafund fcntx reduce stake delta airline dal reclaim buy point stock begin form cup handle pattern mid december buy point handle be delta clear handle soft volume then fall back buy point friday retake buy point come hefty volume warren buffett berkshire hathaway have position delta trim stake blue chip be mostly winner lead loser ratio boee ba pop higher volume moderately average chevron cvx sag also moderately higher volume oil price drop market watcher say president trump pullout paris climate pact lead more drill therefore lower price increase supply highly rate stock stock move fast trade include tal education tal align technology algn broadcom avgo ferrari race canada goose goos apply material amat related wait big stock market pullback read firstin oil war be only winnerbig airline fly buy range strong revenue trafficbank stock get hit again
308,ALGN,tuesday bard cr bcr get upgrade ibd smartselect composite rating new score indicate company be now outperform stock term most important fundamental technical stock pick criterium history show top market performer tend have higher score launch major move bard cr soar nearly massive volume monday report earning leave far extend proper buy point stock have hold gain edge higher tuesday wednesday stock sport ep rating mean recent quarterly longer term annual earning growth be outpace stock accumulation distribution rating show moderate buy institutional investor last week company post rise earning sale growth fall previous quarter bard cr earn rank peer medical product industry group inogen ingn align technology algn heska hska be top highly rate stock group related company be now outperform stock
309,ALGN,earning season again past quarters investor follow slim stock selection principle be scratch head time wonder stock shoot higher price post low growth figure stock take sinker approach seemingly hit home run quarter
310,ALGN,xgoogle parent alphabet googl online mobile food order company grubhub grub software leader microsoft msft receive multiple stock price target increase friday release march quarter earning elsewhere commerce giant amazon com amzn get stock downgrade dental product firm align technology algn earn upgrade mountain view calif base alphabet receive least price target hike wall street analyst follow first quarter earning report firm have buy rating alphabet other bmo capital market pivotal research group have hold rating internet search leader alphabet late thursday say first quarter earning jump year earlier revenue rise best wall street target alphabet stock rise stock market today putt record high territory buy range intraday trading alphabet notch time high chicago base grubhub nab least price target increase friday beat raise report thursday price target hike come firm have buy rating stock oppenheimer pacific crest wedbush security other firm cowen have market perform rating grubhub grubhub stock climb fraction friday thursday rocket nearly just double bottom buy point redmond wash base microsoft receive least price target increase investment bank fiscal third quarter report late thursday investment firm have buy rating stock bmo capital market cowen pacific crest raymond james rbc capital market microsoft stock rise pacific crest security downgrade amazon sector weight overweight seattle company first quarter earning report amazon beat wall street estimate sale earning revenue forecast current quarter fall short amazon result be impressive pacific crest analyst edward yruma say report however stock be approach target step competition dampen term upside however amazon also receive price target increase least investment bank report have buy rating stock amazon rise record intraday close friday just buy point investment bank baird upgrade align technology outperform neutral raise price target friday maker invisalign tooth straighten system late thursday report better expect first quarter result align tech stock leap hit record intraday san jose calif base align earn cent share year year sale analyst be expect cent ep sale
311,ALGN,stock market be modestly lower head friday close small cap take beating follow heavy slate earning report nasdaq composite fall fractionally major component such amazon com amzn alphabet googl enjoy post earning rally other fall disappointing result amazon be well friday intraday high still buy point facebook fb jump nearly record high needham analyst raise price target say facebook be take market share advertising industry faster initially thought stock start slowly january have picked pace be extend january entry pullback day move average make earlier month dow jone industrial average fall small cap russell lose erase nearly day progress volume be tracking lower nyse higher nasdaq big move top component chip other tech stock be weakest industry group today trading chinese internet company baidu bidu fall heavy volume earning report late thursday bank retailer also underscored selling cruise line sail week high royal caribbean cruise rcl gap add big volume share be now extend pullback week move average royal caribbean report surge earning beating wall street expectation sale rise strong booking caribbean travel drive most outperformance strength europe help offset soft korea market company also announce stock buyback norwegian cruise line nclh rise nearly break past buy point flat base report quarterly result carnival ccl rise new high active trading grubhub grub initially jump be little change head close grubhub surge follow strong quarterly result push meal delivery app slightly buy point double bottom base volume be tracking well average align technology algn soar record high maker invisible dental brace beat earning expectation company give sunny outlook align forecast second quarter ep cent share better consensus estimate cent stock be record high already extend buy point reach february merit medical system mmsi jump nearly make decisive move buy point flat base heavy volume medical product manufacturer beat profit estimate forecast full year ep revenue analyst have forecast ep related facebook get price target hike stock hit record highmicrosoft beat earning view miss sale march quarter
312,ALGN,stock market continue provide steady diet breakout past buy point friday priceline pcln be several travel stock climb book service rise piper jaffray reiterate buy rating stock have price target priceline share be extend find support pullback
313,ALGN,xearly record high nasdaq quickly dissipate midday trading major index trade red intraday lows tech heavy nasdaq edge lower dow jone industrial average fall market appear shrug weaker expect gdp figure early friday stock open higher modest gain be short live gdp growth come vs expect rise growth be slowest pace year dow industrial semiconductor component intel intc drop almost report sale fall just shy expectation share appear find support day line base build process continue american express axp follow decline upside energy component chevron cvx exxon mobil xom pace advancer gain energy giant announce earning beat early friday chevron also top view revenue exxon quarterly revenue come street target amazon com amzn surge record high easily beating street earning sale estimate earning beat lead multiple price target raise analyst share have be much early trading be fading only rise fellow fang member alphabet googl surge impressive earning sale beat result google parent company receive number price target hike wall street analyst chip stock underperform stock market today disappointing earning result chip bellwether intel qualcomm qcom weigh overall sector qualcomm continue downtrend earnest fall chip designer cut earning revenue guidance current quarter qualcomm key customer apple aapl be embroil legal battle lead chip stock broadcom avgo apply material amat fall apiece skywork solution report own earning fall skywork beat fiscal revenue profit estimate late thursday also provide optimistic earning sale guidance lead growth stock trade mixed friday weakness chip offset strength medical stock upside align technology algn soar handily beat earning sale estimate provide upbeat sale guidance invisalign maker stand almost cup handle entry downside chip stock cavium cavm drop cirrus logic crus trade related amazon get several price target hike stock hit record highalphabet grubhub microsoft target raise amazon downgradedintel tumble just shy sale chip play beatwhere be stock market head read more big picture
314,ALGN,homebuilder dominate thursday new high list seemingly unfazed prospect higher interest rate come month think crimp housing demand century community ccs hit new high reversed lower still buy range buy point flat base speculative name
315,ALGN,many lead stock rally break new high tuesday major market index marched record level cbs cbs gain clear flat base buy point volume higher usual share remain buy range entry rbc capital market thursday raise price target medium giant
316,ALGN,general market remain red early afternoon trading stock market today dow jone industrial average be poise fifth straight decline nasdaq limp lower dow fall unitedhealth unh outperformed dow testing support day line report earning earlier week exxon mobil xom lag blue chip index fall ub downgrade sell goldman sachs gs continue descent drop investment bank be rapidly approach day line follow fail move week tight entry tesla tsla give back early gain still rise more follow morgan stanley ms upgrade overweight raise price target stock be currently trading related news highway safety regulator close probe tesla autopilot system seek recall other adverse action ibd take netflix apple breakout investor be tempt jump early several big internet work basis facebook netflix alibaba netease lack proper handle netflix nflx soar follow big earning beat last night market close subscriber growth be highlight release video stream company add new stream video customer vs expect figure predict back october nvidia nvda continue bounce light volume testing price level coincide week line chip stock be lead growth stock be mixed head afternoon trading financial stock once again lag day bank ozark ozrk lead decline bank regional bank fall approach day volume have be relatively heavy decline upside gatx gatx rise follow earning release company adjust earning surpass analyst estimate revenue also top street view stock have recently find support day line downside align technology algn drop day support level surge volume related tesla mobileye upgrade target exxon downgrade netflix pt hikedsteel stock erase wednesday trump trade gainsoclaro revenue speed fiber stock demand key takeaway netflix terrific earning report
317,ALGN,more year stock market bottom march top perform company stock market today be still flash sign economy be still transform new product service be emerge other financial asset be rebound piece such evidence need be snapshot earning forecast ibd
318,ALGN,market tread water high so do lead stock tight action lead stock follow large advance be constructive give savvy investor opportunity add exist position initiate new one be miss tight action indicate institution be unwilling sell share anticipation higher price primerica pri
319,ALGN,market continue make new high many lead stock have already break moved higher however few compelling candidate be still trading proper entry area broadcom avgo align technology algn be ibd leader be currently inflection point broadcom leaderboard member have be build flat base entry
320,ALGN,stock remain lower morning oil price rally ahead wednesday opec meeting stock market today major index fall modestly dow jone industry average be weigh blue chip index be unitedhealth group unh nike nke fall nasdaq decline component energy sector be higher crude price rally top perform stock be energy company southwestern energy swn lead pack stock be almost finisar fnsr gain be upgrade strong buy buy needham co asset management firm analyst also raise price target fiber optic company report earning close dec share be extend flat base entry align technology algn moved stifel nicolaus raise price target analyst firm maintain buy rating company breaking flat base early last week orthodontic medical treatment developer have be find resistance level stock be currently entry cognizant technology ctsh soar hedge fund elliott management outlined value enhancement plan letter send company letter indicated cognizant achieve value share end least premium friday close thor industry tho recreational vehicle manufacturer report earning bell today analyst expect ibd member report ep share be currently cup base entry point oil price rally strongly morning trading fall friday saudi arabia cancele meeting russia price oil be report indicated iraq say cooperate opec member reach agreement production curb investor continue speculate lead wednesday opec production meeting be much overnight trading dollar index have trim loss be essentially unchanged economic calendar be light today dalla fed general activity index only notable item index be expect be november compare october related finisar upgrade panera darden downgrade align pt uppedopec meeting preview damned do damned don
321,ALGN,fiber optic communication gear maker finisar fnsr be upgrade strong buy monday restaurant stock cracker barrel cbrl darden restaurant dri panera bread pnra be downgrade hold neutral also dental technology firm align technology algn be give price target hike investment bank needham upgrade finisar strong buy buy raise price target finisar stock climb close stock market today hit intraday best march sunnyvale calif base finisar be schedule report fiscal second quarter earning market close dec related finisar be buy other hot optical stock breakoutsmaxim group downgrade cracker barrel darden restaurant hold buy wedbush security lower rating panera bread neutral outperform maxim reiterate price target cracker barrel darden wedbush maintain price target panera panera bread fall cracker barrel slide darden restaurant fall related dave buster panera wingstop yum restaurant back menucracker barrel beat profit raise guidance see trump effect darden earning top restaurant slump firm stifel reiterate buy rating align technology raise price target align slip close monday align be rank ibd list top growth stock san jose calif base align make product dentist orthodontist include tooth straighten gear invisalign brand product related growth still vogue ibd nail third straight weekly gain
322,ALGN,nasdaq last week race new high prompt shift back confirm uptrend market pullback look lead stock find support key move average prior buy point new stock idea breaking proper entry point ross store rost continue consolidate follow breakaway gap earning several week retailer break
323,ALGN,ab discovery growth chclx be see light end tunnel be stick lag many midcap growth peer track morningstar inc notch middle road record fund be top peer group year go tuesday top past month top past month discovery growth be year ahead gain midcap growth peer lag nearly gain fund seek capital appreciation small midcap stock earning exceed analyst expectation undergo upward revision estimate fund have be manage bruce aronow kumar kirpalani samantha lau wen tse tseng oct commentary manager say give increase uncertainty global growth be increase emphasis secular grower company have greater normal control future earning growth self help opportunity consistent investment discipline holding regardless absolute level growth degree economic sensitivity be well position many purchase have unique secular growth driver company specific initiative help drive earning fund have make headway number top holding top new buy sporting ibd composite rating example ariad pharmaceutical aria top new buy have composite rating biotech company develop therapy treat aggressive advanced stage cancer regulate cell signale share be year top new buy have composite rating higher cyberark software cybr new buy have composite rating be top stock ibd computer software security industry group company suite program be design detect respond cyberattack company cause damage ep growth averaged past quarters trading low share be cup pattern pivot point ollie bargain outlet olli top new buy have composite rating bargain retail chain earning share have grow quarters ollie be stock ibd retail discount variety industry group ibd take ollie standing industry group be due strong growth metric addition good composite rating ep growth averaged past quarters ep growth current stanza be forecast consult ibd stock checkup be quick way get handle trait stock ollie share be so far year trading share be extend fund top holding have comp rating align technology algn be have comp rating be so far year be fund top hold weighting ibd take composite rating start run combine ibd performance rating stock poise move higher often have composite rating higher mean ve outperformed other stock term composite rating align be stock ibd medical product industry group addition composite rating have quarters earning share growth acceleration ep be expect expand year annual return equity be take look ariad target rare cancer include other treatment option available today earning share improve past quarters only quarters be profit actually book trading cup pattern share be buy point watch see stock form handle cup shape base stock flaw cup be deep feature correction sale be increase company isn make money health care sector overall get boost recent election result investor seem decide republican majority congress donald trump white house significantly lighten regulatory burden sector middleby midd top hold have composite rating maker commercial kitchen equipment residential appliance be stock ibd household appliance ware group ep grow past quarters stock have year row annual ep growth trading share be cup pattern pivot point yet top hold bright horizon family solution bfam gap nov ep cent miss analyst consensus expectation penny quarterly revenue fall short forecast then stock have rally regain week line stock have composite rating be consumer service education industry group be rank group related akorn servicenow do stock fund top midcap growth mutual fund look rally
324,ALGN,load player follow lead major average ibd capped third straight weekly price gain friday index lead growth stock have rally past week outperform gain same time shorten week trading didn get way big performance
325,ALGN,stock market rise modestly tuesday keep shake last week weakness nasdaq add nearly composite continue rise day move average climb be less new high dow jone industrial average rise tech heavy nasdaq get worst last week slump
326,ALGN,nasdaq find support day move average line morning trade stock market today moved higher prompt lead stock approach entry point middleby corp midd rank ibd list lead growth stock break cup handle base
327,ALGN,load player be quiet session stock market friday major stock index end small loss once again action be far quiet new high list name appear screen afternoon trading small cap argan agx highest possible composite rating be still buy range
328,ALGN,buy right not only help maximize profit stock market today save unnecessary pain wallet chart current name ibd stock spotlight screen show numerous lead stock be beating major index be most part healthy uptrend market stage
329,ALGN,major stock index be mildly lower afternoon trading monday selling be fairly intense so call trump trade stock have be rally expectation stronger demand result donald trump presidential aggregate maker vulcan material vmc slump martin marietta mlm give back dow jone industrial average nasdaq composite be small cap take hit russell volume nyse nasdaq be tracking higher friday half session level nike nke caterpillar cat american express axp lag dow loss share apple aapl be mostly unchanged busy week economic datum kick tuesday release second estimate gross domestic product personal income spending datum be due wednesday ism manufacturing index be due thursday november employment report be due friday benchmark nymex crude oil rally barrel ahead wednesday opec meeting concern be grow output cut not be slam dunk stock market today fast grow oil gas producer callon petroleum cpe reversed lower buy rating deutsche bank price target share fall hit intraday high ibd sucampo pharmaceutical scmp be big gainer nearly biotech be featured weekend column ibd component align technology algn reversed lower even stifel reiterate buy rating raise price target related oil hit deal fail iraq be optimistic finisar upgrade panera darden downgrade align pt up
330,ALGN,conventional wisdom be buy low sell high great stock winner tend have superior rating make big move monday market close priceline pcln microchip technology mchp fabrinet fn maxlinear mxl align technology algn report earning have composite rating better mean outperform least stock base fundamental technical factor priceline maxlinear align be ibd stock quarterly result tap week here be result estimate adjust ep rise revenue climb result adjust ep rise exclude various item such opentable revenue climb best yearly gain quarters outlook priceline see adjust ep vs analyst estimate stock priceline share shot early hour action share close stock market today back time high set oct stock have retake day move average heavy volume trigger aggressive buy point stock have not consolidated quite long enough form proper base powerful high volume rebound day currently just provide aggressive buy point hurricane matthew strong dollar weigh result late last month rival online travel site expedia expe report earning fall short forecast revenue top tripadvisor trip report late tuesday ep be see flat cent revenue growth related expect priceline report earningsibd take buy selling stock ahead company earning announcement be dicey option play swing trader offer way least cap risk still participate potential upside estimate ep flat cent revenue result ep rise cent revenue climb outlook revenue vs view milllion stock maxlinear share rise modestly initial hour action share close peak july maxlinear have retreat somewhat volatile fashion have find support day move average multiple time include last week maxlinear develop networking semiconductor related time warner merger boost top chip stocksestimate ep cent revenue result ep be cent revenue leap outlook microchip see ep cent revenue analyst expect cent ep sale stock microchip technology edge higher late trading share close retake day line week resistance microchip have be consolidate past month flat base formation traditional buy point pattern also resemble double bottom base suggest aggressive buy point microchip tech semiconductor serve variety industry include pcs automotive fellow top rate chipmaker nvidia nvda microsemi mscc also report earning week estimate ep cent revenue climb result ep jump cent revenue rise fourth straight quarter faster sale growth align technology say cfo david white be retire naming john morici successor outlook align see ep cent revenue analyst expect ep cent sale stock align technology rise early hour action share close share peaked then share have gradually retreat be currently trading day day line align technology be best know invisible invisalign brace estimate ep cent revenue climb be fourth straight quarter accelerate sale growth result ep cent revenue outlook ep cent revenue analyst have expect ep cent sale stock fabrinet jump early hour trading share close stock hit record high oct share have tumble then plunge day line approach day fabrinet be part fiber optic component boom not technically ibd fiber optic group group be still rank ibd industry stock have retreat recent week several optic stock have report last week mixed result acacia communication acia once red hot fiber optic firm report thursday related apply optoelectronic earning beat neophotonic misseshere bonus earning report watch diamondbank energy fang shale company focuse permian basin estimate ep cent revenue result ep rise cent adjust revenue be stock diamondback energy share rise modestly hour trade stock close stock shot oct announce higher production target say be end buyout talk unnamed firm then share have pull back erase oct gain more day line shale company many have already report september quarter result have see stock retreat crude price tumble barrel include drop last week related oil rig count jump month high permian say opec be lose relevance carrizo ep rise
331,ALGN,conventional wisdom be buy low sell high great stock winner tend have superior rating make big move monday market close priceline pcln microchip technology mchp fabrinet fn maxlinear mxl align technology algn report earning have composite rating better mean outperform least stock base fundamental technical factor priceline maxlinear align be ibd stock quarterly result tap week here expect estimate ep rise revenue climb stock priceline fall day last week lose close day move average share be only time high set oct powerful high volume rebound day currently just provide aggressive buy point stock have not consolidated quite long enough form proper base hurricane matthew strong dollar weigh result late last month rival online travel site expedia expe report earning fall short forecast revenue top tripadvisor trip report early wednesday ep be see flat cent revenue growth related expect priceline report ep flat cent revenue stock peak july maxlinear have retreat somewhat volatile fashion have find support day move average multiple time include last week maxlinear develop networking semiconductor related time warner merger boost top chip stocksestimate ep cent revenue stock microchip technology have be consolidate past month flat base formation traditional buy point pattern also resemble double bottom base suggest aggressive buy point past week share have be find resistance day line microchip tech semiconductor serve variety industry include pcs automotive fellow top rate chipmaker nvidia nvda microsemi mscc also report earning week estimate ep cent revenue climb end quarter string accelerate sale growth stock align technology peaked then share have gradually retreat be currently trading day day line align technology be best know invisible invisalign brace estimate ep cent revenue climb be fourth straight quarter accelerate sale growth stock fabrinet hit record high oct share have tumble then plunge day line approach day fabrinet be part fiber optic component boom not technically ibd fiber optic group group be still rank ibd industry stock have retreat recent week several optic stock have report last week mixed result acacia communication acia once red hot fiber optic firm report thursday related apply optoelectronic earning beat neophotonic misseshere bonus earning report watch diamondbank energy fang shale company focuse permian basin estimate ep cent revenue stock diamondback energy shot oct announce higher production target say be end buyout talk unnamed firm then share have pull back erase oct gain more day line shale company many have already report september quarter result have see stock retreat crude price tumble barrel include drop last week related oil rig count jump month high permian say opec be lose relevance carrizo ep rise
332,ALGN,align technology not only help improve customer smile also be make investor much year stock be extend march past buy point month base subsequent pullback week move average advanced more initial entry recent high provide ample opportunity investor take profit most stock pause digest gain run so be profit take rule kick align have be consolidate now mid august so wouldn be surprising form new base share have find support day line february relative strength line draw blue ibd stock chart be new high ground bullish sign san jose calif base company announce patient have begin treatment clear aligner system be more invisalign trained doctor worldwide accord align be very proud now have person have begin treatment invisalign clear aligner instead metal brace ceo president joe hogan say press release reach invisalign patient half time take reach be remarkable reflect accelerate adoption result nearly year experience significant innovation product technology earning growth resume past quarters follow quarters decline analyst expect jump sale growth step past quarters consensus forecast be top line gain second half full year profit slip last year combination investment foreign exchange headwind expect bounce back gain year next ibd take always sound strategy pursue top stock lead industry group ibd stock checkup help find stock have top rating group align be company stock medical product group best possible composite rating carry high mark board include earning share relative strength accumulation distribution rating imply recent institutional demand share do volume ratio well neutral level highly regard fund own share include columbia acorn fund acrnx rowe price new horizon prnhx number mutual fund hedge fund shareholder rise end same year period related leader see growth accelerate dental stock grin consumer spending drife growth
333,ALGN,spending research development have leveled company increase stock buyback dividend say goldman sachs company do better other get most bang buck new research report goldman name company say be best position make dollar work make list be align technology algn amazon com amzn alphabet googl grubhub grub incyte incy universal display oled palo alto network panw regeneron pharmaceutical regn meanwhile intel intc microsoft msft google parent alphabet amazon drugmaker johnson johnson jnj lead way total spending goldman sachs also analyze intensity measure percentage sale other metric regeneron salesforce com crm apple aapl amazon netflix nflx have experience outsized growth come gross profit well price return same period say goldman report ibd take goldman sach favorite palo alto network belong ibd learn many growth stock grubhub sport highest possible composite rating align technology have cr composite rating be part slim investing share total spend pie have be pretty stable suggest corporation have likely be maintenance mode spend opposed be expansion mode say report tech company lead spending follow health care consumer discretionary industrial sector say goldman related do tend buy stock too late lesson align stoke fire deep durable melanoma drug resultsole leader universal display crack misscisco palo alto symantec gear cloud cybersecurity shift
334,ALGN,investment bank morgan stanley thursday select high conviction stock have term catalyst move share higher be technology stock activision blizzard atvi amazon com amzn ibm ibm lam research lrcx fifth align technology algn be medical product tooth alignment company company be currently featured ibd list superior stock activision align amazon be ibd leaderboard list other be wireless tower operator crown castle cci commercial bank svb financial group sivb energy service firm helix energy solution hlx parsley energy pe ibd take investor com offer host proprietary stock list give investor actionable idea company worth consider ibd be ibd flagship screen lead growth stock show strong relative price strength top notch fundamental leaderboard provide select group stock pick show most potential big gain analyst believe more imminent event drive share price stock materially next day group morgan stanley analyst say research report morgan stanley analyst brian nowak expect video game publisher activision beat wall street estimate report third quarter earning nov santa monica calif base company be benefit shift higher margin game download vs package medium sale online mobile game traction say potential catalyst include faster anticipate shift full game download indication activision be monetize king digital user base advertising currently game be download digitally expect increase next year nowak say align technology make tooth straighten system be set report earning nov morgan stanley analyst steve beuchaw be look san jose calif base align report strong result catalyst stock include inflection discretionary spending rollout align feature set collaboration more digital scanner partner commerce leader amazon be likely report result late october nowak be expect amazon beat wall street consensus expectation estimate be drive higher gross profit customer more offset expectation higher forward stream content spending increase fulfillment deleverage amazon large expect warehouse build year nowak say also see potential further upside due ongoing strength amazon aw cloud compute business amazon be move phase improve profitability core commerce business even take market share say potential catalyst include amazon result acceleration commerce penetration core market prime membership growth enterprise cloud adoption hit inflection point nowak say tech service giant ibm see lift make progress transition mainframe other legacy business morgan stanley analyst katy huberty say ibm be become more expose emerge business watson cloud analytic mobile security have double digit growth profile say ibm potential catalyst include accelerate transformation recent acquisition help achieve faster path revenue growth improve profit margin say semiconductor equipment maker lam research be set report september quarter result oct hold analyst meeting nov expect event be positive stock morgan stanley analyst joe moore say investor be likely take fresh look lam wake fail merger inspection equipment vendor kla tencor klac
335,ALGN,load player mutual fund manager other large investor take interest medical product maker zimmer biomet zbh have earn spot ibd list top growth stock industry peer align technology algn edward lifescience ew tuesday stock fall day move average heavy volume
336,ALGN,have second study chart today stock spotlight screen gain valuable insight absolutely enough time see stock be perform respect week move average stock be trading north side line typically mean demand share be strong stock be also rise faster normal week move average plot average close price past week move average fresh week trade new average be calculate prefer stock be see rise week line not fall day move average move similar form be plot only daily chart look stock make screen end thursday trading overall picture be bullish just stock align technology algn paycom software payc be trading respective week line align case be more serious stock be more week volume have accelerate vs prior week maker innovative brace tooth have enjoy run break past buy point march month base align touch week move average week end april july then moved higher pullback follow march give holder opportunity add share winning position paycom seem be toy week line week notice volume recent day have dry more sideway price action yield new base other stock screen chemical polymer expert kraton kra chip play maxlinear mxl be likely form new basis other be show surprisingly strong action choppy yet still make sense take least gain way most stock be incline correct price rise past proper point have ironman conviction stock be act well aim gain don get too greedy related platinum rule selling stock help capture profit way upwill activision align technology see growth accelerate
337,ALGN,stock close lower monday well session lows be major sector move noteworthy change stock such taser international tasr logitech logi nasdaq fall dow jone industrial average lose index make smaller price movement compare volatile activity previous several session calmer trading continue be welcome change market volume be tracking lower board real estate investment trust utility be worst perform industry group spdr utility xlu etf fall hit more month low utility reit be sensitive interest rate treasury yield be only modestly higher year note fiber optic industry group have be market leader many week also be laggard stun gun manufacturer taser get knock loss huge volume cause stock undercut base have be form august stock fall news new york polouse department have award year contract body camera rival vievu also supreme court rule polouse use taser amount excessive force case involve mentally ill man be stunned time minute align technology algn pierce day move average first break support stock moved new high march not immediate sell signal slide heavy trading put investor guard watch more weakness bearish mood wall street couple stock have appear ibd screen break basis logitech gap flat base leap busy trading maker computer peripheral such keyboard mouse have touch week move average last week give stock good bounce ahead base exhibit sign institutional support judge gain week major volume share fall first week base close nearly halfway weekly range positive sign logitech be leader computer hardware peripheral industry group industry remain laggard rank john bean technology jbt reclaim buy point flat base share vault nearly active volume company agree acquire tipper tie make machine clip tie food packaging john bean say acquisition enhance protein process business include production package poultry related taser dife lose nypd body camera contract court leader john bean ply trade food airportsalign technology make patient investor
338,ALGN,nation best perform stock mutual fund past month have be slowly add top rate fabless chip stock such nvidia nvda inphi iphi maxlinear mxl silicon motion simo computer software firm such netease nte ebix ebix veeva system veev paycom payc qualys qlys also make top fund buy list computer networking firm arista network anet netgear ntgr be also favore lead fund wednesday ibd computer software subgroup education medium enterprise gaming be rank top industry click here new buy top perform stock fund past monthsmanager lead stock mutual fund have continue graze medical product firm edward lifescience ew align technology algn inogen ingn vascular solution vasc build stock thor industry thor patrick industry patk aos lgi home lgih central garden pet centa be defensive name top fund be buy latest report period other industrial material stock be look good include metal fabricator gibraltar industry rock worthington industry wor top fund hold big stake chinese internet retail giant alibaba group baba lead fund buy stock investing estimate latest report period clear consolidation mid august alibaba have continue trek north notch new week high ibd take ibd best mutual fund award winning manager michael carman hartford growth opportunity fund explain have be build stake alibaba ibd report ibd see top perform fund snap gibraltar industry investing estimate goldman sachs small cap value fund gssmx add share portfolio latest report period buffalo base firm make distribute build product processed metal industrial infrastructure residential market product include postal approve single unit steel mailbox well centralize mailbox parcel locker industrial area gibraltar fabricate metal bar grating engineer bearing joint be used bridge road airport runway gibraltar have benefit construction boom well diversify material firm have display healthy earning growth recent year ep growth range past quarters firm also raise full year ep guidance range hit week high aug gibraltar have be work fourth stage flat base trading buy range country lead fund have be get rid big household name latest report period include internet search giant alphabet googl online retailer amazon com amzn credit card processor mastercard banking stock such bank america bac suntrust bank sti morgan stanley ms be also cut list related top fund latest sell
339,ALGN,individual investor lookout best stock buy top mutual fund take inspiration michael carman portfolio manager hartford growth opportunity hgoax carman know exactly like seek company put simply giddyap call atom look company accelerate tangible operate momentum carman say mean latch good stock revenue growth margin improvement speed trait open door positive earning surprise share price gain fund be ibd best mutual fund award winner have outperformed year period end dec only diversify stock fund meet standard click here see list ibd mutual fund quarterly leaderscarman be year old senior manage director wellington management subadvisor growth opportunity sidekick opportunity fund be mario stephen mortimer carman be also manager additional fund include hartford global capital appreciation office boston overlook city historic harbor talk ibd investment approach opportunity click here see list mutual fund month leadersibd make fund different rival large cap growth portfolio carman re look company have differentiate view so even find company accelerate revenue growth already reflect market price not interesting interesting have higher view year consensus view approach be less get next quarter right more get next couple year right ibd important be valuation buy sell decision carman do have valuation overlay look company upside case vs downside case want skew portfolio company ratio be greater upside vs downside ratio click here see list mutual fund category performance leadersibd fund be top large cap growth peer group mutual fund track morningstar inc past year year date middle pack have year be so challenge fund carman investor need stick knit biggest mistake manager make be meander try do investment style du ve stick knit past year style work best seek high stability low volatility stock consumer staple utility telecom service be group be typically not sweet spot do ibd yet market have be uniformly favorable defensive sector do expect help carman yes be tale market january early february market get pummeled solid stock invest get hit hard be great buy opportunity type stock didn pivot safer stock double company great long term prospect be better buy opportunity last year ibd be move earlier year carman sell bank america bac jpmorgan jpm thesis company be predicate interest rate move back come second quarter view brexit ability federal reserve raise rate meaningful manner be compromise ibd take investor react once fed finally hike rate understand stock market prevailing trend be key factor be choose growth defensive stock buy pointer visit ibd university ibd buy do make carman add position ve be buy chipotle cmg other stock expedia expe add priceline pcln ibd facebook fb earning share growth have sped quarters have trim exposure recent disclosure carman facebook remain largest holding aug have be ability monetize mobile traffic first come public didn have great solution finally come particularly advertising gear small medium size business trim be not fundamentally related be take profit table reinvest other idea ibd latest disclosure view alibaba baba ve boost stake several portfolio report row carman be premier commerce site china investor try put box be amazon amzn alphabet googl answer be none re little different alibaba core be business business platform taibao be small medium business consumer consumer consumer site big bazaar tmall be brand consumer retail site also have similar product amazon web service be call alibaba cloud have investment often don get credit person be little confused recent month ve take step make more transparent financial report business line be big driver add stock alphabet amazon take step stock take feel alibaba make similar move once investor get more comfortable business model ibd ve trim amazon recently carman still big overweight isn lot last month stock have make huge move take profit company become larger put risk reward back balance ibd summarize do please carman amaze most be be take cent incremental dollar spend online regardless everyone come competitive challenge have become almost habit online user be willing take risk create aw business nothing be fast grow profitable far ahead competition term innovation ibd align technology algn be newcomer portfolio carman make clear aligner brace person tooth re less invasive way move person tooth old fashion brace so have great product great distribution growth rate accelerate have view transpire buy few quarters purchase price ibd american tower amt look steady eddie be carman stock come pressure last year growth be slow strong dollar hurt emerge market underlie business be very stable have let say customer rent space tower third come very profitable have fix cost incremental profit be strong international market offer greater opportunity upgrade service so return equity invest capital improve next several year reverberate investor ibd take profit alphabet view carman still have overweight vs russell growth index have be penalize investment such thing care com crmc mask strength growth core search business so investor be not compensate now investment pay just put strongest quarters year have run rate revenue be grow revenue north last quarter stock be inexpensive teen multiple re not pay much cash balance sheet old name have become verb not many company do strong position ibd hear enjoy yoga exercise do get interested have re foot give basketball exercise carman start yoga year order increase flexibility clear mind usually do yoga twice week good week feel great afterwards help supplement other stuff do run spin lift weight retire basketball year realize be cut away blow achille heel bane older guy existence be get hit head leg too much related janus manager bet proven champ comer calculate risksthis top mutual fund manager win flavor growth stocksmutual fund award top equity fund
340,ALGN,stock retreat late morning trade even ism manufacturing index september come august read also econoday consensus estimate stock market today twitter twtr extend gain more takeover talk share rise late friday bloomberg report alphabet googl be work investment bank lazard specialist buy struggle microblogging service nasdaq dow jone industrial average fall lose elsewhere cabela cab soar nearly news be acquire bass pro shop deal value cabela share premium friday close tesla motor tsla have be lag market badly april jump company say deliver approximately vehicle year quarter new quarterly record company ibd take auto manufacturer stand tesla industry group see ibd stock checkup hint base italy freeport mcmoran fcx initially rally be now deutsche bank raise rating copper producer buy hold lift price target freeport day move average currently be potential resistance level watch early outperformer ibd include logmein logm netease nte momo momo align technology algn callon petroleum cpe lag loss related tesla motor delivery soar musk seek new fundingism manufacturing index signal return growth new order jumpgoogle be back twitter talk disney speculation fade
341,ALGN,earning season just corner amazon amzn facebook fb other top rate stock be expect post quarter strong number else make list table show company beat ep estimate be expect post higher earning growth third quarter make list stock also have have better composite rating meaning outperform least stock term most important fundamental technical stock pick criterium stock also have average daily volume share current share price stock list range well know megacaps amazon facebook younger ipos acacia communication acia cotiviti cotv thing investor keep mind stock list such acacia cotiviti weibo wb draw industry dw have already make big move mean high expectation earning be already baked share price substantial earning beat propel stock even higher just meeting just miss forecast send stock sharply lower always be sure run stock buy checklist invest use sound buy sell rule check overall market condition datum stock expect higher earning growth generate marketsmith click ticker latest quote article stock related be ready next week earning report market action be time get market quickly find top rate stock buy point
342,ALGN,second quarter report season largely now past analyst new ep update place follow result time start look third quarter expectation ibd stock spotlight list be several change stand expectation current quarter first nearly member stock spotlight group be expect post solid
343,ALGN,stock index show word vocabulary friday afternoon word be sell few stock escap damage stock market today loser overwhelmingly lead winner virtually index be major average close session lows nasdaq fall lose dow jone industrial average sank drop day move average small cap russell plunge volume be run higher major exchange compare previous session comment federal reserve official slather gloom bull have grow rely low interest rate boston fed president eric rosengren say favore gradual normalization rate street interpreted rate hike early next week late december rosengren be voting member fed dalla fed president rob kaplan nonvoting member say case rate hike have strengthen ibd proxy top stock virtually stock be many loser be move bearishly strong volume stock drop day move average line include broadcom avgo aos cyberark software cybr other lead stock lose short term day line include acacia acia lgi home lgih ubiquiti network ubnt align technology algn nvidia nvda momo momo weibo wb tpi composite tpic sina sina short term trader often use day line something place exit line be violate blue chip be exception dow caterpillar cat boee ba verizon vz coca cola ko lose
344,ALGN,be rough year growth stock fast grow issue stock spotlight screen have react well better expect earning report recent week new issue lumentum lite report result aug close beating earning revenue estimate handily next day be volatile stock manage hold own thursday
345,ALGN,numerous company stock spotlight screen show heartening trend accelerate top line growth savvy investor know accelerate growth percentage increase latest quarter top size increase prior quarter be factor drive huge price gain stock institutional money be constantly look company
346,ALGN,earning season wind focus now shift question company be expect post strong number next report table show company beat ep estimate be expect post higher earning growth third quarter make list stock also have have better composite rating meaning outperform least stock term most important fundamental technical stock pick criterium stock also have average daily volume share current share price stock list range well know megacaps amazon amzn facebook fb younger ipos acacia communication acia cotiviti cotv thing investor keep mind stock list such acacia cotiviti weibo wb draw industry dw have already make big move mean high expectation earning be already baked share price substantial earning beat propel stock even higher just meeting just miss forecast send stock sharply lower always be sure run stock idea buy checklist invest use sound buy sell rule check overall market condition big picture tip regularly check investing action plan earning preview timely coverage stock get ready report datum stock expect higher earning growth generate marketsmith click ticker latest quote article stock excerpt ibdextra newsletter
347,ALGN,today ibd show many stock have be winner year real question be one be screen rally start top perform leader didn get ibd make big advance more impressive be stock be list market bottom late
348,ALGN,stock shrug weak gdp datum friday tack gain decline volume nasdaq rise afternoon trade echo gain own blue chip dow jone industrial average retreat volume stock market today be tracking lower major exchange gdp disappoint wall street angle figure come badly miss consensus target figure be revise downward figure be revise rate hike now look less likely ishare gold trust iau pop leave more year high ibd winner loser day be evenly split invisible dental brace provider align technology algn jump almost heavy volume align report earning trounce street consensus estimate rowe price new horizon fund prnhx add position align technology widely hold stock gain stock have be trading tightly month be so far year
349,ALGN,stock spotlight screen boast accelerate sale profit growth hallmark best growth stock strong accelerate quarterly sale profit growth attract institutional investor power drive stock higher ibd take earning growth be most important factor consider stock put watch list click here learn
350,ALGN,be new record high stock market tuesday index fall broadly nasdaq have make time close high previous session fall lose close session lows day loser top winner more ratio board
351,ALGN,country best perform fund past month have be build portfolio market lead stock variety sector include build metal medical retail build stock include aos fortune brand home security fbhs lennox international lii draw industry dw martin marietta material mlm masco mas latest report period other industrial stock perform well include metal fabricator insteel industry iiin gibraltar industry rock handful medical issue also see heavy buy best perform fund include vascular solution vasc edward lifescience ew align technology algn ligand pharmaceutical lgnd market outlook have be confirm uptrend june click here see list new buy top mutual fundsretailer ulta beauty ulta contour way top fund portfolio top fund have add cosmetic fragrance store investing estimate american fund growth fund america recently add share latest report period manager lead fund also shop share discount retailer ollie bargain outlet olli other retailer worth shopping include burlington store burl pool pool ibd find top perform fund add ollie bargain outlet investing estimate pioneer select midcap growth add share newly issue company run chain bargain warehouse style store buy good stuff cheap harrisburg base firm have store selling closeout excess inventory salvage merchandise everything buy ollie have day hard time guarantee customer aren happy purchase return day purchase full refund sale receipt ollie stock clear buy point double bottom base aug have straddle level then bargain store have be grow steadily rac solid double digit earning growth past quarters same period revenue growth be more subdue slightly range other notable stock new buy list act well include gun maker wesson swhc hawaiian holding edward lifescience ew stock be currently etching handle part cup handle base pattern make sure put stock watch list nation lead fund have be take profit online retailer giant amazon com amzn computer software firm symantec symc electronic art ea aspen technology azpn be also sell top perform fund latest report period top fund also unload beverage company monster mnst constellation brand stz monster report second quarter earning result cent miss view cent revenue beat expectation click here see list latest sell top mutual fund
352,ALGN,stock index struggle stay positive thursday afternoon small cap lead second straight day nasdaq rise hover break even line dow jone industrial average edge lower small cap russell advanced volume stock market today be run slightly lower previous session pace blue chip be mostly only narrowly so visa pop day top gainer stock dow industrial visa be sketch somewhat unorthodox double bottom base handle middle peak be only cent left side high normally middle peak be further left side high handle buy point provide better entry other payment processor show similar chart action mastercard be see flat base double bottom handle middle peak entry be best see daily chart handle look complete day minimum requirement today offer entry financial service dfs have etch flat base potential entry problem stock be none have top notch rating wall street expect visa earning rise fiscal year end september mastercard earning be estimate respectively current calendar year so be stock stir wall street expect turnaround visa mastercard earning next year be expect jump visa mastercard be good growth mega cap stock be smaller be expect grow earning only ibd proxy top rate stock winner day lead loser ratio stock striking new high include invisible brace provider align technology algn telecom infrastructure stock ubiquiti network ubnt
353,ALGN,nation best perform stock mutual fund past month have be slowly add financial reit issue such coresite realty cor store capital stor equity lifestyle property el latest report period ibd financial reit group rank ibd industry subsector handful computer software firm be also favore fund industry most successful manager pick include netease nte veeva system veev paycom software payc click here see list new buy top mutual fundsseveral retailer be likewise spot new buy list include burlington store burl pool pool dave buster entertainment play medical product stock such vascular solution vasc teleflex tfx align technology algn ibd leaderboard member edward lifescience ew have be heavily buy lead fund veterinarian medical service firm vca woof be also keeper ibd see lead fund add netease investing estimate john hancock discipline value mid cap fund jvmax add share latest report period netease be chinese provider online gaming software high quality mobile pc game year electronic entertainment expo los angele netease premier several new game include tianxia evercraft fly dagger netease stock break month cup handle base june zip high next day ease back buy range earning growth have be robust ramp past quarters respectively revenue growth have be mostly triple digit same period lead fund have be selling utility such nisource ni exelon exc xcel energy xel cms energy cms spire sr latest report period big manage health care firm be also be offed include unitedhealth group unh centene cnc be top fund selling unitedhealth group buyer leave net total selling fund large insurer be pull state exchange market loss affordable care act plan click here see list latest sell top mutual fund
354,ALGN,international etfs sell thursday european central bank president mario draghi warn europe suffer damage weak productivity subpar growth ishare msci germany ewg give nearly stock market today ewg largest single country foreign exchange trade fund be now red year too slow return output potential be far innocuous draghi say thursday speech brussel contrary have last economic consequence ultimately lead potential be erode well ecb vigorous attempt stimulate eurozone economy quantitative ease aren quite have intend effect comment draghi add structural reform politically sensitive be key putt region back solid economic track cost delay be simply too high draghi say brussel economic forum ishare msci eafe efa dump flagship exchange trade fund invest international develop market europe asia australia stock fund notch loss oil price pull back profit take hit high crude future july delivery settle cent lower barrel thursday financial sector trail decline sector health care lead advance sector device drugmaker punch ishare medical device ihi add post week high bolt relative strength line be sign etf be outperform ibd stock align technology algn invisalign system treat misaligned tooth add here look major exchange trade fund tracking various asset class perform today follow daily etf market action be key successful investing spdr spy rs powershare qqq qqq rs spdr dow jone industrial average dium rs ishare core mid cap ijh rs ishare russell iwm rs ishare msci eafe efa rs vanguard ftse emerge market vwo rs spdr gold share gld rs unite state oil uso rs ishare core aggregate bond agg rs powershare db bullish uup rs ipath vix short term future vxx rs
355,ALGN,dental veterinary supplier patterson co pdco jump month high fiscal earning guidance late thursday beat low expectation further fuel stronger group medical stock dental supplier be few medical group hold well recent downturn thank business model depend more consumer spending government reimbursement patterson however be relative laggard compare such high rate stock align technology algn now ibd henry schein hsic patterson most direct competitor dentsply sirona xray give investor relatively low expectation stock relatively weaker year date quarter date performance vs henry schein stock react somewhat positively today write evercore isi analyst ross muken note market open patterson stock be close stock market today be more earlier even news be mixed adjust earning rise year earlier quarter cent share beating analyst consensus cent accord thomson reuter revenue period end april be slightly estimate patterson guide fiscal share midpoint previous year line consensus mark fourth quarter row double digit profit revenue growth patterson stretch decline ibd ep rank be strong relative strength rating be weak thursday move henry schein stock be close thursday
356,ALGN,large cap mutual fund outperformed small cap midcap fund past year slow global economic growth investor seek relative safety stock bigger company deeper pocket firm be better position withstand unpleasant shock market unveil also bigger company gobble smaller rival fall hard time large cap have look attractive doubt gdp growth other develop market group large cap mutual fund notch average annual gain past year easily outran midcap rival average annual return wallop average annual advance post small cap fund have bet solely more heavily large cap fund other category recent year have be boon overall portfolio retirement plan broad market volatility stem wo oil patch worry weaken energy company impact lender doubt china growth year alone have be tough only midcap fund group be positive territory meager vs setback large cap fund slide small cap entire year have invest cross section large cap fund march now be worth same amount have grow average midcap fund average small cap fund ab large cap growth fund apgax run firm used be know be top perform large cap fund past year rac average annual gain same span averaged annual gain talk sizzle ab large cap growth be ibd best mutual fund award winner outperform year period end dec fund manager frank caruso discuss investment approach detail recently ibd fund manager question answer feature report recent holding be light product maker acuity brand ayi have help fund turn wattage performance lead product be see strong demand share price be past week midday friday acuity brand be buy range alternate entry remain extend prior buy point stock have hold key test price level stock have composite rating ibd composite rating combine ibd performance rating include ep relative strength rating be highest dec acuity complete acquisition juno light group maker lead base track light fixture april acuity report profit february end fiscal second quarter share be nicely consensus estimate sale rise analyst be modele earning share rise prior quarters stock dividend yield be adobe system adbe be hold strong comp rating case share be past week early afternoon friday adobe system be close cup handle buy point ibd market team note volume have dry handle form be positive earlier past handle entry base be successful point view stock be extend however argue right side stock base need more work image editing pdf software giant have make successful transition allow customer receive product cloud pay subscription fee adobe fiscal second quarter end wall street see earning rise cent share extend slowdown ep gain grow prior quarters still represent robust profit growth dental product firm align technology algn be past week ep grow past quarters prior ep shrank straight stanzas company product be used treat misalignment tooth american teen overseas market give tooth realignment expert opportunity stock have comp rating
357,ALGN,huge medical sector be low rate show pocket strength sector include drugmaker manage care many other health related stock be rank friday normally lead stock top few sector have best chance success doesn mean weak sector lack potential winner
358,ALGN,load player zimmer biomet zbh be close new buy zone medical product industry group rise ranking week today maker orthopedic reconstructive product have composite rating earn spot industry leader such align technology algn cambrex cbm edward
359,ALGN,month double dip market correction hardest hit industry have be medicine presidential election debate high drug price health care policy general have give investor jitter soft guidance most recent round earning report didn help matter notable exception have be stock involved dentistry not many
360,ALGN,macom technology solution mtsi hit new high monday couldn quite hold close middle daily range end session volume be average second straight day friday macom break double bottom base buy point be still point market rally
361,ALGN,several growth stock pop list stock hit new high friday breaking field dominate utility other defensive name ibd leaderboard stock facebook fb garner most attention rise volume be heavy social medium giant clear buy point irregular shape base relative strength line
362,ALGN,stock extend gain early friday afternoon weaker expect gdp report suggest federal reserve slow pace interest rate hike dow jone industrial average rise climb nasdaq add volume stock market today be run lower board compare same time thursday economy grow
363,ALGN,morgan stanley analyst bet be right stock be poise rally next week base believe be positive term catalyst top pick range silicon valley social medium icon facebook fb old school new jersey petroleum refiner supplier pbf energy pbf other morgan stanley high conviction list go fourth quarter earning season include chip gear supplier lam research lrcx enterprise datum storage firm pure storage pstg canadian telco medium company bce bce other cable operator amc network amcx paint company sherwin william shw cloud networking specialist arista network anet dental tech supplier align technology algn shopify shop provide cloud base management platform small midsize retailer analyst cover stock have view diverge street report say facebook analyst brian nowak expect strong ad revenue growth fourth quarter positive earning revision come also see year instagram platform add more incremental revenue catalyst cite political ad spending facebook report earning jan morgan stanley view be consensus earning revenue price target be lam research morgan expect company continue outpace overall capital spending level potential upside driver cite be china interest chip manufacturing intel intc ramp internal memory manufacturing potential competition new chip device structure amc network deliver peer ad revenue growth recent content success include term durability ad revenue walking dead series monetization new original programming badland morgan stanley note see pure storage benefitting fast adoption flash array sherwin william best position gain share architectural paint cycle believe have more room grow analyst expect follow marilyn alva twitter ibd_malva
364,ALGN,stock turn mixed midday monday round similarly mixed earning report well economic report foreign domestic
365,ALGN,nasdaq turn loss gain biotechs software issue outperformed pare deficit dow jone industrial average fall volume be tracking sharply lower board stock market today compare same time friday
366,ALGN,highly rate stock globant glob rally nearly time high clear buy point heavy trading hour session thin stock already match day average volume
367,ALGN,nike nke climb more new high be upgrade buy hold bb now past buy point athletic apparel footwear giant be recently mentioned new high column
368,ALGN,downside microsemi mscc drop news offer buy pmc sierra pmcs bid top buyout offer apple aapl supplier skywork solution swks microsemi fall buy point consolidation clear friday pmc share jump
369,ALGN,valeant vrx slump beating view raise guidance open canadian drugmaker post adjust earning share year sale grow third straight period acceleration almost lift full year sale forecast
370,ALGN,profit be now expect share prior outlook last week valeant say receive subpoena federal prosecutor massachusett new york request information patient assistance program drug pricing decision
371,ALGN,follow vincent mao twitter ibd_vmao stock turn mixed midday monday round similarly mixed earning report well economic report foreign domestic nasdaq turn loss gain biotechs software issue outperformed pare deficit dow jone industrial average fall volume be tracking sharply lower board stock market today compare same time friday highly rate stock globant glob rally nearly time high clear buy point heavy trading hour session thin stock already match day average volume nike nke climb more new high be upgrade buy hold bb now past buy point athletic apparel footwear giant be recently mentioned new high column downside microsemi mscc drop news offer buy pmc sierra pmcs bid top buyout offer apple aapl supplier skywork solution swks microsemi fall buy point consolidation clear friday pmc share jump valeant vrx slump beating view raise guidance open canadian drugmaker post adjust earning share year sale grow third straight period acceleration almost lift full year sale forecast profit be now expect share prior outlook last week valeant say receive subpoena federal prosecutor massachusett new york request information patient assistance program drug pricing decision follow vincent mao twitter ibd_vmao
372,ALGN,stock be session high late friday pace snap day slide
373,ALGN,nasdaq rise dow jone industrial average climb small cap fared even better russell rally
374,ALGN,volume be tracking mixed option expiration nyse trade be tracking higher nasdaq volume be run lower
375,ALGN,stock tessera technology tsra rally regain day line heavy trading late thursday chip designer say settle patent dispute amkor technology amkr amkor pay tessera total quarterly payment share amkor rise stock market today
376,ALGN,bitauto bita rise poke back day line still poise weekly loss earlier week china association automobile manufacturer report chinese auto sale grow
377,ALGN,downside bj restaurant bjri slump nearly thursday company report preliminary sale vs view earlier friday security downgrade share hold buy lower price target
378,ALGN,align technology algn drop heavy trading trim loss find support day line still align be track fourth straight loss maker clear brace report earning jan analyst see profit slip cent share stock be session high late friday pace snap day slide nasdaq rise dow jone industrial average climb small cap fared even better russell rally volume be tracking mixed option expiration nyse trade be tracking higher nasdaq volume be run lower stock tessera technology tsra rally regain day line heavy trading late thursday chip designer say settle patent dispute amkor technology amkr amkor pay tessera total quarterly payment share amkor rise stock market today bitauto bita rise poke back day line still poise weekly loss earlier week china association automobile manufacturer report chinese auto sale grow downside bj restaurant bjri slump nearly thursday company report preliminary sale vs view earlier friday security downgrade share hold buy lower price target align technology algn drop heavy trading trim loss find support day line still align be track fourth straight loss maker clear brace report earning jan analyst see profit slip cent share
379,ALGN,stock overcome early volatility finish higher friday first time session nasdaq bolt close back level be finished back mark energy stock be strong friday crude oil jump more barrel dow jone industrial average rally accord preliminary figure volume end mixed stock market today nyse turnover rise nasdaq trade dip market gain few lead stock rise big volume friday alexion pharmaceutical alxn reversed higher gain fast trade end session lose streak alexion find support week move average week hdfc bank hdb add new high follow thursday past buy point flat base downside align technology algn slump nearly heavy trading trim loss find support day line still align fall fourth straight day friday maker clear brace report earning jan analyst see profit growth slip cent share gopro gpro pare loss still plunge week mark worst weekly performance come public june fear competition apple aapl have hammer share lead maker wearable camera
380,ALGN,stock get positive start then fall mild loss early friday surprise jump january consumer sentiment dow jone industrial average be slip nasdaq ease volume rise nasdaq nyse compare trade same time thursday stock market today appear shed weak premarket posture open higher strong trade dow be first drop negative territory weigh intel intc caterpillar cat wal mart wmt early consumer price datum be not positive least line expectation show bulk month decline owing gasoline price federal reserve report industrial production ease december november jump line economist projection utilization factory capacity be just expectation university michigan deliver good news initial estimate january consumer sentiment jump be december well forecast read stock activision blizzard atvi spiked lead nasdaq exxon mobil xom chevron cvx top dow more oil price pull back early gain raft earning report big bank stir share friday early action suntrust bank sti surge top pnc financial service group pnc pop higher brokerage charle schwab schw gain fraction goldman sachs gs dip oilfield service shaker schlumberger slb ride nearly report late thursday earning top expectation revenue growth stop short view company announce cut capital expenditure lay worker stock be early july high lead stock post healthy start ibd list stock move higher open ambarella amba lead group advance maker chip used gopro gpro other digital video camera be rebound straight loss left stock end thursday session just short test week move average gopro share be nearly friday trading early october high loss ibd list be mild deepest cut be drop align technology algn
381,ALGN,share medical equipment maker cyberonic cybx fall sharply report mixed fourth quarter estimate earning estimate full year be lighter expect rolled variety new device maker implantable device treat epilepsy depression other neurological disease say earning share rise vs year cent penny more estimate revenue grow wall street expect full year cyberonic see ep consensus analyst poll thomson reuter be share company light earning projection come shift management higher spending launch several new product april medical device maker name hoare newly create position chief operate officer neill cruz chief medical officer other medical gear maker include highly rate invisalign clear brace maker align technology algn stock be ibd list top rate stock spine disorder treatment gear maker globus medical gmed cyberonic make highly specialize equipment cyberonic make monitoring device system deliver mild electrical pulse vagus nerve patient neck send signal brain cyberonic new aspiresr brand pulse generator treatment epilepsy depression be approve europe february communication food drug administration determine next step approval aspiresr generator be underway cyberonic ceo dan moore say wednesday earning announcement moore have say earlier company be make significant multiyear investment sale force technology pipeline support rollout cyberonic new centro proguardian system be also near submission regulatory agency approval plunge much time usual trading volume cyberonic share be late morning trading stock market today wednesday small company have be steady eddie grow consistent pace last year annual revenue have grow stock price rise early june high feb year begin retreat sync market correction other company company medical product group medical equipment giant medtronic mdt largest group market cap be fractionally baxter international bax fall align technology globus medical be follow james detar twitter ibd_jdetar
382,ALGN,sometimes stock isn just simply form base make pullback case align technology algn be stock have pull back recent week follow huge earning pop oct align be find support week move average be second pullback breaking past buy point july align retreat heavy volume have take accumulation distribution rating neutral gauge institutional buy selling be october stock bolt record high stock correct less more week align also be consider be form flat base traditional buy point flat base be still way ahead alternative entry exist not much difference san jose calif company be best know bread butter invisalign clear brace alternative metal brace roughly comparable cost invisalign sale account more total revenue align also make scanner provide digital service dentist orthodontist new material invisalign system introduce early year realine aligner introduce june be help drive growth firm have rough spot late early year profit fall last year be flat first quarter year sale rise period earning have bounce back align deliver profit growth respectively current quarter analyst poll thomson reuter expect earning cent share year mark quarter accelerate growth
383,ALGN,have brace kid probably remember weave metal bracket wire well align technology algn have develop alternative way straighten tooth earlier year firm introduce new material invisalign clear aligner system call smarttrack be make highly elastic material keep shape
384,ALGN,time stock break conviction refuse give gain worth watch align technology algn soar week end oct company report exceptional third quarter earning be move sideway then hold bulk gain third quarter earning report show invisalign transparent brace tooth be see increase demand brace be clear removable appliance don rely use metal ceramic bracket wire year year growth be strong accelerate nicely second quarter earning rise cent share well consensus estimate cent sale rise gain prior period invisalign shipment rise growth be expect accelerate again current quarter company say expect fourth quarter volume growth sale growth analyst lift price target significantly number come cantor fitzgerald raise target jmp security lift target cadent holding subsidiary align technology provide digital scanning solution orthodontic dentistry interestingly short interest remain relatively high stock improve fundamental oct total short interest stand share base average daily volume just share take day cover entire short position high side stock high short interest make explosive move upside align show oct chartwise align need consolidate more new entry arise just start third week consolidation recent sideway action show flat base take shape here flat base need least week form
385,ALGN,perfectly shape cup base look symmetrical tea cup crack pattern let hard earn money drain away faulty base be warning sign stock fail matter great fundamental shape cup other basis be determine mainly buy selling action institutional investor ultimately determine stock fate align technology algn have respectable fundamental break cup base april also pattern be deep desirable range cup basis yet stock rolled soon clear buy point crash week line double average weekly volume way stock fall entry trigger sell rule close look align chart have reveal several flaw mentioned cup base be symmetrical left side pattern close possible mirror image right align cup be shape lopsided straight weekly decline left side follow only week right breakout occur stock shoot straight deep base new high be especially prone failure volume downside cup be higher upside indicate big fund lack enthusiasm stock near buy point risk factor be align base have form stock have already enjoy sharp run such later stage basis have lower chance success finally market few stock withstand correction least flaw align sell picked speed major average correct late april align never re-cover even market uptrend resume late align end april peak other flaw watch include wide loose action include weekly swing say more stock weekly high low big swing indicate battle be rage buyer seller also flagging relative strength line indicate stock be underperform overall market ideally stock rs line be hit new high break
386,ALGN,country lead fund past month continue add medical transportation stock portfolio stock market continue defy economy wall worry purchase be make nasdaq kick summer gain june rise big drug firm questcor pharmaceutical qcor shire ticker
387,ALGN,stock backed away early gain turn mixed first half hour friday session
388,ALGN,nasdaq backtrack narrow loss priceline pcln netflix nflx intuitive surgical isrg trade lower hold gain dow jone industrial average stand firm
389,ALGN,volume jump nasdaq nyse compare same time thursday
390,ALGN,stock market today jump early advance investor focuse positive side labor department march payroll report datum show payroll increase month better initial february number well new hire expect unemployment rate remain same vs expectation downtick
391,ALGN,anadarko petroleum apc climb putt ahead week woodland texas base oil gas producer agree pay settle toxic chemical claim related subsidiary spun kerr mcgee just prior acquisition anadarko
392,ALGN,week gain hoist anadarko month consolidation new high
393,ALGN,leader ibd stock moved start trade
394,ALGN,align technology algn bit gain early trade maker transparent dental brace announce international trade commission judge affirm earlier determination find patent have be infringe competitor clearcorrect judge issue cease desist order clearcorrect terminate investigation
395,ALGN,gain punch align back day move average continue rebound start monday stock day move average
396,ALGN,myriad genetic mygn jump add already healthy gain week salt lake city base provider genetic test be upgrade mizuho buy neutral stock have already soar week friday gap stock backed away early gain turn mixed first half hour friday session nasdaq backtrack narrow loss priceline pcln netflix nflx intuitive surgical isrg trade lower hold gain dow jone industrial average stand firm volume jump nasdaq nyse compare same time thursday stock market today jump early advance investor focuse positive side labor department march payroll report datum show payroll increase month better initial february number well new hire expect unemployment rate remain same vs expectation downtick anadarko petroleum apc climb putt ahead week woodland texas base oil gas producer agree pay settle toxic chemical claim related subsidiary spun kerr mcgee just prior acquisition anadarko week gain hoist anadarko month consolidation new high leader ibd stock moved start trade align technology algn bit gain early trade maker transparent dental brace announce international trade commission judge affirm earlier determination find patent have be infringe competitor clearcorrect judge issue cease desist order clearcorrect terminate investigation gain punch align back day move average continue rebound start monday stock day move average myriad genetic mygn jump add already healthy gain week salt lake city base provider genetic test be upgrade mizuho buy neutral stock have already soar week friday gap
397,ALGN,nasdaq fall hard friday institutional investor continue take profit growth stock half stock ibd fall more
398,ALGN,nasdaq take day move average conviction crater fall dow jone industrial average give visa microsoft msft be weakest performer dow fall
399,ALGN,nyse nasdaq volume be tracking higher thursday stock market today
400,ALGN,gold utility stock lead way otherwise ugly session
401,ALGN,ibd computer software medical group be day worst performer fall group leader athenahealth athn plunge gain point be now just
402,ALGN,auto manufacturer group lose hurt weakness tesla motor tsla share fall support week line tesla look promising earlier week be question now
403,ALGN,weakness biotech stock have be weigh nasdaq be more same friday ibd medical biom biotech group lose nearly feb high group be
404,ALGN,energy space anadarko petroleum apc buck trend rise share soar nearly thursday woodland texas base oil gas producer agree pay settle toxic chemical claim related subsidiary spun kerr mcgee just prior acquisition anadarko
405,ALGN,align technology algn add maker transparent dental brace receive favorable court ruling find patent have be infringe competitor clearcorrect
406,ALGN,economic news economy add job march consensus estimate unemployment rate be unchanged february job growth be revise higher initially report money flow bond market news year treasury yield fall basis point nasdaq fall hard friday institutional investor continue take profit growth stock half stock ibd fall more nasdaq take day move average conviction crater fall dow jone industrial average give visa microsoft msft be weakest performer dow fall nyse nasdaq volume be tracking higher thursday stock market today gold utility stock lead way otherwise ugly session ibd computer software medical group be day worst performer fall group leader athenahealth athn plunge gain point be now just auto manufacturer group lose hurt weakness tesla motor tsla share fall support week line tesla look promising earlier week be question now weakness biotech stock have be weigh nasdaq be more same friday ibd medical biom biotech group lose nearly feb high group be energy space anadarko petroleum apc buck trend rise share soar nearly thursday woodland texas base oil gas producer agree pay settle toxic chemical claim related subsidiary spun kerr mcgee just prior acquisition anadarko align technology algn add maker transparent dental brace receive favorable court ruling find patent have be infringe competitor clearcorrect economic news economy add job march consensus estimate unemployment rate be unchanged february job growth be revise higher initially report money flow bond market news year treasury yield fall basis point
407,ALGN,wall street rise second day tuesday leave major index just record high higher oil price boost energy stock dow jone industrial average rise nasdaq climb end latter finishing just time peak volume be higher nyse nasdaq compare monday accord preliminary datum
408,ALGN,stock market today oil producer pioneer natural resource pxd driller diamond offshore do rise lead oil price jump more just barrel strike oil worker brazil port shutdown libya
409,ALGN,noah holding noah lead ibd jump heavy volume climb right side deep base provider wealth management service china be due report result nov profit period be see rise cent share be biggest gain quarters
410,ALGN,medical product stock cambrex cbm rise more better expect earning report also climb right side new base
411,ALGN,post session trading luxury electric vehicle maker tesla motor tsla rise sharply narrower expect loss stock fall more regular session end week high
412,ALGN,share real estate zillow be hour follow result
413,ALGN,also close groupon gpn edge higher report provider discount retailer also announce coo rich william replace eric lefkofsky ceo lefkofsky become chairman
414,ALGN,lgi home lgih facebook fb epam system epam cognizant technology solution ctsh be company report quarterly earning wednesday
415,ALGN,economic report due wednesday include institute supply management index service sector activity october adp private sector payroll november crude oil inventory week end oct mortgage banker association index mortgage application week end oct wall street rise second day tuesday leave major index just record high higher oil price boost energy stock dow jone industrial average rise nasdaq climb end latter finishing just time peak volume be higher nyse nasdaq compare monday accord preliminary datum stock market today oil producer pioneer natural resource pxd driller diamond offshore do rise lead oil price jump more just barrel strike oil worker brazil port shutdown libya noah holding noah lead ibd jump heavy volume climb right side deep base provider wealth management service china be due report result nov profit period be see rise cent share be biggest gain quarters medical product stock cambrex cbm rise more better expect earning report also climb right side new base post session trading luxury electric vehicle maker tesla motor tsla rise sharply narrower expect loss stock fall more regular session end week high share real estate zillow be hour follow result also close groupon gpn edge higher report provider discount retailer also announce coo rich william replace eric lefkofsky ceo lefkofsky become chairman lgi home lgih facebook fb epam system epam cognizant technology solution ctsh be company report quarterly earning wednesday economic report due wednesday include institute supply management index service sector activity october adp private sector payroll november crude oil inventory week end oct mortgage banker association index mortgage application week end oct
416,ALGN,sometimes growth stock do exactly suppose do follow heavy volume hold gain trade tightly move sideway give sell signal whatsoever price action tend happen healthy bull market new money be come sideline breakout aren always easy handle sometimes run trouble quickly reverse heavy volume soon happen don have ibd flagship key sell rule trigger rule say always cut loss purchase price fail breakout be reason keep loss even smaller don see stock respond heavy volume reversal recognize institutional selling happen play defense cut loss purchase cut bait breakeven be perfectly acceptable stock doesn act right focus buy odd be favor make money be major average be confirm uptrend market uptrend pressure however mean distribution day higher volume decline be start increase frequency index buy environment be less likely bear fruit so keep overall market health mind buy be distribution day index cut loss quickly be often good strategy april align technology algn break powerfully cup shape base soar more double average volume next day ibd composite rating be ep rs yet instead extend gain follow day fall not ideal action reason sell close only buy point however distribution day be pile nasdaq align rally back light volume next few day briefly hit new high april stock reversed heavy volume fall fast trade be sign unequivocal institutional selling even close entry be need hold stock longer abnormal price action so soon align lose next month
417,ALGN,stock advanced lighter volume thursday close bullishly high day range nasdaq rise add ibd pop volume fall board full plate economic datum release friday have keep player sideline friday report include fourth quarter gdp chicago pmi survey
418,ALGN,stock future show healthy gain early tuesday europe market rebound oil price re-cover lows economic news be fair positive
419,ALGN,dow future trade point fair market value point hour earlier nasdaq future add early gain be point future moved point even hour earlier level
420,ALGN,stock market today have eye wednesday afternoon federal open market committee member head day powwow expectation be high policy shift group announce decision wednesday et
421,ALGN,consumer price be flat november labor department report be gain october line economist expectation core price food energy rise equal october increase meeting consensus projection
422,ALGN,manufacturing activity new york region slow improve rate december accord new york federal reserve empire state manufacturing survey show performance vs show november be better read expect economist
423,ALGN,national association home builder release builder confidence index treasury department report long term treasury international capital flow october
424,ALGN,oil price take modest bounce early trade lift west texas intermediate less brent crude more still trading barrel respectively late day recovery market monday fed rebound european market lead index bounce week lows send dax frankfurt cac paris more midday
425,ALGN,stock miner steel market be rebound issue vale vale arcelor mittal mt ahead more dow diversify operator mmm old minnesota mining manufacturing co tank more lower earning guidance chevron cvx top index premarket trade gain
426,ALGN,also notch worst loss stock network ffiv take second hardest hit bit more
427,ALGN,chipmaker nvidia nvda newell rubbermaid nwl southwestern energy swn top list better
428,ALGN,flooring retailer lumber liquidator ll bolt higher news report detailed letter kase capital management manage partner whitney tilson declare have cover short position stock
429,ALGN,tilson have weigh company follow allegation flooring contain unsafe level formaldehyde tilson conclude management probably do not know problem accord bloomberg mean company be sloppy naive not evil tilson write stock end monday news investigation break february
430,ALGN,lead stock stick moderate move premarket action hawaiian top ibd list slightly more premarket trade dave buster play stake low end loss stock future show healthy gain early tuesday europe market rebound oil price re-cover lows economic news be fair positive dow future trade point fair market value point hour earlier nasdaq future add early gain be point future moved point even hour earlier level stock market today have eye wednesday afternoon federal open market committee member head day powwow expectation be high policy shift group announce decision wednesday et consumer price be flat november labor department report be gain october line economist expectation core price food energy rise equal october increase meeting consensus projection manufacturing activity new york region slow improve rate december accord new york federal reserve empire state manufacturing survey show performance vs show november be better read expect economist national association home builder release builder confidence index treasury department report long term treasury international capital flow october oil price take modest bounce early trade lift west texas intermediate less brent crude more still trading barrel respectively late day recovery market monday fed rebound european market lead index bounce week lows send dax frankfurt cac paris more midday stock miner steel market be rebound issue vale vale arcelor mittal mt ahead more dow diversify operator mmm old minnesota mining manufacturing co tank more lower earning guidance chevron cvx top index premarket trade gain also notch worst loss stock network ffiv take second hardest hit bit more chipmaker nvidia nvda newell rubbermaid nwl southwestern energy swn top list better flooring retailer lumber liquidator ll bolt higher news report detailed letter kase capital management manage partner whitney tilson declare have cover short position stock tilson have weigh company follow allegation flooring contain unsafe level formaldehyde tilson conclude management probably do not know problem accord bloomberg mean company be sloppy naive not evil tilson write stock end monday news investigation break february lead stock stick moderate move premarket action hawaiian top ibd list slightly more premarket trade dave buster play stake low end loss
431,ALGN,share align technology algn pop time high stock market friday company beat analyst estimate even guide low side align late thursday say profit rise year earlier quarter cent share beating estimate cent sale climb
432,ALGN,stock be bounce lows afternoon trading stock market today buyer make late push
433,ALGN,nasdaq be seek support day move average have be much be flirt positive territory dow reversed gain volume be tracking sharply lower nyse higher nasdaq vs friday accord preliminary datum
434,ALGN,build residential commercial machinery construction equipment maker be few group post gain printer maker biotechs top downside
435,ALGN,few leader be show resilience
436,ALGN,qihoo technology qihu fall day line earlier monday rebound be trading higher average volume be work base buy point october
437,ALGN,actavis act also reversed intraday loss be more heavier trade drugmaker stock be recent high be still hold buy point week tight clear early last month
438,ALGN,michael kor kor rise regain day line first time nearly week share have give gain flat base buy point be now level
439,ALGN,downside align technology algn be trading lower busy turnover breach day first time dec have trim intraday loss earlier drop stock be bounce lows afternoon trading stock market today buyer make late push nasdaq be seek support day move average have be much be flirt positive territory dow reversed gain volume be tracking sharply lower nyse higher nasdaq vs friday accord preliminary datum build residential commercial machinery construction equipment maker be few group post gain printer maker biotechs top downside few leader be show resilience qihoo technology qihu fall day line earlier monday rebound be trading higher average volume be work base buy point october actavis act also reversed intraday loss be more heavier trade drugmaker stock be recent high be still hold buy point week tight clear early last month michael kor kor rise regain day line first time nearly week share have give gain flat base buy point be now level downside align technology algn be trading lower busy turnover breach day first time dec have trim intraday loss earlier drop
440,ALGN,facebook fb align technology algn mastercard be ibd stock slate report quarterly result week earning season begin shift more market leader
441,ALGN,other ibd stock deck include la vegas sand lvs armour ua here analyst expect do
442,ALGN,top social network facebook ibd be lose user grow number accord recent report market research firm istrategylab facebook financial number don show last year earning share growth accelerate whopping
443,ALGN,site instagram photo video sharing service growth mobile video advertising be expect propel result further
444,ALGN,facebook be also proprietary ibd leaderboard list top rate stock be slate report earning wednesday wall street expect revenue surge ep climb cent
445,ALGN,align technology invisalign be market leader clear invisible brace market recent product launch include smarttrack highly elastic material maintain shape exert more constant force invisalign aligner
446,ALGN,have also rolled realine entry level clear aligner general practitioner use help minor crowd spacing issue
447,ALGN,wall street project align rank ibd report hike revenue ep surge cent announce result thursday
448,ALGN,armour report thursday outlook be earning advance cent revenue be see climb
449,ALGN,grow rapidly sportswear become more acceptable wear restaurant shop even office company be also advance performance wear further recently launch coldgear infrared line clothing absorb retain body heat
450,ALGN,tuesday inked deal notre dame end school year affiliation adida term weren disclose
451,ALGN,la vegas sand lvs world biggest casino company be slate report earning wednesday growth have zoom expand operation macau gamble enclave china south coast top global gamble playground consensus be ep swell cent revenue rise
452,ALGN,analyst also expect upcoming lunar new year draw bigger crowds gambler macau casino ramp offering middle market tourist
453,ALGN,mastercard report friday rival visa come roar great recession consumer confidence credit card use return
454,ALGN,mastercard have report double digit profit growth least outlook be hike ep cent revenue be see rise stock climb have consolidated first year
455,ALGN,related
456,ALGN,illumina jazz young gun hit new high
457,ALGN,ibd qihoo facebook lead top internet earning
458,ALGN,follow james detar twitter ibd_jdetar facebook fb align technology algn mastercard be ibd stock slate report quarterly result week earning season begin shift more market leader other ibd stock deck include la vegas sand lvs armour ua here analyst expect do top social network facebook ibd be lose user grow number accord recent report market research firm istrategylab facebook financial number don show last year earning share growth accelerate whopping site instagram photo video sharing service growth mobile video advertising be expect propel result further facebook be also proprietary ibd leaderboard list top rate stock be slate report earning wednesday wall street expect revenue surge ep climb cent align technology invisalign be market leader clear invisible brace market recent product launch include smarttrack highly elastic material maintain shape exert more constant force invisalign aligner have also rolled realine entry level clear aligner general practitioner use help minor crowd spacing issue wall street project align rank ibd report hike revenue ep surge cent announce result thursday armour report thursday outlook be earning advance cent revenue be see climb grow rapidly sportswear become more acceptable wear restaurant shop even office company be also advance performance wear further recently launch coldgear infrared line clothing absorb retain body heat tuesday inked deal notre dame end school year affiliation adida term weren disclose la vegas sand lvs world biggest casino company be slate report earning wednesday growth have zoom expand operation macau gamble enclave china south coast top global gamble playground consensus be ep swell cent revenue rise analyst also expect upcoming lunar new year draw bigger crowds gambler macau casino ramp offering middle market tourist mastercard report friday rival visa come roar great recession consumer confidence credit card use return mastercard have report double digit profit growth least outlook be hike ep cent revenue be see rise stock climb have consolidated first year related illumina jazz young gun hit new highsibd qihoo facebook lead top internet earningsfollow james detar twitter ibd_jdetar
459,ALGN,stock fall open continue selling session concern emerge market slower growth china lower federal reserve stimulus
460,ALGN,nasdaq sank dow industrial latter index break support day move average volume swell board accord preliminary datum result second straight distribution day major index
461,ALGN,none industry group track ibd score gain stock market today biggest loser include telecom consumer product solar stock casino operator
462,ALGN,la vegas sand lvs plunge heavy trade breach day move average first time august other casino operator macau exposure continue slide jpmorgan report wednesday spark growth concern gamble enclave
463,ALGN,align technology algn sank twice normal volume give gain past flat base buy point earlier month
464,ALGN,china distance education dl tumble shedding nearly gain past session thinly trade chinese provider online education test prep course have advanced straight session
465,ALGN,synaptic syna be few winner rise much intraday close gain feltl upgrade touch interface supplier miss earning beat sale late thursday buy hold stock fall open continue selling session concern emerge market slower growth china lower federal reserve stimulus nasdaq sank dow industrial latter index break support day move average volume swell board accord preliminary datum result second straight distribution day major index none industry group track ibd score gain stock market today biggest loser include telecom consumer product solar stock casino operator la vegas sand lvs plunge heavy trade breach day move average first time august other casino operator macau exposure continue slide jpmorgan report wednesday spark growth concern gamble enclave align technology algn sank twice normal volume give gain past flat base buy point earlier month china distance education dl tumble shedding nearly gain past session thinly trade chinese provider online education test prep course have advanced straight session synaptic syna be few winner rise much intraday close gain feltl upgrade touch interface supplier miss earning beat sale late thursday buy hold
466,ALGN,market condition weaken week lead medical stock have also lose ground actavis act align technology algn be have tough week so far be breaking support level actavis slightly breach level thursday do so light trade round number act key level support resistance stock find
467,ALGN,stock be hold intraday high midpoint wednesday session
468,ALGN,nasdaq rise fresh year high rally hit record high intraday meanwhile dow jone industrial average outperformed gain component be higher volume be tracking higher board stock market today
469,ALGN,align technology algn rise fast trade stage big upside reversal tuesday now nearly past early buy point flat base stock relative strength line have hit new high ahead price be bullish
470,ALGN,unite rental uri gap gain hit time high lift put past buy point week tight pattern
471,ALGN,nu skin enterprise nus stretched loss share nutrition beauty product marketer plunge follow negative article person daily email statement bloomberg nu skin have say article contain inaccuracy exaggeration stock have fall more buy point week tight pattern
472,ALGN,exone xone be session low be still huge volume gap day line tumble much cut revenue outlook late tuesday stock trim loss find support day move average canaccord downgrade share hold buy lower price target stock be hold intraday high midpoint wednesday session nasdaq rise fresh year high rally hit record high intraday meanwhile dow jone industrial average outperformed gain component be higher volume be tracking higher board stock market today align technology algn rise fast trade stage big upside reversal tuesday now nearly past early buy point flat base stock relative strength line have hit new high ahead price be bullish unite rental uri gap gain hit time high lift put past buy point week tight pattern nu skin enterprise nus stretched loss share nutrition beauty product marketer plunge follow negative article person daily email statement bloomberg nu skin have say article contain inaccuracy exaggeration stock have fall more buy point week tight pattern exone xone be session low be still huge volume gap day line tumble much cut revenue outlook late tuesday stock trim loss find support day move average canaccord downgrade share hold buy lower price target
473,ALGN,monday market tumble result spate high volume downside reversal leader highlighted today column continue hold nicely entry point still market uptrend now pressure keep mind buy tend be more risky confirm uptrend align technology algn fall monday heavier trade then dip early tuesday find support week move average be buy range jan leaderboard stock clear early buy point flat base analyst expect invisible brace maker report jump fourth quarter ep cent sale increase give result jan close medicine co mdco spiked new intraday high monday sharp reversal bring back week line second time past entry pullback support level sometimes offer opportunity buy add share initial new jersey base biotech make clot drug angiomax boast composite earning share rating profit growth have hold better past quarters analyst see drop cent share facebook fb hasn make much headway clear entry cup shape base dec have hold steadily buy range online social network also leaderboard member be slate report result jan close consensus forecast call hike ep cent gun maker sturm ruger rgr buck monday sell rise tuesday extend streak seventh straight session advance share remain just buy range breaking last week late stage cup base
474,ALGN,optimism be operative word wall street tuesday nasdaq snap session lose streak solid gain nasdaq gap open stay strong day composite rise small cap add ibd jump outperform broad market index
475,ALGN,major stock index be lower unison midday monday tech stock bore brunt selling nasdaq pierce day move average
476,ALGN,nasdaq lose fall
477,ALGN,jump caterpillar cat report better expect earning dow be blue chip index be much intraday
478,ALGN,nasdaq nyse volume be tracking lower friday stock market today nasdaq volume fall nyse volume be lower
479,ALGN,many leader remain pressure stock ibd be underwater
480,ALGN,bitauto bita tumble putt further day move average stock have stumble more buy point late stage cup base gain have be large
481,ALGN,align technology algn slump slice day line fast trade lack specific company news align have already trade more average daily volume nearly share now early buy point flat base have be much past trigger maker invisalign clear brace report earning thursday analyst poll thomson reuter see profit rise cent share
482,ALGN,yandex yndx reversed early gain fall month low heavy trading friday stock drop more buy point cup handle base sell signal loss be cut amount most
483,ALGN,upside qihoo qihu reversed higher rise stock find support day move average bigger picture qihoo be third stage cup base buy point major stock index be lower unison midday monday tech stock bore brunt selling nasdaq pierce day move average nasdaq lose fall jump caterpillar cat report better expect earning dow be blue chip index be much intraday nasdaq nyse volume be tracking lower friday stock market today nasdaq volume fall nyse volume be lower many leader remain pressure stock ibd be underwater bitauto bita tumble putt further day move average stock have stumble more buy point late stage cup base gain have be large align technology algn slump slice day line fast trade lack specific company news align have already trade more average daily volume nearly share now early buy point flat base have be much past trigger maker invisalign clear brace report earning thursday analyst poll thomson reuter see profit rise cent share yandex yndx reversed early gain fall month low heavy trading friday stock drop more buy point cup handle base sell signal loss be cut amount most upside qihoo qihu reversed higher rise stock find support day move average bigger picture qihoo be third stage cup base buy point
484,ALGN,just miss leader run doesn mean stop watch lead stock often take breather offer opportunity buy even big move need be ready pull trigger rise reach little day
485,ALGN,stock fall early monday pare loss still finished lower session
486,ALGN,nasdaq continue lose streak new year loss third straight decline dow industrial give preliminary result show higher volume board add distribution day major index
487,ALGN,decliner lead advancer ratio nasdaq be even nyse
488,ALGN,still leader manage post breakout gain stock market today
489,ALGN,align technology algn jump clear flat base triple normal volume end buy point analyst expect maker invisible brace grow fourth quarter ep report result later month
490,ALGN,natus medical baby surge busy trade break week flat base continue rebound day move average now past entry point
491,ALGN,envestnet env rise new high clear week consolidation entry web base investment adviser be also level
492,ALGN,downside select comfort scss gap fall huge turnover mattress maker warn fourth quarter earning miss forecast share be week high
493,ALGN,tuesday economic report include retail datum red book international council shopping center goldman sachs stock fall early monday pare loss still finished lower session nasdaq continue lose streak new year loss third straight decline dow industrial give preliminary result show higher volume board add distribution day major index decliner lead advancer ratio nasdaq be even nyse still leader manage post breakout gain stock market today align technology algn jump clear flat base triple normal volume end buy point analyst expect maker invisible brace grow fourth quarter ep report result later month natus medical baby surge busy trade break week flat base continue rebound day move average now past entry point envestnet env rise new high clear week consolidation entry web base investment adviser be also level downside select comfort scss gap fall huge turnover mattress maker warn fourth quarter earning miss forecast share be week high tuesday economic report include retail datum red book international council shopping center goldman sachs
494,ALGN,stock market close lower monday retailer have bumpy session nasdaq dow jone industrial average fall slip volume rise be surprise friday half session decline stock lead advancer nyse nasdaq stock market today transportation medical retail industry group be weakest monday energy mining stock be strongest lululemon athletica lulu gap loss sink right back day move average analyst fbr capital market downgrade lululemon underperform market perform cut price target investor grow pessimistic early holiday shopping indication other retailer sell heavy trading include ulta beauty ulta urban outfitter urbn regeneron pharmaceutical regn have worst loss ibd bid past buy point have unraveled close unitedhealth group unh say be back forecast earning share revenue be project be health insurer warn nov earning hit obamacare exchange related business cite higher medical cost individual market customer soft enrollment outlook unitedhealth share rise slightly extend trading several economic report be due tuesday manufacturing report purchasing manager institute supply management be due morning automaker report november sale earning report tuesday include fifth street finance fsc guidewire software gwre follow juan carlos arancibia twitter ibd_jarancibia
495,ALGN,haven be do well market lately maybe growth stock have abandon leadership tale be tell relative strength line ibd index measure performance stock outstanding technical fundamental factor relative strength line be carved ratio index change
496,ALGN,look back ahead printing industry burst mainstream backer say ain see nothin yet innovation draw board fast emerge type manufacturing be amazing little frightening printer make food not wild enough printer
497,ALGN,health care company be expect post highest profit gain ibd fourth quarter result start pile week specifically several drug manufacturer be see report earning share increase period align technology algn make invisible dental brace be expect announce surge profit
498,ALGN,stock remain red late trading wednesday be pace snap day streak
499,ALGN,hurt biotechs software issue nasdaq drop dow jone industrial average fall respectively volume be tracking lower board stock market today
500,ALGN,vmware vmw gap day move average slump late tuesday company report better expect earning sale license booking show weakness
501,ALGN,netflix nflx drop erase more half tuesday advance share bolt tuesday reaction late monday better expect quarterly earning news price hike
502,ALGN,upside sodastream international soda erased earlier loss pop report say starbucks sbux be talk buy stake company sodastream hit month high starbucks share slip
503,ALGN,skywork solution swks be session high still solid report better expect earning sale late tuesday stock hit best level more year
504,ALGN,apple aapl align technology algn citrix system ctrx trade financial etfc network ffiv facebook fb nxp semiconductor nxpi reilly automotive orly assignment asgn qualcomm qcom td ameritrade amtd tractor supply tsco xilinx xlnx be slew company report earning close stock remain red late trading wednesday be pace snap day streak hurt biotechs software issue nasdaq drop dow jone industrial average fall respectively volume be tracking lower board stock market today vmware vmw gap day move average slump late tuesday company report better expect earning sale license booking show weakness netflix nflx drop erase more half tuesday advance share bolt tuesday reaction late monday better expect quarterly earning news price hike upside sodastream international soda erased earlier loss pop report say starbucks sbux be talk buy stake company sodastream hit month high starbucks share slip skywork solution swks be session high still solid report better expect earning sale late tuesday stock hit best level more year apple aapl align technology algn citrix system ctrx trade financial etfc network ffiv facebook fb nxp semiconductor nxpi reilly automotive orly assignment asgn qualcomm qcom td ameritrade amtd tractor supply tsco xilinx xlnx be slew company report earning close
505,ALGN,maker medical device be come increase pressure owing fundamental power shift american medicine favore insurance company hospital patient change accord moty avisar president medical system maker surgical theater be base patient be force soar medical cost take control health care let say patient be
506,ALGN,stock start higher open hold most gain session federal reserve datum show economy continue expand
507,ALGN,fed district see moderate growth late november year end october early november accord beige book survey third district report hire increase
508,ALGN,nasdaq outperformed gain mark fresh year high dow industrial rise volume be higher board accord preliminary datum
509,ALGN,leader align technology algn add new close high twice normal trade invisible brace maker be now past early entry point flat base
510,ALGN,invensense invn rise heavy volume continue work handle cup shape base just shy handle buy point sound handle usually form light trade
511,ALGN,unite rental uri rally time high big turnover rise past buy point week tight pattern
512,ALGN,day biggest loser include nu skin enterprise nus negative report china person daily online payment system operator qiwi qiwi sank report russian regulator be mull restraint cross border electronic payment have hurt stock stock start higher open hold most gain session federal reserve datum show economy continue expand fed district see moderate growth late november year end october early november accord beige book survey third district report hire increase nasdaq outperformed gain mark fresh year high dow industrial rise volume be higher board accord preliminary datum leader align technology algn add new close high twice normal trade invisible brace maker be now past early entry point flat base invensense invn rise heavy volume continue work handle cup shape base just shy handle buy point sound handle usually form light trade unite rental uri rally time high big turnover rise past buy point week tight pattern day biggest loser include nu skin enterprise nus negative report china person daily online payment system operator qiwi qiwi sank report russian regulator be mull restraint cross border electronic payment have hurt stock
513,ALGN,medical stock align technology algn actavis act be buy point number spotlight stock consolidate get support week line actavis be buy range rebound week line also just buy point week tight pattern clear entry dec volume be
514,ALGN,stock highly rank medical system equipment group be show bullish action hold high align technology algn maker clear dental brace lead trio composite rating just shy best possible other cepheid cphd natus medical baby boast rating
515,ALGN,choppy market be uncertain market time investor need shift strategy maybe ve have good year so far most stock turn better gain maybe be just start high aim be confident market be set move higher case distribution day quickly stack major index stall market rapidly turn correct market don let comfort overconfidence keep adopt proper stance key shift strategy be ratchet expectation gain healthy market normally shoot minimum gain ride get rough sell thing get even more dicey tamp expectation even further gain tough market be gain even tiny loss hand beat be trap correct stock wait see allow recover lose capital be especially true market turn follow launch uptrend take small gain be more likely leave cash ready positive state tap stock start new uptrend need caution be double market turn choppy earning season let say buy align technology algn come flat base last year early september market be uptrend align quickly run then pull back market turn choppy begin rac distribution day late september investor read big picture see be demonstrate stall action grow sign heavy institutional selling time align be nearly time peak hold day line stock holder significant price cushion have be watch align bounce higher first couple day october be clear overall market be have trouble distribution day be mount market gain occur weak volume align flash real sell sign show sign struggle try stab higher weak volume oct not match high volume be weak reversed lower stock fall back test day line support market outlook shift uptrend pressure market close oct next day market fall hard again ibd market pulse switch outlook correction be red alert stock push almost buy point flat volume oct be good time take profit call day result be due weak report ep just sale set share day line massive trade collapse next session
516,ALGN,general market condition improve more lead stock be get proper buy zone be extend still bear watch pull back herbalife hlf be past buy point handle double bottom base stock initially break dec heavy trading fall buy
517,ALGN,stock further perked late tuesday be track end session slide major index have already re-cover monday loss then
518,ALGN,help mining energy stock surge dow jone industrial average rally nasdaq gain volume be run higher board stock market today
519,ALGN,masco mas gap day line surge company top view earlier stock market today share clear buy point flat base masco make behr paint delta faucet showerhead well denova countertop
520,ALGN,jazz pharmaceutical jazz rally nearly new high stock take buy point flat base jazz have clear several basis september have not produce big gain
521,ALGN,becton dickinson bdx rise fast trade month high share pass buy point cup handle base maker medical supply device report fiscal earning aug analyst poll thomson reuter see profit rise share snap quarters single digit growth march becton dickinson complete buyout carefusion
522,ALGN,leader volume be few ellie mae elli have trim loss stock find support day line nearly return buy point flat base intraday
523,ALGN,akamai technology akam buffalo wild wing bwld citrix system ctxs edward lifescience ew gilead science gild macom mtsi panera bread pnra sturm ruger rgr sunpower spwr twitter twtr yelp yelp be notable company report earning close stock further perked late tuesday be track end session slide major index have already re-cover monday loss then help mining energy stock surge dow jone industrial average rally nasdaq gain volume be run higher board stock market today masco mas gap day line surge company top view earlier stock market today share clear buy point flat base masco make behr paint delta faucet showerhead well denova countertop jazz pharmaceutical jazz rally nearly new high stock take buy point flat base jazz have clear several basis september have not produce big gain becton dickinson bdx rise fast trade month high share pass buy point cup handle base maker medical supply device report fiscal earning aug analyst poll thomson reuter see profit rise share snap quarters single digit growth march becton dickinson complete buyout carefusion leader volume be few ellie mae elli have trim loss stock find support day line nearly return buy point flat base intraday akamai technology akam buffalo wild wing bwld citrix system ctxs edward lifescience ew gilead science gild macom mtsi panera bread pnra sturm ruger rgr sunpower spwr twitter twtr yelp yelp be notable company report earning close
524,ALGN,new high be show encourage sign re not yet unmistakably bullish nature investor dig bit find new high involve breakout new high represent good follow action breakout other time new high score aggressive fashion be recent buy point buy zone be good tally combine new high nasdaq nyse isn yet strong level tuesday canada base valeant pharmaceutical vrx become latest stock quit play hamlet buy point thrust ahead confidently stock rise volume triple usual rate valeant make new high clear buy point stock be now extend buy zone run mean valeant not be buy extend stock shake investor position normal pullback investor buy ideal buy point have much better chance ride minor pullback pullback often end get area investor cut loss buy extend stock however be minor pullback decline reach nerve wrack level flash stock follow tuesday recent breakout good gain new high heavy volume include china base jinkosolar jks cent canadian solar csiq clear dental brace provider align technology algn amira nature food anfi cent mri scanner developer fonar fonr china online social platform provider yy yy other stock moved new high recent include google goog chip designer ambarella amba st jude medical stj major index find horsepower jump higher look more new high highly rate stock such move also bring tally combine new high level not see yet year click here view full list week new high lows
525,ALGN,stock future strengthen ahead friday open investor tune day commentary federal reserve official
526,ALGN,dow future trade point fair market value be rise nasdaq future be point future firm point
527,ALGN,stock market today open bearing mild loss so far week distribution day count raise hefty tough session thursday
528,ALGN,distribution day gauge level selling institution count day be consider be high nasdaq also gain fresh distribution day thursday older day elapse leave count unchanged
529,ALGN,investor keep concern level mind keep careful eye sell signal individual stock be clear sell rule trim first event market turn rocky
530,ALGN,investor be closely follow outpouring federal reserve opinion expect today philadelphia american economic association conference fed official include chairman ben bernanke be schedule speak day
531,ALGN,september new issue fireeye feye torch premarket trade cybersecurity software play drop strong trade regular session thursday spiked hour news company pay acquire mandiant computer forensic specialist base alexandrium va fireeye management also raise revenue guidance previous estimate
532,ALGN,recent ipo have be shape cup base october
533,ALGN,brazil base telecom tim participacoe tsu muscle ahead open apparently speculation spain base telefonica be work takeover plan tim have be climb right side month consolidation early november
534,ALGN,sprint teeter lower loss yesterday cause downgrade wireless telecom provider market perform outperform cowen base valuation low price stock rise dec high clear cup handle base november
535,ALGN,lead stock be subdue premarket action only stock ibd list rise fall more be system ddd align technology algn bit more
536,ALGN,system end thursday ahead so far week work sixth straight weekly gain
537,ALGN,align hold fractional loss week thursday hover buy point week cup handle base
538,ALGN,overseas market china tumble overnight re open holiday break hong kong hang seng index drop shanghai composite fall stock europe be firmly higher midday trading
539,ALGN,oil be steady just barrel tumble thursday gold edge ounce add thursday gain
540,ALGN,economic calendar show december auto truck sale number be due stock future strengthen ahead friday open investor tune day commentary federal reserve official dow future trade point fair market value be rise nasdaq future be point future firm point stock market today open bearing mild loss so far week distribution day count raise hefty tough session thursday distribution day gauge level selling institution count day be consider be high nasdaq also gain fresh distribution day thursday older day elapse leave count unchanged investor keep concern level mind keep careful eye sell signal individual stock be clear sell rule trim first event market turn rocky investor be closely follow outpouring federal reserve opinion expect today philadelphia american economic association conference fed official include chairman ben bernanke be schedule speak day september new issue fireeye feye torch premarket trade cybersecurity software play drop strong trade regular session thursday spiked hour news company pay acquire mandiant computer forensic specialist base alexandrium va fireeye management also raise revenue guidance previous estimate recent ipo have be shape cup base october brazil base telecom tim participacoe tsu muscle ahead open apparently speculation spain base telefonica be work takeover plan tim have be climb right side month consolidation early november sprint teeter lower loss yesterday cause downgrade wireless telecom provider market perform outperform cowen base valuation low price stock rise dec high clear cup handle base november lead stock be subdue premarket action only stock ibd list rise fall more be system ddd align technology algn bit more system end thursday ahead so far week work sixth straight weekly gain align hold fractional loss week thursday hover buy point week cup handle base overseas market china tumble overnight re open holiday break hong kong hang seng index drop shanghai composite fall stock europe be firmly higher midday trading oil be steady just barrel tumble thursday gold edge ounce add thursday gain economic calendar show december auto truck sale number be due
541,ALGN,stock future strengthen ahead friday open investor tune day commentary federal reserve official
542,ALGN,dow future trade point fair market value be rise nasdaq future be point future firm point
543,ALGN,stock market today open bearing mild loss so far week distribution day count raise hefty tough session thursday
544,ALGN,distribution day gauge level selling institution count day be consider be high nasdaq also gain fresh distribution day thursday older day elapse leave count unchanged
545,ALGN,investor keep concern level mind keep careful eye sell signal individual stock be clear sell rule trim first event market turn rocky
546,ALGN,investor be closely follow outpouring federal reserve opinion expect today philadelphia american economic association conference fed official include chairman ben bernanke be schedule speak day
547,ALGN,september new issue fireeye feye torch premarket trade cybersecurity software play drop strong trade regular session thursday spiked hour news company pay acquire mandiant computer forensic specialist base alexandrium va fireeye management also raise revenue guidance previous estimate
548,ALGN,recent ipo have be shape cup base october
549,ALGN,brazil base telecom tim participacoe tsu muscle ahead open apparently speculation spain base telefonica be work takeover plan tim have be climb right side month consolidation early november
550,ALGN,sprint teeter lower loss yesterday cause downgrade wireless telecom provider market perform outperform cowen base valuation low price stock rise dec high clear cup handle base november
551,ALGN,lead stock be subdue premarket action only stock ibd list rise fall more be system ddd align technology algn bit more
552,ALGN,system end thursday ahead so far week work sixth straight weekly gain
553,ALGN,align hold fractional loss week thursday hover buy point week cup handle base
554,ALGN,overseas market china tumble overnight re open holiday break hong kong hang seng index drop shanghai composite fall stock europe be firmly higher midday trading
555,ALGN,oil be steady just barrel tumble thursday gold edge ounce add thursday gain
556,ALGN,economic calendar show december auto truck sale number be due stock future strengthen ahead friday open investor tune day commentary federal reserve official dow future trade point fair market value be rise nasdaq future be point future firm point stock market today open bearing mild loss so far week distribution day count raise hefty tough session thursday distribution day gauge level selling institution count day be consider be high nasdaq also gain fresh distribution day thursday older day elapse leave count unchanged investor keep concern level mind keep careful eye sell signal individual stock be clear sell rule trim first event market turn rocky investor be closely follow outpouring federal reserve opinion expect today philadelphia american economic association conference fed official include chairman ben bernanke be schedule speak day september new issue fireeye feye torch premarket trade cybersecurity software play drop strong trade regular session thursday spiked hour news company pay acquire mandiant computer forensic specialist base alexandrium va fireeye management also raise revenue guidance previous estimate recent ipo have be shape cup base october brazil base telecom tim participacoe tsu muscle ahead open apparently speculation spain base telefonica be work takeover plan tim have be climb right side month consolidation early november sprint teeter lower loss yesterday cause downgrade wireless telecom provider market perform outperform cowen base valuation low price stock rise dec high clear cup handle base november lead stock be subdue premarket action only stock ibd list rise fall more be system ddd align technology algn bit more system end thursday ahead so far week work sixth straight weekly gain align hold fractional loss week thursday hover buy point week cup handle base overseas market china tumble overnight re open holiday break hong kong hang seng index drop shanghai composite fall stock europe be firmly higher midday trading oil be steady just barrel tumble thursday gold edge ounce add thursday gain economic calendar show december auto truck sale number be due
557,ALGN,stock be again red have pare large chunk day loss late trading monday
558,ALGN,nasdaq be fall much intraday meanwhile slip dow jone industrial average be fractionally lower volume continue track higher major exchange stock market today signale possible distribution day nasdaq
559,ALGN,china lodging htht drop fast trade give early gain now past buy point flat base have be much dec peak
560,ALGN,celgene celg pare loss come close day move average earlier goldman sachs downgrade biotech sell neutral even celgene find support key move average not be new buy area stock have already have several test line
561,ALGN,goldman also downgrade alexion pharmaceutical alxn neutral buy alexion share fall
562,ALGN,jinkosolar jks stretched gain push further year high earlier stock blow past buy point cup base chinese maker solar wafer cell say sign loan agreement china development bank solar plant project
563,ALGN,align technology algn be still hold gain clear early buy point flat base monday morning buy point flat base be cent left side high sometimes investor look alternative entry maker clear brace other dental product report earning jan analyst poll thomson reuter see profit rise cent share stock be again red have pare large chunk day loss late trading monday nasdaq be fall much intraday meanwhile slip dow jone industrial average be fractionally lower volume continue track higher major exchange stock market today signale possible distribution day nasdaq china lodging htht drop fast trade give early gain now past buy point flat base have be much dec peak celgene celg pare loss come close day move average earlier goldman sachs downgrade biotech sell neutral even celgene find support key move average not be new buy area stock have already have several test line goldman also downgrade alexion pharmaceutical alxn neutral buy alexion share fall jinkosolar jks stretched gain push further year high earlier stock blow past buy point cup base chinese maker solar wafer cell say sign loan agreement china development bank solar plant project align technology algn be still hold gain clear early buy point flat base monday morning buy point flat base be cent left side high sometimes investor look alternative entry maker clear brace other dental product report earning jan analyst poll thomson reuter see profit rise cent share
564,ALGN,market uptrend gain traction friday november job report come better expect market tide be still flow positive mean nibble name strong fundamental technical recent day stock spotlight screen have serve several name still buy range sierra wireless swir featured column wednesday be testing week move average second time september company technology have be describe disruptive good thing business world disruptive be synonymous new new drive big earning sale growth ahead sierra wireless be well position growth machine machine market communication be frequently see warehouse management robotic logistic service supply chain management fleet management new issue nrg yield nyld meanwhile be buy range recent flat base go public july have nearly double price company operate fossil fuel solar wind power generation facility thermal infrastructure asset provide steam hot chill water electricity commercial business year year revenue growth have accelerate past quarters herbalife hlf be also buy range clear double bottom handle buy point short interest remain high stock consistent track record earning sale growth align technology algn be show support action week line work potential flat base company invisalign transparent brace continue see improve demand latest earning report turn lot head profit cent share sale quarterly record
565,ALGN,stock sell ramp close send major index session lows
566,ALGN,nasdaq give index fall early trading midday attempt recoup loss dow industrial boost american express axp jump big volume late thursday earning report manage hold slim gain
567,ALGN,volume spiked board stock market today due option expiration
568,ALGN,preliminary datum show nasdaq dow manage small weekly gain
569,ALGN,intel intc also report thursday close weigh nasdaq gap fall more busy trade miss profit view penny
570,ALGN,qiwi qiwi plunge month low huge turnover extend wednesday loss stem report russian regulator be consider restraint cross border electronic payment
571,ALGN,nu skin enterprise nus slide heavy trade now give past session negative article be publish china person daily follow chinese government launch probe network marketer business practice
572,ALGN,upside align technology algn rise new high move well past flat base entry point leaderboard member join close jan replace tractor supply tsco
573,ALGN,china lodging group htht add heavy turnover fourth straight session putt flat base buy point clear dec stock sell ramp close send major index session lows nasdaq give index fall early trading midday attempt recoup loss dow industrial boost american express axp jump big volume late thursday earning report manage hold slim gain volume spiked board stock market today due option expiration preliminary datum show nasdaq dow manage small weekly gain intel intc also report thursday close weigh nasdaq gap fall more busy trade miss profit view penny qiwi qiwi plunge month low huge turnover extend wednesday loss stem report russian regulator be consider restraint cross border electronic payment nu skin enterprise nus slide heavy trade now give past session negative article be publish china person daily follow chinese government launch probe network marketer business practice upside align technology algn rise new high move well past flat base entry point leaderboard member join close jan replace tractor supply tsco china lodging group htht add heavy turnover fourth straight session putt flat base buy point clear dec
574,ALGN,few tool trader workshop see much active duty move average line useful marker be chart stock price bar come many variety most commonly used week day line follow similar trajectory former weekly latter daily chart week average be sum stock weekly close price prior week divide day line sum most recent day close price divide institutional investor favor buy price weakness often use day line baseline stock price ease step buy day line buy fuel rebound used slim investor add opportunity stock cut day line serious volume be warning be not automatic sell signal alert investor stock be weaken week day move average also provide sell signal usually late one align technology algn hold closely week line winning run last year huge third quarter earning surprise launch stock week line oct also set week handle long cup base stock break nov week week line moved back normal alignment week meaning week lead week align climb pull back support week average build basis way stock briefly shake free week move average april earning release drop back line begin base run late june align make small stab week line firm trade early january yet most case stock sprang lows finished week higher line july begin punch line more serious volume stock re-cover huge trade incursion be enough investor be alert final break day line come oct see daily chart heavy trade align drop next day december be september high
575,ALGN,stock slip mixed trade go noon hour tuesday trader continue handicap upcoming earning report nasdaq be dow jone industrial average rise smidgen stock market today volume run higher same time monday nyse nasdaq exchange
576,ALGN,hawaiian holding parent hawaiian airline be only claw way back loss morning stock report earning beat estimate close monday sidoti co downgrade stock neutral cowen raise price maintain market perform rating
577,ALGN,amazon amzn fall tuesday morning report consumer intelligence research partner say amazon prime have customer spend average year site triple size year research organization say
578,ALGN,amazon report earning close thursday analyst forecast loss cent share
579,ALGN,facebook fb have carved similar pattern amazon be slightly touch new intraday high stock be find resistance century mark open jeffery lift price target facebook
580,ALGN,ibd company be higher be lower best performer be bank ozark ozrk nearly break cup handle base late monday announce have buy atlanta base community southern holding stock
581,ALGN,worst performer be egg producer cal maine food calm fall pull back hit new high monday
582,ALGN,follow ken hoover twitter ibd_khoover stock slip mixed trade go noon hour tuesday trader continue handicap upcoming earning report nasdaq be dow jone industrial average rise smidgen stock market today volume run higher same time monday nyse nasdaq exchange hawaiian holding parent hawaiian airline be only claw way back loss morning stock report earning beat estimate close monday sidoti co downgrade stock neutral cowen raise price maintain market perform rating amazon amzn fall tuesday morning report consumer intelligence research partner say amazon prime have customer spend average year site triple size year research organization say amazon report earning close thursday analyst forecast loss cent share facebook fb have carved similar pattern amazon be slightly touch new intraday high stock be find resistance century mark open jeffery lift price target facebook ibd company be higher be lower best performer be bank ozark ozrk nearly break cup handle base late monday announce have buy atlanta base community southern holding stock worst performer be egg producer cal maine food calm fall pull back hit new high monday follow ken hoover twitter ibd_khoover
583,ALGN,align technology algn stock vault time high morning trading friday day dental supplier handily beat estimate give upbeat guidance align stock be stock market friday far ahead former high touch oct align stock earlier session rise high
584,ALGN,stock start generally bullish month december note follow seesaw session monday nasdaq fall close session low snap session streak squander early gain give rise much intraday hold barely level round
585,ALGN,stock rebound strength thursday hour earning be mixed give little clue friday action be repeat
586,ALGN,nasdaq rise be dow jone industrial average gain volume exchange be lighter previous day accord preliminary datum
587,ALGN,close chipotle grill cmg be sharply report earning share line estimate increase year revenue be vs estimate stock be form shallow base
588,ALGN,amazon amzn be sharply miss revenue consensus be share have find support day line regular session
589,ALGN,google goog be volatile moderately report ep estimate close thursday new high find support day line
590,ALGN,align technology algn be also give guidance exceed street estimate
591,ALGN,economic datum due friday morning incude personal income spending employment cost index chicago pmi michigan sentiment index
592,ALGN,market be propel powerful move lead growth stock give better expect quarterly report facebook fb armour ua harman international industry har la vegas sand lvs be stock show strong upside stock rebound strength thursday hour earning be mixed give little clue friday action be repeat nasdaq rise be dow jone industrial average gain volume exchange be lighter previous day accord preliminary datum close chipotle grill cmg be sharply report earning share line estimate increase year revenue be vs estimate stock be form shallow base amazon amzn be sharply miss revenue consensus be share have find support day line regular session google goog be volatile moderately report ep estimate close thursday new high find support day line align technology algn be also give guidance exceed street estimate economic datum due friday morning incude personal income spending employment cost index chicago pmi michigan sentiment index market be propel powerful move lead growth stock give better expect quarterly report facebook fb armour ua harman international industry har la vegas sand lvs be stock show strong upside
593,ALGN,stock slide monday seller come woodwork holiday period nasdaq drop respectively lowest level week fall third straight session fade higher open small cap suffer biggest blow russell lose
594,ALGN,buyer be nowhere be find friday major average extend loss dow jone industrial average broad base nyse composite fall day move average nasdaq slump fall dow lose decliner outnumber advancer nyse nasdaq preliminary datum show nyse volume tracking higher thursday nasdaq volume rise money continue flow bond thursday yield year note fall basis point fall basis point today stock market today lead growth stock take hardest hit several ibd name plunge day move average include hexcel hxl wuxi pharmatech wx system ddd yandex yndx la vegas sand lvs downside align technology algn round trip gain flat base buy point sell signal buy share fall elsewhere china base jinkosolar jks plunge day move average recent share tumble trigger sell rule today fall more past buy point opentext otex be sole bright spot share gap rise software maker report strong earning set stock split juniper network jnpr also do well gap rise company report profit cent share year sale rise first double digit sale increase more year notable earning report close today next week once again be busy monday apple aapl report close earning be see rise share sale share fall ahead result
595,ALGN,unequivocal day institutional selling major average thursday morphed solid day gain market friday money flow bond stock scad lead growth stock snap back most case wasn much conviction buy thursday ibd lose bounce back
596,ALGN,number ibd stock be work flat basis market uptrend march flat basis take least week form stock move mostly sideway tight fashion correct more typically form later market uptrend stock have already break cup type double bottom base
597,ALGN,santarus snt be expect remain earning growth leader top small cap medical stock report thursday beating medicine co mdco questcor pharmaceutical qcor align technology algn today screen day be small cap leader top rate company market capitalization less top medical stock be sort year year earning share growth last report quarter specialty drugmaker santarus have be top performer year due large part strong sale bowel disease drug uceris be launch earlier year santarus earning jump santarus be only company group hasn announce result slate report thursday market close consensus analyst poll thomson reuter be rise ep cent hike revenue share fall wednesday trading stock market today medicine co develop heart drug include coagulant used critical care unit see ep rise lead angiomax injectable clot drug used heart surgery account company revenue medicine share have be rise prospect possible food drug administration approval next year questcor pharmaceutical treat autoimmune inflammatory disease star be acthar gel used treat different illness include multiple sclerosis rheumatology related condition questcor earning share advanced last quarter post double triple digit ep growth quarters row align technology name imply make technology help straighten tooth earlier device proprietary invisalign brace be clear removable don rely metal ceramic bracket wire make more comfortable align stock be ibd list top rate stock ep advanced cent last quarter send stock time high report last month related facebook linkedin lead top big cap sale gainsvipshop system lead top outperform stocksfollow james detar twitter ibd_jdetar
598,ALGN,align technology algn know invisible dental brace be set report result early monday analyst expect continue double digit sale growth thomson reuter poll find analyst expect sale rise year quarter however estimate profit be flat cent share keep company recent
599,ALGN,everything be go digital day orthodontic be exception
600,ALGN,align technology algn inventor invisible tooth aligner be bring orthodontist office st century
601,ALGN,san jose calif base firm acquire cadent holding last year digital scanning technology dentist use chair side get digital impression mold patient tooth use various procedure
602,ALGN,case today be now do digitally say matt dolan analyst roth capital partner doctor office create digital image ll take impression traditional goo put mouth then ll send dental lab create digital image
603,ALGN,so clearly dentistry be go digital align buy cadent effort capitalize trend little bit complementary little bit strategic
604,ALGN,align patented invisalign system be launch be today distribute trained dentist orthodontist more country company have manufacture aligner ship case date
605,ALGN,invisalign technology
606,ALGN,first quarter ship more case
607,ALGN,digitize industry isn only strong point align thank continuous innovation company have significantly expand invisalign portfolio treatment
608,ALGN,example new feature launch invisalign october invisalign october make easier doctor address more challenge tooth movement improve predictability lead better overall outcome say thomas prescott align president ceo
609,ALGN,new feature help open bite treatment extrusion upper lateral root control canine central incisor say
610,ALGN,other product range invisalign express very minor treatment invisalign full invisalign invisalign assist more comprehensive treatment adult teenager
611,ALGN,benefit technology invisalign prescott say
612,ALGN,january align release invisalign express cost effective treatment very minor malocclusion misalignment tooth
613,ALGN,believe many patient want correct little crowd other minor malocclusion don actually pursue treatment believe orthodontic treatment be too expensive minor correction prescott note
614,ALGN,dentist cost invisalign treatment be final number be base volume treatment usually take month tray month then practitioner decide much charge patient price have range
615,ALGN,north american addressable patient population be person year write thinkequity analyst spencer nam report globally have exceed patient annually translate dollar be expect grow
616,ALGN,main advantage invisalign next generation product be be address severe case malocclusion represent more case be segment align not treat previously
617,ALGN,company be also focuse more teenage market have be underrepresent
618,ALGN,align business age group be reverse orthodontic market align historically have more adult oriented case say dolan
619,ALGN,thank next generation technology treatment new software invisalign product be start chip away now core teenage market be grow organically excess think continue be driver say
620,ALGN,align have also be expand internationally even still very much underpenetrated many region
621,ALGN,international represent increasingly significant part align business say prescott past year international sale have more triple quarter align total revenue primary focus be drive growth direct sale region include core european country market japan newest direct market china
622,ALGN,addition align be pursue new market distribution partner be smaller fast grow market asia pacific emea latin america
623,ALGN,collectively continue make good progress represent international invisalign revenue growth rate outpace europe north america prescott note market also usually have more complex case malocclusion
624,ALGN,chinese market
625,ALGN,china present area opportunity align be probably few individual country market orthodontic have size potential be big north america long term say prescott
626,ALGN,be just dip toe water try understand market better say dolan think big opportunity investor ask lot question re still wait see unfold become growth driver certainly something expect next few year
627,ALGN,financial standpoint company generate healthy amount cash flow have debt generate sale earning sale grow most recent quarter align also announce share repurchase program end
628,ALGN,re make shift manufacturing today so gross margin be little depress say dolan pretty nice high margin business mid high gross margin time so think earning potential business be pretty dramatic typical device company have gross margin
629,ALGN,don see direct competition be dominant area long term be very clear strategic argument be make align be acquisition target bigger player especially start chip away core orthodontic market everything be go digital day orthodontic be exception align technology algn inventor invisible tooth aligner be bring orthodontist office st century san jose calif base firm acquire cadent holding last year digital scanning technology dentist use chair side get digital impression mold patient tooth use various procedure case today be now do digitally say matt dolan analyst roth capital partner doctor office create digital image ll take impression traditional goo put mouth then ll send dental lab create digital image so clearly dentistry be go digital align buy cadent effort capitalize trend little bit complementary little bit strategic align patented invisalign system be launch be today distribute trained dentist orthodontist more country company have manufacture aligner ship case date invisalign technologyin first quarter ship more case digitize industry isn only strong point align thank continuous innovation company have significantly expand invisalign portfolio treatment example new feature launch invisalign october invisalign october make easier doctor address more challenge tooth movement improve predictability lead better overall outcome say thomas prescott align president ceo new feature help open bite treatment extrusion upper lateral root control canine central incisor say other product range invisalign express very minor treatment invisalign full invisalign invisalign assist more comprehensive treatment adult teenager benefit technology invisalign prescott say january align release invisalign express cost effective treatment very minor malocclusion misalignment tooth believe many patient want correct little crowd other minor malocclusion don actually pursue treatment believe orthodontic treatment be too expensive minor correction prescott note dentist cost invisalign treatment be final number be base volume treatment usually take month tray month then practitioner decide much charge patient price have range north american addressable patient population be person year write thinkequity analyst spencer nam report globally have exceed patient annually translate dollar be expect grow main advantage invisalign next generation product be be address severe case malocclusion represent more case be segment align not treat previously company be also focuse more teenage market have be underrepresent align business age group be reverse orthodontic market align historically have more adult oriented case say dolan thank next generation technology treatment new software invisalign product be start chip away now core teenage market be grow organically excess think continue be driver say align have also be expand internationally even still very much underpenetrated many region international represent increasingly significant part align business say prescott past year international sale have more triple quarter align total revenue primary focus be drive growth direct sale region include core european country market japan newest direct market china addition align be pursue new market distribution partner be smaller fast grow market asia pacific emea latin america collectively continue make good progress represent international invisalign revenue growth rate outpace europe north america prescott note market also usually have more complex case malocclusion chinese marketchina present area opportunity align be probably few individual country market orthodontic have size potential be big north america long term say prescott be just dip toe water try understand market better say dolan think big opportunity investor ask lot question re still wait see unfold become growth driver certainly something expect next few year financial standpoint company generate healthy amount cash flow have debt generate sale earning sale grow most recent quarter align also announce share repurchase program end re make shift manufacturing today so gross margin be little depress say dolan pretty nice high margin business mid high gross margin time so think earning potential business be pretty dramatic typical device company have gross margin don see direct competition be dominant area long term be very clear strategic argument be make align be acquisition target bigger player especially start chip away core orthodontic market
630,ALGN,stock strip early loss moved higher late morning trade thursday be dow jone industrial average nasdaq nasdaq volume remain nyse volume hung fraction wednesday midday level stock market today be keep careful ear testimony federal reserve vice chairman
631,ALGN,intuitive surgical isrg stock be early trading stock market friday specialist robotic assist surgery late thursday report revenue miss view
632,ALGN,sunnyvale calif base intuitive say earn share year earlier revenue fall analyst estimate
633,ALGN,company say sell da vinci surgical robot year earlier quarter intuitive executive say new health care law be putt crimp hospital spending
634,ALGN,third quarter result be impact same pressure face first half year namely moderate growth benign gynecology combine change hospital capital spending priority associate implementation affordable care act intuitive ceo gary guthart say statement
635,ALGN,company say full year revenue be lower half earlier guidance unchanged growth growth
636,ALGN,intuitive surgical stock have plunge regulator have be review robotic procedure
637,ALGN,ibd medical system equipment group also include dexcom dxcm align technology algn cantel medical cmn rank industry group track
638,ALGN,related stryker bet robotic surgery mako surgical acquisition intuitive surgical isrg stock be early trading stock market friday specialist robotic assist surgery late thursday report revenue miss view sunnyvale calif base intuitive say earn share year earlier revenue fall analyst estimate company say sell da vinci surgical robot year earlier quarter intuitive executive say new health care law be putt crimp hospital spending third quarter result be impact same pressure face first half year namely moderate growth benign gynecology combine change hospital capital spending priority associate implementation affordable care act intuitive ceo gary guthart say statement company say full year revenue be lower half earlier guidance unchanged growth growth intuitive surgical stock have plunge regulator have be review robotic procedure ibd medical system equipment group also include dexcom dxcm align technology algn cantel medical cmn rank industry group track related stryker bet robotic surgery mako surgical acquisition
639,ALGN,just look align technology algn have perfect tech invisible brace company find yet way improve early year san jose calif maker alternative metal brace introduce new material invisalign clear aligner system smarttrack highly elastic material better maintain
640,ALGN,recent market volatility few lead stock consumer cyclical sector be still act well la vegas sand lvs be make orderly pullback rise past buy point cup handle base clear early september even volume be heavy stock fall nearly week close upper half range week show support stock be trading close week move average watch support la vegas sand pull back further thank strong business macau top gamble destination world company have deliver accelerate growth recent quarters profit growth have zoom latest period top line growth have picked same time frame rv maker winnebago industry wgo be pull back quiet fashion clear buy point cup base late september have lose ground latest week volume have be mostly tame winnebago have previously rally straight week most gain average volume week heavy trade signal buy institution company have deliver triple digit profit growth past quarters not quite strong sale have climb past period align technology algn continue hold relatively tightly huge earning inspire pop week end oct tight action be sign support stock be buy range go form new base last month align crushed expectation earning jump cent share sale grow nearly gain be highest recent quarters fellow consumer play bloomin brand blmn ruth hospitality group ruth be showcased thursday ibd
641,ALGN,most ibd stock extend buy point few choice remain new purchase most recent breakout be have mixed result few stock break past couple week be buy point act well enough chipotle grill cmg last week get track jump new
642,ALGN,stock be flat thursday afternoon investor weigh mixed economic datum new stimulus effort european central bank
643,ALGN,nasdaq dow jone industrial average be flat slip index be modestly higher early session volume be run lower board compare same time wednesday
644,ALGN,stock market today get early boost ecb announce launch bond buy stimulus monday help offset generally weak economic datum include unexpected dip january factory order
645,ALGN,pharmacyclic pcyc jump new high illinois base abbvie abbv say buy maker blood cancer drug imbruvica abbvie drop
646,ALGN,qualys qlys provider cloud security software be nearly new high volume be heavy stock be profit take zone climb more past flat base buy point
647,ALGN,ceo philippe courtot be due speak thursday morgan stanley technology medium telecom conference
648,ALGN,sprout farmer market sfm rise heavy volume be hit resistance day move average
649,ALGN,joy global joy maker mining machinery drop heavy turnover lower full year earning outlook depress commodity price see follow story more detail stock be flat thursday afternoon investor weigh mixed economic datum new stimulus effort european central bank nasdaq dow jone industrial average be flat slip index be modestly higher early session volume be run lower board compare same time wednesday stock market today get early boost ecb announce launch bond buy stimulus monday help offset generally weak economic datum include unexpected dip january factory order pharmacyclic pcyc jump new high illinois base abbvie abbv say buy maker blood cancer drug imbruvica abbvie drop qualys qlys provider cloud security software be nearly new high volume be heavy stock be profit take zone climb more past flat base buy point ceo philippe courtot be due speak thursday morgan stanley technology medium telecom conference sprout farmer market sfm rise heavy volume be hit resistance day move average joy global joy maker mining machinery drop heavy turnover lower full year earning outlook depress commodity price see follow story more detail
650,ALGN,stock finished sharply higher friday back encourage job report volume appear be lighter
651,ALGN,nasdaq rise gain dow jone industrial average be stock market today market continue recent pattern drop rise volume gain lighter volume
652,ALGN,employer add job april confirm suspicion sluggish growth march be anomaly april job growth help lower unemployment rate march
653,ALGN,shoemaker skecher skx vault nearly time high sterne agree raise price target stock stock trade find resistance cause even number stock be more break base january
654,ALGN,trex trex make wood alternative decking fencing rise earning revenue come better expect stock be back day move average close lower half daily range
655,ALGN,lead growth stock monster beverage mnst tableau software datum have opposite reaction earning report
656,ALGN,monster gap close lower post weaker expect earning be also downgrade neutral conviction buy goldman sachs stock slice day move average
657,ALGN,tableau gap close higher report robust earning growth exceed expectation stock catapult day line new time high stock finished sharply higher friday back encourage job report volume appear be lighter nasdaq rise gain dow jone industrial average be stock market today market continue recent pattern drop rise volume gain lighter volume employer add job april confirm suspicion sluggish growth march be anomaly april job growth help lower unemployment rate march shoemaker skecher skx vault nearly time high sterne agree raise price target stock stock trade find resistance cause even number stock be more break base january trex trex make wood alternative decking fencing rise earning revenue come better expect stock be back day move average close lower half daily range lead growth stock monster beverage mnst tableau software datum have opposite reaction earning report monster gap close lower post weaker expect earning be also downgrade neutral conviction buy goldman sachs stock slice day move average tableau gap close higher report robust earning growth exceed expectation stock catapult day line new time high
658,ALGN,thursday boston scientific bsx get upgrade ibd smartselect composite rating upgrade mean stock be now outperform other stock term key performance metric technical strength boston scientific be currently form consolidation entry look stock break volume least average see ibd help make more money stock earn ep rating mean recent quarterly annual earning growth be outpace stock accumulation distribution rating show moderate buy institutional investor last week get newsletter deliver inbox more info product service privacy policy term usein company post earning share growth sale be flat match prior report boston scientific hold rank peer medical product industry group abiom abmd align technology algn globus medical gmed be top highly rate stock group related company be now outperform stock see stock just come ibd top stock list
659,ALGN,earning tap apr ibd sector leader member align technology algn be currently buy point current formation be third stage cup handle mean more prone failure first second stage formation keep mind risky buy stock just report reduce risk wait see company report market react see ibd help make more money stocksin term top bottom line number company have post rise ep growth last report revenue growth have also rise same period analyst expect earning share growth quarter growth full year earning estimate full year be recently revise upward align technology have composite rating hold rank peer medical product industry group align technology algn edward lifescience ew be also group highest rate stock note date earning report be subject change check company update get newsletter deliver inbox more info product service privacy policy term also earning calendar analyst estimate stock watchnew option strategy limit risk earning
660,ALGN,california base align technology algn accelerate sale past year revenue rise then point aggressive growth stock raise question do handle stock involve more risk first bit more fundamental street expect sale pop
661,ALGN,thursday close medical sector rank broad sector ibd track middle long term performance sector have rally jan so ibd reader likely not be surprised see many individual stock hit sector leader screen come key section economy unemployment record lows consumer spending rev medical care firm stand benefit american be more willing spend improve health ibd ranking industry group please see page ibd weekly medical product group rank month progress week group have rise jan group big winner abiom abmd have vault be right time pick share innovator heart pump true market leader storm basis run basis be nothing more period time stock peak correct price bottom rise back old high break new high abiom week flat base correct buy point produce jan april break flat base good stock have break look rebound week move average first instance offer secondary opportunity establish position add small amount share exist abiom bounce week line week end april volume increase week average then next week turnover really shot large cap medical device firm rally hit new high align technology algn healthequity hqy supernus pharmaceutical supn have also go steep run up breakout notice weekly chart align developer invisalign orthodontic brace have stage week winning streak way stock clear entry base show essential element cup handle align be very close rise past prime buy point take most profit selling winner be smart portfolio management hold share longer high conviction play locking gain way allow raise cash future buy please follow saito chung twitter ibd_dchung more analysis lead stock chart buy point sell signal financial market related tesla face critical test nowwhy rule help become savvy portfolio manager stocksusing week move average stock latest investor find correct entry hot growth stock
662,ALGN,second quarter earning season be begin bull be hope get respect time first quarter be triumph financial result disappointment stock market reaction stock beat estimate generally didn find much traction do happen thing overshadowed report season concern president trump trade war flatten yield curve unfortunately neither factor have be resolve bull be hope strong earning season do time fail do last time shove market news drive creature earning drive beast get newsletter deliver inbox more info product service privacy policy term usewell fargo wfc jpmorgan chase jpm citigroup give earning season unofficial start july last time major bank turn sideway story stock market lackluster result later month stock recently appear big cap report quarterly result street expect netflix nflx grow earning company report july close leisure sector play match expectation first quarter report april close stock gap next day netflix be more hold vs sell decision right now chart be not offer legitimate buy point online platform twitter twtr be expect report result open july street estimate earning come cent share improvement vs year quarter profit cent share be twitter second biggest profit least quarters ep cent cent previous quarters twitter be extend stock form new base be third stage research show first second stage breakout be more likely work later stage basis facebook fb report close july analyst expect facebook increase earning pop be smallest quarters last time facebook beat consensus view earning stock rally next week invisible brace provider align technology algn report also july close street expect earning grow first quarter align top consensus view intuitive surgical isrg report quarterly result july close analyst estimate earning increase share top year growth rate stock clear flat pattern june couldn rise buy zone intuitive test find support week line past couple week get instant access more trading idea exclusive stock list ibd proprietary rating only related second chance buy stock rebound take profit hold guidelinesare trump tariff stock market
663,ALGN,past week see group stock lead netflix nflx co tif align technology algn decker outdoor deck break consolidation start early year process notch new high beat resistance have capped progress month broad defeat resistance well signal fresh upward momentum market confirm so far constrain uptrend grab headline wednesday gapping gain include past cup handle buy point huge gap advance also present investor breakaway gap buy point open price wednesday gap session gain next session left stock week extend buy point easily surpass retailer previous weekly best gain january earn spot ibd leaderboard get newsletter deliver inbox more info product service privacy policy term usenetflix also leaderboard name be more re-serve chalk gain week be enough move buy point flat base stock remain buy range friday still work sixth month advance have lift share december low netflix have also climb month advance drive share december decker outdoor break previous week drive buy range heavy trade monday align retook buy point then rise sixth weekly advance decisively rout resistance move new high related top fang stock here netflix have reach new buy pointtiffany blast buy zone crush earning viewsnetflix get price target hike grow competitive subscriber willing pay higher price surveyretail commerce news stock watch
664,ALGN,keep watch list date be key make money stock market ibd help do regularly update stock screen ibd sector leader ibd big cap ipo leader table see stock have just be add remove list ibd display video id
665,ALGN,globus medical gmed be top medical stock watch ibd member abiom abmd inogen ingn stock medical product industry group have highest possible composite rating composite rating mean stock be outperform stock
666,ALGN,keep watch list date be key make money stock market ibd help do regularly update stock screen ibd sector leader ibd big cap ipo leader table see stock have just be add remove list ibd display video id
667,ALGN,teleflex tfx have relative strength rs rating upgrade thursday welcome improvement still shy higher score look look best stock buy watch factor watch closely be relative price strength exclusive rating investor business daily identify market leadership worst best score grade show stock price performance last week stack other stock database year market history reveal stock go make biggest gain typically have higher rs rating begin largest climb see teleflex continue rebound hit benchmark look winning stock try simple routineteleflex be build consolidation entry see break volume least higher normal top bottom line growth moved higher company most recent quarter earning be compare prior report revenue increase company hold rank peer medical product industry group abiom abmd align technology algn icu medical icui be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term also ibd stock rating upgrade rise relative strengthwhy use ibd relative strength rating relative strength line help judge stock
668,ALGN,ibd sector leader member abiom abmd be expect report earning stock be now trading buy point sixth stage flat base clear earlier understand buy stock just ahead earning involve risk typically don have enough time build profit cushion latest quarterly number come be sure follow sound buy sell rule minimize exposure look winning stock try simple routineearning share growth decrease company most recent report sale rise analyst expect earning growth quarter growth full year annual growth estimate be recently revise lower company have composite rating earn rank peer medical product industry group align technology algn globus medical gmed be also group highest rate stock note date earning report be subject change check company update get newsletter deliver inbox more info product service privacy policy term also earning calendar analyst estimate stock watchnew option strategy limit risk earning
669,ALGN,teleflex tfx be form base buy point next quarterly ep report expect base be first stage consolidation buy stock just ahead earning involve risk typically don have enough time build profit cushion latest quarterly number come be sure follow sound buy sell rule minimize exposure look best stock buy watch start company report ep growth latest quarterly report sale growth come analyst expect ep growth quarter growth full year annual growth estimate be recently revise lower company have composite rating hold rank peer medical product industry group abiom abmd align technology algn globus medical gmed be top highly rate stock group note date earning report be subject change check company update get newsletter deliver inbox more info product service privacy policy term also earning calendar analyst estimate stock watchnew option strategy limit risk earning
670,ALGN,ibd stock screen be regularly update add new stock watch well weed have start show weakness table ll see stock have be add remove list ibd sector leader ibd big cap screen be
671,ALGN,build earning season watch list look stock potential buy zone ahead next quarterly report inogen ingn currently fit bill expect report market close april stock be approximately buy point second stage flat base keep mind risky buy stock just report minimize exposure wait see actual number market reaction look best stock buy watch start hereinogen report ep growth most recent report sale gain come analyst expect earning share growth quarter growth full year annual growth estimate be recently revise lower inogen have composite rating hold rank peer medical product industry group align technology algn globus medical gmed be also group highest rate stock note date earning report be subject change check company update get newsletter deliver inbox more info product service privacy policy term also earning calendar analyst estimate stock watchnew option strategy limit risk earning
672,ALGN,globus medical gmed be expect report earning stock be now trading buy point second stage flat base clear earlier understand buy just stock report be risky ep sale miss send sharply lower reduce exposure wait see company report market react look best stock buy watch start hereearning grow last quarter prior report revenue also increase consensus analyst estimate call earning growth quarter growth full year ep estimate full year be recently revise higher company have composite rating earn rank peer medical product industry group align technology algn globus medical gmed be also group highest rate stock note date earning report be subject change check company update get newsletter deliver inbox more info product service privacy policy term also earning calendar analyst estimate stock watchnew option strategy limit risk earning
673,ALGN,re look stock be set base ahead earning here fit bill icu medical icui expect release latest number be currently approximately shy entry entry be base third stage flat base involve more risk first second stage formation buy stock just ahead earning involve risk typically don have enough time build profit cushion latest quarterly number come be sure follow sound buy sell rule minimize exposure see ibd help make more money stocksregard fundamental company have post rise ep growth last quarters top line growth have also rise same time frame analyst expect ep growth quarter growth full year annual earning share estimate be recently revise higher company have composite rating earn rank peer medical product industry group align technology algn globus medical gmed be also group highest rate stock note date earning report be subject change check company update get newsletter deliver inbox more info product service privacy policy term also earning calendar analyst estimate stock watchnew option strategy limit risk earning
674,ALGN,edward lifescience ew be form base show buy point get ready report next round earning apr base be first stage flat base buy stock just ahead earning involve risk typically don have enough time establish profit cushion latest quarterly number come be sure follow sound buy sell rule minimize exposure see ibd help make more money stocksearning grow last quarter prior report revenue also increase consensus analyst estimate call earning share growth quarter growth full year annual growth estimate be recently revise lower company have composite rating earn rank peer medical product industry group abiom abmd align technology algn globus medical gmed be top highly rate stock group note date earning report be subject change check company update get newsletter deliver inbox more info product service privacy policy term also earning calendar analyst estimate stock watchnew option strategy limit risk earning
675,ALGN,keep watch list date be key make money stock market ibd help do regularly update stock screen ibd sector leader ibd big cap ipo leader table see stock have just be add remove list ibd display video id
676,ALGN,important metric look stock be higher relative strength rating nephew snn clear benchmark tuesday jump tuesday re research best stock buy watch keep close eye relative price strength exclusive rating investor business daily identify price movement worst best score grade show stock price movement trail week compare other stock database history show stock go make biggest gain typically have rs rating launch biggest climb look winning stock try simple routinesmith nephew be buy zone clear entry cup handle proper buy range extend initial entry once stock move range best hold investing set buy opportunity company post ep growth last quarter revenue gain come company be expect report latest number apr company hold rank peer medical product industry group abiom abmd align technology algn globus medical gmed be top highly rate stock group get newsletter deliver inbox more info product service privacy policy term also stock be show improve price performance use ibd relative strength rating relative strength line help judge stock
677,ALGN,ibd stock screen be regularly update add new stock watch well weed have start show weakness table ll see stock have be add remove list ibd sector leader ibd big cap screen be
678,ALGN,stock stage positive turnabout late wednesday rise close boee ba walt disney exxon mobil xom lead rebound dow jone industrial land gain first advance session boee top index ride strong first quarter result disney kick late aid upgrade market perform underperform bmo capital exxon surge raise quarterly dividend more hold gain edward lifescience ew drop hard miner freeport mcmoran fcx tumble fourth straight day head list railroad norfolk southern nsc tax man block hrb jump respectively heavy loss tripadvisor trip checkpoint software chkp generic drugmaker mylan myl prevent nasdaq composite shedding fractional loss texas instrument txn hop biogen biib gain first quarter result report late tuesday biogen also receive upgrade outperform neutral robert baird wednesday crude oil price gain benchmark crude settle barrel bond edge lower send year yield basis point telecom fiber optic gear maker mortgage service group post session heaviest loss industry group track ibd get free access ibd digital april
679,ALGN,get premium stock list pass fail stock rating more start herein fiber optic group name include oclaro ocrl lumentum lite finisar fnsr take hard hit rate sensitive mortgage service stock lendingtree tree hff hf drop respectively apple aapl pare gain close investor await detail meeting chief executive tim cook president trump cook reportedly also meet trump economic advisor larry kudlow well trade representative robert lighthizer well president wednesday morning trump tweet meeting cover many topic include have be treat unfairly many year many country trade apple share be fight regain day move average fang stock tech leader finished session lower alphabet googl lead group fraction stifel nicolaus upgrade stock buy hold follow company result tuesday netflix nflx slump pricing offer high yield bond share be week rebound back day move average facebook fb end flat investor look social medium giant report close consensus view project rise ep revenue accord zack investment research be facebook first quarterly report cambridge analytica datum privacy scandal break last month facebook share have be recover march low be now week meeting resistance day move average boee throttle report first quarter revenue earning significantly expectation management also raise full year earning guidance well consensus target stock be attempt retake week move average be form cup type base buy point other top defense name also post result early wednesday northrop grumman noc trim early loss report result general dynamic gd slump chip stock return volatile trade late day texas instrument stretched gain teradyne ter collapse robert baird cut stock neutral outperform chip equipment maker tuesday warn second quarter result miss consensus target due weaken demand mobile testing device advanced micro device amd tank report earning close comcast maintain gain follow first quarter result company also formally offer long run battle walt disney st century fox fox take base broadcaster sky disney share close fox also advanced ibd stock align technology algn gain ahead quarterly result due today close maker clear orthodontic brace be week line month base pattern bottom list edward lifescience pare loss finish medical product leader deliver strong first quarter sale earning beat second quarter guidance be softer expect sale come short company closely watch tavr segment management raise full year earning outlook analyst forecast share be shallow consolidation march high related big picture be bull market finally facebook twitter boee paypal visa earning action planboee lift earning cash flow view crush estimate twitter stock jump beating earning revenue forecast northrop grumman general dynamic top earning view
680,ALGN,ibd sector leader member abiom abmd be trading buy area next quarterly report tap stock be right buy point sixth stage flat base understand buy stock just ahead earning be risky typically don have enough time build profit cushion latest quarterly number come be sure follow sound buy sell rule minimize exposure look winning stock try simple routineearning growth fall most recent quarter revenue moved higher analyst expect ep growth quarter growth full year annual growth estimate be recently revise lower abiom have composite rating earn rank peer medical product industry group align technology algn globus medical gmed be also group highest rate stock note date earning report be subject change check company update get newsletter deliver inbox more info product service privacy policy term also earning calendar analyst estimate stock watchnew option strategy limit risk earning
681,ALGN,index dow jone industrial average nasdaq tumble week alphabet googl caterpillar cat mmm earning treasury yield spook investor stock market average pare loss strong earning amazon amzn facebook fb boee ba visa other index dow jone nasdaq find support day move average rebound close week fractional loss year treasury hit first time year hit week pull back short term yield continue rise faster long term rate squeeze yield spread alphabet googl expense ongoing chip weakness also hit stock amazon amzn facebook fb boee ba visa rally strong result intel intc microsoft msft initially hit buy point friday pull back amazon first quarter earning sky-rocket more double ep estimate revenue rise fifth straight quarter accelerate sale growth revenue amazon web service rise aw account most amazon overall operate profit amazon share shot record high friday pare gain advance ebay ebay stock drop report result fall short consensus estimate end quarter global active buyer facebook fb stock surge post first quarter result blow past expectation dash fear exodus user advertiser social medium giant twitter twtr report strong earning guidance share fall ceo make cautious comment slow growth get free access ibd digital april
682,ALGN,get premium stock list pass fail stock rating more start hereboee ba easily beat forecast raise full year guidance aerospace giant say aircraft completion center china be nearly finished downplay china trade war fear fellow dow jone stock unite technology utx report stronger expect earning sale industrial giant also raise full year adjust ep sale forecast lockheed martin lmt top first quarter estimate defense contractor raise ep revenue target maker didn raise cash flow expectation northrop grumman noc also report earning estimate northrop say didn submit bid air force gps iii contract leave lockheed likely lone bidder raytheon rtn raise full year earning forecast consensus earning revenue top estimate general dynamic gd beat earning meet revenue view share defense contractor sell sharply week software kingpin earn cent share year year sale fiscal third quarter analyst expect cent microsoft msft have be shift business desktop pc software cloud compute infrastructure application such office azure microsoft commercial cloud revenue rise fiscal software giant initially reclaim recent buy point friday pare gain intel intc earning rise sale grow well analyst view chip giant guide higher current quarter sale indicate third straight quarter top line growth share initially jump year high friday reversed close slightly lower texas instrument txn advanced micro device amd stm xilinx xlnx get boost upbeat earning report chip gear maker teradyne ter tumble warning weak demand equipment test mobile device western digital wdc make disk drife memory chip tumble friday beating fiscal view philadelphia semiconductor index fought support day move average google parent alphabet googl report earning revenue top view sharp rise capital spending margin pressure higher traffic acquisition cost spark sell internet search giant capex jump year period include real estate purchase manhattan traffic cost google pay partner website generate advertising revenue jump google have hike spending youtube video content cloud compute smart home consumer appliance artificial intelligence project paypal pypl top earning revenue expectation total payment volume rise year year vs estimate company raise revenue adjust ep guidance management point momentum partnership visa international bank technology platform such baidu bidu exxon mobil xom miss earning view output slip recent surge oil price chevron cvx fall short revenue conocophillip cop crushed estimate hess hes report shallower expect loss royal dutch shell rdsa report highest profit oil price crash energy information administration say crude inventory rise barrel vs drop analyst expect domestic production rise barrel day barrel increase crude oil future briefly top barrel highest level late trade little change week general motor gm ford motor fiat chrysler fcau beat quarterly estimate ford not invest traditional sedan north america go forward almost phase passenger car consumer migrate suvs light truck gm still see small car opportunity home abroad even too shift focus larger more profitable vehicle casino operator la vegas sand lvs top first quarter result estimate help strong demand global gaming hub macau singapore macau also help result wynn resort wynn overall macau sale disappoint analyst wynn resort also approve dividend increase earning report wynn be first steve wynn resign ceo sell stake follow allegation sexual misconduct mgm resort mgm narrowly beat stock tumble decline traffic location mgm be more focuse sand wynn amgen amgn alexion pharmaceutical alxn broadly top view amgen sale adjust profit outlook be bit soft midpoint sale alexion blockbuster soliris miss estimate share pop promising study new drug alxn biogen biib sale lag sluggish spinraza multiple sclerosis drug revenue prothena prta tank monday scrap rare disease drug fail phase study eli lilly lly broadly beat consensus diabetes drug chemotherapy help offset short sale psoriasis drug taltz glaxosmithkline gsk sale adjust profit lag abbvie abbv bristol myer squibb bmy top profit view raise full year guidance bristol sale miss estimate shire shpg say consider raise takeover bid japan takeda vertex pharmaceutical vrtx top view sale decline vs last year vertex say ll move triple pill regimen phase study domino dpz deliver ep gain revenue leap blow view share rise thursday chipotle grill cmg stock vault month high ep unexpectedly jump same store sale also top starbucks sbux be par earning ep rise cent rise sale outdo analyst prediction new oriental education edu earn cent share revenue grow total student enrollment rise year year ibd stock tal education tal ep jump cent share revenue soar student enrollment balloon vs year earlier new oriental tal share pop respective earning day be slightly lower week intraday friday pultegroup phm tuesday crushed view ep jump cent home sale revenue leap homebuilder stock be generally muted due rise interest rate horton dhi biggest builder thursday best view ep surge revenue swell homebuilder stock rally solid gain help cool treasury yield new home sale rise march annualize sale pace unit month high meanwhile exist home price rise february vs year earlier china search engine leader baidu bidu report profit blow past estimate lift share baidu still own majority iqiyi iq hold ipo march video stream iqiyi account roughly parent revenue share iqiyi fall release earning tandem baidu visa report ep gain revenue rise beating fiscal view credit debit card giant raise full year revenue outlook share leap thursday mmm meet ep view revenue rise just consensus dow jone giant slash full year ep target stock plunge caterpillar cat report strong earning sale share heavy construction equipment maker reversed sharply lower tuesday warning operate margin hit high watermark year servicenow now report profit revenue estimate customer now spend annually metric be year year edward lifescience ew top sale adjust profit view share tank sale transcatheter heart valve replacement lag illumina ilmn beat consensus adjust profit rise share sale swell align technology algn report adjust earning share revenue handily beating view cent respectively td ameritrade amtd deliver impressive ep revenue growth fall short lofty expectation share fall week trade financial etfc continue rise last week strong result first solar fslr hit year high earning top expectation due sale several solar project expand production proofpoint pfpt cybersecurity firm top adjust first quarter earning revenue view guide low profit share fall friday advanced protection solution nearly double make new add booking prior quarter
683,ALGN,keep watch list date be key make money stock market ibd help do regularly update stock screen ibd sector leader ibd big cap ipo leader table see stock have just be add remove list ibd display video id
684,ALGN,earning tap globus medical gmed be trading approximately buy point pattern be second stage flat base understand buy stock just report be risky poor number send sharply lower minimize risk wait see actual number market reaction look winning stock try simple routineglobus medical see earning sale growth rise last quarter earning share increase revenue rise consensus analyst estimate call earning share growth quarter growth full year earning estimate full year be recently revise higher company have composite rating hold rank peer medical product industry group align technology algn globus medical gmed be also group highest rate stock note date earning report be subject change check company update get newsletter deliver inbox more info product service privacy policy term also earning calendar analyst estimate stock watchnew option strategy limit risk earning
685,ALGN,here be investing action plan wednesday need know investor come day social medium platform facebook fb twitter twtr report quarterly earning wednesday so do aerospace giant boee ba ebay ebay paypal pypl ford visa servicenow now network ffiv also report facebook
686,ALGN,earning tap teleflex tfx be trading approximately entry entry be base first stage consolidation understand buy stock just ahead earning be risky typically don have enough time build profit cushion latest quarterly number come be sure follow sound buy sell rule minimize exposure see ibd help make more money company report earning share growth last quarter revenue rise analyst expect ep growth quarter growth full year annual growth estimate be recently revise lower company have composite rating earn rank peer medical product industry group abiom abmd align technology algn globus medical gmed be top highly rate stock group note date earning report be subject change check company update get newsletter deliver inbox more info product service privacy policy term also earning calendar analyst estimate stock watchnew option strategy limit risk earning
687,ALGN,align technology algn free report have continue develop itero scanner line be fast expand footprint grow field digital scanning sync strategy company have announce plan advance itero element intraoral scanner strategic partnership exocad gmbh align collaboration cad cam software provider exocad gmbh enable chairside cad software chairside prosthetic design software application be specially integrate align itero element intraoral scanner integration chairside cad software support same day dentistry itero element scanner integrate system be expect be market middle align claim minute scanning new itero chairside cad software have capacity design produce precision fit tooth restoration patient connect office milling system additionally system have be claim deliver enhance patient engagement showcase crown design streamline itero element scanner integrate restorative design software market lead certify milling system align technique be affordable option perform same day dentistry restorative practice interestingly revenue scanner service segment improve last quarter moreover company see increase adoption itero scanner invisalign case submission instead pvs impression especially north america thus drive invisalign utilization report research market global market dental scanner be project witness cagr period consider market potential align current development scanner service space collaboration seem be strategic believe unhealthy lifestyle rise awareness expenditure healthcare continue drive growth dental scanner market however area be dominate well establish player dentsply sirona inc xray free report align have be gain investor confidence consistently positive result past month company share price have outperformed broader industry stock have surge compare broader industry gain company have also outperformed gain market same time frame zack rank other key picksalign sport zack rank strong buy other top rank medical stock be petm express inc pet free report myriad genetic inc mygn free report sporting zack rank see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year myriad genetic have long term expect earning growth rate stock have soar year wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
688,ALGN,masimo corporation masi free report have rally last year ahead gain broader industry rise stock have market cap company year historical growth rate be also favorable compare index broader industry company current year earning growth be project be higher broader industry solid prospect zack rank buy stock be attractive pick present let find recent positive trend be sustainable company estimate revision trend current year have be positive past day analyst moved north movement opposite direction earning estimate rise share company also have stellar average return last quarters masimo exit third quarter solid note earning increase year year revenue rise almost third quarter solid cash flow buoy optimism also company raise revenue guidance be encourage masimo recently announce release proprietary patient datum visualization report software trace unite state be specifically design masimo root radical monitor also masimo announce full market release ra single use adhesive respiration sensor rainbow acoustic monitoring ram respiration rate launch be expect strengthen company foothold grow global respiratory care market other key picksother top rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report notably petm align technology myriad genetic sport zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year time align technology have long term expect earning growth rate stock have gain year myriad genetic have long term expect earning growth rate stock have gain year more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
689,ALGN,share price luminex corporation lmnx free report scale new week high nov close nominally lower company have gain last month much higher gain luminex have also surpass broader industry gain stock have market cap further luminex estimate revision trend current year be favorable past day estimate moved moved estimate be cent share cent company also have trail quarter average positive earning surprise long term growth hold promise luminex corporation price consensus luminex corporation price consensus luminex corporation company current year earning growth be project be higher broader industry growth driversluminex exit third quarter solid note earning increase year year revenue rise almost third quarter see solid cash flow well profit further expansion operate margin buoy optimism also luminex reiterate annual revenue guidance be encourage company also witness favorable tiding regulatory front regard ary group strep assay moderate complexity sample answer test direct detection streptococcus pyogene throat swab specimen used ary system recently receive fda clearance zack rank other key picksluminex carry zack rank buy few other top rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report notably petm align technology myriad genetic sport zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year myriad genetic have long term expect earning growth rate stock have gain year more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
690,ALGN,align technology inc algn free report recently sign agreement glidewell dental distribute itero element intraoral scanning system latest glidewell io office solution north america scanner be power glidewell fastdesign io software notably glidewell io office solution be chairside restorative ecosystem simplify deliver prescribe laboratory quality dental restoration management collaboration widen itero reach more dentist used glidewell service notably company aim launch first quarter moreover deal be expect enhance efficiency accessibility same day restoration joint customer align technology manufacture market system clear aligner therapy intra oral scanner cad cam computer aid design manufacturing digital service used dentistry orthodontic dental record storage have be work hard expand work flow option itero scanner context company sign distribution agreement patterson dental business unit patterson company inc pdco free report august exclusive agreement align technology itero element intraoral scanning system be available part patterson dental cad cam portfolio unite state canada align technology have launch software upgrade itero element intraoral scanner be capable compare patient scan time latest timelapse technology also company collaborate exocad gmbh march integrate portfolio result high tech solution efficient scanning design manufacturing house dental prosthesis february company announce addition digital nobel biocare implant itero intraoral scanner portfolio interestingly revenue scanner service segment improve last report third quarter moreover company see increase adoption itero scanner invisalign case submission instead pvs impression especially north america thereby drive invisalign utilization report research market global market dental scanner be project see cagr period consider market potential align technology current development scanner service space collaboration seem be strategic believe unhealthy lifestyle rise awareness expenditure healthcare continue drive growth dental scanner market however market be dominate well establish player dentsply sirona inc xray free report align technology have be gain investor confidence consistently positive result past month company share price have outperformed broader industry stock have gain compare broader industry company have also outperformed gain market same time frame zack rank other key picksalign technology currently sport zack rank strong buy top rank medical stock be petm express inc pet free report zack rank see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
691,ALGN,share price intuitive surgical inc isrg free report scale new week high nov eventually close bit lower company have gain last month much better rise broader industry gain take stock stable performance consideration expect intuitive surgical scale higher come quarters company long term growth also hold promise average volume share trade last month be remarkable approximately stock have market cap last day analyst have raise earning estimate current year have slash same net effect have take zack consensus estimate share period sunnyvale base company post impressive third quarter peformance earning revenue have register year year increase quarter company also witness growth segment international performance be encourage too more good news be market be upbeat intuitive surgical procedure performance asia show continue strength solid growth china japan korea company gain significantly ce mark approval da vinci europe stock receive further boost recent fda approval same believe increase adoption intuitive surgical da vinci system physician general surgery oncology urology gynecology procedure be key growth catalyst also grow procedural volume outside unite state open considerable opportunity company additionally solid outlook come quarters raise investor confidence stock further incremental spending product development higher investment international market be prudent move be likely drive long term growth company be also expect enhance organizational capability gain prominence market europe asia zack rank key picksintuitive surgical carry zack rank hold few better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report sporting zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technologyha long term expect earning growth rate stock have soar year time myriad genetic have long term expect earning growth rate stock have surge year wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
692,ALGN,nov issue update research report medical device major medtronic plc mdt free report stock carry zack rank sell company release second quarter fiscal earning result nov market depict bearish picture latest preliminary sale update medtronic past month share company have significantly underperform broader industry stock have decline versus broader industry gain preliminary result worldwide revenue quarter be expect dip year year dull revenue estimate quarter be report be mainly due company divestiture patient care deep vein thrombosis compression nutritional insufficiency business cardinal health begin quarter also preliminary report impact hurricane marium be approximately company second quarter top line hurricane left adverse impact roughly cent second quarter gaap earning share ep however year year drag preliminary sale be encourage note latest projection be actually improvement company earlier anticipation marium impact financial standing provide month back time medtronic have project fiscal second quarter revenue adjust net earning extent also believe aforementioned divestiture align company discipline portfolio management strategy company business do not fall medtronic core product line hence remain deprive require investment focus present divestment core profitable business help medtronic focus more core product turn also enable company invest long term high return internal external opportunity be more directly align company growth strategy therapy innovation globalization economic value stabilize trend global cardiac rhythm heart failure crhf market be upside be optimistic solid growth trend continue unite state well healthy global acceptance advanced therapy key picksa few better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report sporting zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have surge roughly year align technology have long term expect earning growth rate stock have sky-rocket last year myriad genetic have long term expect earning growth rate stock have soar last year look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
693,ALGN,ecolab inc ecl free report recently announce offer exchange outstanding note due note be exchange newly issue lower cost note due refinancing debt be smart move reduce cost debt delay maturity note ecolab have impressive run bourse last month trading industry term price performance company share have return compare industry rise only recently ecolab slash earning guidance due impact hurricane divestiture equipment care business company expect adjust earning year range much lower previous range notably ecolab expect impact hurricane sale cost be approximately cent divestiture equipment care be go hurt earning penny ecolab be lead provider water hygiene energy technology service protect person vital resource company program service help promote safe food maintain clean environment optimize water energy use improve operational efficiency customer food energy healthcare industrial hospitality market more country company prospect global industrial global institutional business segment reflect positivity last report quarter sale segment scale respectively year year basis further ecolab boast compelling fundamental revenue adjust earning multiply rate last year flip side unfavorable foreign currency impact venezuelan deconsolidation be expect hurt earning term escalate cost expense be weigh margin october comparative study ecolab forward forward month basis multiple reflect stock be overvalue zack rank key picksecolab currently carry zack rank hold few better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report petm align technology myriad genetic sport zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have return year myriad genetic have long term expect earning growth rate stock have return year look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
694,ALGN,nov issue update research report luminex corp lmnx free report manufacturer marketer proprietary biological testing technology application life science diagnostic industry third quarter company see strong top line performance solid cash flow higher profit company assay business be likely be key growth driver long term luminex report earning cent share third quarter revenue quarter improve almost year year luminex reiterate annual revenue guidance range depict growth year year basis luminex expect gross margin next few quarters mid meanwhile company project fourth quarter revenue range recently company also witness favorable tiding regulatory front regard recent ce ivd mark ary norovirus assay fda approval ary assay reimbursement approval verigene assay japan be noteworthy luminex be verge complete clinical study group strep be close submit same fda review company have diverse product portfolio comprise advanced xmap xtag multicode technology moreover luminex have collaborative agreement several company help expand use product technology notably luminex have earlier announce signing new supply distribution agreement bio techne luminex also enter similar deal affymetrix term agreement ebioscience business division affymetrix commercialize magpix luminex flexmap multiplexed assay platform select country americas asia europe flipside reimbursement landscape cutthroat competition continue be major challenge also price movement luminex have be unfavorable last year notably stock have gain only compare industry rally roughly zack rank other key picksluminex carry zack rank buy few other top rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report petm align technology myriad genetic sport zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly last year align technology have long term expect earning growth rate stock have return last year myriad genetic have long term expect earning growth rate stock have return last year zack best private investment ideaswhile be happy share many article best recommendation most depth research be not available public start today next month follow zack private buy sell real time expert cover kind trade value momentum stock etf option move stock corporate insider be buy company be report positive earning surprise even look exclusive portfolio be normally close new investor click here zack private trade
695,ALGN,nov issue update research report intuitive surgical inc isrg free report manufacturer da vinci surgical system advanced robot assist surgical system related instrument accessory major positive sunnyvale base company have have impressive run bourse late glimpse recent price performance reveal favorable return past year compare industry rally company have solid track record characterize earning beat trail quarters recently intuitive surgical report stellar performance back higher adoption da vinci system physician overall growth global procedure system enable minimally invasive surgery help avoid trauma associate open surgery company performance be also drive grow volume courtesy general surgery oncology urology gynecology procedure intuitive surgical consistently introduce technology surgical system company plan launch upgrade da vinci flagship vinci xi technology management confirm submission document ce mark approval vinci further company expect availability device europe end long haul extensive expenditure product pipeline expansion international market europe drive growth company flipside company expect procedure growth rate slow outside unite state upcoming quarters lengthy sale purchase order cycle da vinci system have add company wo also expense research development increase significantly first half reflect high spending advanced imaging advanced instrumentation next generation robotic zack rank key picksintuitive surgical carry zack rank hold few better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report stock sport zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly last year align technology have long term expect earning growth rate stock have gain last year myriad genetic have long term expect earning growth rate stock have gain last year zack best private investment ideaswhile be happy share many article best recommendation most depth research be not available public start today next month follow zack private buy sell real time expert cover kind trade value momentum stock etf option move stock corporate insider be buy company be report positive earning surprise even look exclusive portfolio be normally close new investor click here zack private trade
696,ALGN,laboratory corporation america holding lh free report labcorp recently announce agilent dako pathology division development pd ihc pharmdx assay be now available unite state new expand use labcorp test have get approval be used complementary diagnostic bristol myer squibb company bmy free report opdivo nivolumab new indication metastatic urothelial carcinoma bladder cancer squamous cell carcinoma head neck respectively be encourage note test clinical study support approval new indication assay be perform company center molecular biology pathology laboratory labcorp opdivo be already approve aforementioned indication use test however pd ihc pharmdx test provide vital information patient be most likely respond positively opdivo earlier pd ihc pharmdx assay be approve use complementary diagnostic opdivo treat certain patient squamous small cell lung cancer nsclc melanoma time too labcorp central clinical trial laboratory be only provider testing support clinical trial approval squamous nsclc treatment indication company successfully demonstrate combine capability labcorp clinical laboratory infrastructure covance central clinical trial laboratory be pave new way clinical trial labcorp consistent effort expand grow field complementary companion diagnostic be gradually fetch unmatched result notably company have adopt strategy work closely health system have expressed interest become prefer partner labcorp covance clinical trial regard company have sign agreement several major health system recently earlier year company enter agreement thermo fisher scientific join ngs companion diagnostic center excellence program have also inked exclusive deal distribute omniseq immune profile tumor profile test diagnostic labcorp have make strong progress consumer patient face initiative company labcorp walgreen collaboration be terrific start respect patient volume net promoter score patient feedback ride year experience site drug development business company be focuse drive future profitable growth expand solution enhance operational capability acquisition chiltern close sep be significantly strengthen labcorp strategic position clinical development well accelerate revenue profit growth covance labcorp be trading broader industry last month stock have gain compare industry gain zack rank key pickslabcorp carry zack rank hold better rank medical stock be petm express inc pet free report align technology inc algn free report sporting zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have soar roughly year align technology have long term expect earning growth rate stock have sky-rocket year time zack best private investment ideaswhile be happy share many article best recommendation most depth research be not available public start today next month follow zack private buy sell real time expert cover kind trade value momentum stock etf option move stock corporate insider be buy company be report positive earning surprise even look exclusive portfolio be normally close new investor click here zack private trade
697,ALGN,nov issue update research report haemonetic corporation hae free report company have be trading broader industry last month stock have gain broader industry gain stock have also outperformed gain stock currently carry zack rank hold haemonetic exit second quarter fiscal promising note year year growth earning revenue continue expansion newer geography have help company deliver strong result recent past meanwhile company strong cash position boost investor confidence company be also optimistic strong market adoption nexsys pcs plasmapheresis system recently receive fda approval further raise fiscal adjust earning guidance be encourage market be upbeat haemonetic encourage growth plasma haemonetic management franchise plasma continue witness strong growth second quarter rise revenue constant currency quarter north america plasma disposable revenue increase growth continue be lead strong end market demand plasma derive haemonetic be confident maintain growth commercial plasma collection business flip side company have be witness sluggish revenue growth blood center franchise significantly affect result past few quarters management also doesn expect early recovery blood center outcome macroeconomic uncertainty continue challenge haemonetic management also anticipate slower expect product adoption customer reduce revenue profit also currency fluctuation stiff competition continue hamper stock contraction gross operate margin be also discourage key picksa few better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report notably petm align technology myriad genetic sport zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly last year align technology have long term expect earning growth rate stock have gain last year myriad genetic have long term expect earning growth rate stock have gain last year hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
698,ALGN,earning growth enthrall almost everyone right top brass research analyst not company doesn make money win last long haul consider company revenue give period time subtract cost production have earning metric be also consider most important variable influence share price expectation earning also play significant role earning estimate determine share priceswe have often see decline stock price earning growth rally price follow earning decline be largely result company earning fail meet market expectation earning estimate embody analyst opinion factor such sale growth product demand competitive industry environment profit margin cost control thus earning estimate serve valuable tool make investment decision earning estimate also help analyst assess cash flow determine fair value firm investor thus be lookout stock be ready make big move hence be important investor buy stock have historical earning growth be also see rise quarterly annual earning estimate screening parameter order shortlist stock have striking earning growth positive estimate revision have add follow parameter zack rank less equal only zack buy strong buy be allow zack rank prove be best rating system be great way start thing year historical ep growth greater industry stock strong ep growth history change ep greater equal company see year year earning growth more last report fiscal change estimate last week greater stock have see current quarter earning estimate revise higher last week change estimate last week greater stock have see annual earning estimate revise higher last week change estimate last week greater stock have see annual earning estimate revise higher last week criterium narrow universe stock only here be top stock lululemon athletica inc lulu free report design distribute retail athletic apparel accessory woman man female youth company have zack rank buy company estimate growth rate year be versus textile apparel industry expect increase domino pizza inc dpz free report operate pizza delivery company unite state internationally company have zack rank company estimate growth rate year be versus retail restaurant industry project growth burlington store inc burl free report operate retailer brand apparel product unite state company have zack rank company project growth rate year be versus retail discount store industry estimate increase see complete list today zack rank stock here align technology inc algn free report design manufacture market system clear aligner therapy intraoral scanner computer aid design computer aid manufacturing cad cam digital service company have zack rank strong buy company estimate growth rate year be versus medical dental supply industry project growth get rest stock list signing now week free trial research wizard start used screen own trading further also create own strategy test first take investment plunge research wizard be great place begin easy use everything be plain language very intuitive start research wizard trial today next time read economic report open research wizard plug find see gem come click here sign free trial research wizard today disclosure officer director employee zack investment research own have sell short security hold long short position option be mentioned material affiliated investment advisory firm own have sell short security hold long short position option be mentioned material disclosure performance information zack portfolio strategy be available https www zack com performancezack restaurant recommendation addition dine special place feast stock share zack special report spotlight recent ipos watch stock offer immediate promise boom sector download free
699,ALGN,quest diagnostic incorporate dgx free report first quarter adjust earning share ep be par zack consensus estimate adjust earning rise year number report ep come reflect rise year quarter report revenue first quarter moved year year fall short zack consensus estimate accord company year year improvement come back successful execution point strategy accelerate growth drive operational excellence volume measure number requisition increase year year fourth quarter also revenue requisition tick diagnostic information service revenue quarter rise year year basis cost service report quarter be year year gross margin come reflect basis point bps contraction year year come operate expense selling general administrative expense increase report quarter consequently adjust operate margin show contraction bps quest diagnostic incorporate price consensus ep surprise quest diagnostic incorporate price consensus ep surprise quest diagnostic incorporate quotequest diagnostic exit first quarter cash cash equivalent marked decline end net cash provide operate activity be compare year period first quarter company repurchase share mar quest diagnostic be left authorization approve share repurchase plan guidance intactquest diagnostic have reiterate guidance exclude impact special item amortization expense etb excess tax benefit associate stock base compensation adjust ep full year be project range zack consensus estimate be guide range revenue be expect range annualize growth current zack consensus estimate revenue be peg well company project range operate cash flow be expect current estimate capital expenditure range takequest diagnostic be currently refocusing core diagnostic information service business work discipline capital deployment be also highly optimistic company focus point strategy company latest collaboration hospital integrate delivery network continue act major growth driver further company seem be satisfied revenue growth lower medicare reimbursement protect access medicare act severe winter weather headwind notably last couple year quest diagnostic have face several reimbursement issue have hurt revenue zack rank other key picksquest diagnostic carry zack rank buy other top rank stock broader medical sector be abaxis inc abax free report bio rad laboratory inc bio free report align technology inc algn free report abaxis bio rad sport zack rank strong buy align carry zack rank see complete list today zack rank stock here abaxis be expect release fourth quarter fiscal result apr zack consensus estimate adjust ep be peg cent revenue stand bio rad be expect report first quarter result zack consensus estimate adjust ep be cent revenue be align technology be slate release first quarter result apr zack consensus estimate adjust ep be cent revenue be hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
700,ALGN,corp abc free report be set report third quarter fiscal result aug open bell track record have be quite impressive company comfortably beating estimate trail quarters last report quarter deliver positive earning surprise bring quarter average let see thing be shape prior release factor pharmaceutical distribution segment continue face headwind form contract renewal lower generic inflation drug corporation abdc business be also be hurt several factor include accelerate deflation generic drug lower contribution generic launch generic inflation have be nominal rate deflation be rise gradually factor combine anticipate shift product mix lower margin higher price specialty brand drug lack generic inflation adversely impact bottom line however company renew relationship largest health system customer have be make persistent effort address headwind abdc segment boost top line extent fiscal third quarter company estimate revision trend be mixed current quarter see upward downward estimate movement last month current quarter estimate earning share be peg also company be apprehensive earning revenue growth expectation fiscal due uncertainty surround drug pricing trend company currently expect revenue growth range company expect adjust diluted earning share range meanwhile expect brand drug inflation range corporation hold co price ep surprise corporation hold co price ep surprise corporation hold co quoteearning whispersour quantitative model doesn point earning beat quarter be stock need have positive earning esp zack rank strong buy buy hold happen be not case here see zack esp earning esp be be most accurate estimate be zack consensus estimate be peg uncover best stock buy sell re report earning esp filter zack rank carry zack rank sell caution stock zack rank strong sell go earning announcement especially company be see negative estimate revision stock considerhere be company want consider proven model show have right combination element post earning beat quarter becton dickinson company bdx free report have earning esp carry zack rank see complete list today zack rank stock here align technology inc algn free report have earning esp carry zack rank thermo fisher scientific inc tmo free report have earning esp hold zack rank more stock news company verge apple run do miss apple stock explosion launch iphone now look be pivotal year get emerge technology expect rock market demand soar almost nothing report suggest save life decade turn save healthcare cost bonus zack special report name breakthrough best stock exploit apple company be already strong coil potential mega gain click see right now
701,ALGN,abaxis inc abax free report global provider point care blood analyzer report first quarter fiscal adjust earning share cent zack consensus estimate cent also be also year figure total revenuein fiscal first quarter abaxis record revenue increase year top line however miss zack consensus estimate accord company foreign currency exchange rate fluctuation have negligible impact abaxis top line segment detailin quarter geographic basis revenue north america accounting total revenue grow revenue international market accounting rest improve abaxis operate main segment namely veterinary medical other report quarter veterinary sale account total sale medical sale contribute remain be generate other abaxis inc price consensus ep surprise abaxis inc price consensus ep surprise abaxis inc quoteveterinary market revenue improve year year drive improvement veterinary consumable revenue veterinary instrument revenue be year year revenue medical market be year year strength piccolo instrument be offset decline medical rotor also revenue north american medical division totale year year global basis abaxis sell piccolos quarter compare year abaxis exhibit strong consumable growth year year quarter consumable product line total rotor revenue be almost line year quarter upside vet rotor revenue be mostly offset decline medical rotor revenue global basis abaxis sell rotor unit current quarter unit year quarter hematology reagent rapid assay drive growth consumable revenue report quarter however total instrument sale decrease due lower veterinary instrument sale abaxis sell total instrument global basis fiscal first quarter year quarter operational updatesfiscal first quarter gross profit drop gross margin contract basis point bps research development expense increase year year sale marketing expense rise general administrative expense also increase resultant operate income be quarter operate margin decline bps financial updateabaxis exit fiscal first quarter cash cash equivalent short term investment compare fourth quarter fiscal takeabaxis start fiscal disappointing note fiscal first quarter company miss estimate front also decline gross operate margin be matter concern however year year increase revenue buoy optimism be look forward improve consumable revenue boost veterinary sale performance abaxis quarter meanwhile be encourage note company be initiate new sale marketing strategy company launch new phenobarbital profile rotor furthermore company have launch pack phenobarbital rotor supplement pack launch company have also recently launch new canine specific pancreatic lipase test abaxis plan additional product launch fiscal include vetscan fuse connectivity system accord company addition product potentially drive growth long haul zack rank key picksabaxis currently have zack rank hold few better rank medical stock be mesa laboratory inc mlab free report insys therapeutic inc insy free report align technology inc algn free report notably insys therapeutic sport zack rank strong buy mesa laboratory align technology carry zack rank buy see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock have gain last month mesa laboratory have positive earning surprise last quarters stock have add roughly last month align technology have expect long term adjust earning growth almost stock have add roughly last month hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
702,ALGN,gnc holding inc gnc free report report second quarter adjust earning share ep cent reflect massive year year deterioration however quarter adjust ep surpass zack consensus estimate cent penny year year decline be attribute dull revenue performance report quarter primarily canada manufacturing wholesale segment include time item company report earning cent share year year revenuesrevenue report quarter drop year year figure also miss zack consensus estimate apart lower sale canada international manufacturing wholesale segment decline revenue be attribute overall drop sale protein vitamin weight management food drink category gnc holding inc price consensus ep surprise gnc holding inc price consensus ep surprise gnc holding inc quotesame store sale decrease domestic company own store include gnc com sale second quarter domestic franchise location same store sale decline segment detailsgnc holding report operation segment canada include company own store puerto rico canada franchise store commerce international include franchise location approximately country health store china operation manufacturing wholesale comprise manufacture product sell other segment third party contract manufacturing sale wholesale partner report quarter gnc holding revenue canada segment drop primarily owing decrease due discontinuation gold card program domestic franchise location revenue however rise nearly higher average store base partially offset decrease retail same store sale second quarter also witness steepest decline protein vitamin weight management food drink category decline be partially offset strong performance supplement health beauty herb green category also gnc com comp decrease second quarter revenue international segment increase revenue international franchisee decrease primarily due impact drop retail same store sale also tough year year comparison due year quarter additional sale associate timing shipment result annual franchise conference act adversely revenue china business increase current quarter year quarter partially offset decline revenue international franchisee revenue manufacturing wholesale segment exclude intersegment revenue decrease segment third party contract manufacturing sale fall be partially offset decline wholesale sale drop intersegment sale sale wholesale partner decrease year year quarter intersegment sale deteriorate year quarter quarter margingross profit deteriorate report quarter primarily due impact pricing loyalty associate new gnc plan dent retail margin rate consequently gross margin contract basis point bps owing lower sale product margin company gnc com business selling general administrative expense rise however adjust operate margin deteriorate huge bps owing steeper decline gross profit financial positiongnc holding exit report quarter cash cash equivalent end first quarter long term debt be end quarter compare end first quarter year date net cash flow operate activity be compare year further company generate year date free cash flow compare year quarter new gnc plan updateearlier management have announce plan revamp exist business model dub new gnc company have be see change second quarter well transaction growth be second quarter result sequential improvement first quarter same store sale end second quarter consumer joined mygnc reward program be approximately pro access member company also launch gnc storefront amazon part company omnichannel strategy takegnc holding exit second quarter disappointing note revenue miss zack consensus estimate earning exceed consensus estimate year year decline front be huge disappointment decline be attribute lower sale company canada manufacturing wholesale segment also decline gross adjust operate margin be matter concern positive note second quarter management witness positive response new gnc plan new consumer enrollment mygnc reward program launch gnc storefront amazon buoy optimism zack rank key picksgnc currently have zack rank sell few better rank medical stock be mesa laboratory inc mlab free report insys therapeutic inc insy free report align technology inc algn free report notably insys therapeutic sport zack rank strong buy mesa laboratory align technology carry zack rank buy see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock have gain last month mesa laboratory have positive earning surprise last quarters stock have add roughly last month align technology have expect long term adjust earning growth almost stock have add roughly last month hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionary still leave plenty money regular investor make right trade early see zack best stock play trend
703,ALGN,align technology inc algn free report report adjust earning share ep cent second quarter substantial year year earning be also higher company guide range cent figure handily beat zack consensus estimate cent revenuesrevenue grow year year quarter surpass zack consensus estimate management strong top line be drive robust invisalign case shipment year year doctor ship second quarter upside be backed growth north america international region year year increase teenage case board thereby reach new benchmark patient adopt invisalign treatment align technology inc price consensus ep surprise align technology inc price consensus ep surprise align technology inc quotesegment detailrevenue clear aligner segment total revenue increase year year report quarter primarily drive continue strong invisalign case volume growth customer channel geography second quarter invisalign case shipment amount year year aid growth region quarter align technology add invisalign doctor worldwide be north america be international region revenue scanner service improve substantially marginsgross margin second quarter be basis point bps year year rise cost net revenue quarter align technology witness year year increase selling general administrative expense hike research development expense operate margin however contract bps due higher operate expense financial detailsalign technology exit second quarter cash cash equivalent short term marketable security marked rise precede quarter report quarter align technology paid accelerate stock repurchase plan asr company receive initial delivery roughly share common stock management have available repurchase repurchase plan be announce last april third quarter company project ep cent revenue company also expect invisalign case shipment band same period year takealign technology end second quarter solid note earning revenue beating zack consensus estimate be upbeat continue strong invisalign volume turn drive top line additionally company announce receipt patent align smarttrack aligner material be exclusively used invisalign aligner treatment go forward management anticipate consistent growth asia pacific region bid grow region company also open new invisalign treatment plan facility china be also upbeat multus dollar marketing campaign initiate company invisalign brand order gain increase awareness be also optimistic company expand work flow option lead itero scanner context align technology recently launch software upgrade itero element intraoral scanner be capable compare patient scan time new timelapse technology additionally company have strong cash balance enable carry share repurchase program turn provide solid return investor flip side unfavorable foreign currency affect company revenue be report quarter also company be expose seasonal demand fluctuation higher operate expense pertain increase head count higher investment target growth acceleration geographical expansion portfolio expansion zack rank other key pickscurrently align technology sport zack rank buy other top rank medical stock be mesa laboratory inc mlab free report insys therapeutic inc insy free report becton dickinson company bdx free report notably insys therapeutic sport zack rank strong buy mesa laboratory becton dickinson company carry zack rank buy see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock have gain last month mesa laboratory have positive earning surprise last quarters stock have add roughly last month becton dickinson company have positive earning surprise last quarters stock have gain last month hottest tech mega trend last year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
704,ALGN,qiagen qgen free report report second quarter adjust earning share consider restructure expense time item cent year year report figure beat zack consensus estimate penny constant exchange rate cer company report adjust earning share ep cent fail meet company guidance cent cer consider time item qiagen report ep quarter be cent year year revenue detailnet sale actual rate first quarter grow year year basis cer top line surpass zack consensus estimate adverse currency translation impact top line meanwhile consider acquisition omicsoft january revenue increase adverse currency translation impact top line organic expansion drive total cer growth also company face headwind hpv test sale report quarter moreover total cer growth come jun acquisition exiqon lesser extent omicsoft buyout region wise sale americas revenue grow cer revenue europe middle east africa asia pacific japan increase respectively cer sale top emerge market exhibit growth year year cer quarter qiagen price consensus ep surprise qiagen price consensus ep surprise qiagen quotesegment detailqiagen primarily generate revenue molecular diagnostic apply testing pharma academia represent net sale respectively report quarter molecular diagnostic sale be cer drive substantial growth quantiferon latent tb test qiasymphony automation system consumable portfolio personalize healthcare sale derive apply testing rise cer increase uptake new product human id forensic pharma sale rise cer second quarter academia sale improve cer backed grow demand operational updateadjusted operate income second quarter increase year year also adjust operate margin expand basis point financial updateqiagen exit second quarter cash cash equivalent sequentially last quarter year date net cash operate activity be year moreover company report year date free cash flow compare year period jan qiagen complete synthetic share repurchase combine direct capital repayment reverse stock split part commitment return shareholder transaction be announce aug involved approach used various large multinational dutch company provide return shareholder faster more efficient manner traditional open market purchase qiagen intend repay balance commitment open market share repurchase present company be left return commitment company intend complete end guidancebanking solid second quarter performance qiagen have raise full year guidance adjust net sale growth cer peg high end previously project range however adjust ep guidance have be reiterate band cer be base operate financial leverage include benefit completion share repurchase plan end efficiency action take however exclude expect cent share restructure cost plan zack consensus estimate earning be guide range zack consensus estimate revenue be peg company also provide financial guidance third quarter net sale be expect grow cer adjust ep be expect cent cer underlie basis also adverse currency translation be expect have penny negative impact bottom line zack consensus estimate third quarter revenue be peg earning estimate remain stable cent takeqiagen end second quarter solid note earning revenue beating zack consensus estimate be impressed balanced growth company segment however adverse foreign currency translation continue be drag overall sale furthermore profitability front qiagen deliver strong performance respect operate margin meanwhile commitment return more shareholder increase share repurchase reflect solid cash position be also upbeat company strategic focus drive growth sample insight offering space company recently receive fda approval quantiferon tb gold also company experience increase momentum genereader ngs system company be also form collaboration drive growth personalize homecare space recently collaborate bristol myer squibb investigate use ngs technology development gene expression profile gep predictive prognostic tool be used novel bristol myer squibb novel bms immuno oncology therapy cancer treatment also company qiasymphony continue grow substantially target more cumulative placement end moreover end second quarter system portfolio be widen new fda approve test especially jak assay zack rank other key pickscurrently qiagen have zack rank buy other top rank medical stock be mesa laboratory inc mlab free report insys therapeutic inc insy free report align technology inc algn free report notably insys therapeutic sport zack rank strong buy mesa laboratory align technology carry zack rank buy see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock have gain last month mesa laboratory have positive earning surprise last quarters stock have add roughly last month align technology have expect long term adjust earning growth almost stock have add roughly last month hottest tech mega trend last year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
705,ALGN,nov issue update research report medical group wmgi free report company recently report third quarter result adjust earning be line zack consensus estimate exclusive platform technology perform reversed glenoid ortholoc di simpliciti shoulder system be key catalyst third quarter medical be focuse product innovation research development company recently launch invision total ankle revision system first system develop total ankle revision arthroplasty other major platform launch perform reversed be expect boost revenue medical solid guidance boost investor confidence company expect net sale band include negative impact foreign currency exchange approximately company forecast adjust ebitda continue operation however lackluster international performance lower extremity segment be matter concern sale segment decline year year basis third quarter lower extremity business sale fall third quarter internationally lower extremity sale decline year year other concern pricing pressure continue trouble medical increase cost related product launch re build infrastructure be expect exert pressure margin problem associate distributor be major headwind past month medical have underperform industry respect price company share have lose industry rally almost zack rank key pickswright medical carry zack rank hold few better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report sporting zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have sky-rocket year time myriad genetic have long term expect earning growth rate stock rally year wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
706,ALGN,second quarter earning season gain momentum broader picture longer look bright be expect be putt together member release result jul constitute index total membership note earning growth pace be less last quarter however be more less line trail quarter average earning growth exceed trail quarter average latest second quarter scorecard total earning increase year year higher revenue earning beat ratio remain revenue beat ratio be more information please consult zack earning analysis store medical space investor be concern healthcare space sector have be see lot struggle past half year thank political power change ongoing policy restructure related battle yesterday be finally president donald trump republican healthcare bill pass more barrier very narrow margin investor be however not much optimistic development vox article today effort repeal replace obamacare president donald trump continue make bold promise bill do promise available analysis suggest bill not keep be still chance senate amend latest bill extent still remain unclear accordingly uncertainty medical space be towering high investor be currently adopt see policy space let sneak peek performance major medical product company broader medical space expect jul align technology inc algn free report be upbeat align technology execution strategic initiative international expansion ensure invisalign treatment grow base patient context company strengthen foothold internationally acquire invisalign distributor highly lucrative europe middle east africa emea region well brazil february be likely drive company result soon be report quarter align be expect beat expectation report second quarter result market open have right combination key ingredient stock currently carry zack rank strong buy have earning esp note positive zack esp serve lead indicator likely positive earning surprise bullish zack rank increase predictive power esp uncover best stock buy sell re report earning esp filter read more align technology earning beat card align technology inc price ep surprise align technology inc price ep surprise align technology inc quote boston scientific corporation bsx free report believe medical device major second quarter performance be grossly impact company product recall issue europe other hand company downbeat interventional cardiology business get sort boost company acquisition switzerland base symetis sa boston scientific be schedule report second quarter result market close company currently carry zack rank sell have earning esp hence be unable conclude boston scientific be likely beat earning quarter note sell rate stock never be consider go earning announcement read more boston scientific earning await stock boston scientific corporation price ep surprise boston scientific corporation price ep surprise boston scientific corporation quote cerner corporation cern free report believe cerner strong sale performance well solid portfolio strategic initiative have position well stellar growth cerner announce have be choose department veteran affair develop electronic health record ehr system department veteran affair use same system company be develop department defense begin operation first site february system facilitate exchange datum military care facility civilian health provider current former service member receive care lead healthcare information technology hcit company be schedule report second quarter earning market close company currently carry zack rank earning esp hence be expect beat expectation quarter see complete list today zack rank stock here read more cerner deliver beat earning season cerner corporation price ep surprise cerner corporation price ep surprise cerner corporation quotestryker corporation syk free report second quarter renown medical device maker expect adjust earning share range notably indicate rise year year basis believe grow adoption mako robot drive sale orthopedic reconstructive surgery market additionally stryker be well poise acquisition sage physio control past company also expect beat expectation report second quarter result close bell be stock currently carry zack rank hold earning esp read more stryker deliver beat earning season stryker corporation price ep surprise stryker corporation price ep surprise stryker corporation quote mckesson corporation mck free report major player pharmaceutical medical supply distribution market expect gain gradually stabilize generic brand market company distribution solution segment perform favorably fiscal weak pricing trend customer consolidation be unable conclude mckesson be likely beat earning quarter stock carry zack rank increase predictive power esp earning esp need have positive esp be confident earning beat read more mckesson earning stock likely beat estimate mckesson corporation price ep surprise mckesson corporation price ep surprise mckesson corporation hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
707,ALGN,cheme corp che free report second quarter adjust earning share ep consider stock base compensation expense related tax benefit regular be compare year adjust ep figure year year include time item company report second quarter net loss share compare unfavorably earning year quarter detailsrevenue quarter increase year year beating zack consensus estimate cheme currently operate wholly own subsidiary namely vita healthcare corporation major provider end life care roto rooter lead commercial residential plumbing drain clean service provider second quarter net revenue vita healthcare totale reflect increase year year quarter revenue be drive increase average net medicare reimbursement rate rise average daily census however be offset acuity mix shift negatively impact revenue roto rooter report sale second quarter year year accord company revenue water restoration increase year year cheme corp price consensus ep surprise cheme corp price consensus ep surprise cheme corp quotegross margin expand basis point bps year year adjust operate margin expand bps quarter rise selling general administrative expense cheme exit second quarter total cash cash equivalent end first quarter company have total debt end second quarter compare end precede quarter jun company have approximately undrawn borrow capacity exist year credit agreement second quarter company repurchase share worth mar board have authorize additional cheme exist share repurchase plan jun company have remain share repurchase authorization plan outlookvita healthcare revenue growth projection be revise downward range prior medicare cap earlier range also admission average daily census be expect increase earlier be medicare cap bill limitation be expect be earlier roto rooter business be estimate grow full year compare earlier provide range raise guidance be backed increase job pricing water restoration service growth full year adjust ep be expect grow range previously compare report takecheme better expect revenue performance second quarter back solid growth roto rooter business buoy optimism also be encourage note company subsidiary see year year revenue growth quarter strong bottom line projection also raise hope however downward revision revenue growth guidance vita healthcare be matter concern further reimbursement related issue seasonality business competitive landscape dependence government mandate continue challenge cheme zack rank key pickscheme currently have zack rank hold few better rank medical stock be mesa laboratory inc mlab free report insys therapeutic inc insy free report align technology inc algn free report notably insys therapeutic align technology sport zack rank strong buy mesa laboratory carry zack rank buy see complete list today zack rank stock here align technology have expect long term adjust earning growth almost stock have add roughly last month insys therapeutic have long term expect earning growth rate stock have gain last month mesa laboratory have positive earning surprise last quarters stock have add roughly last month hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
708,ALGN,investor be always look stock be poise beat earning season align technology inc algn free report be such company firm have earning come pretty soon event be shape quite nicely report be align technology be see favorable earning estimate revision activity late be generally precursor earning beat analyst raise estimate right earning most date information possible be pretty good indicator favorable trend surface algn report fact most accurate estimate current quarter be currently cent share algn compare broader zack consensus estimate cent share suggest analyst have very recently bump estimate algn give stock zack earning esp head earning season align technology inc price ep surprise align technology inc price ep surprise align technology inc quotewhy be important positive read zack earning esp have proven be very powerful produce positive surprise outperform market recent year backtest show stock have positive earning esp zack rank hold better show positive surprise nearly time have return average annual return see more top earning esp stock here give algn have zack rank strong buy esp positive territory investor want consider stock ahead earning see complete list today zack rank stock here clearly recent earning estimate revision suggest good thing be ahead align technology beat be card upcoming report hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionary still leave plenty money regular investor make right trade early see zack best stock play trend
709,ALGN,st loui mo base pharmacy benefit manager express script hold company esrx free report post second quarter adjust earning share beating zack consensus estimate furthermore adjust earning jump share year quarter revenue miss zack consensus estimate be roughly year year basis gross profit second quarter be flat year year adjust selling general administrative expense be prior year quarter total adjust claim amount second quarter flat year year company ebitda earning interest tax depreciation amortization witness rise second quarter upside be drive operational cost improvement backed focus technology digital tool home delivery specialty service balance company exit quarter cash cash equivalent compare end total debt end quarter be versus end fact company be strive reduce debt level express script hold company price consensus ep surprise express script hold company price consensus ep surprise express script hold company quoteguidance raise company raise guidance adjust earning fiscal adjust earning share be project band previously provide range represent increase mid point range come guidance third quarter express script expect total adjust claim range adjust earning diluted share third quarter be estimate range represent growth year year basis furthermore company anticipate compound annual ebitda growth rate core pbm business exclude contribution anthem other transition client express script likely lose script recently announce biggest customer lead health insurer anthem inc antm free report be not likely extend pharmacy benefit management agreement be slate expiration end anthem sue express script overcharge drug operational failure management anthem refuse participate further discussion pricing concession probable adjustment agreement meanwhile second quarter anthem generate revenue compare second quarter takewe be highly upbeat company core pharmacy benefit management long term outlook include ongoing volatile healthcare market trend inflation patent expiration lower industry utilization growth other headwind furthermore expect express script continue benefit increase generic utilization shift mail order strong specialty growth age population brand drug be become increasingly expensive due double digit brand inflation continue rise price specialty drug overwhelming regulatory burden be actually pave way manifold prospect generic key picksnotably express script currently have zack rank hold better rank stock broader medical sector include insys therapeutic inc insy free report align technology inc algn free report notably insys therapeutic sport zack rank strong buy align technology carry zack rank buy see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock have gain last month align technology have expect long term adjust earning growth almost stock have add roughly last month hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world second trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
710,ALGN,lead packaging paper manufacturer international paper company ip free report be schedule report second quarter result open bell jul last report quarter company adjust earning beat zack consensus estimate cent trail quarters company top earning estimate thrice average positive surprise let see thing be shape announcement factor considerdure quarter international paper inked definitive agreement divest foodservice business china foodservice business offer innovative single use packaging solution cater evolve need customer past couple year company have strategically offloaded business china focus more operation believe cater chinese asian market more effectively supply globally competitive product primarily ilim joint venture russia export other part world company be take initiative drive further margin expansion time business however international paper depend heavily raw material such wood fiber purchase form pulpwood wood chip old corrugated container occ certain chemical include caustic soda starch energy source principally natural gas coal fuel oil rise energy chemical occ cost remain headwind particularly harsh winter condition be likely lower profitability extent international paper have huge burden pension obligation substantially salaried employee hire prior jul largely hourly union employee regardless hire date pension plan asset be primarily make equity fix income investment fluctuation actual equity market return change general interest rate number retiree be likely increase pension cost reduce cash flow thereby limit positive acquisition binge primary growth driver earning whispersour proven model do not conclusively show international paper be likely beat earning quarter do not possess key component stock need have positive earning esp zack rank strong buy buy hold happen be not case here see zack esp earning esp represent difference most accurate estimate zack consensus estimate be be zack consensus estimate be peg cent most accurate estimate stand cent uncover best stock buy sell re report earning esp filter international paper company price ep surprise international paper company price ep surprise international paper company quotezack rank international paper have zack rank increase predictive power esp need have positive esp be confident earning surprise note caution stock zack rank sell rate go earning announcement especially company be see negative estimate revision momentum stock considerhere be company want consider model show have right combination element post earning beat quarter agco corporation agco free report earning esp zack rank see complete list today zack rank stock here inc agen free report earning esp zack rank align technology inc algn free report earning esp zack rank more stock news tech opportunity worth driverless car artificial intelligence ve see unsurpassed growth high tech product recent month yesterday science fiction be become today reality innovation be single component tech company survive demand critical device reach year alone likely grow even faster future zack have release brand new special report help take advantage exciting investment opportunity most importantly reveal stock massive profit potential see stock now
711,ALGN,lead security software firm vasco datum security international inc be set report second quarter result market close jul company have solid earning surprise history beating estimate last quarters positive average earning surprise let see thing be shape announcement key factor considervasco be global leader authentication electronic signature identity management company strategic investment promon help firm develop mobile application security solution synergy deal likely augment company top line be report quarter last quarter vasco announce ability help organization detect mitigate mobile application overlay attack add functionality digipass apps runtime application self protection module module be expect augment company revenue quarter company continue make investment build capability sale marketing remain focuse generate high operate margin drive continuous investment shift product mix higher gross margin product however investment lead higher expense curb profitability be report quarter earning whispersour proven model do not conclusively show vasco be likely beat earning quarter be stock need have positive earning esp zack rank strong buy buy hold post earning beat however be not case here see uncover best stock buy sell re report earning esp filter zack esp earning esp represent difference most accurate estimate zack consensus estimate be zack consensus estimate most accurate estimate stand cent vasco datum security international inc price ep surprise vasco datum security international inc price ep surprise vasco datum security international inc quotezack rank vasco zack rank combine esp make earning beat uncertain caution stock zack rank sell rate go earning announcement especially company be see negative estimate revision stock considerhere be company want consider model show have right combination element post earning beat quarter agco corporation agco free report earning esp zack rank see complete list today zack rank stock here inc agen free report earning esp zack rank align technology inc algn free report earning esp zack rank more stock news tech opportunity worth driverless car artificial intelligence ve see unsurpassed growth high tech product recent month yesterday science fiction be become today reality innovation be single component tech company survive demand critical device reach year alone likely grow even faster future zack have release brand new special report help take advantage exciting investment opportunity most importantly reveal stock massive profit potential see stock now
712,ALGN,petm express inc pet free report lead pet pharmacy americas announce earning share ep cent first quarter fiscal year quarter cent also earning surpass zack consensus estimate year year rise earning be drive increase sale improve margin net sale report quarter rise year year outpace zack consensus estimate accord company upside sale be result increase new order reorder quarter petm express inc price consensus ep surprise petm express inc price consensus ep surprise petm express inc quotein report quarter reorder sale increase year year basis new order sale rise average order value be approximately quarter compare year quarter note variation average order value be mainly drive shift sale higher price item accord company seasonality business be mainly proportion flea tick heartworm medication product mix spring summer be consider peak season fall winter represent season quarter review petm acquire new customer year roughly order be generate versus prior year quarter gross margin expand basis point bps year year report quarter general administrative expense be year year also advertising expense rise lead increase adjust operate expense depreciation expense amount adjust operate margin quarter rise bps year quarter petm exit fiscal first quarter cash cash equivalent compare end fiscal company also declare quarterly dividend cent share payable shareholder record aug takepetm kick fiscal impressive fiscal first quarter result beating revenue earning be encourage note stellar increase reorder new order sale quarter meanwhile company be strive implement several strategy revitalize top line include increase focus advertising efficiency boost new order sale shift sale higher margin item also expand product offering petm currently offer wide range product cater dog cat horse be also work upgrading exist portfolio zack rank other key pickspetm currently have zack rank strong buy other top rank medical stock be mesa laboratory inc mlab free report insys therapeutic inc insy free report align technology inc algn free report notably insys therapeutic sport zack rank mesa laboratory align technology carry zack rank buy see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock have gain last month mesa laboratory deliver positive earning surprise last quarters stock have add roughly last month align technology have expect long term adjust earning growth almost stock have add roughly last month more stock news tech opportunity worth driverless car artificial intelligence ve see unsurpassed growth high tech product recent month yesterday science fiction be become today reality innovation be single component tech company survive demand critical device reach year alone likely grow even faster future zack have release brand new special report help take advantage exciting investment opportunity most importantly reveal stock massive profit potential see stock now
713,ALGN,st paul mn base ecolab inc ecl free report lead provider water hygiene energy technology service be expect report second quarter result aug last quarter company report earning cent share miss zack consensus estimate cent meanwhile trail quarters company deliver average earning miss let see thing be shape prior release factor playecolab earning growth challenge business environment raise investor confidence additionally company large base recur revenue industry lead technology excellent field service be significant propeller quarter review ecolab project adjust diluted earning share range compare year period be also upbeat acquisition abednego environmental service notably abednego part ecolab nalco water business operation be expect boost performance quarter nalco be worldwide leader sustainability service integrate water treatment solution current quarter analyst moved south compare upward revision last month zack consensus estimate earning share be stable same time frame slightly unfavorable price trend stock have solid potential appreciation long term expect earning growth rate furthermore uncertainty associate possibility repeal affordable care act president trump add company concern ecolab inc price ep surprise ecolab inc price ep surprise ecolab inc quoteearning whispersour quantitative model doesn conclusively point earning beat quarter stock be stock need have positive earning esp zack rank strong buy buy hold happen be not case here see zack esp earning esp ecolab be be most accurate estimate zack consensus estimate be peg uncover best stock buy sell re report earning esp filter zack rank ecolab carry zack rank increase odd earning beat earning esp keep prediction inconclusive please note caution stock zack rank sell rate go earning announcement especially company be see negative estimate revision stock considerhere be company want consider proven model show have right combination element post earning beat quarter becton dickinson company bdx free report have earning esp carry zack rank see complete list today zack rank stock here align technology inc algn free report have earning esp sport zack rank stryker corporation syk free report have earning esp carry zack rank more stock news tech opportunity worth driverless car artificial intelligence ve see unsurpassed growth high tech product recent month yesterday science fiction be become today reality innovation be single component tech company survive demand critical device reach year alone likely grow even faster future zack have release brand new special report help take advantage exciting investment opportunity most importantly reveal stock massive profit potential see stock now
714,ALGN,cerner corporation cern free report be schedule report second quarter result jul market close base north kansa city mo company provide healthcare information technology hcit solution worldwide cerner have stellar quarter average earning surprise last quarter cerner report adjust earning cent share beating zack consensus estimate cent notably earning improve cent year quarter company report net revenue beating zack consensus estimate meanwhile revenue rise year period delve deeper fundamental stock let see thing be shape prior release likely positive surprise proven model show cerner be likely beat earning have right combination key ingredient zack esp earning esp cerner be most accurate estimate stand cent zack consensus estimate be peg cent favorable zack esp serve meaningful lead indicator likely positive earning surprise uncover best stock buy sell re report earning esp filter zack rank cerner currently carry zack rank hold note stock zack rank strong buy buy have significantly higher chance beating earning conversely sell rate stock never be consider go earning announcement combination cerner zack rank positive esp make reasonably confident positive earning surprise season cerner corporation price ep surprise cerner corporation price ep surprise cerner corporation quotefactor considerview upbeat believe cerner strong sale performance solid portfolio strategic initiative have position stellar growth second quarter company forecast revenue adjust earning be now expect band cent cent share full year management expect revenue cerner currently forecast adjust earning band share development electronic health record system cerner announce have be choose department veteran affair develop electronic health record ehr system department veteran affair use same system company be develop department defense begin operation first site february system facilitate exchange datum military care facility civilian health provider current former service member receive care stable estimate revision trend current quarter analyst moved south compare upward revision last month zack consensus estimate earning share be stable cent same time frame robust portfolio believe cerner strong product portfolio help boost customer base frequent contract win reflect grow traction furthermore company have strong growth opportunity revenue cycle management rcm ambulatory space solid global foothold cerner be largest pure play hcit company wide footprint large reference able client base composite array solution make ideal candidate investor seek exposure hcit industry cerner offer exposure worldwide healthcare automation international operation provide more diversify revenue stream past company have win contract well middle east company have also be work client organization globally focus population health management profile other stock warrant lookhere be few other company want consider proven model show also have right combination element post earning beat quarter becton dickinson company bdx free report have earning esp zack rank see complete list today zack rank stock here align technology inc algn free report have earning esp zack rank stryker corporation syk free report have earning esp zack rank more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
715,ALGN,anthem inc antm free report release second quarter result jul market open last quarter company pull positive earning surprise let see thing be shape announcement factor be consider be likely witness increase overall enrollment primarily backed substantial medical enrollment growth solid revenue growth be expect government business commercial business backed strong enrollment growth iowa medicaid contract be likely have boost company top line significantly medicare advantage product offering have support medicare enrollment growth again boost company top line however anthem expect witness higher medical cost individual aca compliant product be case last quarter addition company be also likely have experience higher benefit expense ratio medicaid business due higher claim administrative cost have rise second quarter continue previous quarter trend earning whispersour proven model do not conclusively show anthem be likely beat earning quarter be stock need have positive earning esp zack rank strong buy buy hold happen be not case here see zack esp anthem have earning esp be most accurate estimate be zack consensus estimate be peg higher uncover best stock buy sell re report earning esp filter zack rank anthem currently sport zack rank favorable zack rank increase predictive power esp need positive earning esp be confident earning beat anthem inc price ep surprise anthem inc price ep surprise anthem inc quoteconversely sell rate stock never be consider go earning announcement stock considerhere be company medical sector want consider have right combination element post earning beat quarter align technology inc algn free report be set report second quarter earning jul have earning esp zack rank see complete list today zack rank stock here pfizer inc pfe free report have earning esp zack rank company be set report second quarter earning aug humana inc hum free report have earning esp zack rank company be set report second quarter earning aug more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
716,ALGN,centene corporation cnc free report release second quarter result jul market open last quarter company deliver positive earning surprise let see thing be shape announcement factor be consider buyout health net be expect have boost company growth potential significantly increase revenue company missouri medicaid contract active be likely have increase membership thereby boost revenue growth second quarter medicare advantage plan operational new state jan be expect have continue contribute company revenue growth company government sponsored health insurance business be anticipate have perform well add top line company share repurchase program intend enhance shareholder value have impact margin positively reduce outstanding share count nevertheless health net high selling general administrative expense be expect have increase overall cost thereby limit bottom line growth increase cost related interest payment reserve settlement legal judgment lawsuit impairment long live asset have affected earning earning whispersour proven model do not conclusively show centene be likely beat earning quarter be stock need have positive earning esp zack rank strong buy buy hold happen be not case here see zack esp centene have earning esp be most accurate estimate zack consensus estimate be peg uncover best stock buy sell re report earning esp filter centene corporation price ep surprise centene corporation price ep surprise centene corporation quotezack rank centene carry zack rank favorable zack rank increase predictive power esp need positive earning esp be confident earning beat caution sell rate stock zack rank go earning announcement especially company be see negative estimate revision stock considerhere be company medical sector want consider have right combination element post earning beat quarter align technology inc algn free report be set report second quarter earning jul have earning esp zack rank see complete list today zack rank stock here pfizer inc pfe free report have earning esp zack rank company be set report second quarter earning aug humana inc hum free report have earning esp zack rank company be set report second quarter earning aug more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
717,ALGN,universal health service inc uhs free report be set report second quarter result jul market close last quarter company pull positive earning surprise let see thing be shape announcement factor be consider health be likely have witness rise revenue adjust patient day behavioral health division continue previous quarter trend company acute care division be expect have deliver decent performance back adjust admission growth universal health service inc price ep surprise universal health service inc price ep surprise universal health service inc quoteuniversal health effort enhance shareholder value share repurchase have boost bottom line limit share count nevertheless increase cost related interest payment reserve settlement legal judgment lawsuit impairment long live asset have put pressure margin earning whispersour proven model do not conclusively show universal health be likely beat earning quarter be stock need have positive earning esp zack rank strong buy buy hold happen be not case here see zack esp universal health have earning esp be most accurate estimate zack consensus estimate stand uncover best stock buy sell re report earning esp filter zack rank universal health carry zack rank favorable zack rank increase predictive power esp need positive earning esp be confident earning beat conversely caution sell rate stock zack rank go earning announcement especially company be see negative estimate revision stock considerhere be company medical sector want consider have right combination element post earning beat quarter align technology inc algn free report be set report second quarter earning jul have earning esp zack rank see complete list today zack rank stock here pfizer inc pfe free report have earning esp zack rank company be set report second quarter earning aug humana inc hum free report have earning esp zack rank company be set report second quarter earning aug more stock news tech opportunity worth driverless car artifical intelligence ve see unsurpassed growth high tech product recent month yesterday science fiction be become today reality innovation be single component tech company survive demand critical device reach year alone likely grow even faster future zack have release brand new special report help take advantage exciting investment opportunity most importantly reveal stock massive profit potential see stock now
718,ALGN,stryker corporation syk free report lead player medical technology space be set report second quarter result jul bell last quarter company post earning share surpass zack consensus estimate cent notably average stryker beat zack consensus estimate almost last quarters let see thing be shape prior release likely positive surprise proven model show stryker be likely beat estimate have right combination key ingredient zack esp stryker earning esp be most accurate estimate be higher zack consensus estimate favorable esp serve meaningful indicator likely positive surprise uncover best stock buy sell re report earning esp filter zack rank stryker currently have zack rank buy note stock zack rank strong buy hold have significantly higher chance beating earning estimate conversely sell rate stock zack rank never be consider go earning announcement combination stryker favorable zack rank positive esp make reasonably confident beat stryker corporation price ep surprise stryker corporation price ep surprise stryker corporation quotefactor second quarter stryker expect adjust earning share range notably indicate rise year year basis believe grow adoption mako robot drive sale orthopedic reconstructive surgery market additionally stryker be well poise acquisition sage physio control past full year company expect adjust earning band stryker expect organic sale growth full year tie indo uk institute health medicity program be important factor well notably be year partnership aim offer primary joint replacement orthopedic area hip knee trauma product healthcare service india low cost company estimate revision trend be encourage current quarter stryker see upward estimate movement movement opposite direction last month current quarter estimate earning share be peg stock warrant lookhere be company want consider proven model show have right combination element post earning beat quarter becton dickinson company bdx free report have earning esp zack rank see complete list today zack rank stock here align technology inc algn free report have earning esp zack rank thermo fisher scientific inc tmo free report have earning esp zack rank make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
719,ALGN,jul issue update research report qiagen qgen free report company business be expect get boost flourishing molecular diagnostic market international expansion extend test menu growth drive strategic collaboration meanwhile past month share qiagen have underperform industry stock have lose versus industry increase decline hpv sale unite state persist be drag qiagen slow apac sale also remain soft due sluggish apply testing business moreover qiagen be expose stiff competition company be face severe rivalry firm provide similar pre analytical solution other product used customer incite fierce cut throat contest industry qiagen wo be further aggravate highly aggressive price sensitive market product also heavy reliance collaboration decline hpv human papillomavirus sale unite state act other negative industry player qiagen price qiagen price qiagen quoteon positive note be upbeat qiagen progress test menu expansion strategy april company announce receipt fda pre market approval partosure same month launch qiastat dx europe follow closure recently announce stat dx acquisition completion defined development activity stat dx company be plan launch qiastat dx test unite state well other geography additionally qiagen introduce novel liquid biopsy panel namely adnatest ar kit adnatest lungcancer kit first quarter qiagen announce receive approval japan ministry health labor welfare quantiferon tb gold qft diagnostic detect tuberculosis tb infection further recently change guideline issue world health organization center disease control international panel physician association add impetus rise popularity proactive latent tb screening treatment also look forward implementation recently draw strategy boost top line contribution ngs next generation sequence portfolio zack rank key picksqiagen currently carry zack rank sell better rank stock broader medical space include genomic health ghdx free report align technology inc algn free report stryker corporation syk free report genomic health have expect earning growth rate quarter be report stock sport zack rank strong buy see complete list today zack rank stock here align technology have project long term earning growth rate zack rank buy stryker have estimate long term earning growth rate zack rank medical stock buy nowzack name company poise ride medical breakthrough be target cure leukemia aids muscular dystrophy hemophilia other condition new product field be already generate substantial revenue even more wondrous treatment be pipeline early investor realize exceptional profit click here see stock
720,ALGN,home more half world population asia pacific apac have significant unmet healthcare need hold attractive growth potential medtech bigwig add further optimism corner healthcare be trump clear focus market article publish economic time asian healthcare market be expect grow more upside be attribute improve access healthcare facility increase government private investment china trade warmeanwhile investor be concern ongoing trade dispute severely hurt medtech company profit emerge market accuse china unfair trade practice president donald trump have impose tariff import china just day slap punitive duty chinese good be follow immediate retaliation china impose tariff export blow follow trump proposal implement tariff more worth chinese good article christian jone mondaq medtech firm unite state currently sell worth medical device annually china import total go jp morgan report trade war bring collateral damage country closely tie china supply chain include south korea taiwan malaysia singapore thailand india korea relation raise hopeamid trade war uproar trump latest stance rest apac have be breather investor last landmark asia trip trump reveal stronger reliance india strategic partner fact see india heart asia policy keep trump new policy lower drug price have positive impact india bilateral trade relation further help fix price certain exorbitant pharmaceutical medical device emergo article show indian medical device market be value expand moreover business standard article suggest india import medical device unite state grow inr inr meanwhile ty north korea seem be improve recent historic summit president kim jong trump put age old war tactic hold korea summit trump swear provide security guarantee dprk democratic person republic korea complete korean peninsula successful nuclear talk be likely pave way mutually beneficial trading relationship begin point future datum publish korea country commercial guide total import medical device korea gross unite state contribute more furthermore market share represent approximately korean import market choose right economy be gradually focuse lucrative asia pacific market be right time investor cash opportunity market have shortlist few medical device stock have carved niche asian market such stock be likely log massive gain give solid stand apac region present first pick be baxter international bax free report have solid presence asia research hub japan china company renal care team recently launch kaguya peritoneal dialysis technology japan baxter complete acquisition india base claris injectable global generic injectable pharmaceutical company almost buyout bolster baxter foothold generic pharmaceutical space same year baxter sign agreement india base dorizoe lifescience expansion generic injectable pipeline zack rank buy stock have outperformed industry year time company share have rally compare industry rise see complete list today zack rank strong buy stock here next list be align technology algn free report zack rank company invisalign technology have be widely adopt apac region asia pacific region company witness first quarter volume growth lead china japan australia moreover align technology china stand second largest market unite state company also introduce clear aligner solution class ii correction invisalign technology mandibular advancement certain market apac fda approval same be expect second half past year share align technology have sky-rocket compare industry rise investor also consider intuitive surgical inc isrg free report zack rank hold company flagship da vinci general surgery urology procedure have be witness consistent growth asia intuitive surgical also see multispecialty growth china last report quarter recently additional procedure be grant reimbursement ministry health japan earlier year california base manufacturer surgical system announce start operation india distributor vattikuti technology pvt ltd read more intuitive surgical commence direct operation india past year share intuitive surgical have rally whopping industry decline medical stock buy nowzack name company poise ride medical breakthrough be target cure leukemia aids muscular dystrophy hemophilia other condition new product field be already generate substantial revenue even more wondrous treatment be pipeline early investor realize exceptional profit click here see stock
721,ALGN,recent year grow healthcare cognizance have lead continuous technological innovation dental equipment space time have emerge most favore sector medical device investor look consistent attractive return let delve deeper last year dental supply market have be fare better index market have gain eclipse broader market ally market research report global dental implant prosthetic market be expect catapult value cagr go estimate american dental association publish grand view research year implant be carry unite state indicate huge market potential today fast pace time implant be prefer conventional removable denture owing comfort convenience factor drive demand dental treatmenthigh demand child teenager market market report child teenager be expect dominate global orthodontic market come year high number patient malocclusion jaw disorder be likely drive demand also rise need fix brace child teenager act major demand propeller notably orthodontic treatment be more effective successful childhood teenage noteworthy development niche space be launch align technology clear aligner solution class ii correction invisalign technology mandibular advancement certain market canada emea apac cosmetic need grow awareness esthetic need have also be major growth catalyst dental prosthetic market market market global cosmetic dentistry be expect make cagr moreover increase disposable income give rise higher demand cosmetic dental surgery rise geriatric population age population have also be significant contributor higher incidence calcium deficiency older person lead tooth loss accord national institute dental craniofacial research more adult age year have lose tooth person medication chronic metabolic disorder also reach edentulous state other factor poor lifestyle choice unhygienic dental care lead higher demand dental procedure increase dental disease be factor also dental injury cause road accident lead higher demand dental implant prosthetic technological advancement shape dental implant marketthe global dental implant prosthetic market be gradually shift conventional technologically advanced laser dentistry be much demand dental patient painless extraction tooth orthodontic periodontal decay market market dental laser market be expect scale value cagr dental printing be process create dimensional solid dental model such implant surgical guide brace denture crown bridge etc notably printing be gain popularity allow dentist carry procedure more precision efficiency save patient excess trauma go report transparency market research global dental printing market be expect see cagr reach worth stock focuswe have select company believe be well poise provide impressive long term return give encourage growth prospect global dental implant prosthetic market align technology inc algn free report have long term earning growth rate current quarter estimate revision trend stock have be encourage estimate move upward compare downward movement past month resultantly zack consensus estimate earning share rise company year historical growth rate be favorable compare industry company share price movement past year have be encourage company yielded almost better industry align technology recently sign agreement glidewell dental distribute itero element intraoral scanning system latest glidewell io office solution north america henry schein inc hsic free report have long term earning growth rate company historical year earning growth rate compare favorably industry past month share henry schein have outperformed industry belong stock have lose compare industry fall estimate revision current year have be solid estimate north compare move south past month resultantly consensus estimate earning climb ride strength full range dentsply sirona inc xray free report line company have be gain solid uptake product key dental equipment manufacturer dec midmark shape furthermore management believe company be well position gain wave digitalization corporation dhr free report have long term earning growth rate estimate revision current year have be solid estimate move compare movement opposite direction past month resultantly consensus estimate earning rise company year historical growth rate be higher industry share company have rally past year outperform industry decline today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
722,ALGN,share price align technology inc algn free report scale new week high nov close nominally lower company have gain last month much higher gain align technology have also beat broader industry gain respect share price last month stock have market cap further align technology estimate revision trend current year be favorable past day estimate moved shift consequently estimate be share company also have trail quarter average positive earning surprise positive long term growth hold promise well company year historical growth rate be also favorable compare broader industry align technology sport zack rank strong buy company have impressive growth style score growth style score highlight vital metric company financial obtain clearer picture quality sustainability growth research show stock style score combine zack rank buy hold offer best investment opportunity align technology inc price consensus align technology inc price consensus align technology inc quote growth market be upbeat align technology recently report impressive third quarter performance year year growth earning revenue be encourage additionally company have strong cash balance enable carry share repurchase turn provide solid return investor expansion gross operate margin also buoy optimism company be also constantly investing product innovation recently company open first office canada support growth region accord company canada be second largest market base invisalign case volume align technology have also become part nasdaq index nasdaq equal weight index recently factor be expect boost company share price other key picksother top rank stock broader medical sector be petm express inc pet free report luminex corporation lmnx free report intuitive surgical inc isrg free report notably petm luminex sport zack rank intuitive surgical carry zack rank see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly last year luminexha long term expect earning growth rate stock have gain last year intuitive surgical have long term expect earning growth rate stock have gain last year wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
723,ALGN,investor wish have magical portfolio stock way ticket success be easier say do market be volatile be now thing take turn moment matter discipline systematic investor be equity market volatility always manage get better few lucky one rake moolah other fall victim ad strategy resort commonly used technique find beaten stock have potential recover faster other however even such investment choice bear risk disappointment particularly be stick value trap hide weakness select stock be not identify so wouldn be safer strategy look stock be winner currently have potential gain further here execute primarily look stock be witness price increase actually stock see price strength recently have high chance carry momentum forward stock be continuously move higher be good reason rise else probably have fall loser so look stock have already win game be capable beating benchmark have set be rational however recent price strength alone create magic therefore need set other relevant parameter create successful investment strategy here create screen shortlist current well potential winner screening parameter percentage change price week greater criterion show stock have moved higher last week percentage change price week greater indicate stock have see momentum last month lower risk choose stock have draw attention due overwhelming performance overall market very short period zack rank matter market condition be good bad stock zack rank strong buy have proven history outperformance see complete list today zack rank stock here average broker rating indicate broker be also highly hopeful stock future performance current price greater stock be trading minimum current price week high low range more criterion filter stock be trading respective week high indicate be strong enough term price here be stock make screen columbus mckinnon corporation cmco free report be broad line designer manufacturer supplier sophisticated material handle product integrate material handle solution be widely distribute industrial consumer market worldwide last quarter company deliver positive earning surprise par pacific holding inc parr free report manage maintain interest energy infrastructure business last quarter company deliver positive earning surprise braskem bak free report figure largest petrochemical operation latin america largest private company brazil last quarter company deliver positive earning surprise cnb financial corporation ccne free report be bank hold company headquarter clearfield pa conduct business principally county national bank market area include convenient office location pennsylvania last quarter company deliver positive earning surprise connectone bancorp inc cnob free report be community base full service commercial bank hold company last quarter company deliver positive earning surprise align technology inc algn free report design manufacture market invisalign system proprietary method treat malocclusion last quarter company deliver positive earning surprise advansix inc asix free report be producer supplier nylon material last quarter company deliver positive earning surprise get rest stock list start putt other idea test be do research wizard stock pick backtesting software research wizard be great place begin easy use everything be plain language very intuitive start research wizard trial today next time read economic report open research wizard plug find see gem come click here sign free trial research wizard today disclosure officer director employee zack investment research own have sell short security hold long short position option be mentioned material affiliated investment advisory firm own have sell short security hold long short position option be mentioned material disclosure performance information zack portfolio strategy be available https www zack com performance zack restaurant recommendation addition dine special place feast stock share zack special report spotlight recent ipos watch stock offer immediate promise boom sector download free
724,ALGN,becton dickinson company bdx free report be big mover last session company see share rise nearly day move come solid volume too far more share change hand normal session stock remain volatile trade range past month time frame witness sharp increase yesterday move come company post better expect third quarter result becton dickinson have see positive estimate revision versus negative estimate revision past month zack consensus estimate current quarter have also revise upward past day suggest more solid trading be ahead company so make sure keep eye stock go forward see recent jump turn more strength road becton dickinson currently have zack rank buy earning esp be positive becton dickinson company price consensus becton dickinson company price consensus becton dickinson company quotea better rank stock medical dental supply industry be align technology inc algn free report carry zack rank strong buy see complete list today zack rank stock here be bdx go predict see other think downlooking stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
725,ALGN,oct issue update research report align technology inc algn free report stock currently sport zack rank strong buy align technology manufacture market system clear aligner therapy intra oral scanner cad cam computer aid design manufacturing digital service used dentistry orthodontic dental record storage have be trading industry past month stock have gain period compare growth industry company deliver encourage third quarter post better expect earning revenue be encourage company solid invisalign technology prospect growth north america internationally company receipt patent smarttrack aligner material also buoy optimism moreover align technology have be see strong international sale especially emea apac region third quarter marked milestone company china become second largest market globally unite state top number align technology witness balanced sale growth channel recent past primarily drive high invisalign technology case volume solid performance summer drive invisalign growth global market encourage development company recently sign distribution agreement patterson dental exclusive agreement effective september align technology itero element intraoral scanning system be available part patterson dental cad cam portfolio unite state canada flipside adverse foreign exchange translation continue raise concern align technology international operation also escalate cost expense be weigh margin moreover tough competitive landscape other macroeconomic headwind threat other key picksother top rank stock broader medical sector be petm express inc pet free report luminex corporation lmnx free report intuitive surgical inc isrg free report notably petm luminex sport zack rank intuitive surgical carry zack rank buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly last year luminexha long term expect earning growth rate stock have gain last year intuitive surgicalha long term expect earning growth rate stock have gain last year zack best private investment ideaswhile be happy share many article best recommendation most depth research be not available public start today next month follow zack private buy sell real time expert cover kind trade value momentum stock etf option move stock corporate insider be buy company be report positive earning surprise even look exclusive portfolio be normally close new investor click here zack private trade
726,ALGN,automate financial management betterment wealthfront burton malkiel be market too random resource deep learn ai future face qplum automate investing used ai datum science concern qplum same science work takeaway qplum episode roundup podcast zack comwelcome back mind money kevin cook field guide story teller fascinating arena behavioral economic remember try pick mutual fund list employer retirement saving program be always feel limit available choice question fund top holding wonder manager skill commitment incentive even innovation target date fund probably feel lock somebody else idea blend investment risk vs return matrix achieve goal thankfully innovation be accelerate fintech moniker fast change field financial technology new investing platform model have betterment accord company used diversification automate rebalance better behavioral guardrail low fee approach long term investing help generate higher return typical diy investor nod enable better investor behavior want learn more imagine behavioral guardrail be thing prevent warning person take too much risk too short time horizon place too much concentration sector panic selling extreme move lower be buy even take cash retirement fund too early incur extremely negative penalty tax consequence wealthfront be similar new enterprise say investment strategy be sophisticated philosophy be simple technology do thing better person claim used software better execute time test investment strategy ultimately reduce risk reduce taxe reduce fee be also keen share self description wealthfront fortune favor smart not bold pick stock chasing market fluctuation be exciting come long term investing expect outperform market so solution indexing simply mean parking money diversify portfolio low cost index fund have patience stay course wealthfront say be radical idea economist burton malkiel first introduce smart guy burt so smart make wealthfront chief investment officer now here get interesting idea person have more choice grow retirement saving be also active investor stock picker trader heart be most follower newsletter zack burton malkiel be progenitor philosophy run counter belief market be too random succeed stock picker invest index mutual fund author classic finance book random walk wall street be lead proponent efficient market hypothesis contend price publicly trade asset reflect publicly available information respect wealthfront approach believe be good solution million don care make time research stock mutual fund ll also stick belief follower indeed beat market many time frame year more come minute video investing lesson make last month introduce ai power platform call qplumin episode mind money re go focus new platform call qplum yes lower case learn more nvidia nvda free report ai podcast episode last june be precise host michael copeland interview qplum co founder guarav chakravorty ai podcast seem be learn lot new thing day not just be enthusiastic nvda investor also find future machine learn deep learn technology so exciting copeland episode start last november have create library fascinating interview exciting topic involve bleed edge technology consider listen podcast back qplum claim investing now be science not game achieve goal be used dynamic ai strategy protect downturn describe core investment belief company qplum team say believe mathematics datum drive decision make science behavioral economic art effective communication qplum emphasize be offer investing strategy not product product be come datum scientist engineer chakravorty spend start career build machine learn model take finance class wharton inspire bring world together contrary wall street hedge fund hire quantitative phds build complex investing trading algorithms qplum taught ai learn market datum work best long term give chance re balance portfolio day qplum utilize best practice process institutional investor manage wealth rather make great prediction portfolio many growth opportunity avoid downturn addition low fee cost also have unique risk management model prevent compound loss market slide potentially turn bigger longer downturn firm offer different strategy base risk tolerance time horizon thing don make perfectly clear podcast be qplum only used etfs investment strategy selection nearly dozen etfs pool employ tax efficient strategy loss capture still be market model say be be sure listen mind money podcast attach article learn more exciting ai power investing approach qplum also challenge company scientific approach market vein everybody do still work be important question ask deal infinite complexity wild randomness social beast market say read black swan nassim nichola taleb taught severe limit standard deviation measure market risk anything happen be standard deviation look forward learn more qplum hope have mr chakravorty company representative mind money podcast great resource last week episodenow want make sure have resource only briefly mentioned last week episode deep learn first be time com article college student prepare automate future joseph aoun aoun be president northeastern university author robot proof higher education age artificial intelligence copyright mit press next be recent report tesla tsla free report be tesla bear year bail company solarcity didn understand company commitment develop next iteration electric consumer vehicle model revenue ramp be come next year send tesla stock new high here article bear day tesla tsla free report finally offer minute video successful growth investing bull market other wring hand interest rate correction valuation explain winning equal follow other smart well heeled investor really do homework approach have help stay winning stock facebook fb free report alibaba baba free report align technology algn free report here best investing advice give just minute trick bull own share nvda baba fb algn zack tazr trader portfolio kevin cook be senior stock strategist zack investme
727,ALGN,edward lifescience corporation ew free report have be gain investor confidence consistently positive result past month stock have gain industry decline also company have outperformed increase manufacturer tissue heart valf repair product used replace repair patient diseased defective heart valve have market cap company historical year growth rate be favorable compare industry solid prospect zack rank buy stock be attractive pick investor moment style score edward lifescience have growth score be reflective company strong prospect research show stock growth style score combine zack rank strong buy offer best upside potential let find recent positive trend be sustainable impressive long term growth strategy last december edward lifescience announce outlook focuse long term growth technology pipeline thv edward lifescience expect maintain leadership position global tavr market enhance focus expand patient access actively leverage current valve platform additional indication develop next generation valve platform maintain trust relationship clinician payer regulator long term edward lifescience expect generate organic underlie sale growth meaningfully higher rate industry average margin front company anticipate moderate expansion gross margin improve mix partially offset capacity investment solid global prospectswe believe huge untapped potential emerge market be likely act positive catalyst edward lifescience management be strive strengthen foothold market asia especially japan management continue believe japan hold immense prospect business expansion major emerge nation launch sapien valve japan edward lifescience gas see strong adoption device nation company be look forward launch inspiris resilium aortic valve japan product pipeline development trackwe be encourage edward lifescience focus build pipeline strengthen foothold operate business company also witness growth emerge portfolio mitral tricuspid repair therapy latest development edward lifescience recently announce clinical trial sapien ultra system management expect receive ce mark ultra system second half moreover edward lifescience new ultra system include balloon delivery system next generation sheath technology be expect be available unite state late other key pickssome other top rank stock broader medical space be genomic health ghdx free report align technology inc algn free report stryker corporation syk free report genomic health have expect earning growth rate current quarter stock sport zack rank see complete list today zack rank stock here align technology have project long term earning growth rate zack rank stryker have project long term earning growth rate stock carry zack rank medical stock buy nowzack name company poise ride medical breakthrough be target cure leukemia aids muscular dystrophy hemophilia other condition new product field be already generate substantial revenue even more wondrous treatment be pipeline early investor realize exceptional profit click here see stock
728,ALGN,bioscrip inc bio free report have be gain investor confidence consistently positive result past month company stock have outperformed industry stock have gain compare industry company have also outperformed gain market well lead pure play infusion service provider have market cap solid prospect zack rank buy stock be attractive pick investor moment company earning estimate revision trend current year have be positive past day analyst revise estimate upward movement opposite direction resultantly estimate loss share have narrow cent cent zack style score system bioscrip have growth score reflect company solid prospect research show stock growth style score combine zack rank strong buy offer best upside potential let find recent positive trend be sustainable core turnaround plan bode wellwe be upbeat bioscrip bio free report progress last report quarter courtesy multus faceted core plan improve financial position company launch core initiative plan represent focus identify execute strategy accelerate bioscrip core revenue growth mix drive operational efficiency improve revenue collection increase employee effectiveness organization end first quarter company announce be track achieve goal core revenue mix register core mix quarter grow infusion have be record consistent growth core infusion service business enjoy competitive advantage solid growth business have be primarily account strong organic growth particularly chronic nutrition other therapy order boost infusion service business bioscrip have take number step sale legacy specialty mail service pharmacy sale home health service business divestment pbm business effort expand business look healthcare landscape change rapidly bioscrip have be focuse recent year grow core infusion service platform clinically focuse customer orientated model company focus be drive growth core infusion service be also engage aggressive reduction cost currently company aim emerge smaller more focuse organization significantly improve profitability improve operate cash flow other key pickssome other top rank stock broader medical space be genomic health ghdx free report align technology inc algn free report stryker corporation syk free report genomic health have expect earning growth rate current quarter stock sport zack rank see complete list today zack rank stock here align technology have project long term earning growth rate zack rank stryker have project long term earning growth rate stock carry zack rank hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
729,ALGN,abbott free report medical device business have be go strong late solid sub segmental performance expect strength get reflect second quarter result be schedule release jul market open click here know company overall performance be expect be medical device focusabbott medical device segment presently comprise new cardiovascular neuromodulation heart failure structural heart rhythm management vascular business diabetes care business abbott laboratory price ep surprise abbott laboratory price ep surprise abbott laboratory quotemanagement expect mid high single digit growth medical device second quarter sale continue double digit growth certain sub segment consequently zack consensus estimate medical device revenue unite state indicate rise year quarter internationally consensus estimate show growth last quarter sale improvement segment be drive double digit growth neuromodulation diabetes care moreover company receive approval few product achieve clinical trial milestone let see thing be shape sub segment second quarter result account medical device revenue have be gain strongly recent launch confirm insertable cardiac heart monitor unite state europe furthermore continue uptake ensite precision cardiac mapping system be expect contribute strongly top line second quarter abbott strengthen position business successive receipt fda ce mark new advisor hd grid mapping catheter company have launch product country then currently await commercial launch unite state zack consensus estimate revenue indicate increase year company be expect keep gain strength business last report quarter company witness impressive sale growth heart failure business solid uptake recently launch heartmate system unite state zack consensus estimate heart failure business revenue indicate rise year quarter provide impetus vascular total medical device revenue business unite state abbott recently announce receipt fda approval xience sierra encouragingly note vascular business company have see slew development regard xience sierra coronary stent system company also achieve national reimbursement xience sierra company have also be get positive response xience sierra coronary stent system post launch europe zack consensus estimate vascular revenue show improvement year quarter structural heart business have maintain impressive top line performance last report quarter business account total revenue broader medical device segment upside be lead continue double digit growth mitraclip march abbott announce receipt national reimbursement japan same notably nearly country more person have be treat mitraclip further company announce receipt fda approval world smallest rotatable bileaflet mechanical heart valve master hp mm approval company have expand master series portfolio structural heart positive development be expect boost top line contribution sub segment be report quarter estimate structural heart revenue also indicate rise year quarter diabetes care international sale growth prior quarter be drive abbott freestyle libre company recently initiate launch freestylelibre unite state well proceed initiative boost arm company announce availability freestyle librelink app europe use smartphone iphone android zack consensus estimate diabetes care revenue indicate surge year quarter meanwhile be upbeat abbott kick start receipt fda approval magnetic resonance mr conditional labele quadra assura mp cardiac therapy defibrillator crt fortify assura implantable cardioverter defibrillator icd company most widely used high voltage medical device approval come heel recent mr conditional labele approval assurity mri pacemaker ellipse icd associate mri compatible lead development be expect boost rhythm management business consensus estimate rhythm management revenue show improvement year zack rank stock considerabbott carry zack rank hold better rank stock broader medical space be genomic health ghdx free report align technology inc algn free report stryker corporation syk free report genomic health have expect earning growth rate current quarter stock sport zack rank strong buy see complete list today zack rank stock here align technology have project long term earning growth rate zack rank buy stryker have project long term earning growth rate stock carry zack rank hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
730,ALGN,now volley earning release be corner investor be look stock beat market expectation be investor always try position ahead time look tap stock be high quality nature be positive earning surprise so important historically stock company solid quarterly earning nominal basis tank miss merely meet market expectation earning rise apparently look good doesn tell earning growth have be exhibit decelerate trend also seasonal fluctuation come play sometimes company be seasonally weak strong then be likely report sequential earning decline such case growth rate be mislead judge true health company other hand much brainstorm analysis company financial initiative wall street analyst project earning company fact club insight company guidance derive earning estimate thus outperform estimate be almost equivalent beating company own expectation well market perception margin earning surprise be big typically drife stock higher right release thus more anything else earning surprise push stock higher find stock beat now find stock have potential beat bottom line be investor dream not easy job way do be look earning surprise history company impressive track regard generally act catalyst send stock higher indicate company ability surpass estimate investor generally believe company apply same secret sauce execute yet earn beat next release winning strategyin order shortlist stock be likely come earning surprise choose follow primary screening parameter last ep surprise greater equal stock deliver positive surprise last quarter tend surprise again average ep surprise last quarters greater lift bar outperformance slight higher set average earning surprise last quarters average ep surprise last quarters greater point more consistent surprise history make case surprise even stronger addition place few other criterium push chance positive surprise zack rank less equal only company zack rank strong buy buy rating get earning esp greater stock need have positive earning esp zack rank earning beat happen proven model order have long term growth potential high trading liquidity have add follow parameter too next year estimate ep growth year greater solid expect earning growth exhibit stock long term growth prospect average day volume greater high trading volume imply stock have adequate liquidity handful criterium have narrow universe stock here be stock decker outdoor corporation deck free report be global leader design distribute innovative footwear apparel accessory develop everyday casual lifestyle use high performance activity belong top rank zack industry top stock carry zack rank see complete list today zack rank stock here wellcare health plan inc wcg free report zack rank company focus provide government sponsored manage care service stock belong top rank zack industry top align technology inc algn free report be global medical device company hail top rank zack industry top have zack rank capstone turbine corporation cpst free report zack rank company develop design assemble sell capstone microturbine hail top rank zack industry top twitter inc twtr free report zack rank social medium company belong top rank zack industry top get rest stock list signing now week free trial research wizard start used screen own trading further also create own strategy test first take investment plunge research wizard be great place begin easy use everything be plain language very intuitive start research wizard trial today next time read economic report open research wizard plug find see gem come click here sign free trial research wizard today disclosure officer director employee zack investment research own have sell short security hold long short position option be mentioned material affiliated investment advisory firm own have sell short security hold long short position option be mentioned material disclosure performance information zack portfolio strategy be available http www zack com performance zack restaurant recommendation addition dine special place feast stock share zack special report spotlight recent ipos watch stock offer immediate promise boom sector download free
731,ALGN,boston scientific corporation bsx free report have be gain investor confidence consistently positive result past month company share price have outperformed industry stock have rally compare industry rise also company have surpass breakeven share performance developer manufacturer marketer medical device use interventional medical specialty have market cap company have long term historical earning growth rate next year solid prospect zack rank buy stock be attractive pick investor moment company estimate revision trend current year have be positive past day only analyst have revise estimate upward movement be noticed opposite direction however earning estimate remain unchanged boston scientific corporation price boston scientific corporation price boston scientific corporation quotelet find recent positive trend be sustainable solid quarterly scientific continue deliver better expect quarterly earning revenue number be upbeat company witness growth business line geography strategic buyout be upbeat boston scientific recent acquisition apama medical deal company aim expand suite arrhythmia solution fall ep sub segment further gain traction ep market boston scientific announce plan acquire securus medical privately hold developer thermal monitoring system continuous measurement esophageal temperature be also look forward company recent agreement acquire cryterion medical privately hold company develop single shot cryoablation platform treatment atrial fibrillation addition cryoballoon platform help boston scientific emerge first entity cryothermal radiofrequency single shot balloon base ablation therapy portfolio geographic expansionboston scientific integral growth strategy be continue pursue developmental opportunity outside unite state expand global presence inclusive emerge market company be gradually fortify footprint emerge market include brazil russia india china first quarter business emerge market register growth company be gain strong ground india well target emerge market additional stimulus boston scientific hope sustain robust overall international performance ride high product launch currently early stage rollout suspension medtech decision house senate suspend medical device tax year have come relief medical device bigwig boston scientific company temporary suspension allow continue investment plan innovative medical product company meanwhile have plan work full repeal medtech tax other stock considerother top rank stock broader medical space include genomic health ghdx free report align technology inc algn free report stryker corporation syk free report genomic health have expect earning growth rate quarter be report stock sport zack rank strong buy see complete list today zack rank stock here align technology have project long term earning growth rate zack rank stryker have estimate long term earning growth rate zack rank hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
732,ALGN,abaxis inc abax free report be close heel takeover bid zoetis inc zts free report be announce last end company recently state wait period hart scott rodino antitrust improvement act hsr act have expire transaction be still subject other customary close condition include approval abaxis shareholder accordingly jul company stockholder vote transaction soon acquisition get close meanwhile let glance deal detail once again animal health company zoetis have make cash offer share total value abaxis shareholder be premium close abaxis share price denote figure just news release expect synergy adoption abaxis point care diagnostic instrument zoetis expect consolidated company veterinary diagnostic category grow faster animal health industry management integration fetch significant synergy benefit company abaxis announce have recently invest expand operation europe latin america asia pacific region revenue expect be draw internationally fiscal meanwhile zoetis already have substantial global presence direct veterinary customer relationship deliver greater value more customer worldwide undoubtedly buyout discussion then accelerate growth combine entity overseas business market market report veterinary diagnostic market be anticipate witness cagr reach value share price performancein past month share abaxis have rally outperform industry growth zack rank key picksabaxis currently carry zack rank hold better rank stock broader medical space be genomic health ghdx free report align technology inc algn free report genomic health have expect earning growth rate quarter be report stock sport zack rank strong buy see complete list today zack rank stock here align technology have project long term earning growth rate zack rank buy hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
733,ALGN,jul issue update research report medtronic plc mdt free report be encourage company global accept advanced therapy escalate cost expense raise concern stock have zack rank hold past month share medtronic have outperformed industry stock have grow compare industry rise notably medtronic exit fiscal solid note better expect fourth quarter performance major business group contribute solid top line growth cer highlight sustainability group region addition display successful integration achievement synergy target also gradually stabilize cardiac rhythm heart failure crhf market buoy optimism stock receipt fda approval dbs deep brain stimulation therapy adjunctive treatment reduce partial onset seizure raise hope company target medical market medtronic be also focuse geographical diversification business company be highly positive foray standalone cgm continuous glucose monitoring market guardian connect be currently upbeat latest fda nod minime system patient type diabetes year age significantly medtronic new restructure initiative enterprise excellence plan be aim annual growth run rate saving end fiscal company new program have be design increase effectiveness growth related reinvestment ability provide consistent boost margin expansion well drive ep leverage flip side company have be expose steep cost expense weigh heavily margin also guidance remain conservative apprehension lackluster cardiac vascular group cvg minimally invasive therapy group mitg performance turn dampen investor confidence stock key picksa few better rank stock broader medical sector be genomic health ghdx free report align technology inc algn free report stryker corporation syk free report genomic health have expect earning growth rate quarter be report stock sport zack rank strong buy see complete list today zack rank stock here align technology have project long term earning growth rate zack rank buy stryker have estimate long term earning growth rate zack rank look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
734,ALGN,boston scientific corporation bsx free report recently announce acquisition cryterion medical inc privately hold developer single shot cryoablation platform treatment atrial fibrillation acquisition boston scientific become only company boast comprehensive portfolio cover cryothermal radiofrequency single shot balloon base ablation therapy cryterion medical plan submit clinical evidence ongoing study cryoablation system get ce mark early further company plan submit investigational device exemption application fda seek regulatory approval unite state financial term dealboston scientific have exist investment cryterion medical be go make net upfront payment approximately cash remain stake however transaction be not expect be accretive company adjust earning share glimpse ep businessboston scientific ep business develop less invasive medical technology diagnose treat disorder heart rate well rhythm first quarter revenue division improve year year organically upside be drive higher uptake new rhythmia hdx platform management continue roll hdx platform europe recently launch platform unite state well japan overall company continue expand toolkit support rhythmia hdx provide ablation technology match excellence mapping system additionally focus add tool expand reach utility rhythmia hdx different procedure moreover expand ep business boston scientific recently announce acquisition securus medical group inc privately hold developer thermal monitoring system continuous measurement esophageal temperature market potentialboston scientific strategy boost ep business seem be align datum provide ally market research report global cardiac monitoring cardiac rhythm management market be expect reach value cagr company global ep market be expect worth further grow double digit single shot ablation therapy be estimate be most rapidly grow sub segment ep market thus addition single shot cryoablation platform help boston scientific cash abundant opportunity global cardiac monitoring cardiac rhythm management market share price scientific have be gain investor confidence consistently positive result past month share company have outperformed broader industry stock have rally versus industry increase zack rank other key picksboston scientific currently carry zack rank buy other top rank stock broader medical space be genomic health ghdx free report align technology inc algn free report stryker corporation syk free report genomic health have expect earning growth rate current quarter stock sport zack rank strong buy see complete list today zack rank stock here align technology have project long term earning growth rate zack rank stryker have project long term earning growth rate stock carry zack rank make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
735,ALGN,bio rad laboratory inc bio free report have be gain investor confidence consistently positive result past month company share price have outperformed industry stock have gain compare growth industry also company have outperformed fall renown manufacturer global supplier clinical diagnostic life science research product healthcare analytical chemistry life science research other market have market cap company project year growth rate be favorable compare industry solid prospect zack rank buy stock be attractive investment pick now company estimate revision trend current year have be positive past day analyst revise estimate upward movement opposite direction resultantly earning estimate increase share further zack consensus estimate current year revenue reflect improvement year year let find recent positive trend be sustainable solid global prospectsin first quarter bio rad derive net sale globally europe happen be largest international market company first quarter revenue growth region be apparently sluggish offset softness bio rad perform reasonably well primarily north america china asia pacific region growth linesbio rad witness sale growth channel first quarter sale life science segment be drive higher demand droplet digital pcr process chromatography cell biology product line further rise net sale clinical diagnostic indicated growth immunology diabetes quality control product line impressive synergy raindancebio rad complete acquisition raindance technology inc february acquire entity be integrate life science segment bid solidify position droplet digital pcr space further bio rad have begin realize synergy raindance acquisition first quarter bio rad record raindance sale comparison previous year company have also be witness solid growth sale droplet digital pcr solid balance sheeteffective capital deployment have be key contributor ep growth bio rad exit first quarter cash cash equivalent short term investment compare end other key pickssome other top rank stock broader medical space be genomic health ghdx free report align technology inc algn free report stryker corporation syk free report genomic health have expect earning growth rate current quarter stock sport zack rank strong buy see complete list today zack rank stock here align technology have project long term earning growth rate zack rank stryker have project long term earning growth rate stock carry zack rank make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
736,ALGN,jul initiate research report insulet corporation podd free report be upbeat company achievement milestone respect expansion omnipod market reach tough competitive landscape raise concern stock carry zack rank hold lead developer manufacturer marketer omnipod insulin management system have be outperform industry past year stock have gain versus industry rise insulet kick start positive reimbursement update begin cms issue guidance january require omnipod be cover medicare part prescription drug benefit program moreover effective apr express script magellan medicare part plan sponsor add omnipod cover benefit start april insulet receive access network coverage omnipod insulet have also take new role direct seller omnipod system europe start jul company be confident infrastructure believe be well position cash rapidly grow european customer base be also upbeat year year revenue growth last report quarter solid uptake omnipod system unite state other geography expand global customer base consistent strength market drive revenue meanwhile insulet operate highly competitive environment dominate firm range large multinational corporation significant resource start up also competitive regulatory condition market company operate limit insulet ability switch strategy price increase company omnipod system primarily compete medtronic plc mdt market lead minime system also company be expose risk associate weaker global economy lower reimbursement rate key pickssome better rank stock broader medical space be genomic health ghdx free report align technology inc algn free report stryker corporation syk free report genomic health have expect earning growth rate current quarter stock sport zack rank strong buy see complete list today zack rank stock here align technology have project long term earning growth rate zack rank buy stryker have project long term earning growth rate stock carry zack rank look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
737,ALGN,look find strong medical stock be prudent search company group be outperform peer have align technology algn free report be stock year quick glance company year date performance comparison rest medical sector help answer question align technology be individual stock medical sector collectively company sit zack sector rank zack sector rank include different group be list order best worst term average zack rank individual company sector zack rank be proven model highlight variety stock right characteristic outperform market next month system emphasize earning estimate revision favor company improve earning outlook algn be currently sporting zack rank buy zack consensus estimate algn full year earning have moved higher past quarter signal analyst sentiment be improve stock earning outlook be more positive latest available datum show algn have return start calendar year meanwhile medical sector have return average year date basis mean align technology be perform better sector term year date return look more specifically algn belong medical dental supply industry group include individual stock currently sit zack industry rank group have gain average so far year so algn be perform better area investor interest medical stock continue track algn stock be look continue solid performance
738,ALGN,align technology inc algn free report have be gain investor confidence consistently positive result past month company share price have outperformed industry stock have gain compare industry company have also outperformed gain market well lead manufacturer marketer system clear aligner therapy intra oral scanner cad cam computer aid design manufacturing digital service used dentistry orthodontic dental record storage have market cap company year historical growth rate be also favorable compare industry solid prospect zack rank buy stock be attractive pick investor moment company earning estimate revision trend current year have be positive past day analyst revise estimate upward movement opposite direction resultantly earning estimate increase share further zack consensus estimate current year revenue reflect improvement year year zack style score system align technology have growth score reflect company solid prospect research show stock growth style score combine zack rank strong buy offer best upside potential let find recent positive trend be sustainable solid global prospectsalign technology have undertake several strategy drive adoption invisalign technology include product technology development extend clinical effectiveness extension invisalign technology brand drive international growth year year basis align technology international invisalign technology volume last report quarter be reflect continue strong performance emea apac region emea company witness solid adoption invisalign technology market ofiberium france well rapid growth smaller market eastern europe central europe benelux asia pacific region company deliver solid performance lead china japan australia expand invisalign portfolio align technology invisalign portfolio offer orthodontic treatment straighten tooth metal brace bid broaden flagship invisalign portfolio company recently announce addition invisalign first clear aligner treatment younger patient early mixed dentition company plan commercially launch offer invisalign trained doctor unite state canada australia new japan emea region start july same time company extend invisalign clear aligner range latest launch vivera retainer precision bite ramp solid development invisalign be likely lendalign technology competitive edge medtech space grow itero portfolioalign technology have be focuse expand work flow option lead itero scanner further align technology announce receipt china food drug administration cfda approval commercially launch itero element intraoral scanner china be also upbeat company expand itero element portfolio launch itero element itero element flex scanner unite state majority european country include france germany italy spain unite kingdom align technology also announce plan launch invisalign go product improve user interface itero digital chairside experience increase flexibility treat variety mild moderate case other key picksother top rank stock broader medical space be genomic health ghdx free report abiom abmd free report stryker corporation syk free report genomic health have expect earning growth rate current quarter stock sport zack rank strong buy see complete list today zack rank stock here abiom have project long term earning growth rate zack rank stryker have project long term earning growth rate stock carry zack rank today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
739,ALGN,here be stock buy rank strong momentum characteristic investor consider today june align technology inc algn free report designer manufacturer clear aligner therapy system intraoral scanner have zack rank buy witness zack consensus estimate current year earning advance last day align technology inc price consensus align technology inc price consensus chart align technology inc quotealign technology share gain last month more loss company possess momentum score align technology inc price align technology inc price align technology inc quoteabiom inc abmd free report developer seller have zack rank strong buy witness zack consensus estimate current year earning advance last day abiom inc price consensus abiom inc price consensus chart abiom inc quoteabiom share gain last month company possess momentum score abiom inc price abiom inc price abiom inc quoteautomatic datum process inc adp free report provider business process outsource service have zack rank buy witness zack consensus estimate current year earning advance last day automatic datum process inc price consensus automatic datum process inc price consensus chart automatic datum process inc quoteautomatic datum share gain last month company possess momentum score automatic datum process inc price automatic datum process inc price automatic datum process inc quotesee full list top rank stock herelearn more momentum score be calculate here wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
740,ALGN,align technology inc algn free report strategy international expansion get solid impetus company achieve new landmark invisalign adoption company announce have complete shipment case europe middle east africa emea region align be significant milestone company reflect accelerate adoption invisalign clear aligner therapy align note millionth invisalign patient emea be year old julia leibold freiburg germany julia be be treat invisalign comprehensive package change aligner weekly basis follow new breakthrough align launch pro campaign july work doctor emea belt offer invisalign treatment multiple patient disability align intenrational profile glance align have undertake several strategy improve adoption invisalign technology globally include product technology development extend clinical efficacy extension invisalign technology brand recent time company international invisalign volume trend have consistently remain strong growth register first quarter reflect continue strong performance emea apac region emea first quarter volume be solid adoption invisalign technology market iberium france well owing rapid growth smaller market eastern europe central europe benelux asia pacific zone company witness surge first quarter volume lead china japan australia china stand close second largest market unite state align iberium follow third largest destination international case soar year year same quarter notably be sixth straight quarter invisalign teenage patient base grow faster adult patient population not only company late accomplish new feat respect invisalign treatment option introduce clear aligner solution class ii correction invisalign technology mandibular advancement certain market canada emea apac fda approval same be expect second half development be indicative grow popularity align dental product foreign market long term expect similar innovation act major catalyst align growth new well exist market share price performance share align have outperformed industry past month stock have surge compare industry rise zack rank other key picksalign currently carry zack rank buy few other top rank stock broader medical sector be genomic health ghdx free report abiom abmd free report stryker corp syk free report genomic health have expect earning growth rate second quarter stock sport zack rank strong buy see complete list today zack rank stock here abiom have project long term earning growth rate zack rank stryker have project long term earning growth rate zack rank hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
741,ALGN,walgreen boot alliance inc wba free report be slate release third quarter fiscal result market open jun last quarter company deliver positive earning surprise walgreen boot have outperformed zack consensus estimate precede quarters average positive earning surprise be let take look thing be shape prior announcement key catalystsover recent past walgreen boot retail pharmacy usa division have witness comparable prescription growth benefit strength retail prescription market notably revenue division account total second quarter fiscal revenue several plan development early benefit new pharmacy contract well increase volume owing previously announce pharmacy partnership have be drive growth space same time company have be gain strategic partnership fedex respect exist store last report quarter walgreen boot witness strength pharmacy sale account increase prescription volume company have already start gain recently acquire rite aid store walgreen boot alliance inc price ep surprise walgreen boot alliance inc price ep surprise walgreen boot alliance inc quotemoreover retail pharmacy market have be see rise expenditure prescription drug grow demand specialty drug furthermore company effort boost digital capability have start pay regard company retail resale script be initiate digital channel walgreen mobile app record download launch zack consensus estimate total revenue retail pharmacy usa division reflect rise year meanwhile tough market condition particularly retail have be lead sluggishness retail pharmacy international division however company have be take action enter tie up control cost boost segment zack consensus estimate revenue retail pharmacy international division highlight improvement prior year quarter strong growth certain emerge market be expect continue drive company pharmaceutical wholesale division zack consensus estimate division revenue show rise prior year quarter zack consensus estimate total revenue reflect rise year year basis flip side walgreen boot gross margin figure have be decline recent past however company be work gain efficiency provide high quality cost effective pharmacy service order reduce pharmacy cost overall walgreen boot fiscal earning outlook look quite promising company expect register ep range zack consensus estimate earning share remain guidance range here be quantitative model predict walgreen boot have right combination main ingredient positive earning esp zack rank hold higher need increase odd earning beat zack esp earning esp walgreen boot be uncover best stock buy sell re report earning esp filter zack rank walgreen boot carry zack rank zack consensus estimate earning reflect rise year year basis other stock worth lookhere be few other medical stock worth consider have right combination element post earning beat quarter align technology inc algn free report have earning esp zack rank buy see complete list today zack rank strong buy stock here boston scientific corporation bsx free report have earning esp zack rank henry schein hsic free report have earning esp zack rank hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
742,ALGN,here be stock buy rank strong momentum characteristic investor consider today june abiom inc abmd free report developer seller have zack rank strong buy witness zack consensus estimate current year earning advance last day abiom inc price consensus abiom inc price consensus chart abiom inc quoteabiom share gain last month more gain company possess momentum score abiom inc price abiom inc price abiom inc quotebunge limit bg free report owner operator agribusiness food company have zack rank buy witness zack consensus estimate current year earning advance last day bunge limit price consensus bunge limit price consensus chart bunge limit quotebunge share gain last month company possess momentum score bunge limit price bunge limit price bunge limit quotealign technology inc algn free report designer manufacturer clear aligner therapy system intraoral scanner have zack rank buy witness zack consensus estimate current year earning advance last day align technology inc price consensus align technology inc price consensus chart align technology inc quotealign technology share gain last month company possess momentum score align technology inc price align technology inc price align technology inc quotesee full list top rank stock herelearn more momentum score be calculate here hottest tech mega trend last year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
743,ALGN,here be stock buy rank strong momentum characteristic investor consider today june atla air worldwide holding inc aaww free report provider aviation operate service have zack rank buy witness zack consensus estimate current year earning advance last day atla air worldwide holding price consensus atla air worldwide holding price consensus chart atla air worldwide holding quoteatla air share gain last month more gain company possess momentum score atla air worldwide holding price atla air worldwide holding price atla air worldwide holding quoteautomatic datum process inc adp free report provider business process outsource service have zack rank buy witness zack consensus estimate current year earning advance last day automatic datum process inc price consensus automatic datum process inc price consensus chart automatic datum process inc quoteautomatic datum share gain last month company possess momentum score automatic datum process inc price automatic datum process inc price automatic datum process inc quotealign technology inc algn free report designer manufacturer clear aligner therapy system intraoral scanner have zack rank buy witness zack consensus estimate current year earning advance last day align technology inc price consensus align technology inc price consensus chart align technology inc quotealign technology share gain last month company possess momentum score align technology inc price align technology inc price align technology inc quotealtra industrial motion corp aimc free report designer mechanical power transmission component have zack rank buy witness zack consensus estimate current year earning advance last day altra industrial motion corp price consensus altra industrial motion corp price consensus chart altra industrial motion corp quotealtra industrial share gain last month company possess momentum score altra industrial motion corp price altra industrial motion corp price altra industrial motion corp quotesee full list top rank stock herelearn more momentum score be calculate here more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
744,ALGN,be not surprising earning season investor look stock beat market expectation be investor always try position ahead time look tap stock be high quality nature be positive earning surprise so important historically stock company solid quarterly earning nominal basis tank miss merely meet market expectation earning rise apparently look good doesn tell earning growth have be exhibit decelerate trend also seasonal fluctuation come play sometimes company be seasonally weak strong then be likely report sequential earning decline such case growth rate be mislead judge true health company other hand much brainstorm analysis company financial initiative wall street analyst project earning company fact club insight company guidance derive earning estimate thus outperform estimate be almost equivalent beating company own expectation well market perception margin earning surprise be big typically drife stock higher right release thus more anything else earning surprise push stock higher find stock beat now find stock have potential beat bottom line be investor dream not easy job way do be look earning surprise history company impressive track regard generally act catalyst send stock higher indicate company ability surpass estimate investor generally believe company apply same secret sauce execute yet earn beat next release winning strategyin order shortlist stock be likely come earning surprise choose follow primary screening parameter last ep surprise greater equal stock deliver positive surprise last quarter tend surprise again average ep surprise last quarters greater lift bar outperformance slight higher set average earning surprise last quarters average ep surprise last quarters greater point more consistent surprise history make case surprise even stronger addition place few other criterium push chance positive surprise zack rank less equal only company zack rank strong buy buy rating get earning esp greater stock need have positive earning esp zack rank earning beat happen proven model order have long term growth potential high trading liquidity have add follow parameter too next year estimate ep growth year greater solid expect earning growth exhibit stock long term growth prospect average day volume greater high trading volume imply stock have adequate liquidity handful criterium have narrow universe stock here be stock weight watcher international inc wtw free report zack rank stock be largest provider weight control program world stock belong top rank zack industry top jill inc jill free report zack rank company operate specialty retailer woman apparel zack industry rank stock be top stock come top rank zack industry top see complete list today zack rank stock here wellcare health plan inc wcg free report zack rank company provide government sponsored manage care service stock belong top rank zack industry top align technology inc algn free report zack rank stock be global medical device company stock hail top rank zack industry top caterpillar inc cat free report be manufacturer construction mining equipment diesel natural gas engine industrial gas turbine diesel electric locomotive stock belong top rank zack industry top get rest stock list signing now week free trial research wizard start used screen own trading further also create own strategy test first take investment plunge research wizard be great place begin easy use everything be plain language very intuitive start research wizard trial today next time read economic report open research wizard plug find see gem come click here sign free trial research wizard today disclosure officer director employee zack investment research own have sell short security hold long short position option be mentioned material affiliated investment advisory firm own have sell short security hold long short position option be mentioned material disclosure performance information zack portfolio strategy be available http www zack com performance zack restaurant recommendation addition dine special place feast stock share zack special report spotlight recent ipos watch stock offer immediate promise boom sector download free
745,ALGN,trump protectionist stance trade lead sluggish trading wall street be especially true series tariff talk unite state other major ally be intensify fear trade war even trigger global recession tariff talkstrade war fear surface march trump levy tariff steel aluminum import country world action have prompt retaliatory action ally tit tat import tariff turmoil intensified recent week trump unveil list chinese good worth target tariff lead retaliation china duty same scale strength response unite state again threaten impose tariff chinese good top worth good tariff worth chinese good first potential total be due take effect jul additionally latest report wall street reveal trump be seek bar many chinese company investing technology firm block additional technology export china trade dispute european union eu also deepen jun trump tweet impose tariff target import auto european union response come follow eu threat duty worth american good export member bloc start jun tariff european steel aluminum canada mexico have also threaten use american steel aluminum import canada be seek duty steel import unite state other good include play card inflatable boat yogurt toilet paper total value american good subject tariff be effective jul mexico plan retaliate target product congressional district trump republican party be fight retain november election impose levy wide range good steel pipe product lamp berry grape apple cold cut pork chop various cheese product amount comparable level damage link tariff market round sanction retaliation have intensified fear global trade war hurt worldwide economy corporate profit particularly big exporter such large cap stock be struggle past month give substantial exposure country however be still winner many corner large cap space be easily survive trade turmoil have highlighted stock different corner market have gain more month have solid zack rank strong buy buy stock also have market cap least lululemon athletica inc lulu free report athletic apparel company design retail athletic clothing woman man female youth stock see positive earning estimate revision cent fiscal end january past month have expect growth rate market cap lulu have zack rank fall top rank zack industry top hollyfrontier corporation hfc free report company be engage refine petroleum produce market gasoline diesel jet fuel asphalt heavy product specialty lubricant product zack consensus estimate year have moved past month company have market cap estimate earning growth rate hollyfrontier have zack rank belong top rank zack industry top see complete list today zack rank stock here abiom inc abmd free report abiom be provider mechanical circulatory support device offer continuum care heart failure patient stock see positive earning estimate revision cent year past month have expect growth rate have zack rank belong top rank zack industry top abiom have market cap twitter inc twtr free report twitter be public real time global platform stock see positive earning estimate revision cent year past month have expect growth rate market cap have zack rank belong top rank zack industry top align technology inc algn free report be global medical device company industry lead innovative product such invisalign clear aligner itero intraoral scanner orthocad digital service stock see solid earning estimate revision cent year past month have expect growth rate have zack rank belong top rank zack industry top align technology have market cap hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
746,ALGN,patterson company inc pdco free report be big mover last session company see share rise nearly day move come solid volume too far more share change hand normal session break recent trend company stock be now trading volatile price range past month time frame company have see negative estimate revision past few week zack consensus estimate current quarter have also moved lower past few week suggest be trouble road so make sure keep eye stock go forward see recent move higher last patterson company currently have zack rank hold earning esp be positive patterson company inc price patterson company inc price patterson company inc quoteinvestor interested medical dental supply industry consider align technology inc algn free report have zack rank strong buy see complete list today zack rank stock here be pdco go predict see other think hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
747,ALGN,abbott laboratory free report report second quarter adjust earning continue operation cent share higher zack consensus estimate year year adjust quarterly number also remain ahead company guidance range cent cent report earning quarter come cent share way year number cent second quarter worldwide sale come year year report basis quarterly figure also remain slightly ahead zack consensus estimate comparable operational basis adjust impact foreign exchange certain acquisition divestment sale increase year year report quarter abbott laboratory price consensus ep surprise abbott laboratory price consensus ep surprise abbott laboratory quotequarter detailabbott lab operate segment establish pharmaceutical division epd medical device nutrition diagnostic epd sale be report basis comparable operational basis be positive impact back currency fluctuation sale key emerge market increase drive strong growth russia china several country latin america however positive effect be partially offset impact associate implementation new good service tax gst system india medical device business sale spiked report basis however comparable operational basisexclude impact favorable resolution third party royalty agreement last year sale increase cardiovascular neuromodulation sale soar report basis comparable operational basis growth structural heart neuromodulation vascular product sale be structural heart business grow year yearon comparable operational basis diabetes care sale improve report basis drive double digit international sale growth lead continue consumer uptake freestyle libre revolutionary continuous glucose monitoring system abbott lab nutrition sale slip year year report basis comparable operational basis unfavorable foreign exchange impact sale marginal pediatric nutrition sale increase comparable operational basis adult nutrition sale however decrease comparable operational basis diagnostic sale rise year year comparable operational basis core laboratory sale increase point care diagnostic sale grow comparable operational basis molecular diagnostic sale be strong growth infectious disease testing business be partially offset plan scale genetic business guidanceabbott lab raise full year guidance company forecast earning share continue operation remain range earlier range cent adjust certain net specify item full year adjust earning share continue operation be expect stay band earlier guidance be current zack consensus estimate be peg midpoint project range takeone more time abbott lab successfully exceed zack consensus estimate earning sale front be optimistic company strong consistent epd medical device performance however strong performance be extent offset sluggish nutrition business however company stand benefit recently complete acquisition st jude medical have already start offer industry lead pipeline cardiovascular neuromodulation diabetes vision care look forward achieve synergy benefit company have raise outlook buoy investor confidence stock company plan execute exist operate model focus selling portfolio core therapeutic area lead creation unique channel opportunity differentiate relationship physician retailer pharmacy look offer complete line solution treat prominent local health condition also abbott lab have plan beef development capability expand epd innovation center india however india transition new tax system have significantly hampered growth report quarter company transitory impact new gst be eliminate total epd sale have grow high single digit report quarter abbott lab currently carry zack rank buy stock considerbetter rank medical stock be mesa laboratory inc mlab free report insys therapeutic inc insy free report align technology inc algn free report notably insys therapeutic sport zack rank strong buy mesa laboratory align technology carry zack rank buy see complete list today zack rank stock here mesa laboratory have positive earning surprise last quarters stock have add roughly last month insys therapeutic have long term expect earning growth rate stock have rally last month align technology have expect long term adjust earning growth almost stock have surge roughly last month top pick ride hottest tech trendzack just release special report guide space have already begin transform entire economy last year be generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money make right trade early download report top tech stock
748,ALGN,pharmacy benefit manager express script hold company esrx free report be schedule report second quarter result jul market close st loui mo base company be largest pharmacy benefit manager pbm north america meanwhile company earning exceed zack consensus estimate almost last report quarter stock have deliver positive earning surprise past quarters average express script stock have underperform zack classify medical service industry last month specifically stock lose period compare industry gain moreover current rate be way lower same time frame indicate loom concern ahead express script hold company price ep surprise express script hold company price ep surprise express script hold company quotelet take look thing be shape prior second quarter earning announcement factor playsecond quarter outlook second quarter express script expect total adjust claim range adjust earning diluted share second quarter be estimate band represent growth year year basis furthermore company anticipate compound annual ebitda growth band core pbm business favorable macroeconomic scenario expect express script continue benefit increase generic utilization shift mail order strong specialty growth age population brand drug be become increasingly expensive due double digit brand inflation thus continue rise price specialty drug increase regulatory burden have be drive demand generic key catalyst company cutthroat competition niche space flipside express script face intense competition pbm industry company face competition independent pbms medimpact navitus health solution moreover niche space be dominate player cvs aetna cigna other expect intensify competition mar second quarter revenue estimate revision trend express script estimate revision trend lack luster moment current quarter analyst moved south compare upward revision last month fact last month current quarter estimate decline almost share probable loss biggest customer be too early gauge loss express script be verge lose biggest customer lead health insurer anthem inc antm follow series legal conundrum anthem be longer expect extend pharmacy benefit management agreement withexpress script be slate expiration end management express script lose almost revenue related anthem contract second quarter earning whispersbuoy factor proven model do not conclusively show express script be likely beat earning quarter be stock need have positive earning esp zack rank strong buy buy hold be able beat estimate be not case here see zack esp earning esp express script be most accurate estimate be peg zack consensus estimate stand uncover best stock buy sell re report earning esp filter zack rank express script currently carry zack rank favorable zack rank increase predictive power esp company negative esp make surprise prediction difficult meanwhile caution stock zack rank sell rate go earning announcement especially company be see negative estimate revision stock warrant lookhere be few company want consider proven model show have right combination element post earning beat quarter becton dickinson company bdx free report have earning esp zack rank see complete list today zack rank stock here align technology inc algn free report have earning esp zack rank stryker corporation syk free report have earning esp zack rank top pick ride hottest tech trend zack just release special report guide space have already begin transform entire economy last year be generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money make right trade early download report top tech stock
749,ALGN,expect align technology inc algn free report beat expectation report second quarter earning jul market close last quarter company have post positive earning surprise be worth note align technology have outperformed zack consensus estimate precede quarters average positive earning surprise let take look thing be shape prior announcement likely positive surprise proven model show align technology be likely beat earning have perfect combination key ingredient zack esp align technology have earning esp most accurate estimate be cent zack consensus estimate be peg lower cent favorable zack esp serve meaningful lead indicator likely positive earning surprise uncover best stock buy sell re report earning esp filter zack rank align technology currently carry zack rank buy note stock zack rank strong buy hold have significantly higher chance beating earning estimate conversely caution stock zack rank sell rate stock go earning announcement especially company be see negative estimate revision combination align technology zack rank esp make reasonably confident earning beat drive better expect earning be upbeat align technology execution strategic initiative international expansion thereby ensure invisalign treatment grow base patient context company strengthen foothold internationally acquire invisalign distributor highly lucrative europe middle east africa emea region well brazil feb be likely drive company result be report quarter company announce receipt patent align smarttrack aligner material be exclusively used invisalign aligner treatment moreover bid gain traction invisalign platform align collaborate digital design march post collaboration align invisalign clear aligner treatment be used dentist tooth alignment procedure design protocol align technology inc price ep surprise align technology inc price ep surprise align technology inc quotenotably expand invisalign brand offering align technology introduce patient friendly solution invisalign mandibular advancement teen march accord company advancement help offer more option treatment boost top line yet be report quarter recently company expand work flow option lead itero scanner context align collaborate exocad gmbh march integrate portfolio result high tech solution efficient scanning design manufacturing house dental prosthesis february company have announce addition digital nobel biocare implant itero intraoral scanner portfolio moreover company see increase adoption itero scanner invisalign case submission instead pvs impression especially north america thereby drive invisalign utilization management expect bullish trend likely continue yet be report quarter notably second quarter company project earning share cent revenue company also expect invisalign case shipment band year flip side unfavorable foreign currency affect company revenue be report quarter also company be expose seasonal demand fluctuation higher operate expense pertain increase head count higher investment target growth acceleration geographical expansion portfolio stock considerhere be other company consider model show also have right combination element post earning beat upcoming quarter becton dickinson company bdx free report have earning esp zack rank see complete list today zack rank stock here thermo fisher scientific inc tmo free report have earning esp zack rank stryker corporation syk free report have earning esp zack rank top pick ride hottest tech trendzack just release special report guide space have already begin transform entire economy last year be generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money make right trade early download report top tech stock
750,ALGN,well ahead expect time completion quest diagnostic dgx free report close earlier announce deal acquire laboratory business lewisville tx namely med fusion clear point be line company plan fast expand high growth cancer diagnostic market business jointly provide complete range diagnostic service physician provider network acquisition allow quest diagnostic establish center excellence provide diagnostic service detection management cancer baylor scott white health bswh oncology network network support mckesson specialty health texas oncology pathologist bio medical laboratory pbm be co owner business quest diagnostic team mckesson specialty health network texas oncology enhance med fusion model have be create standardize next generation gene sequence panel help select therapy monitoring cancer completion deal quest diagnostic be now prefer provider advanced oncology diagnostic network texas oncology primarily quest diagnostic offer service bswh hospital north texas independent community base physician nationally be affiliated network include texas oncology believe deal be perfectly align quest diagnostic goal capture high potential global oncology diagnostic market account datum provide american cancer society nearly person be likely be diagnosed cancer regard quest diagnostic be take strategic step capture market accord market market global cancer diagnostic market be expect reach worth be poise see cagr period company clearly have bountiful opportunity niche market last month quest diagnostic have be observed outperform zack categorize medical outpatient home healthcare industry latest share price movement company have gain compare gain broader industry recent quest diagnostic announce plan acquire outreach laboratory service business cape cod healthcare cchc notably cchc provide healthcare service resident visitor cape cod deal conclude be expect provide quality affordable convenient laboratory service cape cod resident advanced diagnostic business quest diagnostic onchology francise partner memorial sloan ketter have team ibm form ibm health watson oncology prospect be community healthcare center instead large urban center be huge opportunity company zack rank key picksquest diagnostic currently carry zack rank hold few better rank medical stock be mesa laboratory inc mlab free report insys therapeutic inc insy free report align technology inc algn free report notably insys therapeutic sport zack rank strong buy mesa laboratory align technology carry zack rank buy see complete list today zack rank stock here mesa laboratory have positive earning surprise last quarters stock have add roughly last month insys therapeutic have long term expect earning growth rate stock have gain last month align technology have expect long term adjust earning growth almost stock have add roughly last month top pick ride hottest tech trendzack just release special report guide space have already begin transform entire economy last year be generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money make right trade early download report top tech stock
751,ALGN,murray hill nj base cr bard inc be schedule report second quarter earning market close jul last quarter company report adjust earning exceed zack consensus estimate cent also company earning top zack consensus estimate last quarters average beat delve deeper fundamental stock let see thing be shape prior release factor playwe believe grow adoption company flagship lutonix drug coat balloon dcb continue be key growth catalyst be report quarter regard lutonix dcb be used treat patient suffering peripheral arterial disease pad endovascular business peripheral pta line sale be solely drive accelerate demand lutonix dcb expect see product significantly contribute company top line quarter furthermore company investment emerge market have strengthen position internationally be also upbeat solid contribution company vascular product line urology oncology segment be likely drive second quarter sale flip side challenge med tech environment especially hernia fixation peripheral stent business raise concern company continue witness significant pricing pressure well also unfavorable foreign currency continue hurt top bottom line growth furthermore uncertainty associate possibility repeal affordable care act president trump add company concern earning whispersour quantitative model doesn point earning beat quarter be stock need have positive earning esp zack rank strong buy buy hold happen be not case here see zack esp earning esp cr bard be be most accurate estimate zack consensus estimate stand uncover best stock buy sell re report earning esp filter zack rank cr bard carry zack rank increase predictive power esp however company esp make surprise prediction difficult caution stock zack rank sell rate go earning announcement especially company be see negative estimate revision bard inc price ep surprise bard inc price ep surprise bard inc quotestock consider here be few company want consider proven model show have right combination element post earning beat quarter becton dickinson company bdx free report have earning esp carry zack rank see complete list today zack rank stock here align technology inc algn free report have earning esp hold zack rank stryker corporation syk free report have earning esp carry zack rank top pick ride hottest tech trend zack just release special report guide space have already begin transform entire economy last year be generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money make right trade early download report top tech stock
752,ALGN,gnc holding inc gnc free report specialty retailer health nutrition related product be schedule report second quarter result jul open bell last quarter company post positive earning surprise however gnc holding trail quarter earning average lag zack consensus estimate let see thing be shape prior announcement factor playgnc holding last report first quarter adjust earning share ep reflect massive year year deterioration revenue quarter drop year year dismal performance be primarily due lower sale canada international manufacturing wholesale segment also first quarter gross margin adjust operate margin deteriorate hence expect similar trend second quarter well gnc holding inc price ep surprise gnc holding inc price ep surprise gnc holding inc quotemoreover gnc holding have number tough competitor market include large international pharmacy chain major international supermarket firm large base company global operation thus expect company slash product price face stiff competition turn hurt margin also currency headwind continue be grow concern gnc holding management also expect failure comply ftc regulation change consumer preference hamper business however bright side performance new gnc be quite encourage first quarter banking expect company continue gain yet be report quarter meanwhile launch pro access program have add member company customer base be expect drive growth earning whispersour proven model do not conclusively show earning beat gnc holding quarter be stock need have positive earning esp zack rank strong buy buy hold happen be not case here see zack esp gnc holding have earning esp be most accurate estimate zack consensus estimate be peg cent uncover best stock buy sell re report earning esp filter zack rank gnc holding have zack rank sell please note caution stock zack rank strong sell go earning announcement especially company be see negative estimate revision stock considerhere be few company want consider proven model show have right combination element post earning beat quarter becton dickinson company bdx free report have earning esp zack rank see complete list today zack rank stock here align technology inc algn free report have earning esp zack rank stryker corporation syk free report have earning esp zack rank look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
753,ALGN,dec issue update research report align technology inc algn free report stock carry zack rank hold notably align technology manufacture market system clear aligner therapy intra oral scanner cad cam computer aid design manufacturing digital service used dentistry orthodontic dental record storage share company have be trading industry last day stock have rally compare industry growth period further good news be company deliver encourage performance third quarter post better expect earning revenue align technology inc price align technology inc price align technology inc quotewe be also impressed company solid invisalign technology prospect growth north america well internationally company receipt patent smarttrack aligner material also buoy optimism moreover align technology have be logging strong international sale especially emea apac region last quarter marked milestone company china emerge second largest market globally unite state lead bandwagon company have also witness balanced sale growth channel recent past primarily drive high invisalign technology case volume solid performance summer too drive invisalign growth global market positive aspect be company have recently sign distribution agreement patterson dental exclusive deal effective september onward align technology itero element intraoral scanning system be available part patterson dental cad cam portfolio unite state canada flip side adverse foreign exchange translation continue raise concern align technology international operation also escalate cost expense be weigh company margin moreover tough competitive landscape other macroeconomic headwind threat key pickssome better rank stock same space be masimo corporation masi free report tactile system technology tcmd free report integer holding corporation itgr free report sporting zack rank buy see complete list today zack rank strong buy stock here masimo have expect growth rate year stock have increase broader industry gain last year tactile system have estimate current annual growth rate stock have soar broader industry rise year integer holding have project growth rate next quarter stock have surge outperform broader industry increase year time today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return respectively outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
754,ALGN,universal health service inc uhs free report solid inorganic strategy position well long term growth acquisition adult service division cambian group desert view hospital nevada be worth mention here company top line have be grow consistently drive primarily solid inorganic growth strong performance segment acute care behavioral health acute care platform have be deliver strong underwriting result consistently same trend continue first month well addition behavioral platform have be perform well too fact behavioral facility acquisition help universal health market share fast grow addiction mental health disorder market segment continue deliver strong result first month month date share universal health have gain industry have rally however stock be currently trading trail month price earning ratio be median range same compare unfavorably industry average suggest stock be overvalue compare peer addition company high debt level have be concern last few year also lead rise interest expense have be putt pressure margin area concern company be increase operate expense continue rise first month also keep weigh company bottom line zack rank stock health currently have zack rank hold investor interested medical sector consider better rank stock align technology inc algn free report amedisys inc am free report cerus corporation cers free report align technology sport zack rank strong buy other stock carry zack rank buy see complete list today zack rank stock here align technology deliver positive surprise last quarters average beat amedisys deliver positive surprise last quarters average beat cerus corp deliver positive surprise last quarters average beat wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
755,ALGN,zimmer biomet holding inc zbh free report recently announce positive result progress ii treatment knee osteoarthritis oa datum study base patient symptomatic knee oa pain trial site europe demonstrated safety efficacy nstride autologous protein solution aps kit therapy company investigator prepared aps used zimmer biomet nstride aps kit concentrate inflammatory cytokine growth factor sample enrolled patient blood delivery single intra articular injection knee joint outcome show significant improvement percentage change baseline pain score comparable safety saline notably nstride aps kit be market europe japan asia pacific well however kit be commercially unavailable unite state be clinical evaluation country furthermore positive finding confirm basis more trial namely progress iv progress development knee businesslast quarter revenue derive knee be year year however company be putt consistent effort improve knee business regard note zimmer biomet announce global launch persona partial knee system aug advanced addition company portfolio personalize anatomically design knee implant system major development zimmer biomet knee business be unveil ray base patient specific instrument know psi knee system june be world first ce marked surgical plan system enable patient specific implant position sole use ray technology market prospectsper report globaldata oa market be expect reach value major market cagr unite state continue dominate oa market even end target year total sale be accredit country account take grow oa market consideration believe latest development boost company sale segment solid stock performance last day zimmer biomet have be trading broader industry company have gain versus broader industry decline also company have outperformed gain same time frame zack rank key pickszimmer biomet carry zack rank sell few better rank medical stock be bruker corporation brkr free report align technology inc algn free report cheme corporation che free report notably bruker align technology sport zack rank strong buy cheme carry zack rank buy see complete list today zack rank stock here bruker have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have sky-rocket year cheme have long term expect earning growth rate stock have soar year zack editor chief go stockfull disclosure kevin matra now have more own money particular stock other believe short term profit potential also prospect more double today reveal explain surprising move new special report download free
756,ALGN,share masimo corporation masi free report have rally year ahead index gain broader industry rise stock have market cap masimo be global medical technology company develop manufacture innovative noninvasive patient monitoring technology medical device wide array sensor company year historical growth rate be also favorable compare index broader industry current year earning growth be project higher broader industry index solid prospect zack rank buy stock be attractive pick present let find recent positive trend help sustain stock long run company have witness positive estimate revision current year stock have see zack consensus estimate be revise upward analyst move north past day movement opposite direction earning share estimate be increase company also have stellar average return last quarters market be upbeat masimo solid guidance company expect fiscal revenue approximately previously issue guidance total fiscal product revenue be project approximately prior view fiscal earning share be expect meanwhile masimo win fda approval announce release full family nomoline capnography sampling line latest development artemis hospital multus specialty hospital delhi ncr region india be adopt masimo patient safetynet hospital care area patient safetynet allow clinician central station review patient datum be continuously relay bedside monitoring device mark company globally extend foothold also masimo announce full market release ra single use adhesive respiration sensor rainbow acoustic monitoring respiration rate launch be expect strengthen company position grow global respiratory care market key picksother top rank medical stock include bruker corporation brkr free report align technology inc algn free report cheme corporation che free report bruker align technology sport zack rank strong buy cheme carry zack rank see complete list today zack rank stock here bruker have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have sky-rocket year cheme have long term expect earning growth rate stock have soar year zack editor chief go stockfull disclosure kevin matra now have more own money particular stock other believe short term profit potential also prospect more double today reveal explain surprising move new special report download free
757,ALGN,dec issue update research report haemonetic corporation hae free report stock currently carry zack rank hold lead provider hematology product solution have be trading broader industry year date stock have rally compare broader industry gain stock have also outperformed gain remain encourage strength haemonetic hospital business hemostasis management have be witness strong growth past few quarters interestingly fiscal growth be evenly split teg teg solid performance unite state uk china management teg have become global leader hemostasis management teg be approve broad set indication top market teg teg manager be approve same set indication europe australia japan unite state teg be indicated cardiovascular surgery company be currently plan get approval broader set indication begin trauma fiscal haemonetic expect hospital business grow majorly back strength transfusion management be also upbeat haemonetic growth plasma franchise strong end market demand plasma derive continue drive company growth haemonetic be confident maintain growth commercial plasma collection business company be also optimistic strong market adoption nexsys pcs plasmapheresis system recently receive fda approval further raise fiscal adjust earning guidance be also encourage meanwhile company strong cash position boost investor confidence flip side haemonetic operate very competitive environment manual automate system include company mak system many other moreover company have be witness sluggish revenue growth blood center franchise significantly affect result past few quarters management also doesn expect early recovery blood center outcome add concern key picksa few better rank medical stock be bruker corporation brkr free report align technology inc algn free report cheme corporation che free report bruker align technology sport zack rank strong buy cheme carry zack rank buy see complete list today zack rank stock here bruker have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year cheme have long term expect earning growth rate stock have moved year zack editor chief go stockfull disclosure kevin matra now have more own money particular stock other believe short term profit potential also prospect more double today reveal explain surprising move new special report download free
758,ALGN,dec issue update research report abbott global healthcare company dedicate improve life development product technology stock carry zack rank hold last month abbott have be trading broader industry stock have gain compare industry growth overall company stand benefit ongoing integration synergy achievement st jude meanwhile endure legal battle company recent completion alere acquisition be upside successful wrap transaction combine company anticipate emerge lead player point care diagnostic space be also look forward abbott plan focus marketing product portfolio core therapeutic area recently abbott freestyle libre flash receive fda approval also company have receive approval regulatory body magnetic resonance conditional labele ellipse implantable cardioverter defibrillator recently overall be encourage abbott yet quarter better expect earning revenue performance apart fda approval buyout be upbeat abbott freestyle libre flash glucose monitoring system prospect post receipt full partial reimbursement french health ministry platform company announce health canada license freestyle libre june also inform freestyle libre system be now available reimbursement flip side abbott sluggish pediatric business china continue mar growth also management be concern economic problem venezuela expect remain unresolved time foreign exchange be major headwind company considerable portion revenue come outside unite state key picksa few better rank medical stock be athenahealth inc athn free report align technology inc algn free report luminex corporation lmnx free report sporting zack rank strong buy see complete list today zack rank stock here athenahealthha long term expect earning growth rate stock have rally roughly year align technologyha long term expect earning growth rate stock have sky-rocket year luminex have long term expect earning growth rate stock have gain past month look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
759,ALGN,share laboratory corporation america holding lh free report scale new week high dec close nominally lower company have gain last month much higher broader industry gain respect share price stock have market cap take stable stock performance consideration expect labcorp scale higher come quarters also company long term expect earning growth rate hold promise further company estimate revision trend current year be favorable past day estimate moved shift consequently estimate be share laboratory corporation america holding price consensus laboratory corporation america holding price consensus laboratory corporation america holding company also have trail quarter average positive earning surprise positive long term growth hold promise well labcorp recently announce agilent dako pathology division development pd ihc pharmdx assay be now available unite state new expand use labcorp test receive approval be used complementary diagnostic bristol myer squibb company bmy free report opdivo nivolumab new indication metastatic urothelial carcinoma bladder cancer squamous cell carcinoma head neck encourage strong third quarter show gradually improve foreign exchange scenario company raise outlook net revenue growth be maintain band year year ahead earlier range free cash flow expectation have be raise new band previous range prior year recent past company successfully close chiltern international group buyout specialty contract research organization chiltern be major partner labcorp serve top biopharma segment help company focus high growth emerge mid market biopharma segment follow takeover company covance drug development report strong growth third quarter several quarters tepid performance zack rank key pickslabcorp carry zack rank hold few better rank medical stock be athenahealth inc athn free report align technology inc algn free report sport zack rank strong buy see complete list today zack rank stock here athenahealth have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year zack best private investment ideaswhile be happy share many article best recommendation most depth research be not available public start today next month follow zack private buy sell real time expert cover kind trade value momentum stock etf option move stock corporate insider be buy company be report positive earning surprise even look exclusive portfolio be normally close new investor click here zack private trade
760,ALGN,dec issue update research report corporation abc free report world largest pharmaceutical service company company focus provide drug distribution related service reduce health care cost improve patient outcome be positive deal sign boost top line company enter strategic agreement boot alliance wba free report agreement include year pharmaceutical distribution contract walgreen boot alliance company distribute brand generic pharmaceutical product boot believe benefit generic growth long run company be well position help product get market efficiently have be actively pursue acquisition strengthen core area mwi veterinary acquisition have diversify company exist pharmaceutical distribution service business highly lucrative animal health market flip side cutthroat competition niche space be concern operate highly competitive pharmaceutical distribution related health care service market company primary competitor be national generic regional distributor generic industry be witness consolidation customer manufacturer globalization increase quality regulatory challenge company also face competition manufacturer chain drugstore specialty distributor packaging health care technology company last month have be trading industry term price share company have lose compare industry rally zack rank key carry zack rank hold few better rank medical stock be athenahealth inc athn free report align technology inc algn free report notably athenahealth align technology sport zack rank strong buy see complete list today zack rank stock here athenahealth have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year zack best private investment ideaswhile be happy share many article best recommendation most depth research be not available public start today next month follow zack private buy sell real time expert cover kind trade value momentum stock etf option move stock corporate insider be buy company be report positive earning surprise even look exclusive portfolio be normally close new investor click here zack private trade
761,ALGN,share abbott free report rally new week high dec close session nominally lower represent strong year date return approximately higher stock have zack rank hold take stable stock performance consideration expect abbott scale higher quarters ahead company also have trail quarter average positive earning surprise positive long term growth hold promise well majority last month company share price have considerably outperformed broader industry stock have rally last month beating industry gain just factor drive stockalere acquisition abbott successful closure alere acquisition prolong legal battle have instilled confidence investor acquisition close october amend financial term favor abbott take attractive prospect point care testing diagnostic market consideration abbott be highly optimistic alere integration accord company alere buyout significantly expand diagnostic presence moreover abbott expect alere contribute top line recent fda approval abbott be effectively focuse core therapeutic area recently freestyle libre flash receive fda approval also receive approval mr conditional labele ellipse icd develop diabetes business have be slew development diabetic business be upbeat abbott freestyle libre flash glucose monitoring system recent reimbursement approval company recently announce receipt health canada license same company receive full partial reimbursement french health ministry product solid emerge market performance abbott emerge market performance have be promising courtesy latest strategic development notably company have be witness double digit growth brazil russia india china late key picksa few better rank medical stock be athenahealth inc athn free report align technology inc algn free report luminex corporation lmnx free report notably athenahealth align technology luminex sport zack rank strong buy see complete list today zack rank stock here athenahealth have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year luminex have long term expect earning growth rate stock have gain past month zack best private investment ideaswhile be happy share many article best recommendation most depth research be not available public start today next month follow zack private buy sell real time expert cover kind trade value momentum stock etf option move stock corporate insider be buy company be report positive earning surprise even look exclusive portfolio be normally close new investor click here zack private trade
762,ALGN,america have best doctor best nurse best hospital best medical technology best medical breakthrough medicine world rep bill fristin term market size health care market be largest world report health access suggest america unparalleled purchasing power massive demand medical service equipment opportunity innovation have lend competitive edge further market get boost president donald trump ardent proponent live big live large come power constant effort boost american lifestyle focus middle class incorporate best health care america have be create stir trump effort eliminate country jobless stature be remarkable report unemployment rate be peg november lowest february undoubtedly trump america first pitch have be drive employment growth never factor drive medtech increase consolidation latest trend increase consolidation healthcare space have lead reduction number player greater market concentration reduce competition well increase barrier entry industry company benefit higher market cap put position negotiate supplier consumer recent deal aetna inc aet free report cvs health cvs free report be significant example qualify vertical integration enable newly form entity sell range service product drug insurance cover president trump focus emerge marketsper recent bcg report share emerge market revenue be less quarter medtech global revenue be likely increase nearly third thus unite state trade plan emerge country be likely favor domestic company regard investor find president trump day asia trip last month interesting visit be aim boost country trade relation particularly emerge nation trump promise augment bilateral trade agreement indo pacific nation instill confidence apac policy also emphasize free open indo pacific trade focus nation japan australia india ivd pbm market thrive research report evaluatemedtech world preview indicate global medtech sale be expect witness cagr ivd diagnosis rake annual sale cagr increase investment government private player form reimbursement coverage speedy patent approval be drive demand role pharmacy benefit manager pbm healthcare sector have be evolve pbms manage pharmaceutical spending enhance health benefit end user report market research report biz global pbm market see cagr investing pbm stock be prudent move register solid gain look best stock be first see top stock portfolio here robot base application boost medtechthe ai base application have be enhance healthcare space clinical application diagnostic support operational efficiency electronic health record system practice workflow supply chain management grow prevalence minimally invasive robot assist surgery self automate home base care use quick improve patient care shift payment system value base model example medtech major intuitive surgical design manufacture market da vinci surgical system advanced robot assist surgical platform ai platform enable minimally invasive surgery help avoid trauma associate open surgery company plan expand usage da vinci general thoracic surgery colorectal surgery hernia repair day come pick right stocksbased certain parameter have select medtech growth stock be poise impressive return stock carry solid zack rank strong buy buy growth style score note growth style score encompass essential metric company financial statement get true sense quality sustainability growth research show stock growth style score combine zack rank offer best investment opportunity growth investing space growth pickscheme corp che free report stock have zack rank growth score zack consensus estimate cheme sale be peg next year reflect growth year year basis stock have market cap long term expect earning growth rate cheme raise guidance banking roto rooter business strength buoy optimism moment roto rooter be currently nation lead provider plumbing drain clean service network company own branch independent contractor franchise roto rooter offer plumbing drain clean service population cheme corp price consensus cheme corp price consensus cheme corp quote athenahealth inc athn free report stock flaunt zack rank growth score zack consensus estimate athenahealth sale be peg signify growth year year basis stock have market cap long term expect earning growth rate moment athenahealth strong product portfolio solid network expansion strategy unique business model be key tailwind athenahealth portfolio comprise wide array product include electronic health record revenue cycle management medical bill patient engagement care coordination population health management epocrate notably company launch athenainsight online news hub report healthcare activity trend healthcare provider identify patient athenahealth inc price consensus athenahealth inc price consensus athenahealth inc quote align technology inc algn free report stock have zack rank growth score zack consensus estimate align technology sale be peg next year signify growth year year basis stock have market cap long term expect earning growth rate now align technology consistent effort boost product development balanced growth channel focus international market bolster confidence stock be encourage company strong invisalign technology prospect growth north america international region be also upbeat company signing distribution agreement patterson company recently align technology inc price consensus align technology inc price consensus align technology inc quote idexx laboratory inc idxx free report stock have zack rank growth score zack consensus estimate idexx laboratory sale peg next year reflect growth year year basis stock have market cap long term expect earning growth rate idexx laboratory continue depict solid growth globally strong international expansion management innovation base global strategy be lead cag diagnostic growth notably idexx widen cloud technology portfolio add rvetlink solid organic revenue growth raise guidance buoy optimism idexx laboratory inc price consensus idexx laboratory inc price consensus idexx laboratory inc quotestraumann hold ag stock have zack rank growth score zack consensus estimate straumann hold sale peg next year signify growth year year basis stock have market cap long term expect earning growth rate now see complete list today zack rank stock here straumann hold be global leader implant restorative dentistry oral tissue regeneration company collaborate lead clinic research institutes university research develop manufacture dental implant instrument prosthetic tissue regeneration product use tooth replacement restoration solution prevent tooth loss straumann hold ag price consensus straumann hold ag price consensus straumann hold ag quotepra health science inc prah free report stock have zack rank growth score zack consensus estimate straumann hold sale be peg next year signify growth year year basis stock have market cap long term expect earning growth rate now company operate global contract research organization provide outsourced clinical development service biotechnology pharmaceutical industry offer therapeutic service area cardio metabolic biosimilar infectious disease immunology neurology psychiatry oncology hematology rare disease respiratory need pra health science inc price consensus pra health science inc price consensus pra health science inc quote medical stock buy nowzack name company poise ride medical breakthrough be target cure leukemia aids muscular dystrophy hemophilia other condition new product field be already generate substantial revenue even more wondrous treatment be pipeline early investor realize exceptional profit click here see stock
763,ALGN,perkinelmer inc pki free report recently announce completion buyout euroimmun medical laboratory diagnostic ag approximately cash latter be autoimmune testing company emerge player infectious disease allergy testing feel acquisition be strategic move perkinelmer lubeck germany base euroimmun have approximately employee serve customer more country financial acquisition euroimmun medical laboratory diagnostic expand perkinelmer reach autoimmune allergy diagnostic market buyout also enhance perkinelmer capability china new infectious disease market management acquisition be expect add cent cent share adjust earning management expect addition euroimmun drive expense margin company be consistently try drive inorganic growth acquisition company recently complete buyout tulip diagnostic private limit company base goa india total consideration diagnostic segment get now have advanced detection capability imaging assay development prospect deliver better more complete solution customer fact post acquisition perkinelmer complete global diagnostic portfolio get boost segment now include solution focuse reproductive health autoimmune infectious disease allergy testing gene analysis genomic offering oncology other molecular test wide range instrument reagent assay platform software offering regard company diagnostic segment grow organically year year basis last quarter believe latest development further boost growth segment stock price performance perkinelmer have be favorable last year stock have gain outperform broader industry gain almost current level compare favorably return zack rank key carry zack rank hold few better rank medical stock be athenahealth inc athn free report align technology inc algn free report luminex corporation lmnx free report notably athenahealth align technology sport zack rank strong buy luminex carry zack rank buy see complete list today zack rank stock here athenahealth have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year luminex have long term expect earning growth rate stock have gain past month medical stock buy nowzack name company poise ride medical breakthrough be target cure leukemia aids muscular dystrophy hemophilia other condition new product field be already generate substantial revenue even more wondrous treatment be pipeline early investor realize exceptional profit click here see stock
764,ALGN,dec issue update research report dexcom inc dxcm free report company have be trading broader industry past month stock have gain higher broader industry gain believe glucose monitoring market represent significant opportunity dexcom diabetes market be large grow third quarter management dexcom confirm company be well poise meet unmet demand global diabetic space especially come continuous glucose monitoring facility dexcom have collaborative agreement several company not only bring cash form milestone payment royalty also help expand product portfolio regard dexcom announce collaboration september lead wearable brand fitbit develop market product better management diabetes get clearer picture overall health easy use mobile tool dexcom continue focus international market especially germany company be also eyee sizeable market india china japan give demographic trend lifestyle country outside unite state europe believe dexcom have bountiful opportunity international market however company face reimbursement risk owing effort control healthcare expense further increase demand offering dexcom face supply constraint term market blood glucose monitoring device be highly competitive subject rapid change significantly affected product launch respect platinum system dexcom compete directly roche diabetes care division roche diagnostic lifescan inc division johnson johnson medisense therasense division abbott laboratory bayer corporation zack rank key picksdexcom carry zack rank hold few better rank medical stock be athenahealth inc athn free report align technology inc algn free report luminex corporation lmnx free report notably athenahealth align technology sport zack rank strong buy luminex carry zack rank buy see complete list today zack rank stock here athenahealth have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year luminex have long term expect earning growth rate stock have gain past month medical stock buy nowzack name company poise ride medical breakthrough be target cure leukemia aids muscular dystrophy hemophilia other condition new product field be already generate substantial revenue even more wondrous treatment be pipeline early investor realize exceptional profit click here see stock
765,ALGN,dec issue update research report nuvasive inc nuva free report stock carry zack rank hold lead medical device company have be trading broader industry past month stock have gain comparison broader industry be upbeat nuvasive solid top line gain international business third quarter company international business exceed expectation record growth cer continue strong demand company spine technology particularly key market italy germany japan overall company believe share international market rise double digit next several year banking stellar first half performance company raise international business growth guidance more nuvasive recently adopt few strategy drive adjust operate margin reach revenue mark include plan well align strategy technology marketing order enhance product development capability also nuvasive plan merge commercial international sale function global commercial organization apart company intend global operation enhance efficiency combination manufacturing supply chain information technology regulatory affair quality assurance ra qa be also encourage company receipt certain fda approval late october nuvasive receive expand clearance fda tlx interbody system notably tlx have be design minimally invasive spine surgery approach same month company announce expand fda approval advanced magnetic invasive limb lengthen technology precice nuvasive also receive fda approval use redesign magec system reline small stature system september flip side pricing continue remain major headwind nuvasive have be face decline product price due intensify competition spine market pricing pressure experience hospital customer manage care organization insurance provider other third party payer further continuous contraction gross margin be matter concern key picksa few better rank medical stock be athenahealth inc athn free report align technology inc algn free report luminex corporation lmnx free report notably athenahealth align technology sport zack rank strong buy luminex carry zack rank buy see complete list today zack rank stock here athenahealth have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year luminex have long term expect earning growth rate stock have gain past month medical stock buy nowzack name company poise ride medical breakthrough be target cure leukemia aids muscular dystrophy hemophilia other condition new product field be already generate substantial revenue even more wondrous treatment be pipeline early investor realize exceptional profit click here see stock
766,ALGN,dec issue update research report genomic health inc ghdx free report global cancer research company focus advanced molecular diagnostic genomic health have be trading broader industryover past month stock have rally compare broader industry decline fact stock have sky-rocket past week couple development market be particularly optimistic genomic health recently announce outcome series trial underscore efficiency oncotype dx breast recurrence score test oncotype dx dcis score test breast cancer notably ductal carcinoma also know dcis be most common type invasive breast cancer be also upbeat company multus year research collaboration agreement janssen pharmaceutical evaluate oncotype dx genomic prostate score gps test prostate cancer drug pipeline part deal genomic health test sample janssen study examine association gps result clinical outcome overall be encourage year year rise revenue drive solid performance unite state internationally third quarter international test volume expand represent total test volume period so far genomic health have witness healthy progress regard establish coverage oncotype dx breast cancer test genomic health expect several key catalyst drive strong revenue growth catalyst include anticipate implementation pama protect access medicare act reimbursement higher level invasive breast rate ajcc american joint committee cancer stage criterium be effective january prostate cancer business oncotype dx genomic prostate score test receive positive local coverage determination expand medicare coverage palmetto gba company also make positive development oncotype dx breast recurrence score test addition establish private coverage test germany flip side revenue third quarter lag zack consensus estimate due disruption hurricane certain region unite state estimate have affected domestic test volume approximately company rise operate loss also continue be huge concern addition sole reliance profitability breast oncotype dx test be challenge cope management decision not issue guidance have be discourage too fail provide definite visibility company upcoming performance zack rank key picksgenomic health have zack rank hold few better rank medical stock be athenahealth inc athn free report align technology inc algn free report luminex corporation lmnx free report notably athenahealth andalign technology sport zack rank strong buy luminexcarry zack rank buy see complete list today zack rank stock here athenahealthha long term expect earning growth rate stock have rally roughly year align technologyha long term expect earning growth rate stock have gain year luminex have long term expect earning growth rate stock have gain past month medical stock buy nowzack name company poise ride medical breakthrough be target cure leukemia aids muscular dystrophy hemophilia other condition new product field be already generate substantial revenue even more wondrous treatment be pipeline early investor realize exceptional profit click here see stock
767,ALGN,transenterix inc trxc free report recently sign agreement great belief international limit gbil commercialize surgibot system globally notably transenterix surgibot system be single port robotically enhance laparoscopic surgical platform base british virgin island gbil be focuse make investment manage asset healthcare industry gbil revenue be mainly generate investment chinese medical sector agreement have result transfer surgibot system asset ownership transenterix retain option distribute system outside china transfer surgibot system asset gbil manufacture system china also get regulatory approval china food drug administration cfda gbil expressed plan enter distribution agreement china national scientific instrument material company csimc meanwhile transenterix retain exclusive right file fda clearance pma approval surgibot exclusive right distribute surgibot unite state accord management company get least be likely be receive end december mar market prospectseas highly prevalent issue rise labor cost china be advance lightning pace establish world lead manufacturer robot accord report market market global medical robot market be expect value cagr china lead contributor revenue robot base technology have be enhance healthcare space clinical application diagnostic support operational efficiency electronic health record system practice workflow supply chain management grow prevalence minimally invasive robot assist surgery self automate home base care use quick improve patient care be worth mention regard thus latest development be strategic keep bountiful opportunity niche space mind share price estimate revision share have outperformed industry past month stock have sky-rocket compare industry gain current level be better return estimate revision trend have be favorable company current quarter estimate moved north compare movement opposite direction last month result zack consensus estimate current year have narrow loss cent share loss cent consensus estimate current quarter earning have rise zack rank key carry zack rank hold few better rank medical stock be athenahealth inc athn free report align technology inc algn free report luminex corporation lmnx free report notably athenahealth align technology luminex sport zack rank strong buy see complete list today zack rank strong buy stock here athenahealth have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year luminex have long term expect earning growth rate stock have gain past month zack editor chief go stockfull disclosure kevin matra now have more own money particular stock other believe short term profit potential also prospect more double today reveal explain surprising move new special report download free
768,ALGN,higher hope tax reform be pass have act latest catalyst drive wall street new high particular nasdaq composite index gain day outperform other benchmark dow jone hit major milestone first time surge technology sector account nearly half index well broad bullish sentiment help nasdaq lead higher gain year compare gain dow jone read tech etfs crushed fang etfs combination factor improve global fundamental strong corporate earning rise interest rate scenario emergence cut edge technology be act key catalyst stock consumer discretionary industrial stock index be also gain accelerate economic growth rise consumer confidence rise oil price pick activity most part world well improve global sentiment have add strength result powershare qqq qqq serve proxy index have climb nearly year so far let take closer look fundamental qqq qqq etf provide exposure largest domestic international financial company list nasdaq tracking nasdaq index be largest most popular etf large cap space aum average daily volume share charge investor bps annual fee fund have zack etf rank buy medium risk outlook see large cap etfs here most stock fund portfolio deliver strong return few be real star have gain more have highlighted best perform stock etf respective position fund basket top perform stock qqqalign technology inc algn free report stock make just allocation fund basket have deliver incredible return nearly year have see solid earning estimate revision cent year past day expect earning growth rate align technology have zack rank strong buy vgm style score additionally belong solid industry have zack rank top read sector etf stock winner year great recession mercadolibre inc meli free report stock have surge nearly year currently carry zack rank strong sell vgm style score stock have see negative earning estimate revision cent year past month expect earning decline further mercadolibre have ugly zack industry rank bottom stock account share qqq micron technology inc mu free report stock have gain year have see solid earning estimate revision past month year expect earning growth rate micron technology currently have zack rank top vgm style score also boast solid zack industry rank top stock make share fund basket vertex pharmaceutical vrtx free report stock have surge year carry zack rank hold vgm style score company have see solid earning estimate revision cent year past month expect earning growth stock belong industry have zack rank top account just share qqq read value biotech etfs buy now wynn resort limit wynn free report stock have gain so far year have exposure fund basket have see solid earning estimate revision cent past month year expect earning growth rate wynn resort have zack rank vgm style score additionally have solid industry rank top want key etf info deliver straight inbox zack free fund newsletter brief top news analysis well top perform etfs week get free
769,ALGN,henry schein inc hsic free report recently complete buyout evetpractice provider cloud base practice management solution veterinary clinic financial term deal have be keep wrapped company expect deal prove accretive earning share post company evetpractice be part henry schein veterinary solution portfolio comprise avimark improme north america well vision rxwork robovet globally notably evetpractice be rapidly grow cloud solution provider unite state customer base believe latest takeover widen henry schein customer base portfolio development technology vasin september henry schein have announce receipt office national coordinator health information technology onc health edition health module certification group llc practice management electronic health record software micromd company offer wide range practice management software system cover dental animal health medical have customer base more practice inclusive micromd physician practice continue slew development company have earlier announce partnership medical system simplifeye combine entity aim create mobile experience integration simplifeye henry schein micromd furthermore collaboration aim allow physician provide more customize patient experience simplify practice workflow keep concern team member well connect away workplace performance technology vaswe believe latest development boost sale company global technology value add service vas business interestingly segment see increase revenue last report quarter include growth local currency rise related foreign currency exchange acquisition contribute quarter review market potentialaccord report global veterinary software market be expect reach value cagr consider substantial potential market believe latest development be strategic company increase trend cost control have potential drive demand technology solution go report global healthcare market be project reach value cagr period believe agee population unhealthy lifestyle rise awareness expenditure healthcare continue drive growth healthcare market market be dominate number well establish player nextgen division quality system inc qsii free report be prominent share price performance
770,ALGN,sep issue update research report amedisys inc am free report stock carry zack rank buy renown home health hospice service provider have be trading broader industry past month stock have gain broader industry decline amedisys personal care segment have be stabilize integration latest tuck acquisition moreover company be upbeat bountiful prospect segment recently announce intercity takeover company have close total personal care acquisition last september be await regulatory approval buyout east tennessee personal care service amedisys also plan evolve traditional home health hospice care company be focuse bring home continuum care be company intend better serve patient diversify source payment lower dependence medicare regard company see rise medicare revenue medicare revenue decline home health division third quarter hospice division company record strong growth segment also favorable home health final rule buoy optimism accord report healthcarefirst home health final rule be finalize implementation home health grouping model hhgm schedule rollout meanwhile amedisys be poise benefit age demographic population need higher acuity patient home nursing environment furthermore company strong cash balance position bolster investor confidence stock flip side escalate operate expense decline gross margin continue raise concern also intensely competitive landscape regulatory concern weigh home health hospice industry other key picksother top rank medical stock be athenahealth inc athn free report align technology inc algn free report luminex corporation lmnx free report notably athenahealth align technology luminex sport zack rank strong buy see complete list today zack rank stock here athenahealth have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have rally year luminex have long term expect earning growth rate stock have gain past month zack editor chief go stockfull disclosure kevin matra now have more own money particular stock other believe short term profit potential also prospect more double today reveal explain surprising move new special report download free
771,ALGN,express script hold company esrx free report recently complete buyout evicore healthcare notably evicore provide evidence base integrate medical benefit management service mbm solution help reduce cost provide quality care post acquisition evicore operate standalone business unit express script enhance capacity provide better clinical outcome saving health plan purchaser patient express script pharmacy benefit management couple evicore complementary mbm platform be likely build comprehensive patient benefit management pbm solution buyout provide express script opportunity cross sell client basis furthermore buyout widen express script ability drive value use specialty medication notably specialty medication be used treat complex chronic condition medicine be exorbitantly expensive form fastest grow part pharmaceutical expense express script enter mbm spacembm be exclusive platform check specialty drug spending mbm also provide care service patient ensure safe efficient timely outcome deal express script aim eradicate long medical procedure lack coordinate evidence base care target healthcare industry represent worth annually management be more time larger pharmacy segment pbm market be expect maintain solid trend report market research report biz pbm market see cagr so latest development be strategic fit keep bountiful opportunity niche space mind financial acquisition be expect prove accretive express script adjust diluted earning share exclude transaction related expense amortization intangible guidance raisedexpres script increase previously issue consolidated full year adjust ep guidance range reflect growth consolidated adjust ep result midpoint range company have also provide adjust earning diluted share guidance range reflect growth midpoint update adjust ep guidance range share price estimate revision trendexpress script stock have outperformed broader industry last month stock have gain period compare industry gain company recent earning estimate revision trend have be encourage well current quarter have see estimate go last day compare revision opposite direction consensus estimate current quarter earning have rise zack rank key picksexpress script carry zack rank hold few better rank medical stock be athenahealth inc athn free report align technology inc algn free report luminex corporation lmnx free report notably athenahealth align technology luminex sport zack rank strong buy see complete list today zack rank stock here athenahealth have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year luminex have long term expect earning growth rate stock have gain past month wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
772,ALGN,phenomenal growth story be align technology algn free report maker revolutionary invisalign clear tooth straightener continue make early investor apparently catch majority surprise past year algn share be vs performance certainly make member healthcare innovator portfolio big own stock now trading time high close hit june algn share trade time consensus ep estimate year explain so many pass board way train big gain majority miss be company breakthrough dental technology be go maintain growth domestically nearly growth internationally more dental professional find invisalign system be extremely effective highly desirable solution patient align trajectory here tell follower few day take profit position biggest success story healthcare innovator keep roll base same catalyst have keep name quarter last year wider adoption invisalign technology consumer dental professional low competitive threat international growth company hold investor analyst day wednesday wow crowd compete product month american association orthodontist tradeshow be see limit type malocclusion be treat many also lack support case management software orthodontist be critical overall process today market company provide long term revenue guidance growth expectation previous long term guidance key growth driver remain place geographic product perspective align remain most compelling growth story medical technology here be slide company presentation post twitter capture essence growth trajectory get cut bottom be label quarters be so see year year sequential growth indicated bracket thousand unit ship top row number green circle be utilization rate calculate case ship doctor case be ship measure indicate trajectory dental professional adoption vs just new physician try product once twice now let hear analyst help pop stock leerink swann analyst richard newitter raise price target align technology say come away company analyst day increase confidence sustainability market lead position still significantly underpenetrated clear aligner orthodontic market opportunity jeffery analyst brandon couillard raise price target align technology say left wednesday company presentation more confident durability company competitive advantage align stand benefit analog digital shift underway ortho dentistry stifel nicolaus analyst block go ahead pack earlier week raise price target algn note algn share have rally aao meeting believe additional upside exist investor get more comfortable align future growth increase competition company update investor analyst day boy block nail call so do sell low nearly gain do regret first sell thought stock have moved really quickly fulfill best expectation just so be quickly back trading ep even new improve growth guidance thought back fill little boy cooker drop ball do regret only little mean be achieve bulk mission caputure meat move also book long term gain healthcare innovator portfolio just trade short term tazr portfolio grab be wider lesson here bull market work follow long term investor great business early growth stage year let growth fully materialize really pay learn more idea article write recently wonder behold last innings bull market kevin cook be senior stock strategist zack investment research run tazr trader healthcare innovator service click follow author receive latest stock research macro analysis look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
773,ALGN,medical group have plenty great stock investor always be look company be outperform peer have align technology algn free report be stock year quick glance company year date performance comparison rest medical sector help answer question align technology be individual stock medical sector collectively company sit zack sector rank zack sector rank gauge strength individual sector group measure average zack rank individual stock group zack rank be successful stock pick model emphasize earning estimate estimate revision system highlight number different stock be poise outperform broader market next month algn be currently sporting zack rank strong buy past month zack consensus estimate algn full year earning have moved higher show analyst sentiment have improve company earning outlook be stronger latest available datum show algn have return start calendar year meanwhile medical sector have return average year date basis mean align technology be perform better sector term year date return look more specifically algn belong medical dental supply industry group include individual stock currently sit zack industry rank stock group have gain so far year so algn be perform better group term year date return go forward investor interested medical stock continue pay close attention algn look continue solid performance
774,ALGN,medical instrument industry broader medical universe have be gain innovation higher consolidation focus emerge market tax abolition industry increase month time higher index rise fundamentally industry have benefit massive change consumer behavior well be evident rise minimally invasive surgery higher demand liquid biopsy test well use quick improve patient care shift payment system value base model be interesting analyze best medical instrument stock be likely yield solid return day come first let glance latest headline space latest medical instrument headline glance stryker takeover plan boston medical instrument fraternity have be ride current merger acquisition trend recent report reuter stryker corporation syk free report be likely take boston scientific corporation bsx free report create market value more however possibility deal be uncertain thre be confirmatory statement press release company representative fact investor never forget stryker highly rumore acquisition plan nephew never materialize brighter side be not first time stryker have be tie boston scientific company acquire boston scientific neurovascular unit indicate probability second collaboration read more stryker likely acquire boston scientific stryker have zack rank buy deal materialize combine entity have medtech broadest spectrum product offering include cardiology orthopaedic surgical supply neuroscience reduce pricing pressure competition further company strong acquisition policy gain rapidly expand customer base moderate leverage enhance cash flow glance major acquisition recent past becton dickinson company takeover bard johnson johnson buyout covidien deserve mention abiom reserve slot lead medical instrument player abiom inc abmd free report replace wyndham worldwide corp enter global industry classification standard gic health care supply sub industry index research report globe mail abiom be follow trend medical device technology company reserve top slot index remind investor align technology inc algn free report top index abiom currently have market capitalization further company financial viability adequate liquidity reasonable price sector representation have lend competitive edge medical instrument industry read more abiom replace wyndham benchmark tax abolition boost da bipartisan year suspension medical device tax impose excise tax medtech manufacturer have be temporary relief tax take toll entire medical device industry enactment advanced medical technology association lobbying group tax have negative impact medical innovation result loss defer creation job now deferral encourage activity space repeal tax paradigm be expect boost hire investment america base medical device manufacturer instilling investor optimism ratification tax repeal amendment have invoked massive investment sector top medical instrument existence number player medical instrument industry choose right stock potential yield return be daunting task proprietary zack methodology make fairly simple have take help zack stock screener select favorable stock have select stock have favorable growth style score carry zack rank strong buy research show stock style score combine zack rank offer best investment opportunity see complete list today zack rank stock here varian medical system inc var free report outperformed industry month time stock have return have zack rank zack consensus estimate full year earning be currently peg year year june varian medical system demonstrated comprehensive portfolio advanced brachytherapy solution american brachytherapy society annual meeting development be likely boost varian oncology system segment apart various volumetric modulate arc therapy vmat stereotactic radiosurgery stereotactic radiotherapy brachytherapy unit be significant contributor oncology system company have be gain consistently coveted halcyon platform cost effective radiotherapy cancer treatment system notably company also launch halcyon kilovoltage imaging solid revenue oncology grow adoption particle therapy strong overseas presence particularly emerge country be positive varian have also be go global acquisition agreement recent buyout include sirtex australia coop taiwan partnership ministry health brazil solid guidance fiscal instill confidence intuitive surgical inc isrg free report outperformed industry month stock have rise almost sport zack rank zack consensus estimate full year earning be currently peg year year grow adoption company da vinci system increase procedure volume continuous innovation solid recur revenue base be key catalyst intuitive surgical da vinci surgical system enable minimally invasive surgery help avoid trauma associate open surgery da vinci system be power robotic technology allow surgeon hand movement be translate smaller precise movement tiny instrument patient body da vinci have bolster company foothold market cardiac surgery colorectal surgery general surgery gynecologic surgery head neck surgery thoracic surgery urologic surgery da vinci system have make available minimally invasive surgery more patient worldwide recently system have cure patient diagnosed inguinal hernia integer holding corporation itgr free report outperformed industry last month stock have return industry decline zack consensus estimate full year earning be currently peg year year company witness impressive start high organic year year growth earning revenue cardio vascular arm deserve special mention here other segment have also be deliver solid performance strategic divestment advanced surgical orthopedic portable medical wing medplast llc be expect prove profitable quarters ahead company have multus year plan long term development impressive guidance decline operate expense clear debt be other major positive hottest tech mega trend last year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
775,ALGN,company ability provide good return investor even meeting business related cost expense be measure used profitability analysis fundamentally strong company generally have high level profitability respect have used accounting ratio evaluate profitability position company identify profitable company loss make best accounting tool understand company profitability position be ratio analysis generally be key profitability ratio gross income ratio operate income ratio pre tax profit margin net income ratio here have used most effective frequently used profitability ratio net income ratio net income rationet income ratio give exact profit level company reflect percentage net income total sale revenue used net income ratio determine company capability meet operate operate expense sale revenue higher net income ratio usually imply company ability generate ample sale revenue successfully manage business function screening parametersnet income ratio be not only indicator future winner so have add few more criterium arrive winning strategy zack rank equal only zack rank strong buy stock be allow zack rank prove be best rating system be great way start thing see complete list today zack rank stock here month trail sale net income growth higher industry stock possess higher sale net income growth last month showcase better financial performance month trail net income ratio higher industry high net income ratio indicate company solid profitability rating strong buy greater indicate analyst cover stock be optimistic few parameter narrow universe stock only here be stock qualify screen align technology inc algn free report be designer clear aligner therapy intraoral scanner cad cam digital service have average quarter positive earning surprise momo inc momo free report be operator mobile base social networking platform have average quarter positive earning surprise tokyo electron limit toely free report be developer semiconductor flat panel display production equipment have average quarter positive earning surprise solaredge technology inc sedg free report be designer direct current optimized inverter system solar photovoltaic installation have average quarter positive earning surprise atla air worldwide holding inc aaww free report be provider outsourced aircraft aviation operate service globally have average quarter positive earning surprise get rest stock list signing now week free trial research wizard start used screen own trading further also create own strategy test first take investment plunge research wizard be great place begin easy use everything be plain language very intuitive start research wizard trial today next time read economic report open research wizard plug find see gem come click here sign free trial research wizard today disclosure officer director employee zack investment research own have sell short security hold long short position option be mentioned material affiliated investment advisory firm own have sell short security hold long short position option be mentioned material disclosure performance information zack portfolio strategy be available https www zack com performance zack restaurant recommendation addition dine special place feast stock share zack special report spotlight recent ipos watch stock offer immediate promise boom sector download free
776,ALGN,delek holding inc dk free report be independent diversify energy business focuse petroleum refine zack consensus estimate current year company have improve last day also have strong earning outlook go forward top line growth be expect improve double digit bottom line growth be expect improve triple digit align technology inc algn free report be global medical device company industry lead innovative product company begin solid note earning be strongly last earning report see balanced sale growth channel first quarter be outperform industry past year strong balance sheet show high growth prospect hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
777,ALGN,welcome back mind money kevin cook field guide story teller fascinating arena behavioral economic today want tell special video make subscriber zack com title rule bull market risk simplify want crystallize favorite principle earn year experience good market bad lesson future bull market hope be video become teach tool investor age lesson certainly stand test time next bull market too also take half podcast do quasi review new book title emotion be make secret life brain neuroscientist lisa feldman barrett more come talk investor stock market year still hear reason time be cautious end be experience tell differently have often thought year market be inning have few fundamental reason believe couldn keep make new high year so look back portfolio body content ve create year help investor profit wonder simplify message even further often prefer not simplify lean instead parse complexity nuance economic matter work do have same persistent theme so realize very easily crystallize rule just word total video accompany article go back message past year bull market then summarize rule video also promise useful link review latest fundamental update baba case miss here be strategy session presentation last clip minute zuss top stock pick baba even then awesome earning growth guidance remind investor get do moral bull storygot minute think better way quickly sum moral story minute video record last year cboe tv host angela mile ask favorite trader tip know instantly only have minute share thousand investor choose core idea follow smart moneyfinally here be message offer tracey ryniec marketedge podcast back january cooker melt recipethree ingredient melt recipe investor profit multiple expansion be control be inning bull market multiple expansion isn yet high be peak other bull rally still be plenty more upside go competition less stock more investor additionally wall street most retail investor have buy doesn have sell global macro worry happened eurozone crisis china have hard landing first time decade global economy be sync grow same time virtually economic crisis loom end excerpt marketedge podcast grant market head correction right new global macro worry trade war also warn zack ultimate member temporary exuberance stock week prior so trade war anxiety be good surprising antidote wring excess bullishness part short term swing extreme optimism pessimism market very healthy overall long term bullishness always ready dry powder pullback buy more favorite stock chemistry culture emotionsince begin mind money podcast november have frequently read book different group scientist form foundation knowledge human psychology market first group be course behavioral theorist daniel kahneman richard thaler dan ariely have help create field behavioral economic smaller nich finance trading second group be compose neuroscientist antonio damasio john ratey candace pert discoverer opiate receptor have taught much latest discovery structure function incredibly complex brain just start read new book lisa feldman barrett phd week offer initial reaction podcast dr barrett be university distinguish professor psychology northeastern university appointment harvard medical school massachusett general hospital addition book emotion be make secret life brain dr barrett have publish peer review scientific paper appear science nature neuroscience other top journal psychology cognitive neuroscience well academic volume publish guilford press have also give popular ted talk dr barrett receive national institutes health director pioneer award revolutionary research emotion brain highly competitive multimillion dollar award be give scientist exceptional creativity be expect transform biomedical behavioral research natural attraction openness book brain actually have initial reaction resistance confusion first start read introduction dr barrett point attack seem be cultural even scientific misconception emotion be create read nearly dozen book other neuroscientist guess assume much confusion have already be clear page page bibliography page note book appear offer several month instruction insight so be more willing give expert benefit doubt dive summer be sure check full podcast hear read few paragraph book offer amateur observation be worth don forget watch video rule bull market share friend fellow investor know be anywhere disclosure own share nvda lrcx baba zack tazr trader portfolio kevin cook be senior stock strategist zack investment research run tazr trader healthcare innovator service click follow author receive latest stock research macro analysis
778,ALGN,talk investor stock market still hear reason time be cautious end be experience tell differently have often thought year market be inning have few fundamental reason believe couldn keep make new high year so look back portfolio body content ve create year help investor profit wonder simplify message even further often prefer not simplify lean instead parse complexity nuance economic matter work do have same persistent theme so realize very easily crystallize rule just word total video accompany article go back message past year bull market then summarize rule hope be video become teach tool investor age lesson certainly stand test time next bull market too video also promise useful link review latest fundamental update baba case miss here be strategy session presentation last clip minute zuss top stock pick baba even then awesome earning growth guidance remind investor get do moral bull storygot minute think better way sum moral story minute video record last year cboe tv host angela mile ask favorite trader tip know instantly only have minute share thousand investor choose core idea follow smart moneyfinally here be message offer tracey ryniec marketedge podcast back january cooker melt recipethree ingredient melt recipe investor profit multiple expansion be control be inning bull market multiple expansion isn yet high be peak other bull rally still be more upside go competition less stock more investor additionally wall street most retail investor have buy doesn have sell global macro worry happened eurozone crisis china have hard landing first time decade global economy be sync grow same time virtually economic crisis loom end excerpt marketedge podcast grant market head correction right also warn zack ultimate member week prior long term bullishness always ready dry powder pullback buy more favorite stock disclosure own share nvda lrcx baba zack tazr trader portfolio kevin cook be senior stock strategist zack investment research run tazr trader healthcare innovator service click follow author receive latest stock research macro analysis today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
779,ALGN,respiratory division teleflex incorporate tfx free report have recently enter new group purchasing agreement healthtrust purchasing group hpg respiratory heater accessory agreement name respiratory heater accessory hpg become effective dec agreement cover teleflex full line active humidification invasive ventilation niv high flow nasal cannula therapy hfnct product more member hospital healthtrust now access teleflex wide range humidification product include hudson rci neptune heated humidifier conchasmart technology iso gardheat wire circuit technology recent introduction comfort floplus high flow nasal cannula contract also complement teleflex exist general respiratory agreement hpg healthtrust contract exclusive teleflex provide hpg member opportunity consolidate respiratory purchase single supplier notably hfnct have be grow rate year year therapy have be show improve patient outcome reduce day mortality rate compare noninvasive ventilation standard oxygen therapy base datum expect teleflex deal healthtrust be strategically accretive former well boost top line significantly come period take cue teleflex have be putt lot effort strategic expansion top line growth september company have make substantial investment grow field urology have make acquisition neotract privately hold developer minimally invasive clinically effective device apart strengthen teleflex presence urology market company expect buyout accelerate company term sale growth trajectory provide significant sale channel opportunity additionally enhance teleflex organic growth profile long term past month teleflex have be trading broader industry stock have gain compare broader industry gain period zack rank key picksteleflex carry zack rank hold few better rank medical stock be petm express inc pet free report align technology inc algn free report luminex corporation lmnx notably petm align technology luminexsport zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technologyha long term expect earning growth rate stock have gain year luminex have long term expect earning growth rate stock have gain past month wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
780,ALGN,momentous healthcare consolidation have commence cvs health corporation cvs free report decide acquire health insurance giant aetna inc aet colossal sum yahoo finance article julia la roche valuable deal reshape landscape american health care follow news share company have be slightly pre market trading dec deal detailson dec cvs health announce definitive merger agreement company acquire outstanding share aetna cash stock approximately share almost consider rough estimate aetna debt total transaction value be calculate more specifically aetna shareholder receive share cash cvs health share aetna share cvs health note term merger agreement have be unanimously approve respective board director company involved post close transaction aetna shareholder own nearly combine entity cvs health shareholder acquire rest company expect takeover complete second half subject approval company shareholder regulatory approval well fulfillment certain other customary close condition synergy benefit forecaston deal successful completion cvs health expect earn term synergy low mid single digit accretion second year post transaction closure company shareholder look forward several outcome respect term synergy include enhance competitive position new combine platform redefine access high quality care low cost substantially accelerate consolidated business growth acquirer be highly optimistic merger slate combine analytic aetna touch humanity health care turf help create robust platform serve individual better cvs health merger long term have great potential deliver significant incremental value be likely spur development new product generate new growth opportunity uniquely integrate retailer pharmacy benefit manager far sight health planner share price comparisonshare cvs health have outperformed broader industry past month stock have drop compare favorably industry decline same time frame current value be however lower gain zack rank key pickscvs health carry zack rank hold better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report sporting zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technologyha long term expect earning growth rate stock have gain year myriad genetic have long term expect earning growth rate stock have soar year zack best private investment ideaswhile be happy share many article best recommendation most depth research be not available public start today next month follow zack private buy sell real time expert cover kind trade value momentum stock etf option move stock corporate insider be buy company be report positive earning surprise even look exclusive portfolio be normally close new investor click here zack private trade
781,ALGN,bid enhance inorganic growth cooper company inc coo free report announce coopervision have complete buyout paragon vision science headquarter gilbert az paragon provide orthokeratology ortho specialty contact lense oxygen permeable rigid contact lens material transaction be close accord company buyout be likely prove neutral earning share fiscal exclude time charge deal related amortization company have trail quarter revenue approximately coopervision segment manufacture sell wide range contact lense globally segment develop manufacture market broad range single use week monthly contact lense feature advanced material optic product be primarily design solve vision challenge astigmatism presbyopia ocular dryness last report third quarter fiscal coopervision revenue increase constant currency cc year year basis geographically coopervision revenue increase americas revenue asia pacific emea rise year year cc also fourth quarter fiscal result be schedule release dec be expect show steady growth coopervision segment market prospectsaccord report grand view research global contact lense market be estimate reach worth thus company clearly have bountiful prospect market focus company be focuse strategic acquisition drive inorganic growth recently complete takeover flagship contraception platform israel base teva pharmaceutical industry paragard intrauterine device cash transaction bolster cooper company coopersurgical business contraceptive device market stock performance solidover last year cooper company have gain compare favorably broader industry addition moreover current level be higher gain cooper company be poise gain expand product portfolio increase penetration international market accretive acquisition be also key catalyst long haul furthermore outlook contact lens industry be favorable be likely boost stock price company long term expect earning growth rate hold promise well estimate revision trendfurther cooper company estimate revision trend current quarter be favorable past day estimate moved moved estimate be share zack rank other key pickscooper company carry zack rank buy other top rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report notably petm align technology myriad genetic sport zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year myriad genetic have long term expect earning growth rate stock have gain year zack best private investment ideaswhile be happy share many article best recommendation most depth research be not available public start today next month follow zack private buy sell real time expert cover kind trade value momentum stock etf option move stock corporate insider be buy company be report positive earning surprise even look exclusive portfolio be normally close new investor click here zack private trade
782,ALGN,lot have be say president latest most controversial tax move impact economy once pass so far reaction hoi polloi have be mixed person favor republican treat latest move big stimulant economic growth offset financial deficit accord new system replace exist complicate antiquated unfair tax code have not be update more year opponent however slam new plan job killer report new york time critic say deficit finance tax cut be odd longstanding republican call fiscal discipline include tax cut not add ballooning federal deficit federal debt top earlier month be project grow next decade talk medtech tax repealthere be still lack clarity medtech space be unable gauge impending impact latest tax bill regard note community be extremely hopeful trump regulatory agenda promise abolition infamous medical device tax dread tax commonly address fund aca dealt heavy blow medical device industry enactment tax impose selling price instead net profit amount stupendous sum wipe almost quarter profit medical technology company realize house senate temporarily suspend year begin go available datum be quite evident partial year repeal medical device tax have benefit sector overall development datum provide medical device trade group ken blackwell article publish daily caller period be roughly rise research development investment medtech player republican current stance be tightlip tax increase probability return undoubtedly comeback be additional burden medtech fraternity largely discourage activity dental bear brunt condition dental industry significant part medical device space be equally bad notably sector post stellar performance bourse last year gain outperform gain just unfortunately give political challenge performance industry have deteriorate last year have gain just much lower gain almost furthermore discourage broader industry rank bottom more industry indicate persist concern dental space also note industry project earning share growth rate be lower dental stock bet onow adversity market watcher have adopt bearish stance dental space present only dental stock be expect beat ongoing medtech blue apart strong zack rank strong buy buy stock be witness favorable estimate revision see complete list today zack rank stock herealign technology inc algn free report zack rank company manufacture market system clear aligner therapy intra oral scanner cad cam computer aid design computer aid manufacturing digital service used dentistry orthodontic dental record storage align recent slew product development continue growth observed channel company consistent focus international market drive growth boost confidence stock meanwhile company recent earning estimate revision have be promising current year estimate have go past day movement opposite direction have positive impact zack consensus estimate increase cent past month align technology inc price consensus align technology inc price consensus align technology inc cooper company inc coo free report zack rank company be specialty medical device manufacturer operate global basis cooper company be poise gain expand product portfolio increase penetration international market accretive acquisition be also key catalyst long haul company recently sign asset purchase agreement acquire flagship contraception platform israel base teva pharmaceutical industry teva paragard intrauterine device cash transaction bolster company coopersurgical business segment contraceptive device market furthermore outlook contact lens industry be favorable be likely boost stock long haul meanwhile company recent earning estimate revision have be favorable current year estimate have moved higher past day compare movement opposite direction current year estimate have increase past month cooper company inc price consensus cooper company inc price consensus cooper company inc quotemerit medical system inc mmsi free report zack rank stock produce single use medical product high quality superior company expect gain decision purchase certain asset becton dickinson company include soft tissue core needle biopsy product also acquire aspira pleural effusion drainage kit aspira peritoneal drainage system bard be likely expand footprint meanwhile company recent earning estimate revision trend have be encourage estimate current year have moved higher past day compare movement opposite direction have positive impact consensus estimate increase cent past month merit medical system inc price consensus merit medical system inc price consensus merit medical system inc quotestraumann hold ag zack rank stock be global leader implant restorative dentistry oral tissue regeneration collaboration lead clinic research institutes university straumann research develop manufacture dental implant instrument prosthetic tissue regeneration product use tooth replacement restoration solution prevent tooth loss stock have long term expect earning growth rate straumann hold ag price consensus straumann hold ag price consensus straumann hold ag quotetoday stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return respectively outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
783,ALGN,nov issue update research report genomic health inc ghdx free report global cancer research company focus advanced molecular diagnostic genomic health have be trading broader industry past month stock have lose wider broader industry decline revenue third quarter lag zack consensus estimate due disruption hurricane certain region unite state estimate have affected domestic test volume approximately company rise operate loss also continue be concern sole reliance profitability breast oncotype dx test be challenge cope management decision not issue guidance have be discourage too fail provide visibility company upcoming performance however be encourage year year rise revenue drive solid performance unite state internationally third quarter international test volume expand represent total test volume quarter revenue grow year year so far genomic health have witness healthy progress regard establish coverage oncotype dx breast cancer test genomic health expect several key catalyst drive strong revenue growth catalyst include anticipate implementation pama protect access medicare act reimbursement higher level invasive breast rate ajcc american joint committee cancer stage criterium become effective january prostate cancer business oncotype dx genomic prostate score test receive positive local coverage determination expand medicare coverage palmetto gba company also make positive development oncotype dx breast recurrence score test addition establish private coverage test germany zack rank key picksgenomic health carry zack rank hold few better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report sporting zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have surge roughly year align technology have long term expect earning growth rate stock have sky-rocket year time myriad genetic have long term expect earning growth rate stock have soar year zack best private investment ideaswhile be happy share many article best recommendation most depth research be not available public start today next month follow zack private buy sell real time expert cover kind trade value momentum stock etf option move stock corporate insider be buy company be report positive earning surprise even look exclusive portfolio be normally close new investor click here zack private trade
784,ALGN,myriad genetic inc mygn free report have rally last month ahead gain also better broader industry decline stock have market cap solid prospect zack rank strong buy stock be attractive pick present let find recent positive trend be sustainable company estimate revision trend current year have also be positive past day analyst moved north movement opposite direction estimate rise share company also yielded average return last quarters myriad genetic kick start fiscal solid note exit first quarter year year improvement earning revenue company observed strong growth genesight endopredict test revenue continue year year growth hereditary cancer volume pricing match expectation expansion operate margin be also encourage company reaffirm guidance fiscal also buoy optimism myriad genetic wholly own subsidiary assurex health recently form alliance department veteran affair va prime care precision medicine mental health care multus center national trial evaluate effectiveness genesight test improve health result retire soldier suffering major depressive disorder mdd myriad genetic carefirst bluecross blueshield recently inked agreement collaborate clinical utility study vectra da test patient rheumatoid arthritis ra company be look forward collaboration expect speed reimbursement process new technology other key picksother top rank medical stock be petm express inc pet free report align technology inc algn free report luminex corporation lmnx free report notably petm align technology sport zack rank luminex carry zack rank buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly last year align technology have long term expect earning growth rate stock have gain last year luminex have long term expect earning growth rate stock have gain last year zack best private investment ideaswhile be happy share many article best recommendation most depth research be not available public start today next month follow zack private buy sell real time expert cover kind trade value momentum stock etf option move stock corporate insider be buy company be report positive earning surprise even look exclusive portfolio be normally close new investor click here zack private trade
785,ALGN,illumina inc ilmn free report recently introduce second fda regulate ce ivd marked next generation sequence ngs system nextseq dx instrument have be design deliver power high throughput ngs clinical laboratory company announce intend use miseqdx instrument first fda regulate ngs sequencer have be extend include use dna library generate formalin fix paraffin embed ffpe tissue enable clinical lab use ffpe sample develop clinical test new application also allow development more diagnostic product service clinical lab clinician gain access information generate illumina ngs technology illumina now have solid diagnostic ngs portfolio courtesy nextseq dx miseqdx product portfolio be capable meeting clinical requirement ngs base diagnostic ivd product accord market market global next generation sequence market be estimate reach worth cagr illumina be strive expand ngs platform line company recently announce launch solution noninvasive prenatal testing nipt kit europe product veriseq nipt solution be ce ivd marked ngs base approach nipt meanwhile illumina telegraph hill partner announce plan set independent company verogen inc entity be expect strengthen illumina ngs business forensic genomic market also illumina announce extend ra panel fda approve ngs kit meet newly publish guideline evaluation colorectal cancer company have also launch bio rad single cell sequence solution first ngs single cell analysis collaboration bio rad laboratory inc last month illumina have gain broader industry decline estimate revision estimate revision trend have be favorable company current year estimate moved north compare movement opposite direction last month result zack consensus estimate full year have rise share same period zack rank key picksillumina carry zack rank hold few better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report notably petm align technology myriad genetic sport zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly last year align technology have long term expect earning growth rate stock have gain last year myriad genetic have long term expect earning growth rate stock have gain last year zack best private investment ideaswhile be happy share many article best recommendation most depth research be not available public start today next month follow zack private buy sell real time expert cover kind trade value momentum stock etf option move stock corporate insider be buy company be report positive earning surprise even look exclusive portfolio be normally close new investor click here zack private trade
786,ALGN,myriad genetic inc mygn free report wholly own subsidiary assurex health recently form alliance department veteran affair va prime care precision medicine mental health care multus center national trial evaluate effectiveness genesight test improve health veteran suffering major depressive disorder mdd slate complete prime care be expect enroll patient mdd moreover trial include pharmacogenomic testing evaluate patient response genesight guide therapy study also include healthcare provider va medical center market mdd therapy be grow rapid pace company veteran have be find suffer mdd other mental health disorder high suicide rate addition company state roughly soldier position iraq afghanistan have be suffering form mental health disease mdd believe favorable outcome study drive uptake genesight test genesight be initial stage adoption be place highly penetrate preventive care market product have huge growth potential also management have be take necessary step strengthen genesight testing platform regard november assurex health announce favorable result multus center double blind randomize controlled trial evaluate impact genesight psychotropic test psychiatric treatment response patient major depressive disorder moreover october assurex health announce favorable result test patient generalized anxiety disorder gad favorable datum support superiority genesight test better treatment patient gad be present world congress psychiatric genetic meeting orlando last report first quarter fiscal company witness rise genesight test revenue highest revenue gross molecular diagnostic test segment accounting total revenue thus myriad genetic latest alliance seem be line company expectation witness consistent growth genesight test revenue quarters ahead myriad genetic have be consistently gain investor confidence positive result last month stock have gain loss broader industry zack rank other key picksmyriad genetic currently carry zack rank strong buy other top rank medical stock be petm express inc pet free report align technology inc algn free report luminex corporation lmnx free report notably petm align technology luminex currently sport zack rank see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly last year align technologyha long term expect earning growth rate stock have gain last year luminex have long term expect earning growth rate stock have gain last year hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
787,ALGN,luminex corporation lmnx free report have rally last month ahead gain also better broader industry rise stock have market cap company current year historical growth rate be also favorable compare index broader industry solid prospect zack rank strong buy stock be attractive pick present let find recent positive trend be sustainable company estimate revision trend current year have also be positive past day analyst moved north moved opposite direction magnitude estimate revision increase cent share company also have stellar average return last quarters luminex exit third quarter solid note company report earning cent share third quarter increase year year revenue quarter rise almost year year company third quarter see solid cash flow well profit further expansion operate margin buoy optimism also luminex reiterate annual revenue guidance be encourage company also witness favorable tiding regulatory front recently regard luminex announce receipt fda clearance ary group strep assay be moderate complexity sample answer test direct detection streptococcus pyogene throat swab specimen used ary system other key picksother top rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report notably petm align technology myriad genetic sport zack rank see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly last year align technology have long term expect earning growth rate stock have gain last year myriad genetic have long term expect earning growth rate stock have gain last year hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
788,ALGN,cheme corporation che free report have be gain investor confidence consistently strong performance upbeat result past month company share price have outperformed industry stock have gain compare industry also company have outperformed gain cheme have market cap moreover have deliver average earning beat trail quarters solid prospect zack rank buy stock be attractive pick investor moment company estimate revision trend current year have be positive past day analyst revise estimate upward movement opposite direction magnitude estimate revision earning share increase zack style score system cheme sport growth score hint solid prospect research show stock growth style score combine zack rank strong buy offer best upside potential regard cheme have favorable net margin net income sale better industry project annual earning growth rate compare favorably industry moreover debt capital ratio bode well compare industry let find recent positive trend be sustainable cheme kick start solid note earning revenue beating zack consensus estimate stellar performance be drive steady year year revenue growth company subsidiary cheme vita business management note recent admission trend have be positive momentum be expect continue first quarter vita perform well financially operationally increase geographically weight average medicare reimbursement rate average daily census decline medicare cap also lend support revenue moreover be encourage vita median length stay recently report quarter turn be key indicator company penetration high acuity sector market roto rooter business also see consistent growth strong performance core plumbing drain clean service segment well solid growth water restoration further company see year year rise commercial residential revenue additionally cheme strong cash balance allow carry share repurchase program provide solid return investor moreover expansion gross operate margin buoy optimism flip side reimbursement related issue seasonality business competitive landscape dependence government mandate challenge moreover more vita revenue be payment medicare medicaid program raise concern other key picksother top rank stock broader medical sector be intuitive surgical isrg free report align technology inc algn free report baxter international inc bax free report intuitive surgical sport zack rank align technology baxter carry zack rank see complete list today zack rank stock here intuitive surgical have long term expect earning growth rate align technology have long term expect earning growth rate baxter international have long term expect earning growth rate medical stock buy nowzack name company poise ride medical breakthrough be target cure leukemia aids muscular dystrophy hemophilia other condition new product field be already generate substantial revenue even more wondrous treatment be pipeline early investor realize exceptional profit click here see stock
789,ALGN,align technology inc algn free report first quarter adjust earning share ep come year year earning be also higher company guide range cent figure comfortably beat zack consensus estimate cent well revenuesrevenue grow year year quarter surpass zack consensus estimate revenue be well ahead company guide range management top line be drive year year increase invisalign case shipment quarter upside be support growth north america international region expand customer base increase utilization solid worldwide case growth moreover increase revenue itero scanner contribute majorly segment detailrevenue clear aligner segment total revenue soar year year report quarter primarily drive continue strong invisalign case volume growth customer channel geographical region first quarter invisalign case shipment amount year year aid growth region well expansion customer base quarter align technology invisalign case be ship doctor worldwide be north america international region align technology inc price consensus ep surprise align technology inc price consensus ep surprise align technology inc quoterevenue scanner service improve significant marginsgross margin quarter review be basis point bps year year rise cost net revenue quarter align technology witness year year increase selling general administrative expense rise research development expense operate margin expand bps financial detailsalign technology exit first quarter cash cash equivalent short term marketable security compare end report quarter align technology repurchase share stock april stock repurchase program company currently have approximately left buy back program second quarter company project ep revenue company project invisalign case shipment band year meanwhile zack consensus estimate second quarter ep be revenue earning estimate be project range estimate revenue fall same takealign technology end first quarter solid note be upbeat continue strength invisalign volume north america company continue witness expand gp dentist customer base sustain strength invisalign utilization orthodontist be also encourage solid performance emea asia pacific market scanner service company witness rapid uptake itero scanner geography moreover company continue see increase adoption itero scanner invisalign case submission instead pvs impression thereby drive invisalign utilization further align technology recently announce receipt china food drug administration cfda approval commercial launch itero element intraoral scanner be also upbeat company expand itero element portfolio lauch itero element itero element flex scanner unite state majority european country cover france germany italy spain unite kingdom align technology have strong cash balance enable carry share repurchase turn provide solid return investor flip side company be expose foreign exchange fluctuation seasonal demand fluctuation higher operate expense pertain increase head count higher investment target expansion geographical presence portfolio zack rank key picksalign technology carry zack rank hold few better rank stock broader medical space report solid earning season be laboratory corporation america holding lh free report cheme corporation che free report intuitive surgical inc isrg free report intuitive surgical sport zack rank strong buy labcorp cheme carry zack rank buy see complete list today zack rank stock here intuitive surgical report first quarter adjust earning share beat zack consensus estimate revenue totale also surpass zack consensus estimate labcorp report first quarter adjust earning shareof beating zack consensus estimate revenue come exceed zack consensus estimate cheme post first quarter adjust earning share beating zack consensus estimate revenue come beating zack consensus estimate more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
790,ALGN,investor focuse medical space have likely hear align technology algn free report be stock perform well comparison rest sector peer let take closer look stock year date performance find align technology be member medical sector group include individual stock currently hold zack sector rank zack sector rank consider different group measure average zack rank individual stock sector gauge strength group zack rank be proven model highlight variety stock right characteristic outperform market next month system emphasize earning estimate revision favor company improve earning outlook algn be currently sporting zack rank buy zack consensus estimate algn full year earning have moved higher past quarter be sign improve analyst sentiment positive earning outlook trend base most recent datum algn have return so far year meanwhile stock medical group have lose average mean align technology be perform better sector term year date return breaking thing more algn be member medical dental supply industry include individual company currently sit zack industry rank group have gain average so far year so algn be perform better area investor interest medical stock continue track algn stock be look continue solid performance
791,ALGN,align technology inc algn free report first quarter adjust earning share ep come year year earning be also higher company guide range cent figure comfortably beat zack consensus estimate cent well revenuesrevenue grow year year quarter surpass zack consensus estimate revenue be well ahead company guide range management top line be drive year year increase invisalign case shipment quarter upside be support growth north america international region expand customer base increase utilization solid worldwide case growth moreover increase revenue itero scanner contribute majorly segment detailrevenue clear aligner segment total revenue soar year year report quarter primarily drive continue strong invisalign case volume growth customer channel geographical region first quarter invisalign case shipment amount year year aid growth region well expansion customer base quarter align technology invisalign case be ship doctor worldwide be north america international region align technology inc price consensus ep surprise align technology inc price consensus ep surprise align technology inc quoterevenue scanner service improve significant marginsgross margin quarter review be basis point bps year year rise cost net revenue quarter align technology witness year year increase selling general administrative expense rise research development expense operate margin expand bps financial detailsalign technology exit first quarter cash cash equivalent short term marketable security compare end report quarter align technology repurchase share stock april stock repurchase program company currently have approximately left buy back program second quarter company project ep revenue company project invisalign case shipment band year meanwhile zack consensus estimate second quarter ep be revenue earning estimate be project range estimate revenue fall same takealign technology end first quarter solid note be upbeat continue strength invisalign volume north america company continue witness expand gp dentist customer base sustain strength invisalign utilization orthodontist be also encourage solid performance emea asia pacific market scanner service company witness rapid uptake itero scanner geography moreover company continue see increase adoption itero scanner invisalign case submission instead pvs impression thereby drive invisalign utilization further align technology recently announce receipt china food drug administration cfda approval commercial launch itero element intraoral scanner be also upbeat company expand itero element portfolio lauch itero element itero element flex scanner unite state majority european country cover france germany italy spain unite kingdom align technology have strong cash balance enable carry share repurchase turn provide solid return investor flip side company be expose foreign exchange fluctuation seasonal demand fluctuation higher operate expense pertain increase head count higher investment target expansion geographical presence portfolio zack rank key picksalign technology currently carry zack rank hold few better rank stock broader medical space report solid earning season be laboratory corporation america holding lh free report cheme corporation che free report intuitive surgical inc isrg free report intuitive surgical currently sport zack rank strong buy labcorp cheme carry zack rank buy see complete list today zack rank stock here intuitive surgical report first quarter adjust earning share beat zack consensus estimate revenue totale also surpass zack consensus estimate labcorp report first quarter adjust earning share beating zack consensus estimate revenue come exceed consensus estimate cheme post first quarter adjust earning share beating zack consensus estimate revenue come steering past zack consensus estimate more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
792,ALGN,edward lifescience corporation ew free report be schedule report second quarter earning jul market close last quarter company have post positive earning surprise be worth note edward lifescience have outperformed zack consensus estimate precede quarters average positive earning surprise let take look thing be shape prior announcement factor playedward lifescience post strong global sale last report quarter primarily buoy strength transcatheter heart valve tavr banking continue therapy adoption geography notable strength company be expect maintain bullish trend second quarter well tavr space edward lifescience report highly encourage european post approval clinical trial result sapien transcatheter heart valve company also demonstrated successful result pertain centera valve transcatheter aortic valve replacement procedure much await europcr hold edward lifescience corporation price ep surprise edward lifescience corporation price ep surprise edward lifescience corporation quotewe be also upbeat company initiative strategic investment research development receipt regulatory approval product move latest breakthrough achieve tavr segment be fda approval sapien valve early jun bullish company ongoing performance management raise growth expectation high end project full year guidance segment moreover note company project total sale adjust earning share cent cent second quarter apart management complete acquisition israel base valtech cardio developer cardioband system transcatheter repair mitral tricuspid valf end be expect boost top line quarter be report flip side tough competition cardiac device market reimbursement issue continue challenge company also believe unfavorable foreign currency affect company gross margin be report quarter earning whispersour proven model do not conclusively show earning beat edward lifescience quarter be stock need have positive earning esp zack rank strong buy buy hold happen be not case here see zack esp edward lifescience have earning esp be most accurate estimate zack consensus estimate be peg uncover best stock buy sell re report earning esp filter zack rank edward lifescience have zack rank increase predictive power esp however esp make surprise prediction difficult meanwhile caution stock zack rank sell rate go earning announcement especially company be see negative estimate revision stock considerhere be few company want consider proven model show have right combination element post earning beat quarter becton dickinson company bdx free report have earning esp zack rank see complete list today zack rank stock here align technology inc algn free report have earning esp zack rank stryker corporation syk free report have earning esp zack rank look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
793,ALGN,quest diagnostic inc dgx free report be schedule report second quarter earning result open bell jul last quarter company beat zack consensus estimate cent deliver positive earning surprise be worth note quest diagnostic outperformed zack consensus estimate precede quarters average let take look thing be shape prior announcement factor playpose threat quest diagnostic revenue requisition performance last report first quarter see basis point bps decrease same moreover remain apprehensive company professional lab service pls engagement wj barnabas health healthone system hca holding inc hca carry lower revenue requisition due nature work apart unit price headwind have less bps first quarter unit price headwind stay moderate range approximately last few year company continue expect same too quest diagnostic incorporate price ep surprise quest diagnostic incorporate price ep surprise quest diagnostic incorporate quotealso last year quest diagnostic face several reimbursement issue affected revenue company be concern cms center medicare medicaid service proposal related protect access medicare act pama however reimbursement pressure have likely act overhang performance be report quarter company expect beat pressure test business mix positive note observed report first quarter fiscal quest diagnostic seem be determine stimulate performance adhere point growth strategy accelerate growth drive operational excellence be also optimistic successful execution company strategy grow esoteric testing business drive profitable growth also recent past quest diagnostic witness significant growth infectious disease testing prescription drug monitoring industry lead wellness business expect growth driver remain active second quarter well drive same metric precede quarter believe recent development significantly contribute company top line second quarter company currently expect full year revenue range annualize growth current zack consensus estimate revenue be peg close low end company guide range addition company adjust earning share have be forecast zack consensus estimate be range earning whispersour proven model do not conclusively show quest diagnostic be likely beat earning quarter be stock need have positive earning esp zack rank strong buy buy hold happen be not case here see zack esp quest diagnostic have earning esp be most accurate estimate zack consensus estimate be peg uncover best stock buy sell re report earning esp filter zack rank quest diagnostic have zack rank increase predictive power esp however esp make surprise prediction difficult meanwhile caution stock zack rank sell rate go earning announcement especially company be see negative estimate revision stock considerhere be few company want consider proven model show have right combination element post earning beat quarter becton dickinson company bdx free report have earning esp zack rank see complete list today zack rank stock here align technology inc algn free report have earning esp zack rank stryker corporation syk free report have earning esp zack rank trade profit big league trump policiesif stock spark interest look company prime make substantial gain washington change course today zack reveal ticker benefit new trend streamline drug approval tariff lower taxe higher interest rate spending surge defense infrastructure see buy recommendation now
794,ALGN,share price san jose base align technology inc algn free report reach new week high jul eventually close bit lower company have gain past month outperform gain stock have market cap last month align have outshined zack categorize medical dental supply industry respect share price movement stock have climb way higher broader industry gain further align estimate revision trend current quarter be favorable past day estimate have moved downward revision however magnitude estimate revision same time period have remain peg cent share company also have trail quarter average positive earning surprise additionally align long term growth fundamental be compelling zack rank buy company record long term historical growth rate revenue compare broader industry gain long term historical growth rate earning be compare industry average company have impressive growth style score growth style score highlight vital metric company financial obtain clearer picture quality sustainability growth research show stock style score combine zack rank strong buy hold offer best investment opportunity growth driverswe believe week high come back recent series development align announce addition prestigious health care supply sub industry index jun same month company announce encourage step strengthen position invisalign brand company most popular offer keep company strategy expansion investment rapidly grow asia pacific region align announce plan build first invisalign manufacturing facility china be upbeat receipt patent align smarttrack aligner material be used exclusively invisalign aliner treatment move bid gain traction same platform mar align collaborate digital design post collaboration align invisalign clear aligner treatment be used dentist tooth align procedure design protocol moreover expand invisalign brand offering align introduce patient friendly solution invisalign solution mandibular advancement patient mar company have also expand work flow option lead itero scanner company introduce software upgrade itero element intraoral scanner base sophisticated timelapse technology context align collaborate exocad gmbh mar integrate portfolio result high tech solution efficient scanning design manufacturing house dental prosthesis factor be expect boost company share price key picksother top rank medical stock be mesa laboratory inc mlab free report insys therapeutic inc insy free report stryker corporation syk free report notably mesa laboratory insys therapeutic sport zack rank strong buy stryker corporation carry zack rank see complete list today zack rank stock here mesa laboratory have positive earning surprise last quarters stock have add roughly last month insys therapeutic have long term expect earning growth rate stock have gain last month stryker corporation have expect long term adjust earning growth almost stock have add roughly last month trade profit big league trump policiesif stock spark interest look company prime make substantial gain washington change course today zack reveal ticker benefit new trend streamline drug approval tariff lower taxe higher interest rate spending surge defense infrastructure see buy recommendation now
795,ALGN,world largest medical technology service solution company medtronic plc mdt free report be make effort expand pelvic health gastric therapy business part company core restorative therapy group company have announce interstim system provide sustain long term efficacy improve quality life overactive bladder oab patient end year be interstim system notably interstim system deliver sacral neuromodulation therapy bladder control issue interstim therapy used neuromodulation gentle nerve stimulation normalize brain bladder communication pathway other hand oab hamper quality life disturbing routine activity individual urinary incontinence excessive urination interstim system be thought restore bladder function target sacral nerve help alleviate symptom take rapidly grow market oab consideration expect development be perfectly strategic medtronic go datum provide medtronic number oab patient america be imply individual face problem america accord market research report technavio analyst oab therapeutic market see cagr almost period insite study result reveal oab patient have therapeutic success greater improvement symptom end year sustain safe better quality life notably thestudy assessed efficiency safety system year patient have bothersome oab symptom not tolerate more traditional treatment include urinary urge incontinence ui urgency frequency uf however implant interstim system be risky surgical procedure device related unfavorable event be undesirable change stimulation implant site pain ineffectiveness last month medtronic have outperformed index latest share price movement company have gain compare gain zack rank key picksmedtronic currently carry zack rank hold few better rank medical stock be mesa laboratory inc mlab free report insys therapeutic inc insy free report align technology inc algn free report notably mesa laboratory insys therapeutic sport zack rank strong buy align technology carry zack rank buy see complete list today zack rank stock here mesa laboratory have positive earning surprise last quarters stock have add roughly last month insys therapeutic have long term expect earning growth rate stock have gain last month align technology have expect long term adjust earning growth almost stock have add roughly last month trade profit big league trump policiesif stock spark interest look company prime make substantial gain washington change course today zack reveal ticker benefit new trend streamline drug approval tariff lower taxe higher interest rate spending surge defense infrastructure see buy recommendation now
796,ALGN,jul issue update research report haemonetic corporation hae free report base lead provider blood management solution customer encompass blood plasma collector hospital health care provider globally stock currently carry zack rank hold past year haemonetic have be trading zack categorize medical product industry period stock have surge compare broader industry be particularly encourage company consistent growth plasma segment well haemonetic management franchise haemonetic have be witness strong flourish plasma franchise quite time now management have also maintain high confidence continue growth commercial plasma collection business late management declare nextgen plasma collection software have be see avid customer interest management guidance plasma revenue growth be inclusive divestiture sebra bench top handheld sealer represent annual plasma revenue fourth quarter company hospital business be also progress well teg line product have gain popularity worldwide teg be approve broad set indication top market teg teg manager be sanction same set indication europe australia japan teg be be used cardiovascular surgery company be presently pursue broader set indication begin trauma flip side company have be witness sluggish revenue growth blood center franchise have significantly affected haemonetic result past few quarters management also doesn expect early recovery blood center outcome macroeconomic uncertainty continue challenge haemonetic management also anticipate slower expect product adoption customer reduce revenue profit also currency fluctuation stiff competition continue hamper stock other key pickssome better rank medical stock be mesa laboratory inc mlab free report edward lifescience corp ew free report align technology inc algn free report mesa laboratory edward lifescience sport zack rank strong buy align technology carry zack rank buy see complete list today zack rank stock here mesa laboratory deliver positive earning surprise last quarters stock gain roughly last month edward lifescience have long term expect earning growth rate stock climb last month align technology have expect long term adjust earning growth almost stock surge approximately last month today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return respectively outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
797,ALGN,waltham base thermo fisher scientific inc tmo free report be scientific instrument maker world leader serve science company be healthy growth trajectory late andha rally past month ahead gain stock have market cap company have also considerably outperformed zack categorize medical product sub industry gain notably zack rank buy company estimate revision trend current year be favorable last day estimate have moved revision opposite direction magnitude estimate revision increase share company deliver quarter positive average earning surprise earning surprise last report first quarter strong growth prospect thermo fisher be attractive pick present growth catalyststhermo fisher continuous effort drive growth inorganically acquisition activity have be generate lot enthusiasm investor company have announce agreement acquire netherlands base patheon global provider high quality drug solution pharmaceutical biopharma sector thermo fisher expect derive lot synergy buyout help expand biopharma offering europe combination be anticipate strengthen thermo fisher foothold pharmaceutical biotech market add highly complementary service portfolio also acquisition fei have already start generate synergy contribute largely company analytical instrument portfolio have turn boost market optimism stock market be also upbeat company focus gain traction high potential emerge geography china thermo fisher have be deliver solid result market biopharma healthcare environment order meet rise demand clinical trial south korea company recently launch biopharma service unit significantly thermo fisher be continuously work cash opportunity biopharma healthcare food safety market india other key picksother top rank medical stock be mesa laboratory inc mlab free report edward lifescience corp ew free report align technology inc algn free report mesa laboratory edward lifescience sport zack rank strong buy align technology carry zack rank see complete list today zack rank stock here mesa laboratory deliver positive earning surprise last quarters stock add roughly last month edward lifescience have long term expect earning growth rate stock surge last month align technology have expect long term adjust earning growth almost stock jump nearly last month today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return respectively outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
798,ALGN,biotelemetry inc beat free report recently announce acquisition lifewatch ag deal value buyout biotelemetry enhance position wireless medicine space enlarge product profile customer base cardiac monitoring diagnostic service space stock price performance biotelemetry have be favorable last month stock have gain outperform zack classify medical service sub industry gain almost current level compare favorably return same time frame estimate revision trend current year have be positive last month estimate moved south movement opposite direction together solid long term earning growth rate instill confidence stock come back news management expect acquisition yield significant synergy next month company make product be utilize remotely monitoring cardiac care patient headquarter zug switzerland lifewatch be lead healthcare technology solution company specialize advanced digital health system wireless remote diagnostic patient monitoring service go forward biotelemetry have be gain prominence late expand payer coverage introduction innovative product furthermore note biotelemetry mar have strong financial position more cash company post stellar first quarter revenue year year basis meanwhile company expect double digit revenue growth expect approximate ebitda return fiscal quarter end jun company expect revenue growth ebitda return headquarter conshohocken pa biotelemetry provide cardiac monitoring service cardiac monitoring device manufacturing zack rank key pickscurrently biotelemetry carry zack rank hold few better rank medical stock be mesa laboratory inc mlab free report edward lifescience corp ew free report align technology inc algn free report notably mesa laboratory edward lifescience sport zack rank strong buy align technology carry zack rank buy see complete list today zack rank stock here mesa laboratory have positive earning surprise last quarters stock have add roughly last month edward lifescience have long term expect earning growth rate stock have gain last month align technology have expect long term adjust earning growth almost stock have add roughly last month today stock zack hottest strategy hard believe even zack market gain top stock pick screen have return respectively outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
799,ALGN,share price batesville base hill holding inc hrc free report scale new week high jul stock have market cap company year historical growth rate be also favorable compare index broader industry comparison broader company have gain much better gain zack categorize medical product industry gain last month earning surprise estimate revision zack rank hold company post positive earning surprise last quarter lead quarter average earning beat also hill current year estimate revision trend be promising past day estimate go downward revision current year magnitude estimate have improve same period growth market be upbeat hill strategic plan divest profitable volker business focus more core operation hill recently enter agreement divest volker business affiliate cobe capital volker business primarily serve european long term care bed market hill holding inc price consensus hill holding inc price consensus hill holding inc quotewe be also encourage note hill continue grow strongly strategy product expansion diversification company recently unveil hill envella air fluidized therapy bed latest innovative solution provide highest quality care patient advanced wound also company launch hill accella bed system higher acuity patient intensive acute care setting apart management announce introduction monarch airway clearance system represent hill debut mobile therapy next chapter company patient center respiratory care solution be major breakthrough company digital health space hill raise full year adjust earning guidance have also bolster investor confidence stock key picksa few better rank medical stock be mesa laboratory inc mlab free report insys therapeutic inc insy free report align technology inc algn free report notably mesa laboratory insys therapeutic sport zack rank strong buy align technology carry zack rank buy see complete list today zack rank stock here mesa laboratory have positive earning surprise last quarters stock have add roughly last month insys therapeutic have long term expect earning growth rate stock have gain last month align technology have expect long term adjust earning growth almost stock have add roughly last month today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return respectively outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
800,ALGN,edward lifescience corporation ew free report be schedule report third quarter earning oct market close last quarter company have post positive earning surprise be worth note edward lifescience have outperformed zack consensus estimate precede quarters average positive earning surprise let take look thing be shape prior announcement key catalystsimilar prior quarter edward lifescience be expect gain strength transcatheter heart valve therapy segment thvt banking continue therapy adoption geography notable strength unite state company be expect maintain bullish trend third quarter well growth thvt be drive excellent clinical performance result sapien well continue strong therapy implementation region last report quarter moreover receipt expand fda approval sapien valve early june be expect further boost top line thvt segment be report quarter also zack consensus estimate thvt net sale reflect increase year quarter zack consensus estimate transcatheter heart valf thv sale unite state show increase year quarter overall third quarter revenue be project edward lifescience corporation price ep surprise edward lifescience corporation price ep surprise edward lifescience corporation quotehere be other factor influence edward lifescience third quarter result domestic market edward lifescience be expect continue strong performance base strength thvt other segment surgical heart valve therapy critical care company witness strength surgical heart valve therapy back strong uptake edward intuity elite valve system progress surgical heart valve therapy company receive fda approval inspiris resilium aortic valf july other hand growth critical care group be lead double digit growth enhance surgical recovery program especially unite state also zack consensus estimate net sale unite state reflect increase year quarter edward lifescience earlier raise full year sale expectation high end previously provide range moreover note company project total sale adjust earning share cent cent third quarter flip side tough competition cardiac device market reimbursement issue continue challenge company also believe unfavorable foreign currency affect company gross margin be report quarter also management expect third quarter be seasonally lowest quarter add concern here be quantitative model predict edward lifesciencesdoe not have right combination main ingredient positive earning esp zack rank hold higher increase odd earning beat zack esp earning esp foredward lifescience be uncover best stock buy sell re report earning esp filter zack rank edward lifescience carry zack rank increase predictive power esp however also need have positive esp be confident positive earning surprise nonetheless zack consensus estimate earning cent reflect improvement year year basis stock worth lookhere be few medical stock worth consider have right combination element post earning beat quarter abbott free report have earning esp zack rank buy see complete list today zack rank strong buy stock here align technology inc algn free report have earning esp zack rank henry schein inc hsic free report have earning esp zack rank hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
801,ALGN,boston scientific corporation bsx free report be schedule report third quarter result open bell oct last quarter company deliver positive earning surprise trail quarter average beat be peg let see thing be shape prior announcement key catalystswe be optimistic company gradually improve performance interventional cardiology ic lead innovative portfolio robust commercial team globally company gain share number cardiovascular segment de drug eluting stent continue build momentum globally boston scientific corporation price ep surprise boston scientific corporation price ep surprise boston scientific corporation quote however ahead earning release believe quarter ic business be grossly impact company product recall issue europe notably last february company recall prime product lotus range heart device europe due device malfunction company also delay submission marketing application lotus edge device product line have little hope return european other market fourth quarter lead major setback company fast grow transcatheter aortic valve replacement tavr business ic soon be report quarter believe downbeat ic business earn boost company recent acquisition switzerland base symetis sa full recovery take time accordingly zack consensus estimate third quarter ic revenue be currently peg lower sequentially last quarter report number other factor playamong segment medsurg be expect demonstrate consistent performance lead endoscopy urology woman health be also estimate grow market level drive investment strategy key international geography zack consensus estimate third quarter endoscopy revenue be peg significantly higher year quarter report figure urology woman health current zack consensus estimate remain ahead year report tally flip side severe currency headwind boston scientific have be face late remain concern fact company record sale international market remain highly expose currency fluctuation boston scientific expect unfavorable foreign exchange challenge tune revenue bps cent share earning overall boston scientific third quarter adjust earning be expect band cent share revenue here quantitative model predict boston scientific do not have right combination main ingredient positive earning esp favorable zack rank strong buy buy hold increase odd earning beat see complete list today zack rank stock here zack esp boston scientific have earning esp uncover best stock buy sell re report earning esp filter zack rank boston scientific carry zack rank sell fail increase predictive power esp stock considerhere be few medical stock worth consider right combination element beat estimate quarter thermo fisher scientific tmo free report have earning esp zack rank align technology inc algn free report have earning esp zack rank henry schein inc hsic free report have earning esp also carry zack rank hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
802,ALGN,weight management product service provider nutrisystem inc ntri free report be schedule release third quarter result oct nutrisystem have impressive track beating estimate trail quarters overall company record be favorable evident quarter average positive surprise let see thing be shape prior quarter factor playnutrisystem innovative product be expect expand customer base eventually drive reactivation revenue be generate exist customer first month purchase however sluggish dieting market intense competition be primary headwind term third quarter management expect revenue range zack consensus estimate third quarter revenue be currently peg meanwhile adjust ebitda be anticipate range earning share be expect band cent share positive note company portray impressive price performance past month share nutrisystem have return industry decline however overall activity nutrisystem third quarter be inadequate analyst confidence result zack consensus estimate be report quarter fall cent cent share last day earning whispersour proven model do not conclusively show nutrisystem be likely beat earning quarter be stock need have positive earning esp zack rank strong buy buy hold happen be not case here see zack esp nutrisystem have earning esp most accurate estimate zack consensus estimate be peg cent uncover best stock buy sell re report earning esp filter zack rank nutrisystem currently carry zack rank increase predictive power esp however company esp make surprise prediction difficult caution stock zack rank sell rate go earning announcement especially company be see negative estimate revision nutrisystem inc price ep surprise nutrisystem inc price ep surprise nutrisystem inc quote stock warrant lookhere be company want consider model show have right combination element post earning beat quarter abbott free report have earning esp carry zack rank see complete list today zack rank stock here align technology inc algn free report have earning esp carry zack rank henry schein inc hsic free report have earning esp carry zack rank look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
803,ALGN,medical instrument manufacturer thermo fisher scientific inc tmo free report be slate release third quarter result oct market open last quarter company post earning share surpass zack consensus estimate fact thermo fisher earning outpaced zack consensus estimate past quarters average beat let see thing be shape prior announcement key acquisition fei have already start generate synergy largely contribute waltham base company analytical instrument portfolio last quarters acquisition have enabled thermo fisher access fei industry lead high performance electron microscopy platform used protein study facilitate life science research be also vital highlight quarter be report thermo fisher scientific inc price ep surprise thermo fisher scientific inc price ep surprise thermo fisher scientific inc quotethermo fisher anticipate realize total synergy approximately end year follow deal closure cost synergy roughly adjust operate income benefit revenue related synergy get reflect third quarter performance overall company be gear yet quarter strong analytical instrument segmental growth third quarter thermo fisher expect see positive impact electron microscopy business well strong volume leverage productivity zack consensus estimate analytical instrument operate income be peg line sequentially last quarter report number total revenue estimate segment also remain impressive level here be other factor influence thermo fisher third quarter result company focus boost growth implementation strategy strengthen product offering be encourage initiative be likely help post solid result third quarter company have spend research development same trend be continue last couple quarters major development field be novartis chimeric antigen receptor cell car therapy kymriah first fda approve cell therapy leukemia utilize thermo fisher ct dynabead technology expect innovation product launch significantly contribute company top line third quarter company aim expand capability fast grow asia pacific zone well emerge market also lead impressive result standout contributor recent time be china india south korea strategic investment support key customer application thermo fisher hope maintain bullish momentum rest growth be also likely be see apply market such environmental food safety apart life science addition company be currently bet key area focus enormous opportunity be advance precision medicine mass spectrometry target gene sequence structural biology however be apprehensive thermo fisher cite foreign exchange headwind revenue adjust ep also unfavorable macroeconomic condition continue weigh heavily stock stiff competition continue impose challenge stock value here quantitative model predict thermo fisher have right combination main ingredient positive earning esp favorable zack rank strong buy buy hold earning beat see complete list today zack rank stock here zack esp thermo fisher have earning esp uncover best stock buy sell re report earning esp filter zack rank thermo fisher carry zack rank buy increase predictive power esp other stock considerhere be few medical stock worth consider model indicate consist right combination element post earning beat quarter abbott free report have earning esp zack rank align technology inc algn free report have earning esp zack rank henry schein inc hsic free report have earning esp aslo carry zack rank look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
804,ALGN,intuitive surgical isrg free report third quarter result schedule release oct be expect show steady growth instrument accessory revenue major revenue component majorly drive third quarter earning expect improvement revenue other segment help company generate solid result season be important note intuitive surgical deliver positive earning surprise past quarters average be similar prior quarter strong procedure growth increase sale stapling vessel sealing product be expect be main factor drive surge instrument accessory revenue zack consensus estimate instrument accessory revenue stand third quarter reflect increase year quarter continue development european market solid access company product asia new platform imaging advanced instrument be likely drive revenue segment intuitive surgical inc price consensus intuitive surgical inc price consensus intuitive surgical inc quoteother factor playwe believe grow adoption intuitive surgical da vinci system physician general surgery oncology urology gynecology procedure be catalyst third quarter overall revenue be expect prior year quarter be other factor influence intuitive surgical quarterly result earning season solid procedure trend expectation outperformance mature growth procedure especially general thoracic surgery be likely boost company top line add solid growth prostatectomy procedure volume be likely lend intuitive surgical competitive edge broader prostate surgery market third quarter geographically procedure growth third quarter be expect be lead china germany japan germany procedure growth be likely be support solid install base expansion furthermore procedure trend be expect be solid globally growth lead general surgery global urology segment system service unit hold promise solid growth company product system segment be expect drive company third quarter earning fact zack consensus estimate revenue segment stand year year basis increase reflect higher system placement operate lease revenue however be partially offset lower average selling price lease buyout revenue segment come revenue service segment zack consensus estimate stand year year basis growth system install base buoy higher system placement operate lease revenue expect company total system install base be unit unit last quarter be important note intuitive surgical generate approximately revenue operate lease last quarter compare second quarter here be quantitative model predict intuitive surgical do not have right combination main ingredient positive earning esp zack rank hold higher increase odd earning beat zack esp earning esp intuitive surgical be most accurate estimate be zack consensus estimate be peg uncover best stock buy sell re report earning esp filter zack rank intuitive surgical carry zack rank increase predictive power esp however also need positive esp be confident earning beat fact zack consensus estimate earning reflect decline year year basis stock worth lookhere be few medical stock worth consider have right combination element post earning beat quarter abbott free report have earning esp zack rank buy see complete list today zack rank strong buy stock here align technology inc algn free report have earning esp zack rank henry schein inc hsic free report have earning esp zack rank look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
805,ALGN,cr bard inc be schedule report third quarter earning market close oct last quarter company report adjust earning exceed zack consensus estimate cent also company earning surpass zack consensus estimate last quarters average beat delve fundamental stock let see thing be shape prior release factor playwe believe grow adoption company flagship lutonix drug coat balloon dcb continue be key growth catalyst be report quarter regard lutonix dcb be used treat patient suffering peripheral arterial disease pad endovascular business peripheral pta line sale be solely drive accelerate demand lutonix dcb unite state expect product significantly contribute company top line quarter zack consensus estimate third quarter revenue be currently peg however management expect revenue growth report basis exclude impact foreign exchange company project revenue increase prior year furthermore company investment emerge market have strengthen position internationally be also upbeat solid contribution company vascular product line urology oncology segment be likely drive third quarter sale positive note company portray impressive price performance past month share cr bard have return compare industry decline flip side challenge med tech environment especially hernia fixation peripheral stent business raise concern company continue witness significant pricing pressure well also unfavorable foreign currency continue hurt top bottom line growth furthermore uncertainty associate possibility repeal affordable care act president trump add company concern earning whispersour quantitative model doesn point earning beat quarter be stock need have positive earning esp zack rank strong buy buy hold happen be not case here see zack esp earning esp cr bard be be most accurate estimate zack consensus estimate be peg uncover best stock buy sell re report earning esp filter zack rank cr bard currently carry zack rank increase predictive power esp however company esp make surprise prediction difficult caution stock zack rank sell rate go earning announcement especially company be see negative estimate revision bard inc price ep surprise bard inc price ep surprise bard inc quote stock considerhere be few company want consider proven model show have right combination element post earning beat quarter abbott free report have earning esp carry zack rank see complete list today zack rank strong buy stock here align technology inc algn free report have earning esp carry zack rank henry schein inc hsic free report have earning esp carry zack rank trade profit big league trump policiesif stock spark interest look company prime make substantial gain washington change course today zack reveal ticker benefit new trend streamline drug approval tariff lower taxe higher interest rate spending surge defense infrastructure see buy recommendation now
806,ALGN,resm rmd free report be slate report first quarter fiscal result market close oct last quarter company deliver positive earning surprise average earning beat trail quarters let see thing be shape announcement key prior quarter resm be expect gain strong performance domestic international front company revenue domestic front be drive solid growth device well low double digit software sale growth previous quarter internationally company receipt french reimbursement approval telemonitoring buoy optimism company believe reimbursement grant drive uptake air solution ecosystem include airsense aircurve device platform well airview myair software platform be report quarter zack consensus estimate domestic revenue include contribution reflect increase year quarter also zack consensus estimate international revenue indicate rise year quarter overall fiscal first quarter total revenue be project prior year quarter resm inc price ep surprise resm inc price ep surprise resm inc quotehere be other factor influence resm first quarter result management be particularly upbeat top line contribution launch make last fiscal last report quarter introduce product include airfit airfit airtouch full face mask world smallest continuous positive airway pressure cpap resm airmini resm continue progress steadily back prong growth strategy regard company recently announce tuck acquisition product portfolio conduit technology llc allcall connect moreover last report quarter company progressed new offer outcome assessment information set oasis home health hospice market expect get reflect resm top line first quarter current zack consensus estimate revenue reflect increase year quarter flip side management expect sg expense margin band be report quarter be fourth quarter fiscal also expense margin be project first quarter fiscal compare precede quarter guidance reflect quarter gloomy operate margin scenario meanwhile company generate significant portion revenue international market expose company foreign currency fluctuation notably last report quarter foreign exchange movement hurt earning cent share reflect unfavorable impact weaker euro stronger australian dollar relative dollar be likely dent result first quarter moreover overall macroeconomic uncertainty be major obstacle company international operation also market sleep disordered breathe sdb product be highly competitive respect product price feature reliability other challenge competitive bidding reimbursement pressure continue hurt stock here be quantitative model predict resm do not have right combination main ingredient positive earning esp zack rank hold higher increase odd earning beat zack esp earning esp resm be most accurate estimate zack consensus estimate be peg cent uncover best stock buy sell re report earning esp filter zack rank resm carry zack rank buy increase predictive power esp however also need have positive esp be confident positive earning surprise nonetheless zack consensus estimate earning cent reflect improvement year year basis stock worth lookhere be few medical stock worth consider have right combination element post earning beat quarter abbott free report have earning esp zack rank see complete list today zack rank strong buy stock here align technology inc algn free report have earning esp zack rank henry schein inc hsic free report have earning esp zack rank trade profit big league trump policiesif stock spark interest look company prime make substantial gain washington change course today zack reveal ticker benefit new trend streamline drug approval tariff lower taxe higher interest rate spending surge defense infrastructure see buy recommendation now
807,ALGN,august make video share public circle stock own zack portfolio feel be race club facebook beat alibaba first here be approximate close price day round nearest dollar alibaba baba free report facebook fb free report lam research lrcx free report align technology algn free report video accompany article show fresh chart month later up down day clearly most high flyer be still great buy august facebook have trouble hand deal adjustment advertising police wake fake news epidemic still recommend long term investor own accumulate fb also reveal big mistake make selling memberof club thankfully screw shrewd trader investor head back buy nvidia nvda free report right make run time high so now have algn nvda lead charge baba lrcx run neck neck video also take look buy philadelphia semiconductor index chart opportunity spell way be interested mental game trading irrational self sabotage deal active investor enjoy podcast tribute latest nobel prize economic science winner richard thaler expect be perfect trader investor know trip lift be key top performance thaler probably doesn know much active trading daniel kahneman life long battle bring psychology economic thus give birth behavioral economic have help daily battle immensely here link thaler nobel brilliant lazy own share baba nvda fb algn zack tazr trader kevin cook be senior stock strategist zack investment research run tazr trader service
808,ALGN,do play watch poker even don not regret learn apply poker wisdom investing stock start video attach article quick focuse dive check bit apply wisdom share tazr trader member week portfolio ve successfully game market ride several stock new high many expert player have say buy too expensive get best make most itthat actually quote mathematics gamble expert mason malmuth book read many year title gamble theory other topic be familiar probability statistic application poker investing already know malmuth be talk randomness viciousness poker demand ruthlessly apply optimally rational probability base think decision addition deep active psychoanalysis opponent player be master poker hand probability analysis want very little opponent interaction body language facial read social gamesmanship be player wear sunglass try avoid most interaction table then be true behavioral scientist daniel negreanu behavioral finance economic be pet project mine start mind money podcast year dedication fascinating arena be vastly interested related topic negreanu be unparalleled practitioner apply behavioral science be so secure probability weight strategy give hand spend majority time attention table analyze dissect gaming player behavior interaction be real difference edge be find game high randomness component focus meta awareness table deck player give uncanny ability determine card opponent be likely hold begin hunch guess verbalize joke sometimes taunt other player nearly always confirm suspicion amazing degree accuracy want learn play poker better watch read negreanu now do have do investing trading stock know probability scenario play opponent strength come know risk reward trade then gaming institutional demand expect different price level short term technical trader use price chart indicator include volume live die analysis do short medium term portfolio hold fundamentally strong stock several quarterly earning report be bigger version short term technical analysis game add fundamental behavioral component cautious player get wrong curious one get rightwhile big name fund manager ray dalio bridgewater howard mark value distressed investment firm oaktree capital come wave red flag have be able discern be be overly conservative once again miss next leg big global economic cycle last year other successful player table david tepper appaloosa dan loeb third point steve mandel lone pine lee ainslee maverick capital andrea halvorsen vike global be not wring hand global macro worry be still head pick stock long run year alibaba baba free report important keep history table perspective too have be numerous high profile call market melt past year jeff gundlach perma bear albert edward socgen also come mind macro analysis miss simplest factor technological innovation investment liquidity tie global equity market stable economic growth liquidity favorable interest rate equity premier growth investment many year long cycle equation only lead miss great lengthy rally have happened several time career trading growth stock be think still be buy growth stock dip bull market have little reason believe time be different want dissect behavior player be convince something be wrong throw towel check video accompany article share news month fund manager call quit cite wrong almost impossible stock market be still buy alibaba beyondi also share more insight remain investor alibaba share level seem week jack company reveal market initiative be sure capture new expand source revenue china globally continue dominant growth multiple business segment video also show fund manager be still buy start new position alibaba second quarter finally review go club mistakenly sell lam research lrcx free report monday add nvidia nvda free report today thankfully facebook fb free report align technology algn free report have not be remove disclosure own baba nvda algn fb share zack tazr trader portfolio cookerkevin cook be senior stock strategist zack investment research run tazr trader service stock watch massive equifax stock spiked recent news datum breach affect american stock be best buy candidate right now do future hold cybersecurity industry equifax be just most recent victim computer hacking identity theft be more common ever zack have just release cybersecurity investor guide inform zack com reader year space more importantly highlight cybersecurity pick strong profit potential get new investing guide now
809,ALGN,sep issue update research report align technology inc algn free report stock currently have zack rank hold align technology manufacture market system clear aligner therapy intra oral scanner cad cam computer aid design manufacturing digital service used dentistry orthodontic dental record storage have be trading industry past month stock have gain period compare growth industry company strong invisalign technology prospect growth north america international region look encourage align technology witness balanced sale growth channel recent past primarily drive continue strong invisalign technology case volume customer channel geography align technology inc price align technology inc price align technology inc quotemoreover align technology have be ride high back strong growth internationally reflect continue strong performance emea apac region company also reach new benchmark patient have adopt invisalign treatment encourage development company recently sign distribution agreement patterson dental exclusive agreement effective september align technology itero element intraoral scanning system be available part patterson dental cad cam portfolio unite state canada be also upbeat company sopening new invisalign technology treatment plan facility china company receipt patent smarttrack aligner material also buoy optimism contrary foreign exchange headwind continue raise concern align technology international operation also escalate cost expense be weigh margin moreover tough competitive landscape other macroeconomic headwind pose concern key picksa few top rank medical stock be edward lifescience corporation ew free report idexx laboratory inc idxx free report amedisys inc am free report edward lifescience sport zack rank strong buy idexx laboratory amedisys carry zack rank buy see complete list today zack rank stock here edward lifescience have long term expect earning growth rate stock have rally roughly last month idexx laboratory have long term expect earning growth rate stock have gain last year amedisys have long term expect earning growth rate stock have gain last year look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
810,ALGN,week shaky trading wall street continue second largest bull run dodge list wo include geopolitical tension washington turmoil elevated valuation aftermath hurricane harvey irma well round downbeat economic datum particular be spotlight index breach milestone first time bring year date gain nearly accord bloomberg rally overtake increase index bull run add almost value american equity journey point come less month suggest strong complacency stock market renew hope trump tax reform end year be main catalyst drive stock market new high additionally steady economic fundamental strong corporate earning add strength upward trend be likely continue month ahead read etf asset report equity rule give enthusiasm investor be flock etf ishare core etf ivv free report let take closer look fundamental ivv performance ivv focusivv be top asset creator year pull nearly capital track index hold stock basket security hold more total asset suggest nice balance security prevent heavy concentration however product be slightly tilt information technology sector share health care financial consumer discretionary industrial account double digit exposure etf be low cost choice space charge bps fee year investor trade solid volume share day average fund have gain year date time frame have zack etf rank buy medium risk outlook most stock fund portfolio have deliver impressive return few be real star gain more read etf industry face regulatory oversight have highlighted best perform stock etf respective position fund basket best perform stock ivvvertex pharmaceutical vrtx free report stock have surge so far year carry zack rank hold vgm style score company have see positive earning estimate revision cent year past month expect earning growth rate compare industry average stock have solid zack industry rank top account just share ivv align technology inc algn free report stock make allocation fund basket have deliver incredible return so far year stock have see solid earning estimate revision cent past month year reflect year year earning growth much higher industry average growth further align technology have zack rank vgm style score have dismal zack industry rank bottom nrg energy inc nrg free report stock have gain year date time frame nrg have see positive earning estimate revision cent past month year earning be expect decline annually compare industry average growth nrg energy currently have zack rank vgm style score stock have ugly zack industry rank bottom make share ivv read trade oil rally etfs stock activision blizzard inc atvi free report stock have surge so far year have exposure fund basket have see solid earning estimate revision cent past month year earning be expect decline year year compare industry average growth activision blizzard have zack rank strong buy vgm style score belong solid zack industry rank top centene corporation cnc free report stock account asset fund basket have gain year date time frame have see solid earning estimate revision cent past month year however earning be expect grow well industry average centene corporation have zack rank vgm style score belong robust zack industry rank top want key etf info deliver straight inbox zack free fund newsletter brief top news analysis well top perform etfs week get free
811,ALGN,share price align technology inc algn free report scale new week high sep eventually close nominally lower company have gain year much higher gain same frame align technology have also beat broader industry gain respect share price movement year stock have market cap further align technology estimate revision trend current year be favorable past day estimate moved moved estimate be share same time frame company also have trail quarter average positive earning surprise positive long term growth hold promise align technology inc price consensus align technology inc price consensus align technology inc company year historical growth rate be also favorable compare broader industry align technology carry zack rank hold company have impressive growth style score growth style score highlight vital metric company financial obtain clearer picture quality sustainability growth research show stock style score combine zack rank strong buy buy offer best investment opportunity growth market be upbeat exclusive distribution agreement sign patterson dental september agreement align technology itero element intraoral scanning system be available patterson dental cad cam portfolio unite state canada boost itero scanner customer base considerable extent further june align technology have announce inclusion esteem index boost investor confidence stock considerably be also encourage align technology solid second quarter performance year year increase earning revenue company encourage invisalign technology prospect growth north america international region also raise hope company recently open new invisalign technology treatment plan facility china meanwhile company multus dollar marketing campaign invisalign technology brand be encourage factor be expect boost company share price day ahead key picksa few better rank medical stock be edward lifescience corporation ew free report lantheus holding inc lnth free report idexx laboratory inc idxx free report edward lifescience sport zack rank lantheus holding idexx laboratory carry zack rank cansee complete list today zack rank stock here edward lifescience have long term expect earning growth rate stock have rally roughly last month lantheus holding have long term expect earning growth rate stock have gain last month idexx laboratory have long term expect earning growth rate stock have gain last month surprising tech stock keep eye tech stock have be major force market record high pick best one buy be tough simple way invest success entire sector zack have just release special report reveal thing tech company literally function more importantly reveal top stock set skyrocket increase demand device encourage get report now next wave innovation really take see stock now
812,ALGN,aug issue update research report co base bioscrip inc bio free report company be lead infusion service provider strive deliver cost effective program patient stock currently have zack rank hold past month bioscrip have be trading broader industry stock have gain period industry loss market be upbeat company announcement continue offer certain core product line deal be significantly accretive bioscrip top line company progress new multus faceted core plan improve financial position be also encourage plan involve identify execute strategy accelerate core revenue growth favorable product mix drive operational efficiency improve revenue collection increase employee effectiveness further bioscrip have successfully complete home solution integration earlier year company expect core revenue well continue growth acquire asset prove accretive go forward notably bioscrip have be record persistent growth core infusion service business strong presence well competitive advantage company witness consistent rise business primarily account strong organic growth chronic nutrition other therapy have be build robust core infusion platform organic development acquisition management expect bioscrip focus fast grow core infusion business drive increase profitability company be currently track achieve previously announce home solution synergy other incremental annualize cost reduction end flip side bioscrip guidance be lackluster inclusion estimate negative impact cure act legislation large portion company revenue used come directly medicare state medicaid program other government payer however new cure act bill do not reimburse service payment administration certain drug patient home infusion pharmacy healthcare industry be also highly competitive bioscrip competitor include large well establish company higher financial marketing technological resource key picksa few better rank medical stock be idexx laboratory inc idxx free report lantheus holding inc lnth free report align technology inc algn free report align technology sport zack rank strong buy lantheus holding idexx laboratory carry zack rank buy see complete list today zack rank stock here idexx laboratory have long term expect earning growth rate stock have gain last month lantheus holding have long term expect earning growth rate stock have surge last month align technology have long term expect earning growth rate stock have rally roughly last month be reissue article correct mistake original article issue aug longer be rely
813,ALGN,california base align technology inc algn free report recently sign distribution agreement patterson dental business unit patterson company inc pdco free report exclusive agreement effective september align technology itero element intraoral scanning system be available part patterson dental cad cam portfolio unite state canada thus believe align technology slatest deal boost itero scanner customer base considerable extent be also optimistic company expand work flow option lead itero scanner context align technology recently launch software upgrade itero element intraoral scanner be capable compare patient scan time latest timelapse technology also align technology collaborate exocad gmbh march integrate portfolio result high tech solution efficient scanning design manufacturing house dental prosthesis february company announce addition digital nobel biocare implant itero intraoral scanner portfolio interestingly revenue scanner service improve substantial last report second quarter moreover company see increase adoption itero scanner invisalign case submission instead pvs impression especially north america thereby drive invisalign utilization line latest development itero scanner space align technology latest deal buoy optimism report medgadget global market dental scanner be project see cagr period consider market potential align technology current development scanner service space collaboration seem be strategic believe unhealthy lifestyle rise awareness expenditure healthcare continue drive growth dental scanner market however market be dominate many well establish player dentsply sirona be prominent align technology have be gain investor confidence consistent positive result past month company share price have outperformed broader industry stock have gain broader industry fall company have also outperformed gain market same time frame zack rank key picksalign technology currently have zack rank hold few better rank medical stock be edward lifescience corporation ew free report idexx laboratory inc idxx free report edward lifescience sport zack rank strong buy idexx laboratory carry zack rank buy see complete list today zack rank stock here edward lifescience have long term expect earning growth rate stock have gain last month idexx laboratory have long term expect earning growth rate stock have rally roughly last month simple trading ideasince zack system have more double average gain year compound rebalance exclusive fee turn thousand million dollar proven stock pick system be ground single big idea be fortune shape life change apply portfolio start today learn more
814,ALGN,first quarter earning season see starry start most member beating earning maintain revenue momentum apr however number positive revenue surprise be lag precede year number be par sequential figure latest earning preview total earning company have report so far be year year higher revenue total beat earning surpass revenue estimate week member be line release quarterly result expect get clearer picture first quarter earning season have offing end week medical sector snapshotmedical zack sector be expect stand quarter sector benefit favorable consumer behavior grow prevalence minimally invasive surgery demand liquid biopsy test use ensure quick improve patient care shift payment system value base model broadly speaking latest tax cut job act many other change slash corporate tax rate earlier have also buoy optimism inventor medical product space be part broader medical sector have be hog lot limelight certain favorable development consider favorable demographic change market dynamic artificial intelligence ai big datum application upbeat consumer sentiment increase business investment sector have be go strong further senate decision defer implementation industry wide excise tax couple year know medical device tax have instilled confidence investor tax be put effect jan bill also delay so call cadillac tax tax employer insurance moreover medtech company have be ride high innovation grow consolidation focus emerge market backdrop let take look major medical product stock schedule release result apr quantitative zack model stock advantageous combination solid zack rank strong buy buy hold positive earning esp have higher chance beating estimate uncover best stock buy sell re report earning esp filter laboratory corporation america holding lh free report labcorp first quarter result be expect reflect gain strong labcorp diagnostic segment favorable price mix tuck acquisition organic volume zack consensus estimate earning be peg indicate year year growth further predict earning beat quarter labcorp have zack rank earning esp read more launchpad aid labcorp covance arm earning see complete list today zack rank stock here stock surpass zack consensus estimate trail quarters average beat reflect chart laboratory corporation america holding price ep surprise laboratory corporation america holding price ep surprise laboratory corporation america holding quotethermo fisher scientific inc tmo free report have be progress well analytical instrument business rise global demand company focus growth implementation strategy consolidation product offering be encourage initiative be likely reflect first quarter result zack consensus estimate earning be peg show year year growth however be difficult conclusively predict earning beat thermo fisher have zack rank earning esp read more offing thermo fisher earning stock surpass zack consensus estimate last quarters average beat be see chart thermo fisher scientific inc price ep surprise thermo fisher scientific inc price ep surprise thermo fisher scientific inc quoteboston scientific corporation bsx free report have be gradually witness improve performance interventional cardiology ic lead innovative portfolio efficient commercial team globally watchman platform be set see stellar first quarter consistent global momentum boston scientific effort continue drive growth zack consensus estimate be peg cent indicate year year growth model show earning beat boston scientific have zack rank earning esp read more watchman aid boston scientific earning wo stock beat zack consensus estimate trail quarters average beat be negative show chart boston scientific corporation price ep surprise boston scientific corporation price ep surprise boston scientific corporation quotealign technology inc algn free report first quarter result be likely reflect gain continue adoption invisalign technology strong scanner service business zack consensus estimate earning be peg cent reflect year year improvement foresee beat align technology have zack rank earning esp read more steady overall growth drive align earning stock trump zack consensus estimate trail quarters average beat be see chart align technology inc price ep surprise align technology inc price ep surprise align technology inc quotevarian medical system inc var free report favorable revenue opportunity various oncology imaging component product grow adoption proton therapy strong overseas presence be likely have influenced company second quarter fiscal result zack consensus estimate earning be pin highlight year year rise however don see beat varian have zack rank earning esp read more varian medical earning be surprise store stock beat zack consensus estimate trail quarters average beat demonstrated chart varian medical system inc price ep surprise varian medical system inc price ep surprise varian medical system inc quote make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
815,ALGN,investor be always look stock be poise beat earning season align technology inc algn free report be such company firm have earning come pretty soon event be shape quite nicely report be align technology be see favorable earning estimate revision activity late be generally precursor earning beat analyst raise estimate right earning most date information possible be pretty good indicator favorable trend surface algn report fact most accurate estimate current quarter be currently share algn compare broader zack consensus estimate cent share suggest analyst have very recently bump estimate algn give stock zack earning esp head earning season align technology inc price ep surprise align technology inc price ep surprise align technology inc quotewhy be important positive read zack earning esp have proven be very powerful produce positive surprise outperform market recent year backtest show stock have positive earning esp zack rank hold better show positive surprise nearly time have return average annual return see more top earning esp stock here give algn have zack rank hold esp positive territory investor want consider stock ahead earning see complete list today zack rank strong buy stock here clearly recent earning estimate revision suggest good thing be ahead align technology beat be card upcoming report make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
816,ALGN,cvs health cvs free report be schedule report first quarter result open bell last report quarter company deliver positive earning surprise trail quarter average positive earning surprise be let take look thing be shape prior announcement factor playcvs health have so far progressed well pbm selling season last report number gross new business win totale net new business win gross impressive client retention rate momentum be expect continue be report quarter tough pricing competition cvs health be currently gain high level service execution competitive pricing unique integrate model company be also upbeat sustain solid year year earning trend first quarter gain be realize pharmacy service segment performance be be drive higher specialty pharmacy pharmacy network claim volume well brand inflation management state cvs health specialty business be top priority help company expand customer base cvs health be poise capitalize opportunity back wide differentiate offering include specialty connect cvs health corporation price ep surprise cvs health corporation price ep surprise cvs health corporation quotefurther company expect drug price inflation product launch higher utilization fuel growth expect pharmacy service segment be stable growth platform cvs health also project better expect performance be report quarter primarily back ofscript utilization retail company have project rise consolidated net revenue first quarter further strong flu season have lead improve outlook overall first quarter company expect register adjust operate profit growth range zack consensus estimate total revenue reflect increase year year cvs health retail ltc business register revenue growth several quarters slump last report quarter be multiple factor raise concern firstly year year growth be just marginal further continue reimbursement pressure increase generic dispense rate andrecent generic drug introduction have be affect business apart marketplace change keep cvs pharmacy participate certain network have basis point negative impact same store prescription volume previously report quarter however cvs health have be strive return growth retail ltc business management claim company be focuse work payer drive volume capture market share cvs health be also poise gain program such health tag extracare health card company also expect witness revenue growth operate profit growth low mid single digit range retail ltc business here be quantitative model predict proven model do not conclusively show cvs health beat estimate earning season be stock need have positive earning esp solid zack rank strong buy buy hold happen be not case here see zack esp cvs health have earning esp uncover best stock buy sell re report earning esp filter zack rank cvs health carry zack rank sell please note stock zack rank strong sell never be consider go earning announcement especially company be see negative estimate revision meanwhile zack consensus estimate first quarter adjust ep reflect increase year year stock considerhere be few medical stock worth consider right combination element beat estimate time laboratory corporation america holding lh free report have earning esp zack rank henry schein inc hsic free report have earning esp zack rank align technology inc algn free report have earning esp be zack rank player today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
817,ALGN,resm inc rmd free report be slate report third quarter fiscal result market close apr last quarter company deliver positive earning surprise moreover company surpass estimate trail quarters average beat let see thing be shape announcement key catalystsresm be expect gain strong performance domestic well international front previous quarter past few earning company domestic revenue be drive solid growth device mask well continue double digit software sale rise moreover sleep apnea patient volume consistently witness steady growth expect trend find reflection impending third quarter result well internationally revenue europe asia other market be likely register solid increase banking strong device mask performance device sleep apnea patient volume continue expand company marketing effort channel partner canada latin america sturdy uptake airsense device platform air solution cloud base software platform further add value company portfolio resm inc price ep surprise resm inc price ep surprise resm inc quote france company receipt french reimbursement approval telemonitoring buoy optimism stock company believe reimbursement grant continue drive uptake air solution ecosystem include airsense aircurve device platform well airview myair software platform be report quarter moreover company keep investing expand footprint high growth market china south korea india brazil several country eastern europe mask accessory outside unite state company be expect benefit nasal full face category namely airfit airfit respectively resm more night medical sleep medical respiratory care datum company be successfully work simplify improve patient outcome improvement drive company top line performance quarter yet be report zack consensus estimate international revenue indicate rise year quarter domestically resm be extremely upbeat latest tax reform see transformation territorial tax system fact allow company invest global cash asset artificial constraint resm be now free invest new way firstly grow exist strong manufacturing footprint secondly expand exist base research development capability finally build exist valuable base intellectual property asset effective january be expect remain accretive company operational result fiscal third quarter zack consensus estimate domestic revenue include contribution reflect increase year quarter other factor likely influence resm resm continue progress back prong growth strategy regard company diligently aim growth adjacent product geographic market include homecare ventilation chronic obstructive pulmonary disease copd amyotrophic lateral sclerosis al other respiratory disorder well emerge market china india brazil resm still consider portable oxygen concentrator pocs important addition menu respiratory care product moreover resm acquisition fiscal former have strongly progressed latter software service business latest offering target home health hospice market expect upside further boost resm top line third quarter zack consensus estimate revenue mark increase year quarter here quantitative model predict proven zack model company favorable zack rank strong buy buy hold have good chance beating estimate also have positive earning esp resm have zack rank increase predictive power esp however earning esp make surprise prediction difficult thus combination do not suggest company be likely beat earning quarter caution sell rate stock go earning announcement especially company be see negative estimate revision uncover best stock buy sell re report earning esp filter stock considerhere be few medical stock worth consider right combination element beat estimate time align technology inc algn free report have earning esp zack rank see complete list today zack rank stock here laboratory corporation america holding lh free report have earning esp be zack rank player quest diagnostic incorporate dgx free report have earning esp zack rank hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
818,ALGN,align technology inc algn free report be set report first quarter earning result apr market close last quarter company post positive earning surprise align technology have outperformed zack consensus estimate precede quarters average positive earning surprise be let take look thing be shape prior announcement invisalign system major growth driversimilar prior quarters align technology be expect gain continue adoption invisalign technology first quarter well accordingly company project invisalign case shipment band be report quarter year notably november align technology announce achievement milestone patient undergo treatment invisalign system interestingly consider fast expand market clear aligner therapy align technology have undertake several strategy drive adoption core invisalign product line include product technology development extend clinical effectiveness promote invisalign brand name boost international growth company have also be focuse increase invisalign utilization orthodontist particularly target teenager align technology have adopt marketing strategy accelerate consumer demand allow gp dentist treat increase number case invisalign system align technology inc price ep surprise align technology inc price ep surprise align technology inc quotestrength scanner service businessalign technology have also be witness strong revenue growth scanner service business past few quarters moreover company have be witness increase adoption itero scanner invisalign case submission instead pvs impression especially north america thereby drive invisalign utilization management expect bullish trend reflect company first quarter result well same time align technology have be focuse expand option itero scanner context last november company sign agreement glidewell dental distribute itero element intraoral scanning system latest glidewell io office solution north america align technology have also sign distribution agreement patterson dental make available itero element intraoral scanning system part patterson dental cad cam portfolio unite state canada solid global prospect align technology have introduce clear aligner solution class ii correction invisalign technology mandibular advancement certain market canada emea apac be indicative grow popularity dental product international market further recent past align technology report strong international invisalign technology volume continue strong performance emea apac region last report quarter emea volume be continue adoption invisalign technology core market spain france well rapid growth smaller market eastern europe central europe middle east africa asia pacific region company witness impressive volume growth lead china japan australia expect see similar trend yet be report quarter result well overall align technology project ep cent revenue first quarter zack consensus estimate total revenue first quarter indicate rise year quarter quantitative model suggestsper proven zack model company favorable zack rank strong buy buy hold have good chance beating estimate also have positive earning esp align technology have earning esp zack rank combination suggest company likely beat earning quarter uncover best stock buy sell re report earning esp filter zack consensus estimate earning cent reflect rise year year basis other stock considerhere be few other medical stock worth consider have right combination element beat estimate time laboratory corporation america holding lh free report have earning esp zack rank see complete list today zack rank stock here henry schein inc hsic free report have earning esp zack rank edward lifescience corporation ew free report have zack rank earning esp hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
819,ALGN,abbott free report report first quarter adjust earning continue operation cent share beating zack consensus estimate penny bottom line also improve year year meet high end company guide range cent moreover report earning quarter come cent share compare year figure cent first quarter worldwide sale come year year report basis top line also exceed zack consensus estimate organic basis adjust impact foreign exchange certain divestment sale increase year year report quarter quarter detailabbott operate segment namely establish pharmaceutical division epd medical device nutrition diagnostic epd sale rise report basis organic basis include positive impact currency fluctuation sale key emerge market increase drive double digit growth india china brazil medical device business sale increase report basis organic basis sale grow cardiovascular neuromodulation sale reportedly organic basis rise double digit growth neuromodulation vascular product sale however decline report basis rhythm management company see sale increase report basis decline abbott laboratory price consensus ep surprise abbott laboratory price consensus ep surprise abbott laboratory quote diabetes care sale improve buoy double digit international sale growth lead consistent consumer uptake freestyle libre revolutionary continuous glucose monitoring system abbott nutrition sale be year year report basis organic basis foreign exchange drive sale pediatric nutrition sale increase organic basis adult nutrition sale be organically diagnostic sale soar year year report basis comparable operational basis core laboratory point care diagnostic sale grow respectively organic basis molecular diagnostic sale be nominal strong growth infectious disease testing business be partially offset plan scale other testing area primarily unite state rapid diagnostic record sale drive solid contribution infectious disease testing include flu strep testing full year guidanceabbott have reiterate earning share guidance adjust certain net specify item full year adjust earning continue operation be still expect band zack consensus estimate remain project range company have also provide second quarter adjust earning share outlook expect report adjust earning continue operation range cent consensus mark cent fall lower end predict range takeabbott have steer past zack consensus estimate earning revenue be optimistic company strong consistent epd medical device performance also solid contribution company other business encourage company continue benefit strong integration synergy st jude medical offer industry lead pipeline cardiovascular neuromodulation diabetes vision care be also impressed abbott alere buyout synergy consolidation form revenue rapid diagnostic have be drive company growth meanwhile company emerge market performance have be extremely promising several strategic development zack rank key picksabbott carry zack rank hold few better rank stock broader medical sector be abaxis inc abax free report bio rad laboratory inc bio free report align technology inc algn free report abaxis bio rad sport zack rank strong buy align carry zack rank buy see complete list today zack rank stock here abaxis be expect release fourth quarter fiscal result apr zack consensus estimate quarter adjust ep be peg cent revenue stand bio rad be expect release first quarter result zack consensus estimate period adjust ep be cent revenue align technology be slate release first quarter result apr zack consensus estimate adjust bottom line be report quarter be cent top line hacker put money portfolio earlier year credit bureau equifax announce massive datum breach affect american cybersecurity industry be expand quickly response similar event stock be better investment other zack have just release cybersecurity investor guide help zack com reader make most year investment opportunity create hacker other threat reveal stock worth look right away download new report now
820,ALGN,bid fortify dental business henry schein inc hsic free report recently form joint venture internet brand notably internet brand be provider web presence online marketing software dental office subject certain customary close condition transaction be expect be complete second quarter however financial term deal be keep wrapped henry schein plan integrate portfolio practice management system dental practice management software company henry schein practice solution internet brand web base software application enhance dental practice management marketing well improvise patient communication joint venture company name joint venture henry schein notably comparison internet brand henry schein hold majority ownership joint venture exclude impact time transfer taxe henry schein anticipate deal be immaterial rest earning share accretive thereafter furthermore annual synergy be expect be realize end third year joint venture initiation dental business major growth driverhenry schein dental business contribute total revenue last report quarter accordingly have be leave stone unturned strengthen hold business regard last year henry schein sign distribution agreement dentsply sirona inc xray free report distribute latter entire product line encouragingly note henry schein bank part strategic plan digital dentistry company be busy promote digital workflow general dentistry well dental specialty management solid performance be attribute continue focus offer diversify portfolio value add service favorable end market thus believe company latest tie be strategic market potentialper company dental industry rise oral healthcare expenditure be predict population agee year increase moreover henry schein be upbeat expect increase dental insurance coverage lower insurance reimbursement rate lead rise need new technology believe boost demand henry schein product service moreover report transparency market research global dental practice management software market be expect see cagr consider huge potential market believe latest development be strategic help henry schein cash bountiful opportunity market share price movementover past month henry schein have be underperform broader industry stock lose contrast industry gain believe latest development help boost investor confidence stock reverse downtrend zack rank key pickshenry schein currently carry zack rank hold few better rank stock broader medical sector be bio rad laboratory bio free report align technology inc algn free report bio rad laboratory sport zack rank strong buy see complete list today zack rank stock here have long term expect earning growth rate align technology have long term expect earning growth rate stock carry zack rank buy zack editor chief go stockfull disclosure kevin matra now have more own money particular stock other believe short term profit potential also prospect more double today reveal explain surprising move new special report download free
821,ALGN,co share increase follow company confirmation propose merger bayer ag be complete end second quarter share gms inc gms free report rise follow report company plan buy wsb titan acquisition likely strengthen position biggest wallboard distributor north com ltd free report share increase follow announcement special cash dividend american depositary shareshare align technology inc algn free report increase company announce extension invisalign clear aligner range launch vivera retainer precision bite ramp
822,ALGN,investing world be present fluster politic unite state china pertain trade continue slam import tariff other heart last year market rally tech space have also be wobble lately host issue kind shaky investing backdrop only sweet surprise corporate earning pull market be investor want now be quality pick stock be likely beat earning estimate fall category be positive earning surprise beat matter most irrespective earning growth be positive earning surprise so important historically stock company solid quarterly earning nominal basis tank miss merely meet market expectation earning rise apparently look good doesn tell have be decelerate seasonal fluctuation also come play company be seasonally weak be strong be likely report sequential earning decline such case growth rate be mislead judge true health company only significant research analysis company financial initiative wall street analyst project earning also take company guidance consideration derive earning estimate thus outperform estimate be almost equivalent beating company own expectation well market perception margin earning surprise be big typically drife stock higher right release thus more anything else earning surprise push stock higher locate potential outperformer investor tend look stock have potential beat bottom line not always succeed way identify winner beforehand be look earning surprise history company impressive track record regard generally act driver indicate company ability exceed estimate investor generally believe company have same trick sleeve deliver yet earn beat upcoming release winning strategyin order shortlist stock be likely come earning surprise choose follow primary screening parameter last ep surprise greater equal stock deliver positive surprise last quarter tend surprise again average ep surprise last quarters greater lift bar outperformance slight higher set average earning surprise last quarters average ep surprise last quarters greater point more consistent surprise history make case surprise even stronger addition place few other criterium push chance positive surprise zack rank less equal only company zack rank strong buy buy rating get earning esp greater stock need have positive earning esp zack rank earning beat happen proven model order have long term growth potential high trading liquidity have add follow parameter too next year estimate ep growth year greater solid expect earning growth exhibit stock long term growth prospect average day volume greater high trading volume imply stock have adequate liquidity handful criterium have narrow universe stock here be stock pass screen amazon com inc amzn free report company engage retail sale consumer product subscription north america internationally stock carry zack rank see complete list today zack rank stock here align technology inc algn free report be global medical device company have zack rank axon enterprise inc aaxn free report zack rank company manufacture sell conduct electrical weapon law enforcement federal military correction private security personal defense market antero resource corporation ar free report be independent oil natural gas company have zack rank jone lang lasalle inc jll free report be zack rank company be global professional service investment management firm specialize real estate get rest stock list signing now week free trial research wizard start used screen own trading further also create own strategy test first take investment plunge research wizard be great place begin easy use everything be plain language very intuitive start research wizard trial today next time read economic report open research wizard plug find see gem come click here sign free trial research wizard today disclosure officer director employee zack investment research own have sell short security hold long short position option be mentioned material affiliated investment advisory firm own have sell short security hold long short position option be mentioned material disclosure performance information zack portfolio strategy be available https www zack com performance zack restaurant recommendation addition dine special place feast stock share zack special report spotlight recent ipos watch stock offer immediate promise boom sector download free
823,ALGN,align technology inc algn free report have make extension invisalign clear aligner range latest launch vivera retainer precision bite ramp be claim be first retainer market be customize provide additional support deep bite correction notably vivera retainer be make same state art technology invisalign aligner employ digital imaging proprietary clear thermoplastic material advanced fabrication technology stronger retention precise comfortable fit align precision bite ramp be first introduce be design disocclude posterior tooth open bite improve efficiency deep bite invisalign treatment precision bite ramp be part invisalign integration vivera retainer be expect bring greater clinical success align orthodontic space deep bite malocclusion gradually become very common orthodontic occurrence worldwide consider development major breakthrough align respect customer adoption rate deep bite malocclusion case be mostly high north america emea register patient region accord statistic provide align date more moderate severe deep bite patient include teenager have be treat invisalign clear aligner patient datum also show doctor be increasingly fix severe deep bite invisalign precision bite ramp be important note align have recently undertake several strategy improve adoption invisalign technology globally include product technology development extend clinical effectiveness expansion invisalign technology brand drive international growth parallel press release today company have introduce expand invisalign product portfolio offer new option greater flexibility wider range patient earlier company have introduce clear aligner solution class ii correction invisalign technology mandibular advancement certain market canada emea apac be indicative grow popularity align dental product international market long term expect similar innovation act major catalyst align new well exist market past month share align have outperformed industry stock have surge compare increase industry zack rank key picksalign carry zack rank buy few better rank stock broader medical sector be bio rad laboratory bio free report athenahealth inc athn free report edward lifescience corporation ew free report bio rad laboratory sport zack rank strong buy see complete list today zack rank stock here have long term expect earning growth rate athenahealth be zack rank player have long term expect earning growth rate edward lifescience have long term expect earning growth rate stock carry zack rank today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
824,ALGN,bid broaden flagship invisalign portfolio align technology inc algn free report recently announce addition invisalign first clear aligner treatment younger patient early mixed dentition company plan commercially launch new offer invisalign trained doctor unite state canada australia new japan emea region jul onward note more patient have be treat invisalign first clear aligner date invisalign first clear aligner detailper company latest extension invisalign first clear aligner have be equip feature aid phase treatment younger patient early mixed dentition mixture primary baby permanent tooth notably phase treatment be early interceptive orthodontic treatment young patient typically age year notably invisalign first clear aligner have be develop treat younger patient malocclusion include shorter clinical crown management erupt dentition predictable dental arch expansion invisalign system major growth driverin november align technology announce achieve milestone patient undergo treatment invisalign system consider fast expand market clear aligner therapy align technology have undertake several strategy drive adoption core invisalign product line include product technology development extend clinical effectiveness promote invisalign brand name boost international growth late invisalign technology launch invisalign pilot store san francisco strengthen brand image moreover be encourage align technology solid invisalign technology prospect growth north america internationally particularly asia pacific region market prospectsper market market report child teenager majorly comprise global orthodontic market come year large number patient malocclusion jaw disorder be likely drive demand moreover align technology orthodontic case start year be attribute phase treatment research firm technavio anticipate global invisible orthodontic market witness cagr approximately give market potential align technology consistent effort believe company be well position cash bountiful opportunity market share price performanceover past year align technology have be outperform broader industry latest price movement company share have gain compare rise broader industry zack rank other key picksalign technology carry zack rank buy few other top rank stock broader medical sector be bio rad laboratory bio free report athenahealth inc athn free report hill holding inc hrc free report bio rad laboratory sport zack rank strong buy see complete list today zack rank stock here have long term expect earning growth rate athenahealth be zack rank player have long term expect earning growth rate hill have long term expect earning growth rate stock carry zack rank today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
825,ALGN,myriad genetic inc mygn free report recently announce receipt manufacturing marketing approval bracanalysis diagnostic system japanese ministry health labour welfare system now be used companion diagnostic parp inhibitor lynparza follow approval physician japan be now authorize prescribe bracanalysis patient diagnosed metastatic breast cancer find carry germline brca brca gene mutation encouragingly note bracanalysis be first only diagnostic test parp inhibitor be approve japan furthermore myriad genetic have form exclusive partnership srl inc market bracanalysis japan notably subsidiary miraca group srl be largest laboratory service provider japan meanwhile astrazeneca merck marketer lynparza be look forward get approval treat patient brca mutate metastatic breast cancer japan recent development bracanalysis myriad genetic have be leave stone unturned boost uptake bracanalysis test company market product unite state bracanalysis cdx january myriad genetic have announce receipt fda approval bracanalysis cdx test usage companion diagnostic astrazeneca merck parp inhibitor lynparza olaparib patient negative metastatic breast cancer mbc germline brca mutation october company have announce fda acceptance supplementary premarket approval spma application bracanalysis cdx usage companion diagnostic astrazeneca parp inhibitor lynparza olaparib patient negative mbc again last december company present encourage datum embraca trial demonstrate bracanalysis cdx test ability effectively identify patient mbc respond pfizer investigational parp inhibitor talazoparib market potentialper myriad genetic patient metastatic disease be currently eligible bracanalysis testing japan moreover approximately new case negative breast cancer be diagnosed year promising datum indicate timely strategic role latest approval be go play favor myriad genetic share price genetic have be gain investor confidence consistently positive result past year company share price have outperformed broader industry stock have gain contrast broader industry fall zack rank key picksmyriad genetic carry zack rank hold better rank stock broader medical sector be bio rad laboratory bio free report athenahealth inc athn free report align technology inc algn free report bio rad laboratory sport zack rank strong buy see complete list today zack rank stock here have long term expect earning growth rate athenahealth be zack rank player have long term expect earning growth rate align technology have long term expect earning growth rate stock carry zack rank buy wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
826,ALGN,ensign group inc ensg free report have acquire real estate operation peorium post acute rehabilitation bed skilled nursing facility locate peorium az buyout be effective apr adjacent bed long term acute care hospital operated third party lease arrangement be also include facility detail dealensign group operate large highly fragmented skilled nursing industry generate significant acquisition consolidation opportunity field be monopolized numerous local regional provider follow acquisition ensign group now own real estate healthcare operation purchase acquirer expand portfolio skilled nursing operation consist assist live operation assist independent live operation hospice agency home health agency home care business state management state be actively seek additional opportunity own complete stake real estate activity lease flourishing struggle skilled nursing assist live other healthcare related business unite state company be also confident aligning focus become top class post acute care provider market acquisition facilitate deliver high quality service arizona inorganic growthensign group be always incline achieve growth inorganic mean much company historical growth be attribute expertise buy real estate lease underperform proficiently execute post acute care operation subsequently company apply core operate know improve acquire service clinically financially earlier year ensign group assist independent live portfolio company bridgestone live llc acquire real estate operation assist live facility texas thus expect company continue inorganic effort go forward consolidation hospital industry be witness consolidation due rise expense decline admission increase bad debt flurry regulatory action be compelling player gain scale survival month mednax inc md free report close acquisition pediatric urology practice south florida share price industry headwind share price reflect shareholder confidence stock company inorganic growth endeavor have significantly aid top line growth stock have surge year time substantially outperform industry decline zack rank other stock ensign group carry zack rank buy see complete list today zack rank strong buy stock here investor also look check couple other top rank stock medical sector align technology inc algn free report universal health service inc uhs free report stock carry zack rank align technology pull positive surprise last quarters average beat universal health earning surpass expectation last quarters average beat wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
827,ALGN,boston scientific corporation bsx free report recently announce acquisition securus medical group inc privately hold developer thermal monitoring system continuous measurement esophageal temperature buyout be line company strategy gain traction global ep market be poise reach value datum market market securus medical group integrate catheter base probe imaging system produce real time image temperature esophagus help perform cardiac ablation procedure avoid thermal injury notably infrared esophageal temperature monitoring system have receive clearance fda boston scientific plan introduce thermal monitoring system unite state first half further company integrate thermal monitoring system rhythmia hdx mapping system improve level comprehensive cardiac imaging ablation procedure financial term dealboston scientific have exist investment securus medical group pay net upfront payment approximately cash remain stake milestone fee nearly however transaction be not expect be accretive company adjust earning share glimpse ep businessboston scientific ep business develop less invasive medical technology diagnose treat disorder heart rate rhythm fourth quarter revenue division improve year year cer upside be drive higher uptake new rhythmia hdx platform management continue roll hdx platform europe recently launch unite state well japan overall company continue expand toolkit support rhythmia hdx provide ablation technology match excellence mapping system additionally focus add tool expand reach utility rhythmia hdx different procedure regard boston scientific expect full fledge directsense technology europe unite state follow successful initial launch europe moreover expand ep business boston scientific acquire apama medical inc october company intend integrate rhythmia hdx mapping system apama rf balloon system improve visualization heart ablation process market potentialboston scientific strategy boost ep business seem be align datum provide ally market research report global cardiac monitoring cardiac rhythm management market be expect reach value cagr believe unhealthy lifestyle rise age population continue result high incidence cardiovascular disease be support datum provide gbi research report global cardiovascular disease market be project witness cagr space market be expect witness highest momentum cagr thus addition thermal monitoring system help boston scientific cash abundant opportunity global cardiac monitoring cardiac rhythm management market share price scientific have be gain investor confidence consistently positive result past month share company have outperformed broader industry stock have rally versus industry decline zack rank key picksboston scientific carry zack rank hold few better rank stock broader medical sector be bio rad laboratory bio free report athenahealth inc athn free report align technology inc algn free report bio rad laboratory sport zack rank strong buy see complete list today zack rank stock here have long term expect earning growth rate athenahealth be zack rank player have long term expect earning growth rate align technology have long term expect earning growth rate stock carry zack rank buy wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
828,ALGN,walgreen boot alliance inc wba free report be slate release second quarter fiscal result market open mar last quarter company have deliver positive earning surprise be noteworthy walgreen boot have outperformed zack consensus estimate precede quarters average positive earning surprise let take look thing be shape prior announcement key catalystsover recent past have observed walgreen boot retail pharmacy usa division witness comparable prescription growth benefit strength retail prescription market several plan development early benefit new pharmacy contract well increase volume owing previously announce pharmacy partnership have be drive growth space past few quarters moreover rise expenditure prescription drug grow demand specialty drug have be strengthen retail pharmacy market meanwhile first quarter fiscal company exceed script day adjust roll annual basis first time touch new milestone furthermore company effort boost digital capability have start pay regard more company retail refill script be initiate digital channel walgreen mobile app have be download excess time launch be also encourage increase sale retail pharmacy international segment furthermore company have be gain account company strategic tie up bring more patient pharmacy walgreen boot alliance inc price ep surprise walgreen boot alliance inc price ep surprise walgreen boot alliance inc quote meanwhile strong market growth certain emerge market drive company pharmaceutical wholesale division solid performance first quarter fiscal expect trend get reflect fiscal second quarter result well zack consensus estimate total revenue reflect rise year year basis also be upbeat company expand global footprint decision acquire stake sinopharm hold guoda drugstore co ltd guoda subsidiary china national accord medicine corporation ltd completion investment provide strong impetus walgreen boot worldwide retail pharmacy business notably shanghai base guoda be large national pharmacy chain china be retail pharmacy platform china national pharmaceutical group corporation cnpgc moreover company acceptance proposal sell part investment chinese wholesale partner guangzhou pharmaceutical corporation huge cash return buoy optimism be also upbeat walgreen boot plan expand exist group purchasing effort express script hold company ensure availability specialty brand drug biosimilar have potential lower production cost move be consider be prudent timely flip side walgreen boot gross margin figure continue contract last report quarter well lower pharmacy margin reflect reduction funding lead downside however company be work tirelessly increase efficiency provide high quality cost effective pharmacy service order reduce overall pharmacy cost here be quantitative model predict walgreen boot have right combination main ingredient positive earning esp zack rank hold higher need increase odd earning beat zack esp earning esp walgreen boot be uncover best stock buy sell re report earning esp filter zack rank walgreen boot carry zack rank buy zack consensus estimate earning reflect rise year year basis other stock worth lookhere be few other medical stock worth consider have right combination element post earning beat quarter edward lifescience corporation ew free report have earning esp zack rank see complete list today zack rank strong buy stock here align technology inc algn free report have earning esp zack rank henry schein hsic free report have earning esp zack rank medical stock buy nowzack name company poise ride medical breakthrough be target cure leukemia aids muscular dystrophy hemophilia other condition new product field be already generate substantial revenue even more wondrous treatment be pipeline early investor realize exceptional profit click here see stock
829,ALGN,feb issue update research report align technology inc algn free report stock carry zack rank hold notably align technology manufacture market clear aligner therapy intra oral scanner cad cam computer aid design manufacturing digital service used dentistry orthodontic dental record storage share company have be trading industry last year stock have rally compare industry growth company deliver encourage performance fourth quarter post better expect earning revenue be encourage company solid invisalign technology prospect growth north america internationally particularly asia pacific company have witness year year growth segment also expansion gross operate margin buoy optimism be also upbeat company distribution agreement glidewell dental distribute itero element intraoral scanning system latest glidewell io office solution north america flip side adverse foreign exchange translation continue raise concern align technology international operation also escalate cost expense be weigh margin moreover tough competitive landscape other macroeconomic headwind threat key pickssome better rank stock broader medical sector be bio rad laboratory bio free report resm rmd free report perkinelmer pki free report bio rad laboratory have zack rank buy see complete list today zack rank strong buy stock here company have long term expect earning growth rate resm have zack rank company have long term expect earning growth rate perkinelmer have long term expect earning growth rate stock carry zack rank more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
830,ALGN,align technology inc algn free report fourth quarter adjust earning share ep come exclude net expense share impact tax reform report ep come cent adjust ep figure be year year earning be also higher company guide range cent figure beat zack consensus estimate cent full year adjust ep come beating zack consensus estimate moreover figure beat year number revenuesrevenue grow year year quarter surpass zack consensus estimate revenue be well ahead company guide range net revenue totale outpace zack consensus estimate figure also improve year number align technology inc price consensus ep surprise align technology inc price consensus ep surprise align technology inc quote management top line be drive year year increase invisalign case shipment fourth quarter upside be drive growth north america international region expand customer base increase utilization moreover increase revenue itero scanner contribute top line segment detailrevenue clear aligner segment total revenue soar year year report quarter primarily drive continue strong invisalign case volume growth customer channel geographical region fourth quarter invisalign case shipment amount year year aid growth region well expansion customer base quarter align technology invisalign case be ship doctor worldwide be north america international region revenue scanner service improve significant marginsgross margin quarter review be basis point bps year year spite rise cost net revenue quarter align technology witness year year increase selling general administrative expense rise research development expense operate margin expand bps financial detailsalign technology exit cash cash equivalent short term marketable security marked rise report quarter align technology repurchase share stock april stock repurchase program company currently have approximately left buy back program first quarter company project ep cent revenue company project invisalign case shipment band year meanwhile current zack consensus estimate first quarter ep be cent revenue estimate be fall project range takealign technology end fourth quarter solid note be upbeat continue strength invisalign volume gp dentist see higher demand north america follow summer holiday season orthodontist witness increase adult patient footfall busy season precede quarter internationally be encourage strength emea asia pacific market scanner service company witness strong uptake itero scanner gp dentist record contract come gp summit last september moreover increase uptake due recent deal patterson dental align itero element intraoral scanning system also contribute top line company witness solid demand itero scanner emea asia pacific well align technology have strong cash balance enable carry share repurchase turn provide solid return investor flip side company be expose foreign exchange fluctuation seasonal demand fluctuation higher operate expense pertain increase head count higher investment target expansion geographical presence portfolio zack rank other key picksalign technology carry zack rank buy other top rank stock broader medical sector be resm rmd free report perkinelmer pki free report accuray aray free report company carry zack rank see complete list today zack strong buy rank stock here resm post second quarter fiscal adjust earning prior year quarter revenue report quarter increase year year constant exchange rate cer perkinelmer report fourth quarter adjust earning cent company report adjust revenue approximately surpass year quarter accuray report loss cent second quarter fiscal cent narrower year figure total revenue increase year year hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
831,ALGN,jul issue update research report radnor pa base vwr corporation offer laboratory product service solution company currently carry zack rank buy last month vwr have be trading zack categorize medical dental supply industry company share have rally much gain broader medical dental supply industry period be currently look forward company impending sale ultra high purity material supplier avantor announce back upside potential stock be however limit divestiture post close be expect create major consumable focuse solution service provider high growth life science advanced technology industry acquisition build avantor strength include cgmp current good manufacturing practice process significant exposure emerge market vwr vital position americas well europe combine company therefore be serve global customer base area activity research production reflect unique advantage fast grow marketplace shareholder point view potential merger avantor seem beneficial move moment consolidation deal have be fix cash share vwr common stock represent enterprise value approximately purchase price represent approximate premium unaffected close stock price day start market speculation regard potential sale vwr purchase price also denote approximate premium trading day volume weight average price vwap approximate premium trading day vwap vwr common stock key picksother better rank medical stock be mesa laboratory inc mlab free report edward lifescience corp ew free report align technology inc algn free report mesa laboratory edward lifescience sport zack rank strong buy align technology carry zack rank see complete list today zack rank stock here mesa laboratory have positive earning surprise last quarters stock have add roughly last month edward lifescience have long term expect earning growth rate stock have jump last month align technology have expect long term adjust earning growth almost stock have surge roughly last month more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
832,ALGN,merit medical system inc mmsi free report be big mover last session company see share rise almost day upside be drive company integration argon critical care business catheter connection asset also lead far more share change hand normal session break recent trend company stock be now trading volatile price range past month time frame company have see positive negative estimate revision past day also zack consensus estimate remain unchanged same timeframe yesterday price action be encourage so make sure keep close watch firm future merit medical system currently sport zack rank strong buy merit medical system inc price merit medical system inc price merit medical system inc quoteanother top rank stock medical dental supply industry be align technology inc algn free report hold zack rank buy see complete list today zack rank stock here be mmsi go predict see other think hottest tech mega trend last year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
833,ALGN,mckesson corporation mck free report report first quarter fiscal end jun earning share miss zack consensus estimate earning also lag year figure performance be muted owing brand generic conversion steep competition pharmacy business revenue improve year year fail meet zack consensus estimate quarter detailmckesson operate segment distribution solution technology solution growth rate give be year year basis distribution solution revenue increase north america pharmaceutical distribution service report sale market growth acquisition revenue be hit brand generic conversion revenue international pharmaceutical distribution service be medical surgical distribution service generate sale however revenue technology solution business fall year quarter be due bifurcation technology solution business change healthcare joint venture mar segment reflect only number enterprise information solution business mckesson corporation price consensus ep surprise mckesson corporation price consensus ep surprise mckesson corporation quotefinancial conditiona jun mckesson have cash cash equivalent mar report quarter end jun company generate cash amount operation also fiscal mckesson paid acquisition repurchase common stock repay approximately long term debt paid dividend fiscal outlookmckesson expect gaap earning diluted share fiscal end mar adjust earning same period be expect range diluted share distribution solution business revenue growth be expect increase mid single digit year year upside be expect be drive market growth acquisition revenue technology solution be expect be year year basis zack rank key picksmckesson currently carry zack rank hold few better rank medical stock be mesa laboratory inc mlab free report insys therapeutic inc insy free report align technology inc algn free report notably insys therapeutic sport zack rank strong buy mesa laboratory align technology carry zack rank buy see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock have gain last month mesa laboratory have positive earning surprise last quarters stock have add roughly last month align technology have expect long term adjust earning growth almost stock have add roughly last month more stock news tech opportunity worth driverless car artificial intelligence ve see unsurpassed growth high tech product recent month yesterday science fiction be become today reality innovation be single component tech company survive demand critical device reach year alone likely grow even faster future zack have release brand new special report help take advantage exciting investment opportunity most importantly reveal stock massive profit potential see stock now
834,ALGN,new jersey base medical device manufacturer integra lifescience holding corporation iart free report report adjust earning share ep cent second quarter marked increase year number adjust ep however be line zack consensus estimate include time item company report earning cent share year quarter revenue detailstotal revenue report quarter increase year year miss zack consensus estimate exclude contribution revenue acquisition discontinue product effect currency exchange rate organic revenue rise year year solid revenue growth second quarter be primarily drive strong contribution company specialty surgical solution orthopedic tissue technology segment integra lifescience holding corporation price consensus ep surprise integra lifescience holding corporation price consensus ep surprise integra lifescience holding corporation quotein term product category revenue company specialty surgical solution segment inched organically orthopedic tissue technology revenue come second quarter year year organically margin trendgross margin expand basis point bps report quarter lower purchase accounting adjustment tei acquisition adjust gross margin contract bps primarily due dilution derma science selling general administrative expense increase report quarter research development expense rise adjust operate margin exclude amortization intangible asset see bps contraction second quarter financial positionintegra lifescience exit second quarter cash cash equivalent record end first quarter jun net cash flow operate activity be year quarter outlook have raise low end earlier provide full year revenue guidance range meanwhile full year organic revenue growth range be lower zack consensus estimate full year revenue be guide range company have reaffirm full year adjust ep zack consensus estimate adjust earning be peg share company guide range takeintegra lifescience exit second quarter disappointing note revenue miss zack consensus estimate be concern currency headwind be expect affect company financial performance rest also contraction adjust operate margin adjust gross margin add wo however strong year year increase revenue back orthopedic tissue technology segment buoy optimism also be encourage note company segment see year year revenue growth quarter nonetheless believe company be try execute growth plan product launch efficient management team zack rank key picksintegra lifescience currently have zack rank hold few better rank medical stock be mesa laboratory inc mlab free report insys therapeutic inc insy free report align technology inc algn free report notably insys therapeutic sport zack rank strong buy mesa laboratory align technology carry zack rank buy see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock have gain last month mesa laboratory have positive earning surprise last quarters stock have add roughly last month align technology have expect long term adjust earning growth almost stock have add roughly last month more stock news tech opportunity worth driverless car artificial intelligence ve see unsurpassed growth high tech product recent month yesterday science fiction be become today reality innovation be single component tech company survive demand critical device reach year alone likely grow even faster future zack have release brand new special report help take advantage exciting investment opportunity most importantly reveal stock massive profit potential see stock now
835,ALGN,headquarter utica ny lead medical technology player conm corporation cnmd free report report second quarter adjust earning cent share line zack consensus estimate also earning deteriorate year year basis due unfavorable impact foreign exchange rate partially offset higher sale revenue rise approximately ahead zack consensus estimate revenue also increase constant currency basis cc revenue detailsin term product line orthopedic surgery revenue increase year year basis cc revenue segment totale general surgery segment see solid quarter register increase revenue cc general surgery organic revenue increase year quarter term product category revenue single use product increase cc come capital product revenue decline cc conm corporation price consensus ep surprise conm corporation price consensus ep surprise conm corporation quoteon basis geography conm witness uptick domestic revenue conm see growth international revenue balance sheetconm have cash balance end second quarter compare end first quarter also long term debt be second quarter compare first quarter inventory balance be end quarter review full year conm revise lower end sale growth guidance band cc company reaffirm adjust earning share range takeforeign exchange movement have be impact company result quite few quarters furthermore conm operate highly competitive environment be likely impede top line growth however increase sale orthopaedic surgery general surgery be encourage also company global growth buoy optimism zack rank key picksconm currently have zack rank hold few better rank medical stock be mesa laboratory inc mlab free report insys therapeutic inc insy free report align technology inc algn free report notably insys therapeutic sport zack rank strong buy mesa laboratory align technology carry zack rank buy see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock have gain last month mesa laboratory have positive earning surprise last quarters stock have add roughly last month align technology have expect long term adjust earning growth almost stock have add roughly last month more stock news tech opportunity worth driverless car artificial intelligence ve see unsurpassed growth high tech product recent month yesterday science fiction be become today reality innovation be single component tech company survive demand critical device reach year alone likely grow even faster future zack have release brand new special report help take advantage exciting investment opportunity most importantly reveal stock massive profit potential see stock now
836,ALGN,laboratory corporation america holding lh free report labcorp report second quarter adjust earning share ep year quarter quarter adjust ep also exceed zack consensus estimate report basis labcorp net earning come share decline year year net revenue second quarter increase year year quarterly revenue number also top zack consensus estimate strong growth labcorp diagnostic solid acquisition related growth well organic volume growth contribute year year top line improvement however be partially offset poor show covance drug development also adverse foreign exchange movement hampered quarterly top line number tune basis point bps year year comparison leap year timing easter holiday hinder report quarter growth organic revenue growth net revenue growth revenue acquisition exclude currency impact be laboratory corporation america holding price consensus ep surprise laboratory corporation america holding price consensus ep surprise laboratory corporation america holding quote quarter reviewcurrently labcorp report operate segment labcorp diagnostic covance drug development report quarter labcorp diagnostic report net revenue year year fuel price mix tuck acquisition organic volume measure requisition exclude requisition acquisition first month close acquisition company report increase total volume measure requisition increase revenue requisition quarter covance drug development report drop net revenue second quarter be due impact cancellation sponsor large clinical study late covance drug development used provide central laboratory service negative impact bps foreign currency translation constant exchange rate cer net revenue decline year year gross margin contract bps quarter adjust operate income increase year year adjust operate margin contract bps year quarter rise selling general administrative expense labcorp exit quarter cash cash equivalent compare end year date operate cash flow be year period free cash flow come year period quarter company return shareholder share repurchase currently have authorization remain exist share repurchase plan outlookdespite dull show covance drug development company increase earlier provide outlook net revenue growth be now expect remain band year year ahead earlier range include bps impact earlier projection be bps impact unfavorable foreign exchange headwind current zack consensus estimate revenue be peg adjust ep guidance have also be increase range previous range current zack consensus estimate fall guide range however free cash flow expectation remain unchanged band prior year takelabcorp post better expect quarter second quarter earning revenue top respective zack consensus estimate labcorp diagnostic business be strong covance drug development provide dull number company impact cancellation sponsor large clinical study late affected result apart unfavorable foreign exchange continue hamper company overall result however increase guidance boost investor confidence indicate chance respite anytime soon nonetheless believe integration newer acquisition labcorp be perfectly position drive long term profitable growth combination world class diagnostic drug development expertise knowledge service zack rank key pickslabcorp currently have zack rank sell few better rank medical stock mesa laboratory inc mlab free report insys therapeutic inc insy free report align technology inc algn free report notably insys therapeutic align technology sport zack rank strong buy mesa laboratory carry zack rank buy see complete list today zack rank stock here align technology have expect long term adjust earning growth almost stock have surge roughly last month insys therapeutic have long term expect earning growth rate stock have gain last month mesa laboratory deliver positive earning surprise last quarters stock have add nearly last month hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
837,ALGN,davita medical group subsidiary fortune company davita inc dva free report be consistently make effort expand inorganically line recently acquire dr rahn shaw practice park avenue medical inc winter park health center inc locate orlando notably dr shaw practice have be affiliated davita medical group offersquality care patient age pediatrics geriatric acquisition be complete jul practice remain brand davita medical group company expect acquisition help strengthen foothold orlando last month davita have be observed underperform zack categorize medical outpatient home healthcare industry latest share price movement company have gain compare gain broader industry however investor confidence get boost company consistent effort expand strategic merger acquisition bolster revenue time recent everett clinic medical group medical group davita medical group division have reveal plan buy base family practice clinic open new clinic bothell woodinville year also healthcare partner unit davita medical group magan medical clinic respect multispecialty medical group los angele county san gabriel valley recently announce enter definitive agreement magan join healthcare partner davita announce enter definitive agreement magan join healthcare partner division davita late healthcare partner nevada part davita medical group announce acquisition wellhealth quality care multus specialty medical group accountable care organization affiliated entity zack rank key picksdavita currently carry zack rank sell few better rank medical stock be mesa laboratory inc mlab free report edward lifescience corp ew free report align technology inc algn free report notably mesa laboratory edward lifescience sport zack rank strong buy align technology carry zack rank buy see complete list today zack rank stock here mesa laboratory have positive earning surprise last quarters stock have add roughly last month edward lifescience have long term expect earning growth rate stock have gain last month align technology have expect long term adjust earning growth almost stock have add roughly last month more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
838,ALGN,aug issue update research report align technology algn free report manufacture market system clear aligner therapy intra oral scanner cad cam computer aid design manufacturing digital service used dentistry orthodontic dental record storage stock currently have zack rank hold align technology have be trading industry last month stock have gain period compare decline industry company strong invisalign technology prospect growth north america international region look encourage emea second quarter volume surge year year reflect continue adoption invisalign technology core market spain well rapid growth expansion new market include eastern europe central europe benelux report quarter volume soar year year asia pacific belt lead china follow southeast asia japan australia new great news be company have recently open new invisalign technology treatment plan facility china multimillion dollar marketing campaign invisalign technology brand promotion be also likely keep investor upbeat company receipt patent smarttrack aligner material doubt buoy optimism contrary foreign exchange headwind continue major dampener company international performance also escalate cost expense be weigh margin last month comparative study align technology forward forward month basis multiple reflect stock have be quite overvalue key pickssome better rank medical stock be edward lifescience corp ew free report lantheus holding inc lnth free report stryker corporation syk free report edward lifescience sport zack rank strong buy lantheus holding stryker carry zack rank buy see complete list today zack rank stock here edward lifescience have long term expect earning growth rate stock have climb last month lantheus holding have long term expect earning growth rate stock have surge last month stryker corporation have long term expect earning growth rate stock have rally roughly last month zack minute stock pick secretsince zack system have more double average gain year compound rebalance exclusive fee turn thousand million dollar here something even more remarkable master proven system go single class seminar then apply portfolio little minute month learn secret
839,ALGN,aug issue update research report north kansa city mo base cerner corporation cern free report lead global provider healthcare information technology solution hcit stock currently carry zack rank hold believe cerner have solid growth opportunity revenue cycle management rcm suite solution fact segment have be strong contributor recent time revwork service deliver solid performance fact booking second quarter be time high year year basis secondary growth driver cerner be population health ph management platform notably company clinch high number large contract ph platform last report quarter cerner offer exposure worldwide healthcare automation international operation provide more diversify revenue stream past company have win contract well middle east furthermore cerner constantly pursue complementary business acquisition enable expand solution device offering service flipside company operate hcit space be intensely competitive fast evolve subject rapid technological change share price estimate revisioncerner have impressive run bourse last month trading industry term price performance glimpse price movement reveal cerner share have gain compare favorably rise industry belong flip side estimate revision trend current year remain unfavorable estimate move south last month compare only movement opposite direction company current estimate slip past month key picksa few better rank medical stock be idexx laboratory inc idxx free report lantheus holding inc lnth free report align technology inc algn free report align technology sport zack rank strong buy lantheus holding idexx laboratory carry zack rank buy see complete list today zack rank stock here idexx laboratory have long term expect earning growth rate stock have gain last month lantheus holding have long term expect earning growth rate stock have surge last month align technology have long term expect earning growth rate stock have rally roughly last month zack minute stock pick secretsince zack system have more double average gain year compound rebalance exclusive fee turn thousand million dollar here something even more remarkable master proven system go single class seminar then apply portfolio little minute month learn secret
840,ALGN,aug issue update research report irvine base quality system inc qsii free report lead developer marketer healthcare information system stock currently carry zack rank sell quality system have unimpressive run bourse last month trading industry term price performance glimpse price movement reveal quality system share have lose compare unfavorably industry decline quality system post stellar first quarter fiscal beating zack consensus estimate count however quarter witness lower professional service sale fall almost year year be primarily tough comparison year earlier quarter unimpressive performance new software platform recent quarters be particularly upbeat solid performance company total software hardware related segment however growth segment be partially offset lower software license hardware sale other concern sluggish global economy intensify competition strict regulatory environment be primary headwind recur revenue stream be positive quality system mostly come lower margin electronic datum interchange edi revenue cycle management rcm service quality system continue acquire business improve revenue opportunity aggravate integration risk company frequent acquisition impact balance sheet well overall organic growth limit quality system expansion plan worsen risk profile positive note quality system continue focus grow presence rcm population health solution market be expect drive dividend come quarters key picksa few better rank medical stock be idexx laboratory inc idxx free report lantheus holding inc lnth free report align technology inc algn free report align technology sport zack rank strong buy lantheus holding idexx laboratory carry zack rank buy see complete list today zack rank stock here idexx laboratory have long term expect earning growth rate stock have gain last month lantheus holding have long term expect earning growth rate stock have surge last month align technology have long term expect earning growth rate stock have rally roughly last month zack minute stock pick secretsince zack system have more double average gain year compound rebalance exclusive fee turn thousand million dollar here something even more remarkable master proven system go single class seminar then apply portfolio little minute month learn secret
841,ALGN,walgreen boot alliance inc wba free report continue dominate headline ride inorganic expansion spree follow last week news company plan invest chinese pharmacy chain guoda walgreen boot be once again grab attention piece information revolve partnership kkr co have complete acquisition pharmacy service provider pharmerica corp august walgreen boot privately hold global investment firm kkr have announce definitive merger agreement acquire pharmerica cash transaction value recent close buyout newly form company be predominantly controlled kkr walgreen boot only have minor stake boot expect investment help support quality affordable patient care better fashion pharmerica be entitle additional resource expertise advance grow institutional pharmacy service business back aquirer kkr walgreen boot strength notably walgreen boot have set major milestone global expansion month decision acquire stake sinopharm hold guoda drugstore co ltd guoda subsidiary china national accord medicine corporation ltd good news be investment provide strong incentive walgreen boot worldwide retail pharmacy business successful completion company be also currently focuse strategic collaboration order meet challenge pharmacy market fourth quarter fiscal company announce partnership agreement fareva dint latter buy former contract manufacturing business bcm notably bcm operate factory france germany management earlier note partnership have initiate end october crucial development aid company maximize scope scale retail pharmacy market share price past month walgreen boot have be trading broader industry stock have gain compare industry increase period zack rank key pick walgreen boot carry zack rank hold few better rank medical stock be petm express inc pet free report align technology inc algn free report luminex corporation lmnx notably petm align technology luminex sport zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year luminex have long term expect earning growth rate stock have gain past month wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
842,ALGN,share genomic health inc ghdx free report scale new week high dec close session nominally lower company have gain last month higher genomic health have also outperformed broader industry decline stock have market cap last report third quarter genomic health report adjust earning share ep cent compare favorably zack consensus estimate loss cent share company current year earning growth rate be favorable compare broader industry factor drive stockdeal boost prostate cancer test genomic health prostate cancer business have consistently improve last few quarters increase adoption test have further strengthen evidence support private reimbursement month company announce multus year research collaboration agreement janssen pharmaceutical partnership company evaluate responsiveness genomic health oncotype dx genomic prostate score gps test janssen prostate cancer drug pipeline november genomic health announce exclusive licensing agreement biotechnology company cleveland diagnostic inc agreement genomic health be authorize develop market early late stage new prostate cancer diagnostic test base cleveland diagnostic proprietary isopsa reagent sia technology expand coverage test genomic health have witness healthy progress respect expand coverage oncotype dx breast cancer test establish private coverage test germany well prostate cancer business oncotype dx genomic prostate score test receive positive local coverage determination expand medicare coverage palmetto gba solid international business genomic health revenue have be rise year year basis solid performance unite state internationally third quarter international test volume increase represent total test volume revenue grow year year fourth quarter genomic health expect double digit test growth international business zack rank key picksgenomic health carry zack rank hold few better rank medical stock be petm express inc pet free report align technology inc algn free report luminex corporation lmnx free report notably petm align technology luminex sport zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year luminex have long term expect earning growth rate stock have gain past month wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
843,ALGN,myriad genetic inc mygn free report recently present encourage datum embraca trial san antonio breast cancer symposium sabcs texas datum trial demonstrated bracanalysis cdx test ability effectively identify patient metastatic breast cancer mbc respond pfizer investigational parp inhibitor talazoparib embraca trial cover roughly patient be test positive germline brca mutation determine bracanalysis cdx test recent development bracanalysis company companion diagnostic program recently receive boost collaboration astrazeneca october company have announce fda acceptance supplementary premarket approval spma application bracanalysis cdx usage companion diagnostic astrazeneca parp inhibitor lynparza olaparib patient negative metastatic breast cancer company expect fda priority review process be complete third quarter fiscal management approval test be available metastatic breast cancer patient also companion diagnostic olaparib treatment metastatic breast cancer patient bracanalysis cdx have be submit japan review pharmaceutical medical device agency pmda marketing approval ministry health labor welfare company approval help cash market opportunity more patient year myriad genetic have also receive spma bracanalysis cdx march post approval bracanalysis cdx be be used complementary diagnostic test ovarian cancer patient associate improve progression free survival pfs used tesaro parp inhibitor zejula niraparib maintenance therapy market potentialmyriad genetic have be consistently make effort strengthen hold high potential breast cancer screening market report dpi research medium breast cancer screening market unite state be expect reach value roughly moreover article breastcancer org approximately new case invasive breast cancer woman be likely be diagnosed unite state article also mention expectation new case invasive breast cancer year share price genetic have be gain investor confidence consistently positive result past month company share price have outperformed broader industry stock have gain comparison broader industry rise zack rank key picksmyriad genetic have zack rank hold few better rank medical stock be petm express inc pet free report align technology inc algn free report luminex corporation lmnx free report notably petm align technology luminex sport zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year luminex have long term expect earning growth rate stock have gain past month wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
844,ALGN,medical group wmgi free report recently complete buyout imascap sas transaction be expect diversify company product portfolio boost growth global extremity business notably imascap sas develop software preoperative plan shoulder replacement surgery acquisition hold imascap outstanding equity approximately cash stock earnout imascap glenosys technology have be utilize medical blueprint plan software system enable surgeon simulate position shoulder prosthesis used ct image datum project image shoulder system provide best most suitable implant patient virtual surgical plan lead reduce time better result lesser inventory courtesy simple intuitive interface medical have reiterate previous full year annual net sale guidance range however due close time company expect small increase expense company have be consistent effort strengthen upper extremity business third quarter upper extremity business increase back ongoing launch perform reversed glenoid company be banking benefit blueprint plan software shoulder business upcoming year market prospectsaccord report persistence market research global shoulder replacement market be estimate reach end cagr company clearly have bountiful opportunity niche share price estimate revision trendover last year medical have underperform industry respect price performance company have lose industry decline almost company recent earning estimate revision have be encourage current quarter have see estimate go last day compare revision opposite direction consensus estimate current quarter earning rise cent cent same time frame zack rank other key pickswright medical carry zack rank hold few better rank medical stock be petm express inc pet free report align technology inc algn free report luminex corporation lmnx free report notably petm align technology sport zack rank strong buy luminex carry zack rank buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year luminex have long term expect earning growth rate stock have gain past month investor alert breakthrough pendinga medical advance be now flashpoint theory realization billion dollar research have pour company be already generate substantial revenue even more wondrous product be pipeline cure variety deadly disease be sight so be big potential profit early investor zack name stock buy now click here see
845,ALGN,illumina inc ilmn free report have be gain investor confidence consistently positive result past year company share price have outperformed broader industry stock have gain comparison broader industry gain also company have outperformed gain renown sequence array base genetic analysis solution provider have market cap company have earning growth rate next year solid prospect zack rank buy stock be attractive pick investor moment company estimate revision trend current year have be positive past day analyst revise estimate upward movement opposite direction resultantly earning estimate rise let find recent positive trend be sustainable illumina have be deliver solid quarterly result late post promising third quarter expect illumina maintain growth momentum continue uptake sequence consumable instrument microarray offering be upbeat illumina latest product launch last report quarter growth be fuel strong adoption veriseq nipt ce ivd marked ngs solution europe moreover novaseq platform continue drive growth close novaseq system be deliver launch january also order be ship third quarter november illumina introduce second fda regulate ce ivd marked next generation sequence ngs system nextseq dx company also announce intend use miseqdx instrument first fda regulate ngs sequencer have be extend include use dna library generate formalin fix paraffin embed ffpe tissue also october illumina announce availability novaseq flow cell reagent kit novaseq system moreover same month illumina announce availability nextera dna flex whole genome sequence wg library prep product management development boost demand novaseq platform illumina now have solid diagnostic ngs portfolio courtesy nextseq dx miseqdx product company be capable meeting clinical requirement ngs base diagnostic ivd product be also upbeat positive nipt reimbursement trend globally well unite state netherlands denmark have start cover veriseq nipt ce ivd test first quarter follow england france company continue see positive reimbursement trend europe well illumina effort drive growth internationally also buoy optimism apart north america company market distribute product directly customer europe latin america asia pacific region apac direct selling force distributor specialize life science product be also optimistic illumina expansion strategy enhancement portfolio sequence product development strategic partnership therapeutic diagnostic service provider august illumina partner telegraph hill partner set independent company verogen inc newly establish entity be expect strengthen illumina ngs business forensic genomic market other key picksother top rank medical stock be petm express inc pet free report align technology inc algn free report luminex corporation lmnx free report notably petm align technology sport zack rank strong buy luminex carry zack rank see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year luminex have long term expect earning growth rate stock have gain past month investor alert breakthrough pendinga medical advance be now flashpoint theory realization billion dollar research have pour company be already generate substantial revenue even more wondrous product be pipeline cure variety deadly disease be sight so be big potential profit early investor zack name stock buy now click here see
846,ALGN,dow have come long way trump ascension post president blue chip index be linger time trump election nov however index have surge point notch record high then year benchmark have gain nearly blue chip index run have be power strong economic growth more quarters row last report stupendous corporate earning moreover optimism trump tax reform promise have act necessary catalyst overall gain so far year suggest place bet stock have surpass dow performance year economy highest rate growthaccord latest report commerce department economy improve impressive annual rate come consensus estimate second quarter figure also marked first time economy have expand annual pace consecutive quarters growth rate confirm economy resilience devastate event recent hurricane strength largely come vigorous business spending equipment rebound corporate profit solid government spending october consumer confidence increase upwardly revise level exceed estimate mark be highest level read record november consumer confidence also improve last month initial read be time highest level year fifth straight month gain present situation index advanced expectation index increase large part optimism be attribute consumer view job market section consumer expect job opening increase next few month increase november read more phenomenal corporate earning have be outstanding much be attribute president trump promise introduce tax cut such claim be support fact particularly find be year year increase business investment second quarter follow growth third company have be optimistic likelihood slash corporate taxe optimism come fact tax holiday allow large cap corporation hoard trillion dollar hold cash reserve overseas bring back profit time tax prospect tax reform fuel market gainsthough senate pass republican tax bill narrow margin victory take trump closer ever deliver promise be cornerstone campaign new tax code bill permanently slash corporate tax rate further tax repatriation provision allow big company global operation bring back trillion dollar hold cash reserve overseas finally bill repeal individual mandate obamacare bid provide citizen unite state freedom choose variety health plan relieve penalty not have health insurance cut domestic tax rate mean bank big financial institution be weigh hefty tax load benefit greatly moreover trump time tax repatriation policy be likely improve overall financial health tech drug biotech company tech heavyweight such apple aapl free report alphabet googl free report microsoft msft free report cisco system inc csco free report oracle orcl free report hold money overseas avoid pay corporate tax rate earning thus be position gain immensely trump tax reduction plan expect momentum continue total earning be expect be same period last year higher revenue follow earning growth higher revenue earning growth be expect be positive zack sector earning growth double digit sector energy technology construction industrial product basic material auto read more buy stock outperformed dow have scale record high year banking steadily strengthen economy upbeat corporate earning trump business friendly policy also give boost index have select such stock have even fared better blue chip index such stock be also poise even gain further term stock have favorable zack rank indicate have witness positive estimate revision generally translate rapid price appreciation flaunt zack rank strong buy buy additionally stock have market capitalization more textainer group holding limit tgh free report own lease fleet intermodal container company operate broad segment container ownership container management container resale textainer group holding sport zack rank company have expect earning growth current year zack consensus estimate current year have improve last day company have return year date outperform dow industry belong have gain same period look best stock be first see top stock portfolio here green dot corporation gdot free report be provider personal banking service company also provide reloadable prepay debit card cash reload process service green dot have zack rank company have expect earning growth current year zack consensus estimate current year have improve last day company have return year date better dow industry belong have gain same period american equity investment life hold company ael free report be developer seller fix index fix rate annuity product company have expect earning growth current year zack consensus estimate have improve last day company have return year date outdo dow industry belong have gain same period american equity investment life hold have zack rank see complete list today zack rank stock here extreme network inc extr free report be provider software drive networking solution company also manufacture wire wireless network infrastructure equipment extreme network have zack rank company have expect earning growth current year zack consensus estimate current year have improve last day extreme network have return year date outperform dow industry belong have gain same period align technology inc algn free report be manufacturer system clear aligner therapy intra oral scanner company also provide computer aid design computer aid manufacturing cad cam digital service align technology have zack rank company have expect earning growth current year zack consensus estimate current year have improve last day align technology have return year date outperform dow industry belong have gain same period investor alert breakthrough pendinga medical advance be now flashpoint theory realization billion dollar research have pour company be already generate substantial revenue even more wondrous product be pipeline cure variety deadly disease be sight so be big potential profit early investor zack name stock buy now click here see
847,ALGN,myriad genetic inc mygn free report have be consistently try expand high potential molecular diagnostic market be expect reach value cagr report progress molecular diagnostic so farof late myriad genetic performance molecular diagnostic business have be encourage company have be gain back solid contribution genesight endopredict test management particularly expect double digit volume growth fiscal genesight vectra da prolaris endopredict test make major part molecular diagnostic portfolio genesightper company genesight test represent significant opportunity genesight be place highly penetrate preventive care market product have huge growth potential management expect consistent growth genesight test revenue quarters ahead myriad genetic endopredict present global market opportunity more annually major demand country canada unite state last few month company have be make encourage progress endopredict test march myriad genetic launch endopredict test unite state patient early stage breast cancer august company receive positive coverage decision test palmetto gba medicare administrative contractor mac anthem inc largest private insurer unite state notably full implementation decision lend myriad genetic coverage approximately breast cancer patient company recently announce positive result clinical study evaluate endopredict highlight superiority first generation oncotype dx breast recurrence score predict breast cancer recurrence woman determine be intermediate clinical risk nottingham prognostic index notably myriad genetic have be ride high strength hereditary cancer testing space last report quarter company witness year year growth hereditary cancer testing volume third consecutive quarter pricing meeting expectation myrisk hereditary company believe global market myrisk hereditary cancer other type hereditary cancer test be worth roughly annually december myriad genetic present favorable riskscore test datum san antonio breast cancer symposium sabcs texas september company introduce riskscore myrisk hereditary cancer testing portfolio also present encourage riskscore test datum also announce favorable study result myrisk hereditary cancer suite bracanalysis company companion diagnostic program recently receive boost collaboration astrazeneca october company announce fda acceptance supplementary premarket approval spma application bracanalysis cdx usage companion diagnostic astrazeneca parp inhibitor lynparza olaparib patient negative metastatic breast cancer company expect fda priority review process be complete third quarter fiscal management approval test be available metastatic breast cancer patient also myriad genetic submit bracanalysis cdx japan review pharmaceutical medical device agency pmda marketing approval ministry health labor welfare companion diagnostic olaparib treat metastatic breast cancer patient company approval help cash market opportunity more patient year seem be upbeat prospect prolaris test represent global market opportunity approximately annually myriad genetic announce receipt positive final local coverage determination lcd expand medicare coverage prolaris test palmetto gba medicare administrative contractor mac same month company announce plan present datum demonstrate utility prolaris test efficiently predict year risk metastase man treat prostate cancer american urological association aua annual meeting positive flow news be expect boost top line be report quarter price genetic have be gain investor confidence consistently positive result past month company share price have outperformed broader industry stock have gain compare broader industry rise zack rank other key picksmyriad genetic sport zack rank strong buy other top rank medical stock be petm express inc pet free report align technology inc algn free report luminex corporation lmnx free report notably petm align technology sport zack rank luminex carry zack rank buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year luminex have long term expect earning growth rate stock have gain past month zack editor chief go stockfull disclosure kevin matra now have more own money particular stock other believe short term profit potential also prospect more double today reveal explain surprising move new special report download free
848,ALGN,dec issue update research report cvs health cvs free report company carry zack rank hold lead provider integrate service entire spectrum pharmacy care have be outperform broader industryover past month stock have lose compare industry decline be upbeat company strong pharmacy service business have be gain strength specialty pharmacy management state company specialty business be top priority customer accordingly cvs health be poise capitalize opportunity back wide differentiate offering include specialty connect management expect drug price inflation product launch higher utilization new pbm client fuel growth expect pharmacy service segment be stable growth platform be also impressed cvs health robust pbm pharmacy benefit management selling season solid progress last report quarter gross new business totale net new business reach figure take account loss fep federal employee program specialty contract exclude impact individual medicare part program company have already complete client renewal be encourage company latest announcement buy outstanding share diversify health care benefit company aetna aet free report cash stock deal worth approximately share almost consider rough estimate aetna debt total transaction value be project company expect takeover close second half subject approval company shareholder regulatory body well fulfillment certain other customary close condition deal successful completion cvs health expect term synergy low mid single digit accretion second year post transaction closure additionally company have strong cash balance allow carry share repurchase flip side highly competitive retail pharmacy business be concern precisely company face stiff competition pharmacy segment be availability low cost pharmacy option other retail business continue add pharmacy department discount retailer particular have make substantial inroad gain market share moreover cvs health have deliver sluggish number retail long term care business recent past company decision restrict participate tricare network many fully insure prime network be due negative impact pharmacy sale script comp key picksa few better rank medical stock be petm express inc pet free report align technology inc algn free report notably petm align technology sport zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year zack editor chief go stockfull disclosure kevin matra now have more own money particular stock other believe short term profit potential also prospect more double today reveal explain surprising move new special report download free
849,ALGN,nuvasive inc nuva free report recently enter definitive agreement acquire intraoperative monitoring ionm service provider privately hold safepassage nuvasive acquisition strengthen company intraoperative neuromonitoring business line financial term deal have not be disclose yet transaction be expect close january fulfillment certain customary close condition notably new york city provide ionm eeg service surgeon healthcare facility eastern unite state nuvasive strongly believe integration safepassage be highly strategic help fortify nuvasive clinical service ncs position largest provider outsourced ionm service more oversight physician unite state consolidated giant be expect deliver service more customer surgeon currently safepassage battery clinical specialist support staff handle approximately case annually notably nuvasive clinical service ncs be nation lead provider intraoperative neuromonitoring service surgeon healthcare facility combination impulse monitoring biotronic neuronetwork july intraoperative neuromonitoring business line be form buyout biotronic ever segment company have be grow strong follow acquisition safepassage ncs be likely aid more ionm case annum unite state apart company raise optimistism fact safepassage be complementary current ncs geographical footprint limit overlap exist healthcare account further accelerate growth service business point view deeper reach key strategic market also advantage add significant new coverage particularly populous new york region east coast nuvasive already have strong spine procedural selling presence financial prospectspost closure deal transaction be expect be accretive company adjust earning share ep be also expect support nuvasive long term target revenue growth expansion adjust operate ebitda margin additionally deal completion be expect meet company goal return invest capital tuck acquisition year recent past clinical service business have witness downtrend due decline procedural volume expect integration safepassage nuvasive ncs business add capability company rebound difficulty share price last month nuvasive have be trading broader industry company have decline broader industry gain zack rank key picksnuvasive carry zack rank sell few better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report sporting zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have soar roughly year align technologyha long term expect earning growth rate stock have sky-rocket year myriad geneticsha long term expect earning growth rate stock have surge year time zack editor chief go stock full disclosure kevin matra now have more own money particular stock other believe short term profit potential also prospect more double today reveal explain surprising move new special report download free
850,ALGN,cooper company inc coo free report have rally last year higher broader industry gain stock have market cap company year historical growth rate be compare index broader industry solid growth prospect zack rank buy stock be attractive pick present company have stellar quarter average earning surprise also long term expect earning growth hold promise let find recent positive trend be sustainable company estimate revision trend current year have be positive past day analyst moved north movement opposite direction magnitude estimate revision increase share market be upbeat company just report solid fourth quarter fiscal performance also full year basis earning revenue improve substantially year year rise earning revenue fourth quarter be also encourage furthermore expansion gross operate margin buoy optimism coopervision segment have always be record impressive result coopersurgical segment also deliver strong sale fourth quarter buoy robust toric performance company provide strong guidance fiscal moreover bid drive inorganic growth cooper company recently announce coopervision have complete buyout paragon vision science add lead ortho technology company lens portfolio transaction be close accord company buyout be likely prove neutral earning share fiscal exclude time charge deal related amortization read more cooper company coopervision buy paragon other key picksother top rank medical stock be athenahealth inc athn free report align technology inc algn free report myriad genetic inc mygn free report notably athenahealth align technology myriad genetic sport zack rank strong buy see complete list today zack rank stock here athenahealth have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year myriad genetic have long term expect earning growth rate stock have gain year time make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
851,ALGN,genomic health inc ghdx free report recently announce outcome trial underscore efficiency oncotype dx breast recurrence score test oncotype dx dcis score test breast cancer notably ductal carcinoma also know dcis be most common type invasive breast cancerper report breastcancer org oncotype dx test analyze gene estimate response cancer patient post treatment fact report suggest result oncotype dx test help patient decide not have chemotherapy treat early stage breast cancer radiation therapy treat dcis genomic health flagship product oncotype dx breast recurrence score test help predict probability chemotherapy benefit oncotype dx breast dcis score test predict possibility recurrence pre invasive form breast cancer dcis outcome show oncotype dx breast recurrence score test predict clinical response neoadjuvant hormonal therapy improve surgical result result also show many node positive breast cancer patient avoid chemotherapy base recurrence score test result also company announce new american joint committee cancer ajcc prognostic stage group add oncotype dx breast recurrence score hormonal status pr status nodal status tumor size tumor grade stage breast cancer effective january development oncotype dx breast recurrence score testgenomic health biocartis group nv sign agreement develop diagnostic ivd version oncotype dx breast recurrence score test biocartis proprietary idylla platform september same month genomic health announce new datum show additional evidence unmatched value oncotype dx breast recurrence scoretest predict outcome early stage breast cancer patient accurately focus international market boost growthhave establish strong foothold market genomic health be now make considerable headway international arena company oncotype dx breast cancer test be available country courtesy various collaboration market trend buoy optimismaccord report gbi research global breast cancer therapeutic market be estimate reach worth cagr consider solid prospect market believe latest agreement be strategic fit stock performance solidin past month genomic health have be trading broader industry stock have gain comparison broader industry gain zack rank key picksgenomic health carry zack rank hold few better rank medical stock be athenahealth inc athn free report align technology inc algn free report myriad genetic inc mygn free report notably athenahealth align technology myriad genetic sport zack rank strong buy see complete list today zack rank stock here athenahealth have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year myriad genetic have long term expect earning growth rate stock have gain year time more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
852,ALGN,boston scientific corporation bsx free report have be dominate headline late courtesy fda approval vercise deep brain stimulation dbs system device be used treat symptom parkinson disease pd first commercial implant vercise system be do university minnesota medical center minneapoli mn study support approval come back encourage datum intrepid study first multus center prospective double blind randomize sham controlled study dbs pd unite state study confirm effectiveness safety system moreover system record positive safety datum european multus center prospective single arm vantage study development dbs portfolioboston scientific witness improvement neuromodulation business last report quarter several product launch include vercise gevia mri dbs europe cartesia lead june provide first directional rechargeable magnetic resonance mr conditional system company also introduce neural navigator programming software allow physician visualize stimulation field configure dbs program patient boston scientific be also currently support research use dbs stroke recovery treat alzheimer disease market potentialper transparency market research report global dbs market be project reach value cagr prospect market be primarily base increase number person suffering neurological disease age group company more person unite state globally be suffering pd thus latest fda approval help boston scientific cash bountiful opportunity dbs market share price movementover past month boston scientific have be underperform broader industry stock have decline contrast broader industry gain latest fda approval be expect help stock bounce back zack rank key picksboston scientific currently carry zack rank hold few better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report notably petm align technology myriad genetic sport zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year myriad genetic have long term expect earning growth rate stock have gain year time more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
853,ALGN,nephew plc snn free report recently close acquisition rotation medical inc be significant achievement company emerge space tissue regeneration development global orthopedic giant remain line focuse investment new technology meet urgent clinical need notably october nephew have enter definitive agreement rotation medical buyout incidentally acquire company be developer novel tissue regeneration technology shoulder rotator cuff repair deal be value initial cash consideration next year base acquirer financial performance nephew snat inc price nephew snat inc price nephew snat inc nephew consider rotation medical investment highly strategic advance company position disruptive technology accelerate transformation higher growth be also encourage know rotation medical rotator cuff system be highly complementary sport medicine portfolio rotator cuff system help balancing biomechanic biology enhance body natural heal response already have high customer adoption rate millennium research group datum publish sport medicine device more rotator cuff procedure take place year unite state annual growth rate research report bcc research global tissue engineering regeneration market be expect reach cagr improvement not only signify huge growth potential space also indicate strategic rotation medical takeover be nephew business company expect buyout be earning neutral well earning accretive apart drive strong top line growth past month share nephew have outperformed broader industry stock have gain compare broader industry increase period zack rank key nephew carry zack rank sell few better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report sporting zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technologyha long term expect earning growth rate stock have gain year myriad geneticsha long term expect earning growth rate stock have soar year time more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
854,ALGN,dec issue update research report hill hrc free report stock carry zack rank hold batesville base company have be trading broader industry past month stock have so far gain comparison industry hill have be see increase revenue strong international growth company be currently focuse gain traction untapped international market successful execution strategy efficient international team organizational realignment hill merger acquisition activity be go strong company actively pursue acquisition accelerate growth key clinical area viz advance patient mobility wound care prevention surgical safety efficiency clinical solution respiratory help apart welch allyn trumpf several recent noteworthy acquisition include virtus aspen surgical mortara instrument be also upbeat lead global medical device company focus expansion product development be reflect rise research development spending regard company have be regularly launch product recent fda clearance multus functional operate room table specifically design imris surgical theatre deserve mention notably product integrate hill trusystem surgical table platform imris mr neuro tabletop imris surgical theatre november hill outlined impressive long term growth strategy key initiative company also state financial goal fiscal buoy optimism flip side hill operate highly competitive space dominate large well small regional manufacturer also unfavorable currency movement continue be threat large part company revenue be generate international operation key picksa few better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report notably petm align technology myriad genetic sport zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year myriad genetic have long term expect earning growth rate stock have gain year time more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
855,ALGN,dec issue update research report lead medical device company inogen inc ingn free report stock carry zack rank hold inogen price movement past month have be favourable company represent return almost better industry rally current level be also higher return same time frame inogen expand product portfolio be key catalyst company provide oxygen concentrator solution portable stationary use inogen flagship product be single solution portable oxygen concentrator poc further inogen poc provide mobility independence oxygen therapy user platform be lightest continuous flow oxygen concentrator market consume less power competitive device solid business business sale performance be reason stock solid performance notably inogen have market cap company direct customer business model have lend lead position oxygen therapy market direct consumer model provide company opportunity build unique brand relationship directly customer effort drive growth direct consumer business company announce have secure additional facility cleveland inogen inc price inogen inc price inogen inc quote flip side foreign exchange headwind be concern inogen generate significant portion revenue international market management expect international revenue be lumpy thank timing size distributor adverse foreign currency exchange rate be likely impede revenue growth term due strengthen dollar euro other foreign currency long term oxygen therapy ltot market poc adoption continue witness significant challenge be primarily due lack awareness consumer benefit poc device higher upfront cost compare traditional delivery model reluctance home equipment medical provider support poc adoption believe lack awareness ensure higher cost related sale marketing mar profit believe headwind related poc adoption be major concern hurt inogen prospect long haul key picksa few better rank medical stock be athenahealth inc athn free report align technology inc algn free report myriad genetic inc mygn free report notably athenahealth align technology myriad genetic sport zack rank strong buy see complete list today zack rank stock here athenahealth have long term expect earning growth rate align technology have long term expect earning growth rate myriad genetic have long term expect earning growth rate more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
856,ALGN,profitable company be able meet operate cost offer stupendous return investor company strong profitability weak fundamental fail impress investor several study have highlighted profitable entity commonly provide huge return here have used concept accounting ratio evaluate company profitability be variety profitability ratio have choose most common successful profitability metric determine bottom line performance company net income rationet income ratio give exact profitability level company reflect percentage net income total sale revenue used net income ratio determine company effectiveness pay operate operate expense revenue higher net income ratio usually imply company ability generate ample revenue successfully manage business function screening parametersnet income ratio be not only indicator future winner so have add few more criterium arrive winning strategy zack rank equal only zack rank strong buy stock be allow zack rank prove be best rating system be great way start thing see complete list today zack rank stock here month trail sale net income growth higher industry stock possess higher sale net income growth last month showcase better financial performance month trail net income ratio higher industry high net income ratio indicate company solid profitability rating strong buy greater indicate analyst cover stock be optimistic few parameter narrow universe stock only here be stock qualify screen pra health science inc prah free report be contract research organization have average quarter positive earning surprise align technology inc algn free report be designer manufacturer marketer system clear aligner therapy have average quarter positive earning surprise adobe system incorporate adbe free report be global diversify software company have average quarter positive earning surprise par pacific holding inc parr free report own manage maintain interest energy infrastructure business have average quarter positive earning surprise more get rest stock list signing now week free trial research wizard start used screen own trading further also create own strategy test first take investment plunge research wizard be great place begin easy use everything be plain language very intuitive start research wizard trial today next time read economic report open research wizard plug find see gem come click here sign free trial research wizard today disclosure officer director employee zack investment research own have sell short security hold long short position option be mentioned material affiliated investment advisory firm own have sell short security hold long short position option be mentioned material disclosure performance information zack portfolio strategy be available https www zack com performance zack restaurant recommendation addition dine special place feast stock share zack special report spotlight recent ipos watch stock offer immediate promise boom sector download free
857,ALGN,align technology inc algn free report report earning share ep third quarter substantially year year earning be also higher company guide range cent figure comfortably beat zack consensus estimate cent revenuesrevenue grow year year quarter surpass zack consensus estimate also remain well ahead company guide range management strong top line be drive robust invisalign case shipment year year third quarter upside be backed growth north america international region also year year surge teenage case board reflect very strong summer season contribute top line growth segment detailrevenue clear aligner segment total revenue soar year year report quarter primarily drive continue strong invisalign case volume growth customer channel geographical region third quarter invisalign case shipment amount year year aid growth region well expansion customer base quarter align technology invisalign case be ship doctor worldwide be north america be international region revenue scanner service improve significantly marginsgross margin third quarter be basis point bps year year rise cost net revenue quarter align technology witness year year increase selling general administrative expense rise research development expense operate margin however expand bps financial detailsalign technology exit third quarter cash cash equivalent short term marketable security marked rise precede quarter report quarter align technology close earlier announce accelerate stock repurchase program asr receive total share weight average share price management currently have available repurchase exist stock repurchase authorization fourth quarter company project ep cent revenue company also expect invisalign case shipment band same period year takealign technology end third quarter solid note earning revenue beating zack consensus estimate be upbeat continue strong invisalign volume extremely strong summer season drive company invisalign growth global market scanner service company witness nice uptake itero scanner gp dentist record contract come gp summit last september company expect bullish trend continue rest align be also look forward recently inked distribution agreement patterson dental align itero element intraoral scanning system additionally company have strong cash balance enable carry share repurchase program turn provide solid return investor flip side company be expose foreign exchange fluctuation seasonal demand fluctuation higher operate expense pertain increase head count higher investment target growth acceleration geographical expansion portfolio extension zack rank key pickscurrently align technology carry zack rank hold better rank stock broader medical sector be petm express inc pet free report abbott free report intuitive surgical inc isrg free report notably petm sport zack rank strong buy abbott intuitive surgical carry zack rank buy see complete list today zack rank stock here petm report ep cent second quarter fiscal year quarter cent also gross margin expand bps year year report quarter abbott report third quarter adjust earning continue operation cent share year year also third quarter worldwide sale come year year intuitive surgical post adjust earning share third quarter year year basis also revenue rally year year wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
858,ALGN,latest earning preview depict bullish run ongoing report cycle oct member total market cap report number total earning member have go higher revenue however investor be concern medical sector zack sector see lot struggle first month year thank political change ongoing policy restructure related battle ensue lack visibility have roil favorable trend sector maintain trail few quarters third quarter expect earning growth rate stand mere revenue growth projection comparison second quarter earning growth be quite impressive revenue growth store medical product space twist turn continue unfold capitol hill scenario medical product space important part medical device subcategory broader medical sector be get gloomier latest executive order release republican point shrink customer base indicate cut demand expensive medical procedure device lead major supply demand disequilibrium space however major medical device player have be pin hope abolition infamous medical device sale tax elimination be far reality consider tax issue investor interested medical product space eagerly await earning report medtech bigwig week let take look major medical product stock slate release quarterly report oct quantitative model stock solid zack rank strong buy buy hold be combine positive earning esp then chance beating estimate be always high uncover best stock buy sell re report earning esp filter boston scientific corporation bsx free report be upbeat medical device stalwart gradually improve performance interventional cardiology ic lead innovative portfolio robust commercial team globally company gain fair share few cardiovascular segment de drug eluting stent continue build momentum worldwide however ahead earning release quarter ic business be likely be grossly impact company product recall issue europe downbeat ic business tangled product recall issue possibly gain boost company recent acquisition switzerland base symetis sa full recovery take time zack consensus estimate third quarter ic revenue be currently peg lower sequentially last quarter report number boston scientific corporation price ep surprise boston scientific corporation price ep surprise boston scientific corporation quote notably company earning have outpaced zack consensus estimate average trail quarters further zack consensus estimate third quarter earning cent share have remain unchanged last month however have show rally year report figure zack consensus estimate company revenue be peg yet be report quarter improvement year report number boston scientific have earning esp also carry zack rank recall issue hurt boston scientific earning resm inc rmd free report renown worldwide provider generator mask related accessory treatment sleep disordered breathe sdb be expect gain first quarter fiscal strong performance domestic international front company revenue domestic domain be drive solid growth device well low double digit software sale growth previous quarter internationally company receipt french reimbursement approval telemonitoring buoy optimism zack consensus estimate domestic revenue include contribution reflect increase year quarter also zack consensus estimate international revenue indicate rise year quarter overall fiscal first quarter total revenue be project prior year quarter resm inc price ep surprise resm inc price ep surprise resm inc quote notably company earning have outpaced zack consensus estimate average trail quarters resm carry zack rank sell have earning esp see complete list today zack rank stock here read more resm maintain balanced growth earning align technology inc algn free report be upbeat align technology strategic initiative international expansion ensure invisalign treatment grow base patient also last quarter huge increase international case year year encourage investor figure reflect rise demand quarter be report company reach new benchmark patient have adopt invisalign treatment management also anticipate consistent growth asia pacific region bid flourish region company open new invisalign treatment plan facility china align technology inc price ep surprise align technology inc price ep surprise align technology inc quote notably company earning have outpaced zack consensus estimate average trail quarters align have earning esp carry zack rank stock have see zack consensus estimate third quarter earning cent share be revise penny upward last day have also show improvement significant year tally zack consensus estimate company revenue be peg soon be report quarter compare year report figure reflect gain read more invisalign drive align technology earning cerner corporation cern free report cerner be expect show steady growth system sale major revenue component primarily drive third quarter earning expect improvement revenue other segment also help company generate solid result season zack consensus estimate system sale stand third quarter reflect rally almost year quarter growth acute ambulatory ehr sale population health revenue cycle solution service hold promise cerner cerner corporation price ep surprise cerner corporation price ep surprise cerner corporation quote last quarter management cerner announce company expect growth support maintenance service segment remain year fact zack consensus estimate segment revenue stand year year basis sequentially notably company earning have outpaced zack consensus estimate average trail quarters zack consensus estimate third quarter earning cent share have remain unchanged last month however have improve year figure zack consensus estimate company revenue be peg yet be report quarter improvement year number cerner have earning esp also carry zack rank read more higher system sale drive cerner earning stryker corporation syk free report august stryker announce voluntary recall oral care line offer company sage product unit add voluntary recall company have place temporary hold certain cloth base product mar third quarter result expect improvement revenue major revenue segment help company generate solid result season stryker corporation price ep surprise stryker corporation price ep surprise stryker corporation quote stryker deliver positive earning surprise past quarters average beat be zack consensus estimate third quarter revenue stand year year basis also zack consensus estimate earning stand share year year stryker have earning esp carry zack rank well read more sage unit recall hurt stryker earning mckesson corporation mck free report mckesson major player pharmaceutical medical supply distribution market expect gain gradually stabilize generic brand market company distribution solution segment perform favorably recent time weak pricing trend customer consolidation zack rank company earning have underperform zack consensus estimate average trail quarters mckesson have earning esp mckesson corporation price ep surprise mckesson corporation price ep surprise mckesson corporation quote stock have see zack consensus estimate third quarter earning share be revise cent downward last day have also show decline year report figure zack consensus estimate company revenue be peg yet be report quarter compare year figure read more mckesson report earning beat card zack hide tradeswhile share many recommendation idea public certain move be hide everyone select member portfolio service peek curtain today view start now next month invite follow zack private buy sell real time value momentum stock etf option mover insider trade company be report positive earning surprise ve call accuracy even look portfolio so exclusive be normally close new investor click here zack secret trade
859,ALGN,zimmer biomet holding inc zbh free report be expect beat earning report third quarter result nov open bell last quarter company earning miss zack consensus estimate however report average beat trail quarters let see thing be shape prior announcement key prior quarter company be expect gain strength surgical sport medicine foot ankle extremity trauma arm revenue be drive surgical business sport medicine offering such gel quattro link last report quarter moreover solid uptake plate system foot ankle portfolio boost segment performance zack consensus estimate revenue reflect increase year quarter zimmer biomet holding inc price ep surprise zimmer biomet holding inc price ep surprise zimmer biomet holding inc quote be also upbeat spine thoracic spine cmf segment be expect deliver quarter promising performance spine category zimmer biomet continue gain strong uptake mobi cervical disc moreover initial phase integration ldr holding acquisition be expect contribute approximately basis point company top line be report quarter also management be hopeful gain significant cross selling opportunity ldr acquisition provide back integrate spine sale force unite state also continue solid uptake sternalock blu sternalock primary closure system well ribfix blu thoracic fixation system thoracic arm buoy optimism zack consensus estimate spine cmf revenue indicate rise year quarter here be other factor influence zimmer biomet third quarter result look focuse execution zimmer biomet sale team expect global adoption rate company flagship personalize knee system persona be impressive regard september company announce launch persona partial knee system be latest addition portfolio personalize anatomically design knee implant system also june zimmer biomet announce release ray base patient specific instrument psi knee system be world first ce marked surgical plan system allow patient specific implant position solely utilize ray technology development be expect boost top line third quarter emerge market have always be significant revenue generate source zimmer biomet recent economic downturn affected zimmer biomet business latin america company manage drive growth operation other part emerge market especially asia pacific emea europe middle east africa zack consensus estimate third quarter revenue emea indicate improvement year quarter overall zimmer biomet expect third quarter revenue range reflect negative impact foreign exchange zack consensus estimate third quarter total revenue be peg however factor macroeconomic uncertainty unfavorable currency fluctuation have be adversely dent zimmer biomet sale past few quarters moreover company have also be deal pricing pressure issue regard zimmer biomet face negative pricing pressure approximately second quarter thus absence favorable change line company continue face headwind be report quarter well meanwhile second half management continue expect adverse impact reduce sale expectation continue spending critical program rise manufacturing cost warsaw north campus facility persist here be quantitative model predict zimmer biomet do not have right combination main ingredient positive earning esp zack rank hold higher need increase odd earning beat zack esp earning esp zimmer biomet be uncover best stock buy sell re report earning esp filter zack rank zimmer biomet carry zack rank increase predictive power esp however also need have positive esp be confident positive earning surprise zack consensus estimate earning reflect decline year year basis stock worth lookhere be few medical stock worth consider have right combination element post earning beat quarter cooper company inc coo free report have earning esp zack rank buy see complete list today zack rank strong buy stock here thermo fisher scientific inc tmo free report have earning esp zack rank align technology inc algn free report have earning esp zack rank today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return respectively outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
860,ALGN,henry schein inc hsic free report be expect report third quarter result nov last quarter company deliver positive earning surprise encouragingly henry schein earning surpass zack consensus estimate past quarters average let see thing be shape prior announcement likely positive surprise proven model show henry schein be likely beat earning have perfect combination key ingredient zack esp henry schein have earning esp most accurate estimate be cent zack consensus estimate be lower cent favorable zack esp serve meaningful lead indicator likely positive earning surprise uncover best stock buy sell re report earning esp filter zack rank henry schein currently carry zack rank hold note stock zack rank strong buy buy have significantly higher chance beating earning estimate conversely caution stock zack rank sell rate stock go earning announcement especially company be see negative estimate revision combination henry schein zack rank esp make reasonably confident earning beat henry schein inc price ep surprise henry schein inc price ep surprise henry schein inc quotefactor playhenry schein second quarter result be quite impressive record growth segment dental animal health medical technology value add service geographically company gain traction north america overseas expect similar trend third quarter well company strategy expand digital dentistry globally be also encourage be also upbeat management expectation witness least low single digit growth north america dental consumable merchandise market second half zack consensus estimate third quarter total revenue reflect increase year quarter company be currently banking digital dentistry be part strategic plan henry schein be busy promote digital workflow general dentistry well dental specialty begin sep company start selling full range dentsply sirona dental equipment north america include lead cerec cad cam restoration system be expect boost top line extent notably second quarter henry schein animal health open new national distribution service center ndsc columbus brookhollow neighborhood have help company operate complete solution provider veterinary practice country expect boost top line yet be report quarter flip side henry schein disappointing gross operate margin past few quarters due higher cost sale expense be matter concern apart currency fluctuation tough competitive landscape add wo also entry group purchasing organization gpos unite state have intensified competition overall henry schein expect ep range reflect growth ep figure stock worth lookhere be few medical stock worth consider have right combination element post earning beat quarter cooper company inc coo free report have earning esp zack rank see complete list today zack rank stock here thermo fisher scientific inc tmo free report have earning esp zack rank align technology inc algn free report have earning esp zack rank make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
861,ALGN,penumbra inc pen free report be expect report third quarter fiscal result nov company deliver positive earning surprise trail quarters let see thing be shape announcement catalystsover past few quarters penumbra showcased strong top line performance consistent growth neuro peripheral vascular arm company be presently focuse drive innovation product development geographic expansion be expect help penumbra maintain bullish growth trend be report quarter be be note neuro growth be mainly drive sale penumbra system ischemic stroke company witness increase sequential growth higher procedural volume however company expect see seasonality neuro business third quarter also peripheral vascular growth be drive indigo family peripheral thrombectomy coil portfolio peripheral embolization zack consensus estimate neuro revenue reflect increase year quarter zack consensus estimate peripheral vascular revenue show rise year earlier quarter penumbra inc price ep surprise penumbra inc price ep surprise penumbra inc quote overall fiscal third quarter total revenue be project prior year quarter here be other factor influence penumbra third quarter result penumbra have be deliver strong performance domestic international market back solid contribution neuro business expect trend continue yet be report quarter second quarter gross margin deteriorate operate expense increase accord company increase compensation expense related growth headcount higher clinical trial expense result operate loss quarter expect escalate cost expense continue keep margin pressure third quarter meanwhile research development expense increase second quarter company remain focuse product launch expect expense remain high third quarter further foreign exchange fluctuation stiff competition major commercial laboratory hospital continue raise caution overall company expect revenue decline sequentially third quarter owing seasonality summer company expect report revenue band here be quantitative model predict penumbra have right combination main ingredient positive earning esp favorable zack rank strong buy buy hold increase odd earning beat see complete list today zack rank stock here zack esp earning esp penumbra be uncover best stock buy sell re report earning esp filter zack rank penumbra zack rank increase predictive power esp however zack consensus estimate loss cent be wider loss cent report year quarter stock worth lookhere be few medical stock worth consider have right combination element post earning beat quarter cooper company inc coo free report have earning esp zack rank buy see complete list today zack rank strong buy stock here thermo fisher scientific inc tmo free report have earning esp zack rank align technology inc algn free report have earning esp zack rank make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
862,ALGN,expect idexx laboratory inc idxx free report beat expectation report third quarter result oct open bell last quarter company deliver positive earning surprise be worth note idexx have outperformed zack consensus estimate precede quarters average let take look thing be shape prior announcement key catalystsimilar prior quarter idexx be expect gain strong global growth companion animal group cag diagnostic recur revenue growth cag diagnostic be lead double digit organic revenue gain consumable reference lab rapid assay revenue well continue expansion idexx premium instrument install base be upbeat year year rise uptake snap pro unit north america last quarter management expect solid performance continue be report quarter well zack consensus estimate cag diagnostic revenue reflect increase year quarter here be other factor influence idexx third quarter result idexx laboratory inc price ep surprise idexx laboratory inc price ep surprise idexx laboratory inc quoteidexx expect livestock poultry dairy lpd business witness flat modest growth second half segment have be see continue strength china also expansion recur pregnancy testing franchise buoy optimism zack consensus estimate lpd business third quarter reflect increase year quarter company continue expand globally have be significantly benefitting bountiful opportunity companion animal market emerge nation further management consistent share buyback reflect strong free cash flow reserve believe outcome endeavor be reflect company third quarter performance encourage factor idexx expect revenue range reflect organic revenue growth expectation zack consensus estimate third quarter total revenue be project prior year also estimate ep guidance band share support continue operate margin expansion align long term goal outlook represent ep growth report basis zack consensus estimate earning reflect increase year quarter moreover management be upbeat rise sale force market other area third quarter flip side foreign currency fluctuation be major headwind concern company be high reliance third party distributor purchasing dynamic distributor have significant impact company sale instrument consumable rapid assay product also company be expose higher operate expense pertain increase head count higher investment target portfolio development geographic expansion unite state internationally also competitive landscape domestic overseas market weigh idexx performance struggle gain market traction prove be drag third quarter result here be quantitative model predict idexx do not have right combination main ingredient positive earning esp zack rank hold higher need increase odd earning beat zack esp earning esp idexx be uncover best stock buy sell re report earning esp filter zack rank idexx carry zack rank increase predictive power esp however also need have positive esp be confident positive earning surprise zack consensus estimate earning cent reflect improvement year year basis stock worth lookhere be few medical stock worth consider have right combination element post earning beat quarter cooper company inc coo free report have earning esp zack rank buy see complete list today zack rank strong buy stock here thermo fisher scientific inc tmo free report have earning esp zack rank align technology inc algn free report have earning esp zack rank make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
863,ALGN,index hasn logged fall least nov article publish marketwatch marked longest winning streak north korea induced geopolitical tension hurricane political entanglement europe fed rate hike uncertainty trump tax plan come way index read etf strategy benefit north korea tension rather hope deregulation tax cut well improve global economy keep push market higher bar occasional blip index be nov highlight few etfs stock gain record run trump bump improve economy proshare ultra etf sso free report be most popular liquid etfs leverage space aum more fund seek deliver twice return index charge investor expense ratio fund have gain nov read hit mark trade etfs direxion daily bull share etf offer exposure index charge just bps annual fee have accumulate asset base have add nov direxion daily bull share spuu free report product also provide time exposure index charge lower fee bps have aum fund have add nov proshare ultrapro etf upro free report investor have more bullish view higher risk appetite find upro interesting fund provide time exposure index etf charge slightly higher fee bps year have amassed asset base so far be nov stock picksalign technology inc algn free report align technology manufacture market invisalign system proprietary method treat malocclusion vgm value growth momentum score stock be time writing stock be nov nrg energy inc nrg free report company own operate portfolio power generate facility primarily unite state vgm score stock be time writing stock be nov vertex pharmaceutical incorporate vrtx free report company market small molecule drug address major unmet medical need stock have vgm sore be nov micron technology inc mu free report company business segment include computer networking business unit cnbu mobile business unit mbu storage business unit sbu embed business unit ebu vgm score stock be now nov want key etf info deliver straight inbox zack free fund newsletter brief top news analysis well top perform etfs week get free
864,ALGN,expect align technology inc algn free report beat expectation report third quarter earning oct market close last quarter company post positive earning surprise align technology have outperformed zack consensus estimate precede quarters average positive earning surprise let take look thing be shape prior announcement likely positive surprise proven model show align technology be likely beat earning have perfect combination key ingredient zack esp align technology have earning esp most accurate estimate be cent zack consensus estimate be peg cent favorable zack esp serve meaningful lead indicator likely positive earning surprise uncover best stock buy sell re report earning esp filter zack rank align technology currently carry zack rank hold note stock zack rank strong buy buy have significantly higher chance beating earning estimate conversely caution stock zack rank sell rate stock go earning announcement especially company be see negative estimate revision combination align technology zack rank esp make reasonably confident earning beat align technology inc price ep surprise align technology inc price ep surprise align technology inc quotewhat drive better expect earning be upbeat align technology strategic initiative international expansion ensure invisalign treatment grow base patient also be upbeat international case grow year year last report quarter reflect grow demand quarter company reach new benchmark patient have adopt invisalign treatment management anticipate consistent growth asia pacific region bid grow region company open new invisalign treatment plan facility china be upbeat management expectation continue strong performance international market be report quarter invisalign volume be likely grow sequentially reflect continue strong growth apac however summer holiday emea partially mar performance notably expand invisalign brand align technology introduce patient friendly solution invisalign mandibular advancement teen certain market canada emea apac march accord company advancement help offer more option treatment boost top line yet be report quarter company announce receipt patent align technology smarttrack aligner material be exclusively used invisalign aligner treatment recently company expand work flow option lead itero scanner context align technology recently sign distribution agreement patterson dental business unit patterson company inc pdco free report exclusive agreement effective september align technology itero element intraoral scanning system be available part patterson dental cad cam portfolio unite state canada latest development boost itero scanner customer base start third quarter moreover company see increase adoption itero scanner invisalign case submission instead pvs impression especially north america thereby drive invisalign utilization management expect bullish trend continue yet be report quarter notably third quarter company project ep cent revenue company also expect invisalign case shipment band same period year flip side unfavorable foreign currency affect company revenue be report quarter also company be expose seasonal demand fluctuation higher operate expense pertain increase head count higher investment target growth acceleration geographical expansion portfolio expansion other stock considerhere be few other medical stock worth consider have right combination element post earning beat quarter cooper company inc coo free report have earning esp zack rank see complete list today zack rank stock here thermo fisher scientific inc tmo free report have earning esp zack rank wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
865,ALGN,varian medical system inc var free report be schedule report fourth quarter fiscal earning oct market close last quarter company deliver earning share beat zack consensus estimate cent however adjust earning decline year period factor playwe be upbeat varian medical oncology business account company total revenue fourth quarter notably company have be address tier mid tier market edge truebeam vitalbeam product have also be winning international contract oncology space fourth quarter varian expect adjust earning share range revenue be expect increase year year basis company recently launch fda approve product halcyon strengthen foothold oncology business varian medical also sign agreement vijametech upmc establish radiation oncology center vietnam be also upbeat varian prospect internationally primarily bank proton therapy advanced treatment option cancer patient regard note varian medical recently receive shonin approval japan market probeam system proton therapy varian medical recently enter international agreement concern proton therapy platform bangkok base king chulalongkorn memorial hospital have select probeam compact single room proton therapy system cancer treatment thailand delray medical center florida believe western europe china africa present significant top line growth opportunity term company be open office africa middle east depict be aware opportunity region moreover varian medical strong product pipeline be key catalyst nevertheless increase local competition be primary headwind unfavorable foreign currency affect company revenue be report quarter also company be expose seasonal demand fluctuation higher operate expense pertain increase investment target growth acceleration geographical expansion portfolio expansion earning whispersour proven model do not conclusively show earning beat varian medical quarter be stock need have positive earning esp zack rank strong buy buy hold happen be not case here see zack esp varian medical currently have earning esp be most accurate estimate zack consensus estimate be peg uncover best stock buy sell re report earning esp filter zack rank varian medical carry zack rank increase predictive power esp however company esp make surprise prediction difficult please note caution stock zack rank sell rate go earning announcement especially company be see negative estimate revision varian medical system inc price ep surprise varian medical system inc price ep surprise varian medical system inc quotestock considerhere be company consider model show have right combination element post earning beat upcoming quarter abbott free report have earning esp carry zack rank see complete list today zack rank stock here align technology inc algn free report have earning esp carry zack rank henry schein inc hsic free report have earning esp carry zack rank wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
866,ALGN,baxter international inc bax free report be schedule report third quarter earning oct open bell last report quarter company deliver positive earning surprise take quarter average let see thing be shape prior release factor playwe be encourage company guidance third quarter full year third quarter baxter anticipate sale growth constant currency adjust earning share be forecast range cent versus year figure cent also full year company project earning band share continue operation special item full year earning late baxter international have accelerate pace acquisition strategic collaboration enhance product portfolio thereby open significant long term opportunity also several recent fda approval be likely drive growth yet be report third quarter company estimate revision trend be also encourage current year baxter international witness upward estimate revision movement opposite direction last month however lower sale threat company integrate pharmacy solution franchise third quarter decline sale be expect impact top line low single digit also foray group purchasing organization gpos unite state intensify competition company earning whispersour quantitative model doesn point earning beat quarter be stock need have positive earning esp zack rank strong buy buy hold happen be not case here see zack esp earning esp baxter international be be most accurate estimate zack consensus estimate be peg cent uncover best stock buy sell re report earning esp filter zack rank baxter international carry zack rank increase predictive power esp however company esp make surprise prediction difficult caution stock zack rank sell rate go earning announcement especially company be see negative estimate revision baxter international inc price ep surprise baxter international inc price ep surprise baxter international inc quotestock considerhere be company consider model show have right combination element post earning beat upcoming quarter abbott free report have earning esp carry zack rank see complete list today zack rank stock here align technology inc algn free report have earning esp carry zack rank henry schein inc hsic free report have earning esp carry zack rank wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
867,ALGN,walgreen boot alliance inc wba free report be slate release fourth quarter full year fiscal result market open oct last quarter company have post positive earning surprise be worth note walgreen have outperformed zack consensus estimate precede quarters average positive earning surprise let take look thing be shape prior announcement factor playwalgreen boot retail pharmacy usa division continue witness comparable prescription growth well strength retail prescription market last report quarter notably fiscal second quarter retail pharmacy usa division see highest comparable prescription growth more year several plan development early benefit new pharmacy contract volume increase previously announce strategic pharmacy partnership have be drive growth space past few quarters expect growth momentum continue fiscal fourth quarter well walgreen boot alliance inc price ep surprise walgreen boot alliance inc price ep surprise walgreen boot alliance inc quotebased promising performance precede quarter walgreen boot raise low end guidance fiscal cent currently expect full year adjust earning range also zack consensus estimate fiscal fourth quarter earning reflect improvement year year basis moreover zack consensus estimate fiscal fourth quarter revenue reflect improvement year year basis however sale performance retail pharmacy international division continue disappoint reduction government pharmacy funding have be affect performance absence term catalyst expect scenario persist upcoming quarter well also note slowdown generic introduction have be affect walgreen boot margin late increase reimbursement pressure well generic drug cost inflation have be dent margin third quarter walgreen boot gross margin contract account reimbursement pressure price inflation brand drug management continue witness lower profitability boot uk comparable pharmacy gross profit due lower margin product company be work boost efficiency provide high quality cost effective pharmacy service term outlook remain bleak meanwhile market growth be expect be strong certain emerge market backed timing price increase also order expand footprint asia company launch first boot franchise store south korea april development be expect boost top line fiscal fourth quarter september walgreen boot announce receipt federal trade commission ftc approval purchase store distribution center related inventory rite aid total value post new transaction initial close synergy be expect be entirely realize year initial completion walgreen boot modify merger contract extend growth strategy offer additional operational benefit help company expand optimize retail pharmacy network key market include northeast here be quantitative model predict walgreen bootsdoe not have right combination main ingredient positive earning esp zack rank hold higher need increase odd earning beat zack esp earning esp forwalgreen boot be uncover best stock buy sell re report earning esp filter zack rank walgreen boot carry zack rank sell meanwhile caution stock zack rank sell rate go earning announcement especially company be see negative estimate revision stock worth lookhere be few medical stock worth consider have right combination element post earning beat quarter cooper company inc coo free report have earning esp zack rank buy see complete list today zack rank strong buy stock here align technology inc algn free report have earning esp zack rank henry schein inc hsic free report have earning esp zack rank today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return respectively outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
868,ALGN,illumina inc ilmn free report be slate report third quarter fiscal result market close oct last quarter company deliver positive earning surprise average earning beat trail quarters let see thing be shape announcement key prior quarter illumina be expect gain strong performance product revenue well service other revenue segment last few quarters company product revenue increase primarily onrising sequence consumable revenue total service other revenue be demonstrate strong growth lead continue demand nextseq nipt customer partner expect factor drive yet be report quarter performance well zack consensus estimate product revenue reflect increase year quarter also zack consensus estimate service other revenue indicate rise year quarter overall third quarter total revenue be project prior year quarter illumina inc price ep surprise illumina inc price ep surprise illumina inc quote here be other factor influence illumina third quarter result illumina earlier announce fda approve next generation sequence ngs extend ra panel have meet current colorectal cancer guideline new kit fulfill most date guidance ra testing determine eligibility epidermal growth factor receptor egfr inhibitor metastatic colorectal cancer management expect shipment kit start third quarter hence expect drive top line second quarter illumina witness growth asia pacific region propel rise china emerge market china currently offer most favorable space illumina business growth recent time management have noticed considerable rise demand customer look set nipt operation china china currently be fourth largest develop nation term nominal gdp believe progress country open channel illumina thereby drive top line yet be report quarter also encourage solid second quarter performance illumina have raise full year revenue growth expectation earlier provide range flip side tough competitive landscape challenge company be also apprehensive issue pertain nih funding illumina have be face quite time now here be quantitative model predict illumina do not have right combination main ingredient positive earning esp zack rank hold better increase odd earning beat zack esp earning esp illumina be uncover best stock buy sell re report earning esp filter zack rank illumina carry zack rank increase predictive power esp however also need have positive esp be confident positive earning surprise nonetheless zack consensus estimate earning cent reflect improvement year year basis stock worth lookhere be few medical stock worth consider have right combination element post earning beat quarter abbott free report have earning esp zack rank buy see complete list today zack rank strong buy stock here align technology inc algn free report have earning esp zack rank henry schein inc hsic free report have earning esp zack rank hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
869,ALGN,follow today close bell see fresh quarterly earning result host new company ve see thus far earning season result be generally better expect instance much more so instance zack rank strong buy rate shutterfly sfly free report be hour trading follow big earning beat report afternoon share allow time tax charge revenue easily zip past share respectively be straight earning beat photo service company positive surprise quarter be improve trail quarter average surprise align technology algn free report be also big initial post quarterly result show cent beat share sale be well expect revenue actual also represent year year gain operate income quarter invisalign case shipment sequentially year year advanced micro device amd free report also beat top bottom line afternoon post cent share revenue outpaced cent expect silicon valley semiconductor firm take time tax credit quarter guidance be big revenue compare analyst have be look more amd earning click here don even think buy bitcoin read most popular cryptocurrency sky-rocket last year give investor chance bank return even more gain however come serious volatility risk bitcoin sank more time zack have just release new special report help reader capitalize explosive profit potential bitcoin other cryptocurrency significantly less volatility buy directly see crypto related stock now
870,ALGN,fourth quarter earning season have commence positive note most sector decent picture participant have report jan total earning company be year year higher revenue beating earning estimate surpass top line expectation notably company be report earning week latest earning preview overall earning fourth quarter be expect increase growth revenue indicate improve growth projection previous quarter drive corporate tax overhaul relatively healthy job datum factor have boost corporate earning stoke investment base pattern fourth quarter be expect register modest double digit percentage earning growth year year basis medtech earning so farmedical zack sector be expect stand quarter sector benefit favorable consumer behavior grow prevalence minimally invasive surgery demand liquid biopsy test use ensure quick improve patient care shift payment system value base model be evident result medtech heavyweight abbott free report intuitive surgical isrg free report company exit fourth quarter solid note beating zack consensus estimate count upbeat fy guidance also instill confidence fourth quarter earning growth rate medical sector be peg revenue growth upcoming releaseslet take look major other medtech stock slate release quarterly report jan stryker corporation syk free report result be schedule release market close notably zack consensus estimate fourth quarter revenue be peg year year zack consensus estimate fourth quarter earning be year year basis stryker recently announce better expect preliminary net sale result fourth quarter full year net sale be estimate year quarter constant currency basis figure beat zack consensus estimate buoy prospect quantitative model indicate earning beat stryker quarter be stock need have positive earning esp zack rank strong buy buy hold be able beat estimate stryker earning esp be uncover best stock buy sell re report earning esp filter stryker carry zack rank read more core segmental growth aid stryker earning stryker corporation price consensus stryker corporation price consensus stryker corporation quotezimmer biomet holding inc zbh free report be set report result market open notably zack consensus estimate fourth quarter revenue be peg year year zack consensus estimate fourth quarter earning be project year year basis solid prospect company surgical sport medicine foot ankle extremity trauma arm macroeconomic uncertainty unfavorable currency fluctuation have be dent sale past few quarters company have be deal pricing pressure regard zimmer biomet witness negative pricing pressure approximately last quarter absence favorable change line headwind reflect company fourth quarter result read more arm drive zimmer biomet earning result proven model do not conclusively show earning beat zimmer biomet quarter zimmer biomet have earning esp stock carry zack rank sell see complete list today zack rank strong buy stock here zimmer biomet holding inc price consensus zimmer biomet holding inc price consensus zimmer biomet holding inc quotealign technology inc algn free report be set report result market close notably zack consensus estimate fourth quarter revenue be peg year year zack consensus estimate fourth quarter earning be cent year year basis align technology achieve milestone patient undergo treatment flagship clear aligner system invisalign november company have be adopt several strategy drive adoption core invisalign product line company receive patent align technology smarttrack aligner material be exclusively used invisalign aligner treatment moreover bid gain traction invisalign platform align technology collaborate digital design recent past read more invisalign drive align technology earning positive development proven model do not conclusively show align technology be likely beat earning quarter align technology have earning esp stock carry zack rank align technology inc price consensus align technology inc price consensus align technology inc quotezack top stock addition stock discuss know finest buy hold ticker entirety last year zack top stock portfolio produce double digit winner include fmc corp vmware rac stellar gain now brand new portfolio have be handpick company cover zack rank don miss chance get long term buy access zack top stock today
871,ALGN,dec issue update research report mountain view base omnicell inc omcl free report stock have zack rank strong sell last month omnicell share have be slightly broader industry stock have gain versus broader industry gain omnicell inc price omnicell inc price omnicell inc quoteomnicell exit third quarter mixed note earning beating zack consensus estimate revenue miss same also weak gross margin scenario be matter concern believe company strategy include portfolio expansion acquisition penetration medication adherence market continue drive expense meanwhile cost related recently launch xt series have be exert pressure bottom line omnicell lower upper end adjust revenue guidance be reflective fact overall slump stay tough competitive landscape also act dampener positive note year year increase earning revenue be impressive company witness balanced growth business line quarter be also encourage company effort product innovation research development omnicell have late be observed gain consistently series product launch latest be xt series automate supply dispense system strategic partnership stock considersome better rank medical stock be petm express inc pet free report myriad genetic inc mygn free report align technology inc algn free report sporting zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year myriad genetic have long term expect earning growth rate stock have gain year align technologyha long term expect earning growth rate stock have gain year today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return respectively outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
872,ALGN,myriad genetic inc mygn free report present encourage datum study second generation prognostic gene expression test breast cancer endopredict result be present san antonio breast cancer symposium sabcs texas company datum study demonstrated test ability predict residual cancer burden neoadjuvant chemotherapy neuroendocrine therapy hr breast cancer patient abcsg result also confirm endopredict ability effectively predict distant recurrence patient invasive lobular carcinoma ilc compare invasive ductal carcinoma idc believe finding drive uptake endopredict development endopredict testsmyriad genetic have be gain strong molecular diagnostic performance lead solid contribution genesight endopredict test be also upbeat management expectation double digit volume growth fiscal genesight vectra da prolaris endopredict test make major part molecular diagnostic portfolio march company have be receive encourage response launch endopredict test unite state early stage breast cancer august myriad genetic receive positive coverage decision test palmetto gba medicare administrative contractor mac anthem inc largest private insurer unite state notably full implementation decision lend myriad genetic coverage approximately breast cancer patient company recently announce positive result clinical study evaluate endopredict highlight superiority first generation oncotype dx breast recurrence score predict breast cancer recurrence patient determine be intermediate clinical risk nottingham prognostic index market potentialper report dpi research medium breast cancer screening market unite state be expect reach value roughly moreover article breastcancer org approximately new case invasive breast cancer woman be likely be diagnosed unite state also project new case invasive breast cancer year well believe agee population rise awareness expenditure healthcare continue drive growth breast cancer screening market however market be dominate number well establish player quest diagnostic dgx free report be most prominent space quest diagnostic quest vantage service help discovery genetic variant related hereditary risk type cancer include breast colorectal pancreatic renal share price genetic have be gain investor confidence consistently positive result past year company share price have outperformed broader industry stock have gain comparison broader industry rise zack rank key picksmyriad genetic sport zack rank strong buy other top rank medical stock be petm express inc pet free report align technology inc algn free report notably petm align technology sport zack rank see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have add year today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return respectively outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
873,ALGN,nxstage medical inc nxtm free report announce nx connect health remote patient management system reduce home hemodialysis technique failure conversion center hemodialysis notably nx connect health be telehealth platform collection delivery home hemodialysis treatment patient medical information outcome nx user contemporary match control be compare management technique failure be reduce patient begin used nx month initiate home hemodialysis compare match control moreover patient start used nx home hemodialysis training be more likely complete process nx ipad app be important component nx platform app have be design make home therapy more user friendly capture datum wirelessly send respective center treatment timely receipt electronic flowsheet app enable early intervention lower possibility complication even hospitalization also nx have be integrate center emr system provide treatment bill information physician development dialysis company be consistently try expand dialysis platform nxstage announce fda approval system platform solo home hemodialysis treatment august same month company announce subsidiary nxstage kidney care be partner dialyze direct support patient need site skilled nursing facility snf dialysis treatment ohio nxstage now leverage system platform dialyze direct unique model treat geriatric snf patient end stage renal disease esrd market trend buoy optimismdata market market reveal global hemodialysis peritoneal dialysis market be expect reach worth cagr view solid prospect nxstage effort boost dialysis unit raise optimism nxstage get acquiredin august german dialysis provider fresenius medical care sign agreement acquire outstanding share nxstage share transaction have be value be subject close approval nxstage stockholder other customary condition read more fresenius medical inks deal take nxstage medical share price move upover last month nxstage have add compare favorably furthermore current level be way higher broader industry gain just same time frame zack rank key picksnxstage carry zack rank sell few better rank medical stock be athenahealth inc athn free report align technology inc algn free report myriad genetic inc mygn free report notably athenahealth align technology myriad genetic sport zack rank strong buy see complete list today zack rank stock here athenahealth have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year myriad genetic have long term expect earning growth rate stock have add year time today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return respectively outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
874,ALGN,regardless be young company renown corporation unswerving earning growth be highest priority top brass organization not company doesn make money win last long haul consider company revenue give period time subtract cost production have earning metric be also consider be most noteworthy variable influence share price expectation earning also play significant role influence price stock earning estimate determine share priceswe have often see decline stock price earning growth rally price follow earning decline be largely result company earning fail meet market expectation earning estimate embody analyst opinion factor such sale growth product demand competitive industry environment profit margin cost control thus earning estimate serve valuable tool make investment decision earning estimate also help analyst assess cash flow determine fair value firm investor thus be lookout stock be ready make big move hence be important investor buy stock have historical earning growth be also see rise quarterly annual earning estimate screening parameter order shortlist stock have striking earning growth positive estimate revision have add follow parameter zack rank less equal only zack buy strong buy be allow zack rank prove be best rating system be great way start thing year historical ep growth greater industry stock strong ep growth history change ep greater equal company see year year earning growth more last report fiscal change estimate last week greater stock have see current quarter earning estimate revise higher last week change estimate last week greater stock have see annual earning estimate revise higher last week change estimate last week greater stock have see annual earning estimate revise higher last week criterium narrow universe stock only here be top stock ollie bargain outlet holding inc olli free report operate retailer brand name merchandise company carry zack rank buy estimate growth rate year be higher industry gain dollar tree inc dltr free report operate variety retail store unite state canada operate segment dollar tree family dollar company have zack rank company estimate growth rate year be higher industry gain align technology inc algn free report design manufacture market system clear aligner therapy intra oral scanner computer aid design computer aid manufacturing cad cam digital service align technology sport zack rank strong buy estimate growth rate year be higher industry gain see complete list today zack rank stock here broadcom limit avgo free report design develop supply range semiconductor device worldwide stock have zack rank company estimate growth rate year be higher industry gain get rest stock list signing now week free trial research wizard start used screen own trading further also create own strategy test first take investment plunge research wizard be great place begin easy use everything be plain language very intuitive start research wizard trial today next time read economic report open research wizard plug find see gem come click here sign free trial research wizard today disclosure officer director employee zack investment research own have sell short security hold long short position option be mentioned material affiliated investment advisory firm own have sell short security hold long short position option be mentioned material disclosure performance information zack portfolio strategy be available https www zack com performancezack restaurant recommendation addition dine special place feast stock share zack special report spotlight recent ipos watch stock offer immediate promise boom sector download free
875,ALGN,varian var free report recently announce receipt anvisa registration halcyonsystem brazil registration varian now be able market system country treatment used halcyon platform be cost effective short duration also enhance patient comfort system have be ergonomically design provide user friendly platform clinical staff patient company also state system help accelerate complex image guide imrt plan compare traditional device halcyon treat majority cancer patient offer advanced treatment prostate breast head neck many other form disease notably platform receive order last report fourth quarter order be emea north africa apac development oncologyvarian be consistently try boost oncology segment regard company have initiate first education workshop radiotherapy practitioner algerium further company recently announce first cancer patient be treat used hyperarc high definition radiotherapy hdrt new type radiosurgery treatment sacro cuore don calabrium cancer care center negrar verona italy notably revenue be cer segment fourth quarter late company have be focuse expansion brazil regard varian recently announce plan open new facility jundiai brazil reflect long term commitment partnership brazilian ministry health facility have be fully equip provide varian trilogy linear accelerator hand training physician growth halcyonrecently halcyon platform receive clearance ce mark european directive allow varian start selling system unite state europe also november company announce receipt shonin approval ministry health labor welfare mhlw market halcyon japan company strong overseas presence be expect enable cash opportunity emerge market market prospectsaccord report market market global radiotherapy market be project reach worth cagr look bountiful opportunity niche space believe company latest development be strategic fit stock performance solidover past month varian have outperformed broader industry term price company have return compare favorably sub industry gain just zack rank key picksvarian carry zack rank sell few better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report notably petm align technology andmyriad genetic sport zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year myriad genetic have long term expect earning growth rate stock have gain year time wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
876,ALGN,genomic health inc ghdx free report recently announce multus year research collaboration agreement janssen pharmaceutical partnership company evaluate responsiveness genomic health oncotype dx genomic prostate score gps test janssen prostate cancer drug pipeline agreement genomic health examine sample janssen study evaluate association gps result clinical outcome notably gps be first test predict current state risk prostate cancer genomic health prostate cancer business glancegenomic health prostate cancer business have be consistently accelerate last few quarters company have continue make progress deliver actionable result increase adoption test gather evidence support private reimbursement last report third quarter revenue business more double year year basis product revenue be drive rise prostate test revenue prostate volume increase hurricane impact management company continue be leader low risk intermediate risk prostate cancer market solid test volume last several quarters full year complete medicare coverage company expect prostate revenue continue grow development prostate cancergenomic health recently announce exclusive licensing agreement biotechnology company cleveland diagnostic inc agreement genomic health be authorize develop market early late stage new prostate cancer diagnostic test base cleveland diagnostic proprietary isopsa reagent sia technology october new study result be publish validate oncotype dx genomic prostate score test ability predict prostate cancer death development metastase year study oncotype dx gps test be now uniquely validate predict long term endpoint well risk adverse pathology august genomic health announce expand medicare coverage oncotype dx gps test post issuance positive final local coverage determination lcd palmetto gba medicare administrative contractor mac management successful implementation final lcd october total number medicare patient eligible gps test increase market prospectsper report grand view research global prostate cancer therapeutic market be expect see cagr consider huge potential market believe latest agreement be strategic fit genomic health gain more share space stock performance solidover past month genomic health have be trading broader industry stock have lose narrower broader industry decline zack rank key picksgenomic health carry zack rank hold few better rank medical stock be luminex corporation lmnx free report align technology inc algn free report myriad genetic inc mygn free report notably luminex align technology myriad genetic sport zack rank strong buy see complete list today zack rank stock here luminex have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year myriad genetic have long term expect earning growth rate stock have gain year time wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
877,ALGN,myriad genetic inc mygn free report present encourage datum study evaluate risk breast cancer woman european lineage negative myrisk hereditary cancer test result hereditary cancer mutation notably result be present san antonio breast cancer symposium sabcs san antonio tx company study cover woman woman breast cancer control be design evaluate new riskscore test ability accurately predict year lifetime risk breast cancer compare tyrer cuzick model alone result demonstrated riskscore statistically significant ability predict risk breast cancer woman have be test negative hereditary breast cancer mutation year more interestingly myriad genetic have introduce riskscore myrisk hereditary cancer testing portfolio solidify footprint rapidly grow hereditary cancer testing market base salt lake city ut lead molecular diagnostic personalize medicine provider proprietary riskscore be precision medical tool patient use myrisk get test do recent developmentsin september company introduce riskscore myrisk hereditary cancer testing portfolio also present encourage riskscore test datum also announce favorable study result myrisk hereditary cancer suite result be present annual conference national society genetic counselor nsgc columbus june company present favorable datum patient clinical study myrisk hereditary cancer test american society clinical oncology asco result highlighted importance multus gene panel testing advancement hereditary cancer risk evaluation platform myriad genetic have be ride high strength hereditary cancer testing space last report quarter company witness year year growth hereditary cancer testing volume third consecutive quarter pricing par expectation market potentialper report dpi research medium breast cancer screening market unite state be expect reach value roughly moreover article breastcancer org approximately new case invasive breast cancer woman be likely be diagnosed unite state also project new case invasive breast cancer year well believe agee population rise awareness expenditure healthcare continue drive growth breast cancer screening market however market be dominate many well establish player quest diagnostic dgx free report be most prominent space quest diagnostic quest vantage service help discovery genetic variant related hereditary risk type cancer include breast colorectal pancreatic renal share price genetic have be gain investor confidence consistently positive result past year company share price have outperformed broader industry stock have gain contrast broader industry decline zack rank key picksmyriad genetic sport zack rank strong buy other top rank medical stock be petm express inc pet free report align technology inc algn free report notably petm align technology sport zack rank see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
878,ALGN,hologic inc holx free report announce receipt clearance fda panther fusion adv hmpv rv assay be multiplex assay run new panther fusion system detect adenovirus human metapneumovirus rhinovirus company initial set modular assay respiratory viruse be complete fda nod latest panther fusion assay offer new age approach syndromic respiratory testing prolific ability run assay single patient specimen assay complement other fda approve assay namely panther fusion flu rsv panther fusion paraflu variety panther fusion module be lab upgrade original panther instrument apart panther platform exist benefit new system add flexibility pcr polymerase chain reaction proven performance transcription mediate amplification tma used panther system market prospectsper cision molecular diagnostic market be project reach worth cagr consider huge market potential believe company latest development be quite strategic hologic be consistently try expand diagnostic segment generate total revenue last report fiscal fourth quarter face year year decline segment molecular diagnostic revenue increase cer notably end hologic have ship panther diagnostic customer worldwide stock performance solidover past month hologic have outperformed broader industry stock have gain decline broader industry recent regulatory approval glancerecently company announce receipt fda clearance quantra breast density assessment software october hologic announce receipt clearance fda panther fusion paraflu assay also company announce fda approval panther fusion flu rsv assay run new panther fusion system company also receive fda approval commercial launch aptima herpes simplex virus hsv molecular assay fully automate panther system june also receive fda expand clearance sculpsure product june believe recent spree regulatory approval company array product boost share price further zack rank key pickshologic carry zack rank hold few better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report sporting zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have surge roughly year align technology have long term expect earning growth rate stock have gain year myriad genetic have long term expect earning growth rate stock have soar year zack hide tradeswhile share many recommendation idea public certain move be hide everyone select member portfolio service peek curtain today view start now next month invite follow zack private buy sell real time value momentum stock etf option mover insider trade company be report positive earning surprise ve call accuracy even look portfolio so exclusive be normally close new investor click here zack secret trade
879,ALGN,dec issue update research report cheme corporation che free report stock currently carry zack rank buy last month cheme have be trading broader industry stock have gain industry decline improvement average net medicare reimbursement rate increase average daily census recently report third quarter be encourage raise outlook roto rooter segment earning share be indicative company expectation improve operate result upcoming quarters turn boost investor optimism stock cheme vita business management note recent admission trend have be positive be expect continue third quarter vita perform well financially operationally back increase geographically weight average medicare reimbursement rate rise average daily census company continue display robust performance roto rooter business strength core plumbing drain clean service segment comapny have also witness solid growth water restoration additionally company strong cash balance enable carry share repurchase program provide solid return investor moreover expansion gross operate margin last report quarter buoy optimism however headwind expensive valuation reimbursement related issue seasonality business competitive landscape dependence government mandate challenge cheme moreover more vita revenue be payment medicare medicaid program raise concern also tweak guidance medicare cap bill limitation be dampening estimate revision company estimate revision trend current year be positive past day analyst revise estimate upward movement opposite direction magnitude estimate revision earning increase other key picksa few other top rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report notably petm align technology myriad genetic sport zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year myriad genetic have long term expect earning growth rate stock have gain year time zack hide tradeswhile share many recommendation idea public certain move be hide everyone select member portfolio service peek curtain today view start now next month invite follow zack private buy sell real time value momentum stock etf option mover insider trade company be report positive earning surprise ve call accuracy even look portfolio so exclusive be normally close new investor click here zack secret trade
880,ALGN,align technology inc algn free report be set report fourth quarter earning result jan market close last quarter company post positive earning surprise align technology have outperformed zack consensus estimate precede quarters average positive earning surprise be let take look thing be shape prior announcement factor lead manufacturer marketer system clear aligner therapy intra oral scanner cad cam computer aid design manufacturing digital service used dentistry orthodontic dental record storage have be witness strong revenue growth scanner service business past few quarters moreover company have be see increase adoption itero scanner invisalign case submission instead pvs impression especially north america thereby drive invisalign utilization management expect bullish trend reflect fourth quarter result well same time align technology have be focuse expand work flow option itero scanner context be upbeat company itero element intraoral scanning system available part patterson dental cad cam portfolio unite state canada moreover company launch software upgrade itero element intraoral scanner be capable compare patient scan time latest timelapse technology also boost confidence stock also company collaborate exocad gmbh last march integrate portfolio result high tech solution efficient scanning design manufacturing house dental prosthesis positive place align technology be expect witness solid top line contribution scanner service business fourth quarter result investor also be look forward company recent signing agreement glidewell dental distribute itero element intraoral scanning system latest glidewell io office solution north america management collaboration widen itero reach more dentist used glidewell service notably company aim launch first quarter align technology inc price ep surprise align technology inc price ep surprise align technology inc quotealign technology achieve milestone patient undergo treatment flagship clear aligner system invisalign november company have be adopt several strategy drive adoption core invisalign product line term product development company receive patent align technology smarttrack aligner material be exclusively used invisalign aligner treatment moreover bid gain traction invisalign platform align technology collaborate digital design last march meanwhile order expand invisalign brand offering align technology introduce patient friendly solution invisalign mandibular advancement teen certain market canada europe middle east africa emea asia pacific apac first half come geographic expansion company open first office canada major market term opportunity expansion growth management launch invisalign technology lite north america post introduction emea company witness strong adoption particularly gp dentist moreover align technology have be witness continue adoption invisalign technology core market emea apac region interestingly recently report third quarter company achieve milestone term invisalign therapy adoption china become second largest invisalign market unite state top number align technology register almost threefold year year increase asset customer base major contribution china also bid expand region company open invisalign treatment plan facility china last june zack consensus estimate total revenue fourth quarter indicate rise year quarter earning whisper proven model do not conclusively show align technology be likely beat earning quarter be stock need have positive earning esp zack rank strong buy buy hold happen be not case here see zack esp align technology have earning esp be most accurate estimate be peg cent zack consensus estimate stand cent zack rank align technology carry zack rank increase predictive power esp however esp make surprise prediction difficult meanwhile caution stock zack rank sell rate stock go earning announcement especially company be see negative estimate revision momentum nonetheless zack consensus estimate fourth quarter adjust earning cent reflect growth year quarter stock worth lookhere be few medical stock worth consider have right combination element post earning beat quarter bio rad laboratory bio free report have earning esp zack rank see complete list today zack rank stock here myriad genetic mygn free report have earning esp zack rank henry schein hsic free report have earning esp zack rank make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
881,ALGN,nov issue update research report warsaw base zimmer biomet holding inc zbh free report company carry zack rank sell last month lead musculoskeletal healthcare company be trading broader industry macroeconomic uncertainty pricing pressure unfavorable currency fluctuation stock have gain versus broader industry gain company third quarter result fall short zack consensus estimate own expectation management zimmer biomet be grapple headwind such supply delay certain product lead inability regain lose customer unite state tap new one softened domestic market condition impact consecutive hurricane significant price reduction indian knee market trim guidance add concern indicate little chance recovery ahead estimate revision trend also remain unfavorable estimate move south none opposite direction past month stock have see zack consensus estimate be revise cent downward period share positive note look forward expect synergy be draw recently complete ldr hold acquisition broaden complement company musculoskeletal offer be line strategy grow inorganic mean focuse mega buyout be also impressed strong strategic financial goal combine entity anticipate reach now deal have be close zimmer biomet have be late work strengthen foothold emerge market provide long term opportunity company strategic investment region several quarters view enhance operational sale performance be yielding result key picksa few better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report sporting zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technologyha long term expect earning growth rate stock have gain year myriad geneticsha long term expect earning growth rate stock have surge year today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return respectively outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
882,ALGN,align technology inc algn free report have be gain investor confidence consistent positive result past month company share price have outperformed broader industry stock have gain compare broader industry company have also outperformed gain market lead manufacturer marketer system clear aligner therapy intra oral scanner cad cam computer aid design manufacturing digital service used dentistry orthodontic dental record storage have market cap company year historical growth rate be also favorable compare industry solid prospect zack rank strong buy stock be attractive pick investor moment company estimate revision trend current year have be positive past day analyst revise estimate upward movement opposite direction resultantly earning estimate increase share zack style score system align technology have growth score reflect company solid prospect research show stock growth style score combine zack rank buy offer best upside potential regard align technology have favorable net margin net income sale compare industry company sale asset ratio compare industry show be favorable growth stock moreover project sale growth rate surpass industry let find recent positive trend be sustainable align technology post promising third quarter earning revenue beating estimate be encourage company focus expand work flow option itero scanner context company recently sign agreement glidewell dental distribute itero element intraoral scanning system latest glidewell io office solution north america management collaboration widen itero reach more dentist used glidewell service notably company aim launch first quarter addition company have sign distribution agreement patterson dental business unit patterson company inc pdco free report august exclusive agreement align technology itero element intraoral scanning system be available part patterson dental cad cam portfolio unite state canada moreover align technology have be see strong international sale especially emea apac region third quarter marked milestone company china become second largest market globally unite state top number recently company open first office canada support growth region accord company canada be second largest market base invisalign case volume also company witness balanced sale growth channel recent past primarily drive high invisalign technology case volume buoy optimism solid performance summer drive invisalign volume global market be also upbeat company solid invisalign technology prospect growth north america internationally align technology receipt patent smarttrack aligner material also buoy optimism flipside adverse foreign exchange translation continue raise concern align technology international operation also escalate cost expense be weigh margin moreover tough competitive landscape other macroeconomic headwind threat other key picksother top rank stock broader medical sector be petm express inc pet free report luminex corporation lmnx free report notably petm sport zack rank luminex corporation carry zack rank see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year luminexha long term expect earning growth rate stock have gain year today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return respectively outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
883,ALGN,corporation abc free report sign definitive agreement acquire cash be privately hold national wholesaler offer complete line healthcare product solution expect deal contribute nominally adjust diluted earning share ep fiscal achieve full run rate synergy fiscal deal be expect close early calendar year approval regulator acquisition post closure be expect expand improve pharmaceutical distribution segment last report fourth quarter revenue segment improve year year basis company sign new year agreement supply pharmaceutical express script hold company take buyout consideration company expect revenue growth fiscal range adjust operate income growth band have reiterate rest fiscal financial guidance market research firm evaluate pharma estimate pharma industry see cagr look bountiful opportunity niche space believe company latest development be strategic share have decline past month compare unfavorably thebroader industry fall only estimate revision estimate revision trend have be favorable company current year estimate moved north compare movement opposite direction last month result zack consensus estimate full year have rise share zack rank key carry zack rank hold few better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report notably petm align technology myriad genetic sport zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year myriad genetic have long term expect earning growth rate stock have gain year wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
884,ALGN,nov issue update research report henry schein inc hsic free report company carry zack rank sell henry schein exit third quarter mixed note earning miss revenue beating zack consensus estimate be disappoint company lower high end ep guidance meanwhile year year deterioration henry schein gross operate margin be lead higher cost sale expense tough competitive landscape pricing pressure also weigh stock share company have underperform broader industry past month stock have lose gain broader industry positive note expect trend improve balanced growth operate segment henry schein be also encourage company effort grow internationally apart north america europe have presence australia new well emerge market china brazil israel czech republic poland henry schein inc price henry schein inc price henry schein inc quotealso lead distributor health care product service globe continue ride high dental business majorly accretive strategic merger integration colossal merger field be poland base dental cremer also henry schein gain several trend end market customer demographic increase number life cover follow healthcare reform unite state be likely boost company additionally company gain traction animal health business back tailwind north america well overseas market burgeon demand animal health product unite state further drive company growth key stocksa few better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report sporting zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have surge roughly year align technologyha long term expect earning growth rate stock have sky-rocket year myriad genetic have long term expect earning growth rate stock have soar year wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
885,ALGN,medtronic plc mdt free report announce receipt fda approval commercial launch portfolio azure pacemaker bluesync technology accord company technology enable secure automatic wireless remote monitoring medtronic carelink network security control implement validate bluesync enabled device include access restriction protect integrity device functionality end end encryption protect patient datum azure xt mri azure mri pacemaker be available single chamber dual chamber model pacemaker offer improve longevity longer predecessor better ability detect reduce atrial fibrillation af af most common heart rhythm disorder be irregular rapid beating heart upper chamber pacemaker patient probably need lesser device replacement azure xt pacemaker feature medtronic reactive atp atrial base antitachycardia pace algorithm be prove slow progression af implanted cardiac device patient company be consistently try improve cardiac rhythm heart failure division part cardiac vascular group cvg line medtronic come favorable study result reactive atp atrial base antitachycardia pace therapy june reactive atp therapy slow progression af patient implanted cardiac device couple achievement month be worth mention medtronic receive fda approval portfolio quadripolar cardiac therapy pacemaker crt ps improve therapy delivery patient heart failure medtronic also announce favorable result clinical study show insertable cardiac monitor icm detected high incidence af patient previously undiagnosed suspect be high risk af stroke accord report ally market research global cardiac monitoring cardiac rhythm management market be expect reach worth cagr look bountiful opportunity niche space believe company latest development be strategic last month medtronic have underperform broader industry latest share price movement company have lose broader industry gain estimate revision estimate revision trend have be favorable company current year estimate moved north compare movement opposite direction last month result zack consensus estimate full year have rise share zack rank key picksmedtronic carry zack rank sell few better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report notably petm align technology myriad genetic sport zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year myriad genetic have long term expect earning growth rate stock have gain year zack hide tradeswhile share many recommendation idea public certain move be hide everyone select member portfolio service peek curtain today view start now next month invite follow zack private buy sell real time value momentum stock etf option mover insider trade company be report positive earning surprise ve call accuracy even look portfolio so exclusive be normally close new investor click here zack secret trade
886,ALGN,nov issue update research report dentsply sirona inc xray free report global leader design development manufacture marketing dental consumable dental laboratory product new york base company recently announce renewal exist distribution agreement henry schein canada inc continue dec henry schein agreement dentsply sirona be initiate august deal extension be smart move dentsply sirona preexist agreement do not include cerec cad cam restoration system schick line imaging sensor include aforementioned line product company benefit henry schein distribution network canada recent development company announce renewal partnership pacific dental service move strategic pacific dental network consist center state tenure present agreement management expect number such office utilize dentsply sirona technology exceed dentsply sirona dual brand strategy product innovation growth opportunity emerge market especially asia pacific middle east africa diversify product portfolio recur revenue base be key catalyst company expect solid guidance project adjust ep range flip side apart series macroeconomic headwind currency fluctuation continue be major dampener fact strengthen dollar euro other emerge market currency have dent company growth trajectory further higher capital expenditure product development be expect keep margin pressure dentsply sirona price movement have be favorable last month company share have gain compare industry rise zack rank key picksdentsply sirona currently carry zack rank hold few better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report notably petm align technology myriad genetic sport zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year myriad genetic have long term expect earning growth rate stock have gain year zack hide tradeswhile share many recommendation idea public certain move be hide everyone select member portfolio service peek curtain today view start now next month invite follow zack private buy sell real time value momentum stock etf option mover insider trade company be report positive earning surprise ve call accuracy even look portfolio so exclusive be normally close new investor click here zack secret trade
887,ALGN,nov issue update research report san francisco base mckesson corporation mck free report health care service information technology company past month mckesson have be trading industry stock have shed industry gain company continue witness strong growth pharma biotech backed solid market fundamental plan growth strategy mckesson deliver stable result recently report second quarter fiscal adjust earning revenue miss zack consensus estimate quarter witness strong performance distribution solution segment segment be expect remain consistent performance fiscal weak pricing trend customer consolidation boost growth company recently acquire covermymed approximately come guidance distribution solution business revenue be expect witness robust growth year year basis upside be expect be drive market growth acquisition mckesson expect gaap earning diluted share fiscal year end mar adjust earning same fiscal be project range flipside pricing pressure independent retail pharmacy channel be headwind mckesson enter fiscal assumption brand inflation mid single digit first quarter result slightly surpass expectation mckesson have be witness increase price competition independent retail pharmacy channel result reduce volume company continue witness competitive market selling generic pharmaceutical unite state however expect overcome independent pharmacy sell side pricing impact end second quarter fiscal cutthroat competition niche market currency headwind reimbursement issue remain challenge zack rank key picksmckesson carry zack rank sell few better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report petm align technology myriad genetic sport zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year myriad genetic have long term expect earning growth rate stock have gain year zack hide tradeswhile share many recommendation idea public certain move be hide everyone select member portfolio service peek curtain today view start now next month invite follow zack private buy sell real time value momentum stock etf option mover insider trade company be report positive earning surprise ve call accuracy even look portfolio so exclusive be normally close new investor click here zack secret trade
888,ALGN,share haemonetic corporation hae free report scale new week high nov close nominally lower company have gain last month much higher gain haemonetic have also beat broader industry gain stock have market cap further haemonetic estimate revision trend current year be favorable past day estimate moved movement opposite direction consequently estimate be share company also have trail quarter average positive earning surprise long term growth hold promise well haemonetic corporation price consensus haemonetic corporation price consensus haemonetic corporation quotegrowth market be upbeat haemonetic impressive second quarter performance year year growth earning revenue continue expansion newer geography have help company deliver strong result recent past meanwhile strong cash position boost investor confidence further raise fiscal adjust earning guidance be encourage company be now focuse development launch nexsys pcs plasmapheresis system management be optimistic strong market adoption nexsys pcs plasmapheresis system notably nexsys pcs plasmapheresis device recently receive fda approval company have also plan limit market release device winter also company plan second more advanced limit market release enhancement be introduce factor be expect boost company share price zack rank key pickshaemonetic carry zack rank hold few better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report notably petm align technology myriad genetic sport zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year myriad genetic have long term expect earning growth rate stock have gain year wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
889,ALGN,varian medical system var free report announce receipt shonin approval ministry health labor welfare mhlw market varian halcyon system new system design cancer treatment simplify improve almost aspect image guide volumetric intensity modulate radiotherapy imrt notably platform receive clearance ce mark european directive allow varian start selling system unite state europe company unveil halcyon radiotherapy treatment system astro conference vienna third quarter notably treatment used halcyon platform be cost effective short duration well enhance patient comfort system have be ergonomically design provide user friendly platform clinical staff patient company also state system help accelerate complex image guide imrt plan compare traditional device halcyon treat majority cancer patient offer advanced treatment prostate breast head neck many other form disease notably platform receive order last report fourth quarter order be emea order north africa apac varian medical be consistently try boost oncology segment regard company have initiate first education workshop radiotherapy practitioner algerium further company recently announce first cancer patient be treat used hyperarc high definition radiotherapy hdrt new type radiosurgery treatment sacro cuore don calabrium cancer care center negrar verona italy notably revenue be cer segment fourth quarter accord report market market global radiotherapy market be project reach worth cagr look bountiful opportunity niche space believe company latest development be strategic fit past month varian medical have outperformed broader industry term price performance company have return compare favorably sub industry gain just zack rank key picksvarian medical carry zack rank sell few better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report notably petm align technology myriad genetic sport zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year myriad genetic have long term expect earning growth rate stock have gain year wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
890,ALGN,investor always seek winning strategy however find such strategy be easier say do market be shake widespread global growth concern be difficult even insightful investor come foolproof approach matter discipline systematic investor be equity market volatility always manage get better few lucky one rake moolah other fall victim ad strategy resort commonly used technique find beaten stock have potential recover faster other however even such investment choice bear risk disappointment particularly be stick value trap hide weakness select stock be not identify so wouldn be safer look stock be winner currently have potential gain further here execute primarily look stock have recently be witness price increase actually stock see price strength recently have high chance carry momentum forward stock be continuously move higher be good reason rise else probably have fall loser so look stock have already win game be capable beating benchmark have set be rational however recent price strength alone create magic so need set other relevant parameter create successful investment strategy here create screen shortlist current well potential winner screening parameter percentage change price week greater criterion show stock have moved higher last week percentage change price week greater indicate stock have see momentum last month lower risk choose stock have draw attention due overwhelming performance overall market very short period zack rank matter market condition be good bad stock zack rank strong buy have proven history outperformance see complete list today zack rank stock here average broker rating indicate broker be also highly hopeful stock future performance current price greater stock be trading minimum current price week high low range more criterion filter stock be trading respective week high indicate be strong enough term price here be stock make screen daqo new energy corp dq free report be engage manufacture sale high quality polysilicon photovoltaic product manufacturer last quarter company deliver positive earning surprise align technology inc algn free report design manufacture market invisalign system proprietary method treat malocclusion last quarter company deliver positive earning surprise columbus mckinnon corporation cmco free report be broad line designer manufacturer supplier sophisticated material handle product integrate material handle solution be widely distribute industrial consumer market worldwide last quarter company deliver positive earning surprise smart global holding inc sgh free report be designer manufacturer supplier electronic subsystem oem last quarter company deliver positive earning surprise triton international limit trtn free report offer acquisition lease re lease sale intermodal container last quarter company deliver positive earning surprise get rest stock list start putt other idea test be do research wizard stock pick backtesting software research wizard be great place begin easy use everything be plain language very intuitive start research wizard trial today next time read economic report open research wizard plug find see gem come click here sign free trial research wizard today disclosure officer director employee zack investment research own have sell short security hold long short position option be mentioned material affiliated investment advisory firm own have sell short security hold long short position option be mentioned material disclosure performance information zack portfolio strategy be available https www zack com performance zack restaurant recommendation addition dine special place feast stock share zack special report spotlight recent ipos watch stock offer immediate promise boom sector download free
891,ALGN,nov issue update research report chesterbrook pa base corporation abc free report world largest pharmaceutical service company company focus provide drug distribution related service reduce health care cost improve patient outcome have unimpressive run bourse last month trading industry term price performance glimpse price movement reveal share have return only compare industry rally unfavorable performance be result pricing pressure generic drug space lackluster guidance full year expect fiscal adjust earning share fiscal band revenue growth be expect range expect adjust operate expense increase range adjust operate income growth be estimate band meanwhile operate income growth pharmaceutical distribution service segment be project range acquire pharmedium healthcare holding back believe temporary slowdown pharmedium growth mar bottom line upcoming quarters notably company aim boost investment enhance pharmedium quality assurance qa quality control qc system term product quality patient safety lend company competitive advantage long haul result bottom line headwind fiscal lackluster performance hepatitis revenue segment be concern recently witness negative revenue impact decline sale owing adverse impact hepatitis segment cutthroat competition niche space be additional concern operate highly competitive pharmaceutical distribution related health care service market company primary competitor be national generic regional distributor generic industry be witness consolidation customer manufacturer globalization increase quality regulatory challenge company also face competition manufacturer chain drugstore specialty distributor packaging health care technology company zack rank key carry zack rank hold few better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report sporting zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have surge roughly past year align technology have long term expect earning growth rate stock have sky-rocket year time myriad genetic have long term expect earning growth rate stock have soar past year wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
892,ALGN,aug issue update research report rhode island base pharmacy retail giant cvs health corp cvs free report provide integrate offering entire spectrum pharmacy care post better expect performance second quarter cvs health be observed trading significantly ahead broader industry last month share price movement stock have lose period narrower broader industry loss positive note strong pharmacy service number benefit upside specialty pharmacy recent datum person be currently need specialty treatment have high potential cost management emphasize cvs health specialty business remain top priority customer believe be well position tap opportunity base broad differentiate offering include like specialty connect company strong pbm selling season also look encourage regard selling season magnitude bidding opportunity be flat year year company have successful quarter gross new business be net new business also reach impressive new business number include loss fep specialty contract lack impact individual med pdp prescription drug plan company have already complete client renewal soft bottom line company narrow earning outlook indicate chance recovery ahead believe omnicare target pharmacy buyout have already start benefit cvs health multiple prospect drive enterprise value significantly come day however poor year year retail ltc long term care number margin debacle drag bottom line last quarter notably highly competitive retail pharmacy market too seem threat also sluggish economic condition be concern stock currently carry zack rank hold key picksa few better rank medical stock be edward lifescience corporation ew free report myriad genetic inc mygn free report align technology inc algn free report notably edward lifescience align technology sport zack rank strong buy myriad genetic carry zack rank buy see complete list today zack rank stock here align technology have expect long term adjust earning growth almost stock have add roughly last month edward lifescience have long term expect earning growth rate stock have gain last month myriad genetic have long term expect earning growth rate stock have add roughly last month zack ipo watch listbefore look stock mentioned want get head start potential tech ipos be pop zack radar imagine be first wave investor jump company almost unlimited growth potential special report give current scoop go public time have drive valuation year other be little less obvious already show jaw drop growth download ipo watch list today free
893,ALGN,chimerix inc cmrx free report report net loss continue operation cent share second quarter compare net loss cent year moreover report loss be narrower zack consensus estimate loss cent revenuesin second quarter chimerix report contract revenue year year year year decline be due fall reimbursable expense related company barda developmental contract research development expense totale general administrative expense amount year year consequently loss operation come highlight improvement operate loss prior year quarter however operate loss be attribute significant year year decline revenue chimerix inc price consensus ep surprise chimerix inc price consensus ep surprise chimerix inc exit second quarter cash cash equivalent short term investment compare record end first quarter takechimerix exit second quarter positive note narrower expect loss however revenue decline year year nonetheless be encourage company progress second quarter courtesy advancement lead product candidate brincidofovir company witness encourage enrollment multiple ascend dose study iv bcv further chimerix anticipate several important development second half start first human study cmx initiation adapt well datum iv bcv advance zack rank other key pickschimerix currently have zack rank buy few other top rank medical stock be edward lifescience corp ew free report myriad genetic inc mygn free report align technology inc algn free report edward lifescience align technology carry zack rank strong buy myriad genetic carry zack rank see complete list today zack rank stock here edward lifescience second quarter adjust earning improve year year primarily drive strong sale growth company transcatheter heart valf business stock have gain last month align technology second quarter adjust ep cent be year year revenue grow year year stock have rally roughly last month myriad genetic report adjust ep cent fourth quarter fiscal year year also total revenue rise year year fourth quarter stock have rally roughly last month simple trading ideasince zack system have more double average gain year compound rebalance exclusive fee turn thousand million dollar proven stock pick system be ground single big idea be fortune shape life change apply portfolio start today learn more
894,ALGN,aug issue update research report haemonetic corporation hae free report base lead provider blood management solution customer encompass blood plasma collector hospital health care provider globally stock currently carry zack rank buy past month haemonetic have be trading broader industry period stock have rally compare broader industry haemonetic exit first quarter fiscal mixed note earning beating zack consensus estimate revenue miss same encourage growth plasma haemonetic management franchise bloodcenter franchisee be quite dampener meanwhile company strong cash position boost investor confidence also year year increase report sale gross margin buoy optimism company swung operate income first quarter fiscal loss year quarter haemonetic be also optimistic strong market adoption nexsys pcs plasmapheresis system recently receive fda approval flip side last month haemonetic valuation look stretched term price earning ratio compare own industry also haemonetic have be consistently witness sluggish revenue growth blood center franchise further macroeconomic uncertainty continue challenge moreover stiff competitive landscape add wo other key picksother top rank medical stock be edward lifescience corporation ew free report myriad genetic inc mygn free report align technology inc algn free report notably edward lifescience align technology sport zack rank strong buy myriad genetic carry zack rank see complete list today zack rank stock here align technology have expect long term adjust earning growth almost stock have add roughly last month edward lifescience have long term expect earning growth rate stock have gain last month myriad genetic have long term expect earning growth rate stock have add roughly last month simple trading ideasince zack system have more double average gain year compound rebalance exclusive fee turn thousand million dollar proven stock pick system be ground single big idea be fortune shape life change apply portfolio start today learn more
895,ALGN,bio techne corporation tech free report report fourth quarter fiscal adjust earning share consider stock base compensation expense related tax impact regular expense year quarter figure also earning surpass zack consensus estimate year year rise earning be drive increase sale full year adjust ep come compare year period quarter detailsnet sale report quarter rise organically year year outpace zack consensus estimate full year sale grow year year organically currency fluctuation have negative impact acquisition contribute revenue bio techne corp price consensus ep surprise bio techne corp price consensus ep surprise bio techne corp company have division namely biotechnology protein platform diagnostic biotechnology division register year year revenue growth fourth quarter increase organically division be impact end market issue academia biopharma also lower primegene sale china have negative impact product growth be drive sale antibody protein platform division witness growth prior year quarter organically management growth be drive new product introduction application diagnostic segment net sale be organically year quarter upside be drive large order control kit bulk reagent oem customer geographic basis fourth quarter revenue witness mid single digit growth meanwhile growth europe be impressive witness double digit growth fourth quarter asia particularly china perform well japan register low single digit growth rest apac experience solid growth quarter review margin margin contract basis point bps year year report quarter selling general administrative expense sg be year year research development expense totale year quarter lead increase operate expense amount adjust operate margin quarter contract bps year quarter balance sheetbio techneexite fiscal cash cash equivalent compare end fiscal company have total long term debt end fiscal compare end precede fiscal takebio techneexite fourth year solid note earning revenue exceed thezack consensus estimate company witness growth segment be encourage note company be currently focuse global expansion management hope complete more acquisition fiscal company be focuse product innovation research development however currency headwind poor margin raise concern zack rank other key picksbio techne currently have zack rank buy other top rank medical stock be edward lifescience corp ew free report myriad genetic inc mygn free report align technology inc algn free report edward lifescience align technology sport zack rank strong buy myriad genetic carry zack rank see complete list today zack rank stock here edward lifescience second quarter adjust earning improve year year primarily drive strong sale growth company transcatheter heart valf business stock have gain last month align technology second quarter adjust ep cent be year year revenue grow year year stock have rally roughly last month myriad genetic inc mygn free report report adjust earning share ep cent fourth quarter fiscal year year total revenue rise year year fourth quarter simple trading ideasince zack system have more double average gain year compound rebalance exclusive fee turn thousand million dollar proven stock pick system be ground single big idea be fortune shape life change apply portfolio start today learn more
896,ALGN,nevro corp nvro free report report second quarter loss share cent compare unfavorably loss cent share year quarter figure be also much wider zack consensus estimate loss cent revenue report quarter however rise stupendous year year exceed zack consensus estimate solid result be primarily backed continue global adoption company hf therapy geographic basis second quarter revenue represent total sale gross year quarter figure also international sale total sale advanced year year constant exchange rate cer nevro corp price consensus ep surprise nevro corp price consensus ep surprise nevro corp quote company international growth be moderate capitation constraint however expect full year international growth be range high single low double digit operational updatenevro second quarter gross margin be reflect huge basis point bps expansion year year account rise gross profit company fundamental cost improvement result margin expansion company research development expense totale sale general administrative expense amount surge year year operate loss report quarter come wider operate loss prior year quarter financial updatenevro exit second quarter cash cash equivalent compare end first quarter guidancenevro reiterate revenue guidance range current zack consensus estimate remain project range takenevro exit second quarter mixed note company worldwide revenue exceed zack consensus estimate loss share remain widely zack consensus estimate year year comparison earning be unfavorable company witness strong growth company be putt effort product innovation research development however escalate cost expense affected margin zack rank key picksnevro currently carry zack rank hold better rank medical stock be edward lifescience corp ew free report insys therapeutic inc insy free report align technology inc algn free report sporting zack rank strong buy see complete list today zack rank stock here edward lifescience second quarter adjust earning soar stupendous year year primarily drive strong sale growth company transcatheter heart valf business stock have gain surprise last month insys therapeutic gross profit margin be second quarter flat year year align technology second quarter adjust ep cent be substantial year year revenue climb year year stock have surge roughly last month simple trading ideasince zack system have more double average gain year compound rebalance exclusive fee turn thousand million dollar proven stock pick system be ground single big idea be fortune shape life change apply portfolio start today learn more
897,ALGN,profitable company be able meet operate operate expense provide awesome return investor profitable company weak fundamental be expect perform unfavorably several study show profitable entity normally offer enormous return here have used concept accounting ratio evaluate company profitability be variety profitability ratio have choose most common successful profitability metric determine bottom line performance company net income rationet income ratio give exact profitability level company reflect percentage net income total sale revenue used net income ratio determine company effectiveness pay operate operate expense revenue higher net income ratio usually imply company ability generate ample revenue successfully manage business function screening parametersnet income ratio be not only indicator future winner so have add few more criterium arrive winning strategy zack rank equal only zack rank strong buy stock be allow zack rank prove be best rating system be great way start thing see complete list today zack rank stock here month trail sale net income growth higher industry stock possess higher sale net income growth last month showcase better financial performance month trail net income ratio higher industry high net income ratio indicate company solid profitability rating strong buy greater indicate analyst cover stock be optimistic few parameter narrow universe stock only here be qualify screen gray television inc gtn free report be television broadcast company have average quarter positive earning surprise align technology inc algn free report be manufacturer marketer system computer aid design computer aid manufacturing cad cam digital service have average quarter positive earning surprise solaredge technology inc sedg free report be developer seller direct current dc optimized inverter system solar photovoltaic pv installation have average quarter positive earning surprise nova measure instrument ltd nvmi free report be developer seller process control system have average quarter positive earning surprise brook automation inc brk free report be provider automation cryogenic solution various application market have average quarter positive earning surprise get rest stock list signing now week free trial research wizard start used screen own trading further also create own strategy test first take investment plunge research wizard be great place begin easy use everything be plain language very intuitive start research wizard trial today next time read economic report open research wizard plug find see gem come click here sign free trial research wizard today disclosure officer director employee zack investment research own have sell short security hold long short position option be mentioned material affiliated investment advisory firm own have sell short security hold long short position option be mentioned material disclosure performance information zack portfolio strategy be available https www zack com performance zack restaurant recommendation addition dine special place feast stock share zack special report spotlight recent ipos watch stock offer immediate promise boom sector download free
898,ALGN,steris plc ste free report report first quarter fiscal adjust earning share ep cent year quarter adjust ep figure also surpass zack consensus estimate cent report basis quarter ep come cent year year revenue detailsteris generate revenue year year however top line beat zack consensus estimate year year decline be result foreign currency fluctuation well divest business organic revenue growth constant currency be year year primarily drive balanced growth segment steris plc price consensus ep surprise steris plc price consensus ep surprise steris plc company operate segment healthcare product healthcare specialty service apply sterilization technology life science revenue healthcare product segment inched year year report quarter be drive growth service revenue increase capital equipment revenue turn be partially offset dip consumable due divestiture revenue healthcare specialty service segment plunge report basis due divestiture however organic revenue grow reflect growth im north america csd outsource business europe other hand revenue apply sterilization technology rise organic revenue growth be back increase volume segment core medical device customer lastly revenue life science segment drop quarter growth service revenue increase consumable revenue be more offset decrease capital equipment revenue organic basis revenue nudge year year marginsadjusted gross margin improve basis point bps year year report quarter expansion be account positive impact divest low margin business improvement operational efficiency favorable foreign currency cost synergy pricing steris witness year year rise selling general administrative expense research development expense fall adjust operate margin expand bps year year basis report quarter financial detailssteris exit first quarter fiscal cash cash equivalent compare end fiscal company have long term debt end first quarter fiscal compare end fiscal company generate cash flow operation first quarter year period free cash flow period be compare prior year time frame guidancesteris continue expect organic revenue growth constant currency basis fiscal prior fiscal year adjust ep be expect range share takesteris post better expect first quarter fiscal earning revenue beating zack consensus estimate however year year decline revenue be disappointment positive note organic growth performance be strong segment further growth free cash flow reserve be indicative company strong cash balance recently company have make couple organizational change expect better align operation zack rank key pickssteris currently have zack rank buy few other top rank medical stock be edward lifescience corp ew free report insys therapeutic inc insy free report align technology inc algn free report sporting zack rank strong buy see complete list today zack rank stock here edward lifescience second quarter adjust earning improve stupendous year year primarily drive strong sale growth company transcatheter heart valf business stock have gain surprise last month insys therapeutic gross profit margin be second quarter flat year year align technology second quarter adjust ep cent be substantial year year revenue grow year year stock have surge roughly last month more stock news tech opportunity worth driverless car artificial intelligence ve see unsurpassed growth high tech product recent month yesterday science fiction be become today reality innovation be single component tech company survive demand critical device reach year alone likely grow even faster future zack have release brand new special report help take advantage exciting investment opportunity most importantly reveal stock massive profit potential see stock now
899,ALGN,cheme corporation che free report lead manufacturer product service primarily companion animal veterinary have gain last month thus beating gain stock have market cap company year expect growth rate be also impressive company further represent return almost substantially higher industry gain last year solid prospect zack rank buy stock be attractive pick moment company estimate revision trend current year have also be positive past day estimate moved north movement opposite direction magnitude estimate revision earning share rise same time frame let find recent positive trend be sustainable cheme second quarter performance be quite promising bottom line significantly improve year year basis stellar performance be drive company increase average net medicare reimbursement rate average daily census keep momentum encourage revenue growth raise guidance further indicate company brighter prospect promising outlook roto rooter segment bottom line also support company estimation improve operate result upcoming quarters fact view raise be backed company expectation significant gain roto rooter business cheme vita business be trouble past few quarters due certain admission coding change initiate center medicare medicaid service cms however management recently note recent admission trend have be positive continue come quarters second quarter vita perform well financially operationally thereby surpass company estimate additionally company strong cash balance enable carry share repurchase program turn provide solid return investor other key picksother top rank medical stock be idexx laboratory inc idxx free report lantheus holding inc lnth free report align technology inc algn free report align technology sport zack rank strong buy lantheus holding idexx laboratory carry zack rank see complete list today zack rank stock here idexx laboratory have long term expect earning growth rate stock have gain last month lantheus holding have long term expect earning growth rate stock have surge last month align technology have long term expect earning growth rate stock have rally roughly last month more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
900,ALGN,aug issue update research report elmsford ny base bioscrip inc bio free report company be lead infusion service provider strive deliver cost effective program patient stock currently have zack rank hold past month bioscrip have be trading broader industry stock have gain period industry loss market be upbeat company announcement continue offer certain core product line deal be significantly accretive bioscrip top line company progress new multus faceted core plan improve financial position be also encourage plan involve identify execute strategy accelerate core revenue growth favorable product mix drive operational efficiency improve revenue collection increase employee effectiveness further bioscrip have successfully complete home solution integration earlier year company expect core revenue well continue growth acquire asset prove accretive go forward notably bioscrip have be record persistent growth core infusion service business strong presence well competitive advantage company witness consistent rise business primarily account strong organic growth chronic nutrition other therapy have be build robust core infusion platform organic development acquisition management expect bioscrip focus fast grow core infusion business drive increase profitability company be currently track achieve previously announce home solution synergy other incremental annualize cost reduction end flip side bioscrip guidance be lackluster inclusion estimate negative impact cure act legislation large portion company revenue used come directly medicare state medicaid program other government payer however new cure act bill do not reimburse service payment administration certain drug patient home infusion pharmacy healthcare industry be also highly competitive bioscrip competitor include large well establish company higher financial marketing technological resource key picksa few better rank medical stock be idexx laboratory inc idxx free report lantheus holding inc lnth free report align technology inc algn free report align technology sport zack rank strong buy lantheus holding idexx laboratory carry zack rank buy cansee complete list today zack rank stock here idexx laboratory have long term expect earning growth rate stock have gain last month lantheus holding have long term expect earning growth rate stock have surge last month align technology have long term expect earning growth rate stock have rally roughly last month more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
901,ALGN,aug issue update research report kalamazoo mi base stryker corporation syk free report largest medical device company global orthopedic market company currently have zack rank buy stryker have impressive run bourse last month trading industry term price performance glimpse price movement reveal stryker share have gain compare favorably rise industry belong company have diverse product portfolio cushion significant sale shortfall economic downturn stryker pipeline include product hip knee mako robotic arm assist surgery mako result last quarter be solid almost global robot installation be unite state furthermore platform bone cement sport medicine bone substitute soft tissue repair trauma extremity endoscopy more fortify company market position stryker have be follow acquisition drive strategy boost growth profile june company announce definitive agreement acquire novadaq technology inc share net purchase price transaction be structure arrangement canada business corporation act be subject customary close condition include approval novadaq shareholder stryker have be focuse international growth well particular company medsurg product line have witness strong demand european australian market second quarter flip side china prove be challenge market stryker strong guidance be also catalyst third quarter company expect adjust earning range share full year company estimate adjust earning band stryker expect organic sale growth full year other key picksother top rank medical stock be edward lifescience corp ew free report steris plc ste free report align technology inc algn free report edward lifescience align technology sport zack rank strong buy steris carry zack rank buy see complete list today zack rank stock here edward lifescience have positive earning surprise trail quarters stock have gain last month align technology have long term expect earning growth rate stock have rally roughly last month steris have positive earning surprise trail quarters stock have gain last month more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
902,ALGN,aug issue update research report warsaw base zimmer biomet holding inc zbh free report lead musculoskeletal healthcare company design distribute orthopedic reconstructive product spine bone heal thoracic product dental implant related surgical product last month zimmer biomet be trading industry factor macroeconomic uncertainty pricing pressure unfavorable currency fluctuation stock have now lose compare industry gain company deliver dull second quarter result expect downside continue upcoming period management company be still fight headwind such slump knee business shortage supply product thus lead inability recapture lose customer unite state gain new one also trim guidance add concern indicate slim chance recovery ahead market also seem be apprehensive departure zimmer biomet decade old ceo david dvorak notably year tenure zimmer biomet have transform global leader musculoskeletal healthcare combination organic growth strategic acquisition company revenue have double phase have introduce broad portfolio technology solution personalize service only time tell step drovak leave adverse impact company business currently remain sideline further visibility be obtain matter positive note look forward ongoing synergy ldr hold acquisition broaden complement company musculoskeletal offer be line strategy grow inorganic mean focuse mega merger management be also strive develop strong spine portfolio order cash opportunity company spine offering such mobi cervical disc prosthesis vitality spinal fixation system show considerable progress performance zimmer biomet have be late work strengthen foothold emerge market provide long term opportunity company strategic investment region several quarters view enhance operational sale performance be yielding result zack rank key pickszimmer biomet currently carry zack rank sell better rank medical stock be idexx laboratory inc idxx free report lantheus holding inc lnth free report align technology inc algn free report align technology sport zack rank strong buy lantheus holding idexx laboratory carry zack rank buy see complete list today zack rank stock here idexx laboratory have long term expect earning growth rate stock have gain last month lantheus holding have long term expect earning growth rate stock have surge last month align technology have long term expect earning growth rate stock have rally roughly last month surprising tech stock keep eye ontech stock have be major force market record high pick best one buy be tough simple way invest success entire sector zack have just release special report reveal thing tech company literally function more importantly reveal top stock set skyrocket increase demand device encourage get report now next wave innovation really take see stock now
903,ALGN,molecular diagnostic personalize medicine major myriad genetic inc mygn free report achieve milestone endopredict test get positive coverage decision palmetto gba medicare administrative contractor assess molecular diagnostic technology notably endopredict be myriad genetic next generation multigene prognostic test breast cancer test provide information help doctor devise personalize treatment plan follow full implementation decision myriad genetic have coverage breast cancer patient post implementation decision consider endopredict have be used clinically more patient areconfident grow adaptability test post medicare coverage approval report provide gbi research global breast cancer treatment market reach worth cagr thus company clearly have bountiful prospect market also note company have recently receive extend medicare coverage prolasis test regard note past month myriad genetic have be trading broader industry stock have gain higher industry gain recent genetic announce bracanalysis cdx companion diagnostic test successfully identify brca mutate patient metastatic breast cancer olympiad trial respond better treatment olaparib standard chemotherapy also myriad genetic present favorable finding bracanalysis cdx test successfully identify patient metastatic breast cancer phase olympiad study zack rank key picksmyriad genetic carry zack rank hold few better rank medical stock be idexx laboratory inc idxx free report lantheus holding inc lnth free report align technology inc algn free report align technology sport zack rank strong buy lantheus holding idexx laboratory carry zack rank buy cansee complete list today zack rank stock here align technology have long term expect earning growth rate stock have rally roughly last month lantheus holding have long term expect earning growth rate stock have gain last month idexx laboratory have long term expect earning growth rate stock have gain last month surprising tech stock keep eye ontech stock have be major force market record high pick best one buy be tough simple way invest success entire sector zack have just release special report reveal thing tech company literally function more importantly reveal top stock set skyrocket increase demand device encourage get report now next wave innovation really take see stock now
904,ALGN,aug issue update research report walgreen boot alliance inc wba free report illinois base lead pharmacy lead health wellbeing enterprise stock currently carry zack rank hold walgreen have outperformed industry respect share price movement last month stock have gain ahead industry rise period walgreen shelving rite aid rad free report acquisition deal come huge setback company investor buyout deal have once promise strong platform develop company brand presence well overall future business growth however delve deal latest detail believe be still much hope new agreement enable walgreen purchase nearly half rite aid business deal value almost third original price more specifically acquirer take nearly store distribution center related inventory rite aid cash notably latter run store state district columbia jun apart contract financial outcome be pretty attractive post new transaction initial close walgreen expect be modestly accretive adjust diluted net earning share first full year synergy new takeover be expect excess be entirely realize year initial close walgreen modify merger contract also extend growth strategy offer additional operational financial benefit help company expand optimize retail pharmacy network key market include northeast partial consolidation rite aid help walgreen gain competitive edge company new strategic pharmacy tie up several recent program include skin product launch vaccination be encourage earlier year company partner communication service provider wpp operate develop multiple marketing communication channel retail wholesale business well health beauty product brand walgreen boot also inked multus year partnership agreement global express delivery service provider fedex corporation alliance be aim offer convenient access fedex drop pickup service several walgreen boot location unite state last few year slowdown generic introduction increase reimbursement pressure generic drug cost inflation have be hamper company margin significantly also walgreen boot face obstacle increase competition tough industry condition even company continue gain decent market share other traditional drug store retailer major mass merchant namely target wal mart be track expand pharmacy business risk other channel such supermarket mail order operation also threat addition industry condition remain challenge insurer slash reimbursement rate raise prescription co payment currency fluctuation weak macroeconomic environment delay walgreen boot long impending buyout rite aid emerge other headwind key pickssome better rank medical stock be align technology inc algn free report idexx laboratory inc idxx free report align technology sport zack rank strong buy idexx laboratory carry zack rank buy see complete list today zack rank stock here idexx laboratory have long term expect earning growth rate stock have gain last month lantheus holding have long term expect earning growth rate stock have surge last month align technology have long term expect earning growth rate stock have rally roughly last month surprising tech stock keep eye ontech stock have be major force market record high pick best one buy be tough simple way invest success entire sector zack have just release special report reveal thing tech company literally function more importantly reveal top stock set skyrocket increase demand device encourage get report now next wave innovation really take see stock now
905,ALGN,south san francisco base fluidigm corporation fldm free report lead player analysis single cell industrial application genomic recently announce have enter licensing agreement baylor genetic agreement fluidigm license right commercialize cftr cystic fibrosis transmembrane conductance regulator library prep assay develop baylor genetic research purpose be used proprietary juno automate microfluidic system target library prep assay enable accurate identification variant exon cftr gene select intronic region combine fluidigm microfluidic solution have potential significantly simplify complex labor intensive laboratory workflow improve efficiency cftr sequence invariably improve efficiency juno automate microfluidic system help company capture considerable market share next generation sequence offer more comprehensive approach cftr genetic analysis allow complete view sequence target sequence library prep workflow however be very labor intensive application fluidigm automate microfluidic technology library preparation be streamline provide significant efficiency past month fluidigm have underperform broader industry stock have shed compare industry decline fluidigm develop manufacture market life science analytical preparatory system market such mass cytometry high throughput genomic single cell genomic company cater lead academic institution clinical research laboratory pharmaceutical biotechnology agricultural biotechnology company worldwide zack rank key pickscurrently fluidigm have zack rank hold few better rank medical stock be edward lifescience corp ew free report lantheus holding inc lnth free report align technology inc algn free report edward lifescience align technology sport zack rank strong buy lantheus holding carry zack rank buy see complete list today zack rank stock here edward lifescience have long term expect earning growth rate stock have gain last month lantheus holding have long term expect earning growth rate stock have gain last month align technology have long term expect earning growth rate stock have rally roughly last month surprising tech stock keep eye ontech stock have be major force market record high pick best one buy be tough simple way invest success entire sector zack have just release special report reveal thing tech company literally function more importantly reveal top stock set skyrocket increase demand device encourage get report now next wave innovation really take see stock now
906,ALGN,renown information technology service provider healthcare organization allscript healthcare solution inc mdrx free report announce have enter strategic partnership elligo health research agreement company focus assist clinician conduct clinical trial study own clinic aforementioned partnership clinical trial manage clinical research organization cro be help bring new treatment patient major therapeutic area combine offer enable physician directly participate study investigator select cro clinical trial provide patient benefit more direct comprehensive care additionally physician be able generate research revenue cover investigator fee associate trial procedure allscript proprietary eparticipate service be available cro allscript professional ehr allscript touchwork ehr allscript sunrise cro market be become more more lucrative company estimate continue increase investment support bring new clinical therapy market more payment study investigator eparticipate expand reach clinical trial investment enable allscript research capable site become study investigator elligo health infrastructure service allscript physician have access clinical trial several therapeutic area include neurology pain urology pulmonology oncology woman health key area focus cro past month allscript have outperformed broader industry stock have gain compare loss industry belong allscript be lead provider healthcare information technology solution look forward management be focuse various restructure initiative such streamline operational efficiency increase cater client need believe favorable demographic trend reinforce supportive regulatory environment be expect sustain growth demand service higher client demand company population health management solution healthcare system hospital ambulatory market also drive growth long haul zack rank key picksallscript healthcare currently carry zack rank hold few better rank medical stock be edward lifescience corp ew free report lantheus holding inc lnth free report align technology inc algn free report edward lifescience align technology sport zack rank strong buy lantheus holding carry zack rank buy see complete list today zack rank stock here edward lifescience have long term expect earning growth rate stock have gain last month align technology have long term expect earning growth rate stock have rally roughly last month lantheus holding have long term expect earning growth rate stock have gain last month surprising tech stock keep eye ontech stock have be major force market record high pick best one buy be tough simple way invest success entire sector zack have just release special report reveal thing tech company literally function more importantly reveal top stock set skyrocket increase demand device encourage get report now next wave innovation really take see stock now
907,ALGN,world first pharmacy lead health wellbeing enterprise walgreen boot alliance wba free report have recently come center health wellbeing research put progressive foot forward achieve strategic goal value creation healthcare company be contain more walgreen outcome study complete past year research area center health wellbeing research provide access care patient experience adherence clinical outcome digital health member engagement health care cost hiv specialty pharmacy vaccination other twin target new online institution intend help improve patient care outcome scientific research reasonable health care cost walgreen center health wellbeing research team comprise more walgreen health service researcher clinician statistician public health practitioner actuary datum scientist notably be also quite few scientific research partner walgreen dedicate enhance healthcare value academic institutes be johns hopkin medicine johns hopkin bloomberg school public health scripps translational science institute university california san francisco school pharmacy university chicago medicine several research study have already be publish entire team such study be pharmacy patient enrolled medicare prescription drug plan company study find patient be late refill prescription receive reminder call local walgreen pharmacist demonstrated nearly greater adherence first day expect refill date context let brief few line company earlier announce strategic goal aim maximize scope scale time plan reflect significant value create opportunity company drive long term shareholder value also focus improve core performance term price performancein past month walgreen have be see outperform industry respect share price movement stock have gain ahead industry rise period zack rank key pickswalgreen currently carry zack rank hold few better rank medical stock be edward lifescience corp ew free report lantheus holding inc lnth free report align technology inc algn free report edward lifescience align technology sport zack rank strong buy lantheus holding carry zack rank buy see complete list today zack rank stock here edward lifescience have long term expect earning growth rate stock have gain last month lantheus holding have long term expect earning growth rate stock have surge last month align technology have long term expect earning growth rate stock have rally roughly last month simple trading ideasince zack system have more double average gain year compound rebalance exclusive fee turn thousand million dollar proven stock pick system be ground single big idea be fortune shape life change apply portfolio start today learn more
908,ALGN,medication supply management adherence tool provider omnicell inc omcl free report recently advanced patient management access portal pmap new enhancement help improve patient outcome notably single web base portal host functionality guide track patient note intervention appointment also provide detailed information patient respective pharmacist identify prepare document ongoing patient engagement latest enhancement pmap include target adherence intervention patient be new chronic therapy also be time med dashboard provide pharmacist individualized performance snapshot enhancement also consist single sign integration third party software help pharmasist assist patient medicare plan option immunization solution aid identify need vaccination simplify pharmacist omnicell advancement together make pmap more comprehensive web portal prompt pharmacist provide personalize care medically complex patient maintain effective service further good news be initiative lead curb healthcare cost datum provide omnicell currently more american be take more maintenance medication daily however only half chronic condition patient require medication do not take prescribe account treatment failure death annually person gradually realize importance medication adherence market potential pmap web portal seem huge expect latest feature enhancement pmap result better market adoption system most part past month omnicell share price consistently underperform industry however company have picked steam post impressive second quarter result year year increase earning revenue accordingly stock have surge significantly ahead industry gain omnicell putt effort product innovation research development expect company maintain bullish momentum go ahead zack rank key picksomnicell currently carry zack rank hold few better rank medical stock be edward lifescience corp ew free report lantheus holding inc lnth free report align technology inc algn free report edward lifescience align technology sport zack rank strong buy lantheus holding carry zack rank buy see complete list today zack rank stock here edward lifescience have long term expect earning growth rate stock have gain last month lantheus holding have long term expect earning growth rate stock have soar last month align technology have long term expect earning growth rate stock have rally roughly last month simple trading ideasince zack system have more double average gain year compound rebalance exclusive fee turn thousand million dollar proven stock pick system be ground single big idea be fortune shape life change apply portfolio start today learn more
909,ALGN,lead distributor health care product service henry schein inc hsic free report be constantly focuse expand dental business account nearly half total revenue keep line henry schein dental enter agreement distribute caek inc flagship product health insurance portability accountability act hipaa software layercompliance notably caek be software service saas company focuse compliance related software healthcare industry layercompliance be cloud base tool help doctor navigate requirement hipaa notably hipaa be federal law provide privacy security standard protect patient health information layercompliance help user manage datum security program online dashboard tool help streamline process oral health care expenditure dental industry be likely rise increase population believe boost demand henry schein product service well meanwhile management have enter year agreement dentsply sirona broaden henry schein digital dentistry product line moreover second quarter henry schein announce extension agreement dentsply sirona extend agreement be valid dec henry schein include cerec cad cam restoration system schick line imaging sensor henry schein also be entitle represent entire dentsply sirona product line start sep addition henry schein continue offer planmeca shape well dental equipment consumer product longstanding partner kavo kerr brand past year henry schein have outperformed broader industry stock have gain compare gain broader industry zack rank key pickshenry schein currently carry zack rank hold few better rank medical stock be edward lifescience corp ew free report lantheus holding inc lnth free report align technology inc algn free report edward lifescience align technology sport zack rank strong buy lantheus holding carry zack rank buy see complete list today zack rank stock here edward lifescience have long term expect earning growth rate stock have gain last month align technology have long term expect earning growth rate stock have rally roughly last month lantheus holding have long term expect earning growth rate stock have gain last month simple trading ideasince zack system have more double average gain year compound rebalance exclusive fee turn thousand million dollar proven stock pick system be ground single big idea be fortune shape life change apply portfolio start today learn more
910,ALGN,bioscrip inc bio free report report net loss continue operation cent share second quarter compare net loss cent year zack consensus estimate be peg loss cent revenueswith completion company core pbm business divestment treat discontinue operation previous quarter bioscrip currently have simplified business structure focuse core infusion service revenue continue operation second quarter fall year year also miss zack consensus estimate year year decline be due company shift strategy focus grow core revenue mix couple impact cure act contract modification be partially offset synergy home solution acquisition bioscrip inc price consensus ep surprise bioscrip inc price consensus ep surprise bioscrip inc quotegross profit second quarter be year year gross margin also expand basis point bps adjust operate income be mark year year increase rise adjust operate expense adjust operate margin expand bps year year exit second quarter cash cash equivalent significantly record end first quarter guidance intactbioscrip reiterate guidance adjust ebitda range full year guidance incorporate estimate adverse effect cure act legislation company estimate regard contract company have update revenue outlook range include impact revise contract revenue zack consensus estimate revenue lie company guide range takebioscrip exit second quarter dismal note wider expect loss revenue miss zack consensus estimate management guidance include negative impact cure act legislation also add concern nonetheless be encourage company progress second quarter courtesy new multus faceted core plan be adopt improve financial position further company achieve annualize supply chain improvement roughly acquisition home solution company expect core revenue home solution continue core growth prove accretive also be upbeat company raise number immunoglobulin ig therapy stock previous quarter zack rank other key picksbioscrip have zack rank buy few other top rank medical stock be edward lifescience corporation ew free report insys therapeutic inc insy free report align technology inc algn free report notably edward lifescience insys therapeutic align technology sport zack rank strong buy see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock post stellar quarter average earning surprise align technology have expect long term adjust earning growth almost stock have add roughly last month edward lifescience have long term expect earning growth rate stock have gain last month more stock news tech opportunity worth driverless car artificial intelligence ve see unsurpassed growth high tech product recent month yesterday science fiction be become today reality innovation be single component tech company survive demand critical device reach year alone likely grow even faster future zack have release brand new special report help take advantage exciting investment opportunity most importantly reveal stock massive profit potential see stock now
911,ALGN,biotelemetry inc beat free report report second quarter adjust earning cent share beat zack consensus estimate cent year equivalent couple cent revenue detailsrevenue increase year year almost line zack consensus estimate upside have be primarily drive increase healthcare revenue owing rise mcot patient however be partially offset impact slower medicare rate effective jan notably marked consecutive quarter year year revenue growth meanwhile research revenue increase lead imaging study volume growth full quarter impact acquisition virtualscopic partially offset lower cardiac revenue technology revenue increase higher sale wireless blood glucose monitor telcare division biotelemetry inc price consensus ep surprise biotelemetry inc price consensus ep surprise biotelemetry inc profit increase year quarter primarily drive increase revenue gross margin contract basis point bps due impact medicare rate reduction acquisition carry lower margin exist business decline be partially offset volume drive efficiency adjust operate expense totale reflect increase year quarter upside be lead increase selling marketing research development expense year year respectively meanwhile adjust operate margin expand bps financial exit second quarter cash cash equivalent compare end first quarter guidancepost acquisition lifewatch biotelemetry currently expect full year revenue range zack consensus estimate full year revenue be peg company expect revenue third quarter fourth quarter company also expect time expense related acquisition approximately be further expect be reflect third quarter result exit second quarter strong note earning exceed zack consensus estimate revenue meeting same raise full year revenue guidance be also encourage company also register growth segment be encourage note company be putt effort product innovation research development company recently complete acquisition lifewatch ag post acquisition company be look prospect solidify position cardiac monitoring however decline gross margin be matter concern zack rank key have zack rank hold few better rank medical stock be edward lifescience corporation ew free report insys therapeutic inc insy free report align technology inc algn free report notably edward lifescience insys therapeutic align technology sport zack rank strong buy see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock post stellar quarter average earning surprise align technology have expect long term adjust earning growth almost stock have add roughly last month edward lifescience have long term expect earning growth rate stock have gain last month more stock news tech opportunity worth driverless car artificial intelligence ve see unsurpassed growth high tech product recent month yesterday science fiction be become today reality innovation be single component tech company survive demand critical device reach year alone likely grow even faster future zack have release brand new special report help take advantage exciting investment opportunity most importantly reveal stock massive profit potential see stock now
912,ALGN,myriad genetic inc mygn free report report adjust earning share ep cent fourth quarter fiscal year year however adjust ep beat zack consensus estimate cent surpass company guide range cent include time item company report net income earning cent share quarter exhibit decline respectively fiscal company adjust ep come year number full year ep figure exceed zack consensus estimate revenuestotal revenue rise year year fourth quarter figure also outpaced company guidance top line exceed zack consensus estimate theyear year rise top line be primarily account sequential growth hereditary cancer revenue strong result genesight myriad genetic inc price consensus ep surprise myriad genetic inc price consensus ep surprise myriad genetic inc fiscal company report revenue equivalent figure fiscal top line also steer past zack consensus estimate quarter detailssegment wise molecular diagnostic test total revenue record total revenue year year mainly account rise endopredict testing revenue genesight revenue grow year year report quarter prolaris testing space company witness more market penetration thereby register revenue quarter experience fall year year however hereditary cancer testing revenue drop year year deliver third consecutive quarter sequential growth testing volume year year vectra da testing revenue come year year other testing revenue fall other hand pharmaceutical clinical service revenue accounting rest quarter be show year year decline margin trendsgross margin quarter review expand basis point bps accord management improvement gross margin be attribute improve efficiency hereditary cancer business genesight laboratory operate expense rise owing rise selling general administrative sg expense research development expense however decline report quarter overall operate margin contract stupendous bps financial positionmyriad genetic exit fiscal cash cash equivalent marketable security compare end fiscal end fiscal cash flow operation totale year comparable period consequently free cash flow gross compare fiscal guidancemyriad genetic have provide guidance fiscal company currently expect revenue range zack consensus estimate lie guide range bottom line front company expect generate adjust ep range current zack consensus estimate be higher company guidance management have provide outlook first quarter fiscal company estimate adjust earning share cent total revenue zack consensus estimate adjust ep cent revenue exceed company guide range viewmyriad genetic end fiscal solid note fourth quarter number exceed zack consensus estimate thecompany particularly observed strong growth endopredict genesight testing revenue sequential rise hereditary cancer volume flip side unfavorable foreign currency translation continue threat company considerable portion revenue come outside company face risk exchange rate fluctuation additionally macroeconomic uncertainty higher expense owing extensive pipeline testsmay impact company margin zack rank other key picksmyriad genetic have zack rank buy few other top rank medical stock be edward lifescience corporation ew free report insys therapeutic inc insy free report align technology inc algn free report notably edward lifescience insys therapeutic align technology sport zack rank strong buy see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock post stellar quarter average earning surprise align technology have expect long term adjust earning growth almost stock have add roughly last month edward lifescience have long term expect earning growth rate stock have gain last month more stock news tech opportunity worth driverless car artificial intelligence ve see unsurpassed growth high tech product recent month yesterday science fiction be become today reality innovation be single component tech company survive demand critical device reach year alone likely grow even faster future zack have release brand new special report help take advantage exciting investment opportunity most importantly reveal stock massive profit potential see stock now
913,ALGN,penumbra inc pen free report report second quarter loss share cent compare unfavorably earning cent year quarter loss figure be line zack consensus estimate revenue report quarter rise year year constant exchange rate cer exceed zack consensus estimate geographic basis second quarter revenue represent total sale gross year quarter figure same cer meanwhile international sale total sale advanced year year cer penumbra inc price consensus ep surprise penumbra inc price consensus ep surprise penumbra inc quotego product category revenue neuro product grow cer second quarter revenue peripheral vascular product business rise second quarter reflect increase cer year year operational updatepenumbra second quarter gross margin be reflect basis point bps contraction year year account rise cost revenue however gross profit rise research development expense totale sale general administrative expense amount year year operate loss report quarter come massively wider operate loss prior year quarter financial updatepenumbra exit second quarter cash cash equivalent compare end first quarter takepenumbra exit second quarter mixed note company report impressive top line result revenue exceed zack consensus estimate loss figure be line same year year comparison earning be unfavorable company witness strong growth geography product line company be putt effort product innovation research development however escalate cost expense affected margin penumbra be active player fast grow interventional therapy space fact company product primarily cater unmet clinical need major market neuro peripheral vascular zack rank key pickspenumbra have zack rank hold few better rank medical stock be edward lifescience corporation ew free report insys therapeutic inc insy free report align technology inc algn free report notably edward lifescience insys therapeutic align technology sport zack rank strong buy see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock post stellar quarter average earning surprise align technology have expect long term adjust earning growth almost stock have add roughly last month edward lifescience have long term expect earning growth rate stock have gain last month more stock news tech opportunity worth driverless car artificial intelligence ve see unsurpassed growth high tech product recent month yesterday science fiction be become today reality innovation be single component tech company survive demand critical device reach year alone likely grow even faster future zack have release brand new special report help take advantage exciting investment opportunity most importantly reveal stock massive profit potential see stock now
914,ALGN,stock continue rally friday job number mid morning today europe close market stall most major market average run gas even solid earning retailer michael kor couldn provide enough fuel market sell close check dave daily dive video break market action today day dave bartosiak zack com twitter bartosiastic dive chart point key price action level watch doesn stop highlight today video see free click be uncover zack rank strong buy stock be breaking new week high today stock have ton momentum be charge higher list stock cover today include align tech algn free report align technology inc price consensus align technology inc price consensus align technology inc quotealign technology inc design manufacture market system clear aligner therapy intra oral scanner computer aid design computer aid manufacturing cad cam digital service company clear aligner segment offer invisalign full treatment used range malocclusion invisalign treatment address orthodontic need teenage patient such compliance indicator compensation tooth eruption free single arch replacement aligner invisalign assist treatment anterior alignment aesthetically oriented case alibaba baba free report alibaba group hold limit price consensus alibaba group hold limit price consensus alibaba group hold limit quotealibaba group hold limit subsidiary operate online mobile commerce company person republic china internationally company operate segment core commerce cloud compute digital medium entertainment innovation initiative other operate taobao marketplace mobile commerce destination tmall third party platform brand retailer rural taobao program enable rural resident business sell agricultural product urban consumer juhuasuan sale marketing platform flash sale alibaba com online wholesale marketplace alitrip online travel book platform com online wholesale marketplace consumer marketplace caterpillar cat free report caterpillar inc price consensus caterpillar inc price consensus caterpillar inc inc manufacture sell construction mining equipment diesel natural gas engine industrial gas turbine diesel electric locomotive heavy general construction rental quarry aggregate mining waste material handle oil gas power generation marine rail industrial market construction industry segment offer backhoe compact track type small medium wheel knuckleboom skid steer loader small medium track type site prep tractor mini wheel forestry small medium large track excavator motorgrader pipelayer telehandler cold planer asphalt paver compactor road reclaimer wheel track skidder feller buncher chemour cc free report chemour company price consensus chemour company price consensus chemour company chemour company provide performance chemical north america asia pacific europe middle east africa latin america operate segment titanium technology fluoroproduct chemical solution titanium technology segment manufacture sell titanium dioxide tio ti pure brand name deliver whiteness brightness opacity protection various application such architectural industrial coating flexible rigid plastic packaging pvc window profile laminate paper coat paper paperboard used packaging unilever ulunilever plc price consensus unilever plc price consensus unilever plc quoteunilever plc operate fast move consumer good market company operate personal care food home care refreshment segment personal care segment offer skincare haircare product deodorant oral care product food segment provide soup bouillon sauce snack mayonnaise salad dressing margarine spread home care segment offer home care product include powder liquid capsule soap bar various clean product refreshment segment provide ice cream tea base beverage now see private trade today zack rank new addition be be share public other trade be hide everyone select member peek curtain view start today next month follow zack private buy sell real time value momentum stock etf option move insider trade company be report positive earning surprise ve call accuracy even look portfolio so exclusive be normally close new investor click here zack trade
915,ALGN,cvs health corporation cvs free report second quarter adjust earning share ep be nominal year year basis quarter adjust ep also exceed zack consensus estimate cent earning performance be sluggish year year disappointing retail ltc number well weaker margin time adjustment report ep continue operation first quarter surge year year net revenue quarter increase year year exceed zack consensus estimate close margin strong revenue growth pharmacy service segment be partially offset decline retail ltc performance quarter cvs health corporation price consensus ep surprise cvs health corporation price consensus ep surprise cvs health corporation quotequarter detail pharmacy service revenue increase report quarter drive growth specialty pharmacy volume higher pharmacy network claim volume well brand inflation be however partially offset increase generic dispense price compression pharmacy network claim processed quarter climb day equivalent basis backed net new business growth also mail choice processed claim count be day equivalent basis continue adoption maintenance choice offering rise specialty pharmacy claim revenue cvs health retail ltc dip year year primarily due decrease same store sale continue reimbursement pressure increase generic dispense rate front end same store sale be year year shift easter holiday second quarter first quarter have bps positive impact front end same store sale front store sale be however affected soft customer traffic effort rationalize promotional strategy be again partially offset increase basket size pharmacy same store sale also decline report quarter sale be affected approximately bps due recent generic drug introduction also pharmacy same store prescription volume be flat day equivalent basis apart marketplace change restrict cvs pharmacy participate certain network have bps negative impact same store prescription volume generic dispense rate proportion generic prescription total number prescription dispense soar bps pharmacy service segment bps retail ltc segment gross profit drop gross margin contract bps total operate margin quarter contract bps plunge operate profit cvs health exit quarter cash cash equivalent short term investment compare end first quarter year date net cash provide operate activity be year period second quarter cvs health open new retail store shut retail location further company relocate retail store jun cvs health operated retail store include pharmacy target store state well district columbia puerto rico brazil outlookcvs health have narrow adjust ep guidance earlier band zack consensus estimate be guide range however full year operate cash flow guidance have be reiterate range free cash flow range third quarter company expect deliver adjust ep projection take consideration timing medicare part operate profit third fourth quarters relative precede year current zack consensus estimate third quarter be peg way company projection takecvs health post better expect second quarter result adjust ep revenue beating zack consensus estimate however poor year year retail ltc number margin debacle result dull earning performance company quarter nonetheless year year growth top line be due strong pharmacy service segment benefit upside specialty pharmacy unimpressive bottom line scenario also prompt company narrow earning outlook zack rank key pickscvs health have zack rank hold few better rank medical stock be edward lifescience corp ew free report insys therapeutic inc insy free report align technology inc algn free report sporting zack rank strong buy see complete list today zack rank stock here edward lifescience have long term expect earning growth rate stock have gain last month insys therapeutic have long term expect earning growth rate stock deliver stellar quarter average earning surprise align technology have expect long term adjust earning growth almost stock have surge roughly last month look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
916,ALGN,henry schein inc hsic free report report adjust earning share ep second quarter year year adjust ep also surpass zack consensus estimate year year upside earning be drive strong revenue growth henry schein report net income second quarter come share reflect year year growth respectively revenue detailhenry schein report revenue second quarter year year also zack consensus estimate year year improvement come back growth local currency partially offset decline owing foreign currency exchange local currency internally generate sale increase acquisition growth be henry schein inc price consensus ep surprise henry schein inc price consensus ep surprise henry schein inc company record sale north american market year year sale be international market year year segment analysis henry schein derive revenue operate segment dental medical animal health technology value add service second quarter company derive revenue global dental sale year year include growth local currency decline owing foreign currency exchange local currency internally generate sale increase acquisition growth be internal growth local currency include growth north america rise internationally company global animal health segment witness improvement revenue include growth local currency decline related foreign currency exchange local currency internally generate sale increase acquisition growth be internal growth local currency include growth north america growth internationally worldwide medical revenue scale year year growth local currency be decrease owing adverse foreign exchange revenue global technology value add service grow include growth local currency decline related foreign currency exchange be contribution acquisition quarter review margin trend gross profit increase report quarter however gross margin decline basis point bps year quarter due rise cost sale higher revenue growth rate rise selling general administrative expense adjust operate income improve year year moreover adjust operate margin remain flat year year report quarter financial positionhenry schein exit second quarter cash cash equivalent compare end first quarter year date net cash provide operate activity be compare year period quarter review company buy back approximately share almost close second quarter company have authorize future repurchase common stock ep guidance intacthenry schein reaffirm report ep guidance litigation settlement expense company still expect ep range reflect growth ep figure zack consensus estimate adjust ep be guide range takehenry schein exit second quarter solid note earning sale beating zack consensus estimate operate segment deliver strong year year growth company strong share gain north american overseas market strong revenue raise optimism however better expect earning performance be disappoint company unchanged ep guidance meanwhile year year deterioration henry schein gross operate margin be due higher cost sale expense also foreign currency fluctuation continue mar company financial zack rank key pickshenry schein have zack rank buy few other top rank medical stock be edward lifescience corporation ew free report insys therapeutic inc insy free report align technology inc algn free report notably edward lifescience insys therapeutic align technology sport zack rank strong buy see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock post stellar quarter average earning surprise align technology have expect long term adjust earning growth almost stock have add roughly last month edward lifescience have long term expect earning growth rate stock have gain last month look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
917,ALGN,orthofix international ofix free report report second quarter adjust earning share ep continue operation cent line zack consensus estimate adjust earning improve year year primarily strong sale growth company biologic spine fixation strategic business unit sbu exclude time item net income second quarter come cent share show remarkable year year improvement net loss cent sale detailsorthofix second quarter sale improve constant exchange rate cer figure also beat zack consensus estimate sale be primarily drive better expect performance company sbus significant contribution biologic spine fixation orthofix international price consensus ep surprise orthofix international price consensus ep surprise orthofix international quotesbu second quarter company report biostim sale reflect same cer growth prior year quarter favorable nass coverage recommendation introduction advanced spinal fusion therapy product extensive sale force be major driver biostim business biologic sbu sale quarter totale same cer prior year quarter be lead strong demand trinity elite due expand distributor network reacquisition national hospital contract increase contribution national distributor partner extremity fixationsale be report quarter show decline cer second quarter however exclude plan subsidiary restructure loss sale due divestiture core business impact trail month growth rate business be cer orthofix report spine fixation sbu sale reflect same cer growth prior year quarter be attribute strong growth strategic initiative second quarter gross margin expand basis point bps solid top line growth be major factor have contribute improve gross margin sale marketing expense rise year year millionow increase sale mix newly add distributor biologic elevated spending extremity fixation accelerate sale growth general administrative expense be lead increase investment implement strategic initiative design company legal settlement stock base compensation company also witness rise research development expense accordingly adjust operate margin quarter contract bps result increase operate expense cash exit second quarter cash cash equivalent compare end first quarter year date net cash provide operate activity be compare year period exclude capital expenditure free cash flow be report quarter compare capital expenditure lead free cash flow year period update guidancebanking solid second quarter performance orthofix have raise full year sale expectation previous zack consensus estimate full year revenue be peg guide range adjust ep expectation have also be raise zack consensus estimate full year adjust ep stand line low end company project range company exit second quarter mixed note sale beating zack consensus estimate earning meeting same management top line be substantially drive strength biologic spine fixation business be expect continueon back improve performance sale partner expand distributorship network introduction product moreover company seem be upbeat encourage response receive spinal stim cervical stim bone growth therapy device launch earlier moreover company cetra anterior cervical plate have witness strong market adoption result sale first month launch continue slew product development launch company recently launch rival full line foot ankle internal fixation system also extremity fixation space company recently launch juniortho new brand orthopedic product currently account roughly third extremity fixation sale also believe raise full year guidance be indicative enhance prospect flip side currency fluctuation competitive landscape macroeconomic headwind continue challenge company moreover higher operate expense be also matter concern orthofix also increase dependence third party final distribution product expose company increase risk zack rank key picksorthofix have zack rank hold few better rank medical stock be edward lifescience corporation ew free report insys therapeutic inc insy free report align technology inc algn free report notably edward lifescience insys therapeutic align technology sport zack rank strong buy see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock post stellar quarter average earning surprise align technology have expect long term adjust earning growth almost stock have add roughly last month edward lifescience have long term expect earning growth rate stock have gain last month look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
918,ALGN,haemonetic corporation hae free report report adjust earning share ep cent first quarter fiscal year year figure also beat zack consensus estimate cent report basis haemonetic post net income cent share year quarter net loss loss cent total revenuerevenue inched year year constant exchange rate cer report quarter miss zack consensus estimate management hospital business cell salvage transfusion management revenue increase cer year year decline orthopat cell saver decline be more offset growth bloodtrack other hospital software product haemonetic corporation price consensus ep surprise haemonetic corporation price consensus ep surprise haemonetic corporation report quarter haemonetic witness year year same cer fall revenue north america also international revenue decline cer revenue product report operate result business franchise plasma haemostasis management cell process blood center plasma report revenue total revenue be year year cer revenue bloodcenter total revenue decline cer hemostasis management franchise revenue total revenue rise cer revenue cell process inched only cer total revenue first quarter gross margin be basis point bps year year uptick gross profit operate income be first quarter fiscal operate loss year quarter financial exit first quarter fiscal cash cash equivalent compare end precede year company long term obligation exclude current portion be report quarter end fourth quarter fiscal haemonetic generate operate cash flow end first quarter fiscal compare year quarter end first quarter fiscal company report free cash flow transformation restructure cost compare year quarter fiscal reaffirm fiscal guidance company still expect full year revenue be line fiscal revenue guidance plasma revenue growth be range inclusive sebra divestiture represent annual plasma revenue zack consensus estimate sale be peg company also expect adjust ep band zack consensus estimate be guide range management continue expect strong cash generate activity fiscal cash hand fund business activity takehaemonetic exit first quarter fiscal mixed note earning beating zack consensus estimate revenue miss same encourage growth plasma haemonetic management franchise other franchise be quite dampener meanwhile company strong cash position boost investor confidence year year increase report sale gross margin buoy optimism company be also optimistic strong market adoption nexsys pcs plasmapheresis system recently receive fda approval further company reaffirm guidance fiscal be encourage zack rank key pickshaemonetic have zack rank hold few better rank medical stock be edward lifescience corporation ew free report insys therapeutic inc insy free report align technology inc algn free report notably edward lifescience insys therapeutic align technology sport zack rank strong buy see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock post stellar quarter average earning surprise align technology have expect long term adjust earning growth almost stock have add roughly last month edward lifescience have long term expect earning growth rate stock have gain last month look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
919,ALGN,bio rad laboratory inc bio free report report second quarter earning cent share huge decline year earning cent quarter figure also miss zack consensus estimate cent wide margin notably net income second quarter be hit lower sale weaker gross profit increase acquisition related expenditure new product technology higher expense implementation new system operation europe net sale quarter come year year constant exchange rate cer sale also miss zack consensus estimate year year fall sale be largely due slowdown productivity related recent go live company global erp system western europe well shift sale first quarter anticipation erp deployment bio rad laboratory inc price consensus ep surprise bio rad laboratory inc price consensus ep surprise bio rad laboratory inc quotequarter detailon segmental basis life science segment net sale come year year cer cer sale rise back strong sale droplet digital pcr ddpcr instrument reagent offset decrease process chromatography medium sale erp related disruption clinical diagnostic company register sale year year cer decline result significant slowdown european sale especially infectious disease product directly related disruption post go live new erp system gross margin second quarter be basis point bps year year decline gross profit adjust operate loss report quarter be compare operate profit year quarter company exit second quarter cash cash equivalent short term investment compare end year date net cash provide operate activity be compare year period guidance dismal second quarter performance bio rad continue expect organic sale growth approximately cer full year growth rate assume recovery substantial portion erp related sale disruption take place second quarter lower anticipate operate profit first half include addition raindance technology company have lower currency neutral operate margin projection full year range earlier guidance bottom linebio rad post disappointing quarterly show earning sale significantly lag zack consensus estimate sale growth be majorly hampered slower productivity result erp deployment western europe well lower expect sale process medium business however company reiterate organic growth expectation indicate chance recovery zack rank key picksbio rad have zack rank hold few better rank medical stock worth consider be edward lifescience corporation ew free report insys therapeutic inc insy free report align technology inc algn free report sporting zack rank strong buy see complete list today zack rank stock here edward lifescience have long term expect earning growth rate stock have gain last month insys therapeutic have long term expect earning growth rate stock deliver stellar quarter average earning surprise align technology have expect long term adjust earning growth almost stock have rally roughly last month look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
920,ALGN,aug issue update research report st paul mn base cardiovascular system inc csii free report company be medical device manufacturer develop commercialize innovative solution treat patient suffering peripheral coronary arterial disease include arterial calcium majority last month cardiovascular system have outperformed broader industry respect price currently stock be better gain broader industry cardiovascular system deliver remarkable fourth quarter result earning revenue beating zack consensus estimate company lower operate expense drive year year improvement earning strong revenue performance also contribute upside earning moreover improvement margin be encourage overall company fiscal performance have be impressive company fiscal guidance also instill confidence investor recent development cardiovascular system have receive fda approval radial access diamondback peripheral orbital atherectomy device also year result liberty study be be present amputation prevention symposium amp flip side company operate competitive medical device industry get significantly affected product introduction failure expand business overseas hamper growth also profitability front cardiovascular bear long history net loss inception immediate recovery sight fiscal company incur net loss management still expect incur net loss first quarter fiscal zack rank key system have zack rank hold few better rank medical stock be edward lifescience corporation ew free report insys therapeutic inc insy free report align technology inc algn free report notably edward lifescience insys therapeutic align technology sport zack rank strong buy see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock post stellar quarter average earning surprise align technology have expect long term adjust earning growth almost stock have add roughly last month edward lifescience have long term expect earning growth rate stock have gain last month trade profit big league trump policiesif stock spark interest look company prime make substantial gain washington change course today zack reveal ticker benefit new trend streamline drug approval tariff lower taxe higher interest rate spending surge defense infrastructure see buy recommendation now
921,ALGN,headquarter menlo park pacific bioscience california inc pacb free report pioneer field single molecule long resequence technology smrt report loss cent share second quarter figure be cent wider zack consensus estimate fact figure be also wider loss cent report year quarter revenue miss zack consensus estimate decline year year basis service revenue rise year year basis gross margin second quarter be net revenue versus year quarter research development expense totale lower report year quarter pacific bioscience california inc price consensus ep surprise pacific bioscience california inc price consensus ep surprise pacific bioscience california inc quotesel general administrative sg expense totale significantly higher year balance sheetcash investment end second quarter be compare end first quarter guidance pacific bioscience reaffirm guidance product service revenue full year range company also expect gross margin growth assume revenue increase anticipate overall company expect gross margin percentage reach mid end year takepacific bioscience exit second quarter disappointing note loss wider estimate revenue miss zack consensus estimate also gap loss widen year quarter revenue decrease same poor margin also add wo however be encourage new agreement inked august pacific bioscience california novogene corp novogene purchase sequel system give dna sequence service provider capacity run sequel system time zack rank key pickspacific bioscience have zack rank hold few better rank medical stock be edward lifescience corp ew free report insys therapeutic inc insy free report align technology inc algn free report notably edward lifescience insys therapeutic align technology sport zack rank strong buy see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock post stellar quarter average earning surprise align technology have expect long term adjust earning growth almost stock have add roughly last month edward lifescience have long term expect earning growth rate stock have gain last month today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return respectively outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
922,ALGN,medical group wmgi free report report adjust loss cent share second quarter narrower zack consensus estimate loss cent also loss narrow cent year year basis net sale second quarter totale surpass consensus mark meanwhile last quarters company deliver positive earning surprise average be currently stock have zack rank hold quarter detailwright medical currently report revenue total extremity biologic segment consolidated sale segment increase year quarter almost internationally sale extremity biologic business be year year medical group price consensus ep surprise medical group price consensus ep surprise medical group quotetotal extremity biologic include sub segment namely lower extremity upper extremity biologic sport med other lower extremity sale segment increase year year basis quarter lower extremity business sale increase second quarter management growth lower extremity be drive total ankle growth rate reduce headwind synergy result percentage point improvement first quarter growth rate internationally lower extremity sale fall year year basis upper extremity sale segment increase year year basis quarter review upper extremity business grow year year basis drive ongoing launch perform reversed glenoid expand blueprint surgical plan module become available quarter however upper extremity sale decrease year year basis internationally biologic sale segment rise year year basis quarter biologic business grow quarter management augment have impressive quarter improvement average daily revenue compare first quarter core biologic portfolio continue be challenge management expect growth biologic business second half sale force expansion initiative lower extremity cross selling program core biologic product upper extremity sale force sale segment grow internationally year year basis sport med other sale segment drop year quarter sport med other segment sale decline increase internationally second quarter margin detailsadjust gross margin percentage revenue be peg quarter expansion roughly basis point bps year year basis selling general administrative expense account total revenue second quarter totale contraction bps year quarter notably expense research development be second quarter year year basis guidancewright medical reiterate full year guidance company continue expect net sale full year band represent growth include negative impact foreign currency exchange approximately notably midpoint net sale guidance represent constant currency growth approximately company forecast full year adjust ebitda continue operation range takewright medical exit second quarter impressive note revenue earning beating zack consensus estimate also strong margin reiterate full year outlook buoy optimism company be putt effort product innovation research development medical launch invision total ankle revision system july be first system develop total ankle revision arthroplasty management perform reversed launch boost revenue later half year company deliver additional instrument set field however decrease lower extremity sale upper extremity sale internationally be matter concern key picksa few better rank medical stock be edward lifescience corporation ew free report insys therapeutic inc insy free report align technology inc algn free report notably edward lifescience insys therapeutic align technology sport zack rank strong buy see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock post stellar quarter average earning surprise align technology have expect long term adjust earning growth almost stock have add roughly last month edward lifescience have long term expect earning growth rate stock have gain last month today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return respectively outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
923,ALGN,goleta base inogen inc ingn free report report second quarter earning cent share year year comfortably beat zack consensus estimate cent year figure cent upside be drive roughly growth revenue totale beating zack consensus estimate almost detailssale revenue surge rental revenue decline business business business business domestic sale be year year basis almost primarily drive traditional home medical equipment provider purchase consistent strength private label partner inogen inc price consensus ep surprise inogen inc price consensus ep surprise inogen inc quotemeanwhile business business international sale rise almost back solid demand company partner europe direct consumer direct consumer domestic sale advanced almost however direct consumer rental sale fall decline be attribute decrease rental reimbursement rate company increase strategic focus sale margin detailsin report quarter inogen register gross margin percentage revenue basis point bps year year basis meanwhile sale gross margin expand bps quarter percentage revenue management increase sale gross margin be drive lower material cost result decrease cost good sell quarter rental gross margin be report quarter much lower second quarter be primarily drive lower net revenue rental patient lead fall reimbursement rate however decline rental gross margin be partially offset decrease cost rental revenue particularly lead lower depreciation servicing cost adjust ebitda rise year year basis guidancebanking solid performance second quarter inogen raise revenue adjust net income guidance moreover company narrow full year adjust ebitda guidance inogen project revenue range higher previous range represent year year growth previously provide range company expect rental revenue decline courtesy lower average rental revenue patient continue focus sale adjust ebitda be now project band compare project previously thereby present increase year year inogen expect adjust net income range previously provide range represent year year growth compare previous range takeinogen report stellar second quarter beating zack consensus estimate count company witness solid growth revenue adjust earning year year basis view solid domestic international business business sale have drive stellar quarterly performance fact company expect direct consumer sale be fastest grow channel follow domestic business business sale come quarters solid focus europe context company recently sign lease expansion site ohio accelerate growth domestic direct consumer sale channel moreover second quarter company take series strategic initiative strengthen product offering market position regard company successfully integrate medsupport system acquire continue slew product development launch company receive ec certificate product jun management company also effectively launch new customer relationship management crm system jun latest development be expect enhance productivity sale bill customer service team long term flip side decline rental revenue raise concern mar company prospect moreover company generate significant portion revenue international market volatile foreign exchange rate always continue concern company zack rank key picksinogen currently carry zack rank hold few better rank medical stock be edward lifescience corporation ew free report insys therapeutic inc insy free report align technology inc algn free report notably edward lifescience insys therapeutic align technology sport zack rank strong buy see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock post stellar quarter average earning surprise align technology have expect long term adjust earning growth almost stock have add roughly last month edward lifescience have long term expect earning growth rate stock have gain last month today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return respectively outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
924,ALGN,aug issue update research report san diego base illumina inc ilmn free report company provide tool integrate system analysis genetic variation function illumina exit second quarter solid note earning revenue beating zack consensus estimate top line be strong new product launch include veriseq nipt solution europe strength novaseq more good news be rate nipt adoption be increase outside notably last month illumina have be trading broader industry stock have grow period compare gain broader industry company raise guidance be also encourage enough indicate bullish trend continue come period also demand novaseq surpass company expectation order beating forecast more novaseq instrument have be order launch january be also look forward grail illumina own develop company focuse cancer screening market clinical market demand customer undergo oncology testing remain robust be currently look forward performance extend ra panel slate launch third quarter significantly june company announce fda approval receipt extend ra companion diagnostic kit class iii pma flip side weak margin owing novaseq launch higher array service revenue product mix sequence consumable continue act deterrent also national institutes health nih funding issue tough competitive landscape be other few concern deal zack rank key picksillumina currently have zack rank hold better rank medical stock be edward lifescience corporation ew free report insys therapeutic inc insy free report align technology inc algn free report sporting zack rank strong buy see complete list today zack rank stock here edward lifescience have long term expect earning growth rate stock have gain last month insys therapeutic have expect long term earning growth rate stock have gain last month align technology have expect long term adjust earning growth almost stock have surge roughly last month today stock zack hottest strategy hard believe even zack market gain top stock pick screen have return respectively outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
925,ALGN,bruker corporation brkr free report report adjust earning share ep cent second quarter year figure adjust ep also beat zack consensus estimate cent exclude time adjustment bruker report net income cent share second quarter reflect increase respectively year quarter revenue detailbruker report revenue second quarter year year top line surpass zack consensus estimate exclude positive effect acquisition negative effect change foreign currency rate bruker report year year organic revenue growth second quarter geographically currency adjust european revenue increase high single digit second quarter backed encourage impact acquisition north america revenue increase low single digit lead growth best ost acquisition asia pacific organic revenue rise roughly drive continue strong performance china management company register organic revenue growth base mid teen growth calid group strength best bruker corporation price consensus ep surprise bruker corporation price consensus ep surprise bruker corporation bruker biospin group report mid single digit revenue growth lead grow uptake lower field nmr nuclear magnetic resonance bruker nano report decline year year organic revenue second quarter mainly due lower revenue semiconductor metrology product bruker calid group report year year mid teen revenue growth second quarter upside be largely drive increase rapiflex revenue strong performance consumable aftermarket service sale best revenue rise substantial organically year year basis backed higher mri oem consumer demand bruker ost acquisition nov margin trendgross margin report quarter contract basis point bps accord company adjust gross margin decline bps lead robust revenue growth lower margin best business further affected acquisition ost together have adverse impact roughly bps moreover biospin business witness drop margin year year due product mix selling general administrative expense increase research development expense rise year period other charge decline year year overall operate margin expand bps financial positionbruker exit second quarter cash cash equivalent short term investment end first quarter year date net cash provide operate activity be compare year period guidancebruker provide update guidance full year total revenue growth rate expectation year have be significantly raise new band earlier moreover organic revenue growth guidance have be raise previously continue acquisition growth expectation unchanged change foreign currency rate be expect have adverse impact revenue approximately mark improvement project previously current zack consensus estimate revenue be peg company also expect adjust operate margin increase approximately bps year year unchanged previous guidance include approximate bps headwind fiscal recent acquisition bottom line front bruker raise adjust ep projection new range current zack consensus estimate ep be peg takebruker exit second quarter solid note earning revenue beating zack consensus estimate company also raise full year guidance be indicative brighter prospect move company strategic acquisition activity have be encourage context company recently announce completion acquisition field portable platform technology platform product line acquisition widen bio detection offering encapsulate range bacterial viral toxin detection solution homeland security microbiology application be also upbeat company current focus product development latest fda approval add new species maldi biotyper system efficient microbial identification flip side currency fluctuation competitive landscape macroeconomic headwind continue challenge company zack rank other key picksbruker currently carry zack rank buy few top rank medical stock be edward lifescience corporation ew free report insys therapeutic inc insy free report align technology inc algn free report notably edward lifescience insys therapeutic align technology sport zack rank strong buy see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock post stellar quarter average earning surprise align technology have expect long term adjust earning growth almost stock have add roughly last month edward lifescience have long term expect earning growth rate stock have gain last month today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return respectively outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
926,ALGN,hologic inc holx free report report third quarter fiscal adjust earning share ep cent year year however adjust ep beat zack consensus estimate penny remain upper end company guidance cent strong top line growth lead better expect ep increase report quarter report basis company record net income cent share reflect year year decline respectively revenue detailrevenue gross quarter year year top line also exceed zack consensus estimate company own estimation constant exchange rate cer revenue growth be solid growth hologic molecular diagnostic gyn surgical business segment drive upside top line hologic inc price consensus ep surprise hologic inc price consensus ep surprise hologic inc revenue grow year year exclude blood screening medical aesthetic revenue rise other hand international revenue be cer banking increase revenue breast health gyn surgical product exclude blood screening medical aesthetic international revenue increase constant currency segment detailrevenue diagnostic segment total revenue decline year year cer second quarter segment molecular diagnostic revenue increase cer be primarily drive increase market share utilization fully automate panther system market expansion conform testing guideline internationally result be strong acquire benefit new leadership healthy panther placement multiple new product introduction include viral load assay cytology perinatal revenue also show decline cer revenue breast health segment inched cer revenue decline reduce incremental placement gantry international revenue however climb year year revenue gyn surgical business be cer medical aesthetic business quarter report revenue total revenue revenue skeletal health accounting rest drop cer operational updatein fiscal third quarter hologic gross margin contract basis point bps adjust gross margin also decrease bps due product geographic revenue mix divestiture blood screening business full quarter revenue low margin cynosure product hologic adjust operate expense amount year year adjust operate margin contract massive bps financial updatehologic exit fiscal third quarter cash cash equivalent considerably report end second quarter total long term debt be end fiscal third quarter compare end precede quarter year date operate cash outflow be compare cash inflow same period last year fiscal guidancehologic reduce revenue guidance fiscal company currently expect revenue range earlier band new outlook reflect annualize growth previously be current zack consensus estimate remain company provide guidance management have however raise lower end earlier provide adjust ep outlook fiscal hologic currently project adjust ep range previous fiscal reflect annualize growth current zack consensus estimate adjust ep be peg fall just upper end guide range fourth quarter fiscal hologic expect revenue represent annualize growth current zack consensus estimate fourth quarter revenue be close upper end project range adjust ep be project cent annualize decline current zack consensus estimate fourth quarter adjust ep be peg cent company guidance takehologic post better expect third quarter fiscal result term earning revenue company strong cash position be encourage factor however be disappoint decrease revenue company diagnostic segment blood screening divestiture be expect mar company growth momentum day ahead overall company reduce revenue guidance fiscal lower investor confidence stock zack rank other key pickshologic currently have zack rank sell medical stock worth consider be edward lifescience corporation ew free report insys therapeutic inc insy free report align technology inc algn free report stock sport zack rank strong buy see complete list today zack rank stock here insys therapeutic have expect long term earning growth rate stock have gain last month align technology have expect long term adjust earning growth almost stock have surge roughly last month edward lifescience have long term expect earning growth rate stock have gain last month more stock news tech opportunity worth driverless car artificial intelligence ve see unsurpassed growth high tech product recent month yesterday science fiction be become today reality innovation be single component tech company survive demand critical device reach year alone likely grow even faster future zack have release brand new special report help take advantage exciting investment opportunity most importantly reveal stock massive profit potential see stock now
927,ALGN,cardiovascular system inc csii free report report adjust earning share cent fourth quarter fiscal reflect massive improvement year quarter adjust loss cent share quarter number compare favorably zack consensus estimate loss cent year year improvement be primarily backed revenue growth lower operate expense account company cost realignment action full year adjust earning come loss cent share narrower year loss also loss figure be narrower zack consensus estimate loss cent number system post revenue fiscal fourth quarter mark year year increase figure also surpass zack consensus estimate cardiovascular system inc price consensus ep surprise cardiovascular system inc price consensus ep surprise cardiovascular system inc quotefiscal register revenue year number also revenue outpaced zack consensus estimate management company receive approval new orbital atherectomy device give physician more tool effectively routinely treat patient suffering coronary peripheral artery disease also approval diamondback coronary orbital atherectomy system micro crown japan mark company first international expansion begin calendar year date cardiovascular system sell device lead institution company add new peripheral account coronary account fiscal fourth quarter coronary device revenue improve year year peripheral device revenue rise margingross margin report quarter be basis point bps year year primarily account rise revenue meanwhile selling administrative sg expense contract research development expense be resultant adjust operate expense decrease primarily exhibit management cost realignment initiative consequently operate profit be improve loss year financial company exit fourth quarter fiscal cash cash equivalent compare end third quarter fiscal system issue first quarter fiscal fiscal guidance company expect revenue range fiscal current zack consensus estimate fiscal revenue be peg be company guidance company also expect revenue range first quarter fiscal current zack consensus estimate be peg slightly company guide range moreover company expect gross profit account revenue operate expense be estimate first quarter fiscal company expect incur net loss loss share cent first quarter fiscal current zack consensus estimate be peg breakeven company guide range system deliver remarkable fourth quarter result earning revenue beating zack consensus estimate also cardiovascular system fiscal performance have be impressive company lower operate expense drive year year improvement earning strong revenue performance also contribute upside earning moreover improvement margin be encourage company fiscal guidance also instill confidence investor company achieve several milestone quarter notably have receive fda approval radial access diamondback peripheral orbital atherectomy device year result liberty study be be present amputation prevention symposium amp zack rank key system currently have zack rank hold few better rank medical stock be edward lifescience corporation ew free report insys therapeutic inc insy free report align technology inc algn free report notably edward lifescience insys therapeutic align technology sport zack rank strong buy see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock have gain last month align technology have expect long term adjust earning growth almost stock have add roughly last month edward lifescience have long term expect earning growth rate stock have gain last month more stock news tech opportunity worth driverless car artificial intelligence ve see unsurpassed growth high tech product recent month yesterday science fiction be become today reality innovation be single component tech company survive demand critical device reach year alone likely grow even faster future zack have release brand new special report help take advantage exciting investment opportunity most importantly reveal stock massive profit potential see stock now
928,ALGN,headquarter irvine medical device major edward lifescience corporation ew free report specialize advanced cardiovascular disease especially structural heart disease stock be healthy growth trajectory late have rally last month ahead gain broader industry stock have market cap company year historical growth rate be also favorable compare broader industry solid prospect zack rank strong buy stock be attractive pick company estimate revision trend current quarter have also be positive past day analyst moved north movement opposite direction magnitude estimate revision increase cent share same time frame let find recent positive trend be sustainable edward lifescience second quarter performance be quite promising company beating zack consensus estimate revenue earning moreover raise guidance hint brighter prospect fact guidance raise be backed strong performance company product line market be also upbeat edward lifescience recent fda approval inspiris resilium aortic valve be first class resilient heart valf company also announce receipt fda approval aortic mitral valve valve procedure used edward lifescience sapien transcatheter heart valve believe recent fda approval several product have be boost investor confidence stock be encourage edward lifescience focus build pipeline further strengthen foothold operate business company also witness growth emerge portfolio mitral tricuspid repair therapy latest plan company new ultra system include balloon delivery system next generation sheath technology be expect be available europe second half company be track initiate launch acumen hpi software suite new flotrac iq smart disposable inspiris resilium aortic valve europe japan end however stiff competition currency headwind reimbursement issue be challenge stock other key picksother top rank medical stock be idexx laboratory inc idxx free report lantheus holding inc lnth free report align technology inc algn free report align technology sport zack rank lantheus holding idexx laboratory carry zack rank buy cansee complete list today zack rank stock here align technology have long term expect earning growth rate stock have rally roughly last month lantheus holding have long term expect earning growth rate stock have gain last month idexx laboratory have long term expect earning growth rate stock have gain last month simple trading ideasince zack system have more double average gain year compound rebalance exclusive fee turn thousand million dollar proven stock pick system be ground single big idea be fortune shape life change apply portfolio start today learn more
929,ALGN,california base align technology inc algn free report designer manufacturer invisalign system have rally last month ahead gain stock have market cap company year historical growth rate be also favorable compare broader industry also company represent return almost better broader industry gain last year solid prospect zack rank strong buy stock be attractive pick present company estimate revision trend current year have also be positive past day analyst moved north movement opposite direction magnitude estimate revision increase share same time frame let find recent positive trend be sustainable recently align technology end second quarter solid note earning revenue beating zack consensus estimate moreover align technology be add standard poor index jun company have be add gic health care supply sub industry index have bolster investor confidence stock imply promising prospect ahead same month company announce encourage step strengthen position invisalign brand most popular product line keep strategy expand invest rapidly grow asia pacific region align technology announce plan build first invisalign manufacturing facility china company announce receipt patent smarttrack aligner material be exclusively used invisalign aligner treatment move bid gain traction same platform mar align technology collaborate digital design post collaboration align technology invisalign clear aligner treatment be used dentist tooth alignment procedure design protocol be also upbeat multus dollar marketing campaign initiate company invisalign brand order gain increase awareness be also optimistic company expand work flow option lead itero scanner context align technology recently launch software upgrade itero element intraoral scanner be capable compare patient scan time new timelapse technology additionally company have strong cash balance enable carry share repurchase program turn provide solid return investor however include unfavorable foreign currency affect company revenue also company be expose seasonal demand fluctuation higher operate expense pertain increase head count higher investment target growth acceleration geographical expansion portfolio expansion other key picksother top rank medical stock be edward lifescience corp ew free report steris plc ste free report lantheus holding inc lnth free report edward lifescience sport zack rank steris lantheus holding carry zack rank buy see complete list today zack rank stock here edward lifescience have long term expect earning growth rate stock have gain last month steris have positive earning surprise trail quarters stock have gain last month lantheus holding have long term expect earning growth rate stock have gain last month hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
930,ALGN,share price sunnyvale base intuitive surgical inc isrg free report scale new week high aug eventually close bit lower company have gain last month much better rise broader industry gain take stable performance stock consideration expect intuitive surgical scale higher come quarters company positive long term growth also hold promise average volume share trade last year be remarkable approximately stock have market cap last day analyst have raise earning estimate current year have slash estimate net effect have take zack consensus estimate current quarter share market be upbeat intuitive surgical licensing agreement justright surgical deal enable intuitive surgical global license justright surgical intellectual property energy base vessel sealing tissue stapling technology use robotic field joint product development equity financing arrangement be also part agreement intuitive surgical inc price consensus intuitive surgical inc price consensus intuitive surgical inc quotealso company post impressive second quarter earning revenue register year year increase quarter company also witness growth segment international performance be also encourage believe grow adoption intuitive surgical da vinci system physician general surgery oncology urology gynecology procedure be key catalyst moreover increase procedural volume outside unite state open considerable opportunity company company be further putt effort product innovation research development regard recent fda approval da vinci instill confidence investor apart company be expect gain prominence europe asia enhance organizational capability further drive stock price zack rank key picksintuitive carry zack rank hold few better rank medical stock be edward lifescience corp ew free report lantheus holding inc lnth free report align technology inc algn free report edward lifescience align technology sport zack rank strong buy lantheus holding carry zack rank buy see complete list today zack rank stock here edward lifescience have long term expect earning growth rate stock have gain last month align technology have long term expect earning growth rate stock have rally roughly last month lantheus holding have long term expect earning growth rate stock have gain last month hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
931,ALGN,medical device major medtronic plc mdt free report be focuse expand core coronary structural heart business keep line company recently announce global randomize clinical trial evaluate month dual antiplatelet therapy dapt patient implanted resolute onyx drug eluting stent de percutaneous coronary intervention pci procedure dapt be combination aspirin clot medication notably resolute onyx de be first de work core wire technology evolution continuous sinusoid technology cst resolute onyx de provide enhance visibility surgeon deliver superior clinical performance accord medtronic resolute onyx month dapt study aim help inform dapt guideline newer generation de currently support bare metal stent bms stable ischemic heart disease patient require shorter dual antiplatelet regimen study also demonstrate medtronic clinical investment provide relevant dapt evidence physician current previous generation de dapt therapy guideline vary geographically well patient presentation duration dapt evaluation be make base individual clinical judgment evaluate benefit risk ratio product labele patient preference study be base approximately patient worldwide company press release resolute onyx month dapt study outcome build resolute pooled dapt interruption analysis show increase risk stent thrombosis dapt interruption discontinuation month take consideration huge grow global coronary stent market believe latest initiative medtronic be well time report transparency market research global coronary stent market be expect see cagr recent development coronary stentrecently medtronic announce de have meet primary endpoint target lesion failure tlf year treatment coronary artery disease extra small vessel also late resolute onyx de receive fda approval further post successful launch resolute onyx de medtronic have start selling japan market jul cardiovascular business report release jul note last month medtronic have outperformed index latest share price movement company have gain compare gain zack rank key picksmedtronic currently carry zack rank hold few better rank medical stock be edward lifescience corp ew free report lantheus holding inc lnth free report align technology inc algn free report edward lifescience align technology sport zack rank strong buy lantheus holding carry zack rank see complete list today zack rank stock here edward lifescience have long term expect earning growth rate stock have gain last month align technology have long term expect earning growth rate stock have rally roughly last month lantheus holding have long term expect earning growth rate stock have gain last month hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
932,ALGN,aug issue update research report haemonetic corporation hae free report base lead provider blood management solution customer encompass blood plasma collector hospital health care provider globally stock currently carry zack rank hold past month haemonetic have be trading broader industry stock now have rally compare broader industry increase company exit first quarter fiscal mixed note earning beating zack consensus estimate revenue miss same however year year increase report sale gross margin buoy optimism market be also upbeat haemonetic encourage growth plasma haemonetic management franchise company swung operate income first quarter fiscal loss year quarter haemonetic corporation price consensus haemonetic corporation price consensus haemonetic corporation quotehaemonetic have be witness strong flourish plasma franchise quite time now management have also maintain high confidence continue growth commercial plasma collection business quarter north america plasma disposable revenue increase growth continue be lead strong end market demand plasma derive company hospital business be also progress well teg line product have gain popularity worldwide teg be approve broad set indication top market teg teg manager be sanction same set indication europe australia japan flip side company have be witness sluggish revenue growth blood center franchise significantly affect haemonetic result past few quarters management also doesn expect early recovery blood center outcome macroeconomic uncertainty continue challenge haemonetic management also anticipate slower expect product adoption customer reduce revenue profit also currency fluctuation stiff competition continue hamper stock other key picksa few better rankedmedical stock be edward lifescience corp ew free report steris plc ste free report align technology inc algn free report edward lifescience align technology sport zack rank strong buy steris carry zack rank buy see complete list today zack rank stock here edward lifescience second quarter adjust earning surge stupendous year year primarily drive strong sale growth company transcatheter heart valf business stock have gain last month steris report first quarter fiscal adjust earning share cent year quarter also adjust gross margin improve basis point year year report quarter stock have gain last month align technology second quarter adjust ep cent be substantial year year revenue climb year year stock have rally roughly last month hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
933,ALGN,aug issue update research report palo alto base varian medical system inc var free report company be world lead provider radiotherapy radiosurgery proton therapy brachytherapy treat cancer other medical condition varian medical have unimpressive run bourse last month trading industry term price performance glimpse share price movement reveal varian medical share have lose compare unfavorably decline industry look forward varian medical oncology proton therapy business growth prospect remain impressive company be address tier mid tier market edge truebeam vitalbeam halcyon product company be winning contract not only americas also emerge international market be huge positive believe china africa present significant top line growth opportunity term company be open new office africa middle east provide growth opportunity region varian medical operate technology drive environment success depend innovation frequent product update company have be successful front evident year year growth top line company have approximately revenue opportunity various oncology imaging component product next year varied offering include truebeam edge platform insightive analytic qumulate qa rapidplan knowledge base treatment plan believe varian medical innovative product pipeline continue drive growth long term apart enjoy dominant market share conventional radiotherapy believe proton therapy also hold significant promise varian medical be probeam compact proton therapy system be superior other external beam radiotherapy precisely locate cancerous tumor cause lesser side effect surround tissue proton therapy system used same interface used company truebeam platform finally company strong overseas presence be expect enable leverage opportunity emerge market line grow demand cancer treatment overseas market varian medical sale europe africa particularly asia be grow faster rate domestic market flip side unfavorable currency translation continue be major dampener stock management fear further strengthen dollar foreign currency lead deteriorate operate result intense competition well possibility varian medical new test not generate meaningful profit outweigh cost associate development continue raise concern zack rank key picksvarian medical carry zack rank hold better rank medical stock be edward lifescience corp ew free report steris plc ste free report align technology inc algn free report edward lifescience align technology sport zack rank strong buy steris carry zack rank buy see complete list today zack rank stock here edward lifescience have positive earning surprise trail quarters stock have gain last month align technology have long term expect earning growth rate stock have rally roughly last month steris have positive earning surprise trail quarters stock have gain last month hottest tech mega trend year generate global revenue predict blast roof fame investor mark cuban say produce world first trillionaire still leave plenty money regular investor make right trade early see zack best stock play trend
934,ALGN,civita solution inc civi free report report third quarter fiscal adjust earning share ep continue operation cent surpass zack consensus estimate penny adjust earning improve year year primarily strong sale growth company post acute specialty rehabilitation service srs adult day health adh service revenue detailscivita solution third quarter revenue rise year year figure however lag zack consensus estimate company gain organic growth acquisition third quarter management organic growth be largely drive strong performance intellectual developmental disability dd also company acquire company report quarter total annual revenue moreover deal mostly cover dd srs adh service line segmental third quarter company report dd revenue reflect growth prior year quarter srs service revenue quarter totale prior year quarter risk youth ary servicesrevenue come report quarter flat third quarter level civita solutionsreport adh revenue reflect growth prior year quarter margin detailsin report quarter civita solution register gross margin basis point bps year year basis owing rise cost revenue general administrative expense decline lead enhance cost efficiency company cost restructure program accordingly adjust operate margin quarter expand bps guidancecivita solution lower high end fiscal revenue guidance company project revenue range lower previous range current zack consensus estimate revenue be peg high end company update guide range takecivita solution exit third quarter mixed note better expect earning revenue miss nonetheless be encourage company progress srs adh fastest grow business moreover company be witness steady contribution strategy grow organically acquisition however tweak fiscal guidance raise concern also even company seem be implement cost restructure program efficiently weak margin continue mar financial peer earning stock have perform well earning season be edward lifescience corp ew free report steris plc ste free report align technology inc algn free report edward lifescience second quarter adjust earning improve stupendous year year primarily drive strong sale growth company transcatheter heart valf business stock have gain last month align technology second quarter adjust ep cent be substantial year year revenue grow year year stock have rally roughly last month steris report first quarter fiscal adjust earning share cent year quarter also adjust gross margin improve bps year year report quarter stock have gain last month zack minute stock pick secretsince zack system have more double average gain year compound rebalance exclusive fee turn thousand million dollar here something even more remarkable master proven system go single class seminar then apply portfolio little minute month learn secret
935,ALGN,aug issue update research report salt lake city ut base molecular diagnostic provider myriad genetic inc mygn free report company currently carry zack rank hold past month myriad have be trading broader industry company have rally compare industry gain myriad end fiscal solid note fourth quarter number exceed zack consensus estimate company particularly observed strong growth endopredict genesight testing revenue also myriad witness third consecutive quarter rise hereditary cancer volume also receive provincial reimbursement quebec endopredict notably european league rheumatism eular meeting hold june spain crescendo bioscience wholly own subsidiary myriad release new datum meta analysis clinical study datum have demonstrated vectra da test ability predict joint damage same month company announce bracanalysis cdx companion diagnostic test have successfully identify brca mutate patient metastatic breast cancer olympiad trial have respond treatment olaparib better standard chemotherapy myriad collaboration astrazeneca beigene development companion diagnostic also raise optimism moreover myriad continue make progress kit base version prolaris mypath melanoma international market expect file ce mark prolaris moreover company have introduce elevate program target achieve incremental operate income fiscal management company have select project be anticipate deliver operate income fiscal fiscal flip side unfavorable currency translation continue be major dampener stock management fear further strengthen dollar foreign currency lead deteriorate operate result intensify competition well possibility myriad new test not generate meaningful profit outweigh cost associate development continue raise concern zack rank key pickssome better rank medical stock be edward lifescience corp ew free report steris plc ste free report align technology inc algn free report edward lifescience align technology sport zack rank strong buy steris carry zack rank buy see complete list today zack rank stock here edward lifescience have positive earning surprise trail quarters stock have gain last month align technology have long term expect earning growth rate stock have rally roughly last month steris have positive earning surprise trail quarters stock have gain last month trade profit big league trump policiesif stock spark interest look company prime make substantial gain washington change course today zack reveal ticker benefit new trend streamline drug approval tariff lower taxe higher interest rate spending surge defense infrastructure see buy recommendation now
936,ALGN,aug issue update research report ohio base steris plc ste free report manufacturer marketer infection prevention decontamination microbial reduction surgical support product service company currently carry zack rank buy steris post better expect result first quarter fiscal earning revenue beating zack consensus estimate however year year decline revenue be dampening positive note organic growth performance be strong segment further growth free cash flow reserve be indicative company strong cash balance also gross operate margin expand year year recently company make couple organizational change serve customer better way expect move enhance company cost structure well last month stock have gain outperformed decline broader industry however note government insurance company consistent effort curb healthcare cost have be putt pressure stock quite time be also concern current customer consolidation scenario continue affect company checked immediately competitive landscape weak cost reduction initiative be other overhang other key picksother top rank medical stock be edward lifescience corp ew free report stryker corporation syk free report align technology inc algn free report edward lifescience align technology sport zack rank strong buy stryker carry zack rank see complete list today zack rank stock here edward lifescience have positive earning surprise trail quarters stock have gain last month align technology have long term expect earning growth rate stock have rally roughly last month stryker have long term expect earning growth rate stock have gain last month trade profit big league trump policiesif stock spark interest look company prime make substantial gain washington change course today zack reveal ticker benefit new trend streamline drug approval tariff lower taxe higher interest rate spending surge defense infrastructure see buy recommendation now
937,ALGN,similar wise buy decision exit certain underperformer right time help maximize portfolio return selling loser be difficult share price estimate be fall be time get rid security more loss hit portfolio such stock want consider drop be brookdale senior live inc bkd free report have witness significant price decline past week have see negative earning estimate revision current quarter current year zack rank strong sell further confirm weakness bkd key reason move have be negative trend earning estimate revision full year have see estimate move past day compare upward revision trend have cause consensus estimate trend lower go share month current level also current quarter brookdale senior live have see downward estimate revision versus revision opposite direction drag consensus estimate cent share cent past day stock also have see pretty dismal trading lately share price have drop past month brookdale senior live inc price consensus brookdale senior live inc price consensus brookdale senior live inc quoteso not be good decision keep stock portfolio anymore least don have long time horizon be still interested medical sector instead consider better rank stock align technology inc algn free report stock currently hold zack rank strong buy be better selection time see complete list today zack rank strong buy stock here trade profit big league trump policiesif stock spark interest look company prime make substantial gain washington change course today zack reveal ticker benefit new trend streamline drug approval tariff lower taxe higher interest rate spending surge defense infrastructure see buy recommendation now
938,ALGN,aug issue update research report chesterbrook pa base corporation abc free report world largest pharmaceutical service company company focus provide drug distribution related service reduce health care cost improve patient outcome company currently have zack rank hold have unimpressive run bourse last month trading industry term price performance glimpse share price movement reveal share have lose compare unfavorably decline broader industry unfavorable performance be lead pricing pressure generic drug space lackluster guidance full year expect fiscal revenue growth range significantly lower previous band company expect brand drug inflation range take pharmedium healthcare holding back believe temporary slowdown pharmedium growth mar bottom line come quarters notably company aim boost investment enhance pharmedium qa qc quality assurance quality control system term product quality patient safety lend competitive advantage long haul result bottom line headwind business fiscal lackluster performance hepatitis revenue segment be concern regard witness significant negative revenue impact decline sale segment second quarter revenue improve only quarter have be adverse impact hepatitis segment cutthroat competition niche space be add concern operate highly competitive pharmaceutical distribution related health care service market company primary competitor include cardinal health cah free report mckesson mck free report national generic regional distributor generic industry be face consolidation customer manufacturer globalization increase quality regulatory challenge company also face competition manufacturer chain drugstore specialty distributor packaging health care technology company better rank stock broader medical sector be align technology inc algn free report zack rank strong buy see complete list today zack rank stock here align technology have expect long term adjust earning growth almost stock have add roughly last month trade profit big league trump policy stock spark interest look company prime make substantial gain washington change course today zack reveal ticker benefit new trend streamline drug approval tariff lower taxe higher interest rate spending surge defense infrastructure see buy recommendation now
939,ALGN,staar surgical company staa free report be big mover last session share rise day move come solid volume too far more share change hand normal session continue recent uptrend company stock be now roughly past month time frame none estimate stock be revise past day zack consensus estimate also remain unchanged same time frame friday price action be encourage so make sure keep close watch firm future staar surgical currently carry zack rank hold staar surgical company price staar surgical company price staar surgical company quotea better rank stock medical dental supply space be align technology inc algn free report sporting zack rank strong buy see complete list today zack rank stock here be staa go predict see other think trade profit big league trump policy stock spark interest look company prime make substantial gain washington change course today zack reveal ticker benefit new trend streamline drug approval tariff lower taxe higher interest rate spending surge defense infrastructure see buy recommendation now
940,ALGN,investor always seek winning strategy however find such strategy be easier say do market be shake widespread global growth concern be difficult even insightful investor come foolproof approach matter discipline systematic investor be equity market volatility always manage get better few lucky one rake moolah other fall victim ad strategy resort commonly used technique find beaten stock have potential recover faster other however even such investment choice bear risk disappointment particularly be stick value trap hide weakness select stock be not identify so wouldn be safer look stock be winner currently have potential gain further here execute primarily look stock have recently be witness price increase actually stock see price strength recently have high chance carry momentum forward stock be continuously move higher be good reason rise else probably have fall loser so look stock have already win game be capable beating benchmark have set be rational however recent price strength alone create magic so need set other relevant parameter create successful investment strategy here create screen shortlist current well potential winner screening parameter percentage change price week greater criterion show stock have moved higher last week percentage change price week greater indicate stock have see momentum last month lower risk choose stock have draw attention due overwhelming performance overall market very short period zack rank matter market condition be good bad stock zack rank strong buy have proven history outperformance see complete list today zack rank stock here average broker rating indicate broker be also highly hopeful stock future performance current price greater stock be trading minimum current price week high low range more criterion filter stock be trading respective week high indicate be strong enough term price here be stock make screen johnson outdoors inc jout free report be lead global outdoor recreation company turn idea adventure innovative top quality product last quarters stock surpass zack consensus estimate thrice miss same occasion align technology inc algn free report design manufacture market invisalign system proprietary method treat malocclusion company have surpass zack consensus estimate thrice trail quarters match same occasion deliver average positive surprise orthofix international ofix free report be lead provider high value minimally invasive medical device orthopedic trauma market stock have decent earning surprise history have beaten zack consensus estimate twice match same occasion trail quarters come average positive earning surprise columbus mckinnon corp cmco free report be broad line designer manufacturer supplier sophisticated material handle product integrate material handle solution be widely distribute industrial consumer market worldwide stock have mixed earning surprise history beat zack consensus estimate twice trail quarters miss same twice however still deliver positive earning surprise kadant inc kai free report be lead supplier range product system global papermake paper recycling industry include inking system stock preparation equipment water management system papermake accessory company have surpass zack consensus estimate trail quarters average positive earning surprise sun hydraulic corporation snhy free report be lead designer manufacturer high performance screw hydraulic cartridge valf manifold control force speed motion integral component fluid power system stock have mixed earning surprise history beat zack consensus estimate twice trail quarters miss other occasion however pull positive earning surprise triton international limit trtn free report offer acquisition lease re lease sale intermodal container last quarter company deliver positive earning surprise get rest stock list start putt other idea test be do research wizard stock pick backtesting software research wizard be great place begin easy use everything be plain language very intuitive start research wizard trial today next time read economic report open research wizard plug find see gem come click here sign free trial research wizard today disclosure officer director employee zack investment research own have sell short security hold long short position option be mentioned material affiliated investment advisory firm own have sell short security hold long short position option be mentioned material disclosure performance information zack portfolio strategy be available https www zack com performance zack restaurant recommendation addition dine special place feast stock share zack special report spotlight recent ipos watch stock offer immediate promise boom sector download free
941,ALGN,aug issue update research report elmsford ny base bioscrip inc bio free report company be lead infusion service provider strive deliver cost effective program patient stock currently have zack rank buy last month bioscrip have be trading broader industry stock have gain compare favorably decline broader industry bioscrip exit second quarter wider expect adjust net loss revenue miss management unimpressive guidance include negative impact cure act legislation add concern nonetheless market be upbeat bioscrip announcement continue offer certain core product line also stiff competition raise concern positive note be encourage company recent progress courtesy new multus faceted core plan be adopt improve financial position further company achieve annualize supply chain improvement roughly acquisition home solution bioscrip currently operate attractive market favorable industry dynamic positive fundamental particular market force develop patient management technology age population be drive growth opportunity home health service provider bioscrip healthcare landscape rapidly change company be focuse boost core infusion service platform clinically focuse customer orientated model other key picksother top rank medical stock be edward lifescience corp ew free report steris plc ste free report align technology inc algn free report edward lifescience align technology sport zack rank strong buy steris carry zack rank see complete list today zack rank stock here align technology have expect long term adjust earning growth almost stock have add roughly last month edward lifescience have long term expect earning growth rate stock have gain last month steris post stellar quarter average earning surprise stock have add roughly last month make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
942,ALGN,opko health inc opk free report report loss cent share second quarter earning cent year however report quarter loss be narrower zack consensus estimate loss cent revenuesin second quarter opko health report total revenue year year however revenue second quarter include payment tesaro associate commercial launch varuby europe comparison payment related rayaldee license fresenius same quarter report figure also miss zack consensus estimate gross profit second quarter be year year gross margin contract massive basis point bps research development expense totale selling general administrative expense amount year year consequently loss operation come highlight significant decline operate income prior year quarter decline be attribute rise operate expense owing company significant investment associate commercial launch rayaldee consistent investment pharmaceutical pipeline opko health inc price consensus ep surprise opko health inc price consensus ep surprise opko health inc health exit second quarter cash cash equivalent marketable security compare record end first quarter takeopko health exit second quarter mixed note narrower expect loss revenue miss nonetheless be encourage company progress business include diagnostic business bio reference laboratory pharmaceutical business andbiologic business be also upbeat company recent development genedx bio reference genetic testing unit context company expand association university california health system offer molecular genetic genomic testing service jun however rise operate expense continue mar company financial zack rank key picksopko health currently have zack rank hold few better rankedmedical stock be edward lifescience corp ew free report steris plc ste free report align technology inc algn free report edward lifescience align technology sport zack rank strong buy steris carry zack rank buy see complete list today zack rank stock here edward lifescience second quarter adjust earning improve stupendous year year primarily drive strong sale growth company transcatheter heart valf business stock have gain last month steris report first quarter fiscal adjust earning share cent year quarter also adjust gross margin improve basis point year year report quarter stock have gain last month align technology second quarter adjust ep cent be substantial year year revenue grow year year stock have rally roughly last month make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
943,ALGN,run portfolio zack call tazr trader stand technical analysis zack rank week screen stock get top grade zack rank earning momentum then analyze chart institutional sponsorship stock name pass test early year ve actually hold plan keep hold core position trading swing way bull market video attach article chart prime buy zone want be watch just want read first rationale unstoppable profit price trend here be stock make club align technology algn free report maker invisalign clear tooth straightener continue take world thousand smile time american dental professional love product more consumer become aware option align market share dominate international growth see year come just think market potential clear aligner china india alibaba baba free report amazon china just keep surprising wall street growth dozen business unit ecommerce cloud medium finance jack come june invite small business alibaba gateway selling product service largest middle class planet year dominate growth lie ahead justify valuation lam research lrcx free report premier arm dealer chip maker be big roll demand wafer fabrication equipment wfe be almost traditional cycle right now mean cloud mobile autonomous car machine learn automation be create secular wave demand run well speaking machine learn ai easily argue nvidia nvda free report be head sell too early justify entry here so say buy dip affordable lam instead chasing pricey nvidia facebook fb free report business model be so misunderstand average investor zuckerberg team copy be work google adword create whole new revolution small business advertising ability target re target very specific audience then have access analytic show boost maintain positive ad spend grow digital advertising juggernaut revenue year growth be not steal google simply expand pie revolutionary global reach ten thousand business solo entrepreneur medium size industrial fashion tech company growth be go get even harder understand time next year facebook unveil next software hardware innovation help consumer find more want advertiser used augment reality ar technology shop learn share play zuck didn buy oculus rift vr technology just entertain gamer didn hire former chief engineer darpa regina dugan create new space age toy monthly active user mau need feed advertising machine keep wall street happy know something big be come facebook mark word broader discussion topic apple be also stuff secret engineering lab check recent podcast apple ecosphere own augment realityto see chart club be sure watch video attach article be sure buy dip stock thank later maybe time next year disclosure own share algn baba lrcx fb zack tazr trader kevin cook be senior stock strategist zack investment research follow broadcom formerly simple trading ideasince zack system have more double average gain year compound rebalance exclusive fee turn thousand million dollar proven stock pick system be ground single big idea be fortune shape life change apply portfolio start today learn more
944,ALGN,genomic health inc ghdx free report report second quarter loss share cent reflect improvement year quarter loss cent quarter number be however wider zack consensus estimate loss cent net loss report quarter be compare net loss year quarter revenue detailtotal revenue quarter rise year year slightly zack consensus estimate growth international market drive top line geographically second quarter product revenue improve product revenue growth be fuel invasive breast cancer revenue growth well rise prostate test revenue international product revenue be report quarter cer basis quarter company deliver more oncotype dx test result year year genomic health inc price consensus ep surprise genomic health inc price consensus ep surprise genomic health inc quotemargin trendin quarter review genomic health gross margin expand basis point bps year year apart significant top line growth improvement gross margin be lead decline cost product revenue genomic health also witness rise operate expense owing increase selling marketing expense rise research development expense however general administrative expense decline report quarter genomic health report operate loss show year year improvement operate loss year financial updategenomic health exit second quarter cash cash equivalent short term marketable security include corporate equity investment reflect slight improvement record end first quarter takegenomic health exit second quarter disappointing note be concern company rise operate expense well nevertheless be encourage decline cost sale lead solid gross margin expansion management note strong demand genomic health oncotype test second quarter be partly account growth international prostate global invasive breast business specifically invasive breast cancer oncotype dx test prove be company only test predict major short long term outcome context jun company announce result study base oncotype dx test american society clinical oncology asco annual meeting chicago management result confirm efficiency oncotype dx test predict clinically meaningful endpoint outcome multiple cancer type be also look forward company newly initiate clinical utility program select center prepare commercial launch oncotype dx ar nucleus detect test collaboration epic science flip side management have not issue guidance be discourage moreover company sole reliance breast oncotype dx test be concern zack rank key picksgenomic health currently carry zack rank sell few better rank medical stock be edward lifescience corporation ew free report insys therapeutic inc insy free report align technology inc algn free report zack rank strong buy see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock have gain last month align technology have expect long term adjust earning growth almost stock have add roughly last month edward lifescience have long term expect earning growth rate stock have rally last month more stock news tech opportunity worth driverless car artificial intelligence ve see unsurpassed growth high tech product recent month yesterday science fiction be become today reality innovation be single component tech company survive demand critical device reach year alone likely grow even faster future zack have release brand new special report help take advantage exciting investment opportunity most importantly reveal stock massive profit potential see stock now
945,ALGN,illumina inc ilmn free report report adjust earning share ep cent second quarter beat zack consensus estimate report figure also surpass company guide range cent adjust earning however lag year number include time item company report ep cent compare cent year revenuesin report quarter illumina revenue grow year year exceed company expectation approximately moreover top line beat zack consensus estimate management top line growth second quarter be attribute strong uptake sequence consumable microarray moreover novaseq platform continue drive growth more order launch jan product revenue total revenue increase year year service other revenue be year year illumina inc price consensus ep surprise illumina inc price consensus ep surprise illumina inc updateillumina adjust gross margin come reflect contraction basis point bps year year owing novaseq introduction higher array service revenue product mix sequence consumable exclude amortization acquire intangible asset include stock base compensation expense adjust gross margin be highlight contraction bps prior year period research development expense be year year selling general administrative expense rise consequently adjust operate margin reflect decline bps year period primarily due increase investment grail helix financial updateillumina exit second quarter cash cash equivalent short term investment first quarter year date net cash provide operate activity be compare year period guidancebanking solid second quarter performance illumina have raise full year revenue growth expectation earlier provide range meanwhile zack consensus estimate full year revenue be peg company continue expect adjust ep band unchanged earlier guidance current zack consensus estimate illumina bottom line stand low end guide range takeillumina exit second quarter solid note earning revenue beating zack consensus estimate top line be strong several product launch include veriseq nipt solution europe strength novaseq bottom line be impact margin pressure be currently look forward performance extend ra panel be slate launch third quarter notably company announce receipt fda approval test next generation sequence kit jun also illumina recently develop venture cancer screening market grail have start deliver positive news flip side weak margin owing novaseq launch higher array service revenue product mix sequence consumable continue act deterrent also tough competitive landscape be concern be also apprehensive issue pertain nih funding zack rank other key picksillumina currently have zack rank buy other top rank medical stock be mesa laboratory inc mlab free report insys therapeutic inc insy free report align technology inc algn free report notably insys therapeutic align technology sport zack rank strong buy mesa laboratory carry zack rank see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock have gain last month align technology have expect long term adjust earning growth almost stock have add roughly last month edward lifescience have long term expect earning growth rate stock have gain last month more stock news tech opportunity worth driverless car artificial intelligence ve see unsurpassed growth high tech product recent month yesterday science fiction be become today reality innovation be single component tech company survive demand critical device reach year alone likely grow even faster future zack have release brand new special report help take advantage exciting investment opportunity most importantly reveal stock massive profit potential see stock now
946,ALGN,resm inc rmd free report announce fourth quarter fiscal adjust earning share ep cent prior year quarter level earning also beat zack consensus estimate cent include time item resm report ep cent quarter year year full year adjust ep come increase fiscal figure revenue detailrevenue report quarter increase constant exchange rate cer year year figure also exceed zack consensus estimate exclude contribution business revenue increase year year full year revenue come rally year period resm inc price consensus ep surprise resm inc price consensus ep surprise resm inc revenue americas rise year year include revenue exclude revenue americas totale reflect increase prior year quarter solid result be fuel growth device well low double digit rise software sale combine revenue emea apac region be highlight rise cer compare same period last year growth be particularly strong uk france japan australia new adjust gross margin expand basis point bps year year report quarter selling general administrative expense be year year be increase research development expense have further lead rise adjust operate expense amount accordingly adjust operate margin quarter contract bps financial updateresmed exit year cash cash equivalent compare end entire year company generate cash flow operation year figure display weak underlie earning decline net work capital balance fiscal resm paid dividend also fiscal fourth quarter earning release resm announce increase quarterly dividend cent share dividend be paid sep shareholder record aug previously declare resm temporarily suspend share repurchase program due recent acquisition however company still expect recommence buy back program second quarter fiscal guidancewhile resm have not provide definite guidance fiscal company state be well position achieve financial strategic goal company be successfully work pipeline new product connect care solution sleep apnea copd neuromuscular disease other clinical adjacency takeresm exit fourth quarter fiscal promising note earning revenue beating zack consensus estimate bright side company achieve solid high single digit global revenue growth quarter lead sale sleep device respiratory care device mask system software solution have act significant contributor company operate result yet challenge competitive bidding reimbursement issue continue plague stock foreign exchange movement dent third quarter earning cent thank weaker euro stronger australian dollar relative dollar zack rank key picksresm currently have zack rank buy other top rank stock broader medical space be edward lifescience corporation ew free report insys therapeutic inc insy free report align technology inc algn free report stock sport zack rank strong buy see complete list today zack rank stock here insys therapeutic have expect long term earning growth rate stock have gain last month align technology have expect long term adjust earning growth almost stock have surge roughly last month edward lifescience have long term expect earning growth rate stock have gain last month more stock news tech opportunity worth driverless car artificial intelligence ve see unsurpassed growth high tech product recent month yesterday science fiction be become today reality innovation be single component tech company survive demand critical device reach year alone likely grow even faster future zack have release brand new special report help take advantage exciting investment opportunity most importantly reveal stock massive profit potential see stock now
947,ALGN,davita inc dva free report report second quarter adjust operate earning cent share surpass zack consensus estimate cent however earning decline year quarter total revenue increase year year approximately beat zack consensus estimate segment updateu dialysis related lab servicestotal operate revenue second quarter be approximately year quarter however operate income be prior year quarter davita medical group dmg total operate revenue second quarter be year quarter also segment adjust operate loss come versus loss prior year quarter davita healthcare partner inc price consensus ep surprise davita healthcare partner inc price consensus ep surprise davita healthcare partner inc quotefinancial updatetotal cash cash equivalent davita decline jun dec cash generate operation first half be compare year period davita long term debt be year end report quarter company repurchase share common stock average price share company currently have approximately outstanding board authorize share repurchase authorization pending project davita consolidated operate income range company expect operate income kidney care operate income dmg be now anticipate range operate cash flow projection be expect zack rank stock considerdavita carry zack rank sell few better rank medical stock be mesa laboratory inc mlab free report insys therapeutic inc insy free report align technology inc algn free report insys therapeutic align technology sport zack rank strong buy mesa laboratory carry zack rank buy see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock have gain last month align technology have expect long term adjust earning growth almost stock have add roughly last month mesa laboratory have positive earning surprise last quarters stock have add roughly last month more stock news tech opportunity worth driverless car artificial intelligence ve see unsurpassed growth high tech product recent month yesterday science fiction be become today reality innovation be single component tech company survive demand critical device reach year alone likely grow even faster future zack have release brand new special report help take advantage exciting investment opportunity most importantly reveal stock massive profit potential see stock now
948,ALGN,vwr corporation report second quarter adjust earning share ep cent reflect rise year figure earning also surpass zack consensus estimate cent strong top line performance include time item company report second quarter net ep cent flat year year revenue report quarter be year year figure also surpass zack consensus estimate organic basis revenue increase revenue americas totale year year organically quarter review upside americas net sale be drive strong sale equipment instrumentation vwr corporation price consensus ep surprise vwr corporation price consensus ep surprise vwr corporation quoteemea apac revenue quarter gross year year organic basis foreign exchange impact sale acquisition less disposition dent revenue year year vwr report second quarter gross margin flat year quarter sale general administrative expense rise company post operate income report quarter reflect decline year quarter operate margin contract basis point second quarter vwr exit second quarter cash cash equivalent end first quarter jun year date operate cash flow be compare year period merger updatepost first quarter earning release vwr have inked definitive agreement avantor inc get acquire enterprise value view vwr longer plan provide update financial guidance acquisition be now expect close fourth quarter takevwr second quarter report be quite impressive top bottom line beating zack consensus estimate geographically company record growth americas report quarter however drop emea apac sale be disappointing moreover foreign currency be major dampener vwr poor margin scenario also raise concern brighter note management be look forward benefit propose merger avantor transaction avantor be process combine entity suite product service solution help company generate higher degree relevance biopharma industrial customer also acquisition be expect generate significant synergy next year moreover be expect create robust product service portfolio production scale biopharma furthermore deal help strengthen vwr business asia pacific region zack rank key picksvwr currently have zack rank hold few better rank medical stock be mesa laboratory inc mlab free report insys therapeutic inc insy free report align technology inc algn free report notably insys therapeutic align technology sport zack rank strong buy mesa laboratory carry zack rank buy see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock have gain last month align technology have expect long term adjust earning growth almost stock have add roughly last month mesa laboratory have positive earning surprise last quarters stock have add roughly last month make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
949,ALGN,idexx laboratory inc idxx free report record second quarter earning share ep cent constant exchange rate cer year year report basis further report figure surpass zack consensus estimate cent strong top line growth second quarter drive earning revenue detailidexx second quarter revenue rise year year organic basis beating zack consensus estimate year year increase be drive strong global gain companion animal group cag diagnostic recur revenue include double digit organic revenue gain consumable reference lab well strong acceptance rapid assay veterinary software service diagnostic imaging system idexx laboratory inc price consensus ep surprise idexx laboratory inc price consensus ep surprise idexx laboratory inc quotesegmental analysisidexx derive revenue operate segment cag water livestock poultry dairy lpd other second quarter cag revenue rise organically year year water segment revenue be prior year quarter organically lpd revenue meanwhile increase organically revenue other segment rise organically marginsgross profit increase report quarter gross margin expand basis point bps rise cost revenue sale marketing expense rise general administrative expense rise research development expense increase overall operate margin quarter improve bps financial positionidexx exit second quarter cash cash equivalent end first quarter year date net cash provide operate activity be compare year period guidanceidexx raise revenue outlook midpoint range earlier range reflect organic revenue growth expectation zack consensus estimate revenue be peg low end guide range management also raise ep guidance share earlier range support continue operate margin expansion align long term goal update outlook represent ep growth report basis zack consensus estimate ep be peg guide range takeidexx exit second quarter solid note earning revenue beating zack consensus estimate solid organic revenue growth buoy optimism company raise ep guidance be also encourage stellar quarterly performance be drive company companion animal business companion animal market fundamental remain solid tremendous global runway growth management unique innovation base multus modality global strategy enabled enhance commercial capability accelerate recur cag diagnostic revenue growth moreover strong top line growth quarter be drive considerable contribution rest business segment however foreign currency fluctuation be expect continue hurt company operate result lower extent expect earlier zack rank other key picksidexx currently have zack rank buy other top rank medical stock be mesa laboratory inc mlab free report insys therapeutic inc insy free report align technology inc algn free report notably insys therapeutic align technology sport zack rank strong buy mesa laboratory carry zack rank see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock have gain last month align technology have expect long term adjust earning growth almost stock have add roughly last month mesa laboratory have positive earning surprise last quarters stock have add roughly last month make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
950,ALGN,hill holding inc hrc free report report third quarter fiscal adjust earning share ep cent year quarter adjust earning surpass zack consensus estimate penny be high end company project range cent include time adjustment hill net income fiscal third quarter be cent share compare cent respectively revenue detailsrevenue third quarter fiscal increase year year cer however miss zack consensus estimate revenue growth be drive momentum core business acquisition mortara value newly introduce product line company unveil hill envella air fluidized therapy bed hill accella bed system also company have enter digital health space introduction monarch airway clearance system geographically revenue grow revenue outside increase cer core revenue growth be cer line company guide range hill holding inc price consensus ep surprise hill holding inc price consensus ep surprise hill holding inc quotereportable segmentsin fiscal third quarter patient support system revenue decrease year year cer segment domestic revenue decline due impact watchchild architectural product divestiture lower rental revenue core revenue increase exclude divestiture product revenue increase be partially offset decline rental revenue product revenue include bed patient handle system clinical solution business international revenue increase core basis drive improve trend middle east latin america canada revenue front line care segment include welch allyn respiratory care mortara increase increase cer performance be drive gain new product double digit growth vital sign monitoring benefit leverage hill commercial infrastructure international marketsthe surgical solution segment revenue increase cer upside be backed international growth gain product integrate table motion system iled new ts mobile operate table well growth surgical position equipment aspen medical marginsreport gross margin fiscal third quarter be basis point bps year year account increase total cost revenue adjust gross margin grow bps back company consistent initiative portfolio diversification benefit cost sourcing efficiency new product launch accretive gain mortara adjust operate margin improve bps owing sg leverage provide fourth quarter financial outlook update fiscal adjust earning diluted share cash flow guidance consider mortara revenue approximately hill expect revenue growth report basis cer fiscal fourth quarter exclude mortara impact complete potential divestiture period hill core revenue be expect rise cer hill also expect adjust ep share range zack consensus estimate fiscal fourth quarter earning share be peg full year hill expect revenue growth earlier be report basis approximately cer exclude mortara impact complete potential divestiture annual revenue approximately period hill core revenue be expect increase earlier be cer addition company expect adjust earning share earlier maintain operate cash flow guidance range zack consensus estimate full year earning share be peg zack consensus estimate full year revenue stand takehill exit third quarter fiscal mixed note earning exceed zack consensus estimate revenue miss same company see solid year year increase revenue strong international growth hill be currently aim gain traction untapped international market successful execution courtesy efficient international team organizational realignment company be putt effort product innovation research development also launch slate fourth quarter be encourage regard commercial launch centrella med surg platform be worth mention however decline revenue patient support system segment be quite disappointing also foreign exchange remain headwind zack rank key pickshill currently have zack rank hold few better rank medical stock be mesa laboratory inc mlab free report insys therapeutic inc insy free report align technology inc algn free report notably insys therapeutic align technology sport zack rank strong buy mesa laboratory carry zack rank buy see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock have gain last month align technology have expect long term adjust earning growth almost stock have add roughly last month mesa laboratory have positive earning surprise last quarters stock have add roughly last month make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
951,ALGN,share expedia inc expe free report rise report second quarter adjust earning cent share surpass zack consensus estimate cent share merck co inc mrk free report rise post second quarter earning share beat zack consensus estimate share align technology inc algn free report surge revenue grow year year quarter surpass zack consensus estimate mattel inc mat free report post loss share second quarter be wider zack consensus estimate loss
952,ALGN,nuvasive inc nuva free report report second quarter adjust earning share ep cent reflect rise year quarter figure also surpass zack consensus estimate cent solid revenue growth primarily lead year year improvement earning include time item company report second quarter net income share cent cent year quarter revenue report quarter increase year year constant exchange rate cer figure however miss zack consensus estimate upside revenue be drive robust performance international market market growth geography procedural volume be par company expectation nuvasive inc price consensus ep surprise nuvasive inc price consensus ep surprise nuvasive inc quotein report quarter company spinal hardware business register growth backed continue strong adoption reline posterior fixation system company iga platform company also witness steady uptake recently launch expandable interbody cage base ti interfixated alif procedure surgical support business grow second quarter primarily drive enhance service offering owing biotronic acquisition jul moreover international business record growth cer report basis market contribution geography report quarter be increase cost good sell gross profit rise yet company report basis point bps year year contraction gross margin second quarter include bps year year impact low margin biotronic business sale marketing administrative expense go research development expense increase nuvasive post adjust operate income report quarter reflect rise year number adjust operate margin expand bps quarter review company exit second quarter cash cash equivalent short term investment end previously report quarter outlooknuvasive reiterate full year guidance take integration effect nso biotronic consideration company continue expect revenue growth range cer approximately line current zack consensus estimate nuvasive also maintain guidance full year adjust earning share current zack consensus estimate be line company guidance additionally adjust operate margin year be still expect bps year year basis change upper earning announcement company also inform number change upper management company jason hannon president chief operate officer have step position remain advisory capacity full year company also announce resignation chief financial officer quentin blackfordalso matt link president commercial have be promote influential position executive vice president strategy technology corporate development division have be newly create company accelerate successful implementation company innovation agenda moreover skip kiilwill take position executive vice president global commercial also steve rozow assume role executive vice president global process transformation include ra qa addition current global operation responsibility exit second quarter earning beat revenue miss however year year improvement top line front be account strong growth international business moreover quarter marked third consecutive quarter more growth international business moreover progress business seem be encourage continually grow uptake iga platform also company be set step deformity market reline magec company expectation deliver higher adjust operate profit margin least bps indicate focus operational efficiency house manufacturing facility moreover management believe factor challenge gross margin precede quarters slowly turn tailwind couple several product launch plan company project strong revenue acceleration rest year zack rank key picksnuvasive currently have zack rank hold few better rank medical stock be mesa laboratory inc mlab free report insys therapeutic inc insy free report align technology inc algn free report notably insys therapeutic align technology sport zack rank strong buy mesa laboratory carry zack rank buy see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock have gain last month align technology have expect long term adjust earning growth almost stock have add roughly last month mesa laboratory have positive earning surprise last quarters stock have add roughly last month more stock news company verge apple rundid miss apple stock explosion launch iphone now look be pivotal year get emerge technology expect rock market demand soar almost nothing report suggest save life decade turn save healthcare cost bonus zack special report name breakthrough best stock exploit apple company be already strong coil potential mega gain click see right now
953,ALGN,omnicell inc omcl free report report earning share cent second quarter line zack consensus estimate earning improve year loss cent consider stock base compensation expense regular adjust earning share come cent compare earning cent year quarter revenue detailrevenue second quarter increase year year surpass zack consensus estimate revenue also exceed company guide range accord management company witness strong customer acceptance popularity new xt series product revenue performance be also drive related ramp xt series launch be precise second quarter revenue strength be drive xt revenue iv solution omnicell inc price consensus ep surprise omnicell inc price consensus ep surprise omnicell inc quoteon segmental basis omnicell automation analytic revenue fall year year second quarter however revenue medication adherence segment rise year year operational updateomnicell gross profit report quarter be gross margin contract basis point bps accord company adjust gross margin second quarter be reflect contraction bps year year sg expense second quarter decline year year research development expense increase year year operate expense be second quarter year year accord company adjust operate expense quarter totale year quarter financial updateomnicell exit second quarter cash cash equivalent compare end first quarter full year omnicell expect product booking range unchanged earlier forecast company also reaffirm adjust revenue estimate band adjust earning guidance share zack consensus estimate full year earning share be peg cent zack consensus estimate full year revenue stand company also issue third quarter guidance management expect adjust revenue band omnicell project third quarter adjust earning cent cent zack consensus estimate third quarter revenue be peg third quarter earning share cent takeomnicell second quarter performance be impressive year year increase earning revenue also company be expect gain term revenue profit recent launch strategic partnership company recently launch software xt hardware allow aesynt customer take full advantage xt company also launch xt series automate supply dispense system late jul second quarter company also launch controlled substance dispenser module provide secure dispense administration controlled substance however weak margin be matter concern zack rank key picksomnicell currently have zack rank hold few better rank medical stock be mesa laboratory inc mlab free report insys therapeutic inc insy free report align technology inc algn free report notably insys therapeutic align technology sport zack rank strong buy mesa laboratory carry zack rank buy see complete list today zack rank stock here insys therapeutic have long term expect earning growth rate stock have gain last month align technology have expect long term adjust earning growth almost stock have add roughly last month mesa laboratory have positive earning surprise last quarters stock have add roughly last month more stock news company verge apple rundid miss apple stock explosion launch iphone now look be pivotal year get emerge technology expect rock market demand soar almost nothing report suggest save life decade turn save healthcare cost bonus zack special report name breakthrough best stock exploit apple company be already strong coil potential mega gain click see right now
954,ALGN,walgreen boot alliance inc wba free report have set major milestone expand global footprint decision acquire stake sinopharm hold guoda drugstore co ltd guoda subsidiary china national accord medicine corporation ltd successful completion investment provide strong impetus walgreen worldwide retail pharmacy business follow news share walgreen rise reach dec notably shanghai base guoda be large national pharmacy chain china be retail pharmacy platform china national pharmaceutical group corporation cnpgc financial minority stake guoda be purchase walgreen capital increase worth subject certain regulatory review approval other customary close condition completion walgreen account stake equity method investment china retail market glanceper report ibisworld revenue pharmacy drugstore industry china have be grow annualize rate past year now report substantial growth demand drug domestic retail purchase relatively expensive drug price hospital increase self medication rate be major factor spur stupendous growth prospect guodaper walgreen guoda china lead pharmacy chain be go contribute global pharmacy expertise incidentally walgreen already have strong base china courtesy merger alliance boot latest development guoda further strengthen business densely populate region company be particularly excited opportunity invest country fast grow retail pharmacy sector share price past month walgreen have be trading broader industry stock have lose narrower industry decline period decline sale retail pharmacy international be disappointment lead drop share price company recent past expect improve little latest strategic decision walgreen zack rank key pickswalgreen carry zack rank hold few better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report sporting zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year myriad genetic have long term expect earning growth rate stock have soar year zack hide tradeswhile share many recommendation idea public certain move be hide everyone select member portfolio service peek curtain today view start now next month invite follow zack private buy sell real time value momentum stock etf option mover insider trade company be report positive earning surprise ve call accuracy even look portfolio so exclusive be normally close new investor click here zack secret trade
955,ALGN,edward lifescience corporation ew free report recently acquire harpoon medical inc privately hold medical technology company focuse beating heart repair degenerative mitral regurgitation dmr agreement harpoon medical flagship beating heart repair procedure mitral valve patient harpoon system be add edward lifescience surgical heart valve therapy portfolio treat structural heart disease however harpoon system be yet receive ce mark approval financial detailsedward lifescience paid cash close deal dec moreover company be liable pay achievement certain pre decide milestone next year recent edward lifescience have be witness strength surgical heart valve therapy segment strong uptake edward intuity elite valve system progress space company receive fda approval inspiris resilium aortic valf july notably be first newly create group resilient heart valf incorporate advanced resilium tissue company plan commercially launch product unite state japan follow successful launch inspiris resilium europe earlier market potentialwe believe unhealthy lifestyle rise agee population continue result high incidence cardiovascular disease be further strengthen datum provide gbi research report global cardiovascular disease market see cagr space market be expect witness highest momentum cagr moreover report medgadget global heart valve repair replacement market be expect rise cagr thus view current market potential believe company effort help boost top line share price lifescience have be gain investor confidence consistently positive result last year company share price have outperformed broader industry stock have gain compare broader industry zack rank key picksedward lifescience carry zack rank hold few better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report notably petm align technology myriad genetic sport zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year myriad genetic have long term expect earning growth rate stock have gain year time zack hide tradeswhile share many recommendation idea public certain move be hide everyone select member portfolio service peek curtain today view start now next month invite follow zack private buy sell real time value momentum stock etf option mover insider trade company be report positive earning surprise ve call accuracy even look portfolio so exclusive be normally close new investor click here zack secret trade
956,ALGN,dec issue update research report hologic inc holx free report stock currently carry zack rank hold past month manufacturer mammography system breast examination osteoporosis assessment have be outperform industry term share price stock have gain contrast fall industry hologic deliver promising performance fourth quarter fiscal revenue earning beating zack consensus estimate be upbeat stellar performance company molecular diagnostic business unite state notably company have be gain increase market share utilization fully automate panther system have also be expand market conform testing guideline regard hologic recently announce receipt clearance fda panther fusion adv hmpv rv assay multiplexed assay run new panther fusion system be also upbeat hologic progress well internationally mainly back solid contribution molecular diagnostic business regard company have be reap benefit new leadership healthy panther placement multiple product introduction include viral load assay globally notably last report quarter marked sixth consecutive period double digit growth molecular diagnostic internationally also breast health business november company announce plan make mammography system available dutch breast cancer screening program collaboration tromp medical hologic distributor netherlands also strong cash position buoy optimism flip side hologic operate highly competitive industry mammography related product subsystem compete global level also blood screening divestiture be expect impede company growth momentum key picksa few better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report notably petm align technology myriad genetic sport zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year myriad genetic have long term expect earning growth rate stock have gain year time zack hide tradeswhile share many recommendation idea public certain move be hide everyone select member portfolio service peek curtain today view start now next month invite follow zack private buy sell real time value momentum stock etf option mover insider trade company be report positive earning surprise ve call accuracy even look portfolio so exclusive be normally close new investor click here zack secret trade
957,ALGN,petm express inc pet free report have be gain investor confidence consistently positive result past year company share price have outperformed broader industry stock have gain broader industry decline also company have outperformed gain company have market cap petm have deliver average earning beat trail quarters solid prospect zack rank strong buy stock be attractive pick investor moment company estimate revision trend current year have be positive past day analyst revise estimate upward movement opposite direction resultantly earning estimate rise zack style score system petm have growth score reflect company solid prospect research show stock growth style score combine zack rank buy offer best upside potential regard petm have favorable price earning growth peg ratio compare broader industry attractive annualize project earning growth rate petm score higher industry let find recent positive trend be sustainable petm have be successfully deliver solid quarterly result second quarter fiscal company top zack consensus estimate revenue earning be upbeat stellar increase reorder new order sale quarter encouragingly note company be strive implement several strategy revitalize top line include increase focus advertising efficiency boost new order sale shift sale higher margin item also expand product offering moreover company be work resolve issue limit consumer spending be also optimistic petm focus improve effectiveness campaign have be quite successful drive sale commerce petm boast comprehensive range product be market primarily well know brand medication such frontline advantix advantage heartgard sentinel interceptor other believe improve economic condition conjunction petm broad portfolio provide boost top line additionally company have strong cash balance allow carry share repurchase flip side escalate advertising expense quarter have be dent bottom line also competitive threat raise concern other key picksother top rank medical stock be align technology inc algn free report myriad genetic inc mygn free report idexx laboratory inc idxx free report notably align technology myriad genetic sport zack rank idexx laboratory carry zack rank see complete list today zack rank stock here align technology have long term expect earning growth rate stock have gain year myriad genetic have long term expect earning growth rate stock have gain year idexx laboratory have long term expect earning growth rate stock have rally year wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
958,ALGN,dec issue update research report idexx laboratory inc idxx free report stock currently have zack rank buy lead molecular diagnostic company have be trading broader industry stock have gain last year comparison broader industry idexx derive large share revenue companion animal group cag segment third quarter cag organic revenue rise high single digit cag diagnostic recur organic revenue growth vetlab consumable impressive organic revenue growth be upbeat company expand premium instrument base unite state international market include growth competitive instrument placement increase utilization continue customer retention moreover believe management innovation base global strategy be lead growth cag diagnostic notably idexx widen cloud technology portfolio addition rvetlink expect company demonstrate solid global growth day ahead international revenue second quarter grow high single digit drive rise recur organic revenue cag diagnostic gain water business additionally company have strong cash balance allow carry share repurchase flip side idexx high dependence third party distributor intense competition be major deterrent moreover cag business be likely suffer adverse currency fluctuation owing expand international operation company estimate revision trend current year have be positive last day analyst revise estimate upward movement opposite direction magnitude estimate revision earning increase share other key picksother top rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report notably petm align technology myriad genetic sport zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year myriad genetic have long term expect earning growth rate stock have gain year wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
959,ALGN,dec issue update research report align technology inc algn free report stock sport zack rank strong buy past month align technology have be trading broader industry stock have rally compare industry growth period post promising third quarter performance be encourage company solid invisalign prospect well growth north america internationally particularly asia pacific region report quarter marked milestone company china become second largest global market unite state top number be particularly impressed soar demand invisalign product market worldwide also be upbeat company have sign distribution agreement patterson dental pdco align technology itero element intraoral scanning system be available part patterson dental cad cam portfolio unite state canada additionally company receipt patent smarttrack invisalign aligner material buoy optimism align technology witness balanced rise sale channel recent past primarily drive high invisalign technology case volume solid performance summer drive invisalign growth global market encourage development company recently sign distribution agreement patterson dental exclusive agreement effective september align technology itero element intraoral scanning system be available part patterson dental cad cam portfolio unite state canada flip side adverse foreign exchange translation continue raise concern align technology international operation also escalate cost expense be weigh margin moreover tough competitive landscape other macroeconomic headwind threat key picksother top rank medical stock be petm express inc pet free report myriad genetic inc mygn free report cheme corporation che free report notably petm myriad genetic sport zack rank strong buy cheme carry zack rank buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year myriad genetic have long term expect earning growth rate stock have gain year cheme have long term expect earning growth rate stock have gain year wall street next amazonzack evp kevin matra believe familiar stock have only just begin climb become greatest investment time once generation opportunity invest pure genius click detail
960,ALGN,cvs health corporation cvs free report historic decision acquire health insurance giant aetna aet free report have create quite buzz entire healthcare space most economist consider come together stalwart consolidation cvs health pharmacy benefit management pbm business aetna large unshakable insurance base new dimension add healthcare landscape however critic be view gain combine entity be short live healthcare society large benefit vision favor dealperson support propose integration cvs health aetna opine merger have fair chance pass regulatory hurdle see consolidation vertical integration instead horizontal thus lead efficiency gain formidable cost cut strategy cvs health pbm platform notably horizontal integration dread chance form monopoly powerhouse market article dana blankenhorn publish investorplace state base deal insurer finally achieve vertical integration need control cost article humana hum free report acquisition deal propose aetna be earlier reject obama administration horizontal acquisition economist lap deal be look much forward development think vertical integration finally put brake america soar health care cost notably total medical cost have inflate range last year base increase bill doctor hospital medical device drug datum publish economist article blankenhorn article state counter problem cvc aetna deal enable insurer buy pharmacy fight high drug price formulary list medicine be prescribe various condition used generic formulary choose brand drug generic aren available be method keep drug price check oppose buyout comment company try strengthen footprint health care finally end pay severely merger akin supporter deal contrary view underscore cost control agenda highlight consolidation apparently push unite state third largest insurer aetna huge client base cvs drugstore get prescription filled cvs drug plan move turn eliminate middleman role other intermediary queue finally result reduction drug price overall healthcare cost however critic believe be short live scenario longer term patient end incur more medical expense recent vox report be merger gradually make more difficult new insurer enter market win be able negotiate lower drug price larger firm fact diminish competition sector lead inflate price know more detail please read cvs health aetna buyout change healthcare landscapeshare price comparisonshare cvs health have outperformed broader industry past month stock have drop compare favorably industry decline same time frame current value be however lower gain zack rank key pickcvs health carry zack rank hold better rank medical stock be align technology inc algn free report sporting zack rank strong buy see complete list today zack rank stock here align technologyha long term expect earning growth rate stock have gain year look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
961,ALGN,quest diagnostic dgx free report recently announce completion previously announce buyout cleveland heartlab be line company plan establish national center excellence diagnostic information service cleveland heartlab square foot specialize laboratory cleveland company national center excellence be focuse heart disease diagnostic moreover combine firm integrate quest diagnostic cardio iq lipid particle analysis genetic metabolic testing expertise cleveland heartlab strength personalize evaluation heart disease risk base inflammation other marker focuse heart disease diagnostic quest diagnostic announce first national diagnostic service provider enhance accuracy heart disease screening customize treatment lipid lower medication pcsk inhibitor statin utilize ldl cholesterol calculation believe unhealthy lifestyle rise agee population continue result high incidence cardiovascular disease be further strengthen datum provide gbi research report global cardiovascular disease market see cagr space market be expect witness highest momentum cagr thus view current market potential believe company effort help boost top line be also optimistic company focus point strategy accord quest diagnostic plan divestiture focus diagnostic product business be part strategy refocu diagnostic information service additionally several new collaboration hospital integrate delivery network have turn be major growth driver past regard be encourage company completion thebuyout outreach laboratory service operation hartford healthcare hospital william backus hospital hospital central connecticut company have also complete acquisition acquisition med fusion clear point texas form national precision oncology center expertise moreover company agreement purchase shiel medical laboratory plan acquire outreach laboratory service business cape cod healthcare buoy optimism be also upbeat quest diagnostic clinical genomic major player field colorectal cancer detection jointly announce fda clearance latter insure notably fda approval quest diagnostic make insure available broad base physician organized provider group accountable care organization aco unite state insure be expect be commercially available early development be line quest diagnostic consistent effort grow cancer diagnostic quest diagnostic relationship peacehealth be well track partnership entail acquisition outreach laboratory well professional laboratory service agreement manage laboratory peacehealth medical center washington state oregon alaska relationship be fully operational be contribute quest diagnostic top line company tuck acquisition fit well ambit guideline quest diagnostic takeover plan be consistent goal contribute revenue annually accretive acquisition thus believe latest buyout widen customer base lead diagnostic service information provider share price diagnostic have be gain investor confidence consistently positive result last year company share price have outperformed broader industry stock have gain contrast broader industry decline zack rank key picksquest diagnostic carry zack rank hold few better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report notably petm align technology myriad genetic sport zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year myriad genetic have long term expect earning growth rate stock have gain year look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
962,ALGN,patterson company pdco free report division patterson dental recently announce distribution agreement sprintray deal aim offer high resolution desktop printer resin accessory dental practitioner unite state canada patterson company have be work strategy emphasize digitization dentistry company leverage industry most experience advanced service support structure strengthen dental unit rollout enterprise resource plan erp system dental segment deserve mention regard get back deal sprintray be base los angele offer high resolution printer variety resin accessory company also provide top quality resin variety industry application include dentistry engineering prototyp art design agreement patterson dental distribute sprintray complete range solution include moonray desktop printer notably agreement take effect nov immediately benefitting patterson dental customer unite state canada direct technical support customer be provide sprintray patterson company have be expand business strategic acquisition dental product distributor region development dental patterson dental segment distribute consumable product basic advanced technology dental equipment practice management clinical software patient education system related stationery unite state canada company customer include dentist dental laboratory institution other healthcare professional last report second quarter dental sale total sale decline cc year year owing lower sale cerec digital technology product however company be consistently try make dental segment turn line company sign distribution agreement align technology august exclusive agreement align technology itero element intraoral scanning system be available part patterson dental cad cam portfolio unite state canada also patterson dental announce agreement developer manufacturer shape distribute company line award winning shape trio intraoral scanner well related software dental practice include shape orthodontic shape design studio shape implant studio august stock performance solidover last month patterson company have gain higher broader industry addition moreover current level be higher gain market prospectsaccord report statista global dental market be expect reach worth cagr period be project thus patterson company clearly have bountiful prospect market zack rank key pickspatterson company carry zack rank strong sell few better rank medical stock be petm express inc pet free report align technology inc algn free report myriad genetic inc mygn free report notably petm align technology myriad genetic sport zack rank strong buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year align technology have long term expect earning growth rate stock have gain year myriad genetic have long term expect earning growth rate stock have gain year look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
963,ALGN,profitability analysis be generally used determine ability company generate ample revenue meet business related expense still manage offer satisfactory return investor analysis help determine profitable company loss make best accounting tool understand company profitability position be ratio analysis generally be key profitability ratio gross income ratio operate income ratio pre tax profit margin net income ratio here have used most effective frequently used profitability ratio net income ratio net income rationet income ratio give exact profit level company reflect percentage net income total sale revenue used net income ratio determine company capability bear operate operate expense sale revenue higher net income ratio usually imply company ability generate ample sale revenue successfully manage business function screening parametersnet income ratio be not only indicator future winner so have add few more criterium arrive winning strategy zack rank equal only zack rank strong buy stock be allow zack rank prove be best rating system be great way start thing see complete list today zack rank stock here month trail sale net income growth higher industry stock possess higher sale net income growth last month showcase better financial performance month trail net income ratio higher industry high net income ratio indicate company solid profitability rating strong buy greater indicate analyst cover stock be optimistic few parameter narrow universe stock only here be stock qualify screen align technology inc algn free report be designer computer aid design computer aid manufacturing digital service have average quarterpositive earning surprise sorl auto part inc sorl free report be developer manufacturer distributor automotive brake system have average quarterpositive earning surprise more nova measure instrument ltd nvmi free report be designer developer seller process control system have average quarterpositive earning surprise wagework inc wage free report be management service provider have average quarterpositive earning surprise tactile system technology inc tcmd free report be medical technology company have average quarterpositive earning surprise more get rest stock list signing now week free trial research wizard start used screen own trading further also create own strategy test first take investment plunge research wizard be great place begin easy use everything be plain language very intuitive start research wizard trial today next time read economic report open research wizard plug find see gem come click here sign free trial research wizard today disclosure officer director employee zack investment research own have sell short security hold long short position option be mentioned material affiliated investment advisory firm own have sell short security hold long short position option be mentioned material disclosure performance information zack portfolio strategy be available https www zack com performance zack restaurant recommendation addition dine special place feast stock share zack special report spotlight recent ipos watch stock offer immediate promise boom sector download free
964,ALGN,look stock be good position beat earning next report consider align technology inc algn free report firm medical dental supply industry be great candidate beat company have see nice streak beating earning estimate especially look previous report fact report algn have beaten estimate least case suggest have nice short term history crush expectation earning quarters algn be expect post cent share actually produce cent share beat meanwhile most recent quarter company look deliver cent share actually see share instead represent positive surprise align technology inc price ep surprise align technology inc price ep surprise align technology inc quotethank part history recent estimate have be move higher align technology fact earning esp algn be positive be great sign come beat zack earning esp compare most accurate estimate broad consensus look find stock have see big revision late suggest analyst have recently become more bullish company earning prospect be case algn firm currently have zack earning esp so beat be corner be particularly true consider algn have great zack rank strong buy be harbinger outperformance signal strong earning profile see complete list today zack rank stock here add solid zack rank positive earning esp positive earning surprise happen nearly time so seem pretty likely algn see beat next report especially recent trend be guide look stock skyrocket upside zack have just release special report boom investment opportunity legal marijuana ignited new referendum legislation industry be expect blast already robust early investor stand make kill have be ready act know just look see pot trade re target
965,ALGN,align technology inc algn free report recently achieve milestone patient undergo treatment flagship clear aligner system invisalign take consideration fast expand market clear aligner therapy align technology have undertake several strategy drive adoption core invisalign product line strategy include product technology development extend clinical effectiveness promote invisalign brand name boost international growth term product development company announce receipt patent align technology smarttrack aligner material be exclusively used invisalign aligner treatment moreover bid gain traction invisalign platform align technology collaborate digital design march post collaboration align technology invisalign clear aligner treatment be used dentist tooth alignment procedure design protocol meanwhile order expand invisalign brand offering align technology introduce patient friendly solution invisalign mandibular advancement teen certain market canada emea apac march second quarter company reach milestone patient have adopt treatment be indicative grow popularity align technology dental product international market long term expect similar innovation act major catalyst align technology new well exist market come geographic expansion company open first office canada major market term opportunity expansion growth meanwhile management launch invisalign technology lite north america post introduction europe middle east africa emea company witness strong adoption particularly gp dentist moreover align technology have be witness continue adoption invisalign technology core market emea asia pacific apac region interestingly recently report third quarter company achieve milestone term invisalign therapy adoption china become second largest market globally unite state top number align technology register almost threefold year year increase asset customer base major contribution china also bid expand region company open invisalign treatment plan facility china june be also upbeat company expand foothold internationally acquisition invisalign distributor lucrative emea region well brazil february report technavio global invisible orthodontic market be expect witness cagr approximately give market potential align technology consistent effort believe company be well position cash bountiful opportunity market share price performanceover past month align technology have be trading broader industry latest share price movement company have gain compare gain broader industry zack rank other key picksalign technology currently carry zack rank strong buy other top rank stock broader medical sector be petm express inc pet free report myriad genetic inc mygn free report luminex corporation lmnx free report petm myriad sport zack rank strong buy luminex carry zack rank buy see complete list today zack rank stock here petm have long term expect earning growth rate stock have rally roughly year myriad genetic have long term expect earning growth rate stock have gain last month luminex have long term expect earning growth rate stock have rally last month today stock zack hottest strategiesit hard believe even zack market gain top stock pick screen have return respectively outperformance have not just be recent phenomenon year have be remarkably consistent composite yearly average gain strategy have beaten market more maybe even more remarkable be fact re willing share latest stock cost obligation see free
966,ALGN,latest tax reform plan have be landmark achievement president trump usual initial stage nation give mixed reaction controversial bill few american slam new plan job killer other find be excellent opportunity fix break tax code bill claim primarily focus ease tax wo middle class american massive cut corporate taxe tell different story altogether fact research report cnbc reveal frank clemente executive director american tax fairness slam new tax code big giveaway millionaire corporation neglect one be real need now be be see bill be fated meet overall failure get fulfill promise inclusive economic growth medtech be cut taxe wealthy take health care away million senate democratic minority leader chuck schumer customer base reduction corporate taxe encourage development expensive cut edge medtech product question profitability loom large be higher number uninsured lesser deduction healthcare cost industry be likely witness shrink customer base indicate decline demand expensive medical procedure device tax decision medtech device medtech community have be hopeful trump propose policy entail abolition infamous medical device sale tax such high taxe force company lay employee limit research development activity reduce capital investment furthermore advame lead american medical device trade association have refer medical device tax significant drag medical innovation notably small device company suffer most such worry repeal tax paradigm be expect resume aggressive pace hire investment america base medical device manufacturer instilling investor confidence stock datum provide medical device trade group ken blackwell article publish daily caller partial year repeal medtech tax have result roughly rise research development investment medtech player comeback tax lead rise taxe largely discourage activity undoubtedly future medtech industry depend republican decision medical device tax key picksper trump democrat have establish lousy healthcare model however complete medical device tax renovation be be widely believe new set streamline rule benefit medical device space meanwhile stock strong fundamental give assured return tax conundrum have zero stock sport zack rank strong buy buy boast strong fundamental notably stock promise long term expect earning growth rate more idexx laboratory inc idxx free report headquarter delaware nj idexx be developer manufacturer distributer product service primarily companion animal veterinary livestock poultry water testing dairy market company also sell series portable electrolyte blood gas analyzer human point care medical diagnostic market company continue demonstrate solid growth globally strong international expansion management innovation base global strategy be lead cag diagnostic growth notably idexx expand cloud technology portfolio addition rvetlink solid organic revenue growth raise guidance buoy optimism stock have long term expect earning growth rate idexx have zack rank last year idexx have add higher broader industry gain luminex corporation lmnx free report luminex develop manufacture market proprietary biological testing technology application life science diagnostic industry company open architecture multiplexing xmap multus analyte profile technology be sell worldwide be used lead research laboratory well major pharmaceutical diagnostic biotechnology company conduct biological test luminex assay business be likely be key growth driver long term company also witness favorable tiding regulatory front third quarter regard recent ce ivd mark ary norovirus assay fda approval ary assay reimbursement approval verigene assay japan be noteworthy luminex be verge complete clinical study group strep be close submit same fda review stock have long term expect earning growth rate luminex have zack rank last month luminex have return much higher broader industry see complete list today zack rank stock here masimo corporation masi free report irvine base masimo develop manufacture market family invasive monitoring system company flagship product signal extraction set pulse oximetry be used monitor blood oxygen saturation level protect hypoxemia hyperoxemia believe company expand product portfolio be key catalyst wider adoption invasive patient monitoring technology help company gain traction masimo set pulse oximetry business represent considerable growth opportunity international market moreover fda approval radius wearable regional oximetry device be significant positive masimo have zack rank promise long term expect earning growth rate last month masimo have return higher broader industry align technology inc algn free report base california align manufacture market system clear aligner therapy intra oral scanner cad cam computer aid design computer aid manufacturing digital service used dentistry orthodontic dental record storage be encourage company solid invisalign technology prospect growth north america internationally particularly asia pacific region strong summer season performance drive invisalign growth global market be also upbeat company signing distribution agreement patterson dental company receipt patent smarttrack invisalign aligner material buoy optimism well align have zack rank promise long term expect earning growth last month stock have return way higher broader industry cooper company inc coo free report cooper base pleasanton be specialty medical device company operate global basis company be poise gain expand product portfolio increase penetration international market accretive acquisition be also key catalyst long term company have be see strong growth coopervision business segment late notably segment bank myday clariti biofinity silicone hydrogel lense platform coopersurgical segment also deliver strong sale quarter strong guidance fiscal instill confidence stock cooper recently complete acquisition procornea add lead ortho technology cooper lens portfolio marked foray emerge myopia controlled market stock have zack rank expect earning growth rate last year stock have add much higher broader industry make fortune shift electric car here stock idea consider much petroleum year lithium power soon shake world create millionaire reshape geo politic soon electric vehicle evs be cheaper gas guzzler be already reach mile single charge battery price plummet charge station set multiply company stand stock buy accord zack research not think see ticker free
967,ALGN,similar wise buy decision exit certain underperformer right time help maximize portfolio return selling loser be difficult share price estimate be fall be time get rid security more loss hit portfolio such stock want consider drop be patterson company inc pdco free report have witness significant price decline past week have see negative earning estimate revision current quarter current year zack rank strong sell further confirm weakness pdco key reason move have be negative trend earning estimate revision full year have see estimate move past day compare just upward revision trend have cause consensus estimate trend lower go share month current level also current quarter patterson companiesha see downward estimate revision versus revision opposite direction drag consensus estimate cent share cent past day stock also have see pretty dismal trading lately share price have drop past month patterson company inc price consensus patterson company inc price consensus patterson company inc quoteso not be good decision keep stock portfolio anymore least don have long time horizon be still interested medical dental supply industry instead consider better rank stock align technology inc algn free report stock currently hold zack rank strong buy be better selection time see complete list today zack rank stock here more stock news be bigger iphone become mother technological revolution apple sell mere iphone year new breakthrough be expect generate more device just year create market zack have just release special report spotlight fast emerge phenomenon ticker take advantage don buy now kick click here trade
